Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.9051728841420756,2.006579602216801,0.0,0.20294560059155115,0.12,2/26,0.67%,CPA1;CELA2A
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.9042031948516969,1.8195398364553106,0.0,1.0,0.89,1/7,3.40%,DICER1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.9585237619586465,-1.791031046988097,0.0,0.11530235440982621,0.1,1/14,0.02%,CD44
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,-0.7132263576158978,-1.775078605468129,0.0,0.1104980896427501,0.19,53/120,14.64%,NPY;TCEAL6;STMN2;PDE10A;LRRTM1;PAK5;SHISA6;CCK;HTR5A;RIT2;GAP43;ASTN1;CLVS2;SYT4;TCEAL5;GABRA1;GABRG2;ATP2B3;KCNIP1;VSTM2A;BRINP2;SYNPR;SNAP25;PRSS12;TMEM179;HPCA;CADM3;CXCL14;SCN2A;CDH22;GRM5;NRGN;SULT4A1;CELF4;SNCB;RAB3C;LRRTM3;ARHGDIG;KCNC2;ELAVL4;SH3GL2;ACTL6B;MRTFB;RGS7BP;TAGLN3;ASIC2;ST8SIA3;AQP4;OPCML;OLFM3;BRINP1;GAD2;LRRC3B
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.7558904574418704,1.7510709171079142,0.025,1.0,0.99,5/39,5.18%,CPA1;DPEP1;MGLL;ABCC1;PTGIS
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.895727391273584,1.7426650582033607,0.0,1.0,0.99,1/8,0.15%,BACE2
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.9240587767480345,1.7407999973057755,0.0,1.0,0.99,1/8,0.20%,NGF
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.8654324041718068,1.7336217345283673,0.024390243902439025,1.0,0.99,1/15,0.27%,AMPD1
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),0.7866264846882031,1.7226446317479287,0.0,1.0,1.0,6/28,5.75%,CYP1A2;DAO;CYB5A;GLYAT;PTGIS;ST3GAL1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.6970279443448475,-1.7163197252215663,0.0,0.2786473564904133,0.49,43/118,16.95%,BTBD17;PPP1R17;RND2;IGFBP3;ISG15;PROM1;ZCCHC12;HOPX;STMN2;PAK5;NKAIN1;RHBDL3;RIMS4;NYAP1;GAP43;PLPPR5;ASTN1;CLVS2;CNTFR;IFI44;KCNIP1;SOX9;TMEM200C;DCLK1;PCDH8;DCX;SULT4A1;KLHDC8A;CDK5R2;SOX21;ACTL6B;PLEKHH2;TAGLN3;MAP2;OPCML;INA;PTPRZ1;IFIT1;RBM3;MAPK4;LY6H;ADCYAP1R1;CSPG5
prerank,PanglaoDB_Augmented_2021__Plasma Cells,0.7406782619192258,1.7122117521945026,0.0,1.0,1.0,7/41,2.71%,CXCR4;AMPD1;CD38;EAF2;ITGAL;ZNF165;REN
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.9184484532071799,-1.7083787718724293,0.0,0.27624522410687524,0.58,1/15,0.02%,CD44
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,-0.6964338408992308,-1.7022800017170812,0.0,0.23829153244697412,0.61,52/111,17.59%,TCEAL6;STMN2;PAK5;HTR5A;GAP43;ASTN1;CLVS2;CHST1;TCEAL5;GABRG2;ATP2B3;KCNIP1;VSTM2A;BRINP2;SYNPR;SNAP25;TMEM179;HPCA;CADM3;UBE2QL1;CDH22;GRM5;SYN2;SULT4A1;SNCB;CDK5R2;LRRTM3;KCNC2;SH3GL2;ACTL6B;RGS7BP;LRFN5;ASIC2;ST8SIA3;MAP2;AQP4;GABBR2;OPCML;CBLN4;OLFM3;BRINP1;GAD2;LRRC3B;PHYHIP;PTPRT;TMEM196;MAPK4;LY6H;ADCYAP1R1;GADD45B;GAD1;SPHKAP
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.736752321029992,1.7012624016114715,0.0,1.0,1.0,9/60,9.74%,ADAT1;RPP40;TRMT10C;POP5;TRMT1;ANKRD16;NSUN2;CPSF4;CSTF2
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),0.8810636950947814,1.6946744929906408,0.0,1.0,1.0,2/13,2.10%,HDC;PYCR1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.7227679066512377,-1.6912797396081367,0.0,0.25782887583308356,0.64,25/87,15.63%,CD44;PARP14;ANGPT1;PTPRC;TNFRSF1A;PARP9;IL12A;IL6R;NOX4;HGF;EPHA4;CSF1R;GRM5;CTF1;EFNA1;GATA1;BMP6;CRLF1;IFNA2;LYN;DLG4;TNK2;FGF7;VEGFA;EFNA5
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),0.952640424926027,1.6819550803957917,0.02857142857142857,1.0,1.0,1/7,0.21%,CXCR4
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),0.952640424926027,1.6819550803957917,0.02857142857142857,1.0,1.0,1/7,0.21%,CXCR4
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.9081262413051352,1.6816667580428784,0.0,1.0,1.0,3/14,4.96%,PANK1;PPCDC;CROT
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.8062044976118555,1.6768373739551587,0.0,1.0,1.0,3/19,8.42%,AMPD1;HPRT1;AK3
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.6835459711061972,-1.6753368146430379,0.0,0.3376711807716338,0.78,55/119,18.91%,NPY;HOPX;PCSK2;STMN2;LRRTM1;PAK5;RIMS1;PCSK1;SHISA6;ASTN1;CLVS2;SYT4;TCEAL5;FGF12;KCNIP1;VSTM2A;ROBO2;SNAP25;TMEM179;CNTN1;UBE2QL1;CDH22;CHGA;SULT4A1;CACNA1B;CELF4;RAB3C;CHGB;PFKFB2;NPTX2;ELAVL4;SH3GL2;ACTL6B;SCG3;PAK3;WSCD2;ST8SIA3;GAD2;PAX6;NOL4;PTPRT;EFNA5;SLC2A2;TMEM196;KCNB2;CNTN4;MAPK4;LY6H;UNC5D;SYT13;GABRB3;NRXN1;RAPGEF4;JPH3;CAMK2B
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.9124458455344545,1.6741437508492512,0.02564102564102564,1.0,1.0,2/11,4.77%,PANK1;PPCDC
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.9124458455344545,1.6741437508492512,0.02564102564102564,1.0,1.0,2/11,4.77%,PANK1;PPCDC
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.9124458455344545,1.6741437508492512,0.02564102564102564,1.0,1.0,2/11,4.77%,PANK1;PPCDC
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,-0.7063706335971546,-1.6672024493185893,0.0,0.3435049308459405,0.85,50/114,18.43%,NPY;AKAP12;STMN2;LRRTM1;PCSK1;SHISA6;FAM171B;GAP43;ASTN1;CLVS2;SYT4;TCEAL5;KCNIP1;VSTM2A;RGS4;SYNPR;KALRN;SNAP25;TMEM179;CADM3;CNTN1;CDH22;DCLK1;CHGA;SULT4A1;SCG2;CACNA1B;RAB3C;CPE;CHGB;ELAVL4;SLC26A4;ACTL6B;RGS7BP;TAGLN3;ASIC2;ST8SIA3;MAP2;TMEM35A;OPCML;SLC18A2;BRINP1;PHYHIP;TMEM196;MAPK4;ADCYAP1R1;UNC5D;PCLO;NRXN1;RAPGEF4
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.8878062459143903,-1.6613181864764546,0.0,0.35231274958558,0.89,2/10,5.60%,MEF2C;PIM1
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.6512865443582216,-1.6505956819550676,0.0,0.4083625052014678,0.93,97/271,16.89%,PDE1A;NPY;SEMA3E;TCEAL6;NEFM;PCSK2;STMN2;LRRTM1;ZIC4;PAK5;SHISA6;CCK;HTR5A;SYT1;RIT2;GAP43;PLPPR5;CACNA1E;ASTN1;CLVS2;SYT4;CHST1;CACNG2;NOS1;TCEAL5;TRIM9;FGF12;PDE4A;MAGEE1;GABRG2;ATP2B3;VSTM2A;L1CAM;BRINP2;CALB2;SYNPR;GDAP1L1;SNAP25;TMEM179;HPCA;TCEAL3;PIANP;CXCL14;PCP4L1;CDH22;GRM5;PCDH8;NRGN;KCNQ5;NTNG1;SULT4A1;LMO3;CACNA1B;KCNMA1;CACNB1;CELF4;FCHSD2;SNCB;RAB3C;CDK5R2;GABRA4;ETV1;LRRTM3;KCNC2;ELAVL4;SH3GL2;ACTL6B;NAT14;NRSN2;ADGRL2;RGS7BP;TAGLN3;NRIP3;DLGAP1;ST8SIA3;MAP2;PLCB4;CHN1;AQP4;GRIN2D;GABBR2;OPCML;PACSIN1;OLFM3;BRINP1;GAD2;PAX6;ADCY8;NOL4;DHRS3;RAB15;TMEM196;MAPK4;POU2F2;LY6H;ADCYAP1R1;TACR1
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),-0.9683006672982266,-1.6494034764237497,0.0,0.38259417599624146,0.93,1/12,0.14%,NCEH1
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),0.7577672241263533,1.6461891159654927,0.02857142857142857,1.0,1.0,1/21,0.10%,CYP1A2
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.855521616201638,1.6460850640444427,0.03125,1.0,1.0,1/13,0.20%,NGF
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.7097186304657006,-1.6457473224537953,0.0,0.3803376273935239,0.95,26/76,10.90%,BTBD17;RND2;NEFM;ZCCHC12;STMN2;NKAIN1;RHBDL3;RIMS4;NYAP1;GAP43;PLPPR5;ASTN1;CLVS2;SYT4;CNTFR;GDAP1L1;OGDHL;TMEM179;PURG;PCDH8;SULT4A1;SCG2;CACNA1B;CDK5R2;MYT1;ACTL6B
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.8149184747003778,-1.6414330117029392,0.028985507246376812,0.3843411813660873,0.96,5/25,5.06%,DPP10;KCNIP4;PDZK1;FGF12;KCNIP1
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),0.7774228417975356,1.6406157556608254,0.029411764705882353,1.0,1.0,1/21,0.10%,CYP1A2
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.9205132970851746,1.6328985469897044,0.0,1.0,1.0,1/7,0.10%,MDGA2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.8794662985086384,-1.6313766945012658,0.017857142857142856,0.44336500564730785,0.97,3/13,5.60%,EDN1;MEF2C;PIM1
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),0.9052365749895426,1.6312546137971398,0.025,1.0,1.0,1/9,0.10%,CYP1A2
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.8344110424777523,1.6310756999982803,0.05,1.0,1.0,3/12,4.13%,RPP40;TSR1;RCL1
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.9363497122381144,1.627352099518292,0.0,1.0,1.0,1/6,0.15%,BACE2
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,-0.6628313100383739,-1.6217196377693732,0.0,0.4983623985046932,0.98,52/105,20.33%,TCEAL6;STMN2;PAK5;HTR5A;RIT2;GAP43;ASTN1;CLVS2;GABRA1;GABRG2;ATP2B3;VSTM2A;BRINP2;TMEM130;SYNPR;TRPM3;SNAP25;HPCA;SCN2A;CDH22;GRM5;SLC1A1;CACNA1B;CELF4;LRRTM3;KCNC2;ACTL6B;GABRA2;GRIN2B;ASIC2;ST8SIA3;CACNG3;OPCML;GRIA1;OLFM3;GAD2;NOL4;SRRM4;TMEM196;TMEM132B;CNTNAP5;ADCYAP1R1;SPHKAP;NRXN1;NTRK3;ATCAY;TNR;NEUROD6;SCN1A;PTPN5;SLC17A6;SLC1A6
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.7914134994833046,1.6194005235466369,0.05714285714285714,1.0,1.0,6/13,16.38%,TFB1M;SLC25A33;TFB2M;FASTKD1;PNPT1;EARS2
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,-0.6505576651659056,-1.6192654657869976,0.0,0.4876328738582233,0.98,48/155,15.01%,NEFL;DACT1;NEFM;ZCCHC12;STMN2;PAK5;FAM171B;RIMS4;SYT1;GAP43;PLPPR5;ASTN1;CLVS2;SYT4;CALB2;ATRNL1;GDAP1L1;SLITRK5;SNAP25;INSYN2A;TMEM179;TMEM200C;PURG;ST3GAL5;DCLK1;PCDH8;LZTFL1;SULT4A1;CACNA1B;PNMA2;ELAVL2;SNCB;KCNH7;SH3GL2;ACTL6B;FAT3;TAGLN3;DIPK1B;ST8SIA3;MAP2;CHN1;TMEM35A;OPCML;OLFM3;B3GALT1;BRINP1;NOL4;INA
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.8704090796908918,-1.615320197647112,0.0,0.48664376052382524,0.98,2/20,2.84%,CD44;CLU
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.9587304620782053,-1.6138153529013746,0.0,0.47028413997711516,0.98,2/10,1.11%,CD44;VIL1
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),0.8651542854579342,1.613690445051876,0.05555555555555555,1.0,1.0,2/15,2.74%,ADAT1;POP5
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.7850909201543872,1.606580340072233,0.02564102564102564,1.0,1.0,3/17,6.32%,ABCA13;ABCA8;YJEFN3
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),0.9310827607816674,1.6048340665602683,0.041666666666666664,1.0,1.0,1/5,0.44%,SPIRE2
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.8701180893861133,1.6044989522143103,0.0,1.0,1.0,1/11,0.15%,BACE2
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,-0.6566267382309321,-1.6036661755483241,0.0,0.5426290626392258,0.98,51/135,16.93%,CLGN;TCEAL6;NEFM;STMN2;LRRTM1;PAK5;SHISA6;GAP43;ASTN1;CLVS2;SYT4;TCEAL5;ATP2B3;VSTM2A;SYNPR;GDAP1L1;SNAP25;TMEM179;CADM3;VWA5A;SCN2A;DCLK1;GRM5;SCN9A;SULT4A1;CACNA1B;RAB3C;LRRTM3;PHF24;ELAVL4;ADD2;SH3GL2;ACTL6B;RGS7BP;TAGLN3;LRFN5;ASIC2;ST8SIA3;MAP2;TMEM35A;AQP4;OPCML;OLFM3;BRINP1;ADCY8;NEFH;TMEM196;MAPK4;LY6H;ADCYAP1R1;FKBP1B
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.8213600526845739,1.6000796052865245,0.02702702702702703,1.0,1.0,2/15,1.60%,CPA1;DPEP1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.9685396069347499,-1.5992140932305285,0.0,0.5225209870477043,0.98,1/10,0.02%,CD44
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.9685396069347499,-1.5992140932305285,0.0,0.5225209870477043,0.98,1/10,0.02%,CD44
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.651788770544422,-1.5984408988943601,0.0,0.5040110492005282,0.98,23/152,6.62%,CD44;FSTL1;FBLN1;PCOLCE;IGFBP3;MEST;SFRP4;CD59;TIMP1;BASP1;IGFBP4;ACTA2;FAP;LAMC1;VIM;MAGEE1;COL4A1;ID2;ECM2;RGS4;MFAP5;COL11A1;GPX7
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.8152665052971535,1.5958981522199234,0.021739130434782608,1.0,1.0,1/13,0.14%,ABCA13
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.8615498130035092,-1.5923122951153794,0.0,0.532646745914958,0.99,4/18,6.83%,CD44;CARMIL2;RHOC;CEACAM1
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.9214394833870775,-1.591559616263402,0.0,0.5184602394469615,1.0,1/11,0.02%,CD44
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.8160473509133462,1.5914869013002166,0.06666666666666667,1.0,1.0,1/7,3.61%,ANXA2
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.6603457896200847,-1.5901113355547758,0.0,0.5080990417659674,1.0,40/100,15.96%,KCNT2;LOXL4;DEPP1;PCSK2;STMN2;PCSK1;DNALI1;SSTR1;CNTN3;SYT4;FAP;KCNIP1;RGS4;SNAP25;TMEM179;DDAH1;SORBS2;CHGA;PCDHB4;SCG2;FNDC4;PTGER3;RAB3C;RUNX1T1;CPE;CHGB;SH3GL2;ACTL6B;TSPAN7;RGS7BP;GRIA3;ST8SIA3;FGF14;GPC6;PAX6;NOL4;PTPRT;TMEM196;KCNB2;CNTN4
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,-0.6600848980625723,-1.586281090943443,0.0,0.5225561831265841,1.0,57/146,15.19%,PDE1A;TCEAL6;STMN2;LRRTM1;PAK5;SHISA6;HTR5A;RIT2;GAP43;ASTN1;CLVS2;SYT4;CACNG2;TCEAL5;GABRA1;GABRG2;ATP2B3;VSTM2A;CALY;SYNPR;GDAP1L1;SNAP25;TMEM179;HPCA;ATP2B2;PCP4L1;CDH22;GRM5;PCDH8;SULT4A1;CACNA1B;KCNMA1;CELF4;SNCB;PDE5A;RAB3C;LRRTM3;ELAVL4;ACTL6B;PDE1B;ATP1B2;HCN1;NRIP3;GRIA3;DLGAP1;ASIC2;ST8SIA3;PRKG1;CLSTN3;OPCML;OLFM3;DLG4;BRINP1;GAD2;LRRC3B;ITPR3;SRRM4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.8208293889217763,-1.5859888826293562,0.0,0.5056933506677871,1.0,2/20,1.52%,CD44;NR4A3
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.8526711512704508,-1.5849667755711052,0.0,0.4951824327779143,1.0,3/16,7.92%,CD44;CEMIP;LYVE1
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.8399726190843089,-1.583962569997194,0.0,0.4857277343816241,1.0,2/24,2.84%,CD44;CLU
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.9288828209373962,-1.582342628998769,0.0,0.47914533943638893,1.0,2/8,4.02%,TLR2;EDN1
prerank,PanglaoDB_Augmented_2021__Neurons,-0.6219967815276762,-1.5823145153396847,0.0,0.46368903816424734,1.0,77/264,15.19%,PDE1A;NPY;TCEAL6;NEFM;ZCCHC12;PNMA8A;PCSK2;STMN2;LRRTM1;PAK5;VSNL1;CCK;HTR5A;RIT2;GAP43;ASTN1;CLVS2;SYT4;CACNG2;TCEAL5;GABRA1;AQP1;MAGEE1;GABRG2;ATP2B3;VSTM2A;CALY;NMT1;TMEM130;CALB2;SYNPR;GDAP1L1;SNAP25;TMEM179;HPCA;TCEAL3;SCN2A;CDH22;GRM5;NRGN;SULT4A1;SLC1A1;CACNA1B;KCNMA1;CELF4;SNCB;RAB3C;DGKB;CDK5R2;OGFOD1;LRRTM3;ARHGDIG;ELAVL4;SH3GL2;ACTL6B;NRSN2;ATP1B2;RGS7BP;TAGLN3;DIPK1B;GRIA3;DLGAP1;ST8SIA3;CHN1;CLSTN3;GABBR2;OPCML;MATN2;PACSIN1;OLFM3;DLG4;BRINP1;GAD2;GNG2;NOL4;NEFH;SRRM4
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.805373884341713,1.579834836380504,0.05405405405405406,1.0,1.0,4/13,10.61%,PTH;PHKG2;EPM2AIP1;AKT2
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.8127927578467388,1.5792681858200863,0.030303030303030304,1.0,1.0,3/10,12.01%,TFB1M;SLC25A33;TFB2M
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.8506858639465594,1.5787056964088304,0.024390243902439025,1.0,1.0,5/22,4.33%,CRTAM;AGER;CD274;HMGB1;SCRIB
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,-0.6781156848584434,-1.5778572696510678,0.014492753623188406,0.48402967528291624,1.0,48/111,17.29%,ANGPT1;KCNT2;NEFM;MEST;ASB4;PCSK2;STMN2;PCSK1;GAP43;ASTN1;CLVS2;SYT4;TCEAL5;GNRHR;TMEM130;TRPM3;ROBO2;COL11A1;IGSF1;CHGA;RNF150;SCG2;CELF4;RAB3C;RUNX1T1;AMPH;CHGB;SULF1;THY1;PAK3;NREP;PDZRN4;ZNF385D;GRIA3;ST8SIA3;PRKG1;TMEM35A;FGF14;OPCML;GRIA1;OLFM3;GAD2;FGF7;TMEM196;CNTN4;GNB3;UNC5D;NKTR
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.8905740861249793,-1.5777493348117941,0.0,0.47052677961181594,1.0,5/19,2.85%,PARP14;IRGM;PPARG;PARP9;IFNGR2
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.895898701119972,-1.5767879583353068,0.014492753623188406,0.46262243668844477,1.0,3/12,2.34%,HEY1;OLFM1;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.9354940654842231,1.5763203400541668,0.021739130434782608,1.0,1.0,2/5,5.61%,PASK;ENPP1
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.9354940654842231,1.5763203400541668,0.021739130434782608,1.0,1.0,2/5,5.61%,PASK;ENPP1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.7344880473615195,-1.5732599508098495,0.0,0.4779557119702557,1.0,7/37,5.57%,CD44;ADAMTS5;TIMP1;LAMC1;CAPN1;A2M;SCUBE3
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.8124935911938238,-1.5729720493618409,0.01694915254237288,0.46788200759357707,1.0,1/22,0.02%,CD44
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,-0.6498010903907935,-1.5723085900794618,0.0136986301369863,0.4617287976141238,1.0,48/98,18.66%,NEFL;NEFM;STMN2;LRRTM1;SHISA6;GAP43;ASTN1;CLVS2;TCEAL5;KCNIP1;GDAP1L1;TRPM3;ROBO2;SNAP25;TMEM179;CADM3;TMEM200C;PURG;CNTN1;DCLK1;DCX;SULT4A1;CACNA1B;PNMA2;RAB3C;RUNX1T1;DENND2A;SH3GL2;ACTL6B;PAK3;ATP1B2;FAT3;ST8SIA3;TMEM35A;OPCML;GRIA1;BRINP1;INA;SRRM4;MAPK4;TMEM132B;ADCYAP1R1;UNC5D;GABRB3;SLC35F1;NRXN1;NTRK3;ATCAY
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.7607226315044585,1.5721288538447231,0.0,1.0,1.0,1/19,0.48%,PTH
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.9117325135459036,-1.571174000527751,0.0,0.4569108649529735,1.0,4/13,3.81%,CD44;VIL1;TWF2;CARMIL2
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.7954670121973009,1.5702077700706532,0.05,1.0,1.0,5/17,8.90%,ICAM1;ITGAL;NT5E;TNIP1;SELP
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.6588198657240862,-1.567809518363543,0.0,0.46712235889109077,1.0,38/97,18.18%,TCEAL6;SPARCL1;P2RY12;RASSF4;SHISA6;C1QB;CHL1;SERPING1;SSTR1;MAOB;A2M;SYNPR;CADM3;CSF1R;LRRK2;GRM5;LYVE1;OPALIN;TMIGD3;CHI3L1;PHF24;SLC8A1;RGS7BP;GRIA3;C1QC;BAALC;AQP4;OPCML;CBLN4;EDNRB;TGFA;TMEM176B;PTPRT;SCN4B;FCGR3A;SLCO2B1;MAF;NRXN1
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,-0.6675085310715315,-1.5649658314057782,0.0,0.47658306489394825,1.0,35/97,18.17%,RND2;PAK5;NKAIN1;RHBDL3;RIMS4;GAP43;ASTN1;CLVS2;CNTFR;CALB2;SOX9;TMEM179;HPCA;TMEM200C;PURG;PCDH8;SULT4A1;CACNA1B;SNCB;CPE;CDK5R2;ATP1B2;TAGLN3;OPCML;PAX6;NOL4;NEFH;INA;PTPRZ1;MAPK4;ADCYAP1R1;CSPG5;UNC5D;PCLO;SLC35F1
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.6900151378654878,-1.5620758046041292,0.015384615384615385,0.48792581683182545,1.0,9/66,10.42%,CD44;ANGPT1;PTPRC;IL6R;HGF;EFNA1;GATA1;BMP6;BST1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.9111581843157986,1.5614411998515498,0.0,1.0,1.0,2/8,2.04%,RAB27A;CYBA
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.8963329193969641,1.5605711989710056,0.023255813953488372,1.0,1.0,2/9,3.41%,DHFR;AIFM2
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.7406794796464711,-1.5588537611086115,0.0,0.5001010848013493,1.0,7/37,5.57%,CD44;ADAMTS5;TIMP1;LAMC1;CAPN1;A2M;SCUBE3
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.879712668862034,-1.5588061307299033,0.0,0.4893646437161228,1.0,4/14,6.83%,CD44;CARMIL2;RHOC;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.7954723408833182,1.5572608218899437,0.04878048780487805,1.0,1.0,3/12,10.61%,PTH;EPM2AIP1;AKT2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),0.7563849619726002,1.5561046794007856,0.02631578947368421,1.0,1.0,7/18,19.04%,PLA2R1;SPRED1;SPRED2;UBB;ATR;CHD5;DDX5
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),0.8569023215245775,1.5560361367702435,0.05263157894736842,1.0,1.0,3/8,10.31%,DICER1;HENMT1;PRKRA
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.7159835199714386,1.5549595949913668,0.0,1.0,1.0,2/13,13.41%,RNF128;LAMTOR4
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),0.8782543363982558,1.550125468759649,0.0,1.0,1.0,3/9,8.46%,NUPR1;IFNLR1;PRELID1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.8653484039488263,1.5495310994335234,0.0,1.0,1.0,3/11,3.56%,RPP40;DICER1;LACTB2
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,-0.644068573812346,-1.5476243705452346,0.0,0.5640643587889793,1.0,57/149,16.83%,CARTPT;DMKN;NEFM;STMN2;LRRTM1;PAK5;SHISA6;CCK;GAP43;CACNA1E;ASTN1;CLVS2;SYT4;CNTFR;TCEAL5;ATP2B3;KCNIP1;VSTM2A;ATRNL1;GPR22;GDAP1L1;KALRN;SNAP25;TMEM179;SNX21;CADM3;CNTN1;DCLK1;GFRA2;SULT4A1;SCG2;CACNA1B;CPE;FSTL5;CDK5R2;CASZ1;TOX;ELAVL4;ACTL6B;RGS7BP;TAGLN3;VSTM2L;ASIC2;ST8SIA3;MAP2;TMEM35A;OPCML;OLFM3;BRINP1;CYB561;INA;FBXO7;EFNA5;TMEM196;MAPK4;LY6H;ADCYAP1R1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.6190924412898821,-1.5448961887320707,0.0,0.5758712034135208,1.0,62/130,18.99%,LRTM1;TCEAL6;NEFM;ADAMTS5;PCSK2;TRNP1;STMN2;PAK5;HTR5A;ASTN1;CLVS2;SYT4;TCEAL5;GABRA1;GABRG2;ATP2B3;VSTM2A;TMEM130;SYNPR;GDAP1L1;TRPM3;SNAP25;SCN2A;GRM5;NTNG1;CHGA;CACNA1B;KCNMA1;STX3;CELF4;LIN7A;RAB3C;AMPH;ACTL6B;SCG3;PAK3;ATP1B2;GPR179;CACNA2D3;HCN1;ST8SIA3;CACNG3;OPCML;GRIA1;AP3B2;OLFM3;GAD2;GRM6;SRRM4;VWC2L;TMEM196;CNTN4;GNB3;CNTNAP5;ADCYAP1R1;SPHKAP;B3GALT2;CACNA2D4;NRXN1;NTRK3;ATCAY;TNR
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,-0.6444479985043962,-1.544197684247973,0.027777777777777776,0.5710808640515667,1.0,42/108,18.43%,CARTPT;SEMA3E;PLCXD3;SPARCL1;STMN2;PAK5;SHISA6;MAOB;CNTN3;SYT4;FGF12;CADPS2;KALRN;SNAP25;SYBU;CNTN1;SORBS2;LMO3;PCDHB4;FAM149A;CPE;ETV1;ADGRL2;RGS7BP;PDZRN4;THSD7A;ST8SIA3;MAP2;AQP4;FGF14;PAX6;NOL4;PTPRT;ABCC9;TMEM196;CNTN4;MAPK4;APOBEC2;SYT13;PCLO;NRXN1;RAPGEF4
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.7006835747074254,1.5438790656035917,0.05555555555555555,1.0,1.0,1/31,0.15%,BACE2
prerank,PanglaoDB_Augmented_2021__Neuroblasts,-0.6545153805139844,-1.542546446320382,0.0,0.5726274728757503,1.0,45/113,18.17%,BTBD17;RND2;NEFM;ZCCHC12;STMN2;PAK5;NKAIN1;RHBDL3;RIMS4;NYAP1;GAP43;PLPPR5;ASTN1;CLVS2;SYT4;CNTFR;GDAP1L1;EPHA4;TMEM179;TMEM200C;PURG;GRM5;PCDH8;DCX;NTNG1;SULT4A1;CACNA1B;ELAVL2;CDK5R2;MYT1;ACTL6B;TAGLN3;TRIM32;NOL4;DRAXIN;INA;DAB1;MAPK4;EGFR;ADCYAP1R1;CSPG5;UNC5D;EZH2;PROS1;SLC35F1
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.8243519687242518,-1.5400580104976938,0.0,0.580114970624438,1.0,4/20,5.88%,ZACN;MT1M;GLRA2;PAM
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.9028430640989334,1.5389210509185718,0.02564102564102564,1.0,1.0,2/7,5.12%,NGF;RAPGEF1
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.8623058568439346,1.5359198088734376,0.023255813953488372,1.0,1.0,1/8,0.62%,TNNC2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.8202609037923028,-1.5354054693502341,0.0,0.6072982850463124,1.0,2/19,2.34%,PKP2;TGFB2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.8292526055218689,-1.5342686782927804,0.0,0.6043765076981723,1.0,3/19,3.87%,TLR2;BIRC3;IRF1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.8787029030889983,-1.5341385141709785,0.0,0.5932795980989259,1.0,6/12,8.31%,HLA-F;HLA-E;HLA-A;HLA-DRB1;ERAP1;B2M
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),0.8672277725425812,1.5337696456926964,0.07692307692307693,1.0,1.0,2/8,3.27%,CXCR4;HMGB1
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.7808939555751333,-1.5331860440599656,0.0,0.5898158898656494,1.0,2/30,1.11%,CD44;VIL1
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.650690971481956,-1.5330652206450184,0.014705882352941176,0.5790498741902277,1.0,57/111,20.21%,NPY;GFRA3;PCSK2;STMN2;LRRTM1;PAK5;PCSK1;CCK;GAP43;ASTN1;CLVS2;SYT4;TCEAL5;KCNIP1;VSTM2A;CALY;GDAP1L1;SNAP25;TMEM179;HPCA;CDH22;AFP;CHGA;SULT4A1;SCG2;CACNA1B;CELF4;RAB3C;CPE;CHGB;CDK5R2;ELAVL4;SH3GL2;ACTL6B;SCG3;TAGLN3;ASIC2;ST8SIA3;OPCML;OLFM3;GAD2;PAX6;NOL4;INA;PTPRT;VEGFA;TMEM196;KCNB2;LY6H;UNC5D;SYT13;NRXN1;PTPRN;SCN3A;PLPPR1;SLC17A6;NPSR1
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.7056852161049646,-1.5289895557402016,0.015384615384615385,0.6024903889377646,1.0,8/68,9.94%,CD44;DPEP2;CR1;AQP1;GMFG;CEACAM1;GATA1;VAMP5
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.8143264543267764,-1.5283176002583152,0.0,0.5990481413201424,1.0,5/21,4.85%,PKP2;HEY1;TGFB2;MEF2C;TGFBR2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),-0.9489475913493393,-1.5272104380417508,0.0,0.5988172870391271,1.0,1/5,1.87%,CHRM3
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),0.8713546503636557,1.5270569906654006,0.0,1.0,1.0,2/12,3.64%,CYP1A2;HSD17B7
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.8183613149789803,-1.5267217824916857,0.017857142857142856,0.5925259879393845,1.0,2/18,1.43%,ANGPT1;SFRP4
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.6221518589162114,-1.5264852971385598,0.013157894736842105,0.5841323299555274,1.0,29/109,11.17%,CD44;ANGPT1;TLR2;PROM1;FGL2;CD59;ROBO4;PTPRC;MGST1;HLA-E;TGFB2;C1QB;SERPING1;KITLG;TGFBR2;TRPC6;ADGRG1;HGF;FES;P2RY13;CSF1R;TEK;LYVE1;PROCR;C3AR1;FLI1;FGD5;IL3RA;THY1
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.7613423741591516,1.5262305395839761,0.07894736842105263,1.0,1.0,1/18,0.15%,BACE2
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),0.8394407946506766,1.5241301894173558,0.06666666666666667,1.0,1.0,4/13,6.34%,RPP40;TRMT10C;POP5;RPP25
prerank,PanglaoDB_Augmented_2021__Immature Neurons,-0.6332835389732737,-1.5236616768985236,0.0,0.5978459647436044,1.0,52/122,21.75%,RND2;STMN2;PAK5;EPHA3;GAP43;ASTN1;CLVS2;SYT4;ATP2B3;VSTM2A;ATRNL1;SYNPR;GDAP1L1;ROBO2;SNAP25;TMEM179;PURG;DCLK1;PCDH8;SULT4A1;SLC1A1;CACNA1B;CELF4;RAB3C;LRRTM3;ELAVL4;ACTL6B;PAK3;ATP1B2;FAT3;ST8SIA3;SLITRK3;OPCML;OLFM3;GAD2;PAX6;NOL4;SRRM4;MAPK4;ADCYAP1R1;PCLO;SLC35F1;NRXN1;NTRK3;PTPN5;SLC17A6;LHX6;KIF5A;RBFOX3;GRIK3;SLC12A5;NDRG4
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.7882152044952804,1.5218094097170702,0.0,1.0,1.0,2/18,5.12%,NGF;RAPGEF1
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),0.8071611810175081,1.5183722888572158,0.08823529411764706,1.0,1.0,2/9,1.60%,CYP1A2;DPEP1
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),0.8071611810175081,1.5183722888572158,0.08823529411764706,1.0,1.0,2/9,1.60%,CYP1A2;DPEP1
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),0.8071611810175081,1.5183722888572158,0.08823529411764706,1.0,1.0,2/9,1.60%,CYP1A2;DPEP1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.8660234605628468,-1.5155802955959066,0.0,0.6538604347990561,1.0,3/14,7.92%,CD44;CEMIP;LYVE1
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.9263238882860059,-1.5154649534064029,0.015873015873015872,0.6437714787881963,1.0,4/7,5.14%,F8;SERPING1;F3;A2M
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.7451519983621492,1.5152114495226914,0.14705882352941177,1.0,1.0,1/25,0.17%,TEAD2
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.8074832439878311,1.513848002076287,0.058823529411764705,1.0,1.0,5/15,9.06%,ENPP6;MGLL;ABHD2;PRDX6;PLA2G4C
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.7904408131106516,1.513818221983149,0.05128205128205128,1.0,1.0,1/10,1.90%,SPX
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,-0.6423197538382857,-1.5122707900330208,0.0,0.6622136564424561,1.0,32/108,16.83%,PDGFD;STMN2;SHISA6;TSPAN11;GAP43;ASTN1;CLVS2;CNTFR;KCNIP1;BOC;DKK3;CADM3;TMEM200C;PURG;DCLK1;GJA1;RUNX1T1;CPE;FAT3;RGS7BP;GLI3;MAP2;TMEM35A;AQP4;OPCML;BRINP1;PAX6;LRRC3B;PTPRZ1;MAPK4;LY6H;ADCYAP1R1
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),0.9375162404748927,1.509506392849859,0.0,1.0,1.0,1/7,0.10%,CYP1A2
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.7532574980316504,1.508414003927878,0.13513513513513514,1.0,1.0,3/22,10.45%,USP27X;OTUD3;USP37
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.902159835847085,1.5055503392960952,0.05405405405405406,1.0,1.0,1/12,0.15%,BACE2
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.855918693495441,-1.5055148011808053,0.04477611940298507,0.71011608747639,1.0,2/14,2.14%,KIF19;STMN2
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.7728096787754606,-1.505116485205813,0.0,0.7029239887328207,1.0,5/32,10.64%,CD44;SOX9;CHI3L1;SULF1;XBP1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),0.9310097829855275,1.5047992177514444,0.027777777777777776,1.0,1.0,2/6,1.90%,NMU;SPX
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),0.9490930159719562,1.5040699984407713,0.0,1.0,1.0,1/5,0.10%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.8077784743852667,-1.5037121972056389,0.028985507246376812,0.706153008994538,1.0,4/18,11.26%,RIMS1;RIMS4;LRRK2;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.8636667446508033,-1.5033967977519245,0.03225806451612903,0.6982198128150586,1.0,2/13,1.78%,NR4A3;PPARG
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),-0.9287859831382796,-1.5019018136236437,0.0,0.7024265322130954,1.0,3/6,3.41%,VSIR;IL12A;NCKAP1L
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.8798259999982383,-1.501785300407399,0.014925373134328358,0.6929445416982691,1.0,4/10,5.43%,HEY1;TGFB2;TGFBR2;SOX9
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.9160243366517236,-1.5016080448860962,0.0,0.6840158995906597,1.0,1/8,0.23%,PARP14
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.6735972577087894,-1.500861329827364,0.0273972602739726,0.6815192733866512,1.0,15/51,10.32%,HLA-F;TLR2;FGL2;PTPRC;ITGAM;NCKAP1L;AOAH;CD53;LAPTM5;CSF1R;HLA-DRB1;HLA-DPB1;HLA-DMA;IGSF6;PTAFR
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.794446920271581,-1.4994184817939897,0.031746031746031744,0.6845062307569258,1.0,1/18,0.05%,SLC28A2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.7651348284639887,-1.498097285667978,0.0,0.6890116386781627,1.0,8/29,13.93%,RIMS1;MCTP1;RIMS4;MCTP2;MEF2C;LRRK2;RIMS2;SNCAIP
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.6796983640340521,-1.4971622347791143,0.031746031746031744,0.6866808024612594,1.0,7/53,16.35%,CARTPT;LPL;LRRK2;XBP1;KCNB1;WRN;SREBF1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",0.8382225001929178,1.497147211479457,0.08333333333333333,1.0,1.0,1/7,0.88%,RPP40
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.95995809750799,-1.4969883996180753,0.02,0.6785699371010718,1.0,1/7,1.25%,IRGM
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.9416561520575305,1.4962879330750998,0.0,1.0,1.0,3/8,4.33%,CRTAM;CD274;SCRIB
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.8048530217074912,-1.4948449974436941,0.03225806451612903,0.686689577374076,1.0,6/16,12.42%,HEY1;OLFM1;TGFB2;TGFBR2;EFNA1;ZFPM1
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.7747718596672047,1.4933936583614396,0.05263157894736842,1.0,1.0,5/16,12.05%,AMPD1;POLD3;HPRT1;GMPR;ADA
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.9376022038373807,-1.493069965852946,0.0196078431372549,0.6901705621965364,1.0,3/8,4.62%,PKP2;NEFL;VIM
prerank,PanglaoDB_Augmented_2021__MÃ¼ller Cells,-0.6249569303216307,-1.4927768828156573,0.0,0.6849508910774198,1.0,29/124,14.21%,CD44;FSTL1;TLR2;SPARCL1;PPP1R3C;CRYM;CLU;TSPAN11;PLSCR4;COL4A1;SYNPR;SPC25;COL11A1;BOC;DKK3;CADM3;TEK;DCLK1;PCDHB4;FNDC4;GJA1;CPE;THY1;ADGRL2;RGS7BP;AQP4;OPCML;BRINP1;EDNRB
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,-0.6253814514010221,-1.4918941601644027,0.0,0.6844229498942248,1.0,57/108,23.69%,ZCCHC12;STMN2;LRRTM1;PAK5;RIMS4;GAP43;ASTN1;CLVS2;SYT4;CNTFR;GABRG2;VSTM2A;CALY;ATRNL1;CADPS2;GDAP1L1;SNAP25;TMEM179;HPCA;SCN2A;CDH22;PCDH8;CHGA;SULT4A1;KCNJ6;CACNA1B;CELF4;SNCB;CDK5R2;MYT1;ACTL6B;ST8SIA3;SLC18A2;OLFM3;GAD2;NOL4;TMEM196;KCNB2;MAPK4;LY6H;ADCYAP1R1;SYT13;NRXN1;JPH3;NEUROD6;PTPN5;SLC17A6;KIF5A;GRIK3;PRKCG;HS6ST3;TENM1;TMEM59L;KIF1A;SCRT1;ADCY1;CACNA2D2
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),-0.9430449089331767,-1.488559633757589,0.0,0.7082337655363058,1.0,2/5,4.59%,YBX3;AQP1
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.74736131014063,-1.488180139988977,0.017543859649122806,0.702984042042409,1.0,6/18,12.30%,BEGAIN;SLC8A3;NPTX1;HTR2C;NPTX2;DLGAP1
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.7214665099027685,-1.4877355080697845,0.03076923076923077,0.6991688033863329,1.0,11/26,13.36%,CHRM5;NPY;CHRM3;HTR5A;SSTR1;TSHR;HTR1E;HTR2C;HTR2B;CHRM1;HTR2A
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,0.601160762645939,1.4875847792718835,0.029411764705882353,1.0,1.0,17/87,10.31%,VWA3A;CFAP61;HDC;TTLL9;BPIFB1;DNAH6;NWD1;TTC29;CFAP43;AK8;CFAP70;RGS22;HYDIN;DNAH12;S100B;CFAP54;CROCC
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),0.8132338334807638,1.4871098098168043,0.027777777777777776,1.0,1.0,1/5,11.47%,BMP5
prerank,PanglaoDB_Augmented_2021__Tanycytes,-0.6122000295496841,-1.4861031835745813,0.014285714285714285,0.7071643382757123,1.0,34/112,16.83%,FSTL1;KCNT2;MEST;STMN2;TGFB2;CRYM;TSPAN11;GAP43;ASTN1;CNTFR;COL11A1;BOC;DKK3;CADM3;TMEM200C;DCLK1;PCDHB4;FNDC4;GJA1;RUNX1T1;CPE;THY1;ADGRL2;RGS7BP;LRFN5;PRKG1;MAP2;TMEM35A;OPCML;BRINP1;MAPK4;LMOD1;DIO2;ADCYAP1R1
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.6498910368974198,1.486024102918631,0.0,1.0,1.0,5/31,4.03%,F2;RAB27A;CYBA;SERPINF2;RUNX1
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.8093218475597895,-1.4859715731765437,0.017241379310344827,0.6996861747519975,1.0,2/13,1.81%,COX7A1;SHMT2
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),0.899099542091565,1.48495695083383,0.05405405405405406,1.0,1.0,1/7,0.93%,ORC1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.801843202327951,-1.4839330807432758,0.016666666666666666,0.7109167982709026,1.0,6/18,11.26%,RIMS1;SYT1;SYT4;NEDD4L;OSTN;RIMS2
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),0.8875989427936757,1.4832112793685521,0.058823529411764705,1.0,1.0,3/9,6.27%,CRTAM;LCK;IKZF3
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.9181789690625086,-1.482888395744939,0.0,0.713065932958023,1.0,2/9,3.17%,TLR2;DDX60
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),0.8274687363932833,1.4827384003453707,0.09090909090909091,1.0,1.0,3/11,6.34%,RPP40;POP5;RPP25
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,0.71553453255477,1.4818761149326571,0.14814814814814814,1.0,1.0,3/21,4.09%,NUPR1;CDSN;PLA2R1
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.852736754892125,-1.4807089770412836,0.017543859649122806,0.7253322527408834,1.0,1/13,1.52%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.9044814322327863,-1.4805905848211893,0.01694915254237288,0.7179890862244062,1.0,2/9,3.85%,YBX3;BIRC3
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.8240905681727505,1.480185775409648,0.13157894736842105,1.0,1.0,1/5,0.43%,F2
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.8240905681727505,1.480185775409648,0.13157894736842105,1.0,1.0,1/5,0.43%,F2
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.7115916034185267,1.4792631721552991,0.0967741935483871,1.0,1.0,5/20,12.69%,HMGA2;HDAC1;ZNFX1;BEND3;HELLS
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),-0.8845408604274019,-1.4787359430647098,0.05,0.7244612893079516,1.0,2/6,6.80%,CPS1;DDAH1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.7233726261422809,-1.4782590479521625,0.0625,0.7198839880194018,1.0,5/39,1.87%,PARP14;ISG15;PTPRC;PPARG;H2BC11
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.8290919236851373,-1.4778133943322893,0.0,0.7165827803692161,1.0,2/15,3.85%,DDX60;BIRC3
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.8533475800166076,-1.477404768182511,0.047619047619047616,0.7118758914203739,1.0,3/8,9.23%,CPS1;NOS1;KCNMA1
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),0.8320408734420683,1.4770750934577064,0.06060606060606061,1.0,1.0,1/12,0.10%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),0.932846738604863,1.4768707879798746,0.0,1.0,1.0,1/5,2.04%,CYBA
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.7583719967481467,1.4765126610487747,0.022727272727272728,1.0,1.0,6/24,7.92%,NGF;VAV1;RASGRF1;RAPGEF1;MMD2;RELN
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.7362004507506941,1.4759831179888765,0.045454545454545456,1.0,1.0,4/15,11.26%,TRMT10C;NSUN2;METTL8;VIRMA
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.6650622631859301,1.4757498398310582,0.02564102564102564,1.0,1.0,3/27,10.61%,PTH;ENPP1;AKT2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.815760324267375,-1.4743441018277692,0.029850746268656716,0.7344258661321539,1.0,3/11,2.69%,HLA-F;HLA-E;IL12A
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.7298325295020976,-1.4732620017119968,0.0,0.7373771536047756,1.0,11/37,15.59%,PARP14;TNFRSF1A;PARP9;IL12A;IL6R;CSF1R;CTF1;CRLF1;IFNA2;LYN;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.8208088522688669,1.471544112067988,0.0,1.0,1.0,4/10,12.58%,PTH;PTH1R;AKT2;SLC45A3
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.7254507218284929,1.470295545419941,0.05,1.0,1.0,7/22,11.83%,TRMT10C;PUS7;NSUN2;METTL8;VIRMA;DKC1;PUS1
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.6653425637898661,-1.4701369488692806,0.0,0.7574383388092305,1.0,26/78,13.06%,PARP14;ISG15;PLSCR1;EPSTI1;IFITM3;PARP9;MX1;DDX60;ISG20;IRF1;TRIM5;TMEM140;PSMB8;IFI44;LPAR6;GBP2;SELL;IL7;B2M;SP110;PROCR;MVB12A;TRIM25;NMI;MOV10;IFI35
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.6309714043828988,1.4701091342233787,0.0625,1.0,1.0,3/29,6.76%,RPP40;TSR1;DCAF13
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.9835982462963453,-1.4697532344392192,0.0,0.7530052882290842,1.0,1/5,0.05%,SLC28A2
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.7868324378690771,-1.4695919853820065,0.03278688524590164,0.7464626381844477,1.0,4/15,4.21%,ADAMTS5;ERVW-1;MEF2C;NOS1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.6498535917690992,1.4673287392605374,0.07894736842105263,1.0,1.0,11/32,14.26%,HSPA1A;RAE1;CHMP5;TPX2;NUMA1;FSD1;PARP3;HSPA1B;TPR;HNRNPU;PSRC1
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),0.8989063162965036,1.4666499834768398,0.05263157894736842,1.0,1.0,3/5,6.71%,PDE6A;CNGB1;PDE6B
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.8645425890939602,1.4663293479203086,0.05714285714285714,1.0,1.0,1/8,1.90%,SPX
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.7059960312005561,-1.466290407982604,0.0410958904109589,0.7678899066881208,1.0,13/45,8.55%,CD44;HLA-F;HLA-E;IFNGR2;IRF1;TRIM5;IRF4;GBP2;HLA-A;HLA-DRB1;TRIM22;B2M;HLA-DPB1
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.7836822914464283,-1.4655460869384331,0.03125,0.7682901778532296,1.0,5/14,13.12%,CHRM5;CHRM3;PLCB1;CDK5R1;CHRM1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.7570203141141056,-1.465432963329636,0.034482758620689655,0.7616943412527911,1.0,4/25,10.35%,SFRP4;PTPRC;GJA1;SULF1
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),0.8759300170918882,1.4644977335382974,0.045454545454545456,1.0,1.0,2/6,10.29%,PRDM5;BEND3
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.8367236325548545,-1.4627232264797072,0.07246376811594203,0.7760809304734718,1.0,3/11,4.79%,PKP2;HOPX;ID2
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.6994919147582912,-1.4626033595112187,0.058823529411764705,0.7694434343784442,1.0,14/40,17.19%,CHRM5;AKAP12;P2RY12;CHRM3;HTR5A;ADCY7;HTR1E;GRM7;RGS1;CHRM1;ADCY8;GNAL;GPR37L1;NPY1R
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.92488737793368,1.461830745459316,0.044444444444444446,1.0,1.0,1/6,0.44%,SPIRE2
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.8642746889135002,-1.4598930800618313,0.014705882352941176,0.7862980002114536,1.0,3/10,5.43%,HEY1;TGFB2;SOX9
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.6949104980774017,1.4598123914654293,0.10714285714285714,1.0,1.0,12/27,15.18%,SQLE;SC5D;DHCR24;HSD17B7;MSMO1;HMGCS1;ACAA2;PMVK;HMGCR;IDI1;ARV1;ACAT2
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.8806095652356376,-1.4593679041668286,0.03076923076923077,0.7832350870751624,1.0,2/9,0.99%,KANK2;ZNF366
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.6819643993643437,-1.4593455081198523,0.014492753623188406,0.7757963701757296,1.0,15/63,8.55%,CD44;HLA-F;TLR2;HLA-E;IFNGR2;IRF1;TRIM5;IRF4;GBP2;HLA-A;GBP3;HLA-DRB1;TRIM22;B2M;HLA-DPB1
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),0.9262604666414093,1.4581589451212547,0.0,1.0,1.0,2/6,4.06%,OOEP;MEIOSIN
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.8090910311990696,-1.4577565438506215,0.03636363636363636,0.7841475197919051,1.0,4/10,12.30%,BEGAIN;NPTX1;NPTX2;DLGAP1
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.7464176874994252,-1.4571127669278734,0.0,0.7831858035384421,1.0,11/31,15.59%,PARP14;TNFRSF1A;PARP9;IL12A;IL6R;CSF1R;CTF1;CRLF1;IFNA2;LYN;VEGFA
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.7702488066280809,-1.455450154374569,0.015625,0.7914015961166654,1.0,2/21,3.85%,YBX3;BIRC3
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.7821206147163022,1.4541493855223369,0.0,1.0,1.0,5/14,10.74%,OOEP;ESPL1;LLGL2;LLGL1;KIF25
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.8171462343560856,-1.4538569882107248,0.027777777777777776,0.7993762765218274,1.0,5/15,10.41%,PTPRC;CR1;SFTPD;LAPTM5;NAV3
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.7217893731875689,1.4538563791150032,0.0851063829787234,1.0,1.0,2/12,3.95%,F2;KLK6
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.8105029652515827,-1.4537458453737142,0.01639344262295082,0.7929240656853109,1.0,5/16,7.38%,HLA-F;HLA-E;IL12A;HLA-A;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.7841662073349335,-1.452987303521558,0.07246376811594203,0.7934024887154935,1.0,4/16,14.56%,MMRN2;TMEM204;CNMD;PRKD2
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.9456770739863838,1.4523159522289013,0.06451612903225806,1.0,1.0,2/5,4.35%,MGLL;ABHD2
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.7630512882906919,1.452135254882217,0.06976744186046512,1.0,1.0,7/13,20.86%,SYNE2;PCM1;SYNE3;SUN2;CEP120;TMEM201;DOCK7
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.7664400250724366,-1.451230413387901,0.08955223880597014,0.8015764278040469,1.0,4/13,6.42%,VSIR;IL12A;NCKAP1L;RFTN1
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.884864112584545,-1.4510806410170558,0.09090909090909091,0.7956205616047084,1.0,1/8,4.02%,EDN1
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.7780119083834677,1.4510067769641357,0.058823529411764705,1.0,1.0,1/11,0.05%,GABRE
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),-0.9676216114529999,-1.4499547632276508,0.0,0.7982732324479707,1.0,1/5,1.25%,IRGM
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.7662900184235295,1.4497891207758435,0.05263157894736842,1.0,1.0,1/20,0.14%,ABCA13
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.809750071900896,1.4496192280028057,0.05263157894736842,1.0,1.0,4/14,8.72%,NUPR1;FBP1;MST1;CBFA2T3
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.7550978911310154,1.449557702142813,0.05405405405405406,1.0,1.0,3/9,9.66%,PTH;PTH1R;WNT4
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.6550219140259457,-1.4490371553218635,0.0,0.8001207970851462,1.0,5/67,9.07%,CD44;FGF22;ANOS1;KIF16B;FLRT1
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6756800379063542,1.4488808642287947,0.13793103448275862,1.0,1.0,3/29,1.96%,CRTAM;ICAM1;ITGAL
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),0.9161260045677457,1.448610897853193,0.0975609756097561,1.0,1.0,1/5,0.05%,GABRE
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.8608455909594256,1.4483487545247045,0.04878048780487805,1.0,1.0,3/6,4.10%,SLC22A2;ABCC2;ABCC1
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.7488500763646304,1.4480231001528723,0.1875,1.0,1.0,1/9,3.40%,DICER1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.7675992638710503,1.4466317177753998,0.11904761904761904,1.0,1.0,1/9,0.37%,PDE3A
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),-0.8114037642389801,-1.4448237341816341,0.05,0.8356078597483129,1.0,4/12,10.45%,ACTA2;TPCN2;MYH11;SLC8A1
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.9168596704607884,1.4447170336024073,0.06521739130434782,1.0,1.0,1/5,2.98%,ZNF598
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),-0.7252712952439175,-1.4437795475733541,0.03125,0.8378472089478389,1.0,4/33,7.25%,TRPM1;KDM4D;FIGNL1;RAD9A
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.8210088450859591,1.4428546291418838,0.0975609756097561,1.0,1.0,4/11,12.05%,AMPD1;HPRT1;GMPR;ADA
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.6710601371183252,1.4428068215093868,0.09090909090909091,1.0,1.0,5/40,7.46%,SUN3;CEP55;USP36;CHMP5;NUMA1
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.847632176888818,-1.442245919956133,0.014705882352941176,0.8478500761588643,1.0,2/10,5.71%,KDM4D;KDM3A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.8476603000428989,1.4402695084038173,0.1388888888888889,1.0,1.0,2/8,5.20%,NUPR1;PPP1R10
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.726384577892759,1.4393767052879765,0.16279069767441862,1.0,1.0,1/17,0.70%,SUN3
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),0.839293351048265,1.4389915978809666,0.07142857142857142,1.0,1.0,3/7,11.79%,F2;TMEM98;HES5
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.9584385600043316,-1.43857383698128,0.0,0.8820304399486137,1.0,1/5,1.13%,TLR2
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),0.9283988240405092,1.4355600961080284,0.13513513513513514,1.0,1.0,1/5,0.10%,CYP1A2
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),0.8692302413029785,1.4353194783112648,0.07894736842105263,1.0,1.0,2/6,3.27%,CXCR4;HMGB1
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.5764763542396482,-1.435191378912847,0.0,0.9093383160808561,1.0,10/125,6.03%,CD44;VIL1;STMN2;TWF2;MEF2C;NOS1;TGFBR2;VSTM2A;SOX9;HGF
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.7854403297544704,1.4349275119293283,0.1111111111111111,1.0,1.0,1/11,0.21%,CXCR4
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",-0.8808672895577006,-1.4341757371841055,0.05084745762711865,0.9124900214266524,1.0,2/6,2.50%,DACT1;PLEKHA4
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.7952520149789424,-1.4340742722373587,0.10606060606060606,0.9062193309400388,1.0,1/13,0.33%,CARTPT
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.9058189698058674,-1.433952999487329,0.0,0.8999726802193198,1.0,2/6,5.90%,IRF4;GBP2
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),-0.8793997819998355,-1.4335264559708396,0.06666666666666667,0.896561735475322,1.0,1/6,2.10%,TNFRSF1A
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),-0.8653156598328877,-1.4333678090225668,0.05970149253731343,0.8905712091613794,1.0,3/10,5.43%,HEY1;TGFB2;SOX9
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.713510301539535,1.4330586117535604,0.07692307692307693,1.0,1.0,6/13,14.56%,FHDC1;OPTN;TMED5;VAMP4;STX6;TRIP11
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.8598340256763748,-1.432529030651148,0.06060606060606061,0.8912871995879565,1.0,3/9,2.68%,ISG15;SHMT2;MX1
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.8783656557046982,1.4322571096647094,0.043478260869565216,1.0,1.0,2/6,5.76%,SLIT2;RNF113A
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),-0.9838619917187932,-1.4308962198888444,0.016666666666666666,0.8990075768104768,1.0,1/5,0.14%,NCEH1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.6726516559079077,1.429957680511951,0.027777777777777776,1.0,1.0,2/39,0.27%,PANK1;AMPD1
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.9029934340336903,-1.4299013120049953,0.031746031746031744,0.9024451990816317,1.0,1/6,3.41%,NCKAP1L
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.8199523243266351,1.4298772276800642,0.07142857142857142,1.0,1.0,3/6,16.81%,UXT;UBB;LRPPRC
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.6940589635985197,-1.4292003516300265,0.06153846153846154,0.9027513763883919,1.0,6/34,3.65%,BTBD17;ISG15;PLSCR1;IFITM3;MX1;ISG20
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.7914349976133023,1.4283507301556086,0.09090909090909091,1.0,1.0,2/12,9.71%,B4GALNT2;GFPT2
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),-0.9009473858885793,-1.4282362319540658,0.0,0.9072984360892072,1.0,1/7,2.78%,ARL13A
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),-0.925122160535063,-1.427835648670924,0.05172413793103448,0.9039408938667783,1.0,1/5,1.78%,PPARG
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.5606939031267999,1.4278126938650078,0.06666666666666667,1.0,1.0,8/193,3.03%,CPA1;BACE2;CELA2A;ADAM33;PRSS57;REN;VASH1;MALT1
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.8610148367643147,-1.4277877478601582,0.015384615384615385,0.8971139292535522,1.0,3/10,6.83%,HEY1;ASB4;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.6538844544213058,-1.4271236726909493,0.03278688524590164,0.896868881744614,1.0,9/48,14.73%,CLDN5;DACT1;DTX3L;LRRK2;B2M;ADD2;CAV1;LRP1;NMD3
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),0.8195271401336615,1.4259397372639087,0.08571428571428572,1.0,1.0,1/7,1.24%,TRMT10C
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.7406973781960791,1.4252940606475752,0.09523809523809523,1.0,1.0,4/13,8.90%,F2;CELA2A;PDGFA;SELP
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.7966716962851941,1.424826335378943,0.06666666666666667,1.0,1.0,2/11,2.64%,AMPD1;NT5E
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.7643616586034278,1.4244960151067168,0.11363636363636363,1.0,1.0,1/11,3.61%,ANXA2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.7054176099851589,-1.4243315241942942,0.0410958904109589,0.9173617144711611,1.0,8/33,5.59%,IGFBP3;NR4A3;PPARG;IL12A;IL6R;EDN1;ID2;OGN
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.8816590379953737,-1.42412186280814,0.03278688524590164,0.9125951894116032,1.0,3/5,8.58%,TAPBPL;HLA-DRB1;HLA-DMA
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.7107279174482976,1.4235080550468384,0.058823529411764705,1.0,1.0,2/13,10.31%,DICER1;PRKRA
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.598877431336398,-1.423434775174074,0.013333333333333334,0.9130238286229941,1.0,33/100,16.83%,GFRA3;SPARCL1;STMN2;SHISA6;CHL1;TSPAN11;MAOB;ASTN1;CHST1;CNTFR;TCEAL5;AQP1;KCNIP1;L1CAM;DKK3;CADM3;CXCL14;CNTN1;DCLK1;THY1;TSPAN7;RGS7BP;AQP4;SORCS1;SLC18A2;EDNRB;DHRS3;PHYHIP;PTPRT;PTPRZ1;SCN4B;MAPK4;ADCYAP1R1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.7090432906434495,-1.4234037898235492,0.029850746268656716,0.9064517200233271,1.0,4/25,5.06%,DPP10;KCNIP4;NOS1;KCNIP1
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),-0.9608809782790648,-1.4229332099668253,0.0,0.9044642107476392,1.0,1/5,1.25%,IRGM
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.6839929527803378,-1.422383869363059,0.07692307692307693,0.902923268107866,1.0,7/26,19.76%,IGSF10;ADGRG1;NTNG1;NTNG2;CAMK2B;KIF20B;CX3CL1
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.7783519458969421,-1.4223392597375903,0.06557377049180328,0.8970495522639774,1.0,1/14,0.02%,CD44
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.7743287559303913,-1.4219444240217345,0.08,0.8933873496147068,1.0,5/13,12.21%,TRIM5;FUCA2;TRIM22;TRIM25;CAV1
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.8105966993109156,-1.4216238157490129,0.07042253521126761,0.8905266946971683,1.0,6/10,18.37%,F3;SCG2;CDH13;IL16;VEGFA;NTRK3
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.791080189084591,-1.4215013116298587,0.05263157894736842,0.8858116910675085,1.0,5/17,11.26%,RIMS1;SYT1;SYT4;NEDD4L;RIMS2
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.7622466022104717,1.4199846770650766,0.12195121951219512,1.0,1.0,3/8,14.70%,SNAPC3;ELL;ZC3H8
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),-0.8944982764503449,-1.4192745390442514,0.03225806451612903,0.90118600078356,1.0,3/6,6.15%,PLSCR1;PLSCR4;ANO6
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-0.9703286063654948,-1.4190370472475662,0.0,0.8912739464437714,1.0,2/6,1.78%,PARP14;PPARG
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),-0.9703286063654948,-1.4190370472475662,0.0,0.8912739464437714,1.0,2/6,1.78%,PARP14;PPARG
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.6454766219501193,1.4187488414967382,0.07692307692307693,1.0,1.0,12/44,17.00%,SQLE;SC5D;SOAT2;MSMO1;PMVK;HMGCR;CYP7B1;LIPA;LCAT;ARV1;CLN6;FDX1
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),0.8842281456277364,1.4180943590756137,0.058823529411764705,1.0,1.0,3/5,7.23%,ICAM1;AGER;PIK3R6
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.8230795516003472,-1.4177941288605573,0.046153846153846156,0.896752215290121,1.0,4/10,11.26%,RIMS1;SYT1;UNC13C;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),0.8690398818473842,1.4176061243894436,0.05405405405405406,1.0,1.0,2/6,4.56%,PTH;PTH1R
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.8782130217283628,-1.4175770466164355,0.04838709677419355,0.892416692039318,1.0,1/6,1.33%,ISG15
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.6436079013319113,-1.4159173124773494,0.04411764705882353,0.9028771637260433,1.0,18/55,15.61%,BEGAIN;NEFL;SHISA6;MEF2C;CACNG2;CAPN1;NPTX1;NPTX2;CACNG8;GRIN2B;GRIA3;DLGAP1;CACNG3;GRIA1;DLG4;DAPK1;LRRC7;NETO1
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),-0.8833019290839987,-1.4155221006133143,0.03125,0.9007512787452193,1.0,2/5,4.59%,YBX3;AQP1
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.6625402813817127,1.4150678089858935,0.09375,1.0,1.0,14/30,26.65%,BICDL1;UXT;UBB;BICD2;LRPPRC;TRAK1;CDC42;TMEM201;TRAK2;CLN3;NDEL1;HAP1;ARHGAP21;BORCS5
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.7826907248584738,-1.4150234945840279,0.04838709677419355,0.8996145918508883,1.0,4/15,5.43%,NR4A3;ACADL;FABP3;SOX9
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.7519530697070642,1.4144555851742866,0.1111111111111111,1.0,1.0,5/15,7.35%,GUCA1C;PDE6A;CNGB1;PDE6B;GUCA1B
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),-0.8586460093548705,-1.4144299600495038,0.03278688524590164,0.8987474909957974,1.0,1/7,0.33%,CARTPT
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.6166507557117491,-1.4144235635845075,0.07462686567164178,0.8928346785550357,1.0,10/58,17.10%,ITGB4;FBLN1;ISG15;CEACAM1;ITGBL1;THY1;ITGAV;FYB1;FERMT3;SYK
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",0.8642740887336073,1.4142660417586983,0.13513513513513514,1.0,1.0,3/8,6.71%,PDE6A;CNGB1;PDE6B
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.7905814170188512,-1.4138576124090478,0.014285714285714285,0.8922744288969555,1.0,1/10,0.47%,FSTL1
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.6229034926408544,-1.4137764291415476,0.03125,0.8873539417838464,1.0,8/70,8.31%,CD44;ITGB4;ECM2;L1CAM;ACTN1;ITGBL1;LYVE1;SGCE
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",-0.8913325881498024,-1.4136614285284324,0.046875,0.8770246925435444,1.0,2/5,6.15%,NCKAP1L;ANO6
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),-0.8913325881498024,-1.4136614285284324,0.046875,0.8770246925435444,1.0,2/5,6.15%,NCKAP1L;ANO6
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.9133121239308104,-1.4134773614218967,0.0,0.8681123993672304,1.0,1/7,0.75%,MDFIC
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.9133121239308104,-1.4134773614218967,0.0,0.8681123993672304,1.0,1/7,0.75%,MDFIC
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),-0.903036422843375,-1.4134743802921927,0.037037037037037035,0.8626525729561157,1.0,1/5,0.29%,ANGPT1
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.8924254935306724,-1.4111542927225251,0.03125,0.8793005589941016,1.0,3/6,6.15%,PDZK1;TRPC6;ANO6
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.7296513674254438,1.411029021881836,0.17647058823529413,1.0,1.0,4/11,12.84%,TCOF1;KBTBD8;NOLC1;CDH2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.8038162690545102,-1.4108245843136789,0.08064516129032258,0.8771214817604636,1.0,5/12,14.69%,PKP2;NEDD4L;CAV3;KCNH2;KCNE1
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),0.8879846191613934,1.4106082289624962,0.023809523809523808,1.0,1.0,1/5,1.56%,NMU
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),-0.8508477111263839,-1.409941698037542,0.09836065573770492,0.8792397642856294,1.0,1/8,1.04%,LPL
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),-0.7509768984264696,-1.4095928256298964,0.07575757575757576,0.8775593814412488,1.0,5/15,13.12%,CHRM5;CHRM3;PLCB1;CDK5R1;CHRM1
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.5628453515973935,-1.409522671586747,0.014492753623188406,0.8727942955503967,1.0,17/149,9.33%,CD44;PEX11A;OLFM1;IGFBP4;PDZK1;MPPED2;FOS;PRSS23;CALB2;CCN5;CCND1;SYBU;FKBP5;BCL11B;BHLHE40;SLC1A1;GJA1
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.760893937429075,-1.40927963202461,0.05555555555555555,0.8697757401339212,1.0,2/20,5.94%,TLR2;ROBO2
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.6311356958512981,-1.4091214282794868,0.06153846153846154,0.8662726084826601,1.0,9/57,5.60%,CD44;TLR2;IL13RA1;TNFRSF1A;IFNGR2;IRF1;CNTFR;A2M;PIM1
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),0.8487904998367188,1.4082775996741543,0.07894736842105263,1.0,1.0,2/5,7.49%,HMGA2;MST1
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.8580235897021348,-1.4077345383154105,0.014084507042253521,0.8727076405629959,1.0,3/9,3.94%,MSMP;IL6R;LGALS3
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),0.8105549964584655,1.4077169018660036,0.17142857142857143,1.0,1.0,1/6,1.24%,TRMT10C
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.7486503157113777,-1.4075434020519915,0.01639344262295082,0.8688855993026188,1.0,2/26,2.54%,PARP14;PARP9
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),-0.8501620160354341,-1.4074947739105188,0.09836065573770492,0.8644265268476319,1.0,1/7,1.72%,PTPRC
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.6158877727996367,-1.4074030004902969,0.0,0.8602459971164482,1.0,23/100,12.01%,NCEH1;PARP14;TLR2;FGL2;NR4A3;PTPRC;PPARG;SLA;ITGAM;LGALS3;AOAH;CD53;LAPTM5;GPR34;CSF1R;SLC7A7;LYVE1;C3AR1;RGS1;IGSF6;PTAFR;CX3CR1;CD200
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.673120957278758,-1.4067125938639375,0.08108108108108109,0.8611152930460947,1.0,7/47,3.87%,BTBD17;ISG15;PLSCR1;IFITM3;MX1;ISG20;TRIM5
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.8393600583967746,-1.4060919164019228,0.05660377358490566,0.8608572100074717,1.0,2/10,2.10%,CLDN5;TNFRSF1A
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),-0.7171912735090717,-1.4058170962420582,0.09090909090909091,0.8590469728597214,1.0,7/18,19.59%,PTPRC;MEF2C;IFNA2;IFNK;IFNA6;RASGRP1;CR2
prerank,GO_Biological_Process_2021__negative regulation of protein sumoylation (GO:0033234),0.8806190582743308,1.4054895724892262,0.047619047619047616,1.0,1.0,1/5,4.23%,GNL3L
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.8205112063380353,-1.4052273632978052,0.03571428571428571,0.8602947219112463,1.0,4/13,9.09%,SHISA6;GRIK2;SLC4A10;RAB3A
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.5942350615014834,-1.4051178332361915,0.046153846153846156,0.8564219638497471,1.0,45/103,22.53%,TCEAL6;PCSK2;CCK;HTR5A;CACNA1E;CACNG2;GABRA1;VSTM2A;SYNPR;UNC13C;ATP2B2;CDH22;KCNJ6;SLC4A10;CELF4;KCNC2;ACTL6B;SCG3;PDE1B;ATP1B2;HCN1;WSCD2;ST8SIA3;XKR4;CACNG3;UNC80;AP3B2;GAD2;KCNB1;KCNH2;CACNB2;SRRM4;SLC24A4;CNTNAP5;RPH3A;MYT1L;NRXN1;TNR;SCN1A;RBFOX3;SEZ6L;SLC1A2;FGF13;ADCY2;CACNA1A
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.8096183218689489,1.4045462242186586,0.1111111111111111,1.0,1.0,2/6,10.12%,PTPRU;PTPRD
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.7234433374085603,-1.4041416433144913,0.047619047619047616,0.8605639264025049,1.0,5/26,5.94%,HEY1;TGFB2;CITED2;TGFBR2;ROBO2
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.7027061810907108,1.403544030689285,0.2222222222222222,1.0,1.0,4/17,16.84%,DICER1;HENMT1;PRKRA;SNIP1
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.7286776855522253,-1.4020001960322737,0.07692307692307693,0.8768190340995822,1.0,4/25,11.66%,FSTL1;SFRP4;DKK3;NREP
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.8265441346657125,1.401964474033328,0.1,1.0,1.0,2/7,7.80%,NUMA1;SMC6
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",-0.8700165273625471,-1.4018534319986091,0.06060606060606061,0.8735664800628359,1.0,2/6,6.15%,NCKAP1L;ANO6
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.5679941449885545,-1.4015587744008526,0.014084507042253521,0.8714775250668194,1.0,20/143,7.89%,CD44;FOSL2;TLR2;NR4A3;IFNGR2;TUBB2A;CEBPD;KLF9;STAT5A;NFKBIE;F3;BIRC3;IRF1;EDN1;FOS;ID2;SNN;CCND1;NINJ1;BHLHE40
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.8476964570157886,-1.40117360414712,0.03225806451612903,0.8699989685978459,1.0,2/11,2.54%,PARP14;PARP9
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.6818364704092734,-1.4006868810989621,0.07692307692307693,0.8691737793517883,1.0,5/34,8.31%,ANGPT1;SFRP4;CLU;DGKD;B2M
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),-0.8734184669340366,-1.4002882891881072,0.06779661016949153,0.867882511054548,1.0,2/6,6.32%,SNAP25;UNC13C
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.7406308529648848,1.3996408730512584,0.1590909090909091,1.0,1.0,2/9,7.05%,F2;PDGFA
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.8671436563206638,-1.399227563452328,0.046875,0.8725909963282793,1.0,3/6,10.72%,PLSCR1;IL6R;CEBPB
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.7225749415184628,-1.3986559190372385,0.078125,0.8733317822237017,1.0,3/24,2.96%,VIL1;STMN2;TWF2
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.7004597511042858,-1.3977408687456376,0.029850746268656716,0.8780118474315819,1.0,3/22,7.89%,HEY1;BASP1;BHLHE40
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.8827754365161071,1.3973773724005318,0.044444444444444446,1.0,1.0,2/5,8.42%,CMPK1;AK3
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),-0.9333969481754794,-1.3971498104869076,0.017857142857142856,0.8786638647655617,1.0,1/5,1.72%,PTPRC
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.6905145949783226,-1.397045764864743,0.0410958904109589,0.8747872476948712,1.0,10/38,10.72%,LPL;PPARG;CDS1;ID2;VSTM2A;PIM1;LMO3;FNDC5;XBP1;CEBPB
prerank,GO_Biological_Process_2021__definitive hemopoiesis (GO:0060216),-0.9164796842149063,-1.395952007940605,0.02,0.8792315615745745,1.0,2/5,7.42%,MFAP5;TEK
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.7449496211220527,-1.3955613378726026,0.06349206349206349,0.8782399349337512,1.0,5/22,5.94%,HEY1;TGFB2;CITED2;TGFBR2;ROBO2
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.9160540482858875,-1.3954194277264664,0.03571428571428571,0.8702007533076673,1.0,1/6,1.55%,MCM2
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.9160540482858875,-1.3954194277264664,0.03571428571428571,0.8702007533076673,1.0,1/6,1.55%,MCM2
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.8637646923484179,-1.3953593469933854,0.09375,0.8661689019640936,1.0,1/5,1.72%,PTPRC
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.6483648198242801,-1.3952594841845927,0.04285714285714286,0.8621788314634586,1.0,6/48,3.65%,BTBD17;ISG15;PLSCR1;IFITM3;MX1;ISG20
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.682307652543079,-1.3951700739054305,0.06451612903225806,0.8587747092405397,1.0,9/29,20.28%,CLVS2;GNPTAB;MYO7A;LRRK2;TPCN2;HOOK1;TPP1;ABCA1;NAGPA
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),-0.8390438870019277,-1.39473978287894,0.07017543859649122,0.8550120592099398,1.0,1/7,6.03%,HGF
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),-0.8390438870019277,-1.39473978287894,0.07017543859649122,0.8550120592099398,1.0,1/7,6.03%,HGF
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.6862479186632908,-1.39464959403349,0.015625,0.8515498331815379,1.0,6/30,10.88%,PTPRC;TGFB2;MEF2C;GPM6A;SOX21;HTR2B
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.8662918976011436,-1.3937312216625157,0.018867924528301886,0.8554017681742451,1.0,2/7,7.21%,PPP1R3C;PPP1R3D
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.6122922624041565,-1.3935369552921768,0.04477611940298507,0.8531794817511008,1.0,10/73,12.92%,SRGN;PCSK4;PCSK2;PCSK1;F3;FURIN;CPE;MMP16;TASP1;MAGEF1
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.6295745429595303,1.3919998091802113,0.10810810810810811,1.0,1.0,6/44,6.64%,NGF;GPR143;PIK3C2G;FGFR1;IGF1R;PLCE1
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.7082587862634228,-1.3919973545769302,0.058823529411764705,0.8617890139181094,1.0,6/24,11.80%,IFITM3;TRIM5;HLA-DRB1;TRIM22;TRIM25;IFNA2
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.721065352502235,1.3919554712626612,0.1724137931034483,1.0,1.0,5/15,19.49%,DICER1;HENMT1;PRKRA;DHX9;CELF1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),-0.9342168409038754,-1.391877976021516,0.0,0.8585531862356875,1.0,1/8,0.78%,DPYS
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),-0.9357420504452685,-1.3917579321408509,0.0,0.8553018294732199,1.0,1/7,0.78%,DPYS
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.5799815983052329,1.3911803375127614,0.11428571428571428,1.0,1.0,8/59,8.42%,AMPD1;PTH;CROT;GLYAT;ENPP1;HPRT1;ACOT6;AK3
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.8600654282782,-1.3908414357372447,0.05263157894736842,0.8597977290043074,1.0,1/9,1.55%,MCM2
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),0.7884979790469373,1.3897818860757472,0.16216216216216217,1.0,1.0,2/6,10.49%,SELP;RPS6KA1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.7634669437513196,-1.3892801224765416,0.06557377049180328,0.8685357088714032,1.0,6/12,17.10%,HLA-E;IL12A;HLA-A;HLA-DRB1;GLI3;SYK
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.8113637750678879,-1.3892678880316156,0.058823529411764705,0.8643458201917092,1.0,3/12,7.42%,HEY1;TGFB2;TEK
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.6652598643653119,1.388824128151139,0.125,1.0,1.0,15/53,10.34%,CYP1A2;VDR;RDH16;DHCR24;CYP3A43;HSD17B7;MSMO1;HSD11B1;CYP2C8;PRLR;CYP2E1;CUBN;SLC22A24;CYP7B1;LIPA
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.6881407950448346,-1.3887031015641245,0.0684931506849315,0.8642545812539116,1.0,11/25,24.70%,PARP14;PTPRC;THY1;CAV1;SH3BP5;DMTN;PRKCZ;PRKCD;SOCS3;CADM4;PPP2R1A
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.7037944833636625,1.3885319217530345,0.1282051282051282,1.0,1.0,3/14,8.72%,NUPR1;FBP1;CBFA2T3
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.8593751953719763,1.3885299402432856,0.15,1.0,1.0,3/5,7.33%,DSCAM;SEMA5A;MEGF8
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),-0.9105534795555181,-1.388361429296017,0.0,0.8629109373907686,1.0,2/5,7.20%,PTGR1;ALOX12
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.6854128632276953,-1.3882380527304874,0.07352941176470588,0.8557567882713336,1.0,19/41,16.13%,HLA-F;ISG15;HLA-E;IFITM3;MX1;ISG20;IRF1;IRF4;PSMB8;GBP2;HLA-A;SAMHD1;XAF1;IFNA2;IFI35;RSAD2;IFIT1;STAT1;IFNA6
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.6854128632276953,-1.3882380527304874,0.07352941176470588,0.8557567882713336,1.0,19/41,16.13%,HLA-F;ISG15;HLA-E;IFITM3;MX1;ISG20;IRF1;IRF4;PSMB8;GBP2;HLA-A;SAMHD1;XAF1;IFNA2;IFI35;RSAD2;IFIT1;STAT1;IFNA6
prerank,PanglaoDB_Augmented_2021__Microglia,-0.610406610225399,-1.3879820485382683,0.028985507246376812,0.8541067657810417,1.0,21/81,11.05%,FGL2;PTPRC;P2RY12;ALDH1A2;SLA;ITGAM;C1QB;IL6R;AOAH;FOS;CD53;LAPTM5;P2RY13;GPR34;CSF1R;C3AR1;IGSF6;PTAFR;CYFIP1;GPR183;CX3CR1
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.8695022172559155,-1.3879147912570253,0.03225806451612903,0.850514246963793,1.0,3/9,4.85%,SEMA3E;COL4A1;TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.7713883583784722,1.3876473670632756,0.16666666666666666,1.0,1.0,3/7,9.49%,PTPRU;SERPINF2;ADAM19
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.788996611704531,1.387544092920808,0.14634146341463414,1.0,1.0,1/9,1.51%,RFWD3
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.7924533782384883,1.3874515960882514,0.17142857142857143,1.0,1.0,1/11,0.23%,CRTAM
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.7303472683141785,1.3869354117106807,0.11764705882352941,1.0,1.0,4/10,21.56%,HDAC1;SMARCA4;ZBTB7A;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.6588181273221474,1.386818301485657,0.11627906976744186,1.0,1.0,9/22,17.91%,RASL11A;ATF4;PIH1D1;DHX33;NCL;MARS1;SMARCA4;UBTF;NOL11
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.9094336203600836,-1.3857641531122258,0.05454545454545454,0.865039597588814,1.0,2/6,2.19%,TIMP4;TIMP1
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.5639899084867699,1.3856840570487554,0.0625,1.0,1.0,11/86,5.62%,ABCA13;SLC22A2;VDR;SLC22A6;WNK4;PIK3C2G;MUC4;LARP1B;PLA2R1;PLD1;FRK
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),-0.753505531879477,-1.3853936648857486,0.07017543859649122,0.8649480999428824,1.0,3/16,5.94%,TGFB2;TGFBR2;ROBO2
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.9110054341158926,-1.3844444315723836,0.034482758620689655,0.869886220535815,1.0,2/6,4.45%,COX7A1;HIGD1C
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.9012983214409052,1.3844208021933226,0.11428571428571428,1.0,1.0,2/5,5.20%,NUPR1;PPP1R10
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),0.8193104827869995,1.3842945849076842,0.09523809523809523,1.0,1.0,1/6,2.10%,PYCR1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.768612436822155,-1.384292407824864,0.0821917808219178,0.8670021998258249,1.0,4/14,4.08%,RIMS1;MCTP1;MCTP2;MEF2C
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.8475437376762036,-1.3842222987036057,0.05,0.8637890115470698,1.0,2/9,7.21%,PPP1R3C;PPP1R3D
prerank,GO_Biological_Process_2021__CRD-mediated mRNA stabilization (GO:0070934),0.790228638114566,1.3838128656559818,0.14634146341463414,1.0,1.0,3/5,17.27%,HNRNPU;YBX1;DHX9
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.8302640150888105,-1.383198096450174,0.058823529411764705,0.8677786258539837,1.0,2/8,6.83%,ASB4;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.8875625597894601,1.3824389625370022,0.043478260869565216,1.0,1.0,2/6,4.03%,EVI2B;RUNX1
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.861098537951189,-1.3811323694435,0.030303030303030304,0.8823979874941592,1.0,2/9,2.54%,PARP14;PARP9
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),0.6680595540138945,1.3808750118843505,0.12903225806451613,1.0,1.0,1/19,0.10%,CYP1A2
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.8519950007430264,1.38081356754274,0.1,1.0,1.0,1/6,3.42%,NUTF2
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),-0.8000066992135078,-1.3808098924848862,0.03225806451612903,0.881220619604779,1.0,2/11,1.78%,LPL;PPARG
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),-0.8596304558268246,-1.3796880070261919,0.08064516129032258,0.8871730019419695,1.0,3/7,12.57%,PPARG;IL12A;E2F3
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.8065465214153876,-1.3796555501190042,0.03076923076923077,0.883462987031549,1.0,1/12,0.23%,PARP14
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),-0.7076280026747115,-1.3795211893361836,0.06451612903225806,0.8806087473056771,1.0,6/40,15.82%,FSTL1;PPARG;BMPR1B;CHRDL1;BMPER;VWC2L
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),-0.8620004078196062,-1.3790197072768986,0.0851063829787234,0.8813132874060482,1.0,2/5,11.75%,CARMIL2;CARMIL1
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),0.8364936885726701,1.3788661675147074,0.15,1.0,1.0,1/7,1.24%,TRMT10C
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.8270942664527888,-1.378284789988266,0.03571428571428571,0.8835986601517892,1.0,1/10,0.73%,HEY1
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),-0.8763989100709619,-1.3757886870578007,0.06060606060606061,0.9014935931820115,1.0,2/6,4.28%,CARTPT;FGF12
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.6676709877370064,1.3757820562179308,0.11904761904761904,1.0,1.0,4/13,13.67%,SNAPC3;CAVIN1;MARS1;GTF3A
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.6557191261501136,-1.3752426708946697,0.05172413793103448,0.9025640419491889,1.0,14/43,21.48%,PDHX;NR4A3;ENO4;ME3;PFKFB2;SLC16A8;LDHA;PGK1;SDS;GAPDHS;SLC16A3;PFKM;GPI;DLAT
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.8087311039116076,1.3746015081729486,0.12195121951219512,1.0,1.0,1/9,0.61%,SSC5D
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.7848636343220396,-1.374393659677276,0.08620689655172414,0.9065457138014859,1.0,2/10,2.49%,PROM1;BASP1
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.6768815120795303,-1.3741447915206915,0.07575757575757576,0.9046767697791442,1.0,16/31,26.80%,RIMS1;SYT1;SNAP25;UNC13C;RAB3A;STX3;RIMS2;CDK5;PCLO;STX19;CPLX1;SYT7;STX4;CPLX2;SYT2;DNAJC5
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.8499322857222829,1.3735752914795514,0.13513513513513514,1.0,1.0,3/6,12.38%,DUSP1;PTPN22;DLG1
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.8547021146207393,1.3733676481981953,0.1590909090909091,1.0,1.0,1/7,0.21%,CXCR4
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),0.9246001607444535,1.3731723914158893,0.047619047619047616,1.0,1.0,1/5,0.95%,DHFR
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.7914380456249489,1.3731652097823857,0.10714285714285714,1.0,1.0,4/9,17.06%,ANXA2;SCRIB;SNCA;INPP5F
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.687677142872247,-1.373062331633767,0.0273972602739726,0.9103347457334748,1.0,3/39,5.43%,CD44;MEF2C;SOX9
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.6540673695277153,-1.3727771561561657,0.09722222222222222,0.9085909079925035,1.0,8/35,13.14%,GPAT3;LPL;CPS1;FABP3;DGAT1;PNPLA1;CAV1;CAV3
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),-0.6385924580025253,-1.3718671494863754,0.06944444444444445,0.9121863752552267,1.0,8/54,15.82%,FSTL1;SFRP4;PPARG;SULF1;CRB2;BMPR1B;BMPER;VWC2L
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.7568032812423867,1.3717092824195911,0.11764705882352941,1.0,1.0,4/8,19.26%,SPHK2;SLC25A33;SNCA;MID1IP1
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.6717847638042529,1.3716406498819789,0.125,1.0,1.0,11/26,15.18%,SQLE;DHCR24;HSD17B7;MSMO1;HMGCS1;ACAA2;PMVK;HMGCR;IDI1;ARV1;ACAT2
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),0.7957190177588682,1.3713397840472255,0.15151515151515152,1.0,1.0,2/6,1.44%,CRTAM;ZAP70
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),-0.9183694179195958,-1.3711838618516103,0.01694915254237288,0.9103772446177837,1.0,1/5,0.73%,HEY1
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),-0.9183694179195958,-1.3711838618516103,0.01694915254237288,0.9103772446177837,1.0,1/5,0.73%,HEY1
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.6910824862561292,1.3710368748151815,0.125,1.0,1.0,12/29,15.18%,SQLE;SC5D;DHCR24;HSD17B7;MSMO1;HMGCS1;ACAA2;PMVK;HMGCR;IDI1;ARV1;ACAT2
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.7832903934671478,-1.3710208992744142,0.10526315789473684,0.907677544241171,1.0,6/11,17.10%,P2RY12;TGFB2;NCKAP1L;RAC3;SKAP1;SYK
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.5373979270327579,-1.370598274517111,0.056338028169014086,0.9067180891462076,1.0,20/149,10.64%,CD44;MEST;OLFM1;IGFBP4;IMPA2;ISG20;PDZK1;FOS;PRSS23;ID2;CCN5;CCND1;FKBP5;CXCL14;IGSF1;PTGER3;COX6C;CPE;TST;XBP1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.8296259328964561,-1.370490409703429,0.05660377358490566,0.9039346301578252,1.0,5/9,16.78%,SYT1;SYT4;KCNB1;SCAMP5;CACNA1G
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.8492553929494995,1.3703922389952707,0.13636363636363635,1.0,1.0,3/6,11.72%,ATF4;ZBTB1;C5AR1
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),0.6815735266506874,1.369641212391283,0.0625,1.0,1.0,4/14,8.46%,CRTAM;IKZF3;ABL1;PRELID1
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.7582276942954511,-1.3695895990794364,0.1694915254237288,0.9068505848941604,1.0,5/10,18.98%,TGFB2;NCKAP1L;RSAD2;VEGFA;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),-0.8537365190697424,-1.3694737855712746,0.09523809523809523,0.9039688436941241,1.0,2/5,12.57%,PPARG;E2F3
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.7887684150970362,-1.3692006914555483,0.0847457627118644,0.9026389334760869,1.0,1/13,0.75%,MDFIC
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.8129220873758439,-1.368710711948924,0.0,0.9035220605281103,1.0,4/10,6.83%,HLA-F;HLA-E;HLA-A;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.8207824867907629,-1.3680376650824495,0.1323529411764706,0.9040390339705425,1.0,1/9,0.65%,MMRN2
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.8171033694470049,1.3677603077698568,0.13157894736842105,1.0,1.0,1/6,0.55%,TBXA2R
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.7876827350379171,1.3675357072124725,0.2127659574468085,1.0,1.0,5/6,20.90%,NFKB1;PNPT1;RELA;LIN28B;ZSWIM8
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),-0.8595014420413152,-1.3667638600409853,0.05454545454545454,0.9108250723696324,1.0,2/6,5.60%,CHRM3;PIM1
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.7333970090791637,-1.3664597564994256,0.14754098360655737,0.9099633340306345,1.0,6/13,22.04%,ITGAM;PIK3AP1;NMI;SCIMP;TIRAP;LY96
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.7665858609621772,1.3662118500132807,0.13636363636363635,1.0,1.0,5/12,13.31%,CMPK1;ENPP1;AK8;AK3;SMPDL3A
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.6067134704271819,1.366166231235558,0.1111111111111111,1.0,1.0,5/43,4.10%,CXCR4;CCL28;SEMA5A;CCR3;ABCC1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.5612514477932312,-1.3661005589042696,0.0273972602739726,0.9095812097534719,1.0,27/123,19.71%,IRGM;PTPRC;CENPE;PAK5;TGFB2;CLU;IL6R;NOX4;SPDYA;TGFBR2;EPHA4;CSF1R;GRM5;EFNA1;CAMK1;PAK3;MTCP1;CALM3;DLG4;VEGFA;TOM1L1;CDKN1A;EZH2;BORA;GAS6;NEDD9;DDR2
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.7775828484182365,-1.3659726837641661,0.08196721311475409,0.9070059695360716,1.0,2/14,4.02%,NR4A3;EDN1
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.636645915524968,1.365923604592525,0.07142857142857142,1.0,1.0,2/31,1.30%,GABRE;CHRNA4
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),-0.7553758604296551,-1.3659041261464746,0.05084745762711865,0.9039829574732443,1.0,4/13,5.94%,HEY1;TNFRSF1A;TGFB2;ROBO2
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.8758023638103993,1.3658976930418076,0.04878048780487805,1.0,1.0,1/6,0.27%,AMPD1
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.6606308129546626,-1.3657728799845172,0.07894736842105263,0.9018791446145108,1.0,11/40,14.31%,SLC28A2;VIL1;FMO5;TPH1;SLC5A9;ACSM3;SLC3A1;SLC22A3;ABCG5;SLC18A2;CYP3A5
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),-0.7558236933897076,-1.3648723435336059,0.1206896551724138,0.9054489323110343,1.0,2/13,1.78%,LPL;PPARG
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.7757174040545785,-1.3644468216918988,0.09259259259259259,0.9047453150912934,1.0,5/15,10.24%,GSAP;CLU;EPHA4;EFNA1;LRRTM3
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,-0.5618131120858885,-1.3643868038336988,0.0547945205479452,0.901741279721114,1.0,45/128,18.43%,BTBD17;TCEAL6;SPARCL1;HOPX;SHISA6;CHL1;HTR5A;GAP43;ASTN1;CLVS2;TCEAL5;VIM;KCNIP1;VSTM2A;A2M;SYNPR;TRPM3;ATP2B2;CADM3;SCN2A;GRM5;OPALIN;ALDH1L1;GJA1;LRRTM3;GRIN2B;ATP1B2;RGS7BP;GRIA3;BAALC;ST8SIA3;AQP4;OPCML;GRIA1;ADCY8;LRRC3B;PTPRZ1;EGFR;ADCYAP1R1;GPR37L1;GRIN3A;SPHKAP;NRXN1;NTRK3;RAPGEF4
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.7430780097243143,1.3633964259376123,0.125,1.0,1.0,4/14,8.48%,CHRNA4;NQO1;CHRNB3;CHRNA7
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.8911853364879501,-1.3626708509565058,0.058823529411764705,0.9125423387853375,1.0,2/6,9.09%,CBLN2;RAB3A
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.77669245398012,-1.3619599170821592,0.10606060606060606,0.9148311472734656,1.0,2/14,2.86%,PKP2;TTN
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.8386396739127224,-1.3615839920855708,0.09523809523809523,0.9146332678695138,1.0,2/8,2.03%,PPARG;DND1
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.8173777836712646,1.3612094390617095,0.14893617021276595,1.0,1.0,3/7,8.42%,CMPK1;AK8;AK3
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.5818555370585554,-1.359761516557046,0.05128205128205128,0.9264286940605786,1.0,25/78,19.84%,BTBD17;STMN2;LRRTM1;SYT1;SYT4;CNTFR;ENHO;CALY;OGDHL;TMEM179;CHGA;DACT2;ACTL6B;SEMA4G;ST8SIA3;SLC18A2;KCNH2;GRIK5;SCAMP5;FTCD;SYT13;CAMSAP3;SHD;CARMIL3;PLPPR1
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),-0.7850822058716747,-1.3593483417167076,0.07352941176470588,0.9258477615045227,1.0,2/9,10.73%,PPARG;RARB
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),-0.8495684779080641,-1.3591584489966602,0.06060606060606061,0.923544834833393,1.0,1/11,0.78%,DPYS
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),-0.8937426328658816,-1.3587822145562205,0.10606060606060606,0.9235030662377163,1.0,1/5,0.29%,ANGPT1
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.7065629093886864,-1.3586695206012707,0.07894736842105263,0.9207801713270487,1.0,2/24,0.99%,KANK2;ZNF366
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.6520210126623402,1.3584541218818398,0.14705882352941177,1.0,1.0,7/22,13.90%,GNL3L;CTC1;PINX1;NAT10;TNKS2;TENT4B;HNRNPU
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),0.7803363581037699,1.3582559951261102,0.12121212121212122,1.0,1.0,2/6,10.58%,DUSP1;ANAPC15
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),0.7803363581037699,1.3582559951261102,0.12121212121212122,1.0,1.0,2/6,10.58%,DUSP1;ANAPC15
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.8292022786107758,-1.3580144402409435,0.16129032258064516,0.9232721023800979,1.0,5/8,14.21%,ACTA2;EDN1;SLC8A1;HTR2B;EDNRB
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),0.8604476921400224,1.357925446672346,0.030303030303030304,1.0,1.0,2/7,9.43%,VDR;CUBN
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.6342621368223567,-1.3573944652041374,0.05,0.9250057470762658,1.0,13/54,18.11%,ZACN;PLSCR1;TTN;PAM;NEDD4L;ANXA11;KCNMA1;SNCB;CAV1;CALM3;ITPR3;SLC11A2;PPP3CA
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.8308051338919863,1.357202067914304,0.175,1.0,1.0,2/6,3.25%,PIWIL4;MUC4
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.713059548779286,-1.35698025699983,0.09375,0.9243331783275593,1.0,6/21,18.32%,RIMS1;SYT1;SYT4;RIMS2;SYT13;SYT12
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.8098997270015901,-1.356396774381255,0.08955223880597014,0.9251326947653548,1.0,2/8,10.70%,NEDD4L;HECW1
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.7591722957584137,1.3560565065979797,0.11904761904761904,1.0,1.0,3/8,14.94%,HDAC10;HDAC9;HDAC4
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.6661094264930174,-1.3559062019857995,0.06666666666666667,0.9251954445736497,1.0,9/31,20.28%,CLVS2;GNPTAB;MYO7A;LRRK2;TPCN2;HOOK1;TPP1;ABCA1;NAGPA
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),-0.8819235479545402,-1.3556325179732702,0.034482758620689655,0.9234743176895581,1.0,2/6,1.87%,CHRM5;CHRM3
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.6607822472100243,-1.355581921705015,0.07692307692307693,0.9204608707697634,1.0,6/39,6.03%,HEY1;OLFM1;TGFB2;SOX9;LOXL3;HGF
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.7308441228704898,-1.3551313218852958,0.07462686567164178,0.9209378213278568,1.0,6/19,19.34%,PTPRC;DDX60;HLA-DRB1;XBP1;LILRB1;PTPRJ
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.7648019776351271,1.3551145094413863,0.10256410256410256,1.0,1.0,1/10,0.43%,F2
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),-0.7872638640791336,-1.354913278192541,0.05660377358490566,0.9190720440925566,1.0,4/11,10.50%,GUCY1A1;NOS1;DDAH1;KCNC2
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),-0.7337781037478553,-1.3546766402098807,0.0410958904109589,0.917578717789391,1.0,11/19,22.42%,PPARG;CSF1R;PDE1B;IKZF1;LYN;AXL;VEGFA;LILRB1;GAS6;TRPM2;IL31RA
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),0.8907915967402643,1.354599037376802,0.05128205128205128,1.0,1.0,1/6,0.48%,PTH
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),-0.8572578864259688,-1.3541947222885722,0.11475409836065574,0.9185611356886897,1.0,4/6,14.21%,ACTA2;EDN1;SLC8A1;EDNRB
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),-0.8742717466825767,-1.3541561575009806,0.06557377049180328,0.9153725802868979,1.0,2/5,4.39%,LPL;GPIHBP1
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.6789234431087784,1.3530977102258375,0.16666666666666666,1.0,1.0,4/13,17.42%,TPR;DNMT1;SIRT6;RESF1
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),-0.917967302142924,-1.3530902688758681,0.05172413793103448,0.9211778812797338,1.0,1/5,1.25%,IRGM
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.701931884901335,1.3528423719716087,0.2682926829268293,1.0,1.0,2/15,3.40%,CXCR4;DICER1
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.7826362754944728,-1.3524217225621835,0.05172413793103448,0.9225601371835235,1.0,2/15,2.44%,DACT1;ALDH1A2
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.7329862395276142,1.352246812440352,0.21621621621621623,1.0,1.0,1/8,1.24%,TRMT10C
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.7570829727999018,-1.3520991344430964,0.1111111111111111,0.922137266647572,1.0,3/11,5.93%,HLA-E;TGFBR2;HLA-A
prerank,GO_Biological_Process_2021__negative regulation of meiotic cell cycle (GO:0051447),0.8424307536839906,1.3520243439886495,0.1956521739130435,1.0,1.0,2/5,8.82%,DUSP1;DMRT1
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),-0.7880202252282922,-1.3520238809025453,0.1095890410958904,0.9160946758397676,1.0,4/8,13.99%,CACNG2;CACNG8;CACNG3;DLG4
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),-0.7880202252282922,-1.3520238809025453,0.1095890410958904,0.9160946758397676,1.0,4/8,13.99%,CACNG2;CACNG8;CACNG3;DLG4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.7706167828647957,-1.351971937165837,0.1320754716981132,0.9134021354621407,1.0,2/8,2.59%,HLA-F;ITGAM
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.7668164619425595,-1.3517484570060785,0.15,0.9113534167898204,1.0,4/13,5.93%,H2BC11;HLA-E;SFTPD;HLA-A
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,-0.593113677824207,-1.3513111739113597,0.047619047619047616,0.9111858421181799,1.0,21/108,11.70%,FBLN1;GFRA3;LRRTM1;TSPAN11;CNTFR;COL4A1;FIGN;BOC;DKK3;TUSC3;DCLK1;GFRA2;PTPRG;GJA1;TENM3;FAT1;RUNX1T1;CPE;DENND2A;THY1;ADGRL2
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),0.8117054563793505,1.35122494578355,0.10204081632653061,1.0,1.0,2/5,10.69%,RAB32;AP3D1
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),0.8117054563793505,1.35122494578355,0.10204081632653061,1.0,1.0,2/5,10.69%,RAB32;AP3D1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.6889663968270912,-1.3511374943494376,0.08333333333333333,0.9094352666966189,1.0,6/25,8.31%,HLA-F;HLA-E;IL12A;HLA-A;HLA-DRB1;B2M
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.7321461701293059,-1.3508313170220525,0.07462686567164178,0.9088296292231657,1.0,4/17,8.31%,HEY1;SOX9;DTX1;B2M
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.5723569275176925,1.3495363911377853,0.1,1.0,1.0,16/47,19.04%,EYA4;PLA2R1;HMGA2;SPRED1;H2AX;RNF168;TMEM161A;BRCC3;SPRED2;UBE2N;UIMC1;ATR;DHX9;RNF8;RPS3;DDX5
prerank,GO_Biological_Process_2021__glycerol-3-phosphate metabolic process (GO:0006072),0.81629681434301,1.3490823486192078,0.09375,1.0,1.0,2/5,7.22%,GPAT2;GK5
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.7921725431689951,1.3489406826596848,0.125,1.0,1.0,4/10,16.16%,SYNE2;KIF25;SYNE3;SUN2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),-0.7184613004586302,-1.3488547620099127,0.05660377358490566,0.9203329979064271,1.0,3/14,5.60%,MEF2C;TP73;PIM1
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),-0.8841652340956176,-1.3479820706509205,0.0625,0.9235091648711374,1.0,4/5,11.58%,P2RY12;GPR183;CX3CR1;ATP1B2
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.7136504592399767,1.3477886220113862,0.13513513513513514,1.0,1.0,7/17,16.98%,RASL11A;ATF4;FLNA;POLR2K;DHX33;POLR2L;UBTF
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.6701801657323786,1.3469201730662101,0.0975609756097561,1.0,1.0,1/17,0.20%,NGF
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.7542277908311761,-1.3469008082998855,0.09836065573770492,0.9285981722935059,1.0,4/13,11.05%,GCNT1;SELL;ADD2;CX3CR1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.8111659911487819,-1.3468780348323188,0.016129032258064516,0.9254299589706502,1.0,5/9,11.05%,HLA-F;PTPRC;HLA-E;CEACAM1;CX3CR1
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),-0.8740279525155026,-1.3465492227367981,0.06666666666666667,0.9246102542951705,1.0,1/7,0.47%,FSTL1
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.5920882746391609,-1.3465290119881326,0.015625,0.9214445438223493,1.0,13/73,12.64%,SRGN;PCSK4;VSIR;PCSK2;PCSK1;F3;PRSS12;FURIN;CPE;MMP16;C1R;HJV;ATP23
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.7703305666638549,-1.3461678686642686,0.14516129032258066,0.9213140217781669,1.0,2/11,2.16%,NR4A3;WNT8B
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.7773062283910646,-1.3460655527144434,0.04838709677419355,0.918782273753531,1.0,4/10,13.59%,NCKAP1L;TGFBR2;HLA-DRB1;PRKCQ
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),0.7417588815559739,1.3452374427305998,0.13157894736842105,1.0,1.0,3/9,13.61%,CA6;TAS2R40;RTP5
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),0.7417588815559739,1.3452374427305998,0.13157894736842105,1.0,1.0,3/9,13.61%,CA6;TAS2R40;RTP5
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.7390866778530092,-1.344618639772116,0.078125,0.927804931418861,1.0,2/16,4.02%,NR4A3;EDN1
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),-0.8262669272837797,-1.3444721511298585,0.1206896551724138,0.922682987293294,1.0,1/6,1.13%,TLR2
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),-0.8262669272837797,-1.3444721511298585,0.1206896551724138,0.922682987293294,1.0,1/6,1.13%,TLR2
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.7348375338185485,-1.3444111664891578,0.03571428571428571,0.9200825147411958,1.0,6/27,8.31%,HLA-F;HLA-E;TAPBPL;HLA-A;ERAP1;B2M
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.7418906595866833,-1.3442334271571392,0.1206896551724138,0.918385220491235,1.0,5/14,11.17%,LGALS3;LAPTM5;CEACAM1;CD160;THY1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.7008477336494079,-1.3441324172492157,0.15492957746478872,0.916013148922508,1.0,8/24,19.65%,EPN1;CEACAM1;ADAMTS9;BMPER;VEGFA;CREB3L1;PIK3CB;RHOJ
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.7788417147615762,-1.343632443427415,0.06557377049180328,0.9172400007161343,1.0,3/9,7.38%,VSIR;CR1;HLA-DRB1
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.7232751358941258,-1.3435493209479343,0.11666666666666667,0.9148229031468812,1.0,3/16,13.94%,WNT8B;CAV1;AMER1
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.6323847927146531,-1.3430691364681395,0.047619047619047616,0.9160455008738015,1.0,13/39,18.18%,RIMS1;SYT1;SYN3;SNAP25;SYN2;RAB3A;LIN7A;RIMS2;GAD2;GAD1;CDK5;PCLO;NRXN1
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),-0.9087964166974754,-1.3422565609137778,0.109375,0.9193879568349508,1.0,1/5,0.81%,SRGN
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.8369430424881442,-1.341983522383308,0.1323529411764706,0.9182090781917401,1.0,3/6,15.59%,SCG2;IL16;VEGFA
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.7988843029989436,-1.3415953469478057,0.057971014492753624,0.9187996224874122,1.0,7/12,16.82%,PLSCR1;IL6R;F3;ANO6;CEBPB;HPR;MYLK3
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),-0.8535507639329605,-1.3413988120318916,0.16129032258064516,0.917343233298775,1.0,1/5,2.78%,ARL13A
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),-0.7453194456061054,-1.3413827096308164,0.12727272727272726,0.9144329382154566,1.0,2/14,5.43%,LPL;SOX9
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.8232933411124785,1.3412276186049945,0.10416666666666667,1.0,1.0,1/5,5.74%,SLIT2
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.6858162771006363,-1.3408620348160314,0.09230769230769231,0.9161717055154809,1.0,4/24,3.88%,OLFM1;MUSK;STAT5A;NRCAM
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.7262589645215857,-1.3403406032123097,0.1016949152542373,0.9173933214762077,1.0,4/18,12.42%,CARTPT;CEACAM1;C1QC;ZFPM1
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.6292234646042337,-1.3396831483599136,0.1044776119402985,0.9191739875998631,1.0,16/58,16.12%,EPN1;CLDN5;PTPRM;SEMA3E;PPARG;TGFB2;TEK;SULF1;CD160;EFNA3;PDE3B;CNMD;ADAMTS9;PGK1;STAT1;CREB3L1
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.7544042878532563,-1.3393210533511737,0.09375,0.9192159921005587,1.0,4/13,10.12%,LPL;CPS1;FABP3;PNPLA1
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.8292481083612158,-1.3391673485921458,0.1,0.9174111325898007,1.0,1/6,3.17%,DDX60
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,0.6147387254471843,1.3387671209940453,0.13157894736842105,1.0,1.0,4/26,4.75%,DAO;F2;F11;CREB3L3
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.6298460056454553,-1.3382543898051458,0.06349206349206349,0.9216389221670712,1.0,26/51,20.68%,TLR2;FGL2;ITGAM;AOAH;KLHDC4;LAPTM5;CSF1R;C3AR1;NLRP3;IGSF6;PTAFR;TRIM25;ADGRE2;PLET1;LY86;WDFY4;FCGR3A;TNFRSF1B;CLEC5A;NR1D1;LILRB1;MRC1;GDA;SPI1;TYMP;SLAMF8
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.5856630062130833,-1.3381884723427881,0.05555555555555555,0.9189050364522043,1.0,9/65,15.70%,ANGPT1;FANCI;BIRC3;LAPTM5;PRICKLE1;LRRK2;CAV1;AMER1;BRCA1
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.7221685539751541,-1.3377139054294191,0.13432835820895522,0.9193503048789932,1.0,3/14,5.07%,LPL;MEST;VSTM2A
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.7250661566779217,-1.3376450860279796,0.13114754098360656,0.9166722549141327,1.0,9/17,19.67%,HLA-E;IRF4;HLA-DRB1;NLRP3;CEBPB;ZFPM1;PRKCQ;SYK;PRKCZ
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.692471781419712,-1.3375927720576912,0.13114754098360656,0.914165354781325,1.0,1/16,1.14%,CPS1
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.547475469364275,-1.3375801789086934,0.03896103896103896,0.9113674914054632,1.0,53/147,16.83%,DPP10;NEFL;NEFM;ZCCHC12;STMN2;LRRTM1;PAK5;SYT16;NYAP1;GAP43;PLPPR5;ASTN1;CLVS2;SYT4;CNTFR;TCEAL5;FGF12;ATP2B3;CALY;GDAP1L1;DTX1;SNAP25;TMEM179;HPCA;PIANP;PURG;PCDH8;SULT4A1;CACNA1B;LHFPL5;SNCB;KLHDC8A;NKAIN3;CDK5R2;GRIP1;SH3GL2;ACTL6B;EFNA3;TAGLN3;ASIC2;ST8SIA3;TOX2;RBPMS;OPCML;OLFM3;BRINP1;NELL1;INA;CCDC184;TMEM196;MAPK4;LY6H;ADCYAP1R1
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.6579934529791075,1.3368554011243696,0.0967741935483871,1.0,1.0,5/29,8.90%,TBPL2;PRIM1;TAF13;TAF5;TAF12
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,-0.7082710720154373,-1.336493733510805,0.109375,0.9177981729867082,1.0,12/32,16.31%,HEY1;NRCAM;CNTFR;L1CAM;ADGRG1;SCG2;CDK5R1;THY1;RASA1;ETS2;VEGFA;OPHN1
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),0.5448766274878237,1.3361701594876223,0.125,1.0,1.0,2/64,2.63%,CYP1A2;MGLL
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.699909536371838,1.3358488460986397,0.09523809523809523,1.0,1.0,3/14,8.28%,HSPA1A;ACAA2;BAK1
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.7107178617936241,-1.3357449233428382,0.1044776119402985,0.9209241751288526,1.0,4/17,13.33%,SLC8A3;NOS1;CAV3;CALM3
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.803852416110627,-1.3356332188499183,0.11320754716981132,0.9184963659434652,1.0,3/9,9.51%,TGFB2;TGFBR2;TGFB3
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.6338056412495524,-1.3354600048309697,0.1232876712328767,0.9171447528213778,1.0,14/37,16.24%,FGL2;PTPRC;IL13RA1;ITGAM;AOAH;SOX9;P2RY13;DCLK1;PTAFR;KLF3;NREP;ADGRE3;TMEM176B;FCGR3A
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),-0.8241658306369799,-1.3345501431337123,0.078125,0.9217843097433354,1.0,3/8,14.50%,PTPRC;TOX;AXL
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.778416849281076,1.3342144671114757,0.14634146341463414,1.0,1.0,1/6,6.13%,NPL
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.5964805949272965,-1.3339654371785894,0.15,0.923021250923384,1.0,15/52,18.67%,EPHA3;MCTP1;RIT2;LGALS3;CALY;NEDD4L;CDH13;LRPAP1;LRP1;PACSIN1;OPHN1;SCAMP5;GPC3;LILRB1;FLOT1
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.7619280572934627,-1.3338408609957875,0.09375,0.9210376091580751,1.0,3/12,4.21%,ADAMTS5;ERVW-1;NOS1
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),-0.8513213268844879,-1.3337848979810558,0.11290322580645161,0.9188867278486096,1.0,2/8,9.27%,NECAB1;GATA1
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.8131964505634368,-1.3334663231367097,0.10606060606060606,0.91833073420352,1.0,1/8,0.33%,CARTPT
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.7356767146597264,-1.3333578461880289,0.17142857142857143,0.9164395336180381,1.0,4/16,14.50%,TRIM5;TRIM22;TRIM25;AXL
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.5240890343342913,-1.332863494853361,0.0,0.9175256026454764,1.0,40/191,19.93%,DLK2;MMRN2;HEY1;KANK2;IGFBP3;DACT1;SFRP4;PTPRC;IL12A;GLIS2;TMEM25;NLRP12;DKK3;LRRK2;APCDD1;DDIT4;TCIM;SULF1;CX3CR1;LRPAP1;GLI3;UBASH3B;PRAME;TULP3;PRKCQ;LYN;LRP1;CNMD;PTPRT;CREB3L1;EGFR;GPC3;SIAH1;EZH2;NEURL1;PIK3CB;PTPRJ;PRKCZ;CX3CL1;PID1
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.8536273148710855,-1.3322974216667638,0.06382978723404255,0.9191667175901272,1.0,1/7,2.10%,TNFRSF1A
prerank,PanglaoDB_Augmented_2021__T Helper Cells,0.5977402279656837,1.3321045233023916,0.16666666666666666,1.0,1.0,10/46,4.69%,CXCR4;CD38;ZAP70;ITGAL;IL2RA;IL4R;CCR3;GPR174;PYHIN1;CD247
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),0.7783916588591266,1.3316357922999933,0.18604651162790697,1.0,1.0,1/5,1.24%,TRMT10C
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.7532816244091735,1.331403880329289,0.15384615384615385,1.0,1.0,1/7,6.13%,NPL
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),-0.5554529811318112,-1.3312829794090881,0.08108108108108109,0.9243346463820449,1.0,22/83,21.12%,PKP2;HEY1;TGFB2;CITED2;MEF2C;FGF12;ID2;TGFBR2;SOX9;TEK;CRB2;ZFPM1;SMYD4;MTHFD1;POU6F1;CDKN1A;MICAL2;NTRK3;TGFB1;CACNA1C;KAT2B;PTPN11
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.7070413510611374,1.3312814713467367,0.10526315789473684,1.0,1.0,6/17,11.71%,PPP1R36;SH3RF2;MFHAS1;PPP1R26;PTPA;ENSA
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.8253633536487651,-1.3308450048079172,0.10344827586206896,0.9192646675287967,1.0,1/8,4.07%,DTX3L
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.8253633536487651,-1.3308450048079172,0.10344827586206896,0.9192646675287967,1.0,1/8,4.07%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.8253633536487651,-1.3308450048079172,0.10344827586206896,0.9192646675287967,1.0,1/8,4.07%,DTX3L
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),0.7644400409732239,1.330834411283163,0.17073170731707318,1.0,1.0,2/5,10.64%,HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),0.7644400409732239,1.330834411283163,0.17073170731707318,1.0,1.0,2/5,10.64%,HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),-0.8322195441400952,-1.330574953815342,0.17543859649122806,0.9182551391471436,1.0,2/5,15.59%,RIN3;VEGFA
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.5985229189096407,-1.3304480790471334,0.07692307692307693,0.9162357029801973,1.0,18/72,15.99%,TLR2;ISG15;PLSCR1;PTPRC;IFITM3;MX1;ISG20;IRF1;TRIM5;DDIT4;SAMHD1;IFNA2;AGBL4;MOV10;RSAD2;ABCC9;IFIT1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.8954877436715519,-1.3304465908613448,0.03333333333333333,0.9134759568868834,1.0,2/7,4.08%,NR4A3;MEF2C
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.7599592177160788,-1.3304199476010372,0.1,0.9109636213895453,1.0,3/14,3.11%,FSTL1;SFRP4;TMEM204
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.6230660656838816,-1.3303408800018168,0.046153846153846156,0.9088690825523051,1.0,12/38,18.18%,RIMS1;SYT1;SYN3;SNAP25;SYN2;RAB3A;LIN7A;GAD2;GAD1;CDK5;PCLO;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.7979745997910255,1.3296253628560686,0.2,1.0,1.0,2/5,9.08%,HMGB1;PARP3
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.7760035090071282,1.3293683430976122,0.17647058823529413,1.0,1.0,2/6,6.64%,MOGAT1;PLCE1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.824384722631905,-1.3292680102608203,0.19047619047619047,0.914416507696435,1.0,3/6,17.42%,TNFRSF1A;RIC1;TNFRSF1B
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.7578531969846822,-1.3291375449599967,0.1774193548387097,0.9127531121162777,1.0,2/10,6.70%,NEFL;SYBU
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.8363787622452361,1.328888847546969,0.06666666666666667,1.0,1.0,1/6,5.91%,ATG9A
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),-0.837688130541473,-1.3285188973551536,0.14035087719298245,0.9144925112118609,1.0,1/6,0.29%,ANGPT1
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.764947123627219,-1.327930672413925,0.09090909090909091,0.9159089143812105,1.0,2/12,2.85%,PARP9;IFNGR2
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),0.8133495753219883,1.3277825704073751,0.0625,1.0,1.0,4/9,3.93%,TNNC2;CCDC78;MYH3;STAC3
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.8459844018821966,1.3277691281726245,0.14285714285714285,1.0,1.0,1/5,5.86%,JMJD6
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),-0.8341473412044005,-1.3274401653284023,0.1016949152542373,0.9166083675662166,1.0,1/7,0.30%,ITGB4
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.5944247529449832,-1.32726798034465,0.06779661016949153,0.9154950419378233,1.0,12/71,13.03%,CD44;STAT5A;ADCY7;GMFG;DOK3;PIM1;MFSD2B;GATA1;NMI;FAM117A;ADGRE2;DOCK2
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.7090900651636427,-1.326488298943903,0.09230769230769231,0.9188402920210221,1.0,6/21,14.23%,AQP1;PRKAR1B;ADCY7;RAB11A;AQP4;ADCY8
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.731347350282986,-1.3264296165910179,0.09836065573770492,0.9166312414656407,1.0,2/15,1.52%,PDGFD;NR4A3
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.6191759509996595,-1.3262267562269336,0.0958904109589041,0.9152754678406829,1.0,17/60,19.62%,LPL;PPARG;CDS1;ID2;LMO3;E2F1;RUNX1T1;WWTR1;XBP1;CEBPB;ZFPM1;GNB3;ZFP36;NR1D1;WNT5A;TGFB1;AAMDC
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.5513545090797746,1.325967199225948,0.10526315789473684,1.0,1.0,6/47,12.21%,NUPR1;PSME2;OSBPL7;BAG2;UBB;COMMD1
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.7372841510134786,-1.3245495241642504,0.10144927536231885,0.9245975134869348,1.0,5/14,10.10%,IRGM;PLSCR1;IFITM3;IRF1;XAF1
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.5800087464339548,1.3243454488904884,0.11764705882352941,1.0,1.0,15/54,17.00%,SQLE;DHCR24;HSD17B7;SOAT2;MSMO1;HMGCS1;ACAA2;PMVK;HMGCR;IDI1;LCAT;ARV1;ACAT2;CLN6;FDX1
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.5533681346786412,-1.3239567972065374,0.13043478260869565,0.9261229930410508,1.0,12/108,8.63%,CD44;ANGPT1;ROR1;PDGFD;PTPRC;IL26;PRXL2C;CSF1R;HLA-DRB1;TEK;HTR2C;CHI3L1
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.6808577287659667,1.3234930944198398,0.20512820512820512,1.0,1.0,1/16,0.21%,CXCR4
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.7828441218977068,-1.3226812425012051,0.10526315789473684,0.9326105414607883,1.0,2/11,4.81%,MT1M;GLRA2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.7548505225200222,-1.3224582603916508,0.07352941176470588,0.9315012493627648,1.0,3/15,4.07%,KDM4D;PARP9;DTX3L
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.5945173586639428,-1.322406995949414,0.078125,0.9292662931075456,1.0,18/79,15.99%,TLR2;ISG15;PLSCR1;PTPRC;IFITM3;MX1;ISG20;IRF1;TRIM5;DDIT4;SAMHD1;IFNA2;AGBL4;MOV10;RSAD2;ABCC9;IFIT1;STAT1
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.7178057725298148,-1.3223108143988838,0.125,0.9250268647235937,1.0,3/17,10.81%,VIL1;TWF2;ADD2
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.7178057725298148,-1.3223108143988838,0.125,0.9250268647235937,1.0,3/17,10.81%,VIL1;TWF2;ADD2
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),0.820631981028175,1.322280702107616,0.1951219512195122,1.0,1.0,1/6,7.49%,MST1
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),-0.6571579629254276,-1.3222669020108808,0.12121212121212122,0.9229389551109425,1.0,7/27,20.26%,NDST3;XYLT2;CHST9;CSGALNACT1;BMPR1B;CHST8;B3GAT2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.724024018859162,-1.3222537621598767,0.09836065573770492,0.9204261572786292,1.0,3/14,7.14%,LGALS3;LAPTM5;FGL1
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.7167061865192212,1.3220925034560267,0.125,1.0,1.0,3/11,8.42%,CMPK1;AK8;AK3
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.6463524456138243,-1.3217093012120071,0.04918032786885246,0.9218472230400339,1.0,5/44,5.59%,CD44;NAGLU;PRELP;CEMIP;OGN
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.7732897231518786,-1.3212083956155896,0.11940298507462686,0.9230702610097384,1.0,2/12,1.62%,TLR2;PLSCR1
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.6234610214471658,-1.321200461843812,0.07352941176470588,0.9205783282129127,1.0,1/58,0.11%,GPAT3
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.7910907051996866,-1.3208105663976786,0.16393442622950818,0.9209883519490869,1.0,5/11,20.01%,LPL;PPARG;CDH13;SYK;ABCA1
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.7055095132491706,-1.3205009708047897,0.08620689655172414,0.9205886391768663,1.0,3/17,9.67%,TIMP4;TIMP1;FURIN
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.7461971696871385,-1.3202367139529003,0.15254237288135594,0.9199227647571678,1.0,2/9,14.03%,SFRP4;BMPR1B
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.8823393593171585,-1.3201906858592811,0.05454545454545454,0.9177885411019847,1.0,1/5,2.15%,DOCK8
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.7942307956020069,-1.3199519656611387,0.1346153846153846,0.9169473115161062,1.0,1/8,1.14%,CPS1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.7366977645342301,-1.3195930968208374,0.06557377049180328,0.9166696874132997,1.0,3/15,6.80%,CLU;EDN1;DDAH1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.8484489812270204,-1.3195929166317486,0.05454545454545454,0.914137450707738,1.0,2/6,2.32%,HLA-F;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.625975502858651,1.319529938193454,0.0975609756097561,1.0,1.0,7/44,5.72%,NGF;MAPRE2;VAV1;GPR174;RASGRF1;RAPGEF1;MMD2
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.6164203711771737,1.3188338296586102,0.17647058823529413,1.0,1.0,10/22,22.22%,HDAC10;HDAC1;ABHD17A;HDAC4;ABHD10;SIRT6;HDAC3;LYPLAL1;SIRT1;SIRT7
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),-0.7327633223217968,-1.3182751323097865,0.12903225806451613,0.9213865139237006,1.0,2/11,5.56%,PDZK1;TRPC6
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.833838911148894,-1.3182724642287098,0.16363636363636364,0.9188816293512019,1.0,2/5,9.33%,TIMP1;GJA1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.7292027701083317,-1.3179839919419638,0.10294117647058823,0.918733371895647,1.0,4/15,17.13%,IL26;TGFB2;LYN;SCIMP
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.793056901387679,-1.317721082615321,0.14925373134328357,0.9179558570796863,1.0,1/9,0.33%,PKP2
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.8098668921303013,1.317716681297384,0.16666666666666666,1.0,1.0,3/8,8.72%,NUPR1;FBP1;CBFA2T3
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.8098668921303013,1.317716681297384,0.16666666666666666,1.0,1.0,3/8,8.72%,NUPR1;FBP1;CBFA2T3
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),0.8223421857331645,1.3176967041118866,0.125,1.0,1.0,2/6,8.82%,OOEP;DMRT1
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.7901542114904753,-1.317671810861543,0.10909090909090909,0.9158996967118415,1.0,2/13,1.85%,PTPRC;P2RY12
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.7893028370983725,1.3175760270536694,0.21951219512195122,1.0,1.0,4/7,16.37%,PUS7;DKC1;PUS1;RPUSD2
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.6099870322287952,1.316901431038078,0.12121212121212122,1.0,1.0,8/36,10.88%,KIF3B;MAP10;ZNF207;FLNA;TPX2;KIFC2;KIFC1;BCCIP
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.5611436205443355,-1.3168380408345857,0.06666666666666667,0.9197556015490347,1.0,31/101,20.40%,FBLN1;IGFBP3;SPARCL1;PPP1R3C;SERPING1;MAOB;PLSCR4;NOS1;AQP1;COL4A1;CALB2;CXCL14;TEK;HSD11B2;ADAM21;KIAA1217;GJA1;CPE;C1R;SLC22A3;MATN2;ADGRF5;COL21A1;EGFR;LMOD1;SYNPO;MLANA;GAS6;TIMP3;ANGPTL2;LAMB2
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.6289203416501117,1.3167375917083235,0.10256410256410256,1.0,1.0,6/23,11.32%,VDR;RUNX1;ERRFI1;NUMA1;CTSK;TRIM16
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.8393616633105853,-1.3166731181769735,0.0967741935483871,0.9182264958341692,1.0,1/7,3.17%,DDX60
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.8358731069010753,1.3164384667704214,0.17073170731707318,1.0,1.0,1/8,0.27%,AMPD1
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.6954912237037576,-1.3160985830151635,0.08860759493670886,0.920081625391924,1.0,7/19,13.25%,TGFB2;NCKAP1L;LGALS3;EDN1;SCG2;ADGRE2;SRP54
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.7125005958263761,-1.3157798330414114,0.11475409836065574,0.9205282081735069,1.0,6/19,20.01%,LPL;PPARG;ITGAV;MSR1;NFKBIA;ABCA1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.6228332011046293,1.3151678278293317,0.1388888888888889,1.0,1.0,1/24,0.14%,ABCA13
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.6476666750428092,-1.3146835961373688,0.14925373134328357,0.9259574604027462,1.0,2/26,0.99%,KANK2;ZNF366
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.7474533982584218,1.3144206234869542,0.24324324324324326,1.0,1.0,5/10,24.36%,METAP1D;NAA50;NAA11;NAA40;NTMT1
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.849741530414365,1.3142475467462045,0.08333333333333333,1.0,1.0,3/10,2.49%,ICAM1;AGER;XG
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.6154332045142126,1.3138571593878146,0.16216216216216217,1.0,1.0,6/22,13.90%,HSPA1A;CHMP5;NUMA1;HSPA1B;TPR;HNRNPU
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.5320705139102626,-1.3132747414260195,0.057971014492753624,0.9333153714527285,1.0,12/119,6.37%,CD44;TIMP1;TGFB2;IFITM3;CLU;ISG20;BCL2L2;BIRC3;IRF1;LGALS3;HGF;CCND1
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.6862722805668985,-1.3130299219813026,0.14754098360655737,0.932798102475929,1.0,5/25,9.44%,BIRC3;IRF1;TRIM5;ERAP1;SAMHD1
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.6953479348457517,1.312987522094419,0.15,1.0,1.0,6/11,21.56%,HMGA2;CDK6;YBX1;SLC30A10;ZKSCAN3;SIRT1
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.528258518875956,-1.3128794463222466,0.05714285714285714,0.9313611734317272,1.0,17/158,8.63%,CD44;ANGPT1;ROR1;FBLN1;PDGFD;PTPRC;IL26;APIP;RPS6KA6;CEACAM1;PRXL2C;CSF1R;HLA-DRB1;TEK;HTR2C;LMO3;CHI3L1
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.7806982533467328,1.3127430583349222,0.225,1.0,1.0,2/8,10.45%,OTUD3;USP37
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.7012142523155802,-1.3127138303998722,0.09090909090909091,0.930161879025546,1.0,4/17,4.02%,TGFB2;NCKAP1L;LGALS3;EDN1
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.6523877605679095,1.312219094041082,0.10869565217391304,1.0,1.0,4/22,7.63%,NGF;HMGB1;PYHIN1;PINX1
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),0.7507784230366848,1.3114319666428997,0.20512820512820512,1.0,1.0,1/8,2.12%,OAS3
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.6039507900754613,1.311324561640125,0.07692307692307693,1.0,1.0,10/44,8.97%,SPIRE2;OOEP;HDAC10;HMGB1;EYA4;MGMT;H2AX;RNF168;TMEM161A;BRCC3
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.7910447091437688,1.3107830796539417,0.08888888888888889,1.0,1.0,1/7,3.38%,ACADS
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.6845860752654319,1.3104141721757776,0.18181818181818182,1.0,1.0,2/14,13.22%,SMARCD3;SMARCA4
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),0.7329551748939367,1.3102746248177795,0.22857142857142856,1.0,1.0,2/11,1.96%,ICAM1;ITGAL
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),-0.7787270365777588,-1.3102285163309686,0.06666666666666667,0.9465548497848221,1.0,2/10,5.43%,TGFB2;SOX9
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.7136810435754526,-1.3102138295009311,0.171875,0.944254091548019,1.0,7/18,19.52%,PTPRC;TOX;IFNA2;IFNK;AXL;IFNA6;RASGRP1
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.657967580083829,1.3099925020475267,0.1935483870967742,1.0,1.0,4/20,9.55%,RPP40;ERI1;URB1;EXOSC8
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.7757012979064477,-1.3098892731886744,0.14035087719298245,0.9438161939245844,1.0,7/11,19.59%,PTPRC;MEF2C;IFNA2;IFNK;IFNA6;RASGRP1;CR2
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.602401076134913,1.3097012338993348,0.15151515151515152,1.0,1.0,8/33,19.36%,UBC;CDC26;KNTC1;ANAPC15;UBB;ANLN;ANAPC1;CDC23
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.832237295605692,1.3095714802880694,0.15217391304347827,1.0,1.0,2/5,9.28%,PRPF39;SNRPC
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.561270930459718,1.309303997190721,0.09523809523809523,1.0,1.0,2/57,1.98%,GABRE;GABRR1
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.799906572895528,-1.3091370546998167,0.14035087719298245,0.9469205855906976,1.0,1/8,0.02%,CD44
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.8399531427175491,-1.3086401924914057,0.08064516129032258,0.947915484514903,1.0,3/6,12.46%,TPCN2;CAV1;CAV2
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),0.7676454986042633,1.307648997655658,0.26666666666666666,1.0,1.0,3/6,19.58%,RNF168;RNF8;LIG4
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.770508680982245,-1.3073683740437598,0.09523809523809523,0.9555456242746263,1.0,4/11,15.31%,IGFBP3;IGFBP4;CDH3;IGFBP2
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),0.8125177496055571,1.3069644962009492,0.047619047619047616,1.0,1.0,1/5,11.47%,BMP5
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.7742347925529309,-1.3069181744905982,0.1,0.9561866701427579,1.0,1/10,1.04%,LPL
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),-0.7910078067213706,-1.3069010250108495,0.09836065573770492,0.9537716673262467,1.0,3/10,5.89%,BAIAP2;GAS2L3;BAIAP2L2
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),-0.7846173027403216,-1.3066424135810393,0.14285714285714285,0.9533907447640196,1.0,3/6,20.37%,ROBO2;WNT5A;LHX6
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.7302875957638708,-1.3066226984433935,0.16129032258064516,0.9510452833725862,1.0,4/10,17.10%,CX3CR1;NMI;IFI35;SYK
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),-0.8170396165375503,-1.3065268180158502,0.13846153846153847,0.949506446962744,1.0,1/6,1.13%,TLR2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.6939303829272585,-1.3063925553747469,0.11666666666666667,0.9480250712020974,1.0,1/16,0.75%,MDFIC
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),-0.8870483477416302,-1.305414450622825,0.04918032786885246,0.952331249843798,1.0,3/5,6.83%,HLA-F;NCKAP1L;CEACAM1
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.7308550386603911,1.3052550106286394,0.20588235294117646,1.0,1.0,2/11,8.26%,POLD3;ACTR5
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.8578896148846807,1.3045238578978413,0.2,1.0,1.0,3/5,9.28%,SPRY2;SPRED1;SPRED2
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.5673108495011283,-1.3043860745784284,0.13636363636363635,0.9577486592580307,1.0,22/83,11.05%,CD44;DPEP2;TLR2;FGL2;PLSCR1;PTPRC;IFITM3;ITGAM;MX1;AOAH;CD53;RHOC;SELL;LAPTM5;P2RY13;CSF1R;C3AR1;RGS1;IGSF6;PTAFR;CEBPB;CX3CR1
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.6772762861968945,-1.3043733731531284,0.14705882352941177,0.9552991741959896,1.0,6/22,7.57%,LPL;TLR2;C5;IL6R;CSF1R;IL7
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.7538945248988353,1.30413705933694,0.21621621621621623,1.0,1.0,3/7,2.63%,SCN11A;SPX;MGLL
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.6216284257595747,-1.3039636685691758,0.1388888888888889,0.955582969104395,1.0,13/44,22.33%,VIL1;TGFB2;SOX9;RAB11A;CEACAM1;PTPRG;PTPRR;BMPER;PLCG1;RHOJ;RREB1;PTN;GLIPR2
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.8557249521676497,-1.303956802271115,0.0847457627118644,0.9532003586462878,1.0,2/6,5.61%,GUCY1A1;NPR2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.8528910620897115,-1.3038923531978575,0.058823529411764705,0.9511712624886741,1.0,3/7,8.31%,HLA-A;ERAP1;B2M
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.8356132830217513,-1.3038335256223137,0.05357142857142857,0.9491767656268815,1.0,5/7,16.29%,P2RY12;SFTPD;LGALS3;EDNRB;CXCL17
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),0.772621394277065,1.303656249058408,0.13333333333333333,1.0,1.0,1/7,12.63%,PJVK
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.663563018954936,-1.3034971649519533,0.15254237288135594,0.9492547788765193,1.0,2/15,7.79%,CALY;NSG2
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.7130343863930266,-1.3032691212683913,0.08928571428571429,0.9487031251377764,1.0,3/20,6.27%,CLU;GNPTAB;LAPTM5
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.7429031976550767,1.3028663039959862,0.21212121212121213,1.0,1.0,1/9,0.86%,TRARG1
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.693688703310662,1.3027128007935906,0.23809523809523808,1.0,1.0,6/14,18.05%,NUTF2;BANF1;ANP32A;NXT2;RBM15B;NPM1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),-0.6469036895030038,-1.302632218459242,0.10144927536231885,0.9506167309969255,1.0,12/33,19.54%,PTPRC;NOX4;EPHA4;CSF1R;GRM5;EFNA1;THY1;CAV1;DLG4;SH3BP5;GAS6;NEDD9
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),-0.855466551465076,-1.3024990856537664,0.1774193548387097,0.9494142277793227,1.0,2/5,14.21%,EDN1;EDNRB
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),-0.6933359385239699,-1.3024149726843914,0.3050847457627119,0.9476892679534298,1.0,1/13,1.13%,YBX3
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.7885055505417519,1.3023255942687122,0.23076923076923078,1.0,1.0,1/5,3.40%,DICER1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.6941595931744496,-1.302262942414322,0.09090909090909091,0.9466438311864097,1.0,4/19,4.02%,TGFB2;NCKAP1L;LGALS3;EDN1
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.5940355575906724,1.3022616338515198,0.19230769230769232,1.0,1.0,9/34,11.62%,MBOAT1;GPAT2;ABCA8;SPHK2;AGPAT5;CPNE1;HDHD5;IDI1;CPNE7
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.8273073423366366,-1.3019615945408773,0.046153846153846156,0.9460338282630433,1.0,3/9,6.83%,HLA-F;PTPRC;CEACAM1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.5733583266454448,-1.3018556456569055,0.07462686567164178,0.944377782427379,1.0,32/104,20.40%,FSTL1;MMRN2;SPARCL1;ADAMTS5;ROBO4;ENC1;CLDN16;SERPING1;MAOB;PLSCR4;AQP1;COL4A1;DKK3;TEK;NRGN;SORBS2;C1R;DRAM1;LRP1;EDNRB;ADGRF5;CYYR1;LMOD1;SYNPO;SLC11A2;LDB2;TIMP3;NKAIN4;PLXNA2;CX3CL1;ANGPTL2;LAMB2
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.6185658888810155,-1.3017926249855605,0.10144927536231885,0.9425634504158049,1.0,10/49,13.06%,PLSCR1;HLA-E;PARP9;BIRC3;IRF1;ERAP1;SAMHD1;NMI;IFNK;IFI35
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",-0.8341213240525286,-1.301266201822616,0.06349206349206349,0.9444591412964549,1.0,2/5,7.38%,NCKAP1L;HLA-DRB1
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.6321623880694179,-1.3012330897528723,0.2,0.9422985515561658,1.0,12/33,20.85%,TLR2;IFITM3;GBP2;GBP3;AQP4;DAPK1;DAPK3;STAT1;CALCOCO2;WNT5A;CX3CL1;CIITA
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.5514684898718097,-1.3008639859239748,0.0684931506849315,0.943075993368003,1.0,24/77,20.50%,TRPM1;TRPC4;SLC8A3;ATP2B3;TRPC6;TRPM3;ANO6;RYR3;SLC24A5;SLC8A1;TRPC7;SLC24A1;GRIN2B;GRIN2D;ITGAV;SLC24A4;CACNA1G;CACNA2D4;TRPV4;GAS6;TRPV3;TRPM2;MICU3;CACNA1C
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.8088899812756909,-1.3008221949689742,0.14754098360655737,0.9410942370447435,1.0,2/8,3.88%,OLFM1;NRCAM
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.7411597519393972,-1.3003059081256956,0.12280701754385964,0.9424111546760753,1.0,2/18,4.88%,ENC1;PSMB8
prerank,PanglaoDB_Augmented_2021__Astrocytes,-0.5454447520999997,-1.299259178608791,0.05555555555555555,0.9473541411916288,1.0,47/140,20.33%,TCEAL6;SPARCL1;STMN2;SHISA6;GAP43;ASTN1;CNTFR;TCEAL5;VIM;KCNIP1;SOX9;SYNPR;SNAP25;ATP2B2;DKK3;CADM3;GRM5;OPALIN;ALDH1L1;GJA1;LRRTM3;PHF24;ATP1B2;RGS7BP;GRIA3;BAALC;AQP4;OPCML;BRINP1;EDNRB;ADCY8;LRRC3B;PHYHIP;PTPRZ1;SCN4B;MAPK4;LY6H;DIO2;ADCYAP1R1;GPR37L1;SPHKAP;NRXN1;RAPGEF4;NKAIN4;PTPN5;SLC6A11;SLC1A6
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.7746770284461326,-1.299253125262832,0.15873015873015872,0.945095900115903,1.0,4/11,9.67%,LPL;GPIHBP1;RHOC;FURIN
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.6835190913960852,1.2990944953319563,0.11428571428571428,1.0,1.0,2/14,7.61%,HMGCS1;PMVK
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.7641526116264933,-1.2989023140518658,0.1,0.9452973971062874,1.0,2/11,2.96%,VIL1;TWF2
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.7775994032383335,-1.2984783521693448,0.1,0.9454979183243214,1.0,1/12,3.04%,STAT5A
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.5751488890641483,-1.2983447693198156,0.07936507936507936,0.9440032132176471,1.0,13/64,14.13%,SLC28A2;RIMS1;SYT1;SYN3;SNAP25;SYN2;SLC1A1;RAB3A;LIN7A;GABRA2;SLC22A3;SLC18A2;GAD2
prerank,PanglaoDB_Augmented_2021__Spermatocytes,-0.6629494463732438,-1.2981060564922398,0.16176470588235295,0.943603906420174,1.0,7/18,16.13%,TXNDC8;TP73;CAPN1;TTC6;SYCP2;SLC25A31;SYCP3
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.6682598699946294,-1.2978987687756818,0.1746031746031746,0.942721473404859,1.0,2/21,2.68%,PEX11A;MX1
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.6945712722762091,1.2970211783468895,0.12121212121212122,1.0,1.0,2/13,13.22%,SMARCD3;SMARCA4
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.6945712722762091,1.2970211783468895,0.12121212121212122,1.0,1.0,2/13,13.22%,SMARCD3;SMARCA4
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.6380018737111903,1.296821469574185,0.1891891891891892,1.0,1.0,2/22,7.00%,PDE3A;ZNF335
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.641475938056919,-1.2967148134987472,0.04477611940298507,0.9489632621931019,1.0,11/37,14.28%,TRPM1;GRIK2;GRM5;GRM7;PLCB1;GRIK1;CDK5R1;GRIN2B;GRIA3;GRM6;KCNB1
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.6003223039701522,1.2966619529134127,0.14634146341463414,1.0,1.0,1/19,0.68%,NUPR1
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.6903213296069798,-1.296296606324702,0.06349206349206349,0.9497962483771148,1.0,9/23,13.99%,CARTPT;RIMS1;SYT1;EDN1;GRIK2;LGI1;RIMS2;CLSTN3;DLG4
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),0.7248742839325268,1.2961868498419888,0.21951219512195122,1.0,1.0,6/16,22.06%,HSD17B7;TSPOAP1;STAR;FDX1;FDXR;SRD5A1
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.6905992705029067,-1.2959558321858469,0.1206896551724138,0.9499602290029932,1.0,7/24,8.42%,TLR2;H2BC11;HLA-E;IL12A;GBP2;HLA-A;CHGA
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.767706432872479,1.2957620702049117,0.1282051282051282,1.0,1.0,4/9,17.09%,HDAC1;HDAC9;HDAC4;HDAC3
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.6361018215662961,1.295329727683764,0.15789473684210525,1.0,1.0,3/21,5.04%,CDSN;TXNIP;TGM1
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.7910256292594928,1.2952064973076598,0.17647058823529413,1.0,1.0,2/9,2.44%,EPB41L4B;MAPRE2
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8233318718731201,-1.2942260792607223,0.16393442622950818,0.9607614436101309,1.0,1/7,0.21%,EPN1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),-0.6489378964305668,-1.2939846996402031,0.11666666666666667,0.9600997907676483,1.0,8/27,18.91%,SHISA6;MCTP1;GRIK2;SLC4A10;RAB3A;DLG4;NETO1;CAMK2B
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.5783488787095092,-1.2936878712970161,0.10606060606060606,0.9597372710759448,1.0,17/54,11.04%,SRGN;TLR2;FGL2;PTPRC;HLA-E;ITGAM;IL6R;BIRC3;IRF1;GBP2;LAPTM5;CSF1R;C3AR1;NLRP3;IGSF6;PTAFR;GPR183
prerank,PanglaoDB_Augmented_2021__Delta Cells,-0.5311546113855781,-1.2933822096014773,0.05405405405405406,0.9596263326236244,1.0,53/106,18.43%,BCHE;KCNT2;SPARCL1;PCSK2;STMN2;LRRTM1;PCSK1;SHISA6;SSTR1;MAOB;PPP1R1A;ASTN1;SYT4;TCEAL5;GABRG2;KCNIP1;VSTM2A;KALRN;SNAP25;TMEM179;CNTN1;CDH22;SORBS2;CHGA;SCG2;DACT2;FAM149A;RAB3C;CPE;CHGB;NPTX2;ETV1;ELAVL4;ACTL6B;TSPAN7;RGS7BP;GRIA3;ASIC2;ST8SIA3;GAD2;NOL4;RBP1;PTPRT;TMEM196;KCNB2;CNTN4;MAPK4;LY6H;UNC5D;SYT13;GABRB3;NRXN1;RAPGEF4
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.5425053789735924,-1.293375847130133,0.07894736842105263,0.9574083862237297,1.0,26/113,15.62%,DLK2;NUDT11;TGFB2;TEX15;CLDN16;MX1;C5;EDN1;CNTFR;NOS1;PLAG1;SNN;FGF22;CHST2;HSD11B2;CAMK1D;SNCB;ZC2HC1C;KLHDC8A;ARHGDIG;STAG3;CLSTN3;BMPR1B;RSAD2;IGFBP2;MYOT
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.6337467003317733,-1.2931322434217272,0.1111111111111111,0.9571225831254886,1.0,5/31,10.24%,GSAP;CLU;EPHA4;EFNA1;LRRTM3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),-0.7690448366589727,-1.2925439845789402,0.16923076923076924,0.9591387556579516,1.0,2/7,12.57%,PPARG;E2F3
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.7618710080198758,-1.291966233836321,0.12727272727272726,0.9609879678817402,1.0,2/12,5.43%,PPARG;SOX9
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.7499561617152496,-1.2918174984391657,0.14925373134328357,0.9596631121411294,1.0,3/12,9.33%,FBLN1;PTPRC;GJA1
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.5604932900807408,-1.2916750763936937,0.09859154929577464,0.9585460104268322,1.0,31/95,18.83%,STMN2;RIMS4;NYAP1;GAP43;ASTN1;CLVS2;TMEM179;HPCA;PIANP;GRM5;PCDH8;SULT4A1;CTXN1;SNCB;CDK5R2;CAMK2N2;ACTL6B;TAGLN3;ASIC2;GNG3;OPCML;BRINP1;INA;PHYHIP;SCAMP5;MAPK8IP1;LY6H;CSPG5;GAD1;CNIH2;JPH3
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.4957349571684763,1.2916615980666988,0.0625,1.0,1.0,19/112,11.28%,NUPR1;CRYAB;VASH1;CRHBP;AIFM2;HSPA1A;RAE1;SLC38A2;NUP42;FKBP4;RSL1D1;ATF4;NUP210;ABL1;MLST8;BAG2;CASP9;HSPA1B;ATF3
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),-0.8585562230534786,-1.2915748243892253,0.14,0.9570318870190787,1.0,2/6,2.25%,HEY1;OLFM1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.6095404969987326,-1.2914834265834083,0.13043478260869565,0.9553687347019899,1.0,5/41,6.45%,ANGPT1;PPARG;STAT5A;MEF2C;ANGPT2
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.7852702855160107,-1.2909435007342398,0.16393442622950818,0.9571830289403686,1.0,1/7,3.91%,SYT4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.7139245449926436,-1.2899313862388084,0.1206896551724138,0.9619624833845198,1.0,7/13,19.67%,HLA-E;IRF4;NLRP3;CEBPB;PRKCQ;SYK;PRKCZ
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),0.8098586718006263,1.289680908040256,0.20930232558139536,1.0,1.0,1/5,11.97%,VPS25
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),0.8098586718006263,1.289680908040256,0.20930232558139536,1.0,1.0,1/5,11.97%,VPS25
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.7334221508538676,1.2896556161286938,0.2222222222222222,1.0,1.0,1/6,4.42%,ASAP1
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.8265195298789445,-1.2895502381560262,0.13333333333333333,0.9623805767743345,1.0,3/7,13.26%,AQP1;AQP11;AQP4
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.693299770673476,-1.289456395202507,0.1076923076923077,0.9607425105470094,1.0,2/22,0.73%,DLK2;HEY1
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),-0.8052553025247291,-1.2892913186779866,0.16393442622950818,0.9595967924440103,1.0,5/8,14.21%,HEY1;TMEM204;MEF2C;MRTFB;EDNRB
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.5847792951980954,1.2892744646714303,0.10256410256410256,1.0,1.0,13/67,10.75%,TEAD2;PYCR1;EPHB4;NOC2L;FKBP4;TUBA1C;SLC52A2;EIF3B;PTBP1;TEAD3;MRPS2;HDGF;TUBG1
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.7593390120199587,1.2892531284527942,0.2702702702702703,1.0,1.0,2/8,12.70%,CYP2C8;LTA4H
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.8280128522464814,-1.2884652899559854,0.125,0.9629197767017409,1.0,2/6,11.27%,VIL1;PLEKHH2
prerank,PanglaoDB_Augmented_2021__Glomus Cells,-0.5419810935199941,-1.2884316476309243,0.10294117647058823,0.960984577107467,1.0,24/116,13.67%,TNFRSF1A;PPP1R3C;GAP43;CHST1;CNTFR;NOS1;VIM;COL4A1;FIGN;BOC;DKK3;DCLK1;GFRA2;PCDHB4;FNDC4;GJA1;TENM3;CPE;CBS;THY1;ADGRL2;NR2F1;SMIM10L2B;GPC6
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.6687944727742899,-1.28826281022845,0.14754098360655737,0.9599774609747489,1.0,4/22,13.14%,NR4A3;EDN1;MLIP;CAV3
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),0.7454396740218283,1.2881056165149565,0.17777777777777778,1.0,1.0,2/14,2.73%,LOC400499;CRHBP
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),-0.8431034423394084,-1.2874897264959784,0.2033898305084746,0.9630585476946486,1.0,1/5,6.61%,PIK3AP1
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.5860455936868006,-1.2874809600982324,0.12698412698412698,0.9609401056105393,1.0,12/52,20.02%,DACT1;VSIR;APC2;NEDD4L;HECW1;TRIM32;C4BPA;GPC3;WNT5A;OAZ3;PLK2;DTL
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.8048585618597194,-1.287376797988966,0.09803921568627451,0.9596355831574976,1.0,4/11,5.14%,CD59;SERPING1;CR1;A2M
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),0.7977321460930134,1.2872975441454093,0.2894736842105263,1.0,1.0,2/5,8.25%,FSHR;PAX8
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),-0.7481529921046479,-1.2870141135691093,0.20967741935483872,0.9598769176837582,1.0,3/12,9.67%,LPL;GPIHBP1;FURIN
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),0.8210690683901348,1.2869860655783443,0.23076923076923078,1.0,1.0,1/5,0.95%,DHFR
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.5887162169049421,-1.286921223682272,0.13636363636363635,0.9583642577025437,1.0,5/45,9.31%,DPP10;EPHA3;LGALS3;STAC2;STX3
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.6752580652018552,1.2868841844726164,0.1951219512195122,1.0,1.0,1/10,3.40%,DICER1
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),0.8015809639127632,1.2866657035293556,0.23809523809523808,1.0,1.0,1/6,4.58%,SOD3
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.7869882922393094,-1.285717924901298,0.16071428571428573,0.9641781524000709,1.0,2/7,9.94%,SAMHD1;POLQ
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.6439608118769256,-1.285201696042769,0.140625,0.9655925868177148,1.0,6/33,11.47%,OLFM1;TGFB2;TGFBR2;TGFB3;WWTR1;CRB2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.8559449882007714,-1.284854207883046,0.08333333333333333,0.965517496835601,1.0,4/7,8.31%,HLA-F;HLA-E;HLA-A;B2M
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.75981819980487,1.2847553175351294,0.22727272727272727,1.0,1.0,4/10,15.39%,NLGN3;PTPRD;IL1RAPL1;NLGN2
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.6666284044404257,-1.2847102057124133,0.14084507042253522,0.9644132567693907,1.0,4/15,13.40%,MEF2C;LRRK2;GRIN2B;GRIN2D
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.704636062692084,-1.28452873326886,0.14754098360655737,0.9617497495050725,1.0,1/15,1.75%,MGST1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.704636062692084,-1.28452873326886,0.14754098360655737,0.9617497495050725,1.0,1/15,1.75%,MGST1
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.7964053706907789,-1.2845235393901657,0.15517241379310345,0.9596811815208095,1.0,1/7,8.63%,CHI3L1
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.7300226505846666,-1.2840541054378163,0.10606060606060606,0.9604490550498447,1.0,3/13,6.97%,FBLN1;SPINT2;ACTN1
prerank,GO_Biological_Process_2021__detection of molecule of bacterial origin (GO:0032490),0.8201056517694625,1.283715268892483,0.2391304347826087,1.0,1.0,1/5,0.61%,SSC5D
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.6424928167120696,-1.2835065083511867,0.15151515151515152,0.9624225586812828,1.0,1/25,0.75%,MDFIC
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.713657606280774,1.2834509652444834,0.24324324324324326,1.0,1.0,2/8,2.49%,ZAP70;XG
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.7106349977660927,-1.2831993768182697,0.09859154929577464,0.9626942355065646,1.0,3/19,12.35%,CARTPT;CEBPB;UBASH3B
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),-0.757867745775231,-1.283194526495574,0.16666666666666666,0.9606628945892679,1.0,4/12,16.78%,HEY1;GJA1;NOTCH2;CACNA1G
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.7139246654741909,-1.2831299614298988,0.10144927536231885,0.9590618897959136,1.0,3/14,5.61%,GUCY1A1;ADCY7;NPR2
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.7236076135434121,1.2826100266026015,0.2127659574468085,1.0,1.0,6/11,23.93%,NLGN3;PTPRD;IL1RAPL1;NLGN2;CNTN2;NLGN4Y
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.8270246644959933,-1.28224228689506,0.11475409836065574,0.9630395772041719,1.0,1/7,0.57%,PEX11A
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),-0.8582094454824097,-1.2820418106400508,0.14285714285714285,0.9625732578296298,1.0,1/5,1.78%,PPARG
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),-0.8398123674241724,-1.2808448372133205,0.16129032258064516,0.9691635987857159,1.0,2/5,10.64%,LPL;XBP1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.7444961633165048,-1.2807589557025518,0.17391304347826086,0.9677460289505885,1.0,4/11,18.43%,NOS1;PLN;CAV3;LILRB1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.7003034869599711,-1.2806863708701237,0.1267605633802817,0.9661470239177663,1.0,4/20,13.33%,IRGM;CEMIP;CHI3L1;CALM3
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.8334558978219709,-1.2805682634082707,0.12280701754385964,0.9651788714738841,1.0,4/7,13.26%,AQP1;NEDD4L;AQP11;AQP4
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.8588309088506788,-1.2804316125315445,0.08064516129032258,0.9640488790054114,1.0,1/6,0.33%,CARTPT
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.6020057793305967,-1.2801122119251667,0.12857142857142856,0.964083407310321,1.0,7/32,15.49%,TRPM1;TRPM3;SLC25A19;ASIC2;SLC25A20;ABCC9;SLC7A8
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.8021255449807889,-1.2797754662641072,0.09859154929577464,0.9639731425757709,1.0,2/6,6.27%,DTX3L;LAPTM5
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.6982660833732842,-1.279440318184149,0.19402985074626866,0.9642963534843244,1.0,3/15,5.09%,CYSLTR2;PRKAR1B;ADCY7
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.8558877371423524,-1.2794045586913343,0.15,0.9604218014489423,1.0,3/6,5.93%,HLA-F;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.8558877371423524,-1.2794045586913343,0.15,0.9604218014489423,1.0,3/6,5.93%,HLA-F;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),-0.7672185096938774,-1.2792107061966835,0.16666666666666666,0.9600744371629842,1.0,4/9,15.68%,AQP1;SLC23A1;AQP11;SLC2A2
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.5501123482155331,1.2790772099977719,0.17857142857142858,1.0,1.0,7/39,9.97%,SQLE;SC5D;MSMO1;OSBPL7;PMVK;HMGCR;CYP7B1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.538590506117448,-1.2790216667461496,0.10810810810810811,0.9597285510229239,1.0,9/79,10.89%,HLA-F;CENPE;HLA-E;HLA-A;HLA-DRB1;HLA-DPB1;HLA-DMA;DYNC1LI1;SH3GL2
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),0.7548767465411688,1.278968410020102,0.23809523809523808,1.0,1.0,2/6,5.41%,CFAP43;ODAD2
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-0.783440169600605,-1.2788444129571563,0.10714285714285714,0.9590373289384888,1.0,2/7,4.85%,TGFB2;TGFBR2
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.5956399816084547,-1.2786728989308018,0.13793103448275862,0.9582879645988979,1.0,4/36,10.69%,YBX3;DND1;E2F1;ELAVL4
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.6050551442705184,-1.2782482355839675,0.0967741935483871,0.9588824938701598,1.0,12/48,18.15%,ITGAM;CLU;CIDEB;FOS;MAP3K5;LRRK2;DDIT4;GRIN2B;LRP1;HPR;EFNB2;WNT5A
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.6726770843978073,-1.2781805278161518,0.046875,0.9573865851655559,1.0,14/24,28.86%,RIMS1;SNAP25;RAB3A;SLC18A2;CDK5;PCLO;SLC17A6;SLC17A7;CPLX1;SYT7;CPLX2;DNAJC5;BRSK1;PLD2
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.7803641342174394,-1.2781797397820385,0.19672131147540983,0.9553710344599441,1.0,1/9,3.86%,TSPYL2
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.6809215962765818,-1.2780878125054496,0.1875,0.9539695320472646,1.0,4/18,13.77%,LPL;GPIHBP1;XBP1;SCARB1
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.5533920163007797,1.2780774308023486,0.20588235294117646,1.0,1.0,8/51,8.79%,TRMT1;JMJD6;PUS7;HENMT1;ANKRD16;TFB1M;NAT10;NSUN2
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.7461060940004076,1.2780623990346882,0.15151515151515152,1.0,1.0,7/9,25.04%,WNT4;BMP5;STAR;DGKQ;EGR1;SIRT1;AKR1C3
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),0.7339319802219899,1.277980610207045,0.14285714285714285,1.0,1.0,1/8,0.10%,CYP1A2
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.5988846966444527,-1.2779477009012248,0.14754098360655737,0.9528156299684117,1.0,9/40,20.20%,SRGN;SAR1A;CAV1;CAV2;HOOK1;DNM1;SNX10;PI4K2A;FNBP1L
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.6960353331945538,1.2778817635977078,0.2222222222222222,1.0,1.0,1/9,0.77%,SLC22A2
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.6682073788697279,-1.2776730188191863,0.1346153846153846,0.9531942719246074,1.0,6/19,22.67%,CIDEB;MLLT11;DNM1L;HRK;BBC3;PPIF
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.7162622209423694,1.2774795365608147,0.21951219512195122,1.0,1.0,1/7,6.18%,ATF4
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),-0.8748561991523484,-1.2770934273859431,0.1694915254237288,0.9532462008673479,1.0,2/5,2.03%,PPARG;DND1
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),-0.8748561991523484,-1.2770934273859431,0.1694915254237288,0.9532462008673479,1.0,2/5,2.03%,PPARG;DND1
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.628436565183655,1.2768032681505175,0.2558139534883721,1.0,1.0,3/20,5.61%,DAO;THAP4;ENPP1
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.7673264392033055,-1.2766860397974111,0.10606060606060606,0.953741442990773,1.0,3/12,8.42%,TGFB2;EDN1;CHGA
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.7088569905872282,1.276637209585519,0.1282051282051282,1.0,1.0,2/15,9.90%,AUP1;TMEM129
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.7793149809710659,-1.2763154033264066,0.12307692307692308,0.9539954136647031,1.0,3/10,9.51%,HLA-F;TGFB2;TGFB3
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.744867350137597,1.2762311779020261,0.1951219512195122,1.0,1.0,1/10,0.21%,CXCR4
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.5657677892927517,-1.2758697397735765,0.14705882352941177,0.9549247095204412,1.0,18/61,16.93%,TGFB2;SLC8A3;NOS1;ATP2B3;NPR2;ATP2B2;RYR3;TMIGD3;PLN;CELF2;SLC8A1;ATP1B2;ATP1A1;CAV3;CALM3;ITPR3;ABCC9;FKBP1B
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),-0.8371622563113544,-1.275780156784378,0.1864406779661017,0.9535671469296111,1.0,4/5,16.29%,SFTPD;LGALS3;EDNRB;CXCL17
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),-0.8149890161348481,-1.2748832749674481,0.1206896551724138,0.9577623748434085,1.0,1/5,1.78%,PPARG
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.7898354387699791,1.274744342216915,0.23333333333333334,1.0,1.0,2/6,17.58%,PSAT1;PSPH
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),-0.7932270383641484,-1.2746052957304204,0.14754098360655737,0.9575117157788565,1.0,4/7,12.34%,ITGAM;C1QB;CX3CR1;C1QC
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.7754853136460156,-1.2744056866018665,0.14545454545454545,0.9567688351122008,1.0,2/7,9.85%,TGFBR2;CPE
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.707372465321798,-1.2736762762401521,0.11864406779661017,0.9600063001980697,1.0,3/16,6.80%,CLU;EDN1;DDAH1
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.6325757639903743,-1.2736428579411823,0.19402985074626866,0.9583181879552886,1.0,9/23,26.19%,TMEM204;MEF2C;NINJ1;MRTFB;WNT5B;NEB;HEY2;NEBL;MYOCD
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),-0.8049467266514354,-1.2734606771547068,0.1896551724137931,0.9575782096760276,1.0,3/5,19.28%,TIMP1;LRP1;TIMP3
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),-0.7917744865111533,-1.273299218885636,0.1694915254237288,0.9565085673529335,1.0,2/6,11.74%,AQP1;AQP11
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.7067985708148984,-1.2730283564774425,0.13043478260869565,0.95665410412692,1.0,6/13,18.91%,TGFB2;LAPTM5;TGFB3;WNT5A;LILRB1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.6597566712229647,1.2730162360370076,0.25,1.0,1.0,6/17,13.90%,GNL3L;CTC1;PINX1;NAT10;TENT4B;HNRNPU
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.5217587273727724,-1.2728863036076532,0.04225352112676056,0.9556491453307991,1.0,43/175,19.76%,CD44;ANGPT1;ROR1;PDGFD;PTPRC;IL26;TGFB2;RIT2;TRIM5;EDN1;LAPTM5;PRXL2C;CSF1R;HLA-DRB1;TEK;LRRK2;HTR2C;CHI3L1;DIRAS1;HTR2B;GPR183;CAV2;HTR2A;PRKD2;NOTCH2;BMPER;GFRAL;VEGFA;DENND2B;EGFR;GPR37L1;SCIMP;EZH2;MAP3K12;NTRK3;TGFB1;GAS6;TIRAP;OPRM1;PTPRJ;RASGRP1;PRKCZ;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),-0.7804878035650145,-1.272850875319913,0.12727272727272726,0.9539285880019426,1.0,2/10,3.27%,FBLN1;SPINT2
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.7401946007633251,-1.2727427464066159,0.10344827586206896,0.952700261689271,1.0,1/8,8.01%,TERF2IP
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),-0.8233651731066951,-1.272662375810386,0.11475409836065574,0.9513025399871194,1.0,4/6,14.21%,EDN1;PTGER3;HTR2B;EDNRB
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),0.8167306717461689,1.2719418216829075,0.2647058823529412,1.0,1.0,3/5,2.63%,SCN11A;SPX;MGLL
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.8205234719661254,-1.2718392394124467,0.1864406779661017,0.953366789842425,1.0,3/7,17.07%,MX1;DNM1;DNM1L
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.8205234719661254,-1.2718392394124467,0.1864406779661017,0.953366789842425,1.0,3/7,17.07%,MX1;DNM1;DNM1L
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),0.7762134034846537,1.2712713965708748,0.3181818181818182,1.0,1.0,2/5,4.73%,HSPA1A;ACAA2
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.7570269580316706,1.2711992871409443,0.23809523809523808,1.0,1.0,3/6,20.19%,NSUN2;TPR;IWS1
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.7570269580316706,1.2711992871409443,0.23809523809523808,1.0,1.0,3/6,20.19%,NSUN2;TPR;IWS1
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),0.7472015826831034,1.270780990192236,0.2727272727272727,1.0,1.0,3/5,20.66%,GLA;GALC;NAGA
prerank,GO_Biological_Process_2021__sensory perception of sour taste (GO:0050915),-0.8288164792542148,-1.2704899648397405,0.12727272727272726,0.9605641198620875,1.0,2/5,12.56%,PKD1L3;ASIC2
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.6712657272839273,1.2703795531620654,0.21212121212121213,1.0,1.0,2/21,2.10%,HDC;PYCR1
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.8344523708560075,-1.269627049709381,0.12727272727272726,0.963870031688942,1.0,2/6,8.19%,SHMT2;PRPS1
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),-0.8198340757086846,-1.2693410031788404,0.13793103448275862,0.9638064734716243,1.0,5/7,13.36%,HTR5A;HTR1E;HTR2C;HTR2B;HTR2A
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.794122107595553,-1.2691961718880789,0.1935483870967742,0.9631115320706565,1.0,3/7,18.91%,CENPF;MRTFB;TGFB1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.6337319342640243,1.26873927485461,0.18421052631578946,1.0,1.0,4/20,9.02%,RAB27A;CYBA;SPHK2;SLC25A33
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),0.8074329649561015,1.2685293792792196,0.25806451612903225,1.0,1.0,4/7,16.10%,CD274;PRELID1;ZC3H8;ADAM8
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.7153132160630457,-1.2683455785269897,0.14285714285714285,0.966965735623824,1.0,5/16,9.37%,AKAP12;PRKAR1B;ADGRV1;LRRK2;TCIM
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.4810991516046163,-1.2682283717376346,0.056338028169014086,0.9660957026650038,1.0,56/391,13.06%,CD44;HLA-F;ISG15;IL13RA1;IL26;TNFRSF1A;TIMP1;HLA-E;IFITM3;SLA;ITGAM;MX1;IL12A;IFNGR2;CEBPD;STAT5A;IL6R;DUOX1;ISG20;F3;BIRC3;IRF1;TRIM5;IRF4;CNTFR;FOS;VIM;PSMB8;PIM1;GBP2;HLA-A;HGF;CCND1;CEACAM1;CSF1R;ZEB1;HLA-DRB1;IL7;TRIM22;B2M;HLA-DPB1;CTF1;STX3;SAMHD1;XAF1;PTAFR;IL3RA;PLCB1;CRLF1;IL12RB2;TRIM25;IFNA2;NOD1;IFNK;IL16;IFI35
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.7910359172777957,1.267694878787805,0.20588235294117646,1.0,1.0,2/8,2.44%,EPB41L4B;MAPRE2
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),-0.8025534317593603,-1.2676747914952535,0.15517241379310345,0.9680831340547784,1.0,2/6,15.14%,SULT4A1;UST
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.8672435306442174,-1.2675052262276385,0.12698412698412698,0.9671383749089029,1.0,1/5,1.85%,P2RY12
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.7395868328309598,1.2674455171375352,0.1891891891891892,1.0,1.0,1/6,12.67%,JADE3
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 cell differentiation (GO:2000321),0.7692423347076104,1.2673587092202003,0.25,1.0,1.0,2/5,4.18%,MALT1;NFKBIZ
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.8308618220442064,1.2673029451431248,0.22857142857142856,1.0,1.0,3/6,10.91%,MSRB1;MSRB3;MSRB2
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.583166322922623,-1.2668135846592292,0.12857142857142856,0.9690590545755494,1.0,14/47,14.69%,DPP10;KCNIP4;KCNIP1;NEDD4L;KCNJ4;KCNJ3;KCNJ6;KCNMA1;CAV1;CAV3;GABBR2;GNG2;KCNH2;KCNE1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.6327046548177493,-1.2665562144423201,0.14705882352941177,0.9688159276945056,1.0,5/29,11.75%,VIL1;TWF2;CARMIL2;CYFIP1;CARMIL1
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),0.5768622806125677,1.2665520839053896,0.16666666666666666,1.0,1.0,6/34,9.41%,CYP1A2;MGLL;PTGIS;CYP2C8;PLA2G4C;CYP2E1
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),-0.8172842505662596,-1.2663711725985363,0.12962962962962962,0.9681584562240921,1.0,2/5,12.41%,SFRP4;TMEM79
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),0.7599973081830771,1.2660253408532598,0.23255813953488372,1.0,1.0,2/7,12.18%,SOD3;ADPRS
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.6086767412640183,-1.2657729931883313,0.10294117647058823,0.9699527960916802,1.0,15/46,19.47%,CCK;TUBB2A;ASTN1;NRCAM;MEF2C;GPM6A;DCX;DDIT4;CDK5R1;CEP85L;VEGFA;DISC1;CDK5;KIAA0319;TUBGCP2
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.6072528149841807,-1.2657006584126083,0.18518518518518517,0.9685623411040684,1.0,9/32,22.67%,CLU;CIDEB;HGF;MLLT11;DNM1L;NOL3;HRK;BBC3;PPIF
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.5264716969492697,-1.2655864252804447,0.10606060606060606,0.9674025174922087,1.0,39/129,20.01%,SLC28A2;TLR2;TIMP1;IFNGR2;F3;IRF1;EDN1;MET;SELL;CHST2;SGMS2;C3AR1;NLRP3;RGS1;CXCR6;BEST1;RNF144B;PTAFR;NDP;GPR183;NMI;SCN1B;LYN;AXL;OSMR;GPC3;TACR1;CDKN1A;TNFRSF1B;SLC11A2;CLEC5A;TNFAIP6;HPN;MSR1;NFKBIA;TAPBP;RASGRP1;CX3CL1;ABCA1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.5194205603053704,-1.2653474417835189,0.0958904109589041,0.9669027683070918,1.0,41/147,21.75%,ROR1;STMN2;EPHA3;TWF2;RIT2;PLPPR5;EPHA4;FES;LRRK2;CAMK1D;KNDC1;NTNG1;TENM3;ZDHHC15;TOX;CDK5R1;CAMK1;PAK3;SIPA1L1;ATP1B2;SCN1B;CHN1;ITM2C;LYN;RTN4RL2;FBXO7;LRRC7;EFNB2;NTNG2;PTK7;DISC1;CDK5;WNT5A;NTRK3;TRPV4;CAMK2B;CX3CL1;CSMD3;SERPINI1;PTN;NDRG4
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),0.7432310358979957,1.2651857851549766,0.2558139534883721,1.0,1.0,2/7,5.41%,CFAP43;ODAD2
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.731141900246531,-1.2651608235135992,0.15873015873015872,0.9662741082107515,1.0,2/13,4.59%,MT1M;AQP1
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.7536210217635291,1.2650560823246753,0.1875,1.0,1.0,4/11,9.28%,PLA2R1;PYHIN1;SPRED1;SPRED2
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.6865841665019636,-1.265030279827188,0.19696969696969696,0.9653680294293246,1.0,3/25,2.69%,IRGM;LGALS8;IL12A
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.6982615034035101,1.2649464421903003,0.17073170731707318,1.0,1.0,1/16,0.44%,SPIRE2
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.6627357907429612,-1.2649100396751434,0.1724137931034483,0.9643164931310173,1.0,9/22,18.91%,HEY1;TNFRSF1A;SOX9;ROBO2;EFNA1;TIE1;TNFRSF1B;ELN;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),0.6808538365978118,1.2642928557226953,0.18181818181818182,1.0,1.0,2/13,3.27%,AGER;HMGB1
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.560529391204884,-1.2642820528690215,0.08571428571428572,0.9668002057380979,1.0,19/68,18.15%,ANGPT1;PTPRM;STAT5A;F3;TEK;SCG2;SULF1;HTR2B;CDH13;CAV1;CAV2;TIE1;CNMD;PRKD2;VEGFA;STAT1;ZNF580;NR2F2;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.6408797494696878,1.264186926411554,0.16216216216216217,1.0,1.0,3/18,5.87%,VDR;DHFR;NOS1AP
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.7982462896467409,1.264011915963819,0.21951219512195122,1.0,1.0,2/6,7.11%,GRAMD2A;VAPB
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.8036589556457416,-1.263951204157584,0.23076923076923078,0.9674750480941611,1.0,3/7,11.88%,CENPE;CENPF;CENPA
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.6868622980695716,-1.2637858434519669,0.17647058823529413,0.9665366115404298,1.0,6/14,22.04%,TRIM5;BMP6;LY86;SCIMP;CX3CL1;LY96
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),-0.7710993688609757,-1.2635844919252281,0.29310344827586204,0.965805041713589,1.0,1/8,1.78%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.7038723465189728,-1.2635039238347716,0.21052631578947367,0.9644676785374712,1.0,6/14,23.39%,PPARG;ITGAV;PNPLA2;NFKBIA;ABCA1;TTC39B
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.5537553495859613,-1.2627318548823574,0.08108108108108109,0.968105368427586,1.0,10/67,15.70%,ANGPT1;FANCI;BIRC3;LAPTM5;PRICKLE1;LRRK2;FANCM;CAV1;AMER1;BRCA1
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),-0.8374599956535341,-1.262715641769655,0.23728813559322035,0.9662726784870632,1.0,1/5,9.44%,SAMHD1
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),0.7933265291281112,1.2626225735911365,0.13513513513513514,1.0,1.0,4/6,13.24%,SNAI1;WNT4;BMP5;NFKB1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.7120817566710883,-1.26246583071797,0.18840579710144928,0.9658955977318058,1.0,7/13,24.91%,COL11A1;ADGRV1;LHFPL5;HPN;SCN1A;PDZD7;TMEM120A
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.5067742550675352,-1.2623956440621933,0.08571428571428572,0.9645133456187048,1.0,18/170,8.74%,CD44;PKP2;PYGL;IGFBP3;IL13RA1;NDST3;ISG20;CITED2;CHST1;GLRX;AGL;SOX9;MET;PAM;XYLT2;CHST2;PRPS1;DDIT4
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),0.8832592517350276,1.2620975062321054,0.16666666666666666,1.0,1.0,3/5,5.35%,SLC22A2;SLC25A29;SLC47A1
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.46463260814817464,1.2619172407087602,0.05714285714285714,1.0,1.0,10/165,3.44%,CPA1;CXCR4;HDC;CD274;CFH;RNF128;DUSP1;IL2RA;CCDC141;CCR3
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.5989521986801971,-1.261820926238016,0.19444444444444445,0.9666253780022754,1.0,2/38,2.43%,MDFIC;IFITM3
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.724943415586473,1.2617708762563073,0.20689655172413793,1.0,1.0,2/9,7.94%,GLI2;HDAC1
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),-0.8304066578476303,-1.2617453439015132,0.2153846153846154,0.9652469868454473,1.0,1/5,0.67%,NPY
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.8144693265359837,1.261438357756843,0.25,1.0,1.0,1/5,5.87%,NOS1AP
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),-0.8305660672459441,-1.2610187468754033,0.16923076923076924,0.9684415079904861,1.0,3/6,12.54%,TPH1;TYRP1;TYR
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),0.7661009161056763,1.2608884152573991,0.21739130434782608,1.0,1.0,1/6,2.12%,OAS3
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.7612103971104297,1.2608411694251702,0.2682926829268293,1.0,1.0,3/7,3.12%,F2;SERPINF2;F11
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.8134184296602432,-1.2604282200301797,0.23076923076923078,0.970080047939508,1.0,5/6,18.37%,F3;ANGPT2;CDH13;VEGFA;NTRK3
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.7482612780547786,-1.2602576141607298,0.12307692307692308,0.9694281127919238,1.0,3/10,12.42%,TGFB2;TGFBR2;ZFPM1
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.6641787039718255,1.2602227364631307,0.27906976744186046,1.0,1.0,2/13,8.61%,SAP18;PTBP1
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.7210628758482635,-1.259903403482026,0.234375,0.9697557717406473,1.0,2/12,9.27%,HEY1;GATA1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),0.7607063697613801,1.2597576511929665,0.2,1.0,1.0,1/5,0.23%,CRTAM
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),0.7607063697613801,1.2597576511929665,0.2,1.0,1.0,1/5,0.23%,CRTAM
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.8292497264379847,-1.2597352181610941,0.15,0.9691430193102857,1.0,5/5,17.10%,NCKAP1L;XBP1;CD27;PPP2R3C;SYK
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.708033468908666,-1.2592038460670034,0.17543859649122806,0.9706958373282523,1.0,4/12,18.94%,YBX3;ELAVL4;ZFP36;TIRAP
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),0.721054855119806,1.259160083736483,0.19148936170212766,1.0,1.0,1/12,0.23%,CRTAM
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.6220402436884149,-1.2587167500868992,0.22033898305084745,0.9718469825263923,1.0,7/29,15.99%,FSTL1;LGALS8;FAP;SCG2;CDH13;VEGFA;STAT1
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.7373994941253318,-1.258689052901417,0.18032786885245902,0.9702280046616247,1.0,2/12,9.27%,KLF9;GATA1
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),0.7739949386787452,1.2585474258683014,0.26666666666666666,1.0,1.0,2/7,7.24%,CMPK1;AK8
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.6712977795799291,-1.2584323023941806,0.22857142857142856,0.9700671030058045,1.0,4/19,13.14%,PKP2;PLN;CAV1;CAV3
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.5535121855708074,-1.2581345016123913,0.15492957746478872,0.9701036233764039,1.0,23/93,16.67%,FSTL1;FBLN1;AKAP12;PDE10A;COL4A1;FIGN;PAPPA;PTPRG;RNF150;GPR161;LAMB1;GJA1;TENM3;RUNX1T1;DENND2A;WWTR1;THY1;ADGRL2;FLRT2;ADAMTS9;DZIP1;LRRC49;MYH10
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),-0.7122564330762845,-1.257897017317933,0.24193548387096775,0.9700507093819252,1.0,6/10,16.65%,LRMDA;MEF2C;TYRP1;SLC24A5;HPS6;MREG
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),-0.7460820808610151,-1.2577407514976604,0.1206896551724138,0.9690531827022496,1.0,3/10,5.94%,HEY1;TGFB2;ROBO2
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.880625434806222,-1.2575108159788104,0.09433962264150944,0.968308460590792,1.0,1/5,1.46%,PDHX
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.7374127299938855,1.2574410344167606,0.21621621621621623,1.0,1.0,3/8,18.30%,PINX1;PARP3;MEN1
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),0.727737840041305,1.257435344178111,0.18181818181818182,1.0,1.0,2/10,5.32%,VASH1;RSL1D1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.7343495675065221,1.257425452419251,0.20588235294117646,1.0,1.0,2/7,2.09%,CD274;TARM1
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.830426032894664,-1.2574036498212449,0.15942028985507245,0.9671579959006602,1.0,1/6,1.78%,CENPE
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),0.7192471771950337,1.2573542784598755,0.22727272727272727,1.0,1.0,1/7,8.46%,PRELID1
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),-0.6990261664961644,-1.257038625051637,0.2153846153846154,0.9676959283233045,1.0,1/15,0.11%,GPAT3
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.6553462274090569,1.2568729758734574,0.14285714285714285,1.0,1.0,2/20,1.94%,PDE3A;LHFPL2
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.6803962879752559,-1.2566791070408043,0.15873015873015872,0.9683026604757672,1.0,7/18,7.38%,HLA-F;PTPRC;HLA-E;IL12A;HLA-A;CEACAM1;HLA-DRB1
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.8326417907713639,-1.2565751866657586,0.12903225806451613,0.9672292018744627,1.0,3/5,15.99%,MEF2C;COL4A1;STAT1
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.5331070437778964,-1.2563879843225776,0.12698412698412698,0.9664770285003458,1.0,29/87,18.92%,TRPM1;CACNA1E;TRPC4;SLC8A3;NMUR2;TRPC6;TRPM3;ANO6;ATP2B2;RYR3;CACNA1B;SLC24A5;SLC8A1;TRPC7;CACNG8;SLC24A1;CAV1;CACNG3;ITGAV;CDH23;CACNB2;SLC24A4;CACNA1G;RAMP1;GRIN3A;CACNA2D4;TRPV4;GAS6;TRPV3
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.6591113423963452,-1.256137966611369,0.14925373134328357,0.9664315319176472,1.0,3/18,7.19%,YBX3;AQP1;SCN2A
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.8256884524037698,-1.2561372855376869,0.18181818181818182,0.9646823125348621,1.0,1/5,1.13%,YBX3
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.48117337348751044,-1.2561125728323712,0.08860759493670886,0.9630446800425341,1.0,66/312,19.93%,CLDN5;PDGFD;NR4A3;PTPRC;IL13RA1;TIMP1;TGFB2;IL6R;KITLG;CR1;SPDYA;EDN1;MEF2C;LAMC1;AQP1;ID2;TSHR;TGFBR2;CAPN1;SOX9;PIM1;FGF22;CSF1R;IL7;COX17;LAMB1;CTF1;E2F1;STX3;GJA1;BMP6;TGFB3;WWTR1;BST1;TOX;XBP1;CRLF1;HTR2B;IL12RB2;CDH13;AQP11;PRAME;AR;COPS9;ROMO1;ITGAV;LYN;TGFA;FGF7;VEGFA;STAT1;EFNB2;EGFR;OSMR;NRG1;CDKN1A;EZH2;SERTAD1;WNT5A;NTRK3;TGFB1;GAS6;KIF20B;DDR2;CX3CL1;PID1
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),0.6383482783231671,1.2559881672221118,0.20588235294117646,1.0,1.0,1/12,0.10%,CYP1A2
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),-0.842787948506335,-1.2556450725965025,0.12280701754385964,0.9641258040944286,1.0,2/5,5.94%,GAP43;ROBO2
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),-0.8268586022954346,-1.2554519792833683,0.1694915254237288,0.9635782817921777,1.0,3/6,14.03%,SOX9;SULF1;BMPR1B
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.6110034057168658,-1.2548601355015285,0.2,0.9655787456180408,1.0,4/34,5.43%,PPARG;TGFB2;FOS;SOX9
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.6831165787512117,1.2544087987719577,0.16666666666666666,1.0,1.0,2/17,9.90%,AUP1;TMEM129
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),-0.7961401407728255,-1.2543450862687948,0.19718309859154928,0.9671716059893075,1.0,1/5,12.40%,MOV10
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.5768494654052487,-1.2541893367977177,0.18461538461538463,0.9663087911615542,1.0,12/34,25.19%,CERS6;ST3GAL5;SGMS2;PNPLA1;ST8SIA3;B4GALT6;CERS5;ST6GALNAC5;CERS3;AGK;SPTLC3;SPTLC2
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),-0.8556237420567305,-1.2541664420175018,0.14285714285714285,0.9646686149630764,1.0,1/5,4.08%,MEF2C
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.6738613502117571,-1.2531563782298518,0.14285714285714285,0.9703576069544068,1.0,3/16,6.45%,PPARG;FABP3;SLC22A9
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.632697030816345,1.2530846763671353,0.16666666666666666,1.0,1.0,5/17,13.90%,HSPA1A;CHMP5;HSPA1B;TPR;HNRNPU
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.848932637476782,-1.2527703650772475,0.1111111111111111,0.9707725504522746,1.0,1/5,2.84%,CLU
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.5469608546376696,-1.2527053337373701,0.16666666666666666,0.9695299558491116,1.0,14/86,14.28%,DPP10;ITGAM;EPHA3;PDZK1;LGALS3;TP73;CEMIP;NMT1;STAC2;E2F1;STX3;YWHAH;LRP1;KCNB1
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.5862984009939887,1.2525967574262638,0.10810810810810811,1.0,1.0,4/37,5.08%,NGF;HMGB1;PYHIN1;HMGA2
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),-0.7229955773942952,-1.252539303464154,0.2033898305084746,0.9686878654905575,1.0,2/11,12.26%,PTPRC;GLI3
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),0.8052334781538119,1.2518387853520683,0.2727272727272727,1.0,1.0,2/7,2.60%,F2;SERPINF2
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),-0.5328470287935049,-1.2518331869378228,0.10606060606060606,0.9710459015614654,1.0,18/82,17.10%,PTPRC;SYT1;RIT2;RAB11A;STXBP5L;FES;LRRK2;USP6;RAB3A;RAB3C;RIMS2;CDH13;ITGAV;SCARB1;PACSIN1;RAB15;OPHN1;SYK
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.6589947769173553,1.2512680831409784,0.21212121212121213,1.0,1.0,7/13,20.19%,PTCD2;CDK11A;SRPK3;DHX9;SAFB2;SLTM;IWS1
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),-0.796458103281506,-1.2512409032637202,0.21875,0.9733097256327085,1.0,1/6,1.04%,LPL
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.6565540448870043,1.2511626377869849,0.16666666666666666,1.0,1.0,6/13,21.56%,HMGA2;CDK6;YBX1;SLC30A10;ZKSCAN3;SIRT1
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),-0.8667313687901909,-1.251146347112512,0.14754098360655737,0.9704272888940889,1.0,2/5,10.59%,STPG4;TOX
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),-0.8667313687901909,-1.251146347112512,0.14754098360655737,0.9704272888940889,1.0,2/5,10.59%,STPG4;TOX
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),-0.8133061881886452,-1.2511194386625324,0.13114754098360656,0.9688060169372696,1.0,1/5,10.45%,SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.7393675632554046,-1.2508912772681056,0.25,0.968791915760812,1.0,5/11,19.34%,BMP6;TGFB3;RBPMS;TGFB1;KIAA0319
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.750690759644673,1.250819698325031,0.275,1.0,1.0,3/5,20.37%,COLGALT1;CHADL;RB1
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.6923364750252741,-1.2505005418376443,0.19696969696969696,0.9692200269210641,1.0,3/17,5.09%,CYSLTR2;PRKAR1B;ADCY7
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),-0.6931810245622263,-1.2498309378032744,0.18571428571428572,0.971666793191287,1.0,1/14,0.30%,ITGB4
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.5314944662979387,1.2495353585616815,0.11764705882352941,1.0,1.0,10/49,17.98%,TRARG1;EHD2;RAB35;CMTM6;STX6;MICALL1;SNX3;SNX27;DENND1A;VPS29
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.7643816020779783,-1.2491780965782617,0.22413793103448276,0.9738337887294343,1.0,1/6,13.77%,LRP1
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),-0.7878764951769975,-1.2489082288524043,0.17647058823529413,0.973844767996607,1.0,4/7,17.11%,ANGPT1;SH3GL2;VEGFA;TJP3
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.797070448317644,-1.2486423932145063,0.14516129032258066,0.9737712751966356,1.0,2/8,5.43%,HEY1;SOX9
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.7504407904874816,-1.2483236777044486,0.2857142857142857,0.9743217518323896,1.0,3/7,15.49%,CRYM;SLC22A9;SLC7A8
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.7920642228149144,-1.2481858263225385,0.19298245614035087,0.9736250618502822,1.0,1/7,1.11%,VIL1
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.5611941740103611,-1.2480983874353726,0.19047619047619047,0.9726956340473464,1.0,6/43,13.87%,NR4A3;PPARG;PSMB8;ERAP1;STEAP4;TRIM32
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.7565581931604752,1.2480417316001144,0.23809523809523808,1.0,1.0,1/5,8.44%,PIH1D1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.5102443799609632,-1.24801445330052,0.11842105263157894,0.9714843805088527,1.0,20/112,12.47%,CD44;FSTL1;OLFML1;IGFBP3;SFRP4;OLFML2B;ACTA2;FAP;COL4A1;CCN5;COL11A1;DKK3;TEK;NLRP3;GJA1;PALLD;SULF1;THY1;C1R;NOD1
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),0.8015407346368629,1.247689116682056,0.17647058823529413,1.0,1.0,2/5,12.09%,TRPV1;RYR1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),-0.7955218943325273,-1.247535946169243,0.21212121212121213,0.9727882871396965,1.0,3/8,13.68%,IL12A;CSF1R;LYN
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.656045456312452,-1.2473306978511098,0.18181818181818182,0.9725001622592253,1.0,7/24,12.78%,IGFBP3;PPARG;IL12A;MEF2C;OGN;TGFB3;PRKG1
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),0.7901025354698453,1.2472422150772915,0.2894736842105263,1.0,1.0,3/6,11.82%,LEPR;GREM1;SUCO
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.67400573688459,1.2469629868658918,0.24390243902439024,1.0,1.0,2/11,6.29%,AADAT;IDH2
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.6458298333817891,1.2468660334867694,0.2,1.0,1.0,3/14,9.83%,F2;CHID1;NLRP7
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),-0.7407254946751779,-1.2467615164692047,0.1791044776119403,0.9744817183968195,1.0,4/9,21.64%,COL11A1;ADGRV1;HPN;PDZD7
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.7005616699476456,-1.2466460231780647,0.17857142857142858,0.9734089868099337,1.0,1/14,0.82%,PPP1R17
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),-0.4978191145040828,-1.246426783804881,0.1044776119402985,0.9732376497870926,1.0,18/155,16.00%,GPAT3;PLEKHA2;PLSCR1;PLEKHA4;CDS1;DGKD;BMX;INPP4B;CHKB;DGKB;SLC44A3;ETNPPL;DDHD2;PIP5K1B;ABHD3;PLA2G12A;INPP5D;LIPI
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.6719923178183194,-1.2464130866906602,0.18461538461538463,0.9716397309578761,1.0,3/16,10.64%,CITED2;MET;XBP1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.652323968057432,1.2462871258771584,0.2692307692307692,1.0,1.0,6/27,17.38%,ICAM1;SERPINE1;BMP5;DDX3X;FAIM;PEA15
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.7541607651562213,1.2460474531073638,0.2,1.0,1.0,1/8,6.97%,LRRC8A
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.6545125116362858,-1.245760282951999,0.23376623376623376,0.9740563983095618,1.0,3/17,13.51%,SOX9;HTR2B;ITGAV
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.7351497408497745,1.2451366275353748,0.2222222222222222,1.0,1.0,4/11,16.79%,M1AP;NOC2L;CHAF1B;RBBP4
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.7028158945204233,-1.245116637450263,0.234375,0.9759851470877642,1.0,1/10,3.49%,NOX4
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.5493549212247664,-1.2446355094356543,0.13432835820895522,0.9774450018375944,1.0,8/75,5.53%,KANK2;VIL1;DACT1;PPARG;ALDH1A2;LGALS3;SOX9;LOXL3
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.6053135858554229,1.2446351079284608,0.21621621621621623,1.0,1.0,3/25,10.12%,NUPR1;USP36;FEZ1
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.6063455249349329,1.2437657227664511,0.2,1.0,1.0,4/21,7.25%,CDK10;TESK1;SLIT2;EVI5L
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.847440592673447,-1.2437409452919896,0.13114754098360656,0.9808775904375079,1.0,4/6,13.36%,FABP3;HTR2C;HTR2B;HTR2A
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.8064675302224042,-1.2437122130541771,0.1875,0.9793954410607484,1.0,1/7,2.84%,CLU
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.545844413279722,-1.2434314654618224,0.15714285714285714,0.9797250909105019,1.0,6/53,17.37%,SOX9;CCND1;CSF1R;CEBPB;MOV10;CDKN1A
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),-0.6904992705086057,-1.243427195163316,0.18461538461538463,0.9780696018979141,1.0,4/14,17.85%,PPARG;FABP3;CAV1;PRKAB2
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),0.8053515451467163,1.2433797330014957,0.17857142857142858,1.0,1.0,2/5,8.90%,CCL28;SELP
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.5121195861028698,-1.2431881478590598,0.14666666666666667,0.9782203296260112,1.0,35/120,16.95%,TCEAL6;STMN2;LRRTM1;NYAP1;GAP43;ASTN1;CLVS2;CHST1;CNTFR;TCEAL5;KCNIP1;BRINP2;SNAP25;TMEM179;HPCA;ATP2B2;CADM3;DCLK1;SNCB;LRRTM3;ATP1B2;TAGLN3;ST8SIA3;MAP2;AQP4;OPCML;BRINP1;ADCY8;LRRC3B;PHYHIP;MAPK4;LY6H;ADCYAP1R1;GPR37L1;CSPG5
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),-0.8393414401672263,-1.2431612749339438,0.18309859154929578,0.9768018051589811,1.0,4/5,15.12%,CEACAM1;PTPRG;TENM3;PTPRR
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),0.7665124209985974,1.2427027900508798,0.2564102564102564,1.0,1.0,3/7,19.58%,RNF168;RNF8;LIG4
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.6491068789839434,-1.2426660337698339,0.16,0.9781124173322522,1.0,11/26,17.51%,PTPRM;PPARG;IL12A;MEF2C;SCG2;SULF1;CAV1;CAV2;CNMD;STAT1;NR2F2
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.7913650216913152,1.2423741753233721,0.125,1.0,1.0,1/6,2.77%,DCXR
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.6583445435281015,1.2422714079098438,0.2682926829268293,1.0,1.0,2/14,8.61%,SAP18;PTBP1
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.6605528385545976,1.2420905315642623,0.21052631578947367,1.0,1.0,1/9,0.68%,NUPR1
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.6813180248877828,-1.2417344279208034,0.23076923076923078,0.9822034317529699,1.0,5/17,21.97%,DACT1;AMER1;NELL1;RIC1;VPS35
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.5923447179205814,-1.24141673158997,0.13432835820895522,0.9824111770400672,1.0,9/38,18.43%,MX1;CEACAM1;CAV1;CAV3;LRP1;DNM1;SYK;RAMP1;LILRB1
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.8038199729047104,-1.2413313174847478,0.2037037037037037,0.9812710786752916,1.0,3/6,18.91%,TGFB2;TGFB3;TGFB1
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),-0.8089485851254303,-1.2411629953461687,0.14285714285714285,0.9806695328760413,1.0,3/6,17.89%,GABRG2;GABRB2;GABRB3
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.6764274331335767,-1.241007561809029,0.22033898305084745,0.9798597248001152,1.0,5/18,13.14%,TTN;PKD2L2;LHFPL5;PKD1L3;CAV3
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.48491525436253796,-1.2409354423198764,0.07894736842105263,0.9785035799376188,1.0,23/217,6.74%,CD44;ITGB4;LOXL4;ADAMTS17;ADAMTS5;ADAMTS6;TIMP1;TGFB2;ITGAM;MMP24;LAMC1;COL4A1;ECM2;CAPN1;A2M;P3H2;MMP21;LOXL3;SCUBE3;MFAP5;COL11A1;PAPLN;ST7
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),-0.8253777971787148,-1.240737941532741,0.14035087719298245,0.9781031658339143,1.0,2/5,4.85%,TGFB2;TGFBR2
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),-0.6978590956013446,-1.2406005191276612,0.20967741935483872,0.97735000998558,1.0,1/13,1.25%,IRGM
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),-0.6332679890524358,-1.2404536596853546,0.17857142857142858,0.9765029664022822,1.0,10/32,15.53%,CHRM3;UTRN;PDZK1;FGF12;TRPC6;NEDD4L;SCN1B;CAV3;YWHAH;SCN4B
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.6920645521156997,-1.240315585772219,0.2,0.9760276928798393,1.0,2/14,4.39%,LPL;GPIHBP1
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.6336108245862144,1.2402721306479565,0.16216216216216217,1.0,1.0,4/21,7.62%,DSCAM;PTH;PTH1R;ITGA6
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.6742377881950967,-1.2402427869326882,0.15517241379310345,0.9748013354556293,1.0,9/21,17.10%,P2RY12;TGFB2;NCKAP1L;EFNA1;PDE3B;LYN;RAC3;FERMT3;SYK
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.5682185154621936,1.239812397261819,0.11764705882352941,1.0,1.0,5/18,5.75%,SLC22A2;ABCC2;ABCC1;SLC47A1;ABCA8
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.7930749709039633,-1.2396637729598847,0.22033898305084745,0.9771602747543784,1.0,3/6,16.23%,CPS1;SDS;MTHFD1
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.8029039106785534,1.2396464467159252,0.25,1.0,1.0,4/6,17.27%,DCP1A;DDX3X;YBX1;DHX9
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.6294929683277632,-1.2395447133615867,0.2318840579710145,0.9762553304923891,1.0,8/30,16.78%,HEY1;TTN;GJA1;ZFPM1;ADAMTS9;NOTCH2;NRG1;CACNA1G
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.69325469973332,1.2395408788399611,0.2857142857142857,1.0,1.0,2/11,3.69%,HMGB1;FGFR1
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),-0.8146060922444454,-1.2389230802145748,0.1724137931034483,0.9785084272524333,1.0,1/6,0.47%,FSTL1
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.4989909801796713,-1.2381475391988064,0.08333333333333333,0.9818994510537667,1.0,37/137,19.28%,F8;SRGN;TIMP1;RIMS1;TGFB2;CLU;TTN;SERPING1;TPH1;SYT1;TUBA4A;SYT4;ABCC4;A2M;HGF;SNAP25;ACTN1;RAB3A;TGFB3;SCG3;RIMS2;MANF;RAB27B;TMEM79;LYN;PHACTR2;VEGFA;FERMT3;SYT13;PROS1;CDK5;PCLO;SYT12;TGFB1;GAS6;TMED10;TIMP3
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.6875162441044202,-1.2380086344893981,0.26229508196721313,0.9811182157054301,1.0,2/11,8.26%,KCNK10;KCNK6
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.5881980741882382,-1.2378386434321003,0.23943661971830985,0.9806725275368191,1.0,12/31,18.82%,WNT8B;EPHA3;TWF2;AQP1;BRINP2;SOX9;LYN;BRINP1;PTK7;BRINP3;WNT5A;WNT5B
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.7143931433333504,1.2378245146317752,0.2647058823529412,1.0,1.0,2/11,15.25%,RAP2B;MAP4K4
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.7143931433333504,1.2378245146317752,0.2647058823529412,1.0,1.0,2/11,15.25%,RAP2B;MAP4K4
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.730811902568849,1.23728495747893,0.2926829268292683,1.0,1.0,1/6,8.46%,PRELID1
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.6187048833920745,-1.2371634905087303,0.15789473684210525,0.9833308973007143,1.0,4/27,11.17%,ITGB4;LAMC1;ACTN1;THY1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.7523919870423802,-1.2370486719733085,0.19642857142857142,0.9823457168468744,1.0,1/8,1.55%,MCM2
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.7509290428578175,1.2369713283117552,0.2972972972972973,1.0,1.0,1/7,2.55%,PIK3C2G
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.5691427134154449,1.2367072988561971,0.14634146341463414,1.0,1.0,2/43,1.98%,GABRE;GABRR1
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.808508968760376,-1.2362286380672214,0.2033898305084746,0.985323937499734,1.0,1/5,5.05%,BCAT2
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.572901390143232,-1.2361020843639088,0.140625,0.9844647333688152,1.0,7/37,15.53%,PKP2;TRPC6;ANO6;SCN1B;CHRM1;CACNB2;SCN4B
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.5837557607109509,-1.2359458640744225,0.17142857142857143,0.9838442303038115,1.0,15/42,18.43%,TLR2;FGL2;ITGAM;AOAH;P2RY13;CSF1R;SLC7A7;C3AR1;IGSF6;ADGRE3;LY86;WDFY4;FCGR3A;CLEC5A;LILRB1
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),-0.8075131976403835,-1.235566935594321,0.13793103448275862,0.982766043608929,1.0,3/5,17.47%,NPR2;PDE1B;ZFP36
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),-0.8075131976403835,-1.235566935594321,0.13793103448275862,0.982766043608929,1.0,3/5,17.47%,NPR2;PDE1B;ZFP36
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.7882458863092154,1.2348876064001892,0.12121212121212122,1.0,1.0,2/6,4.18%,MALT1;NFKBIZ
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.6286370879490929,-1.2345112632084188,0.2463768115942029,0.9874720230204185,1.0,9/17,20.50%,PKP2;FGF12;ATP1A1;SCN1B;KCNE1;SCN4B;CACNA1G;SCN1A;CACNA1C
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.730059775630279,-1.2344498860420223,0.25806451612903225,0.9862100972102248,1.0,4/6,21.72%,CEACAM1;XBP1;HPN;PTN
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.6927247718361731,-1.2342019729929212,0.2857142857142857,0.9862625225891369,1.0,1/9,9.67%,FURIN
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.7369118376136138,1.2338881446806114,0.21052631578947367,1.0,1.0,4/9,9.09%,SERPINF2;RUNX1;SERPINE1;MELTF
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.7540118436314103,-1.2336080220822045,0.16071428571428573,0.9882925466715815,1.0,2/10,4.59%,MT1M;AQP1
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.767747757526601,-1.2335498843482027,0.21739130434782608,0.9869732278769912,1.0,4/10,15.59%,PPARG;CSF1R;PDE1B;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),0.7127003618653182,1.233534918181341,0.20930232558139536,1.0,1.0,2/8,17.42%,HMGA2;RESF1
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,0.5292986801145778,1.2332768034040384,0.13333333333333333,1.0,1.0,4/57,4.53%,VWA3A;BPIFB1;TTC29;CFAP43
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.773182437433539,-1.2331939476474088,0.12280701754385964,0.9875053689404836,1.0,3/7,14.61%,TGFB2;ZFPM1;NOTCH2
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.5874451603696937,-1.233120066340916,0.14925373134328357,0.9863310543090025,1.0,13/52,15.99%,CLDN5;PTPRM;SEMA3E;PPARG;TGFB2;TEK;SULF1;CD160;EFNA3;PDE3B;CNMD;PGK1;STAT1
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.7080980690358202,-1.2330682625090277,0.21212121212121213,0.9850522129827126,1.0,3/12,14.46%,HEY1;LRP1;ADAMTS9
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.5341435392758741,-1.2325736546163022,0.14705882352941177,0.987036968785617,1.0,35/96,21.37%,FSTL1;IGFBP3;PPP1R3C;LRIG3;LURAP1L;F3;PLSCR4;COL4A1;CALB2;MUC16;GBP2;NTN4;CDON;KIAA1217;PALLD;WWTR1;SULF1;COBLL1;C1R;CAV1;AR;CAV2;MATN2;ADGRF5;EGFR;OSMR;CCDC80;AOX1;GNG12;TIMP3;NNMT;LAMB2;LOX;COL12A1;CDH1
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.7898483109909045,-1.2323808050725735,0.2222222222222222,0.9865014038410531,1.0,3/7,13.26%,AQP1;AQP11;AQP4
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.6978596521439764,-1.2323000760069185,0.12121212121212122,0.985397818923934,1.0,4/16,5.43%,HEY1;SRGN;ASPN;SOX9
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.638109222048033,-1.2320422729314668,0.22058823529411764,0.9852509316083374,1.0,5/21,17.78%,MDFIC;LRRK2;SIAH3;KCNE1;DMTN
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.6201412917693747,-1.2318472387224721,0.19047619047619047,0.9847821827183225,1.0,3/27,7.35%,KANK2;DACT1;MYO16
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.48868968385477946,-1.231800206749392,0.11842105263157894,0.9834107771381401,1.0,27/156,9.40%,CD44;FSTL1;FOSL2;IGFBP3;COX7A1;ADAMTS5;FBLN7;ASPN;KLF9;NOX4;OLFML2B;ACTA2;PLSCR4;FAP;LAMC1;VIM;COL4A1;SYNPO2;MFAP5;HGF;DKK3;CXCL14;TEK;ITGBL1;LAMB1;FLI1;PALLD
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),0.6938560834874781,1.2317969182751736,0.2631578947368421,1.0,1.0,3/9,7.94%,HMGA2;ZNF639;HDAC1
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.7544544691201742,-1.231666757078431,0.21621621621621623,0.9826863477547646,1.0,2/9,4.85%,TGFB2;TGFBR2
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.6906536019535522,1.2315228768438933,0.3142857142857143,1.0,1.0,2/11,1.51%,SLC22A2;SLC38A1
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.7450900625278754,1.2313939529890632,0.25,1.0,1.0,2/10,12.02%,MGMT;ASCC2
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.7450900625278754,1.2313939529890632,0.25,1.0,1.0,2/10,12.02%,MGMT;ASCC2
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.6705862359046002,-1.2310974744279688,0.2033898305084746,0.9844847422694846,1.0,5/17,11.17%,LGALS3;LAPTM5;CEACAM1;CD160;THY1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",-0.7840953176844996,-1.2310928427557615,0.2641509433962264,0.9829525713437683,1.0,2/7,11.82%,NDST3;CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.7009967470945875,-1.2309027668780461,0.22535211267605634,0.9823845869513375,1.0,2/14,5.09%,IRF1;ADCY7
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.7396448114359845,-1.2308374393953527,0.1746031746031746,0.9813318921533559,1.0,2/10,15.15%,SPEF2;SPAG17
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.7699055011229734,-1.2305935011787603,0.25,0.9810718496861357,1.0,2/9,2.31%,PYGL;PPP1R3C
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),-0.6488086870802944,-1.2304715195734262,0.19696969696969696,0.9803882760800796,1.0,6/20,18.43%,EPHA3;MCTP1;LGALS3;CAV1;SCAMP5;LILRB1
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),0.7819758952333536,1.2298735451148213,0.14705882352941177,1.0,1.0,2/5,14.04%,BEND3;KMT5B
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),0.7819758952333536,1.2298735451148213,0.14705882352941177,1.0,1.0,2/5,14.04%,BEND3;KMT5B
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.59672210311134,-1.2295244933274863,0.2,0.9845186860001222,1.0,10/39,21.68%,NCKAP1L;ID2;GATA1;ZFPM1;IKZF1;LYN;VEGFA;DMTN;UBA5;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),-0.8194847756887145,-1.2294877914154165,0.16417910447761194,0.9832577479107336,1.0,1/6,5.43%,SOX9
prerank,GO_Biological_Process_2021__alditol phosphate metabolic process (GO:0052646),0.772953781524086,1.2293675325384144,0.30303030303030304,1.0,1.0,1/5,4.47%,GPAT2
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),-0.7580614534360965,-1.2292733050781892,0.15625,0.9829510629403878,1.0,4/8,16.13%,GPR183;IFNA2;IFNK;IFNA6
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.7426761533271476,-1.2292588611065218,0.24242424242424243,0.9814706288576233,1.0,1/8,2.34%,TGFB2
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.8229821587413276,-1.229228915385464,0.26229508196721313,0.980024902016226,1.0,3/6,14.94%,TIMP1;LRP1;CLDN4
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.6443202245274658,1.2291604237081837,0.15625,1.0,1.0,5/21,10.61%,PASK;PTH;ENPP1;EPM2AIP1;AKT2
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.575938823646276,-1.2291252502342305,0.15625,0.9789590262561363,1.0,14/51,10.42%,DPEP2;TLR2;DOCK8;ITGAM;CR1;AOAH;SELL;CEACAM1;P2RY13;ARG2;NLRP3;IGSF6;PTAFR;BST1
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.5515187015938051,-1.2290006432859815,0.16901408450704225,0.9782712238031821,1.0,5/42,3.94%,TLR2;PLSCR1;EPHA3;MCTP1;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.6973799930470188,-1.2286913063684488,0.16417910447761194,0.9785284571221243,1.0,2/13,3.94%,CR1;LGALS3
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),-0.7493765741864185,-1.228630431381854,0.2054794520547945,0.9773204488221167,1.0,2/8,4.58%,ITGB4;LAMC1
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.5960680699079365,1.2282830213121436,0.19444444444444445,1.0,1.0,7/38,5.43%,GPT;DPEP1;FOLH1B;PYCR1;AADAT;THAP4;RIMKLA
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.5709070831743335,-1.228153697265221,0.15,0.9785034044073022,1.0,17/67,13.30%,TLR2;IRGM;ISG15;H2BC11;HLA-E;IL12A;IL6R;SFTPD;AQP1;GBP2;HLA-A;CHGA;NAIP;PRB3;CEBPB;NOD1;ROMO1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.692953789960889,1.2280602246897268,0.20588235294117646,1.0,1.0,1/16,1.02%,CRYAB
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),-0.7585432866778348,-1.228048527799893,0.14285714285714285,0.9774928409960678,1.0,3/7,17.44%,EFNA1;NGEF;GRIN3A
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),0.6181687366838091,1.228009659670232,0.13513513513513514,1.0,1.0,11/22,25.57%,LYRM4;CIAO3;CIAPIN1;ISCA2;CIAO2B;NFU1;GLRX3;ISCA1;CIAO1;NFS1;IBA57
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.6663968089610597,-1.2278704753076763,0.22058823529411764,0.9770952355379647,1.0,3/15,12.21%,BASP1;MEF2C;CAV1
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.7760316243322533,1.227720668771734,0.3076923076923077,1.0,1.0,1/6,3.33%,SMYD1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7060037702093591,-1.2277047935655656,0.3013698630136986,0.9764018412394181,1.0,2/7,13.33%,CAV1;CALM3
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),-0.812686568689752,-1.227198483313752,0.19672131147540983,0.9783351390954118,1.0,2/6,8.42%,NR4A3;CHGA
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.7295239871813857,1.22713753918828,0.3,1.0,1.0,3/10,12.37%,PIH1D1;PRR7;ST18
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.5933922083520833,-1.2271057025644716,0.21739130434782608,0.9772718428657187,1.0,6/29,15.59%,ANGPT1;SFRP4;RIN3;LRPAP1;DLG4;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.6739995519484215,1.226622029322684,0.1724137931034483,1.0,1.0,3/11,20.37%,ESPL1;CDC23;RB1
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6739995519484215,1.226622029322684,0.1724137931034483,1.0,1.0,3/11,20.37%,ESPL1;CDC23;RB1
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6739995519484215,1.226622029322684,0.1724137931034483,1.0,1.0,3/11,20.37%,ESPL1;CDC23;RB1
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.8207236111823376,-1.2262493013591724,0.1568627450980392,0.980557830136795,1.0,4/7,5.93%,VSIR;HLA-E;IRF1;HLA-A
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.5846489316059912,-1.225905705601265,0.125,0.9810293894723398,1.0,3/42,4.21%,CPS1;IL12A;NOS1
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.7850645044511756,-1.2255517443016564,0.171875,0.9816616094002227,1.0,3/7,12.34%,C1QB;C1R;C1QC
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.5750240167199488,1.225495784629836,0.15789473684210525,1.0,1.0,6/41,10.19%,CFAP61;TTC29;ODAD2;CFAP70;CFAP54;DNAI4
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.5614259487482297,-1.2252145166432016,0.16393442622950818,0.982071176368124,1.0,8/42,10.12%,CERS6;CPS1;PCSK1;PAM;ARG2;SGMS2;FURIN;PNPLA1
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.7278046154728618,-1.2250063052696307,0.23728813559322035,0.9815392066018945,1.0,5/10,19.76%,PTPRC;CD200;TNFRSF1B;NR1D1;CX3CL1
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",-0.6434413155693615,-1.2242334299643711,0.16129032258064516,0.9845442132589676,1.0,8/18,23.88%,GRIK2;UNC13C;GRIK1;GRIK5;SLC17A6;GRIK3;SLC1A4;SLC17A7
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.7611773447016588,-1.2241631110081368,0.1864406779661017,0.9833363266391871,1.0,3/7,19.76%,PTPRC;NR1D1;CX3CL1
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),0.6133014238072111,1.223859205936015,0.10810810810810811,1.0,1.0,10/21,25.57%,LYRM4;CIAO3;CIAPIN1;ISCA2;CIAO2B;NFU1;ISCA1;CIAO1;NFS1;IBA57
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.640824377062225,-1.2238151210299704,0.24074074074074073,0.9838724747040395,1.0,4/20,18.89%,ACADL;AOAH;PLBD2;ACOT8
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),-0.8185560344747593,-1.2227311691691116,0.1746031746031746,0.9868499308953296,1.0,2/5,8.42%,NR4A3;CHGA
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),-0.8185560344747593,-1.2227311691691116,0.1746031746031746,0.9868499308953296,1.0,2/5,8.42%,NR4A3;CHGA
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.724476557100953,-1.2225805059209878,0.22807017543859648,0.9861699728999012,1.0,1/11,1.55%,MCM2
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),-0.7783588602707276,-1.2224575740219197,0.1694915254237288,0.9851868088466416,1.0,3/8,13.74%,SHMT2;TSFM;MTG1
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.6559474352463958,-1.2224233379994942,0.22033898305084745,0.9839308415712635,1.0,3/17,9.67%,FAP;NEDD4L;FURIN
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.6625471780374912,1.222365007153498,0.2,1.0,1.0,3/23,12.48%,AUP1;TMEM129;LMAN1
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.5560684736241902,1.2221391243157602,0.18421052631578946,1.0,1.0,10/26,23.81%,RNF6;HDAC1;SMARCA4;ZBTB7A;PRMT2;KDM5D;SAFB2;DDX5;SIRT1;KDM4C
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.5692454049855764,-1.2219135099623661,0.171875,0.9853597761033802,1.0,6/39,16.00%,GPAT3;DGKD;DGKB;DDHD2;PLA2G12A;LIPI
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.6877642750711351,-1.221894879648984,0.19672131147540983,0.9824974304710978,1.0,6/11,24.86%,MET;ALOX12;TMEM79;CLDN4;ABCA12;FLG
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.6877642750711351,-1.221894879648984,0.19672131147540983,0.9824974304710978,1.0,6/11,24.86%,MET;ALOX12;TMEM79;CLDN4;ABCA12;FLG
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.6321453147028959,1.2213778648958742,0.21428571428571427,1.0,1.0,2/10,6.13%,ST3GAL1;NPL
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.7061253105837146,1.2212157633887442,0.23255813953488372,1.0,1.0,1/8,7.52%,CCNT1
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.651590101469361,-1.2212051996311644,0.21739130434782608,0.9853503755608496,1.0,5/16,16.55%,RHBDF2;CEACAM1;MVB12A;CDH13;EGFR
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.503035870400066,-1.2207505967053716,0.10294117647058823,0.9860195217752841,1.0,36/133,20.96%,HEY1;WNT8B;TGFB2;CCK;TUBB2A;ASTN1;NRCAM;MEF2C;MET;GPM6A;ATP2B2;ANOS1;BHLHE40;DCX;DDIT4;CTF1;CDK5R1;CX3CR1;EMX1;ITM2C;FZD8;CEP85L;OPHN1;DISC1;CDK5;MYT1L;WNT5A;MYEF2;WNT5B;NEUROD6;KIAA0319;TUBGCP2;CX3CL1;LHX6;PRUNE1;CIT
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.6302968504089151,1.220518377192773,0.21052631578947367,1.0,1.0,6/17,14.26%,RAE1;TPX2;NUMA1;FSD1;PARP3;PSRC1
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),0.758616800594649,1.2204222972816763,0.2765957446808511,1.0,1.0,2/5,20.66%,GLA;NAGA
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.46973327934479475,1.220386063404208,0.14285714285714285,1.0,1.0,13/95,12.01%,ORC1;RFWD3;DDX12P;TSR1;BRPF1;NAT10;EIF3B;PTBP1;NSUN2;EIF3D;HDGF;POLG;UGGT1
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.6978883894122925,-1.2203636140480658,0.23880597014925373,0.9868161207941774,1.0,4/11,18.47%,NCKAP1L;BST1;VEGFA;RHOH
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.6061400542511179,-1.2198092587849843,0.17391304347826086,0.9883715522006228,1.0,7/23,17.78%,P2RY12;CYFIP1;CDH13;CARMIL1;ABLIM2;ABLIM1;DMTN
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),0.6540438976248502,1.2197790828933053,0.2647058823529412,1.0,1.0,1/11,0.10%,CYP1A2
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.6225866874644741,-1.2196993523096253,0.22727272727272727,0.9876134252222749,1.0,10/29,11.80%,NCKAP1L;CR1;SFTPD;LGALS3;LAPTM5;CEACAM1;FGL1;HLA-DRB1;CEBPB;IFNA2
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),-0.7709551531665171,-1.219649781307849,0.22033898305084745,0.9864136467363236,1.0,2/7,16.77%,TGFB2;NRG1
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.5667300359223694,-1.2194680837533605,0.1791044776119403,0.9859180609648742,1.0,15/52,14.27%,DPEP2;PTPRC;SLA;ITGAM;NCKAP1L;AOAH;CD53;GMFG;LAPTM5;SIGLEC10;C3AR1;IKZF2;ARHGAP25;ADGRE3;LY86
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.6929987347186531,-1.2192832107549172,0.25925925925925924,0.9855952738946918,1.0,1/10,4.07%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033),-0.794907401473161,-1.2192501171173777,0.24193548387096775,0.9842755261520314,1.0,2/5,15.59%,PRKD2;VEGFA
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.6123644423921688,-1.219146178570147,0.16666666666666666,0.9833155602372807,1.0,7/35,12.89%,OLFM1;TWF2;NRCAM;L1CAM;TRIM46;GOLGA4;MAP2
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.7922121429791079,1.2191275570582518,0.2682926829268293,1.0,1.0,1/6,1.51%,RFWD3
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),-0.7601506474181394,-1.2185462672197884,0.23214285714285715,0.9854712568962117,1.0,1/7,4.79%,ID2
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.769034977314133,-1.2183954709721394,0.13846153846153847,0.9849239520709377,1.0,3/10,14.07%,FSTL1;LTBP1;CHRDL1
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.6584726003030119,1.2183565619041716,0.2222222222222222,1.0,1.0,8/19,26.60%,DICER1;PRKRA;TENT4B;RAN;LIN28B;XPO5;TUT4;KHSRP
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.7664541258493514,-1.2182725684085076,0.25396825396825395,0.9842081992445438,1.0,4/9,13.12%,GAP43;DGKD;HTR2B;CHRM1
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.6605737159367623,1.2179948307723307,0.2702702702702703,1.0,1.0,5/15,21.31%,GNL3L;ZMIZ1;HDAC4;EGR1;UBA2
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.5716057580378723,-1.2178128837225,0.1875,0.9854615437832457,1.0,6/38,16.00%,GPAT3;DGKD;DGKB;DDHD2;PLA2G12A;LIPI
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),0.7812914166987628,1.2176830845359428,0.23255813953488372,1.0,1.0,1/5,4.02%,RNF6
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.7117776395942755,-1.2176370848148719,0.23880597014925373,0.984817756488633,1.0,3/13,15.66%,NPY;MAP2;B4GALT6
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),0.7497519296230524,1.2175947435588124,0.22448979591836735,1.0,1.0,2/6,14.33%,CROT;CPT1C
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.7500631704534957,-1.2175837305770594,0.3103448275862069,0.9834986067225814,1.0,2/10,4.21%,PKP2;NOS1
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.6465364448723231,-1.2170742934897376,0.25,0.9848742772505987,1.0,5/24,11.86%,PYGL;PPP1R3C;AGL;PHKG1;GYG1
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.6098793811793265,-1.2168516446592674,0.2361111111111111,0.9845718125580888,1.0,10/32,15.59%,HEY1;OLFM1;TGFB2;TTN;SOX9;HTR2B;ZFPM1;SYNPO2L;FLRT2;VEGFA
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.7029006320621073,-1.2168465951427798,0.2459016393442623,0.9831745227569841,1.0,2/10,12.56%,MGST1;SLC6A8
prerank,GO_Biological_Process_2021__cellular response to salt stress (GO:0071472),-0.7844423164978805,-1.216646168078491,0.19402985074626866,0.9827211250119238,1.0,1/5,4.59%,AQP1
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.6455396314651287,-1.2165664524286486,0.2786885245901639,0.9817087850133999,1.0,8/15,29.97%,MEF2C;NRG1;MYEF2;MESP1;CBY1;MYOCD;KDM6B;AKAP13
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.5226218174384262,-1.2164698649438923,0.16129032258064516,0.9806574335030777,1.0,17/102,14.38%,CD44;TGFB2;PRELP;SOX9;SPEF2;CHI3L1;TLL1;KIAA1217;GJA1;BMP6;SULF1;MEPE;MMP16;COL10A1;ETS2;BMPR1B;CNMD
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.6482872100176411,-1.2164253995262633,0.18461538461538463,0.9795393088173922,1.0,3/21,6.37%,ATAD5;RAB11A;CCND1
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.6316862928393224,1.2158712773212832,0.2682926829268293,1.0,1.0,4/15,13.31%,ENPP6;PRDX6;PLA2G4C;SMPDL3A
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.6423414025199667,-1.2158214166446366,0.24242424242424243,0.9816319214934284,1.0,2/27,2.78%,TTC8;ARL13A
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.5191760934122509,-1.2157613615421097,0.1694915254237288,0.980613103283279,1.0,17/87,18.19%,MDFIC;TLR2;DACT1;SFRP4;RSPO4;LRRK2;APCDD1;SULF1;ATP6V1C2;KREMEN1;LRP1;AMER1;ATP6AP2;PTK7;GPC3;DISC1;DEPDC1B
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),0.692427492939255,1.2156222008443645,0.3,1.0,1.0,5/10,24.98%,HSD17B7;HSD17B10;AKR1D1;SRD5A1;HSD17B4
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.6255962281113573,-1.2155933354020094,0.22388059701492538,0.9799309599577027,1.0,4/22,10.72%,CITED2;MET;XBP1;CEBPB
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.7017730809697287,1.2152295450767918,0.3235294117647059,1.0,1.0,3/8,14.06%,STMP1;DHX33;DDX3X
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),-0.68965917612959,-1.2150850487770457,0.2903225806451613,0.9812085954630031,1.0,5/10,23.68%,SLC1A1;SLC25A22;SLC1A6;SLC1A2;SLC25A12
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.7171426640442953,1.2148440988198688,0.3225806451612903,1.0,1.0,6/13,25.03%,DUT;NT5C;NT5M;MBD4;SMUG1;UPP2
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.5509963011266408,-1.214440063666846,0.14705882352941177,0.9835085627352828,1.0,7/56,7.42%,ROR1;PDGFD;TGFB2;SOX9;HGF;PIK3AP1;TEK
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.5814680321777047,-1.2143479574480482,0.19718309859154928,0.9824790674387711,1.0,12/48,15.45%,RHBDF2;RIMS1;MCTP1;SYT1;MCTP2;MEF2C;STXBP5L;RAB3A;RAB3C;RIMS2;SNCAIP;RAB15
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.7769214208785856,-1.214316929765435,0.16923076923076924,0.981383408606896,1.0,4/5,18.67%,CAV1;CAV2;CAV3;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.6279106219056211,-1.2141832175857923,0.2028985507246377,0.9809121393536137,1.0,3/25,4.49%,PPARG;TGFB2;FOS
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),-0.7057964835466073,-1.2139040301928246,0.22641509433962265,0.9810074299990497,1.0,1/12,1.78%,PPARG
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.5496599979572111,-1.2134720623629005,0.18840579710144928,0.9822312433386257,1.0,5/62,3.94%,FSTL1;VIL1;PPARG;BASP1;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.7315451736597111,-1.21323084386252,0.20967741935483872,0.9805778919017564,1.0,1/11,0.61%,FBLN1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.7315451736597111,-1.21323084386252,0.20967741935483872,0.9805778919017564,1.0,1/11,0.61%,FBLN1
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.6317100933045379,1.212868029909417,0.21951219512195122,1.0,1.0,5/13,21.42%,AHCTF1;TPR;NDC1;RTN4;SEH1L
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.524484195314137,-1.2126641857524805,0.12857142857142856,0.982304235470779,1.0,29/93,22.25%,FSTL1;FBLN1;PPP1R3C;ALDH1A2;TSPAN11;COL4A1;BOC;DKK3;LAMB1;FNDC4;GJA1;RUNX1T1;CPE;SULF1;THY1;ADGRL2;PRKG1;ADAMTS9;IGFBP2;LMOD1;TIMP3;DDR2;ANGPTL2;LAMB2;PTN;FAT4;SCARA3;ANTXR1;ZIC1
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.7756063302214334,-1.212646092008777,0.19642857142857142,0.980973378508101,1.0,5/7,18.91%,TNFRSF1A;FAP;CST3;TNFRSF1B;TGFB1
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.660990184820684,-1.2122483024958015,0.2112676056338028,0.9816554881961282,1.0,7/22,17.57%,BASP1;LOXL3;SPEF2;CHI3L1;FGF7;VEGFA;CCDC39
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.4947837836038548,1.2119431290403604,0.21052631578947367,1.0,1.0,8/89,8.46%,ABCA13;ABCC2;PRELID2;MTTP;ABCA8;PLEKHA3;ABCA6;PRELID1
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.7051848437282868,-1.2119021821406317,0.23728813559322035,0.9821991752780223,1.0,4/13,7.76%,CPS1;NOS1;ARG2;MTARC2
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),-0.7598622835931101,-1.2117963921573214,0.23076923076923078,0.9813511497547429,1.0,1/7,1.81%,SHMT2
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.6838940245149226,-1.2117420620662915,0.25,0.9802333302659728,1.0,2/8,4.08%,TGFB2;MEF2C
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",0.6101040045272972,1.2116130842854553,0.3023255813953488,1.0,1.0,4/15,19.98%,PRPF39;SNRPC;DCPS;RBM22
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.8334399530449703,-1.2114327098185669,0.17543859649122806,0.9803961860462096,1.0,1/5,1.62%,PLSCR1
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.7284039480283859,-1.2112152121805315,0.2,0.9802328689163049,1.0,2/11,5.94%,BASP1;ROBO2
prerank,PanglaoDB_Augmented_2021__Platelets,-0.5132369263879712,-1.2109586922153492,0.13846153846153847,0.980422370407201,1.0,23/110,9.40%,ANGPT1;DPEP2;SRGN;FGL2;P2RY12;HLA-E;LGALS8;ITGAM;AOAH;ABCC4;GMFG;HLA-A;SELL;LAPTM5;P2RY13;CXCL14;ALOX12;MAP3K7CL;NRGN;SMOX;MFSD2B;C3AR1;PALLD
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.6968142929440745,1.2109128655301702,0.32653061224489793,1.0,1.0,2/7,2.09%,AGER;TARM1
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),-0.6555984862531572,-1.2105460616376602,0.2537313432835821,0.9811797299790161,1.0,5/11,20.14%,TTN;MYH11;SLC8A1;VEGFA;ALPK2
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.7550725510783142,1.210454081612901,0.3488372093023256,1.0,1.0,2/6,11.59%,PRR5;PRR5L
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.6885206832872133,1.2104511467363552,0.3125,1.0,1.0,1/9,3.32%,KDM8
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),-0.8319762860093918,-1.210293885198416,0.16981132075471697,0.9813943948946997,1.0,3/5,14.68%,HLA-E;HLA-A;RSAD2
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.5952587756092991,-1.210150124896042,0.18309859154929578,0.9807717590225338,1.0,5/32,11.53%,FSTL1;KANK2;FAP;SCG2;CDH13
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),-0.8159019734385543,-1.2092641048811739,0.25862068965517243,0.9843284912111413,1.0,1/5,1.13%,TLR2
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),-0.7141336009171896,-1.2090526069632592,0.22807017543859648,0.984187953712445,1.0,2/8,12.56%,PKD1L3;ASIC2
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.6623311042594153,-1.2086684778708852,0.21311475409836064,0.9846122264451219,1.0,4/13,20.85%,CEACAM1;SLC18A2;ABCD2;CIITA
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.8066601806078961,1.208583970498317,0.22580645161290322,1.0,1.0,3/5,14.06%,STMP1;DHX33;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),-0.4882664179258956,-1.2085706633946707,0.12857142857142856,0.9837604393297402,1.0,46/196,22.04%,TLR2;DACT1;PTPRC;RIMS1;TGFB2;F3;CITED2;ENHO;LOXL3;RSPO4;TEK;IL7;LRRK2;LMO3;BMP6;FGFBP3;SULF1;ATP6V1C2;XBP1;RIMS2;CAV2;ITGAV;DLG4;LY86;JAG2;AXL;TXNDC15;CDH3;PRKD2;ATP6AP2;SCIMP;DISC1;DMTN;NRXN1;DEPDC1B;NTRK3;STAT3;TM2D3;GAS6;PRKCZ;KAT2B;MESP1;PTPN11;WLS;VPS35;LY96
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),0.7751668483981311,1.208482544611909,0.2857142857142857,1.0,1.0,1/5,0.65%,CCDC78
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.7143832305975326,-1.208024603923327,0.16129032258064516,0.9850015869166718,1.0,3/11,17.78%,NCKAP1L;GATA1;DMTN
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.8103756879248463,-1.2079644501931552,0.24615384615384617,0.9838973654734496,1.0,1/5,4.02%,EDN1
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),0.806605381852184,1.2079357586884936,0.2826086956521739,1.0,1.0,4/5,16.84%,CORO1B;MARS1;HYAL1;MTSS2
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.7328553307385277,-1.207491473967201,0.3125,0.9852284163780743,1.0,2/12,4.59%,KLF9;AQP1
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.7218110649560106,-1.2073984764355092,0.22033898305084745,0.9844338863136167,1.0,2/12,6.70%,NEFL;SYBU
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.6482560494794244,-1.2073102615617912,0.1791044776119403,0.9836948668986258,1.0,5/23,18.89%,PEX11A;PEX1;ABCD2;DNM1L;ACOT8
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),-0.7824461221030989,-1.207149826982146,0.22,0.9829712028414799,1.0,1/5,7.92%,GRM5
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.760591774746544,1.2069209142071582,0.225,1.0,1.0,1/8,3.63%,PIWIL2
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.598363363376603,-1.2067884074660256,0.234375,0.9835120721644983,1.0,4/26,5.73%,SEMA3E;COL4A1;TGFBR2;MET
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.5196591658666593,-1.2067044945154703,0.18309859154929578,0.9826446737122871,1.0,8/80,7.42%,ROR1;PDGFD;TGFB2;SOX9;HGF;PIK3AP1;CEACAM1;TEK
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.6042931101188387,-1.206434320410452,0.23333333333333334,0.9826676287437899,1.0,3/30,7.35%,KANK2;DACT1;MYO16
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),-0.6639591356512221,-1.2063537675412028,0.25,0.9816449642942171,1.0,8/17,19.76%,NLRP12;CEACAM1;NLRP3;CX3CR1;CARD18;GIT1;GAS6;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.5551575696558825,-1.2062423146481076,0.16129032258064516,0.980942313651685,1.0,22/75,20.06%,VIL1;BAIAP2;STMN2;CLU;NCKAP1L;EDN1;MET;BAIAP2L2;SYNPO2;FES;FCHSD2;NAV3;CDK5R1;CARMIL1;CAV3;SYNPO2L;LMOD1;MYLK3;SYNPO;TRPV4;CX3CL1;CDC42EP3
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.7629271991885371,-1.2060885764967801,0.18333333333333332,0.9804923654300788,1.0,3/9,12.01%,DOCK8;LRCH1;CD200
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),-0.7817195117412667,-1.2059943801882844,0.21666666666666667,0.9796482388962896,1.0,1/6,2.69%,IL12A
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,-0.4998678495362307,-1.205971137447443,0.14666666666666667,0.9784115539611895,1.0,59/125,16.83%,TCEAL6;STMN2;LRRTM1;PAK5;CCK;HTR5A;KCNQ3;RIT2;GAP43;ASTN1;CLVS2;KCND2;SYT4;TCEAL5;GABRA1;GABRG2;ATP2B3;VSTM2A;CALY;BRINP2;SYNPR;SNAP25;HPCA;CDH22;GRM5;NRGN;CACNA1B;CELF4;SNCB;RAB3C;LRRTM3;PHF24;KCNC2;ELAVL4;ACTL6B;EMX1;GRIN2B;TAGLN3;GRIA3;ASIC2;ST8SIA3;MAP2;GRIN2D;CACNG3;OPCML;GRIA1;OLFM3;DLG4;BRINP1;GAD2;ADCY8;KCNB1;LRRC3B;SRRM4;TMEM196;KCNB2;DAB1;LY6H;ADCYAP1R1
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.7469733298599852,1.2057323558264315,0.3181818181818182,1.0,1.0,1/6,2.44%,MAPRE2
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.7469733298599852,1.2057323558264315,0.3181818181818182,1.0,1.0,1/6,2.44%,MAPRE2
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),-0.7982528097545374,-1.2057275362232929,0.2711864406779661,0.978413822714298,1.0,3/6,7.59%,NOS1;DDAH1;ARG2
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),-0.7223560965250593,-1.2055972256382381,0.16666666666666666,0.9778253969775936,1.0,4/9,26.48%,TENM3;VEGFA;SHROOM2;IFT122
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.652863816478794,1.2055241563003867,0.2702702702702703,1.0,1.0,1/15,5.91%,ATG9A
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.7547661629439083,-1.2053572226411609,0.17857142857142858,0.9777104827207022,1.0,4/8,15.43%,NCKAP1L;MEF2C;LYN;PPP2R3C
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),-0.8087272200702117,-1.2042330155059617,0.13114754098360656,0.982059789716753,1.0,1/6,2.34%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5702127896717482,1.2041824628114226,0.1935483870967742,1.0,1.0,9/26,25.89%,ARRDC4;ARRDC3;UBE2N;BTRC;BMI1;FBXW7;RPS2;UBE2L3;AXIN1
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.47892092653271523,-1.2034959090611732,0.1527777777777778,0.9845278472741973,1.0,15/156,6.74%,CD44;ITGB4;ADAMTS17;ADAMTS5;ADAMTS6;ITGAM;MMP24;LAMC1;COL4A1;ECM2;MMP21;MFAP5;COL11A1;PAPLN;ST7
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.6239094456800381,1.2033371406823872,0.3,1.0,1.0,3/11,7.25%,CDK10;TESK1;EVI5L
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.7151469861126616,-1.2031231955431598,0.19047619047619047,0.9854878654137851,1.0,1/10,1.85%,P2RY12
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.5450923892515995,1.2029187051634564,0.23529411764705882,1.0,1.0,7/36,13.11%,RFWD3;HMGA2;KMT5A;ABL1;CASP9;UBE2N;POLH
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),-0.7399222557128523,-1.2028543044727902,0.2222222222222222,0.9855587383096801,1.0,1/6,4.79%,ID2
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.6082288980737791,1.2025661582863174,0.1891891891891892,1.0,1.0,3/13,4.03%,F2;SERPINF2;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.7120562676552413,-1.2025613997625033,0.2542372881355932,0.9857075372644004,1.0,5/11,20.86%,IFITM3;TRIM5;IFNA2;CIITA;LY6E
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.6278750847796136,-1.202035166475555,0.19117647058823528,0.9870001156522683,1.0,2/32,3.90%,CD44;CITED2
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.5573196467789415,-1.201144478682158,0.1875,0.9897564490138978,1.0,4/45,6.27%,H2BC11;TNFRSF1A;BIRC3;LAPTM5
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),0.72575053881864,1.2010613881447472,0.36363636363636365,1.0,1.0,1/10,0.93%,ORC1
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.7919476277082745,1.2008700728105568,0.23529411764705882,1.0,1.0,1/5,8.95%,PRLR
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.7601930654588008,-1.2006162384611996,0.2714285714285714,0.9913512819770617,1.0,2/6,14.55%,TGFB2;CDH3
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.6749061556050822,1.2003235095333031,0.26666666666666666,1.0,1.0,3/9,6.94%,ABCC2;ABCC1;HMOX2
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.6749061556050822,1.2003235095333031,0.26666666666666666,1.0,1.0,3/9,6.94%,ABCC2;ABCC1;HMOX2
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.5397919472728407,-1.1998046251184267,0.24285714285714285,0.9945993522912299,1.0,12/63,11.53%,PKP2;CLDN5;CDH12;TGFB2;CDH9;CADM3;CSF1R;CDH22;TGFB3;CDH10;CDH18;CDH13
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.6801857915839987,-1.1997784718107023,0.2676056338028169,0.9934029787684633,1.0,4/9,28.13%,GATA1;ZFPM1;UBA5;ZNF385A
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.7337196873788566,-1.1997389531442184,0.2537313432835821,0.9922614800644899,1.0,4/11,12.42%,KITLG;TGFBR2;TPO;ZFPM1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.7188226462524858,-1.1996328264384717,0.234375,0.9915744532143463,1.0,3/11,19.62%,H2BC11;GAS6;ZNF675
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),0.7405446207718581,1.199589299392027,0.3170731707317073,1.0,1.0,1/6,4.21%,RAE1
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.6779604161887014,-1.1995371884250765,0.2857142857142857,0.9907218273960479,1.0,4/14,10.64%,PTPRC;HLA-E;CR1;XBP1
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.8062673410746812,-1.1994765796790736,0.23636363636363636,0.9898328959057735,1.0,2/5,10.64%,AQP1;XBP1
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.6464314076899911,-1.1993308971809316,0.22058823529411764,0.9892546363029329,1.0,3/15,5.43%,SRGN;MEF2C;SOX9
prerank,MSigDB_Hallmark_2020__Myc Targets V2,0.5261220862036846,1.1992490713823605,0.20588235294117646,1.0,1.0,17/51,22.66%,TCOF1;RCL1;BYSL;RRP12;PUS1;TFB2M;NOLC1;TMEM97;PLK4;MPHOSPH10;WDR74;NPM1;SLC29A2;EXOSC5;NOP56;FARSA;CDK4
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),-0.6924619915890194,-1.1990394785720375,0.23529411764705882,0.9896913704950235,1.0,2/8,10.70%,NEDD4L;HECW1
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.5799723972695423,1.1988725229773813,0.21621621621621623,1.0,1.0,6/29,17.00%,SQLE;SOAT2;IDH2;LCAT;CLN6;FDX1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.5980068558363788,1.1983979917662302,0.2,1.0,1.0,3/27,3.53%,ORC1;DHFR;KLF11
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),-0.7122761131067191,-1.1977083597345233,0.23880597014925373,0.9952771118929076,1.0,6/12,19.95%,TGFBR2;LYN;AXL;LILRB1;GAS6;TRPM2
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),0.7832561102232792,1.1976261165035327,0.3023255813953488,1.0,1.0,1/5,0.53%,GJC1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),0.7665267383378916,1.1975696155215119,0.3469387755102041,1.0,1.0,3/5,11.87%,CYBA;MFHAS1;TLR1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.6435402539158639,1.1974368109259406,0.2916666666666667,1.0,1.0,6/12,20.65%,OOEP;PTP4A3;CEP290;CEP120;CORO2B;KIAA0586
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.5929223561821447,1.1973553373211736,0.16666666666666666,1.0,1.0,3/14,4.03%,F2;SERPINF2;RUNX1
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.5175369551091192,-1.1973312983771622,0.2222222222222222,0.9956406921680276,1.0,12/99,8.03%,SLC28A2;VIL1;CPS1;PPARG;ASPN;PDZK1;AQP1;SLC23A1;L1CAM;CEACAM1;TREH;GFRA2
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),0.7640762987233317,1.1972241765994822,0.358974358974359,1.0,1.0,1/5,2.77%,DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),0.7640762987233317,1.1972241765994822,0.358974358974359,1.0,1.0,1/5,2.77%,DCXR
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),0.7640762987233317,1.1972241765994822,0.358974358974359,1.0,1.0,1/5,2.77%,DCXR
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.7342083012802179,-1.196868218808705,0.1864406779661017,0.9966932796696024,1.0,1/7,0.33%,CARTPT
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.5404514066180366,-1.1964152341604586,0.19402985074626866,0.9978834350992948,1.0,19/53,21.14%,P2RY12;TGFB2;IL12A;NCKAP1L;CITED2;ECM2;ADGRG1;EPHA4;STX3;ITGAV;PRKD2;RAC3;VEGFA;SYK;PPP3CA;FBLN2;PTPRJ;RNASE10;TPM1
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.5040581873268628,-1.1964086018020141,0.15625,0.9965854690833386,1.0,27/99,24.07%,CLDN5;DACT1;DTX3L;LRRK2;B2M;ADD2;CAMK1;LRPAP1;CAV1;ZFPM1;LRP1;NMD3;PRMT8;IFIT1;CARD18;DISC1;EFHB;CDKN1A;FLOT1;IFIT2;ADD1;PPP1CA;DDX11;PRKCD;ITGB1BP1;RALB;AURKA
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.645504984595236,-1.1959053410661422,0.24285714285714285,0.9979126063999217,1.0,4/19,13.33%,PKP2;CAV1;CAV3;CALM3
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),0.6888519581272394,1.1958577685057938,0.23076923076923078,1.0,1.0,1/5,4.86%,NEU4
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.4664590514186078,-1.1958147809747603,0.07058823529411765,0.9970628749004029,1.0,42/273,15.69%,CD44;ANGPT1;PDGFD;IRGM;PTPRC;CENPE;TGFB2;MUSK;IL6R;SPDYA;NOS1;CEMIP;SOX9;HGF;FGF22;CCND1;CSF1R;INHBC;HLA-DRB1;TEK;LRRK2;TERF2IP;KNDC1;CHI3L1;EFNA1;GATA1;BMP6;TGFB3;CX3CR1;CAMK1;SH2D3C;CAV1;MTCP1;CALM3;RBPMS;LYN;TNK2;PRKD2;FGF7;VEGFA;EFNA5;TOM1L1
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),0.728938759121577,1.195326337460258,0.24324324324324326,1.0,1.0,5/6,24.63%,DRD4;SNCA;RAB3B;GDNF;TOR1A
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.6502423483657535,-1.1953194232386486,0.22058823529411764,0.9986397333665672,1.0,2/19,8.74%,TP73;DDIT4
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.47566736061563153,-1.195312449427708,0.19718309859154928,0.9973983236618683,1.0,15/155,6.74%,CD44;ITGB4;ADAMTS17;ADAMTS5;ADAMTS6;ITGAM;MMP24;LAMC1;COL4A1;ECM2;MMP21;MFAP5;COL11A1;PAPLN;ST7
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),-0.7644720265660524,-1.1951877822424366,0.16923076923076924,0.9967678391706725,1.0,4/7,18.92%,LYN;AXL;LILRB1;GAS6
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.6903630800404914,1.1940388914072393,0.23076923076923078,1.0,1.0,1/9,7.52%,CCNT1
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.6190199259158384,-1.1937533946968257,0.26153846153846155,1.0,1.0,12/29,17.12%,CDH12;CDH9;SELL;CDH22;PCDHB4;CDH10;CDH18;CDH13;PCDHB11;CDH23;PCDHB9;CDH7
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.5362092771809591,1.1935079233760764,0.25,1.0,1.0,7/33,9.26%,NUPR1;ALK;FBP1;RILP;FLNA;CBFA2T3;HMGCR
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.6730682381836474,-1.1933171726182292,0.2727272727272727,1.0,1.0,2/11,12.34%,ID2;C1QC
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.6136169914266072,-1.1924948531004456,0.2077922077922078,1.0,1.0,4/30,11.36%,NR4A3;CHGA;RAB3A;HPS6
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.7236399890815801,1.1921091921073204,0.2631578947368421,1.0,1.0,1/7,7.60%,MTMR2
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.605795871719241,-1.1919455413349591,0.2,1.0,1.0,2/32,0.98%,FBLN1;SEMA3E
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.531449200694768,1.1917748869415552,0.23076923076923078,1.0,1.0,3/61,4.24%,BACE2;DPEP1;ENPEP
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.7085579602143216,-1.191598140441817,0.25,1.0,1.0,3/10,22.92%,MX1;IFIT1;NLRP1
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.7292591193980502,1.19152547922022,0.34210526315789475,1.0,1.0,1/9,0.95%,DHFR
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.6445781852352983,-1.191372027457778,0.21666666666666667,1.0,1.0,3/23,2.19%,FSTL1;LPL;TIMP1
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.5664057220314557,1.1912656862873703,0.25,1.0,1.0,5/33,15.12%,NUPR1;TBC1D12;FEZ1;UBQLN2;SEC22B
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),-0.4529960409574685,-1.1910791425735037,0.08333333333333333,1.0,1.0,65/240,15.08%,CHRM5;NPY;ZACN;CHRM3;CBLN2;RIMS1;SHISA6;HTR5A;KCNQ3;SYT1;RIT2;CACNA1E;KCND2;GLRA3;GABRA1;SYN3;GLRA2;GABRG2;PRKAR1B;HTR1E;GRIK2;SNAP25;UNC13C;NPTX1;PTCHD1;GRM5;NRGN;HTR2C;SYN2;SLC1A1;PCDHB4;CACNA1B;GRM7;RAB3A;CACNB1;GABRB2;LIN7A;FCHSD2;SNCB;AMPH;GABRA4;NPTX2;HTR2B;GRIK1;GABRA2;CAMK1;GABRA6;PCDHB11;GRIN2B;GPR176;GRIA3;DLGAP1;HTR3B;ASIC2;CHRM1;HTR2A;GRIN2D;GABBR2;SLC18A2;GRIA1;DLG4;GAD2;PCDHB9;CACNB2;HCRTR2
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.6828105124300378,-1.1909570638311497,0.21666666666666667,1.0,1.0,4/11,20.94%,TGFB2;ZFPM1;NOTCH2;MESP1
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.6694622674068644,-1.1909401349192832,0.20689655172413793,1.0,1.0,5/17,19.62%,HEY1;GATA1;H1-0;TGFB1;ZNF675
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),-0.8059644750509463,-1.190769262897683,0.19642857142857142,1.0,1.0,1/5,1.43%,SFRP4
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.564448114864286,-1.1901401061898487,0.2777777777777778,1.0,1.0,10/41,18.91%,DACT1;ALDH1A2;KIAA1217;TGFB3;SULF1;PTPRR;VEGFA;BRCA1;WNT5A;TGFB1
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.8054810061378129,-1.1899759569808486,0.23333333333333334,1.0,1.0,1/6,4.73%,APIP
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.7422566617128944,1.1898390530721878,0.3125,1.0,1.0,3/6,19.73%,PTPN22;DDX3X;MARCHF7
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.738577625530559,-1.1897080509658842,0.2542372881355932,1.0,1.0,1/6,4.34%,DBF4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.7475748204396765,-1.1895914186986112,0.23728813559322035,1.0,1.0,3/8,18.98%,MEF2C;LYN;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.5410814958535661,-1.1895774735804943,0.16176470588235295,1.0,1.0,25/79,21.75%,ROR1;STMN2;EPHA3;TWF2;RIT2;PLPPR5;FES;CAMK1D;TENM3;ZDHHC15;TOX;CAMK1;ATP1B2;SCN1B;LYN;PACSIN1;LRRC7;PTK7;WNT5A;NTRK3;CAMK2B;CX3CL1;SERPINI1;PTN;NDRG4
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.47540617724645723,1.1891109234903479,0.15384615384615385,1.0,1.0,23/85,22.48%,U2AF1;RIDA;HSPA1A;SF3A3;SF3B2;PTBP1;PCF11;KIN;HSPA1B;NUDT16L1;ZC3H12D;PNPT1;SF3A2;HNRNPA2B1;DDX5;CELF1;SF3A1;HSF1;ERN1;HNRNPR;SNRPB;SRSF9;DXO
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),-0.7776320283099898,-1.1888961567495815,0.25806451612903225,1.0,1.0,3/5,20.14%,CAV1;FLOT1;COLEC12
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.716776104707078,-1.1885919115608061,0.22857142857142856,1.0,1.0,6/12,19.71%,CARMIL2;FAP;CST3;LRP1;TGFB1;DDR2
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.540805413653742,-1.1880994660358508,0.19444444444444445,1.0,1.0,6/66,5.75%,DLK2;HEY1;TGFB2;MFNG;ENHO;DTX1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.7029390132431325,-1.1880976831514865,0.2857142857142857,1.0,1.0,1/12,1.52%,NR4A3
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.715636950829253,-1.1878426202205712,0.234375,1.0,1.0,4/10,18.39%,MX1;CRLF1;STAT1;STAT3
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),-0.7663830595443399,-1.1877006671013763,0.20754716981132076,1.0,1.0,1/5,23.07%,AGT
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.5179292261483209,-1.187444237907128,0.18055555555555555,1.0,1.0,25/75,15.65%,DPEP2;LAMP5;PTPRC;DOCK8;SLA;ITGAM;NCKAP1L;MCTP2;AOAH;CD53;GMFG;BLNK;CCR9;SELL;LAPTM5;IL3RA;GPR183;IL16;ARHGAP25;ITM2C;IKZF1;PACSIN1;LY86;ETV6;WDFY4
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.6164003837169838,-1.1873565850037942,0.2835820895522388,1.0,1.0,6/22,17.17%,CHST9;SULF1;CSGALNACT1;BMPR1B;CNMD;CHST8
prerank,GO_Biological_Process_2021__cellular water homeostasis (GO:0009992),-0.824260070211212,-1.1868408240467823,0.3064516129032258,1.0,1.0,3/5,13.26%,AQP1;AQP11;AQP4
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),-0.795249464418238,-1.1864817500668814,0.22641509433962265,1.0,1.0,3/5,18.91%,TGFB2;TGFB3;TGFB1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.5155120482487114,1.186416286906446,0.16216216216216217,1.0,1.0,22/79,20.11%,MRPL58;MRPL32;MRPS10;MRPS7;MRPL3;MRPS2;MRPL50;MRPL15;PTCD3;MRPS5;MRPS26;MRPS27;MRPL52;MRPL24;MRPL47;MRPL39;MRPL13;MTRF1L;MRPS9;MRPS30;MRPS16;MRPL22
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.4743739836372424,1.186415244562548,0.175,1.0,1.0,9/85,7.35%,CXCR4;F2;GUCA1C;PDE6A;MGLL;CNGB1;EPHB2;PDE6B;GUCA1B
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.6971865737752756,-1.186326421878017,0.2903225806451613,1.0,1.0,2/9,11.67%,LIN54;H1-0
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.6641182777598136,-1.1862372297646564,0.2835820895522388,1.0,1.0,3/12,6.83%,ACADL;SOX9;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),-0.7997100654075563,-1.1859310308066768,0.22807017543859648,1.0,1.0,3/5,6.83%,PTPRC;NCKAP1L;CEACAM1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.5938118736483402,-1.185902593484993,0.25396825396825395,1.0,1.0,8/21,15.53%,UTRN;NOS1;FGF12;NEDD4L;SCN1B;CAV3;YWHAH;SCN4B
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.4918172136930381,-1.1856603629556104,0.14666666666666667,1.0,1.0,20/125,5.07%,OLFML1;TLR2;COX7A1;MEST;ADAMTS5;ROBO4;PPARG;EPSTI1;TIMP1;TMEM26;ASPN;SERPING1;MAOB;OLFML2B;ACTA2;PLSCR4;FAP;AQP1;BCAT2;ECM2
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.7907271861072773,1.1854697003176213,0.175,1.0,1.0,2/6,3.27%,AGER;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.7365275656919765,-1.1853194726225227,0.29850746268656714,1.0,1.0,2/9,7.38%,FES;HLA-DRB1
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.7120687762461986,-1.1845830897795173,0.2807017543859649,1.0,1.0,5/10,20.86%,IFITM3;TRIM5;IFNA2;CIITA;LY6E
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.6901317744228871,-1.1844769142362743,0.23728813559322035,1.0,1.0,4/13,22.43%,KLF9;GATA1;HPN;BRD8
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.5602059384731526,-1.1843313290965647,0.2727272727272727,1.0,1.0,15/42,13.23%,DPEP2;PTPRC;SLA;IL6R;NCKAP1L;AOAH;CD53;GMFG;SELL;LAPTM5;GPR183;CD200;IL16;ARHGAP25;IKZF1
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.6072739123062046,-1.1842889596691244,0.2857142857142857,1.0,1.0,6/22,21.75%,MEF2C;TGFBR2;CCDC39;MICAL2;MESP1;NDRG4
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.7048217992238524,-1.1842714208327394,0.25,1.0,1.0,4/17,13.51%,PKP2;NINJ1;CD200;ITGAV
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.4831042485057093,-1.1842255227631895,0.17105263157894737,1.0,1.0,27/152,10.18%,F8;MMRN2;CLDN5;HEY1;SRGN;NOSTRIN;COX7A1;SPARCL1;ROBO4;ELK3;PLSCR4;CHST1;GPIHBP1;AQP1;COL4A1;TGFBR2;PLAC8;A2M;GPM6A;BMX;TEK;SEMA3D;LYVE1;PROCR;FLI1;CASZ1;FGD5
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.6629022509062641,-1.1840853997098424,0.265625,1.0,1.0,2/11,5.43%,SFRP4;SOX9
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.7539589117005182,-1.1840556134570472,0.265625,1.0,1.0,3/8,19.01%,ANO6;CD160;PLCG1
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.5567841477903893,-1.1840247255077305,0.2112676056338028,1.0,1.0,14/44,18.43%,PLSCR1;PTPRC;TGFB2;ITGAM;HLA-DRB1;NLRP3;XBP1;NMI;IFNK;IFI35;RSAD2;SKAP1;SLC15A4;LILRB1
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.6448057925490853,1.1837478801797554,0.2564102564102564,1.0,1.0,8/16,22.45%,CPSF4;CSTF2;TSEN15;TSEN34;ZBTB8OS;RTRAF;ERN1;FAM98B
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.5691220312663173,-1.183704426435687,0.3064516129032258,1.0,1.0,7/32,20.39%,FIGNL1;PPP4C;TERF2IP;H1-0;RAD50;RPA2;MRE11
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.8077020527421129,-1.1835171657726598,0.3559322033898305,1.0,1.0,3/5,18.91%,MEF2C;FLOT1;TGFB1
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.5385319291229729,-1.1833525111626126,0.26153846153846155,1.0,1.0,18/64,21.72%,ANGPT1;PTPRM;EDN1;CEACAM1;TEK;SCARB1;ADAMTS9;PRKD2;BMPER;VEGFA;ZNF580;NR2F2;WNT5A;PIK3CB;EMC10;RHOJ;GPI;PTN
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.6541004682231527,-1.1832907197221993,0.26666666666666666,1.0,1.0,4/15,17.57%,SPEF2;AQP4;SPAG17;CCDC39
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.5427742469094585,1.1832415123141533,0.21875,1.0,1.0,6/34,9.97%,PTCD2;CDK11A;JMJD6;SRPK3;CPSF4;RBM23
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.6923179883998396,-1.182703728026956,0.2807017543859649,1.0,1.0,3/10,18.49%,MCM2;DONSON;MCM7
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.7419817191130864,-1.1826865341346764,0.32786885245901637,1.0,1.0,2/8,13.77%,PPARG;LRP1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.5569449054766107,-1.1825687764519723,0.23728813559322035,1.0,1.0,5/45,9.31%,DPP10;EPHA3;LGALS3;STAC2;STX3
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.7431984341672673,-1.182434691618311,0.23214285714285715,1.0,1.0,2/8,10.68%,TWF2;TMSB10
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),0.6902613761970937,1.1824188676915526,0.3611111111111111,1.0,1.0,1/6,0.23%,CRTAM
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.6956555021944366,1.1822021301490153,0.36363636363636365,1.0,1.0,2/6,19.36%,ANAPC1;CDC23
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.6956555021944366,1.1822021301490153,0.36363636363636365,1.0,1.0,2/6,19.36%,ANAPC1;CDC23
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),-0.7501688197980344,-1.1818456397269514,0.26229508196721313,1.0,1.0,2/5,18.92%,BCL11B;GAS6
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.6283177449956044,-1.181760366883894,0.26865671641791045,1.0,1.0,7/24,18.32%,SYT1;SYT4;KCNB1;SCAMP5;CACNA1G;SYT13;SYT12
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.7325738642277655,-1.181750636908491,0.26666666666666666,1.0,1.0,6/10,22.42%,PTPRC;CD200;LRFN5;NR1D1;CX3CL1;IL31RA
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.7640087188940636,-1.1816781973180006,0.3142857142857143,1.0,1.0,5/6,23.61%,NLRP3;IFNA2;RSAD2;PRKCZ;DENND1B
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.6478683877094336,1.1816720703482977,0.3055555555555556,1.0,1.0,2/18,7.81%,GDAP1;PLD6
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),-0.7647056924315334,-1.1813245144278608,0.21875,1.0,1.0,2/7,15.41%,ASIC2;ABCC9
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),0.7466833219472153,1.1812849200809703,0.3055555555555556,1.0,1.0,1/6,0.60%,HDC
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),0.7466833219472153,1.1812849200809703,0.3055555555555556,1.0,1.0,1/6,0.60%,HDC
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.5140057208284666,1.1810787372594544,0.2222222222222222,1.0,1.0,8/64,11.54%,NGF;PLXNA1;CHODL;SLIT2;ZNF335;SMARCD3;PTPRD;IL1RAPL1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),-0.5889816798641963,-1.1809916142570835,0.27419354838709675,1.0,1.0,5/28,13.51%,LRTM1;SEMA3E;SEMA3D;SEMA4G;ITGAV
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5756459022245487,1.1809366526812914,0.22580645161290322,1.0,1.0,2/16,2.60%,PTPRU;SERPINF2
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.6382965304799239,-1.180852698552278,0.20967741935483872,1.0,1.0,3/18,12.21%,P2RY12;CARMIL2;CAV1
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),-0.7909826173168408,-1.1807913900792544,0.32727272727272727,1.0,1.0,2/6,18.06%,RAB3A;PCLO
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.5045962830268925,-1.180777628512668,0.18666666666666668,1.0,1.0,16/70,18.94%,ARIH2;PTPRC;TGFB2;KITLG;TGFBR2;MFAP5;TPO;CSF1R;TEK;TOX;ZFPM1;NOTCH2;ETV6;WNT5A;TGFB1;TIRAP
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),0.7434060855389515,1.1805120406873155,0.22727272727272727,1.0,1.0,1/5,6.29%,IDH2
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.782478545117334,-1.180509245410488,0.2222222222222222,1.0,1.0,1/7,1.85%,P2RY12
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.5548234331405719,1.1804720660204708,0.19444444444444445,1.0,1.0,4/29,7.94%,CDSN;TXNIP;TGM1;HDAC1
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.8053439313413343,-1.1800162366211284,0.26,1.0,1.0,1/5,9.09%,RAB3A
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),-0.7211430117968756,-1.1799364331892115,0.2835820895522388,1.0,1.0,2/11,11.74%,RNFT1;AQP11
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),-0.7075071539064554,-1.179893137294815,0.2786885245901639,0.9994628373359883,1.0,3/8,18.15%,GRIP1;DLG4;WNT5A
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.6135925666277695,-1.179856828409676,0.2833333333333333,0.9983859061752987,1.0,6/15,18.15%,NTNG1;GRIP1;MOV10;DLG4;NTNG2;WNT5A
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.5992922058633076,1.17956745277079,0.25,1.0,1.0,5/17,26.57%,MTMR2;SNX3;DNAJC13;MAP2K2;VPS11
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.5038373715581832,-1.1794832837032923,0.11764705882352941,0.999275382343148,1.0,16/115,15.88%,PKP2;DPP10;KCNIP4;TNFRSF1A;ANK1;PDZK1;RAB11A;RAB3A;RAB3C;CAV3;PACSIN1;KCNB1;FYB1;CACNB2;RAB15;KCNB2
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),-0.7992338125063599,-1.1793894871565787,0.208955223880597,0.9984114461386296,1.0,3/5,19.76%,P2RY12;CX3CR1;CX3CL1
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.615323265137355,1.1793028473140512,0.2631578947368421,1.0,1.0,1/9,4.33%,ERRFI1
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),0.7383595494986601,1.179031683118806,0.37142857142857144,1.0,1.0,1/5,4.29%,FBP1
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.502140048364528,-1.1786185676228282,0.13043478260869565,1.0,1.0,17/90,12.17%,F8;SRGN;TIMP1;TGFB2;CLU;TTN;SERPING1;TPH1;TUBA4A;ABCC4;A2M;HGF;ACTN1;TGFB3;SCG3;MANF;RAB27B
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),-0.4896367251455402,-1.1784690653499037,0.22535211267605634,1.0,1.0,15/95,19.01%,PLEKHA2;PLEKHA4;CDS1;PLCB3;BMX;INPP4B;CSF1R;PLCB1;PIP5K1B;PLA2G12A;INPP5D;PI4K2A;PTPN13;PIK3CB;PLCG1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.5900685686772594,-1.1784582351127528,0.21875,0.9998687016689065,1.0,3/32,4.85%,TWF2;NOS1;TGFBR2
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.7003193728756887,-1.1782170283945332,0.2923076923076923,0.9999260910492616,1.0,6/15,21.64%,ACTA2;DACT2;TMEM79;LRTOMT;WNT5B;PDZD7
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.5402980881130982,-1.178179101984805,0.2535211267605634,0.9989969589451196,1.0,12/67,17.11%,SEMA3E;CBLN2;TGFB2;SLC8A3;L1CAM;GRM5;TGFB3;SNCB;PAK3;MYOT;OPHN1;TJP3
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.7994549865647484,1.1780376677941087,0.3409090909090909,1.0,1.0,3/5,12.11%,SLC38A1;SLC38A2;SLC38A3
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.5540001742465469,1.1777568635976148,0.21212121212121213,1.0,1.0,1/34,0.21%,CXCR4
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),-0.5278817237135857,-1.1777073323984177,0.19444444444444445,1.0,1.0,17/74,15.63%,SEMA3E;RND2;ARHGAP18;BAIAP2;EPHA3;TWF2;SMIM22;RHOC;PEAK3;CSF1R;BST1;PAK3;LRP1;DAPK3;NOTCH2;RAC3;EFNA5
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.6192235634064696,-1.1776784900381496,0.23943661971830985,0.9991828826773603,1.0,3/19,13.87%,TRIM5;TRIM25;TRIM32
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.528554406024621,-1.1776240297550709,0.22727272727272727,0.9982348739734781,1.0,24/65,24.77%,PPP1R17;ARHGAP15;EPHA3;NOS1;EPHA4;VAV3;FGD5;SIPA1L1;CAV1;PRKG1;CHN1;WRN;EFNA5;NGEF;PLXNC1;PLXNA2;PLXNA4;FGD1;ARHGAP12;ATP5IF1;PLXND1;ITGB1BP1;VAV2;EPHB3
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),-0.775036953975905,-1.17759395132457,0.22641509433962265,0.9972083031429959,1.0,3/5,18.63%,LPL;SCARB1;MSR1
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.7366477911120358,-1.1775275961765859,0.25,0.996368754658501,1.0,2/9,15.15%,SPEF2;SPAG17
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.5277971282814734,-1.1774730311068307,0.2542372881355932,0.9953814462375852,1.0,5/53,5.74%,KANK2;RIT2;MET;ADGRG1;LPAR6
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.511623718282873,1.1774126659337376,0.2558139534883721,1.0,1.0,8/31,15.12%,NUPR1;CDK10;TESK1;EVI5L;FEZ1;KAT2A;STYXL1;SEC22B
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.6884348549343935,-1.177401628141073,0.29850746268656714,0.9945000676162493,1.0,4/15,7.42%,BAIAP2;BAIAP2L2;FES;TEK
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.6933453430889703,1.1771311038573342,0.3333333333333333,1.0,1.0,7/11,25.68%,DKC1;CCT8;CCT2;CCT6A;CCT3;LARP7;MEPCE
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.6933453430889703,1.1771311038573342,0.3333333333333333,1.0,1.0,7/11,25.68%,DKC1;CCT8;CCT2;CCT6A;CCT3;LARP7;MEPCE
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),-0.7234681792158911,-1.1770940433694217,0.31746031746031744,0.9948505973889289,1.0,2/7,6.37%,TIMP1;CCND1
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,0.4748909044793957,1.1770157356954296,0.22580645161290322,1.0,1.0,15/72,7.04%,DAO;SLC22A6;C6;SERPINF2;ABCC2;F11;ENPEP;FBP1;SOD3;KNG1;GLYAT;SLC47A1;CLDN2;HSD11B1;GJB1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.6478389760570452,-1.1767111438992635,0.1896551724137931,0.9956709582862857,1.0,2/23,5.43%,PPARG;SOX9
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.6321626590413068,-1.1763733292849976,0.25,0.9961683125622215,1.0,4/19,15.59%,TGFB2;LRP1;ADAMTS9;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),-0.5934314967064558,-1.175854439801173,0.19696969696969696,0.9979929549399565,1.0,9/31,13.99%,CARTPT;RIMS1;SYT1;EDN1;GRIK2;LGI1;RIMS2;CLSTN3;DLG4
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),0.6881199662512746,1.1758147318849452,0.29545454545454547,1.0,1.0,1/5,0.77%,SLC22A2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.5479038892263738,1.1755168652571966,0.225,1.0,1.0,18/46,24.50%,GNL3L;CTC1;PINX1;NAT10;PKIB;TNKS2;TENT4B;HNRNPU;MAP2K7;ATR;ACD;NAF1;SMG5;HNRNPC;CCT8;CCT2;CCT6A;CCT3
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.7232971615913433,-1.1747832275541996,0.265625,1.0,1.0,2/11,8.27%,LAPTM5;CCDC91
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),0.6732704136279917,1.1746718780928531,0.30952380952380953,1.0,1.0,1/8,0.68%,NUPR1
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.682620374035777,1.1745476728606707,0.3170731707317073,1.0,1.0,2/8,22.59%,METAP1D;NAA20
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.6044657766795474,1.1744629394290669,0.3235294117647059,1.0,1.0,3/13,7.05%,F2;ADAMTS18;PDGFA
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),-0.7552802325304508,-1.1743494682807436,0.29508196721311475,1.0,1.0,1/5,3.52%,HORMAD2
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.7661462268954369,-1.1741047656001702,0.2033898305084746,1.0,1.0,4/9,20.01%,PPARG;ITGAV;NFKBIA;ABCA1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.6583440224763778,1.1739195186305564,0.2972972972972973,1.0,1.0,1/12,0.68%,NUPR1
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.6440331213455788,1.1735913808932459,0.3055555555555556,1.0,1.0,1/12,0.93%,ORC1
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.7121546549296447,-1.173368264724821,0.17567567567567569,1.0,1.0,1/12,1.78%,CENPE
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),0.7419502266370186,1.1733251135737053,0.2777777777777778,1.0,1.0,1/6,2.12%,OAS3
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.6988301761894024,-1.1732802058460454,0.29850746268656714,1.0,1.0,1/8,1.78%,PPARG
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.569620561696119,1.1729809157854387,0.32432432432432434,1.0,1.0,7/22,19.10%,UBC;UBB;UBE2N;ITCH;MAP3K7;IRAK2;TAB3
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.6275479154626383,-1.172934859764855,0.29310344827586204,1.0,1.0,7/18,18.91%,HEY1;SOX9;ROBO2;EFNA1;TIE1;ELN;TGFB1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.6178958219518108,1.1728017320790776,0.21428571428571427,1.0,1.0,1/24,0.20%,NGF
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),0.6455091749325589,1.1725858949725365,0.3225806451612903,1.0,1.0,1/8,2.12%,OAS3
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),-0.6938992784665688,-1.1719887170831593,0.23809523809523808,1.0,1.0,4/11,12.26%,TGFB2;ID2;RARB;GLI3
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),0.6722577152949141,1.1716920781774953,0.3333333333333333,1.0,1.0,2/7,7.63%,BYSL;PINX1
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.81052549469365,-1.1716109652283504,0.3103448275862069,1.0,1.0,2/7,7.59%,CPS1;ARG2
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",0.5158118379601934,1.1715464996158753,0.20689655172413793,1.0,1.0,4/24,13.95%,EAF2;CCNT1;ELL;ZMYND11
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.7194021994302319,1.171242372936509,0.3617021276595745,1.0,1.0,2/6,5.52%,F2;EPHB2
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.6486811966448296,1.1712266801067996,0.3333333333333333,1.0,1.0,2/9,8.56%,RAB39A;RAB7B
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),-0.7806226647289641,-1.1712177732339235,0.3283582089552239,1.0,1.0,2/5,9.23%,ANO6;KCNMA1
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),-0.5815744537281735,-1.1711115909928604,0.25,1.0,1.0,7/34,14.19%,IL6R;MEF2C;HGF;BMP6;WWTR1;BMPR1B;NELL1
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),0.6745989649315917,1.1710225565452699,0.3157894736842105,1.0,1.0,3/9,17.80%,ERI1;EXOSC8;EXOSC7
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.5037590112590774,-1.1708795932277527,0.18840579710144928,1.0,1.0,18/119,15.88%,PKP2;DPP10;KCNIP4;TNFRSF1A;ANK1;PDZK1;RAB11A;RAB3A;LIN7A;RAB3C;CAV1;CAV3;PACSIN1;KCNB1;FYB1;CACNB2;RAB15;KCNB2
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.5609119844702332,-1.1708233991304833,0.2608695652173913,1.0,1.0,9/43,13.68%,IGFBP3;CLU;MCTP1;NLRP12;DDAH1;THY1;AQP11;UBASH3B;LYN
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.7267879124757113,-1.1707130488283528,0.2807017543859649,1.0,1.0,2/8,4.19%,HLA-E;IRF4
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.7219778523437933,-1.1706362607852894,0.25806451612903225,1.0,1.0,2/6,25.90%,MACROH2A1;ZFP36L1
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),-0.7919194522098025,-1.1702528975638289,0.3220338983050847,1.0,1.0,4/5,20.50%,CACNB2;SCN4B;CACNA1G;CACNA1C
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),0.718295746532963,1.1701570978014688,0.3333333333333333,1.0,1.0,1/7,0.42%,ICAM1
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),-0.45814290237038824,-1.1701344581400948,0.14084507042253522,1.0,1.0,57/187,15.08%,CHRM5;NPY;ZACN;CHRM3;HTR5A;KCNQ3;SYT1;RIT2;CACNA1E;KCND2;GLRA3;GABRA1;GLRA2;GABRG2;PRKAR1B;HTR1E;GRIK2;SNAP25;UNC13C;NPTX1;PTCHD1;GRM5;NRGN;HTR2C;SYN2;SLC1A1;PCDHB4;CACNA1B;GRM7;CACNB1;GABRB2;SNCB;AMPH;GABRA4;NPTX2;HTR2B;GRIK1;GABRA2;CAMK1;GABRA6;PCDHB11;GRIN2B;GPR176;GRIA3;DLGAP1;HTR3B;ASIC2;CHRM1;HTR2A;GABBR2;SLC18A2;GRIA1;DLG4;GAD2;PCDHB9;CACNB2;HCRTR2
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.575328826413148,1.1700855829195045,0.2857142857142857,1.0,1.0,6/19,17.43%,HSPA1A;HSPA1B;DAXX;ITCH;ZMIZ1;EGR1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.5434182845807027,-1.1700805293223593,0.19117647058823528,1.0,1.0,15/55,19.76%,PLEKHA2;SEMA3E;EPHA3;UTRN;BST1;THY1;CDH13;RASA1;PLET1;DAPK3;EFNA5;SKAP1;CAMSAP3;PIK3CB;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.593644491224151,1.170056646430391,0.2571428571428571,1.0,1.0,3/23,4.33%,CRTAM;CD274;SCRIB
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.584603537320776,-1.169434796724182,0.1935483870967742,1.0,1.0,6/32,12.33%,ISG15;SERPING1;CR1;A2M;SAMHD1;NMI
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.6947319558775858,-1.1691085852353733,0.25,1.0,1.0,3/11,12.35%,IGFBP3;NLRP12;UBASH3B
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.4976857195753262,-1.1688016828162,0.20270270270270271,1.0,1.0,27/127,12.87%,ANGPT1;FSTL1;COX7A1;PDGFD;ADAMTS5;PPP1R3C;NOX4;ACTA2;PLSCR4;AQP1;COL4A1;OGN;SYNPO2;MFAP5;IRAG1;DKK3;PRXL2C;TEK;MAP3K7CL;PCP4L1;PLN;SULF1;MYH11;THY1;C1R;PRKG1;WFDC1
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.5033028874160623,-1.168624098154351,0.1791044776119403,1.0,1.0,26/131,13.56%,PTPRM;GCNT1;PPARG;F3;CITED2;LAMC1;TGFBR2;RGS4;KALRN;MET;COL11A1;CDON;INPP4B;DDAH1;BHLHE40;KCNMA1;GJA1;AMPH;CELF2;LTBP1;MMP16;SIPA1L1;ADGRL2;CAV1;PLCB4;RBPMS
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.5203625961207928,-1.1685758843988985,0.2535211267605634,1.0,1.0,12/43,18.82%,WNT8B;EPHA3;TWF2;AQP1;BRINP2;SOX9;LYN;BRINP1;PTK7;BRINP3;WNT5A;WNT5B
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.7424836785290746,-1.1685171433613808,0.288135593220339,1.0,1.0,3/7,9.51%,TGFB2;TGFBR2;TGFB3
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.6347435815582073,1.1684374183576551,0.2777777777777778,1.0,1.0,3/8,11.62%,CPNE1;HDHD5;CPNE7
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.5860485321115048,1.1683459710394315,0.2702702702702703,1.0,1.0,2/12,4.63%,FOLH1B;AGBL1
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.6496047927100018,1.168115801086798,0.35714285714285715,1.0,1.0,2/8,8.56%,RAB39A;RAB7B
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.6069344480497797,1.168065699668331,0.18421052631578946,1.0,1.0,3/16,8.63%,AGER;MFHAS1;RELL1
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),-0.726570917948965,-1.168025841863504,0.27586206896551724,1.0,1.0,2/6,10.37%,TTN;MYH11
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.6492509350287717,-1.1677442333369636,0.2727272727272727,1.0,1.0,8/17,20.14%,TTN;SORBS2;MYH11;SLC8A1;FHOD3;VEGFA;MYLK3;ALPK2
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.5796090656731238,1.1674176636865041,0.30303030303030304,1.0,1.0,4/22,11.59%,PRR5;EIF4EBP1;MLST8;PRR5L
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.495944437172041,1.167032283542739,0.13157894736842105,1.0,1.0,4/94,3.10%,NGF;CXCR4;LCK;FGF6
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),-0.7625341822640999,-1.1667366403343253,0.3148148148148148,1.0,1.0,2/5,13.68%,PLSCR1;LYN
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.6538936186153025,1.1664355031607294,0.21212121212121213,1.0,1.0,3/12,12.48%,SNX1;STX10;LMAN1
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.7098508793080712,1.1663512776435487,0.23809523809523808,1.0,1.0,2/7,7.60%,IGF1R;MTMR2
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.7202455029698043,1.1663300444077562,0.358974358974359,1.0,1.0,4/8,21.08%,TSPOAP1;STAR;FDX1;FDXR
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),-0.7085898355563773,-1.1659316154778312,0.3333333333333333,1.0,1.0,1/8,0.73%,HEY1
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.6853612976641903,1.165214795907246,0.2777777777777778,1.0,1.0,4/8,16.23%,KDM1B;KDM5A;KDM5B;KDM5D
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.6735265773252338,-1.1650279844925935,0.34782608695652173,1.0,1.0,4/12,22.38%,IFITM3;TRIM32;ZFP36;TRIM13
prerank,PanglaoDB_Augmented_2021__Myocytes,0.4631180196239202,1.1648863378589103,0.13333333333333333,1.0,1.0,19/83,11.36%,CXCR4;TNNC2;CRYAB;MYH4;CASQ2;SMYD1;IL4R;CHODL;PAX3;TPM2;PLD1;ASB5;SRL;THBS4;ACTN2;TCAP;MYH14;ITGA7;NPHS1
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.632653218453299,1.1648738079054088,0.2727272727272727,1.0,1.0,1/12,0.48%,PTH
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.6534903000768105,1.164727688062501,0.26666666666666666,1.0,1.0,2/11,6.91%,GAB1;MYO1C
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.7269632595068358,-1.164309478890551,0.34615384615384615,1.0,1.0,3/6,5.93%,HLA-E;NCKAP1L;HLA-A
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),-0.7435299169045608,-1.164255292401041,0.25862068965517243,1.0,1.0,1/5,13.94%,AMER1
prerank,MSigDB_Hallmark_2020__Complement,-0.4545039234587764,-1.1639830406557574,0.2191780821917808,1.0,1.0,27/151,14.55%,F8;CD59;PLSCR1;TIMP1;CTSO;ITGAM;CLU;SERPING1;CR1;F3;IRF1;LGALS3;PIM1;ZEB1;PPP4C;CEBPB;CDK5R1;SCG3;CDH13;C1R;C1QC;L3MBTL4;CALM3;CP;LYN;LRP1;GNG2
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.4787714748837577,-1.1637336160966754,0.17142857142857143,1.0,1.0,15/137,13.25%,ANGPT1;COX7A1;HOPX;CENPE;CENPF;CLU;HIGD1C;CALY;TESPA1;NSG2;RPL38;TBCA;CENPA;TMEM35A;SRP54
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),-0.6629798482687993,-1.1634672686732788,0.32786885245901637,1.0,1.0,4/9,18.18%,MYO7A;CDH23;TPP1;NRXN1
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.5999988542885644,-1.1634145571234848,0.24615384615384617,1.0,1.0,1/20,0.11%,GPAT3
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.7383458978981099,-1.1633032075810141,0.2909090909090909,1.0,1.0,1/7,4.34%,DBF4
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),-0.7455927230182059,-1.1630011486744078,0.32142857142857145,1.0,1.0,3/5,21.19%,CARD18;NOL3;BCL2L12
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.523186118816657,1.1629986871585367,0.23333333333333334,1.0,1.0,12/40,22.14%,ASAP1;NUMA1;G3BP2;CROCC;ARHGAP35;PLK4;STX18;CEP120;SAXO1;G3BP1;MARK4;CNOT2
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.7428097348698451,-1.1622304702426596,0.3275862068965517,1.0,1.0,3/6,18.43%,FURIN;CDH3;LILRB1
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),-0.7062316292899384,-1.1618121187165322,0.3076923076923077,1.0,1.0,3/10,15.77%,SHMT2;CBS;SDS
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.6004698166389609,-1.1612688126205548,0.2222222222222222,1.0,1.0,6/23,11.08%,HLA-F;HLA-E;HLA-A;LAPTM5;B2M;CD160
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.744460487619935,-1.1612017774102719,0.2631578947368421,1.0,1.0,3/10,17.39%,ALG10B;PLCB1;RAMP1
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),-0.7588527452180088,-1.1610104670247687,0.31746031746031744,1.0,1.0,1/6,1.25%,IRGM
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),0.7136876159665068,1.160929239521317,0.325,1.0,1.0,5/5,28.65%,ERRFI1;PKD1;ASCL1;GRHL2;RCN3
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.49990584746029465,-1.1608797244710531,0.2222222222222222,1.0,1.0,24/85,19.56%,NR4A3;STAT5A;F3;LAMC1;SOX9;TEK;SCG2;LAMB1;BMP6;XBP1;HTR2B;CDH13;TGFA;CDH3;PRKD2;NOTCH2;FGF7;VEGFA;ZNF580;EGFR;WNT5A;HPN;EMC10;PTPRN
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.6594050686286078,-1.160835367802852,0.29508196721311475,1.0,1.0,2/16,2.30%,CARTPT;RIMS1
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.6946873546955327,-1.1608351041477782,0.3709677419354839,1.0,1.0,4/9,22.57%,ITGAM;SYK;TGFB1;PRKCD
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.6584137159514416,1.1607938791264276,0.36363636363636365,1.0,1.0,4/9,20.32%,AHCTF1;TPR;NDC1;RTN4
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5621906205342388,1.1606940847784728,0.4,1.0,1.0,6/27,20.24%,DICER1;PRKRA;SNIP1;HNRNPA2B1;PUS10;LIN28B
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.7563888520027545,-1.1606762130609247,0.23636363636363636,1.0,1.0,3/6,23.07%,TIE1;TGFB1;AGT
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.67955734168544,-1.1606623246990566,0.18571428571428572,1.0,1.0,2/11,12.89%,STMN2;MAP2
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),-0.7673769735731841,-1.1606508729941816,0.2807017543859649,1.0,1.0,2/7,17.66%,BIRC3;SLC15A4
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.4584546962869244,-1.1605033204288138,0.14285714285714285,1.0,1.0,57/196,20.64%,TRPM1;KCNK10;KCNQ3;KCNS1;KCND2;TRPC4;SLC8A3;KCNV1;TRPC6;TRPM3;ANO6;KCNJ4;SCN2A;SLC6A12;RYR3;SCN9A;KCNQ5;KCNK6;SLC24A5;KCNH7;SLC9C2;SLC8A1;KCNC2;TRPC7;SLC24A1;HCN1;ATP1A1;SLC6A8;ASIC2;SCN1B;ITGAV;SLC9C1;KCNB1;KCNH2;KCNE1;ABCC9;SCN4B;KCNB2;KCNH5;SLC24A4;CACNA1G;SLC11A2;SLC6A4;CACNA2D4;HPN;TRPV4;KCNK1;GAS6;TRPV3;SLC6A7;SCN1A;SCN3A;TRPM2;KCNC3;SLC6A11;CACNA1C;KCNC4
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.4799358482723425,-1.1604320825510184,0.25333333333333335,1.0,1.0,21/120,18.98%,IRGM;DACT1;TRIM5;DTX3L;LAPTM5;PRXL2C;LRRK2;TRIM22;FURIN;PFKFB2;MOV10;GTPBP1;AMER1;DAPK1;TP53INP1;ABCD2;TNFRSF1B;GAPDHS;PNPLA2;PLK2;PIK3CB
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.5575892879537447,1.1603868527129875,0.24324324324324326,1.0,1.0,5/23,11.76%,DAO;AADAT;ALDH4A1;MTRR;THNSL2
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),-0.5858118296588971,-1.1602436135660568,0.24242424242424243,1.0,1.0,9/29,19.54%,NOX4;EPHA4;CSF1R;GRM5;EFNA1;DLG4;TGFA;GAS6;NEDD9
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.7595111082405093,-1.1601539524709839,0.32786885245901637,1.0,1.0,1/5,21.40%,UBA5
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.7595111082405093,-1.1601539524709839,0.32786885245901637,1.0,1.0,1/5,21.40%,UBA5
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.7595111082405093,-1.1601539524709839,0.32786885245901637,1.0,1.0,1/5,21.40%,UBA5
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.6828996936043892,-1.1601534454608846,0.3333333333333333,1.0,1.0,5/13,15.68%,SLC2A12;SLC23A1;SLC5A2;SLC5A9;SLC2A2
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),-0.7229378441142229,-1.160117676587265,0.3,1.0,1.0,3/7,13.77%,LPL;VSTM2A;LRP1
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.6888597788448196,-1.15993549657863,0.2857142857142857,1.0,1.0,3/11,4.07%,KDM4D;PARP9;DTX3L
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.6607492445202321,1.1594883301111585,0.30303030303030304,1.0,1.0,5/8,28.38%,POLG;POLG2;PRIMPOL;SSBP1;DNA2
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.6747156226761604,1.1594045948509395,0.34210526315789475,1.0,1.0,3/8,17.80%,ERI1;EXOSC8;EXOSC7
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.6747156226761604,1.1594045948509395,0.34210526315789475,1.0,1.0,3/8,17.80%,ERI1;EXOSC8;EXOSC7
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.477720957304544,-1.159185805805098,0.2702702702702703,1.0,1.0,32/97,17.91%,TLR2;IL13RA1;RASSF4;C1QB;CEBPD;SERPING1;OLFML2B;KCTD12;CST3;CSF1R;SLC7A7;LRRK2;TMIGD3;CHI3L1;C3AR1;KCNMA1;TCN2;CX3CR1;C1QC;MMP19;EPHB1;ITGAV;LRP1;HNMT;TMEM176B;ITPR3;LTB4R;FCGR3A;EFNB2;SNX10;CLEC5A;TNFAIP6
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.5640652175040298,1.1589863126444786,0.25,1.0,1.0,6/28,12.38%,AGER;DUSP1;MFHAS1;RELL1;PTPN22;DLG1
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),0.6950564108611845,1.158810914157728,0.3333333333333333,1.0,1.0,1/7,0.77%,SLC22A2
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.6075345321438159,-1.1585353984688693,0.3181818181818182,1.0,1.0,4/24,11.27%,STMN2;APC2;NAV3;PLEKHH2
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.6140081986352635,1.158518711956716,0.2631578947368421,1.0,1.0,3/16,9.49%,KLK6;NCSTN;ADAM19
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.569550763918954,1.1582368040203972,0.24390243902439024,1.0,1.0,2/21,7.81%,GDAP1;PLD6
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.7093805701329652,-1.1582027614355868,0.32075471698113206,1.0,1.0,3/6,17.56%,BCAT2;GAD2;GAD1
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.5361190131965999,-1.158025119577898,0.22388059701492538,1.0,1.0,17/59,19.90%,ITGB4;CHRM3;CDS1;C1ORF115;HSD11B2;EFNA1;TMC4;SLC5A9;SLC44A3;CLDN4;OVOL2;EGFR;PPL;TJP3;CAMSAP3;PRKCZ;CBLC
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.6402786180936798,1.1579935401255161,0.34146341463414637,1.0,1.0,2/7,14.18%,CARM1;PRDM4
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),-0.7621119852301129,-1.1579225587620698,0.28888888888888886,1.0,1.0,2/5,14.93%,PDE10A;PDE11A
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.7870249828272314,1.1576688910538684,0.30952380952380953,1.0,1.0,2/6,17.44%,ACAA2;THEM4
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.6546067156193948,1.1575418992189088,0.27906976744186046,1.0,1.0,3/11,9.71%,B4GALNT2;GALT;GFPT2
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.7470495704068427,-1.1571656279741132,0.27586206896551724,1.0,1.0,3/8,17.57%,MET;SRP54;CCDC39
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.6186303119355155,1.1571215281822376,0.3333333333333333,1.0,1.0,4/10,13.78%,CYBA;NOX1;MAPK8;NOS2
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.4722984338592312,1.1570046937427316,0.19230769230769232,1.0,1.0,16/106,11.33%,ABCA13;SLC22A2;SLC22A6;TXNIP;SLC47A1;ABCA8;RILP;ARRDC4;ABCA6;ARRDC3;ARRDC5;CUBN;SLC22A24;CEP290;SCAMP2;CMTM6
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.6118434630917667,1.1569327743491633,0.35714285714285715,1.0,1.0,2/13,11.97%,CHMP5;VPS25
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),-0.7614358493322546,-1.1568844629422093,0.3114754098360656,1.0,1.0,3/6,19.76%,PTPRC;NR1D1;CX3CL1
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.518353281805963,-1.156636116361306,0.24615384615384617,1.0,1.0,11/48,19.24%,MX1;KIF16B;MVB12A;CAV1;LRP1;DNM1;SYK;RAMP1;LILRB1;TGFB1;REP15
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.472442073016076,-1.1565095495240847,0.14666666666666667,1.0,1.0,44/188,18.23%,FAM131C;CARTPT;CLGN;ACBD7;CFAP126;NYAP1;MACROD1;FGF12;PDE4A;CALB2;TTC9;HPCA;SYBU;SCN9A;SPEF2;CTXN1;FLRT1;KLHDC9;CPE;FSTL5;CDK5R2;NAT14;NRSN2;EFNA3;LRRC73;MEIG1;VSTM2L;MAP2;SMIM10L2B;ABHD3;GNAL;CYB561;SCN4B;EFNA5;CCDC184;CNTN4;LRRC49;SCAMP5;MAPK8IP1;NRG1;CSPG5;CERS5;PCLO;ANO2
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.6949415753841417,-1.1564707764265825,0.23809523809523808,1.0,1.0,4/8,18.92%,STK17B;STK17A;BTG1;GAS6
prerank,GO_Biological_Process_2021__cell junction disassembly (GO:0150146),-0.7707934916175094,-1.156385108042833,0.2903225806451613,1.0,1.0,4/5,19.76%,C1QB;CX3CR1;C1QC;CX3CL1
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),0.6812310685632449,1.1563545750118198,0.3488372093023256,1.0,1.0,3/8,14.27%,CAT;PRDX3;PXDNL
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.7848887145912669,-1.1559376347834405,0.22580645161290322,1.0,1.0,2/7,7.30%,CAPN1;ADGRV1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.5073274120009296,1.155866033469046,0.25,1.0,1.0,17/62,24.64%,EAF2;CCNT1;ELL;POLR2K;ELOC;MLLT3;ERCC2;POLR2L;GTF2H5;CTDP1;IWS1;CCNK;POLR2E;ELP4;POLR2D;CCNH;TCEA1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.468340176042879,1.155523449266747,0.24242424242424243,1.0,1.0,7/56,10.31%,CDK10;CDKL1;TESK1;EVI5L;USP6NL;TBC1D19;CROCC
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.7571012012949898,-1.1543802987901814,0.30357142857142855,1.0,1.0,4/6,17.05%,PLSCR1;ITGAM;UHRF1;SETMAR
prerank,GO_Biological_Process_2021__leukocyte chemotaxis involved in inflammatory response (GO:0002232),-0.7654095013394642,-1.1538441060148106,0.25757575757575757,1.0,1.0,3/5,21.72%,NINJ1;SLAMF8;PTN
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.5260337888519719,-1.1534008477675661,0.26153846153846155,1.0,1.0,11/60,21.20%,PTPRC;TNFRSF1A;IFNGR2;BIRC3;IL7;AXL;STAT1;SYK;GAS6;PTPN11;SPPL2B
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.6417801497831714,1.153283999102503,0.30303030303030304,1.0,1.0,2/8,10.23%,NEU4;GLA
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.6844609552420883,-1.1531971274726318,0.3508771929824561,1.0,1.0,2/13,1.43%,DACT1;SFRP4
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.5691811078856823,-1.1531332208201877,0.2835820895522388,1.0,1.0,8/37,10.72%,PTPRC;NCKAP1L;CR1;SFTPD;LGALS3;HLA-DRB1;HLA-DPB1;CEBPB
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.4875312927045531,-1.1530213452825306,0.16901408450704225,1.0,1.0,29/104,21.75%,PKP2;TGFB2;CITED2;MEF2C;FGF12;ID2;TGFBR2;SOX9;MMP21;TEK;HTR2B;ZFPM1;SYNPO2L;SMYD4;FLRT2;VEGFA;MTHFD1;GPC3;POU6F1;CDKN1A;MICAL2;NTRK3;TGFB1;ALPK2;CACNA1C;KAT2B;MESP1;PTPN11;NDRG4
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.6585665236151058,-1.152894529822473,0.29508196721311475,1.0,1.0,4/11,18.91%,DLG4;NETO1;NEURL1;CAMK2B
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.5841569867713151,-1.152848499188038,0.2786885245901639,1.0,1.0,9/31,15.53%,PKP2;NKAIN1;NOS1;FGF12;NKAIN3;ATP1A1;SCN1B;YWHAH;SCN4B
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.5462902130085703,1.1528482143331205,0.30952380952380953,1.0,1.0,6/19,9.81%,TNNC2;MYH4;MYH3;TPM2;ACTN2;TCAP
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.5462902130085703,1.1528482143331205,0.30952380952380953,1.0,1.0,6/19,9.81%,TNNC2;MYH4;MYH3;TPM2;ACTN2;TCAP
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.6165618522584407,1.1527420313724877,0.3235294117647059,1.0,1.0,1/8,1.45%,CD274
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.655564613699881,-1.152674149649341,0.2711864406779661,1.0,1.0,5/13,16.05%,DUOX1;RFC3;ABCC9;STAT1;TYMS
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),-0.7399995559564133,-1.1524994173329628,0.3389830508474576,1.0,1.0,2/7,15.54%,PTPRT;PTPRB
prerank,GO_Biological_Process_2021__positive regulation of protein kinase A signaling (GO:0010739),-0.7554481368281462,-1.1524719025287382,0.3387096774193548,1.0,1.0,2/5,9.37%,ADGRV1;TCIM
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.6273558318220905,1.152412197483634,0.35294117647058826,1.0,1.0,8/14,22.22%,HDAC1;HDAC9;ELK4;HDAC4;SIRT6;HDAC3;SIRT1;SIRT7
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.5989542824648983,-1.152188217790101,0.3225806451612903,1.0,1.0,6/21,16.71%,CHST1;PRELP;OGN;CHST2;B4GALT6;OMD
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.5499346686809272,1.151959913132064,0.28205128205128205,1.0,1.0,9/35,13.19%,PYCR1;OPRD1;BAK1;ABL1;PRELID1;SLC25A33;AKT2;UBB;PRDX3
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.5491624912698241,-1.1518942463059787,0.26153846153846155,1.0,1.0,9/34,19.59%,PTPRC;BLNK;IFNA2;IFNK;NHEJ1;IFNA6;TPD52;PTPRJ;CR2
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.4934907344491134,-1.151560801966225,0.2631578947368421,1.0,1.0,6/73,5.43%,CPS1;PPARG;WNT8B;IL12A;NOS1;SOX9
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.7628048359385309,1.151295632169974,0.2857142857142857,1.0,1.0,2/5,13.31%,ENPP1;SMPDL3A
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.612945454644244,-1.1510181521558676,0.2676056338028169,1.0,1.0,4/28,7.28%,KDM4D;PARP9;DTX3L;CYREN
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.6870400214447288,-1.1508999509555173,0.26229508196721313,1.0,1.0,2/10,17.05%,ISG20;SETMAR
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.5927731444083988,-1.1508308682453465,0.3188405797101449,1.0,1.0,7/25,23.99%,STMN2;APC2;NAV3;TRPV4;CAMSAP3;FGF13;SPEF1
prerank,PanglaoDB_Augmented_2021__Decidual Cells,0.6418245548851622,1.1505459663215418,0.325,1.0,1.0,4/15,4.69%,ZAP70;LCK;PYHIN1;CD247
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.75162935992378,1.1504100154070647,0.2926829268292683,1.0,1.0,2/5,12.54%,CDK6;DLL1
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.5696581080167868,1.1499811136268452,0.2972972972972973,1.0,1.0,6/17,13.67%,TCOF1;CAVIN1;MARS1;GTF3C5;GTF3C6;GTF3A
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.5827947735920342,1.1498752140867625,0.2564102564102564,1.0,1.0,4/23,5.35%,SLC22A2;SLC38A1;SLC25A29;SLC47A1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.5388356988206248,1.1498728770695672,0.25,1.0,1.0,5/26,13.78%,F2;CHID1;NLRP7;IL17D;NOS2
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.49867611096865344,1.1498088319132027,0.27586206896551724,1.0,1.0,7/33,17.38%,ICAM1;SERPINE1;BMP5;SP100;DDX3X;FAIM;PEA15
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.7423802277670342,1.1496284618384616,0.3333333333333333,1.0,1.0,1/5,0.77%,SLC22A2
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.6637811148564976,-1.1494104335529118,0.3382352941176471,1.0,1.0,2/10,3.87%,IRGM;IRF1
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.6359344331583605,1.1494096028247411,0.3076923076923077,1.0,1.0,4/10,20.48%,PSMG2;PSMD13;PSMD11;PSMD4
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.6522622255721771,-1.1489566446075246,0.328125,1.0,1.0,3/11,10.42%,TIMP1;LOXL3;BST1
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.5327677346769879,-1.148887490222227,0.2698412698412698,1.0,1.0,12/39,17.34%,TLR2;C1QTNF4;NLRP12;LAPTM5;TERF2IP;TCIM;NMI;NOD1;IFI35;CD27;EGFR;NR3C2
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),-0.7753221716712386,-1.148612154212218,0.265625,1.0,1.0,2/5,18.31%,SIGLEC10;GIT1
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.520801381924699,1.1485011207367533,0.25806451612903225,1.0,1.0,11/43,14.01%,SQLE;SC5D;MSMO1;OSBPL7;HSD11B1;PMVK;PRLR;HMGCR;CYP7B1;HSD3B7;STAR
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.5736161922235878,-1.148212549007458,0.3220338983050847,1.0,1.0,6/19,18.61%,TEKT3;DNAH7;DNAH2;RSPH9;CCDC39;CFAP44
prerank,GO_Biological_Process_2021__C-terminal protein deglutamylation (GO:0035609),0.7166779106428542,1.148176204527832,0.35555555555555557,1.0,1.0,2/5,4.63%,FOLH1B;AGBL1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.5319542485932958,1.1479721836428773,0.3076923076923077,1.0,1.0,4/42,8.20%,CXCR4;KLK6;BCAS1;ZNF24
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.6658499475975215,1.147897247210426,0.2127659574468085,1.0,1.0,1/10,0.67%,CELA2A
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.739750020423783,-1.147784949004896,0.3157894736842105,1.0,1.0,2/6,5.08%,ABCC4;NMUR2
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.6056510715266885,-1.1476920826468955,0.2982456140350877,1.0,1.0,2/18,9.45%,FAR2;DGAT1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell chemotaxis (GO:2000510),-0.7373902511518353,-1.1476724628755923,0.3283582089552239,1.0,1.0,1/6,2.69%,IL12A
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),-0.6798086570072697,-1.1474217092635262,0.3384615384615385,1.0,1.0,2/12,8.11%,DACT1;IGSF1
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.6606731909795692,1.1473251362257983,0.275,1.0,1.0,1/11,1.72%,RAB27A
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.6797992495787706,-1.147272032955942,0.2898550724637681,1.0,1.0,4/14,9.66%,PYGL;AOAH;AGL;PHKG1
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.5365279568114215,-1.1471627340721606,0.22857142857142856,1.0,1.0,13/45,34.59%,WNT8B;CAV1;AMER1;LIX1;PPP1CA;STX17;UVRAG;DVL1;TSG101;VPS4A;LAMP2;TECPR1;MAP1LC3A
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.49628057407424625,-1.1470301107610466,0.21621621621621623,1.0,1.0,31/121,18.66%,FRY;NPY;PTPRM;STMN2;TGFB2;MEF2C;L1CAM;GPRIN3;GPM6A;RAB11A;DCX;LAMB1;LGI1;STX3;TENM3;ETV1;XBP1;SH3GL2;ACTL6B;CDK5R1;MANF;MAP2;LYN;SRRM4;B4GALT6;CNTN4;OPHN1;CDK5;MYT1L;TENM2;ATCAY
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5916969016097638,1.1470047061209352,0.18181818181818182,1.0,1.0,5/19,10.64%,FGFR1;HSPA1A;EYA4;UNC5B;HSPA1B
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.7073315238745893,1.1469937505676717,0.325,1.0,1.0,4/7,24.40%,NUMA1;SAPCD2;GNAI1;EPB41
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.6851455543401155,-1.1469561805081436,0.359375,1.0,1.0,3/11,12.78%,NR4A3;MEF2C;PRKG1
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.5107668717463584,-1.1465974632601474,0.26865671641791045,1.0,1.0,27/65,21.74%,SLC8A3;SLC23A1;SLC5A4;ANO6;NEDD4L;SCN2A;SLC6A12;SCN9A;SLC5A2;SLC8A1;SLC5A9;SLC24A1;SLC5A12;HCN1;SLC6A8;ASIC2;SCN1B;SCN4B;SLC24A4;SLC6A4;KCNK1;SLC6A7;SCN1A;SCN3A;SLC6A11;FGF13;SLC5A10
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.7245079612434472,-1.1464787314890412,0.3389830508474576,1.0,1.0,2/6,14.97%,MX1;DNM1
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.4741874756356706,-1.146426633521654,0.2835820895522388,1.0,1.0,16/65,14.69%,ROR1;CRYM;CEMIP;COL11A1;ATP2B2;MYO7A;MYO3B;ADGRV1;GRM7;LHFPL5;SLC26A4;NDUFB9;CCDC50;CDH23;LRTOMT;KCNE1
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.6767952049755237,-1.1459899723057894,0.3870967741935484,1.0,1.0,5/12,15.59%,MEST;BMX;IKZF1;TIE1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),0.742611234754542,1.1459833434523865,0.4444444444444444,1.0,1.0,1/5,2.49%,XG
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),0.742611234754542,1.1459833434523865,0.4444444444444444,1.0,1.0,1/5,2.49%,XG
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.6087009427738439,1.1456959303234693,0.34210526315789475,1.0,1.0,5/21,12.28%,DICER1;LACTB2;PCF11;TRIR;ZC3H12D
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.4587163384123839,1.1453204238041492,0.18181818181818182,1.0,1.0,19/102,9.76%,CYP1A2;F2;EPB41L4B;VDR;C6;LEPR;F11;MTTP;MSMO1;SDC2;HMGCS1;KNG1;HSD11B1;GJB1;CYP2C8;ANXA13;SERPINH1;CYP2E1;RND3
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.6734702946357302,-1.1452155342319288,0.2903225806451613,1.0,1.0,1/9,4.34%,DBF4
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.6192692795324783,-1.145076296502218,0.3188405797101449,1.0,1.0,3/15,24.48%,ROBO2;VEGFA;HES1
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.7740799423180702,-1.1449804681728804,0.30357142857142855,1.0,1.0,2/5,9.04%,P2RY12;FLI1
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.620261842620407,-1.1448650374244018,0.29850746268656714,1.0,1.0,4/22,9.20%,TIMP1;PARP9;NOS1;PLN
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.613741005955322,-1.1448396584226879,0.2807017543859649,1.0,1.0,7/22,20.80%,ENO4;PFKFB2;LDHA;PGK1;GAPDHS;PFKM;GPI
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.53271270471455,-1.144452562982703,0.2638888888888889,1.0,1.0,13/49,17.11%,ITGB4;SMIM22;AQP1;SOX9;EFNA1;TMC4;SLC44A3;AQP4;LGALS2;CLDN4;OVOL2;PPL;TJP3
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.6419537600886305,1.1442234763289114,0.2571428571428571,1.0,1.0,1/10,3.40%,DICER1
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.6780101506968352,1.1440410180018927,0.2972972972972973,1.0,1.0,2/10,7.60%,IGF1R;MTMR2
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.7290898618749618,1.1440078402194087,0.4,1.0,1.0,1/5,7.97%,NCK1
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.6793013971221996,1.1437822494452865,0.3902439024390244,1.0,1.0,2/6,8.41%,THBS4;AKIRIN1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.513340947788308,-1.1436183168133487,0.22058823529411764,1.0,1.0,3/52,4.19%,CD44;PTPRC;IRF4
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.47337544454598013,1.143519016235822,0.2962962962962963,1.0,1.0,14/104,10.70%,BCAM;EPB41L4B;PTPRU;RNF128;GPRC5C;COL18A1;SEC23B;UNC5B;ARHGEF10L;HEPACAM2;MYO1D;ATP1B1;PPP1R26;MYH14
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.47302350413825023,-1.143214014650473,0.2608695652173913,1.0,1.0,34/139,18.82%,LPL;IRGM;MGST1;WNT8B;EPHA3;TWF2;SSTR1;MEF2C;AQP1;VIM;BRINP2;SOX9;FES;NLRP3;LDOC1;XBP1;CX3CR1;ABCB4;ATP1A1;AR;LYN;BRINP1;ADCY8;AXL;PTK7;EGFR;BRINP3;TNFRSF1B;ZFP36;NR1D1;WNT5A;GIT1;LILRB1;WNT5B
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6560386980591322,-1.1429157338003628,0.2923076923076923,1.0,1.0,3/15,9.08%,TRPM1;GRM5;GRM7
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.4887379927662954,1.1427693972191661,0.23333333333333334,1.0,1.0,10/75,9.06%,CFAP61;SLC22A6;BPIFB1;NWD1;PLA2R1;ATP6V0A4;FRK;RGS22;HYDIN;SCNN1B
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.5327843186547803,-1.142130991903476,0.2898550724637681,1.0,1.0,14/62,16.55%,CD44;IRGM;NOS1;TERF2IP;CAMK1;IFNA2;SH2D3C;CAV1;IFNK;MTCP1;PRKD2;VEGFA;IFNA6;EGFR
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.5141914923497722,-1.1420129946138007,0.30303030303030304,1.0,1.0,28/74,19.10%,NEFL;SHISA6;KCNS1;MEF2C;CACNG2;NOS1;FGF12;CAPN1;HPCA;JPH4;CACNB1;CACNG8;GRIN2B;GRIA3;FGF14;CACNG3;GRIA1;DLG4;DAPK1;KCNE1;CACNB2;LRRC7;NETO1;FKBP1B;CNIH2;JPH3;CAMK2B;OPRM1
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),-0.4826598113701748,-1.1419870819617348,0.25806451612903225,1.0,1.0,27/97,16.77%,KCNK10;KCNT2;KCNQ3;KCNS1;KCND2;KCNV1;KCNJ4;KCNJ3;KCNQ5;KCNK6;KCNJ6;KCNH7;SLC9C2;KCNC2;SLC24A1;ATP1B2;HCN1;ATP1A1;SLC9C1;KCNB1;KCNH2;KCNE1;KCNJ13;ABCC9;KCNB2;KCNH5;SLC24A4
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.5927865566202487,1.1418096732238605,0.32432432432432434,1.0,1.0,4/10,23.99%,SPHK2;NIPBL;ING2;ZBTB7B
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.6503804203901115,-1.1415245520973079,0.3125,1.0,1.0,7/13,20.68%,NCKAP1L;ID2;XBP1;CD27;PPP2R3C;SYK;SLAMF8
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.6529074775595303,1.1414691332029339,0.28205128205128205,1.0,1.0,1/13,1.72%,RAB27A
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.6369847910887494,1.1413872357747712,0.275,1.0,1.0,7/15,22.45%,CPSF4;CSTF2;TSEN15;TSEN34;ZBTB8OS;RTRAF;FAM98B
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,-0.4957134692076174,-1.141372679101838,0.3037974683544304,1.0,1.0,26/90,22.18%,FSTL1;LRIG3;KITLG;LAMC1;COL4A1;FIGN;CCND1;DDAH1;PTPRG;LAMB1;TENM3;FAT1;WWTR1;ADGRL2;PCGF2;EGFR;NR2F2;WNT5A;MYO1B;GNG12;LARP6;LAMB2;MESP1;COL12A1;SCARA3;ANTXR1
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.6750837977169947,-1.1413245712030695,0.26666666666666666,1.0,1.0,3/11,15.59%,TIMP1;GJA1;VEGFA
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.5893221532665013,-1.1413026990123878,0.26153846153846155,1.0,1.0,9/29,18.91%,EPHA4;LRRK2;EFNA1;ZDHHC15;CDK5R1;SIPA1L1;NGEF;CDK5;CAMK2B
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.5725181979236396,-1.1410072952106123,0.2923076923076923,1.0,1.0,7/24,21.75%,MEF2C;TGFBR2;MMP21;CCDC39;MICAL2;MESP1;NDRG4
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),-0.7083037419796038,-1.140875507624052,0.2857142857142857,1.0,1.0,3/6,26.63%,HLA-DRB1;IL12RB1;TNFSF4
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),-0.7083037419796038,-1.140875507624052,0.2857142857142857,1.0,1.0,3/6,26.63%,HLA-DRB1;IL12RB1;TNFSF4
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),0.7306682440897004,1.1408184155015846,0.4,1.0,1.0,1/5,4.99%,CRACR2A
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),-0.7496704987801062,-1.14075134292165,0.29310344827586204,1.0,1.0,3/6,12.26%,IRF1;IFNA2;GLI3
prerank,PanglaoDB_Augmented_2021__Basophils,-0.5090731750469943,-1.1406722272427328,0.25,1.0,1.0,18/80,14.17%,CD44;TLR2;FGL2;ITGAM;AOAH;L1CAM;HGF;FAR2;P2RY13;CSF1R;C3AR1;PTAFR;IL3RA;GPR183;TULP3;ADGRE3;SNCAIP;GRM6
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),-0.7561849411811447,-1.140652695836831,0.3392857142857143,1.0,1.0,3/5,21.45%,ALDH1A2;RBP1;RBP2
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.6641038303464576,-1.1398318204736577,0.3333333333333333,1.0,1.0,3/14,19.56%,EDN1;RIMS2;PTPRN
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.5851709712439107,1.1396715715167274,0.30612244897959184,1.0,1.0,3/11,16.24%,HES5;HNRNPU;JAG1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.5363740717890743,-1.1390819073142342,0.22727272727272727,1.0,1.0,1/42,0.02%,CD44
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.5143753341247602,-1.1390511526885991,0.23728813559322035,1.0,1.0,8/52,6.16%,CD44;DPEP2;PTPRC;SLA;AOAH;CD53;GMFG;SELL
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.49827608316690836,-1.138968976328767,0.2537313432835821,1.0,1.0,18/88,20.02%,DACT1;CLU;APC2;NEDD4L;HECW1;TRIM32;UHRF1;RAB1B;C4BPA;GPC3;WNT5A;OAZ3;PLK2;TGFB1;NFKBIA;MAP2K5;RASGRP1;DTL
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.7639219436187898,-1.138748039342131,0.3188405797101449,1.0,1.0,4/5,23.61%,NLRP3;RSAD2;PRKCZ;DENND1B
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),0.6569262603958553,1.13869961097609,0.3888888888888889,1.0,1.0,1/5,2.12%,OAS3
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.62118324743709,-1.138515024244036,0.2463768115942029,1.0,1.0,4/20,9.51%,TGFB2;AQP1;LAMB1;TGFB3
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.6641612703946982,1.1384072548248818,0.37254901960784315,1.0,1.0,3/8,14.39%,EPHB2;PAX8;USH1C
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),-0.7286868124047619,-1.138399347273471,0.35,1.0,1.0,4/5,18.15%,CEMIP;TCIM;EGFR;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),-0.7286868124047619,-1.138399347273471,0.35,1.0,1.0,4/5,18.15%,CEMIP;TCIM;EGFR;WNT5A
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.5222261115010957,-1.1382789688124202,0.2535211267605634,1.0,1.0,16/69,17.75%,BAIAP2;CCK;NRCAM;MEF2C;SLITRK5;SLITRK4;NTNG1;RAB3A;PAK3;SLITRK3;MAP2;NEFH;CNTN4;OPHN1;NTNG2;CDK5
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.7352744163656914,1.1381800491212137,0.38636363636363635,1.0,1.0,3/5,25.68%,NFKB1;RELA;RC3H1
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.6917749741275829,-1.137863987519404,0.328125,1.0,1.0,3/8,4.07%,KDM4D;PARP9;DTX3L
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.5119345254116295,1.1378442963333086,0.2222222222222222,1.0,1.0,10/47,13.56%,SPIRE2;MSRB1;CASQ2;CORO7;ZNF207;MSRB2;WASF3;MAP7D3;WASHC5;PSTPIP1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5560878145098154,-1.137747616415728,0.20634920634920634,1.0,1.0,2/37,3.04%,ANGPT1;STAT5A
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.641519316426497,-1.1375119583414588,0.27586206896551724,1.0,1.0,6/18,24.06%,STAT5A;NMI;STAT1;STAT3;IL31RA;STAT4
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.7290547018612028,-1.137164511839547,0.3,1.0,1.0,5/6,27.10%,PRPS1;CARMIL1;SLC16A9;GCKR;SLC2A9
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),0.7388960752318803,1.1371323708138064,0.40540540540540543,1.0,1.0,3/5,15.20%,RAB7B;SGSM2;SNX3
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.5732289546024409,1.1371134198277428,0.3225806451612903,1.0,1.0,2/22,3.26%,BICDL1;KIF3B
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.6476206607233261,1.1370387529484016,0.3142857142857143,1.0,1.0,1/11,1.56%,WNK4
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.4649607521833011,-1.1370116266869288,0.2465753424657534,1.0,1.0,42/199,19.71%,SEMA3E;VIL1;PDGFD;PTPRC;VSIR;TGFB2;NCKAP1L;F3;SMIM22;CARMIL2;EDN1;CEMIP;SOX9;RHOC;HGF;RAB11A;CSF1R;SEMA3D;LAMB1;XBP1;CDH13;CARMIL1;CAV1;SEMA4G;TRIM32;PLET1;GTSE1;CLDN4;VEGFA;EGFR;FERMT3;DMTN;PPP3CA;NTRK3;STAT3;WNT5B;SEMA4B;TGFB1;PLCG1;KIF20B;NEDD9;DDR2
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.6766524885632305,1.136720031578144,0.23076923076923078,1.0,1.0,1/6,3.20%,HDAC10
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),-0.5625759486153452,-1.1363955676573427,0.3013698630136986,1.0,1.0,9/25,23.47%,EPHA4;LRRK2;ZDHHC15;CDK5R1;SIPA1L1;CDK5;WNT5A;VPS35;KIF1A
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.5853300961270675,1.1363498246432882,0.2702702702702703,1.0,1.0,6/25,8.46%,CRTAM;ZAP70;IL2RA;RUNX1;ABL1;PRELID1
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.6496157161517595,1.1363371481493194,0.3055555555555556,1.0,1.0,2/11,12.01%,AUP1;UGGT1
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),0.67153096451817,1.1361494626891506,0.3409090909090909,1.0,1.0,3/7,16.30%,GTF3C5;GTF3C6;POLR2L
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.5062622378735079,-1.1360703071714338,0.23170731707317074,1.0,1.0,20/84,19.52%,PDGFD;IRGM;SPDYA;EDN1;CEMIP;CCND1;CSF1R;LRRK2;TCIM;DIRAS1;HTR2B;CAMK1;MTCP1;CALM3;VEGFA;EGFR;EZH2;WNT5A;TGFB1;RASGRP1
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.778758245115801,-1.1358962363373168,0.3793103448275862,1.0,1.0,2/7,17.39%,ALG10B;RAMP1
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.4452823901093775,1.1356186060778792,0.1111111111111111,1.0,1.0,12/86,13.22%,RFWD3;HDAC10;UBC;NDC80;RAE1;HMGA2;HDAC1;PHF1;ABL1;UBB;CENPT;SMARCA4
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.5469702511403013,-1.135536662970678,0.24193548387096775,1.0,1.0,9/31,21.72%,HEY1;BHLHE40;CX3CR1;PTPRZ1;TNFRSF1B;CX3CL1;PRUNE1;TYMP;PTN
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.4965223735319959,-1.1355270379426676,0.26229508196721313,1.0,1.0,26/88,16.77%,KCNK10;KCNQ3;KCNS1;KCND2;AQP1;KCNV1;KCNJ4;KCNJ3;KCNQ5;KCNK6;KCNJ6;KCNMA1;KCNH7;SLC9C2;KCNC2;SLC24A1;HCN1;SLC9C1;KCNB1;KCNH2;KCNE1;KCNJ13;ABCC9;KCNB2;KCNH5;SLC24A4
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.6933859939034779,-1.1350577643659623,0.3484848484848485,1.0,1.0,4/9,19.92%,EIF2B4;CEBPB;VEGFA;EIF2B2
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.599973849522881,-1.1350352586909638,0.3442622950819672,1.0,1.0,8/26,20.01%,PLSCR1;PLSCR4;ANO6;ABCB4;ATP8B1;ABCB1;ATP8B4;ABCA1
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),-0.7728770514137395,-1.1348455388742111,0.3508771929824561,1.0,1.0,2/5,17.66%,BIRC3;SLC15A4
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.6072695276593176,1.1347333902006302,0.358974358974359,1.0,1.0,4/15,11.46%,RUNX1;CD22;NFAM1;PTPN22
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.6287159194163814,-1.134504314801562,0.32786885245901637,1.0,1.0,6/16,23.10%,IL6R;STAT1;STAT3;SPI1;PTPN11;SOCS3
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.7539476202137545,-1.1343244728444979,0.18840579710144928,1.0,1.0,2/8,5.53%,LOXL4;LOXL3
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.5039724793424454,-1.1342942528308038,0.25,1.0,1.0,9/56,14.27%,EPN1;RHBDF2;DGKD;CEACAM1;MVB12A;SH3GL2;CDH13;DOK1;TGFA
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),-0.7758870700364195,-1.134217257946432,0.3448275862068966,1.0,1.0,2/5,13.75%,MET;PBXIP1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.6122747063993706,-1.134137410524179,0.3582089552238806,1.0,1.0,6/25,13.14%,STMN2;MET;FES;NAV3;CDK5R1;CAV3
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),-0.7221087894670162,-1.1339828777087941,0.38181818181818183,1.0,1.0,2/6,8.91%,CR1;C3AR1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.5246752092659692,-1.1339638191796306,0.3103448275862069,1.0,1.0,11/43,25.19%,CERS6;ASAH2B;SGMS2;PNPLA1;CERS5;CERS3;ABCA12;AGK;PPP2R1A;SPTLC3;SPTLC2
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),0.48264090845143887,1.1338968100601319,0.34375,1.0,1.0,6/50,5.48%,CYP1A2;GPC4;SDC2;ALDH1A3;GPC2;AWAT2
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.4739261010493813,-1.1338192563249672,0.22666666666666666,1.0,1.0,21/116,13.51%,TRPM1;FSTL1;PPARG;FAP;LAMC1;COL4A1;SOX9;CCN5;CCND1;DKK3;FILIP1L;TYRP1;LAMB1;PALLD;WWTR1;SYNC;CAV1;GLI3;TYR;SLC45A2;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.5239457139860265,1.1337002415329316,0.34285714285714286,1.0,1.0,4/42,5.74%,NGF;PLXNA1;CHODL;SLIT2
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.6302824838843792,-1.1336356796016416,0.35294117647058826,1.0,1.0,1/15,1.02%,NEFL
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.4786458460235274,-1.1335982966850517,0.20270270270270271,1.0,1.0,19/108,15.35%,CLDN5;IGFBP3;TIMP1;MCTP1;CITED2;ARHGAP4;ADGRG1;EPHA4;TMIGD3;PTPRG;GJA1;SULF1;NAV3;THY1;ATP1B2;LRP1;PTPRR;PTPRT;TP53INP1
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.6369924916725557,1.133413371832564,0.34210526315789475,1.0,1.0,3/7,20.80%,EXOSC8;EXOSC7;EXOSC5
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.6369924916725557,1.133413371832564,0.34210526315789475,1.0,1.0,3/7,20.80%,EXOSC8;EXOSC7;EXOSC5
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.6949182488240746,-1.1333248251361627,0.36923076923076925,1.0,1.0,4/8,22.57%,ITGAM;SYK;TGFB1;PRKCD
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.4614416861489941,-1.1333087930094543,0.2647058823529412,1.0,1.0,19/129,15.31%,DACT1;SFRP4;BICC1;ANKRD6;SHISA6;IGFBP4;PSMB8;APC2;SOX9;PRICKLE1;DKK3;WWTR1;HECW1;KREMEN1;CAV1;GLI3;AMER1;DRAXIN;IGFBP2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),-0.7492368626336633,-1.1332905000187512,0.41818181818181815,1.0,1.0,1/5,6.14%,MLIP
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.5912731980205663,-1.133262975906394,0.323943661971831,1.0,1.0,3/21,10.41%,STMN2;APC2;NAV3
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.7479693787631613,-1.1330598030335297,0.36363636363636365,1.0,1.0,1/8,1.52%,NR4A3
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),-0.7474130042787777,-1.132687082195219,0.3559322033898305,1.0,1.0,1/5,0.88%,KANK2
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),0.5838813916405499,1.132604509881296,0.2777777777777778,1.0,1.0,1/19,0.20%,NGF
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.4617531415134932,-1.1324083444966813,0.26229508196721313,1.0,1.0,14/133,14.56%,CERS6;CPS1;GCNT1;MGST1;PCSK1;PAM;ARG2;SGMS2;FURIN;CHKB;SLC44A3;SGPP2;ABHD3;PRKD2
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.6760067035061332,-1.1323061933745315,0.38596491228070173,1.0,1.0,3/8,17.13%,TGFBR2;MTHFD1;EIF4A3
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),-0.6053598323959066,-1.1320039044697552,0.3235294117647059,1.0,1.0,3/19,10.35%,NDST3;XYLT2;SULF1
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.5223013211634587,1.1316316910584752,0.24324324324324326,1.0,1.0,3/19,6.40%,JPH1;CASQ2;CLIC2
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.7048600142509782,1.1314451583152156,0.35714285714285715,1.0,1.0,3/6,16.24%,NPHS1;MAGI2;JAG1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.7048600142509782,1.1314451583152156,0.35714285714285715,1.0,1.0,3/6,16.24%,NPHS1;MAGI2;JAG1
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.5441114318636842,-1.1314104916344487,0.29850746268656714,1.0,1.0,9/40,13.25%,CITED2;SOX9;MET;DKK3;TGFB3;XBP1;CAV1;IGSF3;SRP54
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.5281051474964384,-1.1311393455091245,0.2835820895522388,1.0,1.0,6/51,9.51%,TLR2;TGFB2;TTN;FRMD4A;BMP6;TGFB3
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.7080880616835576,-1.1309062050937284,0.3793103448275862,1.0,1.0,4/9,18.46%,P3H2;OGFOD1;P4HTM;P4HA3
prerank,"GO_Biological_Process_2021__complement activation, classical pathway (GO:0006958)",-0.7854001738725206,-1.130855597173772,0.3090909090909091,1.0,1.0,3/5,12.34%,C1QB;C1R;C1QC
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),0.7032665802754573,1.1307757751622551,0.34210526315789475,1.0,1.0,1/7,0.48%,PTH
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),-0.6310622454488088,-1.130767427537709,0.2857142857142857,1.0,1.0,4/9,28.98%,CX3CR1;LRRC19;LPCAT3;CCN3
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.6970885399803834,-1.130712601830204,0.3,1.0,1.0,3/9,12.01%,P2RY12;CX3CR1;CD200
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.46154727913377097,1.1304277378352936,0.21875,1.0,1.0,1/53,0.20%,NGF
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.5458749146758057,-1.1302866086157997,0.2753623188405797,1.0,1.0,4/34,3.42%,TIMP4;TIMP1;SERPING1;CR1
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.4871579499006041,-1.1302838039434517,0.2878787878787879,1.0,1.0,18/72,19.76%,VIL1;CLU;LGALS3;SLF1;RHOC;SYNPO2;CHGA;SYNPO2L;VEGFA;NRG1;SYNPO;SYK;SMPD3;HRK;FLOT1;TGFB1;TIRAP;CX3CL1
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),0.6949825460280655,1.1301974087397963,0.4,1.0,1.0,1/7,0.60%,HDC
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.6782534051385755,-1.129894403810073,0.3050847457627119,1.0,1.0,3/11,17.24%,SLC22A9;SLCO4A1;SLCO2B1
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.7235072245534283,-1.1298579366082053,0.3275862068965517,1.0,1.0,1/5,1.52%,NR4A3
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.5072414683590845,1.1296161315691773,0.225,1.0,1.0,9/35,16.26%,ZDHHC16;NAT9;NAT10;ZDHHC12;KAT2A;ZDHHC3;ZDHHC14;HHAT;ZDHHC7
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.4638469772640701,1.129528560535104,0.2702702702702703,1.0,1.0,20/93,16.62%,MRPL58;ZNF598;MRPL32;MRPS10;EEF1D;EEF1A1;MRPS7;MRPL3;MRPS2;MRPL50;MRPL15;PTCD3;MRPS5;MRPS26;MRPS27;MRPL52;MRPL24;MRPL47;MRPL39;MRPL13
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.48481488399076217,1.1293000640978454,0.23684210526315788,1.0,1.0,22/85,20.11%,MRPL58;MRPL32;MRPS10;MRPS7;MRPL3;MRPS2;MRPL50;MRPL15;PTCD3;MRPS5;MRPS26;MRPS27;MRPL52;MRPL24;MRPL47;MRPL39;MRPL13;MTRF1L;MRPS9;MRPS30;MRPS16;MRPL22
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.5944961313385375,1.129291015811269,0.3333333333333333,1.0,1.0,4/13,22.22%,HDAC1;HELLS;SIRT1;SIRT7
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.5957053123137913,-1.1290930185835757,0.33783783783783783,1.0,1.0,9/24,20.44%,PLSCR1;HLA-E;NMI;IFNK;IFI35;SLC15A4;WNT5A;NLRC5;SPI1
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),-0.645396348989423,-1.1290839636760421,0.4375,1.0,1.0,4/13,14.14%,TLR2;ROBO2;B2M;PAX6
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),-0.529705190764058,-1.1289754554079086,0.3235294117647059,1.0,1.0,11/42,19.02%,NUDT11;IMPA2;PLCB3;NUDT4;INPP4B;PLCB1;ITPKA;PLCB4;INPP5D;PLCG1;ITPK1
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),-0.5961268039002363,-1.1289499927560351,0.3333333333333333,1.0,1.0,6/13,19.95%,SLC8A3;SLC8A1;SLC24A1;TRPV4;TRPV3;TRPM2
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),-0.5961268039002363,-1.1289499927560351,0.3333333333333333,1.0,1.0,6/13,19.95%,SLC8A3;SLC8A1;SLC24A1;TRPV4;TRPV3;TRPM2
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.7578172934419544,1.1289091891918739,0.3783783783783784,1.0,1.0,3/6,20.20%,PUS7;PUS1;PUS10
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.5572484568948777,-1.1285221822301537,0.2916666666666667,1.0,1.0,8/30,13.77%,TLR2;PLSCR1;PTPRC;SFTPD;CAMK1D;DOCK2;ITGAV;SCARB1
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.620287406060877,-1.1284498882880054,0.3064516129032258,1.0,1.0,2/18,4.49%,MT1M;FOS
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.6711910995773848,-1.1283508011149042,0.3582089552238806,1.0,1.0,4/12,15.76%,ISG15;LRRK2;MTCH2;COX18
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.49574113306512363,-1.1283022128245521,0.2727272727272727,1.0,1.0,6/56,17.37%,SOX9;CCND1;CSF1R;CEBPB;MOV10;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.5770512827721368,-1.1282278715216933,0.390625,1.0,1.0,2/17,9.33%,NR4A3;GJA1
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.726055916650937,1.1281888531513378,0.40476190476190477,1.0,1.0,1/5,3.85%,SLC39A8
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.7525985083469083,-1.1280426987446328,0.3793103448275862,1.0,1.0,1/6,9.20%,PLN
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),0.6860154065684486,1.127957556628931,0.40476190476190477,1.0,1.0,2/7,7.24%,CMPK1;AK8
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),-0.6909739722073794,-1.1279164424950636,0.36666666666666664,1.0,1.0,3/10,14.46%,ROBO2;LRP1;ADAMTS9
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),0.5922827171920548,1.1276125379432915,0.3333333333333333,1.0,1.0,1/9,3.76%,ESPL1
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.6071477850780062,-1.1275747831817997,0.25806451612903225,1.0,1.0,2/19,4.49%,MT1M;FOS
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),-0.6725393669703148,-1.127490609497234,0.3389830508474576,1.0,1.0,2/8,8.19%,SHMT2;PRPS1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5585278389527915,-1.127373507244707,0.29577464788732394,1.0,1.0,14/40,18.18%,SYT1;MEF2C;CACNG2;TPRG1L;LRRK2;GRM5;GRM7;GRIK1;CACNG8;CACNG3;GRM6;OPHN1;CDK5;NRXN1
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.7552671436371624,-1.127109411335135,0.26785714285714285,1.0,1.0,2/5,12.42%,TGFBR2;ZFPM1
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.550902393867206,-1.1269905930857989,0.2878787878787879,1.0,1.0,6/25,16.71%,CHST1;PRELP;OGN;CHST2;B4GALT6;OMD
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.4988185777511349,-1.1269355365613383,0.2786885245901639,1.0,1.0,14/73,20.02%,DACT1;APC2;NEDD4L;FURIN;HECW1;TRIM32;AMER1;C4BPA;GPC3;TNFRSF1B;WNT5A;OAZ3;PLK2;DTL
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),-0.7068942726267012,-1.1267715934594076,0.34545454545454546,1.0,1.0,2/11,3.81%,P2RY12;CARMIL2
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),-0.7277498753155769,-1.1266511857062536,0.38596491228070173,1.0,1.0,3/6,13.28%,PTPRM;ROBO2;EPHB1
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.5717044140586176,1.126582378947861,0.2647058823529412,1.0,1.0,1/25,0.10%,MDGA2
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),0.6948496752578392,1.1262913303179936,0.35,1.0,1.0,2/6,6.85%,CYBA;COX10
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.6251161471744904,-1.1261163491411432,0.3442622950819672,1.0,1.0,4/14,11.05%,GCNT1;SELL;ADD2;CX3CR1
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),-0.5293025285340776,-1.1261077840731166,0.3088235294117647,1.0,1.0,9/64,14.19%,PPARG;IL6R;MEF2C;SOX9;HGF;BMP6;WWTR1;BMPR1B;NELL1
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.5232559199418896,1.1259744917023584,0.34210526315789475,1.0,1.0,10/33,17.88%,EHD2;PCM1;NUMA1;ACTN2;CEP290;PRR5L;TPR;STX18;ZFAND1;CAPN10
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.59440150489687,-1.125203409079284,0.28125,1.0,1.0,6/27,9.08%,RHBDF2;TNFRSF1A;IL12A;SYT4;CHGA;GRM7
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.4969211905126006,-1.1251008159461617,0.2898550724637681,1.0,1.0,28/76,21.72%,FSTL1;ADAMTS5;PPP1R3C;ACTA2;PLSCR4;FAP;AQP1;COL4A1;DKK3;TEK;GJA1;PALLD;SULF1;THY1;C1R;PRKG1;LRP1;CCDC80;LMOD1;ELN;LDB2;TIMP3;DDR2;ANGPTL2;LAMB2;TPM1;COL12A1;PTN
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.5038633702376579,-1.1249480484844798,0.2898550724637681,1.0,1.0,21/65,18.91%,ANGPT1;NR4A3;IL26;TGFB2;LAMC1;SOX9;B2M;LAMB1;BMP6;AQP11;SGPP2;TIE1;UHRF1;TGFA;FGF7;VEGFA;EGFR;ZFP36;NR1D1;HPN;TGFB1
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.5369570338077267,-1.1247370920597053,0.2625,1.0,1.0,8/49,14.03%,TGFB2;VSTM2A;SOX9;BMP6;TGFB3;ADAMTS7;HJV;BMPR1B
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),0.6515566872469567,1.1244105677251395,0.3157894736842105,1.0,1.0,3/10,11.32%,VDR;NUMA1;TRIM16
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.4942626183593152,-1.1241953942343754,0.2153846153846154,1.0,1.0,26/89,25.39%,ANGPT1;PAK5;TGFB2;TGFBR2;PRKAR1B;ADCY7;CHI3L1;PAK3;ADCY8;VEGFA;TOM1L1;NRG1;BORA;WNT5A;NTRK3;GAS6;TIRAP;TNFRSF10B;ADCY2;PRKCD;STRADB;ADCY1;ITGB1BP1;PAK1;ADRB2;CLSPN
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.5107985497559698,-1.1240787413233735,0.26153846153846155,1.0,1.0,12/66,20.69%,DPP10;EPHA3;LGALS3;STAC2;STX3;AR;LRP1;EGFR;CDK5;TGFB1;PID1;MRAP
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),-0.5327029302253475,-1.124013761335874,0.3188405797101449,1.0,1.0,11/41,19.02%,NUDT11;IMPA2;PLCB3;NUDT4;INPP4B;PLCB1;ITPKA;PLCB4;INPP5D;PLCG1;ITPK1
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),-0.698460698116378,-1.1236425298796429,0.38333333333333336,1.0,1.0,2/5,11.47%,THY1;CRB2
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),-0.698460698116378,-1.1236425298796429,0.38333333333333336,1.0,1.0,2/5,11.47%,THY1;CRB2
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.6318619486926567,1.12356058579299,0.3333333333333333,1.0,1.0,1/8,2.72%,LEPR
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.5978111833868315,1.1234840931714236,0.32432432432432434,1.0,1.0,6/8,30.97%,MAP3K7;AKT1;MTOR;DAPK2;PIK3CA;IKBKG
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.7103096462053622,-1.123347437700598,0.3389830508474576,1.0,1.0,2/10,7.91%,P2RY12;RYR3
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.4322098869408596,-1.1230063075657912,0.17105263157894737,1.0,1.0,61/303,19.76%,IGSF10;CLDN5;SEMA3E;VIL1;PDGFD;ROBO4;VSIR;MCTP1;F3;SMIM22;CARMIL2;CITED2;EDN1;ARHGAP4;CEMIP;RHOC;HGF;EPHA4;FGF22;CEACAM1;CSF1R;SEMA3D;TMIGD3;NTNG1;LAMB1;SULF1;NAV3;XBP1;TMSB10;THY1;CDH13;CARMIL1;CAV1;SEMA4G;TRIM32;PLET1;GTSE1;CLDN4;FGF7;PTPRT;TP53INP1;VEGFA;NTNG2;EGFR;OSGIN1;FERMT3;PPP3CA;LDB2;NTRK3;STAT3;SRGAP1;PLXNC1;CAMSAP3;WNT5B;SEMA4B;TGFB1;CAMK2B;PTPRJ;NEDD9;PLXNA2;CX3CL1
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.48790315444472765,-1.1228954955060286,0.26153846153846155,1.0,1.0,15/87,17.00%,ANGPT1;MGST1;CHST1;PRELP;OGN;CHST2;CHST9;CBS;CSGALNACT1;CHST15;UST;B4GALT6;OMD;CSPG5;GGT5
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.53862363734939,-1.122629148802206,0.3142857142857143,1.0,1.0,6/33,17.05%,PLSCR1;DNAJC9;ATP1B2;DNAJB1;UHRF1;SETMAR
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),0.707474838093607,1.1225683195578309,0.3953488372093023,1.0,1.0,2/5,14.00%,GPR62;CGAS
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.6877639271123843,-1.1222342809558359,0.36065573770491804,1.0,1.0,3/7,14.61%,TGFB2;ZFPM1;NOTCH2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.6208925298082096,-1.122173702671373,0.3582089552238806,1.0,1.0,1/14,2.64%,ATAD5
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),-0.7121326453692851,-1.121928852792501,0.40350877192982454,1.0,1.0,2/6,15.49%,CRYM;SLC7A8
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),0.65846510663146,1.1214979915217298,0.35714285714285715,1.0,1.0,2/7,23.48%,MLLT3;MEOX1
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),-0.7006042029941995,-1.121357143043721,0.3230769230769231,1.0,1.0,7/8,29.97%,TGFB2;NRG1;MESP1;CBY1;MYOCD;KDM6B;AKAP13
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.6767244455610879,1.1212150576018796,0.3953488372093023,1.0,1.0,3/6,10.71%,REN;ENPEP;AOPEP
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.6767244455610879,1.1212150576018796,0.3953488372093023,1.0,1.0,3/6,10.71%,REN;ENPEP;AOPEP
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.6434803342099141,-1.1211000061610992,0.38235294117647056,1.0,1.0,3/13,12.35%,IGFBP3;NLRP12;UBASH3B
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.6127314457221242,1.1209477918821618,0.35,1.0,1.0,2/12,1.72%,GPR143;RAB27A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.6127314457221242,1.1209477918821618,0.35,1.0,1.0,2/12,1.72%,GPR143;RAB27A
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.6134237461110893,-1.120883150290275,0.2898550724637681,1.0,1.0,2/15,7.03%,PDXDC1;ASAH2B
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.6077503382684001,1.1208669783013576,0.3076923076923077,1.0,1.0,3/19,9.06%,ENPP6;PRDX6;PLA2G4C
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),-0.5995863951622619,-1.1206808456103454,0.3582089552238806,1.0,1.0,8/18,20.94%,TTN;MEF2C;MYH11;SLC8A1;VEGFA;NRG1;ALPK2;MESP1
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.5201850487424743,-1.120604019865816,0.2878787878787879,1.0,1.0,17/69,13.36%,CLDN16;EDN1;SLC8A3;ATP2B3;NEDD4L;ATP2B2;HTR2C;SLC24A5;KCNMA1;TPCN2;SLC8A1;HTR2B;SLC24A1;ATP1B2;ATP1A1;CAV1;HTR2A
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.4771157361385769,-1.120474747711015,0.2878787878787879,1.0,1.0,23/101,20.19%,FBLN1;ARHGAP18;ROBO4;DUOX1;SPINT2;FES;FGF22;CEACAM1;CSF1R;TMSB10;NRG4;TRIM32;DAPK3;FGF7;EGFR;NRG1;OSGIN1;LDB2;PLXNC1;CAMSAP3;TGFB1;PLXNA2;PLXNA4
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.4348397763530384,-1.1202291305184988,0.16,1.0,1.0,35/353,10.64%,CD44;GGH;PYGL;TLR2;FGL2;CD59;PTPRC;MGST1;ITGAM;NCKAP1L;CR1;FRMPD3;LGALS3;NBEAL2;AGL;CD53;PLAC8;CAPN1;GMFG;DOK3;FUCA2;ANO6;SELL;SNAP25;CST3;CEACAM1;B2M;CHI3L1;C3AR1;RAB3A;DGAT1;DYNC1LI1;PTAFR;BST1;CYFIP1
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),-0.702086604909203,-1.1199647514264357,0.34545454545454546,1.0,1.0,2/5,12.62%,ABCB4;SLC51A
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),-0.6524051530869679,-1.1196994443193857,0.42424242424242425,1.0,1.0,2/11,6.25%,EDN1;RFK
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),-0.7340019358248837,-1.1195142609535866,0.37254901960784315,1.0,1.0,1/5,12.42%,AR
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),-0.7340019358248837,-1.1195142609535866,0.37254901960784315,1.0,1.0,1/5,12.42%,AR
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.557905649756734,1.1195062372624742,0.3,1.0,1.0,1/21,0.37%,PDE3A
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.683094960168544,-1.1193854008279234,0.3709677419354839,1.0,1.0,3/7,17.74%,STK17B;STK17A;BTG1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.6982606380716092,-1.1193386960948823,0.3050847457627119,1.0,1.0,2/8,15.59%,IL12A;VEGFA
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.5239576372114375,-1.1192877236578482,0.3382352941176471,1.0,1.0,2/49,1.64%,IRGM;ATG16L2
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),-0.760946325384936,-1.1192793232168357,0.3137254901960784,1.0,1.0,4/5,22.15%,GAD2;GAD1;ABAT;ALDH5A1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.4641953691243736,-1.11911005437313,0.23376623376623376,1.0,1.0,30/127,16.88%,BCHE;ITGB4;NPY;GFRA3;TCEAL6;SPARCL1;SHISA6;GAP43;ASTN1;CHST1;CNTFR;LAMC1;AQP1;CADM3;DCLK1;PCDHB4;CPE;TST;THY1;CTHRC1;AQP4;OPCML;MATN2;EDNRB;PHYHIP;SCN4B;MAPK4;LMOD1;ADCYAP1R1;GPR37L1
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.545687026358946,-1.1190449303991017,0.2571428571428571,1.0,1.0,7/26,17.78%,P2RY12;CYFIP1;CDH13;CARMIL1;ABLIM2;ABLIM1;DMTN
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.7474691212814917,-1.1189828769478616,0.41935483870967744,1.0,1.0,3/5,23.91%,KCNE1;DMTN;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.539932184143729,1.1184725020464852,0.29411764705882354,1.0,1.0,5/19,13.75%,CASQ2;EPHB2;CLIC2;DRD4;GPR35
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.5887648171774648,-1.1182220180980456,0.4,1.0,1.0,7/23,17.68%,IHO1;RNF212B;STAG3;SYCP2;SYCE2;MEIOB;KASH5
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.5476245447304375,-1.118194531000509,0.36619718309859156,1.0,1.0,5/41,10.35%,KANK2;CENPF;TGFB2;ROBO2;SULF1
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.43505181829681605,-1.1178339315508286,0.14864864864864866,1.0,1.0,35/350,10.64%,CD44;GGH;PYGL;TLR2;FGL2;CD59;PTPRC;MGST1;ITGAM;NCKAP1L;CR1;FRMPD3;LGALS3;NBEAL2;AGL;CD53;PLAC8;CAPN1;GMFG;DOK3;FUCA2;ANO6;SELL;SNAP25;CST3;CEACAM1;B2M;CHI3L1;C3AR1;RAB3A;DGAT1;DYNC1LI1;PTAFR;BST1;CYFIP1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.6103679241383229,-1.1176709068615913,0.34328358208955223,1.0,1.0,5/16,19.76%,NCKAP1L;NLRP12;CD200;GAS6;CX3CL1
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.6470552620679175,-1.1175314925575113,0.3387096774193548,1.0,1.0,4/10,25.67%,SNAP25;STX3;STX19;STX4
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.4634869456563279,-1.117528882206078,0.2535211267605634,1.0,1.0,26/161,15.31%,MDFIC;IGFBP3;RGS20;PLSCR1;TIMP1;CLU;MFNG;TMEM204;IGFBP4;TSPYL2;TRIM5;SLC8A3;RGS4;NLRP12;DTX1;LRRK2;WWTR1;SULF1;BST1;PLCB1;UBASH3B;TULP3;CAV3;GRK6;DHRS3;IGFBP2
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.693481321897348,1.1174634631296154,0.42857142857142855,1.0,1.0,2/7,11.11%,SLIT2;NRP2
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.693481321897348,1.1174634631296154,0.42857142857142855,1.0,1.0,2/7,11.11%,SLIT2;NRP2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.7208827127170692,-1.1173930719080194,0.2857142857142857,1.0,1.0,1/7,4.08%,MEF2C
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.45152862013537426,-1.117301665241172,0.2753623188405797,1.0,1.0,15/134,14.20%,ROR1;TNFRSF1A;BIRC3;TRIM5;RHOC;APOL3;HLA-DRB1;TERF2IP;TRIM22;GJA1;HTR2B;TRIM25;NOD1;TRIM32;ALPK1
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.4505904177636659,-1.117188384933744,0.2463768115942029,1.0,1.0,26/166,15.88%,PKP2;DPP10;KCNIP4;TNFRSF1A;ANK1;PDZK1;LRRC4;RAB11A;RFTN1;RAB3A;LIN7A;RAB3C;CPE;ZDHHC15;THY1;HPS6;CAV1;CAV3;PACSIN1;DLG4;KCNB1;FYB1;CACNB2;RAB15;LRRC7;KCNB2
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),-0.7411607501909845,-1.1167721133235968,0.3770491803278688,1.0,1.0,2/6,10.39%,CBS;TST
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.6025488067946358,-1.1166444833807914,0.36065573770491804,1.0,1.0,6/21,24.06%,STAT5A;NMI;STAT1;STAT3;IL31RA;STAT4
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.5865466858744725,-1.1164394926101613,0.3103448275862069,1.0,1.0,7/28,12.42%,TGFB2;BASP1;KITLG;SOX9;ADAM21;GATA1;AR
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.5213904913165357,1.1159537915250854,0.34210526315789475,1.0,1.0,8/25,12.88%,STAC3;EPHB2;NLGN3;RELN;ATPSCKMT;ACTN2;P2RY6;LRRC38
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.7299839055099879,-1.1157925614163497,0.36538461538461536,1.0,1.0,3/5,20.85%,NLRP12;NLRC5;CIITA
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.43310460831801784,-1.1156853985916342,0.17333333333333334,1.0,1.0,35/352,10.64%,CD44;GGH;PYGL;TLR2;FGL2;CD59;PTPRC;MGST1;ITGAM;NCKAP1L;CR1;FRMPD3;LGALS3;NBEAL2;AGL;CD53;PLAC8;CAPN1;GMFG;DOK3;FUCA2;ANO6;SELL;SNAP25;CST3;CEACAM1;B2M;CHI3L1;C3AR1;RAB3A;DGAT1;DYNC1LI1;PTAFR;BST1;CYFIP1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.49054455281657583,1.1155747751125105,0.2857142857142857,1.0,1.0,4/26,7.46%,NDC80;ESPL1;DYNLT1;NUMA1
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.6945172612269892,-1.1153174264884576,0.36764705882352944,1.0,1.0,2/7,18.91%,ACMSD;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.6238777254607637,-1.115226863337515,0.3090909090909091,1.0,1.0,3/10,22.61%,MLIP;CAV3;RGS2
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.5070697587121139,-1.1147381168412607,0.38571428571428573,1.0,1.0,3/78,4.21%,CD44;IRGM;NOS1
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.49542358541522796,-1.1146241419637373,0.26153846153846155,1.0,1.0,9/41,18.91%,NOS1;TRPC6;PLN;IL16;CAV3;CACNB2;EFHB;LILRB1;CAMK2B
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.6978620446875519,1.1145752870268717,0.4358974358974359,1.0,1.0,4/7,17.31%,CA2;NFKB1;RELA;SLC30A10
prerank,GO_Biological_Process_2021__negative regulation of retinoic acid receptor signaling pathway (GO:0048387),-0.7473322146628991,-1.1145275867298807,0.36666666666666664,1.0,1.0,2/5,17.37%,PRAME;EZH2
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.6790079127301547,-1.1144391864012735,0.36065573770491804,1.0,1.0,2/7,15.89%,WRN;RECQL4
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.6360291096791882,-1.114269431889753,0.3684210526315789,1.0,1.0,5/7,34.54%,KYNU;HAAO;NMNAT2;NMNAT3;QPRT
prerank,GO_Biological_Process_2021__positive regulation of respiratory burst (GO:0060267),-0.7373516748803006,-1.114097183511185,0.4576271186440678,1.0,1.0,1/5,8.07%,CAMK1D
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),-0.6327277824383252,-1.1127651146088728,0.35,1.0,1.0,2/14,5.07%,LPL;VSTM2A
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),0.751433344030232,1.1126776220961747,0.38235294117647056,1.0,1.0,2/5,6.84%,LHFPL2;FSHR
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.6615737727159268,-1.1124320934742638,0.36764705882352944,1.0,1.0,4/10,12.27%,CENPE;CENPF;CENPA;NUF2
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),0.6084957393692988,1.1122851615642748,0.3953488372093023,1.0,1.0,5/10,17.91%,PIH1D1;NCL;MARS1;SMARCA4;NOL11
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.5373100586712495,-1.1121761851493384,0.29850746268656714,1.0,1.0,13/57,15.63%,RND2;ARHGAP18;BAIAP2;EPHA3;TWF2;SMIM22;RHOC;PEAK3;BST1;PAK3;LRP1;RAC3;EFNA5
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.5867634879007729,-1.1119213005348723,0.36231884057971014,1.0,1.0,10/19,24.25%,RFTN1;IFNA2;CAV1;IFNK;IFIT1;IFNA6;FLOT1;COLEC12;RALB;PQBP1
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.6044754385962345,-1.1119055947529692,0.3484848484848485,1.0,1.0,9/14,20.40%,COL4A1;NTN4;NTNG1;LAMB1;FLRT2;NTNG2;HPN;LAMB4;LAMB2
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.661034473763606,-1.1117044513653251,0.3220338983050847,1.0,1.0,3/7,22.61%,MLIP;CAV3;RGS2
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.590423853532339,-1.1114868577925023,0.3064516129032258,1.0,1.0,8/25,15.61%,VSIR;CIDEB;PRSS12;FURIN;C1R;TBC1D10A;HPR;PGK1
prerank,GO_Biological_Process_2021__cognition (GO:0050890),-0.5181339703371002,-1.111418882949296,0.34328358208955223,1.0,1.0,7/38,10.64%,TTC8;PTCHD1;TUSC3;GRM5;GPR155;DOP1B;CYFIP1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.6152176007798493,-1.110958665301456,0.3698630136986301,1.0,1.0,4/14,18.43%,NR4A3;LAPTM5;WNT5A;LILRB1
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.7276644969399245,1.1108203931483982,0.37777777777777777,1.0,1.0,1/6,1.80%,TXNIP
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.6246703388034496,-1.1107855737199681,0.34375,1.0,1.0,3/17,11.82%,NDST3;XYLT2;CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.6278043925299901,-1.1106601487044665,0.375,1.0,1.0,3/14,8.31%,HLA-F;HLA-A;B2M
prerank,MSigDB_Hallmark_2020__DNA Repair,0.41693656461847106,1.1106258727175407,0.2,1.0,1.0,21/134,13.11%,BCAM;POLD3;PRIM1;SF3A3;RAE1;ZNF707;PDE4B;TAF13;RALA;HPRT1;DAD1;AK3;DUT;POLE4;TAF12;ELL;POLR2K;RAD52;ADA;GTF3C5;POLH
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.68479004442274,-1.1103264787883753,0.4,1.0,1.0,2/9,13.77%,PPARG;LRP1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.7099463372695667,-1.1103247879805969,0.35,1.0,1.0,2/5,13.77%,LRPAP1;LRP1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.6350987494139086,-1.1101820502827724,0.3333333333333333,1.0,1.0,1/11,1.25%,IRGM
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.6338531784267986,-1.110124400974979,0.30303030303030304,1.0,1.0,4/13,19.76%,P2RY12;CSF1R;CXCL17;CX3CL1
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.6493560983527769,-1.110051813766882,0.34782608695652173,1.0,1.0,3/13,9.66%,PYGL;AGL;PHKG1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.4473007771640584,-1.1097388657149518,0.29577464788732394,1.0,1.0,18/118,13.06%,LPL;TLR2;PPARG;TNFRSF1A;BIRC3;AOAH;NLRP12;PIK3AP1;TEK;NINJ1;FNDC4;NLRP3;BST1;CD200;LRFN5;NMI;IL16;IFI35
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.7621576078932586,-1.1096515091615746,0.4166666666666667,1.0,1.0,1/5,2.61%,CLDN16
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),0.5097412695092499,1.109488495428532,0.34210526315789475,1.0,1.0,16/39,22.12%,PARS2;TARS1;FARSB;DARS1;MARS1;HARS1;IARS1;HARS2;EARS2;TARS2;NARS2;VARS1;CARS1;RARS2;FARSA;KARS1
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.6461671877683983,1.1094809358392232,0.3783783783783784,1.0,1.0,3/9,21.71%,SRPK3;POGLUT1;SMO
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.5972391654018512,-1.109397429117911,0.359375,1.0,1.0,5/21,14.98%,MUSK;UNC13C;LRRK2;CACNB1;CACNB2
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.46690838558073905,-1.1093472154675095,0.25675675675675674,1.0,1.0,41/135,27.61%,TLR2;DACT1;SFRP4;PLEKHA4;PSMB8;RSPO4;LRRK2;SULF1;ATP6V1C2;CAV1;GPC5;AMER1;DAPK3;CDH3;ATP6AP2;PTK7;EGFR;GPC3;DISC1;DEPDC1B;WNT5B;PSMC3;TGFB1;TMEM9;PRDM15;SCEL;WLS;LYPD6;ZBED3;RSPO2;PSME1;PSMA3;PSMB2;FZD9;PSMD5;UBE2B;PIN1;PSMC5;CSNK1D;LRRK1;CSNK1E
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.5452955327282313,-1.1092390932045233,0.373134328358209,1.0,1.0,3/38,6.03%,CD44;AQP1;HGF
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.6157248780248719,1.1089586800888136,0.38095238095238093,1.0,1.0,2/12,16.26%,SCRIB;ZDHHC7
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.5935868133701563,1.1089544193287535,0.3333333333333333,1.0,1.0,3/10,19.13%,PPM1F;SNX3;CORO2B
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.5415655878936518,-1.108697454460142,0.3384615384615385,1.0,1.0,8/30,20.68%,HEY1;BHLHE40;CX3CR1;NOTCH2;CLOCK;CX3CL1;PRUNE1;SLAMF8
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),-0.5947124097752723,-1.108652954335818,0.328125,1.0,1.0,8/18,25.67%,SLC8A3;SLC24A1;GRIN2B;GRIN2D;PLK2;PRKCZ;TSHZ3;STX4
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.588085326942072,1.1086129308927322,0.4,1.0,1.0,2/9,14.49%,KLRD1;CLEC2A
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.463069481233437,-1.1085691650062572,0.3076923076923077,1.0,1.0,24/136,18.97%,PKP2;HEY1;HOPX;PPARG;ID2;SOX9;DTX1;ADGRV1;EFNA1;E2F1;RUNX1T1;WWTR1;ADAMTS7;CAV1;PRAME;ZFPM1;ITGAV;CNTN4;OVOL2;EGFR;WNT5A;HPN;TGFB1;NFKBIA
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.6465613163104722,1.108486967515078,0.3170731707317073,1.0,1.0,2/8,16.58%,PDE4B;SNCA
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.6465613163104722,1.108486967515078,0.3170731707317073,1.0,1.0,2/8,16.58%,PDE4B;SNCA
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.7335782500458193,-1.1084302452048505,0.36065573770491804,1.0,1.0,1/5,1.62%,PLSCR1
prerank,PanglaoDB_Augmented_2021__T Cells,0.4734914797995583,1.108372892194162,0.23529411764705882,1.0,1.0,10/70,4.69%,CXCR4;ZAP70;EEF1B2P3;ITGAL;LCK;IL2RA;EVI2B;GPR174;PYHIN1;CD247
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),-0.7352264239061284,-1.1082604816392385,0.3448275862068966,1.0,1.0,2/5,7.76%,TMEM25;LRRK2
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.5455123247086923,1.108065444991272,0.38235294117647056,1.0,1.0,1/18,1.68%,FBF1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.6869977083168163,-1.1078337697498006,0.2857142857142857,1.0,1.0,3/12,17.80%,PPP1R3C;GYG1;NR1D1
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.6869977083168163,-1.1078337697498006,0.2857142857142857,1.0,1.0,3/12,17.80%,PPP1R3C;GYG1;NR1D1
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.5836763629102689,1.1077855411962725,0.29411764705882354,1.0,1.0,1/21,1.02%,CRYAB
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.732447919497748,1.107721262186717,0.3488372093023256,1.0,1.0,1/6,8.44%,PIH1D1
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.6005414298858909,1.1077000966099955,0.34782608695652173,1.0,1.0,3/13,8.44%,ZNF335;FAM47E;PIH1D1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.4776912771363929,-1.1076491424323676,0.2857142857142857,1.0,1.0,7/62,9.70%,CD44;AQP1;NLRP12;HGF;MAP3K5;NLRP3;NAIP
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),-0.532558904937479,-1.107323153593374,0.38961038961038963,1.0,1.0,16/28,36.11%,TULP3;SNX10;FSIP2;ATP6V1D;WDR35;FAM149B1;EHD1;ODAD4;IFT122;CSNK1D;BBS4;TCTN1;TMEM107;RABEP1;RAB29;TTC21B
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.5143618838274459,-1.107069408890498,0.3382352941176471,1.0,1.0,8/42,13.26%,SHMT2;ALDH1A2;APIP;RYR3;B2M;SAMHD1;HCN1;AQP4
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.6735185759773058,-1.107054652091165,0.375,1.0,1.0,3/9,18.39%,STAT5A;PLCB1;STAT3
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.6735185759773058,-1.107054652091165,0.375,1.0,1.0,3/9,18.39%,STAT5A;PLCB1;STAT3
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.5712909468995351,1.1067876055391703,0.35135135135135137,1.0,1.0,1/10,5.91%,ATG9A
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.5979747689653093,-1.106782219732741,0.3870967741935484,1.0,1.0,9/31,18.83%,CENPK;CENPE;CENPF;MIS18BP1;CENPA;CENPL;CENPQ;ITGB3BP;OIP5
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.44411531805861787,1.1067602703201704,0.25806451612903225,1.0,1.0,24/84,17.63%,ETV5;CYBA;PYCR1;HSPA1A;SOD3;NOX1;ATF4;PRDX6;CAT;TMEM161A;KEAP1;ABL1;VKORC1L1;HSPA1B;PRR5L;RAD52;PRDX3;DDX3X;PRKAA2;PNPT1;CPEB2;SNCA;SERPINB6;ZFAND1
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.690498118651567,-1.1066742221432708,0.40625,1.0,1.0,5/9,26.63%,NLRP3;RSAD2;PRKCZ;DENND1B;TNFSF4
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.46960553044720255,-1.1064865584104708,0.27941176470588236,1.0,1.0,33/122,15.88%,TRPM1;KCNS1;SLC8A3;AQP1;SLC22A4;SLC23A1;SLC5A4;KCNV1;TRPC6;TRPM3;ANO6;NEDD4L;KCNJ4;KCNJ3;SCN2A;SCN9A;KCNK6;KCNJ6;SLC1A1;CNGB3;KCNMA1;SLC5A2;SLC8A1;SLC5A9;PKD1L3;SLC5A12;SLC22A3;SLC18A2;KCNJ13;ABCC9;SLC7A8;SCN4B;KCNB2
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.7122509646740075,-1.1061512222184093,0.36363636363636365,1.0,1.0,3/6,21.97%,LRRK2;CAV2;VPS35
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.5336606142672038,-1.1061095007273845,0.30864197530864196,1.0,1.0,14/50,22.42%,PPARG;TGFBR2;CSF1R;HLA-DRB1;E2F1;GPR183;PDE1B;SRP54;VEGFA;SNX10;CDKN1A;SPI1;RXRA;IL31RA
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.68340594313595,-1.1059775647978698,0.38596491228070173,1.0,1.0,6/10,26.17%,IL12A;IL12RB2;STAT1;STAT3;STAT4;CANX
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",0.6976600502162539,1.105659823586634,0.3902439024390244,1.0,1.0,1/5,6.31%,NCSTN
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),-0.6450515889518977,-1.1055957651143715,0.4,1.0,1.0,3/7,23.47%,SYT4;KIF5A;KIF1A
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.5101843374675817,-1.1055795205081504,0.34328358208955223,1.0,1.0,2/51,1.64%,IRGM;ATG16L2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.5819690489692462,-1.10556752621758,0.4225352112676056,1.0,1.0,3/21,10.64%,TWF2;CARMIL2;CYFIP1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.5135134084522166,1.105524047234203,0.4117647058823529,1.0,1.0,9/32,10.70%,TNNC2;CCDC78;MYH3;CASQ2;STAC3;SCN2B;ATP1B1;TCAP;MYH14
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.5676467930613128,1.1055126094062073,0.38636363636363635,1.0,1.0,3/21,10.69%,GPR143;RAB32;AP3D1
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),0.6753918460529802,1.1054174510458454,0.38461538461538464,1.0,1.0,2/8,7.34%,GK5;COQ2
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),0.7328261511389981,1.1050005635639446,0.36585365853658536,1.0,1.0,1/5,3.26%,KIF3B
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),0.7328261511389981,1.1050005635639446,0.36585365853658536,1.0,1.0,1/5,3.26%,KIF3B
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.5730515987897077,-1.1049770614742769,0.3728813559322034,1.0,1.0,6/24,12.42%,TGFB2;KITLG;SOX9;ADAM21;GATA1;AR
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.4989956789965722,1.104753120436198,0.2564102564102564,1.0,1.0,2/44,2.36%,NUPR1;LCK
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.5092543260614988,-1.1047051514235007,0.2987012987012987,1.0,1.0,9/52,11.23%,PKP2;CLDN5;CDH12;CDH9;RHOC;CDH22;GJA1;CDH10;CDH18
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),0.7101722754739717,1.1047004885803853,0.37777777777777777,1.0,1.0,3/5,11.46%,HSPA1A;HSPA1B;PTPN22
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),-0.6847592029594646,-1.1045557511030497,0.390625,1.0,1.0,1/8,3.88%,NRCAM
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.5382977937862892,1.1044745111858625,0.37142857142857144,1.0,1.0,3/16,18.20%,SLC39A8;SLC30A10;SLC39A6
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.5078997981564101,-1.1044737017725559,0.4,1.0,1.0,17/55,11.05%,GUCY1A1;P2RY12;CHRM3;MCTP1;EDN1;MCTP2;NOS1;NMUR2;DGKD;CCR9;NUDT4;DDAH1;LRRK2;CXCR6;TPCN2;HTR2B;CX3CR1
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.5615907685320163,-1.1043410567148955,0.29310344827586204,1.0,1.0,4/24,11.35%,MGST1;SLC25A19;SLC26A4;SLC35F3
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.60182506376842,1.1043111061753292,0.40625,1.0,1.0,2/9,2.60%,F2;SERPINF2
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.46638911379642023,-1.1042590531725387,0.3492063492063492,1.0,1.0,16/68,14.69%,ROR1;CRYM;CEMIP;COL11A1;ATP2B2;MYO7A;MYO3B;ADGRV1;GRM7;LHFPL5;SLC26A4;NDUFB9;CCDC50;CDH23;LRTOMT;KCNE1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.6772175544680881,-1.1041479651610826,0.34375,1.0,1.0,3/10,18.91%,EDN1;AR;TGFB1
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.4847133779832137,-1.1038911598112846,0.37333333333333335,1.0,1.0,20/104,7.42%,ANGPT1;FSTL1;COX7A1;SPARCL1;ADAMTS5;ROBO4;ASPN;SERPING1;ACTA2;PLSCR4;FAP;GPIHBP1;AQP1;VIM;COL4A1;ECM2;SYNPO2;ANGPT2;INPP4B;TEK
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.585810192709725,-1.1038290207002206,0.3382352941176471,1.0,1.0,6/23,13.33%,NOS1;CHGA;PLN;SLC8A1;CAV3;CALM3
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),0.706999414464092,1.1037595210843723,0.38636363636363635,1.0,1.0,2/6,5.87%,SLC26A3;NOX1
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.5406971624471578,-1.1032478295258974,0.2898550724637681,1.0,1.0,10/35,21.20%,TIMP4;TIMP1;CST3;NELL1;AZIN1;EGFR;RIC1;TIMP3;MAD2L1;PRKCG
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.6577032938575474,1.1032451394014728,0.3888888888888889,1.0,1.0,4/8,29.77%,ABL1;CHEK2;MAP2K6;CHEK1
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.5459068396603999,1.1031353536795758,0.29411764705882354,1.0,1.0,6/33,14.31%,NUPR1;LCK;NCK1;UBB;STYXL1;BECN1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.5802150703782154,-1.103096878123332,0.30985915492957744,1.0,1.0,2/19,6.37%,SPDYA;CCND1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6452642143971298,1.1029942496023823,0.43333333333333335,1.0,1.0,4/8,24.12%,PTBP1;CAMTA1;CIB1;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.6452642143971298,1.1029942496023823,0.43333333333333335,1.0,1.0,4/8,24.12%,PTBP1;CAMTA1;CIB1;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.5304653084381916,-1.102861556766094,0.34285714285714286,1.0,1.0,8/29,12.26%,VSIR;NCKAP1L;CR1;TESPA1;HLA-DRB1;IL7;XBP1;GLI3
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.7225152248583695,1.1028327496666996,0.3142857142857143,1.0,1.0,1/6,5.08%,HMGA2
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),-0.7259622246538846,-1.102805314392118,0.5,1.0,1.0,5/5,27.43%,SLC22A3;SLC18A2;SLC6A4;SLC29A4;PICK1
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.6793004705271406,-1.102504636573511,0.42857142857142855,1.0,1.0,3/7,25.86%,STAT3;STAT4;IL12RB1
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),0.6338891348409486,1.1023840350271439,0.3695652173913043,1.0,1.0,1/6,4.42%,GALT
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.7288254542773244,-1.1021519418028622,0.43636363636363634,1.0,1.0,1/5,3.30%,DPY19L2
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.7288254542773244,-1.1021519418028622,0.43636363636363634,1.0,1.0,1/5,3.30%,DPY19L2
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.5044593049863823,1.1020316447532985,0.23684210526315788,1.0,1.0,2/59,1.98%,GABRE;GABRR1
prerank,GO_Biological_Process_2021__delamination (GO:0060232),0.666420789642675,1.1018108490741394,0.38461538461538464,1.0,1.0,1/7,1.40%,CDSN
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.44569112618178885,-1.1017356708443142,0.26865671641791045,1.0,1.0,24/206,10.89%,ANGPT1;FBLN1;IGFBP3;KDM4D;IRGM;TTN;MUSK;TSPYL2;SOX9;HGF;FGF22;CCND1;CSF1R;HLA-DRB1;TEK;LRRK2;GRM5;TERF2IP;KNDC1;EFNA1;WWTR1;BST1;CEBPB;SH3GL2
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6062496586376087,1.1016293675370055,0.41935483870967744,1.0,1.0,2/11,17.56%,GFPT2;GFPT1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5899265023531447,1.1014884017472866,0.2857142857142857,1.0,1.0,5/16,21.13%,PINX1;TNKS2;HNRNPA2B1;NAF1;SMG5
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.6952467535068318,-1.1014438717015094,0.41818181818181815,1.0,1.0,4/8,20.68%,NCKAP1L;BST1;RHOH;SLAMF8
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),0.7147013498035449,1.1013930225976436,0.39473684210526316,1.0,1.0,1/5,0.77%,SLC22A2
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),0.7147013498035449,1.1013930225976436,0.39473684210526316,1.0,1.0,1/5,0.77%,SLC22A2
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.5863215280053232,-1.1012548546771415,0.42424242424242425,1.0,1.0,7/16,23.68%,SLC1A1;GJA1;SLC25A22;SLC1A6;SLC1A2;GIPC1;SLC25A12
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.551871939768906,-1.100914108860913,0.3333333333333333,1.0,1.0,9/26,16.78%,PKP2;KCNJ3;CAV1;SCN1B;KCNH2;KCNE1;CACNB2;SCN4B;CACNA1G
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.674881879666837,-1.1006607997852205,0.31343283582089554,1.0,1.0,2/9,16.50%,CR1;SLC25A41
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.5590306230215671,1.1006529171490695,0.36666666666666664,1.0,1.0,5/17,16.16%,MORC3;SP100;HNRNPU;TAF3;SUN2
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.7021909400753288,-1.1006424278740705,0.4,1.0,1.0,1/6,2.59%,ITGAM
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.5992311597242331,-1.1005126553163005,0.37142857142857144,1.0,1.0,2/16,6.37%,SPDYA;CCND1
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.48624538979861853,-1.10038398997933,0.323943661971831,1.0,1.0,11/91,13.14%,PTPRC;CENPE;TTN;SPDYA;TSPYL2;CEACAM1;WWTR1;CAMK2N2;THY1;UBASH3B;CAV3
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.494194008049665,-1.1003642609188184,0.3050847457627119,1.0,1.0,15/78,16.30%,ROR1;FSTL1;COL4A1;P3H2;CXCL14;GPR161;GJA1;TENM3;WWTR1;ADAMTS7;ADGRL2;GLI3;AXL;EFNA5;EFNB2
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),-0.7137403174728401,-1.1001832077595004,0.42592592592592593,1.0,1.0,2/7,21.87%,MVB12A;VPS4B
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.7295797096650649,-1.1000499164153612,0.2833333333333333,1.0,1.0,2/7,11.17%,EPHA4;THY1
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),-0.6077170525061948,-1.1000402992285347,0.40350877192982454,1.0,1.0,4/11,29.97%,ADRB2;ADRA1A;ADRA1B;AKAP13
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.5583054233581525,-1.1000139563333469,0.3442622950819672,1.0,1.0,4/25,9.33%,CLDN5;LAMC1;SLC1A1;GJA1
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.5201843300137381,1.100010407997976,0.3611111111111111,1.0,1.0,9/35,18.05%,MALT1;NUTF2;GEMIN6;ANP32A;SNUPN;NXT2;RBM15B;GEMIN5;NPM1
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.6750723788371092,-1.0999838780207452,0.41935483870967744,1.0,1.0,3/8,13.68%,SOX9;CD200;LYN
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.5839133508562945,1.09998141578183,0.35135135135135137,1.0,1.0,1/7,7.74%,BRPF1
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.4531080357837303,1.0998772816915998,0.21052631578947367,1.0,1.0,14/75,11.30%,PTH;GPC4;VDR;SLC22A6;SOWAHA;LGI2;FGFR1;DUSP15;FAM222A;SPRED2;FOXP4;STARD13;CD276;ITGA7
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.4098910441841269,-1.0996950993257801,0.2676056338028169,1.0,1.0,69/401,19.45%,ANGPT1;ROR1;TLR2;PDGFD;PTPRC;P2RY12;IL26;TNFRSF1A;TGFB2;DDX60;KITLG;RIT2;F3;BIRC3;TRIM5;C1QTNF4;SOX9;RHOC;APOL3;NLRP12;MET;HGF;LAPTM5;FGF22;PIK3AP1;ADGRV1;HLA-DRB1;TEK;TERF2IP;TRIM22;CHI3L1;GJA1;TCIM;HTR2B;CX3CR1;TRIM25;CDH13;NRG4;CAV1;NMI;CAV2;NOD1;IFI35;ITGAV;LYN;TRIM32;ALPK1;TGFA;AXL;PRKD2;FGF7;CD27;GFRAL;VEGFA;EGFR;NRG1;GPR37L1;SIAH1;DNM1L;NR3C2;WNT5A;NTRK3;PLK2;TGFB1;GAS6;TIRAP;PIK3CB;PTPRJ;BCAP31
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),-0.6357643518642918,-1.0995019665741164,0.3898305084745763,1.0,1.0,8/14,19.76%,ANGPT1;LGALS3;MET;SCG2;FGF7;VEGFA;PTPRJ;CX3CL1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),-0.568128146341548,-1.099474138533602,0.30357142857142855,1.0,1.0,5/27,11.11%,MEF2C;ID2;CDON;BOC;CAMK1
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.6341349666965597,1.0992363851601346,0.40476190476190477,1.0,1.0,2/8,7.47%,SLC39A8;SLC25A28
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.5815813469481071,-1.0989404847552167,0.3088235294117647,1.0,1.0,2/21,7.42%,P2RY12;TEK
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),0.607699440501592,1.0988360297019837,0.3611111111111111,1.0,1.0,3/11,6.71%,CNGB1;EYS;PDE6B
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.5802979284299074,1.0985766546747744,0.40540540540540543,1.0,1.0,3/16,5.04%,EPB41L4B;VDR;TGM1
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),0.4653836007406227,1.0985366061402553,0.2647058823529412,1.0,1.0,1/59,0.10%,CYP1A2
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.597598800221424,1.0981493211095872,0.42105263157894735,1.0,1.0,3/9,17.58%,RAPGEF1;RAP2B;RAPGEF3
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),-0.6671227625338941,-1.0981338685253301,0.3888888888888889,1.0,1.0,3/8,17.89%,GABRG2;GABRB2;GABRB3
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.6787021279096208,1.0981165413339367,0.35714285714285715,1.0,1.0,1/5,12.13%,ACVR1B
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.6596811314052352,-1.09790396656169,0.40625,1.0,1.0,1/8,2.50%,PLEKHA4
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),-0.7501468596756854,-1.0977837897739295,0.43103448275862066,1.0,1.0,3/5,18.67%,RFTN1;CAV1;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.5993713765153199,-1.0975078110966883,0.38596491228070173,1.0,1.0,7/17,25.22%,POLQ;RADX;KLHL15;MAGEF1;FANCB;SHLD2;MAD2L2
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.697756139998912,-1.097437617831734,0.3492063492063492,1.0,1.0,1/8,2.84%,CLU
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),-0.6324677483908474,-1.0972286903956563,0.36363636363636365,1.0,1.0,3/12,13.14%,TTN;SLC8A1;CAV3
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),0.5768084626180887,1.0967643352643721,0.3142857142857143,1.0,1.0,6/9,28.94%,FBP1;DGKQ;SIRT7;SDHAF3;SELENOS;USP7
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.42432852389822584,-1.096728789164719,0.2638888888888889,1.0,1.0,78/305,20.06%,TLR2;YBX3;IRGM;IL13RA1;IL26;TNFRSF1A;DOCK8;TIMP1;SLA;ITGAM;IL12A;IFNGR2;CEBPD;STAT5A;IL6R;DUOX1;F3;IRF1;IRF4;CNTFR;FOS;VIM;SOX9;PIM1;NPR2;NLRP12;GBP2;HGF;CCND1;GBP3;CSF1R;ZEB1;IL7;CHI3L1;CTF1;STX3;LRCH1;PTAFR;IL3RA;XBP1;CRLF1;IL12RB2;PDE1B;ADAMTS7;IFNA2;IFNK;IL16;AQP4;DAPK1;AXL;DAPK3;PTPRT;INPP5D;PTPRZ1;VEGFA;BRCA1;IFIT1;STAT1;IFNA6;OSMR;MYLK3;SYK;CDKN1A;TNFRSF1B;ZFP36;NR1D1;PTPN13;WNT5A;STAT3;TGFB1;GAS6;PIK3CB;OPRM1;PTPRJ;ZNF675;CX3CL1;PID1;PTPN5
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),-0.6956681877141228,-1.0966459709627303,0.4411764705882353,1.0,1.0,3/7,20.68%,IL12A;GAS6;SLAMF8
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),-0.5781028595893817,-1.0965822767633109,0.36065573770491804,1.0,1.0,3/12,22.08%,CAV1;PTRH2;TLE1
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.605475056988167,1.0963221088246606,0.3333333333333333,1.0,1.0,2/10,3.95%,MYRFL;KLK6
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),-0.7227617083387716,-1.0962765800358312,0.4444444444444444,1.0,1.0,3/7,19.63%,CKMT2;SLC6A8;CKMT1A
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.6064115281549429,1.0962151388479762,0.3870967741935484,1.0,1.0,2/8,21.56%,BEND3;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),-0.6261812154039761,-1.0959690507103002,0.43636363636363634,1.0,1.0,1/9,24.03%,RALB
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),-0.44817076004907025,-1.0958492919142626,0.32857142857142857,1.0,1.0,36/187,14.19%,LPL;IGFBP3;ASB4;PPARG;OLFM1;TGFB2;IL6R;KITLG;NRCAM;MEF2C;CDS1;ID2;TGFBR2;BRINP2;SOX9;HGF;FES;CDON;BOC;CEACAM1;ZEB1;LMO3;GJA1;BMP6;TGFB3;WWTR1;XBP1;CEBPB;PLCB1;CAMK1;CRB2;AR;TRIM32;BMPR1B;BRINP1;NELL1
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.4583413427350296,-1.0957618007416892,0.3611111111111111,1.0,1.0,27/99,14.17%,BEGAIN;RIMS1;MCTP1;SYT1;MCTP2;MEF2C;SLC8A3;SYN3;LRRC4;GRIK2;NPTX1;TPRG1L;NRG3;LRRK2;GRM5;LGI1;CACNA1B;GRM7;NPTX2;GRIK1;CX3CR1;RIMS2;DLGAP1;CLSTN3;SNCAIP;DLG4;GRM6
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.6129088876622276,-1.095710568486458,0.4307692307692308,1.0,1.0,5/18,13.87%,P2RY12;DUOX1;CSF1R;STX3;TRIM32
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.5909679138567087,-1.0954104101425728,0.36363636363636365,1.0,1.0,5/14,25.90%,DND1;MOV10;ZFP36;RBM24;ZFP36L1
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.46580202281982336,1.0953882939600632,0.3055555555555556,1.0,1.0,11/73,14.81%,U2AF1;MALT1;NUTF2;RAE1;NUP42;RBM8A;RANBP17;WASHC4;TPR;NXF1;EIF4E
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.5901470629225547,1.094999037004102,0.3877551020408163,1.0,1.0,5/18,14.00%,EPHB4;SLIT2;GREM1;ID1;MIA3
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.5693261810093077,-1.0946347353516306,0.3582089552238806,1.0,1.0,11/30,19.95%,SEMA3E;BAIAP2;BAIAP2L2;FES;CSF1R;TEK;DAPK3;NOTCH2;CDK5;NTRK3;TRPM2
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.4794058990371105,-1.0945149565366095,0.30158730158730157,1.0,1.0,10/59,13.26%,SHMT2;ALDH1A2;APIP;HLA-DRB1;RYR3;B2M;SAMHD1;GRIN2B;HCN1;AQP4
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),-0.7060806514410356,-1.0943498922974884,0.4057971014492754,1.0,1.0,2/5,6.27%,DTX3L;LAPTM5
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),0.6861596400417627,1.094283527540417,0.37142857142857144,1.0,1.0,3/7,8.56%,BPIFB1;MFHAS1;RAB7B
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),-0.6346635135794311,-1.0941898540098534,0.45614035087719296,1.0,1.0,1/11,1.52%,NR4A3
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),-0.6927831709297556,-1.0941616563205279,0.3559322033898305,1.0,1.0,3/5,19.93%,E2F1;E2F3;PID1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.6435908312906118,-1.0941311584143245,0.40625,1.0,1.0,3/12,11.08%,SFRP4;ANO6;CD160
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.5624401566357378,-1.0940754294226789,0.3108108108108108,1.0,1.0,6/35,18.92%,CARTPT;XBP1;ADCY8;KCNB1;NR1D1;GAS6
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.5295723028412296,-1.0937259360060996,0.3220338983050847,1.0,1.0,1/33,0.21%,EPN1
prerank,GO_Biological_Process_2021__neurotransmitter loading into synaptic vesicle (GO:0098700),-0.7488058661920927,-1.0936998484199838,0.4339622641509434,1.0,1.0,3/5,23.88%,SLC18A2;SLC17A6;SLC17A7
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.6026547758984935,1.0936587079114493,0.35135135135135137,1.0,1.0,4/12,20.19%,NSUN2;TPR;DHX9;IWS1
prerank,GO_Biological_Process_2021__regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188),-0.7347445156344231,-1.0936200839006194,0.40625,1.0,1.0,3/5,25.68%,LGALS3;LILRB1;HAVCR2
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.5221306508922886,-1.093471363411081,0.35384615384615387,1.0,1.0,6/42,10.88%,TGFB2;MEF2C;SOX9;LOXL3;HGF;HTR2B
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.6327138850702764,-1.0932332459507805,0.34328358208955223,1.0,1.0,2/10,12.42%,TTN;ZFPM1
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-0.6458449450497726,-1.09320680327115,0.42592592592592593,1.0,1.0,4/9,10.74%,RAB11A;GRIP2;STX3;GRIP1
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),-0.7074154673640294,-1.0928523818181894,0.4444444444444444,1.0,1.0,4/6,22.04%,BMP6;LY86;SCIMP;LY96
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.46549946459996455,-1.0926710277959208,0.3108108108108108,1.0,1.0,18/75,21.03%,ANGPT1;VIL1;TGFB2;EDN1;SOX9;RAB11A;TEK;SCARB1;PRKD2;FGF7;VEGFA;ZNF580;WNT5A;PIK3CB;PLCG1;EMC10;GPI;RREB1
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.6037349376106429,1.0925831457628554,0.275,1.0,1.0,2/12,9.49%,NCSTN;ADAM19
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),-0.7552264443736169,-1.0919598301904125,0.43103448275862066,1.0,1.0,3/5,21.36%,BMP6;VEGFA;ADD1
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),-0.5493882849337376,-1.0918471359585955,0.3384615384615385,1.0,1.0,13/30,19.59%,NPY;SSTR1;CYSLTR2;GLRA3;GLRA2;NMUR2;CPE;SORCS1;HCRTR2;LTB4R;GPR149;OPRM1;SORCS3
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.6469499670240348,-1.0915908948898543,0.38596491228070173,1.0,1.0,3/9,20.26%,XYLT2;CHST9;B3GAT2
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.6036309882720872,1.0915002053807334,0.3548387096774194,1.0,1.0,3/19,8.40%,NGF;RAPGEF1;RAB35
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,0.5278175922139161,1.091173019398304,0.42857142857142855,1.0,1.0,6/23,4.69%,ZAP70;ITGAL;LCK;GPR174;PYHIN1;CD247
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.497168983742321,-1.0911602734706225,0.36363636363636365,1.0,1.0,11/53,19.34%,STMN2;EPHA4;EFNA1;THY1;ITM2C;RTN4RL2;EFNB2;OMG;NGEF;TRPV4;KIAA0319
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.4718488829162448,-1.0910373249624234,0.3384615384615385,1.0,1.0,9/69,12.07%,KANK2;HLA-F;CLU;CCN5;LRRK2;CHGA;HTR2B;CD200;LRPAP1
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.7087124398825434,-1.0910056754845587,0.36363636363636365,1.0,1.0,3/6,18.39%,STAT5A;STAT1;STAT3
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.7087124398825434,-1.0910056754845587,0.36363636363636365,1.0,1.0,3/6,18.39%,STAT5A;STAT1;STAT3
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.5309961185541056,-1.0908179110668532,0.3709677419354839,1.0,1.0,11/26,20.50%,PKP2;FGF12;SLC8A1;ATP1A1;SCN1B;KCNH2;KCNE1;SCN4B;CACNA1G;SCN1A;CACNA1C
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.6810976969921475,1.0906274738350377,0.46,1.0,1.0,1/5,3.85%,SLC39A8
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.6810976969921475,1.0906274738350377,0.46,1.0,1.0,1/5,3.85%,SLC39A8
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.4363093003487659,1.0903754323292274,0.2962962962962963,1.0,1.0,13/63,15.02%,ICAM1;HSPA1A;EYA4;UNC5B;ITGA6;SERPINE1;ACVR1;HSPA1B;BMP5;SH3RF1;ZMYND11;DDX3X;RELA
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.5496317723146342,1.08997041472082,0.3888888888888889,1.0,1.0,8/24,19.51%,GNL3L;CTC1;PINX1;NAT10;TENT4B;HNRNPU;MEN1;ACD
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.6192406759062902,1.0899523564274092,0.36363636363636365,1.0,1.0,3/9,9.71%,B4GALNT2;ST3GAL1;GFPT2
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.5524918386218515,-1.0897725346595033,0.37681159420289856,1.0,1.0,10/31,18.32%,RIMS1;RIMS4;SYT1;SYT4;LRRK2;RAB3A;RIMS2;RAB15;SYT13;SYT12
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.6384722969453303,-1.0894602333050996,0.3269230769230769,1.0,1.0,4/12,17.10%,NMI;DOCK2;IFI35;SYK
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.5364397931715159,-1.089376083573224,0.373134328358209,1.0,1.0,6/31,12.78%,NR4A3;PPARG;MEF2C;GJA1;TGFB3;PRKG1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.7006949569882294,1.089357820628795,0.4489795918367347,1.0,1.0,3/5,24.40%,NUMA1;GNAI1;EPB41
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),-0.6791064320465632,-1.0892986899268162,0.4090909090909091,1.0,1.0,2/6,18.39%,DCX;STAT3
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),-0.693099370684596,-1.0892892828635532,0.37735849056603776,1.0,1.0,1/7,1.87%,CHRM3
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.5801860871003166,-1.0890894736713599,0.375,1.0,1.0,5/21,14.21%,CPS1;EDN1;NOS1;HTR2B;EDNRB
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.5109389911837037,1.0887944473232425,0.3902439024390244,1.0,1.0,1/24,0.48%,PTH
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),-0.7047217443413308,-1.088738965127519,0.39705882352941174,1.0,1.0,1/6,7.06%,CSF1R
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.5086490971048307,1.0886305715681637,0.21428571428571427,1.0,1.0,5/37,4.78%,F2;PYHIN1;BYSL;TESK1;MFHAS1
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),-0.72134001517752,-1.0886227704390015,0.43103448275862066,1.0,1.0,4/5,21.94%,CDH3;CLOCK;TRPV3;PER1
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),0.6834252023491953,1.0885832341739676,0.4473684210526316,1.0,1.0,1/6,0.95%,DHFR
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.6325339424926404,-1.088544838757539,0.3559322033898305,1.0,1.0,1/9,4.21%,NOS1
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.6924827994695808,-1.088489058481588,0.43859649122807015,1.0,1.0,2/8,18.85%,ALOX12;GPX4
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.4690230734338794,1.0882486374731122,0.2926829268292683,1.0,1.0,22/57,24.02%,BYSL;NOC2L;LTV1;DDX31;NOM1;SDAD1;RIOK1;RIOK2;GTF3A;RRP36;LTO1;URB2;METTL17;WDR74;NPM1;NAF1;RPL11;TGS1;RPS16;RPL7;SURF6;RPS6
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.5002937794008812,-1.0880406378101992,0.3548387096774194,1.0,1.0,3/50,3.85%,TLR2;TNFRSF1A;BIRC3
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.4309632788321524,1.0878441247086312,0.3125,1.0,1.0,10/91,10.92%,U2AF1;SF3A3;YJU2;RNF113A;PRPF4;SF3B2;PTBP1;RBM8A;SNRNP25;RP9
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.5753474260681894,1.0877602859163291,0.29411764705882354,1.0,1.0,5/18,24.64%,EIF5;EIF3D;EIF2S2;EIF3M;EIF4B
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.6716298764324183,-1.0876598469439227,0.38596491228070173,1.0,1.0,1/9,4.08%,MEF2C
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.55750787827152,1.0876460763239961,0.3548387096774194,1.0,1.0,5/26,13.95%,EAF2;RNF168;ELL;HNRNPU;ZMYND11
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.46952728205294064,-1.0874243112194433,0.29411764705882354,1.0,1.0,18/91,12.15%,FSTL1;IGFBP3;ADAMTS5;PPARG;TIMP1;PPP1R3C;ACTA2;PLSCR4;FAP;COL4A1;HGF;DKK3;TEK;GJA1;SULF1;SLC8A1;THY1;C1R
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),-0.7267075244442031,-1.087310028612084,0.39622641509433965,1.0,1.0,1/5,7.76%,LRRK2
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.5053763557680536,1.0872616748800294,0.3125,1.0,1.0,9/35,12.92%,SLC22A2;SLC38A1;SLC7A11;SLC38A2;SLC47A1;SLC38A7;SLC6A13;SLC38A3;SLC7A5
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.6845225311983151,-1.0871239129121621,0.3783783783783784,1.0,1.0,4/8,23.50%,AXL;LILRB1;GAS6;MERTK
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.6786140201835231,-1.0870468529311137,0.41818181818181815,1.0,1.0,5/8,26.73%,CR1;C4BPA;CR2;C4BPB;SUSD4
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.6786140201835231,-1.0870468529311137,0.41818181818181815,1.0,1.0,5/8,26.73%,CR1;C4BPA;CR2;C4BPB;SUSD4
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",-0.6786140201835231,-1.0870468529311137,0.41818181818181815,1.0,1.0,5/8,26.73%,CR1;C4BPA;CR2;C4BPB;SUSD4
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.5721674023099681,-1.0869470315137921,0.38028169014084506,1.0,1.0,9/25,19.65%,P2RY12;NCKAP1L;CYFIP1;ATP1B2;NEFH;RAC3;CSPG5;RHOH;RHOJ
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.7231243912311933,-1.0866863329740684,0.39655172413793105,1.0,1.0,1/5,6.15%,ANO6
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.7474193305654732,-1.0866182876033976,0.36923076923076925,1.0,1.0,2/6,17.96%,AQP11;USP14
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.5068683039566243,1.0864576574374263,0.3548387096774194,1.0,1.0,3/38,2.67%,RFWD3;TONSL;OOEP
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.5780861074970443,-1.0862091515443064,0.375,1.0,1.0,3/12,10.35%,TIMP1;GJA1;SULF1
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.6125109279084401,1.0861664146931491,0.4358974358974359,1.0,1.0,3/13,17.57%,RNF168;HNRNPU;RNF8
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),0.688564580861775,1.0860384959720282,0.42857142857142855,1.0,1.0,3/6,10.76%,DUSP1;SLIT2;GREM1
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.4404172987749529,-1.0859400743205416,0.29411764705882354,1.0,1.0,15/112,19.68%,PLEKHA2;PLEKHA4;CDS1;PIGH;BMX;INPP4B;PIGC;ITPKA;PIP5K1B;INPP5D;PI4K2A;PTPN13;PIGB;PIK3CB;MPPE1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.7430834009131735,-1.0855079250767747,0.45901639344262296,1.0,1.0,2/5,18.98%,MEF2C;PIK3CB
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),0.5185158537719946,1.0852905389224585,0.4318181818181818,1.0,1.0,6/20,19.84%,MDN1;NLE1;RPL23A;BRIX1;RPL3;RPL11
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.5144922399117754,-1.08526817618618,0.3088235294117647,1.0,1.0,1/35,0.21%,EPN1
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.6124873777859948,-1.0851232762434126,0.4393939393939394,1.0,1.0,4/16,14.17%,LGALS3;PLN;CAV3;GRM6
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.5690704462538538,-1.0850541266585252,0.36363636363636365,1.0,1.0,7/22,17.98%,LPL;CPS1;FABP3;PNPLA1;ABHD12B;LIPI;PNPLA2
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.6358625496608825,-1.0850041594855706,0.3787878787878788,1.0,1.0,3/12,18.91%,H1-0;PAX6;TGFB1
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.5572011110949929,-1.0848843035369726,0.3939393939393939,1.0,1.0,2/19,12.40%,WTIP;MOV10
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.5713291252159943,-1.0846735716738356,0.45454545454545453,1.0,1.0,3/10,12.47%,VIM;LDOC1;NOD1
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),0.6350048933056592,1.0843937036309612,0.391304347826087,1.0,1.0,2/8,6.73%,AADAT;AFMID
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),-0.7697290605766836,-1.0842821146109811,0.3898305084745763,1.0,1.0,3/5,22.96%,PLCB1;POMZP3;GLRA1
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",0.6176032122575009,1.0838006978157932,0.34285714285714286,1.0,1.0,2/9,1.45%,CRTAM;CD274
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.7194974483706272,-1.0836858475865143,0.42857142857142855,1.0,1.0,2/7,7.06%,CBLN2;CSF1R
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.5860912906600715,-1.0833611020858473,0.4126984126984127,1.0,1.0,3/22,10.64%,PTPRC;HLA-E;XBP1
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),-0.6208379567879163,-1.0833157142899879,0.40625,1.0,1.0,1/8,2.69%,IL12A
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.6155526895561572,1.0832675674470844,0.47368421052631576,1.0,1.0,3/12,17.57%,RNF168;HNRNPU;RNF8
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.5833528621120901,-1.0831192374583762,0.43243243243243246,1.0,1.0,4/14,16.29%,CSF1R;CAMK1D;BST1;CXCL17
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.5877331455280079,-1.0829135005672745,0.4142857142857143,1.0,1.0,5/21,15.59%,DUOX1;CSF1R;LYN;TRIM32;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.7553885992612359,-1.082878606771278,0.45,1.0,1.0,2/5,17.39%,ALG10B;RAMP1
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.5366289527763041,-1.0827907693307375,0.3448275862068966,1.0,1.0,2/25,9.18%,DND1;E2F1
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),-0.6030027913542584,-1.0827729281475693,0.35,1.0,1.0,8/10,21.67%,GABRA1;GABRG2;GABRB2;GABRA2;CBLN4;GABRB3;WNT5A;FGF13
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),-0.6380404113258129,-1.08269655154478,0.3787878787878788,1.0,1.0,2/8,2.14%,VIL1;STMN2
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.5892047444755069,-1.0826475019075206,0.42028985507246375,1.0,1.0,3/26,3.87%,TLR2;ISG15;IRF1
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.643906727333762,-1.0825898777556873,0.39285714285714285,1.0,1.0,1/10,1.11%,VIL1
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.5242746576239482,1.0825897187768094,0.39473684210526316,1.0,1.0,1/20,0.43%,F2
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.6509981984783398,1.082533538270014,0.37142857142857144,1.0,1.0,1/8,11.05%,MAN2A1
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),-0.6555247305163096,-1.0823724446718292,0.3709677419354839,1.0,1.0,4/9,18.15%,TGFBR2;SOX9;STAT1;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.48162184299564736,-1.082278000384544,0.3548387096774194,1.0,1.0,5/78,7.35%,KANK2;DACT1;AVEN;PSMB8;MYO16
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.48249829077956724,-1.0820899451469812,0.3088235294117647,1.0,1.0,7/58,10.76%,KANK2;DACT1;ID2;CCND1;MYO16;E2F1;PLCB1
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),0.6517876652599405,1.0815945334226673,0.3611111111111111,1.0,1.0,2/7,9.31%,SPHK2;ATPSCKMT
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),-0.6264875052474935,-1.0812326998086519,0.3793103448275862,1.0,1.0,4/9,21.66%,SOX9;PRICKLE1;TGFB1;SRA1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.517648530842016,-1.0811238136640287,0.36619718309859156,1.0,1.0,6/47,13.62%,ARIH2;TP73;NMT1;E2F1;TOMM7;YWHAH
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),-0.6379873471363279,-1.0809670775550442,0.4782608695652174,1.0,1.0,4/8,22.93%,LAPTM5;WNT5A;LILRB1;SEMA7A
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),-0.7246656296507967,-1.0806877986309036,0.47761194029850745,1.0,1.0,2/5,25.79%,EGFR;HEY2
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.5828715343511645,-1.0806706477867274,0.36231884057971014,1.0,1.0,5/15,23.66%,PRKAR1B;ADCY7;ADCY8;ADCY2;ADCY1
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.6849337675324818,-1.0805943958850088,0.390625,1.0,1.0,3/7,16.71%,PRELP;OGN;OMD
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.5497840151956875,1.0802012283814324,0.4117647058823529,1.0,1.0,1/23,0.21%,CXCR4
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.5662233803945291,-1.0801856175067057,0.373134328358209,1.0,1.0,5/26,12.21%,CLU;EDN1;DDAH1;CX3CR1;CAV1
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5565708157805519,1.080164162189484,0.3684210526315789,1.0,1.0,1/18,2.45%,RIDA
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.5969811896327337,1.079801448578741,0.36363636363636365,1.0,1.0,3/11,8.95%,SLC22A2;GUCA1B;PRLR
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.6445405829308755,-1.0796660794742552,0.3333333333333333,1.0,1.0,1/10,1.72%,PTPRC
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.6364103931941327,-1.0796042539624928,0.35135135135135137,1.0,1.0,2/12,7.38%,FES;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.6389567686710056,1.0794273577290394,0.358974358974359,1.0,1.0,2/7,12.85%,EVI2B;MLLT3
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.6661973085601212,-1.0791524826542005,0.4444444444444444,1.0,1.0,1/5,14.83%,PLBD2
prerank,GO_Biological_Process_2021__DNA protection (GO:0042262),-0.6776752355253699,-1.0787543175972054,0.4166666666666667,1.0,1.0,3/5,32.02%,CBS;NUDT1;NUDT15
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),-0.7228162359247328,-1.078671999099376,0.43333333333333335,1.0,1.0,3/6,13.40%,SHISA6;GRIN2B;GRIN2D
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.4391201606453289,-1.078543349938905,0.3088235294117647,1.0,1.0,15/149,10.64%,CD44;FGL2;HOPX;PLSCR1;IFITM3;IRF4;PIM1;SELL;BHLHE40;SCN9A;GATA1;FURIN;IL3RA;CYFIP1;XBP1
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),-0.7308004218895994,-1.0781593047858529,0.45901639344262296,1.0,1.0,3/6,26.34%,UNC80;SLC7A8;CNNM4
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.6767744085227683,1.0779724422430315,0.4444444444444444,1.0,1.0,2/7,9.53%,EHD2;ACTN2
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.6124401554358572,-1.0778300031544583,0.41935483870967744,1.0,1.0,6/18,25.17%,LPL;EIF2B4;EIF2B2;GCKR;ZBED3;PFKL
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.49126956478332023,-1.0776224182596277,0.4,1.0,1.0,6/64,4.17%,HLA-F;RHBDF2;HLA-E;ISG20;IRF1;NBEAL2
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.5908681507458203,1.0774096555650596,0.4146341463414634,1.0,1.0,2/13,1.72%,GPR143;RAB27A
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.5908681507458203,1.0774096555650596,0.4146341463414634,1.0,1.0,2/13,1.72%,GPR143;RAB27A
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.5308269753813828,1.0772569314909204,0.3170731707317073,1.0,1.0,4/18,13.77%,UBC;UBB;UGGT1;AMFR
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.6661673599325706,-1.0772217520140221,0.40625,1.0,1.0,2/8,16.93%,PLN;FKBP1B
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.5899705896797595,1.076867172712672,0.3333333333333333,1.0,1.0,4/9,20.15%,RBFOX1;YBX1;HNRNPA2B1;RTRAF
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.4187283737825756,1.076668301865594,0.2413793103448276,1.0,1.0,16/148,10.72%,TEAD2;TBPL2;VDR;HDAC10;CAVIN1;NR2C2AP;TAF13;TFB1M;MAML2;HDAC1;HDAC9;TAF5;TAF12;POLR2K;TEAD3;HNF4A
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.6444898654687194,-1.076224406357531,0.4393939393939394,1.0,1.0,2/13,4.10%,TGFB2;MMP24
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),-0.6210135872203493,-1.0760794105440419,0.39285714285714285,1.0,1.0,4/12,17.44%,GLRA2;ADCY7;GRIN2B;GRIN3A
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),-0.5992998717181,-1.0758237836887539,0.3880597014925373,1.0,1.0,1/14,0.70%,CLDN5
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.6872411301291315,-1.0752295411167463,0.4482758620689655,1.0,1.0,6/11,29.01%,EDN1;TPM1;SCN3B;ADRA1A;ADRA1B;KCNQ1
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.5367952782357551,1.0747389256125066,0.35714285714285715,1.0,1.0,7/26,13.56%,SPIRE2;MSRB1;CORO7;MSRB2;WASF3;WASHC5;PSTPIP1
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.5881403106297947,1.074547500396649,0.3877551020408163,1.0,1.0,2/7,10.44%,JMJD6;P3H3
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.6025578514860717,-1.074525591936341,0.4406779661016949,1.0,1.0,2/14,6.03%,CLU;HGF
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.5126422726083621,1.074336593844853,0.3611111111111111,1.0,1.0,8/30,19.04%,RNF6;RUNX1;CARM1;PRMT2;KDM5D;KCTD6;SAFB2;DDX5
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.4765403762993902,-1.0742194886080376,0.35135135135135137,1.0,1.0,25/102,22.45%,RND2;PAK5;ANK1;ARHGAP4;RHOC;WTIP;PALLD;FGD5;THY1;PACSIN1;RAC3;PPP2R3C;ZMYM6;CSPG5;ARHGAP10;DIAPH3;MICAL2;DMTN;PCLO;RHOH;NEDD9;TPM1;FGD1;FMNL3;SEMA6A
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.5615211929787904,-1.0741226837026507,0.3389830508474576,1.0,1.0,5/28,17.07%,RIMS1;MX1;DNM1;NAPG;DNM1L
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),-0.5601064808644959,-1.0738426995476733,0.47692307692307695,1.0,1.0,6/22,16.77%,MEF2C;CDON;BOC;CAMK1;OLFM2;NRG1
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.5800407170353816,1.0737812563037508,0.38461538461538464,1.0,1.0,7/13,20.78%,ATF3;DAXX;DDX3X;CPEB2;ZFAND1;GSTO2;HSF1
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),-0.5691342014623848,-1.0735659731778198,0.373134328358209,1.0,1.0,10/24,24.85%,SHISA6;MEF2C;CACNG2;CACNG8;CACNG3;CNIH2;GSG1L;CACNG5;SHISA9;ADRB2
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.6297581220989897,1.073348562282723,0.5,1.0,1.0,6/12,24.50%,GNL3L;DKC1;CCT8;CCT2;CCT6A;CCT3
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.5340284212324303,-1.0733374479825446,0.4,1.0,1.0,7/36,19.92%,LPL;EIF2B4;XBP1;ADCY8;KCNB1;GAS6;EIF2B2
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.5358760661350834,1.0731562991848116,0.325,1.0,1.0,4/23,11.11%,SEMA5A;SLIT2;NLGN3;NRP2
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.4870655548298852,-1.0731158927862463,0.3561643835616438,1.0,1.0,6/46,4.88%,TIMP4;VSIR;TIMP1;SERPING1;BIRC3;PSMB8
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),-0.728570532631297,-1.0731044328577382,0.3870967741935484,1.0,1.0,2/5,14.64%,MAOB;LRTOMT
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.5654096707603394,-1.0730666927603663,0.4032258064516129,1.0,1.0,6/25,21.12%,VIL1;SOX9;EGFR;ZFP36;PLCG1;PTPN11
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.6066404446591119,-1.0729410117834763,0.45454545454545453,1.0,1.0,2/11,7.57%,STAT5A;IL7
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.6066404446591119,-1.0729410117834763,0.45454545454545453,1.0,1.0,2/11,7.57%,STAT5A;IL7
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.4538617152657936,-1.0728929697660572,0.35714285714285715,1.0,1.0,24/79,20.68%,ROR1;EPHA3;TTN;MUSK;TSPYL2;MET;EPHA4;CSF1R;HLA-DRB1;TEK;EPHB6;EPHA6;EPHB1;TIE1;RBL2;AXL;RAD50;EGFR;LDB2;NTRK3;DDR2;NLRC5;MRE11;SLAMF8
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.6126805756334464,-1.0727947544834144,0.46938775510204084,1.0,1.0,3/8,12.47%,VIM;LDOC1;NOD1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.6662085789859369,1.07257515654333,0.39473684210526316,1.0,1.0,1/10,7.60%,MTMR2
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),0.4703043172715156,1.0723397738706226,0.2972972972972973,1.0,1.0,21/79,20.11%,MRPL58;MRPL32;MRPS10;MRPS7;MRPL3;MRPS2;MRPL50;MRPL15;PTCD3;MRPS5;MRPS26;MRPS27;MRPL52;MRPL24;MRPL47;MRPL39;MRPL13;MRPS9;MRPS30;MRPS16;MRPL22
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.6476060431050537,1.0722676579763974,0.4523809523809524,1.0,1.0,2/8,12.37%,PRR7;ST18
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.7005875266422599,-1.072070748259908,0.3620689655172414,1.0,1.0,1/8,6.08%,PTGR1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.6921298786751672,1.0718404531446006,0.4857142857142857,1.0,1.0,1/5,6.91%,MYO1C
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.6461728905698703,1.071838763380503,0.43478260869565216,1.0,1.0,1/6,10.16%,NFAM1
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.5024196043897183,1.0716507491638438,0.41935483870967744,1.0,1.0,4/51,5.74%,NGF;PLXNA1;CHODL;SLIT2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4810486861681689,1.071648076041822,0.3142857142857143,1.0,1.0,4/64,4.36%,NGF;SLC22A2;LCK;ATP2A3
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.61606709714942,-1.0715597679591722,0.373134328358209,1.0,1.0,3/11,22.38%,TRIM5;TRIM32;TRIM13
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),-0.6602426343048191,-1.071547455083226,0.40384615384615385,1.0,1.0,3/10,15.59%,MYO7A;DCX;VEGFA
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.46247949795814103,1.071529135607306,0.30303030303030304,1.0,1.0,2/71,0.68%,NGF;NUPR1
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),0.5012364059376858,1.0713896725283922,0.2972972972972973,1.0,1.0,6/19,18.52%,MRM1;TFB1M;MTERF4;TFB2M;METTL5;FTSJ3
prerank,GO_Biological_Process_2021__nose development (GO:0043584),-0.6958167548443459,-1.0710256909797635,0.4716981132075472,1.0,1.0,1/5,12.26%,GLI3
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.49025232901054056,-1.0707548000664249,0.36619718309859156,1.0,1.0,12/63,17.51%,FAM131C;NKAIN1;RIMS4;TENM3;CDK5R2;NR2F1;PCGF2;FHOD3;MEX3A;RAC3;CSPG5;NR2F2
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),-0.7163452623870465,-1.070711536911739,0.4117647058823529,1.0,1.0,3/5,27.20%,TPM1;ADRA1A;ADRA1B
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),-0.7161034956017612,-1.0706342921465881,0.3870967741935484,1.0,1.0,3/5,26.63%,NLRP3;PRKCZ;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),-0.7161034956017612,-1.0706342921465881,0.3870967741935484,1.0,1.0,3/5,26.63%,NLRP3;PRKCZ;TNFSF4
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),-0.5268239744646033,-1.07058354761475,0.3064516129032258,1.0,1.0,14/36,19.95%,PTPRC;SLC8A3;RYR3;HTR2C;SLC8A1;HTR2B;SLC24A1;GRIN2B;HTR2A;GRIN2D;ITPR3;TRPV4;TRPV3;TRPM2
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.6102408812716578,-1.0705795040867723,0.390625,1.0,1.0,5/11,26.40%,STAG3;SYCP2;SYCE2;SYCP1;P3H4
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.6102408812716578,-1.0705795040867723,0.390625,1.0,1.0,5/11,26.40%,STAG3;SYCP2;SYCE2;SYCP1;P3H4
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),-0.42144302360481,-1.070408536495173,0.3194444444444444,1.0,1.0,57/212,19.01%,LRTM1;GFRA3;SEMA3E;ROBO4;BAIAP2;EPHA3;CCK;NRCAM;DOK6;EMB;L1CAM;ROBO2;NTN4;EPHA4;SLITRK5;ANOS1;SEMA3D;SLITRK4;GFRA2;NTNG1;LGI1;RAB3A;EFNA1;PALLD;CYFIP1;CDK5R1;PAK3;EFNA3;SPTB;EPHB6;DOK1;EPHA6;VSTM2L;SEMA4G;SLITRK3;SCN1B;EPHB1;PRKCQ;NOTCH2;DRAXIN;NEFH;EFNA5;B4GALT6;CNTN4;DAB1;EFNB2;OPHN1;NTNG2;SIAH1;UNC5D;CDK5;WNT5A;NRXN1;SEMA4B;PIK3CB;TNR;PLCG1
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),-0.5461330782734211,-1.0703964784186748,0.3770491803278688,1.0,1.0,3/16,22.08%,CAV1;PTRH2;TLE1
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),-0.5447351968275111,-1.0702797398800032,0.391304347826087,1.0,1.0,3/30,11.47%,RPS6KA6;PLCB1;CRB2
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),0.691691072950523,1.0702783371955928,0.42857142857142855,1.0,1.0,2/5,11.50%,PMVK;IDI1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.7086393113393432,1.0701192281727907,0.35555555555555557,1.0,1.0,2/5,4.03%,HMGB1;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.4440763298074935,-1.0688122352899627,0.2698412698412698,1.0,1.0,25/92,18.94%,TGFB2;CLU;LGALS3;SLF1;CALY;RHOC;NEDD4L;FRMPD4;TGFB3;CAMK1;ABCB4;AR;LRP1;VEGFA;GPC3;NRG1;PPP1R15A;SYK;NRXN1;HRK;NEURL1;FLOT1;TGFB1;CAMK2B;TIRAP
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),-0.7496036423986255,-1.068464505459498,0.4489795918367347,1.0,1.0,3/5,16.82%,EDN1;CAV3;MYLK3
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),-0.6630997932830863,-1.0679971583366386,0.423728813559322,1.0,1.0,3/7,15.99%,TGFBR2;SOX9;STAT1
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.5059040713283607,-1.067810823340324,0.38596491228070173,1.0,1.0,15/43,22.39%,ABCC4;CEACAM1;SLC16A14;SLC6A12;SLC16A8;ABCB4;SLC6A8;SLC51A;ATP8B1;SLCO2B1;SLC16A3;SLC6A11;SLC16A9;RXRA;SLC10A6
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),-0.5307729497465662,-1.0677480294999842,0.375,1.0,1.0,10/35,24.17%,TGFB2;ENHO;ROBO2;JAG2;STAT3;TM2D3;KAT2B;MESP1;ITGB1BP1;TSPAN14
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),0.6227930183632624,1.06770250446213,0.3783783783783784,1.0,1.0,3/5,6.74%,SLC52A1;ENPP1;SLC52A2
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),0.6227930183632624,1.06770250446213,0.3783783783783784,1.0,1.0,3/5,6.74%,SLC52A1;ENPP1;SLC52A2
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),-0.5684968599636679,-1.0676158940848672,0.38571428571428573,1.0,1.0,10/22,22.53%,CACNA1E;TRPC4;CACNA1B;SLC8A1;CACNB2;CACNA1G;TRPV4;MICU3;CACNA1C;CACNA1A
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.6474282720067241,1.0676130349391921,0.42105263157894735,1.0,1.0,1/7,1.08%,AGER
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.4927792631965249,1.0675383651976533,0.42105263157894735,1.0,1.0,5/29,8.48%,ICAM1;AGER;ABCC1;IGF1R;CHRNA7
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.554358276309518,-1.0673019750383808,0.44776119402985076,1.0,1.0,5/24,14.21%,NPY;TGFB2;RARB;GLI3;EDNRB
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),-0.6564800682172033,-1.067247906559709,0.45,1.0,1.0,1/7,5.73%,MET
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.6023412955300329,-1.0670528321646702,0.45588235294117646,1.0,1.0,1/7,7.38%,HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.6023412955300329,-1.0670528321646702,0.45588235294117646,1.0,1.0,1/7,7.38%,HLA-DRB1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.5779617318288478,-1.0669875528143955,0.3968253968253968,1.0,1.0,8/20,27.04%,LZTFL1;KCNE1;DMTN;TGFB1;PID1;MRAP;ITGB1BP1;RHOQ
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.6598761351329944,-1.0669117622638025,0.4126984126984127,1.0,1.0,4/10,31.06%,LRRK2;MLLT11;FZD9;BCL2
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.695040247109187,1.066849418431905,0.4318181818181818,1.0,1.0,3/5,25.26%,HNRNPU;BECN1;CCNB1
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.6321275274548815,1.0665771581539156,0.42857142857142855,1.0,1.0,2/8,4.04%,SOAT2;MTTP
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.45326452509654,-1.0665657293570705,0.36231884057971014,1.0,1.0,33/157,18.91%,SEMA3E;VIL1;PDGFD;VSIR;DUOX1;F3;SMIM22;CARMIL2;EDN1;CEMIP;RHOC;HGF;CSF1R;SEMA3D;LAMB1;XBP1;CDH13;CARMIL1;CAV1;SEMA4G;TRIM32;PLET1;GTSE1;CLDN4;VEGFA;EGFR;FERMT3;PPP3CA;NTRK3;STAT3;WNT5B;SEMA4B;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),-0.6975735806428385,-1.0665552210592744,0.45901639344262296,1.0,1.0,2/5,18.97%,ITGAV;NFKBIA
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.4812851463142582,1.066401207315134,0.3333333333333333,1.0,1.0,3/47,2.73%,PASK;CELA2A;CRHBP
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.5173752726880556,1.0662778125247476,0.35,1.0,1.0,9/28,16.30%,SNAPC3;ELL;POLR2K;GTF3C5;GTF3C6;GTF3A;ZC3H8;POLR3GL;POLR2L
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.49970092110981257,-1.0657601694975438,0.3620689655172414,1.0,1.0,8/42,16.31%,ANGPT1;SEMA3E;TEK;CDH13;BMPER;VEGFA;EFNB2;RNF213
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.670116886132976,-1.0656596128146671,0.4126984126984127,1.0,1.0,5/7,29.76%,SLC24A1;PLK2;ARF1;PICK1;SHANK2
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.672552487865174,-1.0656516040052268,0.43283582089552236,1.0,1.0,3/7,16.81%,DUOX1;TPO;DIO2
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.4736249450121686,1.0655472125329466,0.38095238095238093,1.0,1.0,12/70,10.14%,NGF;VAV1;FBP1;RASGRF1;SPRY2;RAPGEF1;EPHB2;MMD2;PLCE1;SPRY3;EPS8L2;STARD13
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),-0.70170109137337,-1.0651183961152766,0.46551724137931033,1.0,1.0,2/6,15.59%,SFTPD;VEGFA
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),-0.70170109137337,-1.0651183961152766,0.46551724137931033,1.0,1.0,2/6,15.59%,SFTPD;VEGFA
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.550236023812835,-1.0646317670340395,0.3620689655172414,1.0,1.0,8/33,17.75%,MX1;SYT1;SNCB;AMPH;PACSIN1;DNM1;OPHN1;CDK5
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.6392290175399525,-1.0645876385611588,0.45714285714285713,1.0,1.0,3/13,9.66%,PYGL;AGL;PHKG1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.4958032424847116,-1.064525823044898,0.390625,1.0,1.0,5/38,15.01%,BASP1;MAOB;CALM3;YWHAH;INA
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),-0.7157284665316148,-1.0644413259167753,0.5087719298245614,1.0,1.0,3/5,26.90%,FES;CDKN2D;ALPL
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.6242408253850588,1.0641956202791123,0.47619047619047616,1.0,1.0,3/6,25.55%,TENT4B;LIN28B;TUT4
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.5879514640373203,1.0641588132242468,0.38636363636363635,1.0,1.0,1/10,0.37%,DAO
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),-0.6758012131399604,-1.064129187218863,0.4,1.0,1.0,1/6,15.59%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.46959469233067674,-1.0640672129224575,0.38028169014084506,1.0,1.0,14/78,17.37%,PTPRC;SLC8A3;CEACAM1;WWTR1;SLC8A1;CAMK2N2;THY1;CAV1;UBASH3B;CAV3;SH3BP5;PTPRT;PTPRB;CDKN1A
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.6678019875218623,1.0638774660121675,0.4594594594594595,1.0,1.0,1/5,2.63%,MGLL
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.5939585368164856,-1.0638074567595537,0.4098360655737705,1.0,1.0,4/16,18.49%,MCM2;WRN;RECQL4;MCM7
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.5967785302206087,-1.0637867812025286,0.3333333333333333,1.0,1.0,2/17,7.34%,EDN1;MAP3K5
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.5410391739702896,-1.0637595884411175,0.3870967741935484,1.0,1.0,6/21,23.47%,MEF2C;CAMK1;GRIN3A;NEURL1;CAMK2B;KIF1A
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.4488282535617159,1.0634578524784597,0.35135135135135137,1.0,1.0,7/92,4.36%,NGF;SLC22A2;LCK;MALT1;HMGB1;NLRP2;ATP2A3
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.5445127506586901,-1.063237935893304,0.40540540540540543,1.0,1.0,2/26,9.41%,ARIH2;TOMM7
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.5267550994023845,-1.0631261876863527,0.38095238095238093,1.0,1.0,9/32,23.66%,KLF9;AQP1;AR;ADCY8;GNG2;TRERF1;ADCY2;MAP4K1;ADCY1
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),-0.6799873067334528,-1.0629510845682875,0.4461538461538462,1.0,1.0,2/6,23.76%,TBCA;TBCC
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),-0.5182174424379724,-1.0626625229040412,0.34782608695652173,1.0,1.0,9/41,17.12%,CDH12;CDH9;CADM3;CDH22;CDH10;CDH18;CDH13;CDH3;CDH7
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.5976824831199326,-1.062445976364877,0.35714285714285715,1.0,1.0,2/11,14.23%,HLA-DRB1;ADCY8
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.5437268439652888,-1.062145895485387,0.4603174603174603,1.0,1.0,4/19,10.64%,PTPRC;HLA-E;LAPTM5;XBP1
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),-0.6653739412184463,-1.0618836116934536,0.38235294117647056,1.0,1.0,2/6,17.51%,TIE1;NR2F2
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),-0.7494458159551178,-1.0617623956701099,0.4375,1.0,1.0,4/5,24.91%,MMP24;EPHB1;SCN1A;TMEM120A
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.5170461342924377,-1.0617256425555925,0.4,1.0,1.0,7/34,19.76%,ECM2;BST1;THY1;DMTN;FBLN2;PIK3CB;CX3CL1
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),-0.6800513820828774,-1.0616512844521824,0.42592592592592593,1.0,1.0,5/5,32.02%,SAMHD1;NT5C1A;NUDT18;NUDT16;NUDT15
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.6094379643039161,1.061487045723451,0.3783783783783784,1.0,1.0,2/16,7.63%,FEM1A;PINX1
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.5718029785149696,1.0612865753567675,0.42424242424242425,1.0,1.0,2/12,17.56%,GFPT2;GFPT1
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.6341793346825197,-1.0610439478590075,0.45,1.0,1.0,3/9,20.01%,CLU;SCARB1;ABCA1
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.4489711096648401,1.0609511259189273,0.3055555555555556,1.0,1.0,26/94,21.17%,MRPL58;MRPL32;MRPS10;MRPS7;MRPL3;MRPS2;MRPL50;MRPL15;PTCD3;MRPS5;HARS1;MRPS26;MRPS27;MRPL52;MRPL24;MRPL47;EARS2;MRPL39;MRPL13;MTRF1L;MRPS9;MRPS30;MRPS16;MRPL22;MRPL43;RARS2
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.6040242431443218,-1.0601893365965704,0.375,1.0,1.0,3/11,32.09%,CAV2;TSG101;VPS4A
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),-0.7199696942190357,-1.060063559074125,0.39655172413793105,1.0,1.0,3/5,17.05%,PLSCR1;UHRF1;SETMAR
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),-0.7199696942190357,-1.060063559074125,0.39655172413793105,1.0,1.0,3/5,17.05%,PLSCR1;UHRF1;SETMAR
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),-0.6658722448980714,-1.0600112691326793,0.47058823529411764,1.0,1.0,3/6,17.10%,IRF1;MAPK8IP1;SYK
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.47068200509377595,-1.0599618905034733,0.352112676056338,1.0,1.0,6/68,9.67%,CLDN5;TGFB2;FOS;TGFBR2;TGFB3;FURIN
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.673067011214869,-1.0598965546260972,0.4528301886792453,1.0,1.0,2/7,21.72%,WNT5A;PTN
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),-0.6209020685504888,-1.05969577541301,0.47368421052631576,1.0,1.0,5/12,23.68%,SLC1A1;SLC25A22;SLC1A6;SLC1A2;SLC25A12
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.5173449367514642,-1.0596459284168476,0.3939393939393939,1.0,1.0,2/28,7.42%,P2RY12;TEK
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.6519738600517015,1.0595594889820974,0.42857142857142855,1.0,1.0,3/8,13.51%,EOGT;GALNT11;GALNT1
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.5018584065780398,-1.0594438013082408,0.35,1.0,1.0,13/54,20.80%,NR4A3;LGALS3;MEF2C;FES;GATA1;MOV10;ZFPM1;PRKCQ;LYN;RBBP5;SPI1;KAT2B;SETD1A
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.6174489682271561,1.0593749549155032,0.3888888888888889,1.0,1.0,3/10,12.55%,TTLL9;TTLL1;TTLL11
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.5123864606941749,-1.0593726366500495,0.44285714285714284,1.0,1.0,6/31,11.53%,NR4A3;IL6R;EDN1;ID2;GJA1;CDH13
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.4774661202476541,-1.0593640223639216,0.3387096774193548,1.0,1.0,14/68,19.53%,ANGPT1;STAT5A;EDN1;MET;TEK;SCARB1;PRKD2;VEGFA;ZNF580;WNT5A;TGFB1;PIK3CB;PLCG1;EMC10
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.4710636607030368,-1.0593511487356588,0.3684210526315789,1.0,1.0,16/91,18.67%,RND2;ARHGAP18;BAIAP2;EPHA3;TWF2;SMIM22;RHOC;PEAK3;BST1;PAK3;LRP1;RAC3;EFNA5;DMTN;RHOH;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.4819049541218991,-1.0592779538396768,0.328125,1.0,1.0,17/70,18.15%,HLA-F;ITGAM;CLU;MEF2C;FOS;MAP3K5;LRRK2;CHGA;DDIT4;SNCB;GRIN2B;CD200;EPHB1;EFNB2;TNFRSF1B;CDK5;WNT5A
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),-0.4521852047054163,-1.0591767983437443,0.3424657534246575,1.0,1.0,7/98,7.76%,ANGPT1;ISG15;FANCI;BIRC3;LAPTM5;PRICKLE1;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.5247538339642305,-1.0590091024006771,0.39344262295081966,1.0,1.0,10/57,13.14%,BAIAP2;NCKAP1L;MET;BAIAP2L2;FES;FCHSD2;NAV3;CDK5R1;CARMIL1;CAV3
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),-0.6470984641921979,-1.0589754773324769,0.4393939393939394,1.0,1.0,4/9,23.66%,ADCY7;ADCY8;ADCY2;ADCY1
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),-0.7036389802518893,-1.0589544134061786,0.47692307692307695,1.0,1.0,4/5,29.17%,LMO3;CLOCK;PER1;CRY2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.7116880687469438,-1.0584624229042894,0.48333333333333334,1.0,1.0,1/5,7.72%,POLR3H
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.5599090710037109,1.0581967197721565,0.4878048780487805,1.0,1.0,2/9,6.40%,CASQ2;CLIC2
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.5599090710037109,1.0581967197721565,0.4878048780487805,1.0,1.0,2/9,6.40%,CASQ2;CLIC2
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.630597777885529,-1.058181841277037,0.4716981132075472,1.0,1.0,4/11,22.04%,PGAM5;DNM1L;ITPK1;LY96
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.5796381219859801,1.0581086109419808,0.37142857142857144,1.0,1.0,2/18,8.61%,SAP18;PTBP1
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.5367636566432169,1.0579036818182381,0.4594594594594595,1.0,1.0,4/25,6.43%,ICAM1;AGER;ABCC1;IGF1R
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.5923920526350626,1.057504874975265,0.41379310344827586,1.0,1.0,3/16,14.87%,DUSP1;DUSP7;PPM1F
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.4665095032742975,-1.0570698941953893,0.36231884057971014,1.0,1.0,17/69,17.34%,ITGB4;SMIM22;LGALS3;CDS1;L1CAM;ADGRG1;HSD11B2;KIAA1217;EFNA1;TMC4;SLC44A3;AQP4;KCNE1;CLDN4;OVOL2;PPL;NR3C2
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),-0.5175072935731264,-1.0569793837350956,0.4576271186440678,1.0,1.0,12/40,16.93%,SLC8A3;NOS1;ATP2B3;NPR2;ATP2B2;RYR3;SLC8A1;ATP1B2;ATP1A1;ITPR3;ABCC9;FKBP1B
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.6381092550332008,-1.0567901479447008,0.48,1.0,1.0,4/8,29.97%,ADRB2;ADRA1A;ADRA1B;AKAP13
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.6660892762823508,-1.0567254708800409,0.4406779661016949,1.0,1.0,1/8,18.91%,TGFB1
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),-0.7048590101608648,-1.0567176270529741,0.5081967213114754,1.0,1.0,1/5,8.07%,CAMK1D
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5536196034375414,1.0562035690950398,0.3684210526315789,1.0,1.0,4/32,2.77%,F2;RAB27A;CYBA;DCXR
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.6513402555721899,-1.056042747983721,0.4745762711864407,1.0,1.0,3/7,18.91%,RFTN1;PRKCQ;TGFB1
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.5593435557495399,-1.0560212966708655,0.47058823529411764,1.0,1.0,6/23,19.76%,VIL1;SYNPO2;SYNPO2L;SYNPO;FHOD1;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),-0.6671830536382201,-1.055679575007356,0.46551724137931033,1.0,1.0,2/6,24.85%,GPR37L1;ADRB2
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),-0.7136882166689478,-1.0549675517456727,0.46551724137931033,1.0,1.0,1/5,13.77%,SCARB1
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),-0.7136882166689478,-1.0549675517456727,0.46551724137931033,1.0,1.0,1/5,13.77%,SCARB1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.6165205118052589,-1.0549236587989685,0.4482758620689655,1.0,1.0,3/10,18.39%,WTIP;ZFP36;STAT3
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.6579452407342511,-1.0547273089500961,0.45161290322580644,1.0,1.0,3/7,26.69%,PSMC3;ESR1;PSMC5
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),0.7246231964413326,1.0545652381435062,0.4222222222222222,1.0,1.0,3/5,20.73%,SF3A3;SF3A2;SF3A1
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),-0.6698412899775141,-1.0544579580193556,0.43636363636363634,1.0,1.0,1/6,13.44%,HOOK1
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.47353804967100854,-1.0543931652218075,0.4626865671641791,1.0,1.0,24/65,20.32%,SLC8A3;ANO6;SCN2A;SLC6A12;SCN9A;SLC9C2;SLC5A2;SLC8A1;SLC24A1;ATP1B2;HCN1;ATP1A1;SLC6A8;ASIC2;SCN1B;SLC9C1;SCN4B;SLC24A4;SLC6A4;KCNK1;SLC6A7;SCN1A;SCN3A;SLC6A11
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.49502234876180823,-1.0543176864066992,0.375,1.0,1.0,8/50,16.00%,LPL;ALDH1A2;ACMSD;XBP1;ACSM3;OXSM;SDS;LIPI
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),0.6288797526913708,1.0541440055222995,0.4318181818181818,1.0,1.0,2/6,11.79%,TMEM98;HES5
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.5346272976431747,-1.053854810933897,0.36507936507936506,1.0,1.0,10/25,24.61%,DCX;RSPH6A;SPAG17;SPAG16;RSPH9;CCDC39;CFAP46;SPEF1;CFAP74;RSPH1
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.659329218179476,-1.053742739573373,0.4594594594594595,1.0,1.0,4/10,22.42%,CSF1R;HLA-DRB1;VEGFA;IL31RA
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.4711242507884343,1.0535601046638354,0.3225806451612903,1.0,1.0,3/33,5.72%,NGF;FGFR1;MMD2
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.6281861945729417,-1.0535403249428097,0.4925373134328358,1.0,1.0,1/9,5.00%,PDXDC1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.4325127189238874,-1.0534573448513986,0.4090909090909091,1.0,1.0,24/112,19.76%,ANGPT1;P2RY12;IL26;KITLG;F3;MET;HGF;FGF22;PIK3AP1;TEK;CHI3L1;CX3CR1;NRG4;TGFA;AXL;FGF7;GFRAL;EGFR;NRG1;TGFB1;GAS6;PIK3CB;PTPRJ;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.5777866711837703,-1.05338760072987,0.4666666666666667,1.0,1.0,2/18,15.70%,NOS1;BRCA1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.5310954096171933,-1.0532872864013996,0.43478260869565216,1.0,1.0,7/38,13.14%,STMN2;MET;FES;NAV3;CDK5R1;MAP2;CAV3
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.5255594774704246,-1.0531291219145942,0.45901639344262296,1.0,1.0,7/36,6.16%,DPEP2;PTPRC;SLA;AOAH;CD53;GMFG;SELL
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),-0.7076843792973939,-1.053028244718487,0.4339622641509434,1.0,1.0,3/5,13.51%,FUCA2;CAV1;ITGAV
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.687161879335817,-1.0530199478327509,0.375,1.0,1.0,1/5,7.71%,MAN1A1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.687161879335817,-1.0530199478327509,0.375,1.0,1.0,1/5,7.71%,MAN1A1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.687161879335817,-1.0530199478327509,0.375,1.0,1.0,1/5,7.71%,MAN1A1
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.5358214757721852,-1.0525731759273713,0.36923076923076925,1.0,1.0,3/26,9.27%,HEY1;E2F1;GATA1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.420735796028431,-1.0524818382790975,0.35294117647058826,1.0,1.0,21/152,15.31%,DACT1;SFRP4;BICC1;ANKRD6;SHISA6;IGFBP4;PSMB8;APC2;SOX9;PRICKLE1;DKK3;APCDD1;WWTR1;HECW1;KREMEN1;CAV1;GLI3;LRP1;AMER1;DRAXIN;IGFBP2
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.5152049663523666,-1.052352397721355,0.3620689655172414,1.0,1.0,11/60,12.59%,VIL1;ARHGAP18;BAIAP2;TWF2;NCKAP1L;BAIAP2L2;FCHSD2;ARHGAP28;PAK3;CARMIL1;RASA1
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.7080332374829432,-1.052019577948161,0.4838709677419355,1.0,1.0,1/6,6.11%,EPHA4
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.6352212370183477,1.0519646815025394,0.47619047619047616,1.0,1.0,1/5,10.33%,ALDH7A1
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.4668884196904849,-1.0513947369790029,0.3880597014925373,1.0,1.0,11/56,13.06%,LPL;TLR2;PLSCR1;TNFRSF1A;MEF2C;NLRP12;NINJ1;NMI;IFNK;IL16;IFI35
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.45892642466098843,-1.0513567067674143,0.29577464788732394,1.0,1.0,11/85,11.17%,FBLN1;CLDN5;MCTP1;SPINT2;CITED2;ARHGAP4;EPHA4;TMIGD3;SULF1;NAV3;THY1
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.5500383961470968,1.051014021661045,0.42424242424242425,1.0,1.0,1/16,0.43%,F2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.49290181910305025,-1.0506321197185433,0.42028985507246375,1.0,1.0,17/63,20.44%,MEF2C;LAMC1;ATRNL1;NTN4;ACTN1;TEK;NTNG1;LAMB1;DACT2;EFNA1;ITGAV;OPHN1;NTNG2;FERMT3;LAMB4;LAMB2;SPI1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.6962620369251803,-1.05063182550382,0.49056603773584906,1.0,1.0,2/6,28.80%,PRKD2;HIF1A
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.5114014283064343,1.0506089033772223,0.38235294117647056,1.0,1.0,4/33,6.40%,F2;JPH1;CASQ2;CLIC2
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),-0.6875005854113061,-1.0505668013832503,0.509090909090909,1.0,1.0,1/6,4.79%,ID2
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.6049511810187874,1.0504077022035319,0.46511627906976744,1.0,1.0,1/9,0.43%,F2
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.6044894672966022,1.0504071768305883,0.39473684210526316,1.0,1.0,1/6,4.09%,PLA2R1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),0.668918537600453,1.0501521032693433,0.42857142857142855,1.0,1.0,2/5,24.40%,PDCL3;DNAJB2
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),0.6366788798663128,1.0499648748120267,0.45161290322580644,1.0,1.0,3/10,24.64%,EIF5;EIF2S2;EIF4B
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.7161255991180987,1.0498116605604348,0.5135135135135135,1.0,1.0,1/5,2.21%,RNF128
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.5646331453784238,1.049789031487539,0.375,1.0,1.0,2/13,5.87%,DHFR;NOS1AP
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.6581411681538429,-1.0496983835027576,0.46875,1.0,1.0,2/6,14.69%,CAV1;KCNE1
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.660980894569657,1.0496757229948703,0.4473684210526316,1.0,1.0,1/5,8.61%,ATP6V1G1
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.46836177459887174,-1.0494138103201713,0.3548387096774194,1.0,1.0,12/58,17.91%,PPARG;TNFRSF1A;AOAH;NLRP12;TEK;FNDC4;NLRP3;LRFN5;NMI;CXCL17;NR1D1;TNFAIP6
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),-0.6982134495057368,-1.049143896560414,0.5,1.0,1.0,1/5,3.04%,STAT5A
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),0.6897554213560547,1.0491257952869433,0.42424242424242425,1.0,1.0,3/5,27.97%,KDM1B;KMT2A;GRHL2
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.6590127590367676,-1.049122281523837,0.5,1.0,1.0,4/9,16.13%,RFTN1;IFNA2;IFNK;IFNA6
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.4072780925937268,-1.0490523110611,0.35443037974683544,1.0,1.0,47/280,20.40%,FSTL1;IGFBP3;SPARCL1;ASB4;FBXL16;TIMP1;IGFBP4;ASB18;PRSS23;LAMC1;FBXW9;PSMB8;FUCA2;RAB11A;CST3;AFP;SCG2;FBXL18;LAMB1;FBXO41;FBXL13;RAB3A;CHGB;MEPE;LTBP1;SCG3;ASB14;CP;CHRDL1;FBXL5;FBXO10;CCNF;FBXO7;RAB1B;RCN1;FBXO17;GPC3;HIF3A;PNPLA2;FBXO31;ANKRD9;PSMC3;GAS6;SENP8;DTL;RBBP5;LAMB2
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.4714672389018222,1.048980228116641,0.35294117647058826,1.0,1.0,2/49,2.72%,BACE2;LEPR
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.6088514986984838,-1.0488456170057043,0.4426229508196721,1.0,1.0,1/15,8.01%,TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.72717941932119,-1.048817218368444,0.5636363636363636,1.0,1.0,2/5,12.01%,LRCH1;CD200
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.48579732969100436,1.0487908234199959,0.3333333333333333,1.0,1.0,2/29,2.36%,CRTAM;LCK
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.4460166120840771,-1.0487407274212497,0.36486486486486486,1.0,1.0,26/163,12.38%,FSTL1;SEMA3E;LRIG3;KITLG;PLSCR4;LAMC1;COL4A1;CADPS2;MET;NTN4;DDAH1;PTPRG;LAMB1;KIAA1217;NLRP3;GJA1;PALLD;FAT1;CPE;WWTR1;SULF1;PLEKHH2;CRB2;CDH13;ADGRL2;THSD7A
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.5919121296854092,-1.0486585216628546,0.4375,1.0,1.0,4/17,21.72%,DUOX1;CLDN4;DMTN;PTN
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.5112902057520011,-1.0486142736730855,0.41935483870967744,1.0,1.0,7/30,21.34%,PAM;FAR2;ALOX12;ACSS3;GGT5;AWAT1;SCD
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.6202788302755151,-1.047977037023274,0.484375,1.0,1.0,3/12,24.38%,ALOX12;ELOVL2;FADS2
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.5320186941675827,-1.047934828712308,0.46875,1.0,1.0,2/23,4.39%,ANGPT1;GPIHBP1
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.48487873727868325,1.0476902450261345,0.3870967741935484,1.0,1.0,5/21,22.22%,FBP1;MST1;DGKQ;SIRT1;SIRT7
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),-0.6623193793339315,-1.0475279184434136,0.45098039215686275,1.0,1.0,3/6,25.79%,VEGFA;HES1;HEY2
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5489648166297777,1.0471856202729357,0.41025641025641024,1.0,1.0,3/17,4.33%,OOEP;MTCL1;SCRIB
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.45274841882021766,-1.0471033639809102,0.42424242424242425,1.0,1.0,12/86,10.74%,SPARCL1;PROM1;HOPX;SHISA6;TSPAN11;MAOB;CDS1;KALRN;APCDD1;CHGA;DACT2;SLC44A3
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),-0.5612577526140781,-1.046996856081241,0.4383561643835616,1.0,1.0,2/17,3.42%,FMO5;ACADL
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),-0.6644375449726971,-1.0469962642913708,0.3793103448275862,1.0,1.0,2/7,18.15%,LRRC4;WNT5A
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),0.6570863777837298,1.0468765807614213,0.4772727272727273,1.0,1.0,2/6,13.11%,GTF3C5;GTF3C6
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.49012703784215716,-1.0460866794159651,0.4057971014492754,1.0,1.0,18/62,20.06%,VIL1;BAIAP2;NCKAP1L;EDN1;BAIAP2L2;SYNPO2;FES;TEK;FCHSD2;CARMIL1;SYNPO2L;LMOD1;MYLK3;SYNPO;CDK5;NTRK3;CX3CL1;CDC42EP3
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.5888696500613937,1.0457961691968645,0.48717948717948717,1.0,1.0,2/13,6.83%,CEP55;CHMP5
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),-0.7244069702017488,-1.0457289622025077,0.4576271186440678,1.0,1.0,3/6,22.96%,PLCB1;POMZP3;GLRA1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.5575028804647374,1.045510371769292,0.3695652173913043,1.0,1.0,3/18,10.46%,BCL2A1;BAK1;CASP9
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.4830671365240563,-1.0452217656193659,0.35714285714285715,1.0,1.0,8/60,16.12%,MMRN2;PPARG;SULF1;BMPR1B;CNMD;BMPER;VWC2L;CREB3L1
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),-0.6944663932537,-1.0450482310442117,0.5370370370370371,1.0,1.0,2/5,2.34%,CD59;TGFB2
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.49068318426179425,1.044914780247883,0.41935483870967744,1.0,1.0,6/27,10.74%,NDC80;DYNLT1;LLGL2;NUMA1;LLGL1;KIF25
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.6073957141172812,-1.0445008397326432,0.4426229508196721,1.0,1.0,2/12,9.33%,PTPRC;GJA1
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.5957770456529841,1.044469541874911,0.4,1.0,1.0,2/6,9.53%,CA2;ACTN2
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.535858275242412,-1.0444534527567302,0.3770491803278688,1.0,1.0,3/21,5.21%,ITGAM;PDZK1;CEMIP
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.5961278733696032,-1.044080565116639,0.48148148148148145,1.0,1.0,7/10,38.15%,ZWILCH;MTBP;SPDL1;ZW10;MIS12;CDK1;IK
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.5089571532845885,1.0440423602151103,0.3157894736842105,1.0,1.0,1/20,0.37%,PDE3A
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.709144027003271,1.043963151373432,0.4864864864864865,1.0,1.0,1/5,13.33%,ADIPOR1
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.48749832768708407,-1.0438382321804096,0.453125,1.0,1.0,8/50,15.99%,HEY1;DTX3L;DTX1;SUSD5;SORBS2;JAG2;NOTCH2;STAT1
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.6347775141550069,-1.0438309172956504,0.4782608695652174,1.0,1.0,2/10,15.02%,NDUFAF5;PRMT8
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.6085115493730174,1.0436717450865323,0.42857142857142855,1.0,1.0,7/12,25.04%,TSPOAP1;STAR;HSD17B10;FDX1;AKR1D1;FDXR;AKR1C3
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.4659982263324505,-1.0434537478670285,0.421875,1.0,1.0,12/50,23.24%,SFRP4;WNT8B;LRRK2;CAV1;AMER1;FZD8;CDH3;WNT5A;WNT5B;PPP1CA;BCL9;FZD3
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.6276692753345714,-1.0433718941550933,0.5178571428571429,1.0,1.0,1/7,15.39%,PLA2G12A
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.42794105327523524,-1.0430645745763745,0.36231884057971014,1.0,1.0,31/144,13.06%,PARP14;ISG15;FGL2;PLSCR1;EPSTI1;IFITM3;MX1;SERPING1;DDX60;ISG20;IRF1;IRF4;PSMB8;IFI44;PIM1;HLA-A;HLA-DRB1;IL7;ST3GAL5;B2M;HLA-DMA;SP110;SAMHD1;VAMP5;XAF1;P2RY14;TRIM25;C1R;NMI;NOD1;IFI35
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.5612537403467378,-1.042822421349725,0.40298507462686567,1.0,1.0,2/20,4.08%,CLDN5;MEF2C
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.6557555038223932,1.0427607177289566,0.45,1.0,1.0,5/10,20.78%,ATF4;ZBTB1;C5AR1;DDX5;HSF1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.5174581360623717,-1.0427023279085446,0.423728813559322,1.0,1.0,4/26,7.43%,SEMA3E;ROBO2;ANGPT2;SEMA3D
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.6353383828807232,-1.0424114066062984,0.43103448275862066,1.0,1.0,3/11,11.80%,HLA-E;IRF4;IFNA2
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),-0.731193616997658,-1.0423154786037825,0.46153846153846156,1.0,1.0,1/5,7.06%,CSF1R
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.6581219531002087,1.0421127730851765,0.475,1.0,1.0,1/6,3.26%,KIF3B
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),0.6328701558359285,1.0416821058492396,0.5348837209302325,1.0,1.0,1/6,4.42%,GALT
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.4580222103167788,-1.0416581463665662,0.4266666666666667,1.0,1.0,13/73,13.36%,MT1M;EDN1;SLC8A3;ATP2B3;ATP2B2;HTR2C;SLC24A5;TPCN2;SLC8A1;HTR2B;SLC24A1;CAV1;HTR2A
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.48029050785515875,1.0414863307072504,0.39473684210526316,1.0,1.0,9/28,20.80%,LSM7;EXOSC8;DCP1A;DCP1B;PATL1;DCPS;EXOSC7;DIS3;EXOSC5
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.536896466623486,-1.0411774643446632,0.3968253968253968,1.0,1.0,6/33,10.41%,PTPRC;CR1;SFTPD;IRF4;LAPTM5;NAV3
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.5458366630493067,1.041132956331227,0.4594594594594595,1.0,1.0,5/11,22.56%,OXSR1;GPR35;ACKR3;WNK1;CIB1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.6487761408401482,1.0410347990461102,0.5,1.0,1.0,4/6,34.86%,CNOT2;NBDY;CNOT6;CNOT6L
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.636946326587003,-1.0402432852481085,0.49056603773584906,1.0,1.0,1/6,7.76%,LRRK2
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.43126138644256834,-1.0401509216599445,0.4430379746835443,1.0,1.0,26/123,20.03%,ROR1;PTPRC;PAK5;RIT2;TRIM5;APIP;LAPTM5;CEACAM1;HLA-DRB1;TEK;PAK3;CAV1;CAV2;CAV3;EPHB1;LYN;GFRAL;ATP6AP2;EGFR;GPR37L1;SYK;NTRK3;PTPRJ;RASGRP1;CX3CL1;PRDM15
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),-0.5866013795095363,-1.0401064911850506,0.4426229508196721,1.0,1.0,4/10,12.10%,NEDD4L;SLC8A1;ATP1B2;ATP1A1
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),-0.5208984214362387,-1.0399703925237451,0.4155844155844156,1.0,1.0,12/39,22.57%,GAP43;PLPPR5;GPM6A;TGFB3;DMTN;NEURL1;TENM2;ABITRAM;TRPM2;FNBP1L;TENM1;PRKCD
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.5227705069432397,-1.0398891993829324,0.43661971830985913,1.0,1.0,4/33,9.41%,ARIH2;LRRK2;SIAH3;TOMM7
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.4938934222748847,-1.0397358429754429,0.43103448275862066,1.0,1.0,8/34,19.68%,PIGH;ST3GAL5;PIGC;ST8SIA3;B4GALT6;PIGB;ST6GALNAC5;MPPE1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.5170994080395624,-1.039392500320044,0.4444444444444444,1.0,1.0,3/37,3.87%,TLR2;ISG15;IRF1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),-0.6764331778832657,-1.0392971188419577,0.5373134328358209,1.0,1.0,2/6,7.87%,LRRK2;SIAH3
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.4103580886422238,1.0390792031643714,0.18181818181818182,1.0,1.0,5/96,1.81%,CXCR4;JPH1;EPB41L4B;ONECUT1;SOWAHA
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.5550818365901382,-1.038934738563458,0.3770491803278688,1.0,1.0,6/20,23.51%,TMEM25;LRRK2;SLC24A1;PLK2;GRIK3;ARF1
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.4527023148412279,-1.038914737641536,0.4262295081967213,1.0,1.0,20/91,18.94%,CPS1;IRGM;IL12A;MEF2C;NOS1;VIM;NLRP3;LDOC1;XBP1;CX3CR1;SCARB1;AXL;GGT5;TNFRSF1B;ZFP36;NR1D1;WNT5A;GIT1;LILRB1;TIRAP
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.690126607999023,1.038837012481431,0.5111111111111111,1.0,1.0,1/5,7.60%,MTMR2
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.6355761283175665,1.0386272571311648,0.4883720930232558,1.0,1.0,2/8,9.28%,SPRED1;SPRED2
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.5249061494481168,1.038551342445917,0.40540540540540543,1.0,1.0,4/14,21.56%,HMGA2;SNAI1;HP1BP3;SIRT1
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),0.5988608163776371,1.0381918906503993,0.42424242424242425,1.0,1.0,1/8,4.86%,NEU4
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),0.5564135172352,1.0381283504504164,0.34285714285714286,1.0,1.0,5/13,20.80%,EXOSC8;TRIR;EXOSC7;DIS3;EXOSC5
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.6247314681320407,-1.0380038508277232,0.5081967213114754,1.0,1.0,1/7,12.26%,GLI3
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.5313540673711311,1.0378581686759074,0.325,1.0,1.0,4/18,6.80%,DPEP1;CRHBP;FBP1;PDE4B
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.6205296977052506,-1.0377693426222685,0.484375,1.0,1.0,3/9,24.99%,ID2;TGFB1;IL34
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.6619288637758738,-1.037275594914942,0.49230769230769234,1.0,1.0,2/7,16.22%,IL12A;PRDM1
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.6358157464178685,-1.036533311875817,0.4918032786885246,1.0,1.0,4/12,7.76%,NR4A3;MET;HGF;LRRK2
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.45887520684338756,-1.036139099374933,0.38461538461538464,1.0,1.0,14/57,18.97%,TLR2;C1QTNF4;NLRP12;LAPTM5;TERF2IP;NLRP3;TCIM;NMI;NOD1;IFI35;CD27;EGFR;NR3C2;NFKBIA
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.43730833563082266,-1.0359916432672933,0.32,1.0,1.0,1/72,0.05%,SLC28A2
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.577440879676835,1.0357801803881312,0.45,1.0,1.0,1/11,3.27%,HMGB1
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),-0.5988371450008929,-1.0357759667912712,0.4603174603174603,1.0,1.0,2/8,13.03%,CARMIL1;DOCK2
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.6105773457758232,1.0357562931466002,0.4444444444444444,1.0,1.0,1/10,8.54%,CYP2C8
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.5817045843831444,-1.0357400881061651,0.4861111111111111,1.0,1.0,1/13,6.25%,RFK
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.4565992300349713,1.0356001735863445,0.35,1.0,1.0,16/61,22.20%,U2AF1;PCF11;RBM8A;TENT4A;CPSF4;CSTF2;SYMPK;TENT4B;PNPT1;SARNP;THOC2;LIN28B;CSTF1;MAGOH;ALYREF;SRSF9
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.6129391933703006,1.0349987827148721,0.45,1.0,1.0,2/8,7.82%,ALK;PLIN5
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.6054362789859156,1.0349188931413156,0.46511627906976744,1.0,1.0,2/7,10.64%,HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.5258965383113996,-1.034101461955389,0.41935483870967744,1.0,1.0,4/19,17.85%,FABP3;SLC25A20;ABCD2;PRKAB2
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.6649061958884289,1.034095631113129,0.5,1.0,1.0,2/5,10.26%,SLC39A8;CYBRD1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.4529744097648711,-1.0340725791480019,0.3870967741935484,1.0,1.0,6/66,6.61%,TLR2;ITGAM;SFTPD;BIRC3;RFTN1;PIK3AP1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.47126564737745646,-1.0339900119621541,0.4027777777777778,1.0,1.0,11/49,23.91%,EPHA3;TEK;THY1;DAPK3;VEGFA;EFNA5;DMTN;CAMSAP3;PTPRJ;VCL;ITGB1BP1
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),0.6256636639905377,1.0339839743563903,0.4878048780487805,1.0,1.0,2/8,9.41%,AADAT;CYP2E1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell differentiation (GO:2001200),0.6545762032042997,1.033847804480228,0.5208333333333334,1.0,1.0,2/5,3.27%,AGER;HMGB1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.44837706842485814,1.0337974859890662,0.34375,1.0,1.0,6/62,6.64%,NGF;GPR143;PIK3C2G;FGFR1;IGF1R;PLCE1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.5211834171814209,1.0336956130534793,0.46153846153846156,1.0,1.0,6/25,13.08%,FEM1A;ARRDC4;ABL1;ARRDC3;LIMK1;UBE2N
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.4364430957221572,-1.0336921819948932,0.410958904109589,1.0,1.0,25/88,21.36%,FSTL1;COX7A1;ADAMTS5;ASPN;ACTA2;PLSCR4;AQP1;COL4A1;SYNPO2;TEK;MYH11;C1R;MATN2;ADGRF5;RASD1;LMOD1;ELN;FBLN2;TIMP3;NNMT;DDR2;ANGPTL2;LAMB2;TPM1;COL12A1
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.5256001949169034,1.0334708631218839,0.36585365853658536,1.0,1.0,1/15,0.55%,TBXA2R
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.5267607631861697,1.0334442585755195,0.4166666666666667,1.0,1.0,1/11,3.07%,MBOAT1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),-0.6696650940580545,-1.0333409193023468,0.45454545454545453,1.0,1.0,2/5,26.19%,OLFM2;MYOCD
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.47455995449707344,1.033075872051765,0.3783783783783784,1.0,1.0,9/30,20.80%,LSM7;EXOSC8;DCP1A;DCP1B;PATL1;DCPS;EXOSC7;DIS3;EXOSC5
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.66585709226677,1.0330473793244919,0.5416666666666666,1.0,1.0,1/5,4.69%,SLC38A2
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.4037624248553059,1.0329963962276885,0.34615384615384615,1.0,1.0,14/133,6.75%,CA6;RDH16;MGLL;DHCR24;ACADS;HSD17B7;CA2;HMGCS1;AADAT;ACAA2;KMT5A;ACADVL;PRDX6;ERP29
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.6154082097040932,-1.0325913355391145,0.43859649122807015,1.0,1.0,1/12,0.73%,HEY1
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.4766122074486276,1.0324361363871597,0.375,1.0,1.0,4/32,7.92%,NGF;NLGN3;PXK;RELN
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.42712957428133,-1.032206666447668,0.4305555555555556,1.0,1.0,28/146,13.99%,FRY;NPY;PTPRM;STMN2;NCKAP1L;NYAP1;L1CAM;GPRIN3;GPM6A;RAB11A;EPHA4;ADGRV1;MYO16;LRRK2;DCLK1;LAMB1;LGI1;GRM7;STX3;SH3GL2;CDK5R1;PAK3;MANF;MAP2;EPHB1;LYN;PACSIN1;DLG4
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),-0.43700327424500524,-1.0318348677664992,0.42857142857142855,1.0,1.0,27/108,19.06%,WNT8B;TGFB2;MEF2C;ID2;MET;ATP2B2;MYO7A;ANOS1;DDIT4;CTF1;TENM3;XBP1;CDK5R1;EMX1;MANF;ITM2C;FZD8;PAX6;VEGFA;OPHN1;CDK5;MYT1L;WNT5A;MYEF2;TENM2;WNT5B;NEUROD6
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.3425325658500408,1.031812386802849,0.375,1.0,1.0,24/338,6.91%,POU3F1;NGF;CRTAM;PASK;SLC22A2;EPB41L4B;VDR;RAB27A;FGF6;PIWIL2;NWD1;HSPA1A;PLA2R1;SLC38A2;SPRY2;PLD1;HMGA2;EPHB2;NOS1AP;ATF4;MYOM1;ERP29;SPHK2;MYO1C
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),-0.63188878398897,-1.0317239566278427,0.4426229508196721,1.0,1.0,2/7,20.01%,MAP2K5;ABCA1
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.5773489647935451,-1.0312550006829846,0.47540983606557374,1.0,1.0,2/18,4.07%,PARP9;DTX3L
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.5006963908349986,1.03119617329794,0.3793103448275862,1.0,1.0,4/37,9.64%,ORC1;HMGA2;BRCC3;NABP1
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),-0.6611580602342149,-1.0309468270891284,0.48148148148148145,1.0,1.0,1/5,1.04%,LPL
prerank,GO_Biological_Process_2021__regulation of urine volume (GO:0035809),0.6818061082573087,1.0309270599541729,0.4864864864864865,1.0,1.0,3/5,30.36%,ADCY6;TRPV5;NPR3
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.6475545170352204,-1.030728771488231,0.4827586206896552,1.0,1.0,3/7,19.71%,DMTN;TGFB1;DDR2
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.538924436696226,1.0306756002664852,0.4,1.0,1.0,4/13,14.87%,DUSP1;NCK1;PPP2R2C;PPM1F
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.683411620555898,-1.030424455284438,0.5423728813559322,1.0,1.0,2/5,24.48%,CHRM1;HES1
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.5110650010173294,1.030238637311948,0.4117647058823529,1.0,1.0,7/26,7.19%,CA6;SLC39A8;CA2;CA5A;CYB5R1;CA3;SLC26A7
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.56383910487402,1.0300252144047708,0.48484848484848486,1.0,1.0,5/11,25.10%,SELP;RELA;ST3GAL4;RHOA;NFAT5
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.5537195652192677,-1.0299393010047528,0.4307692307692308,1.0,1.0,8/18,22.79%,BMP6;TGFB3;WWTR1;RBPMS;OVOL2;TGFB1;KIAA0319;PBLD
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.3995206141577728,-1.029715165698833,0.3472222222222222,1.0,1.0,46/226,18.94%,LPL;TLR2;IRGM;NR4A3;P2RY12;WNT8B;EPHA3;TWF2;SSTR1;MEF2C;FOS;AQP1;VIM;TSHR;GLRA2;BRINP2;SOX9;FES;RYR3;NLRP3;LDOC1;KCNC2;XBP1;CX3CR1;ABCB4;HCN1;ROMO1;LYN;BRINP1;DAPK1;AXL;GNG2;KCNE1;PTK7;EGFR;BRINP3;TNFRSF1B;ZFP36;DMTN;NR1D1;WNT5A;NEURL1;GIT1;LILRB1;WNT5B;TIRAP
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.5173623378633557,-1.0295709889794198,0.47540983606557374,1.0,1.0,6/27,18.98%,P2RY12;ACTN1;GATA1;UBASH3B;FERMT3;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.5896885759339681,-1.029555223727943,0.4931506849315068,1.0,1.0,3/10,15.70%,ACADL;CEACAM1;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.6131737668039888,-1.0295005244608968,0.5172413793103449,1.0,1.0,1/9,2.10%,TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6131737668039888,-1.0295005244608968,0.5172413793103449,1.0,1.0,1/9,2.10%,TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),-0.6812752384091068,-1.0291167868140376,0.49206349206349204,1.0,1.0,1/5,4.49%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),-0.6812752384091068,-1.0291167868140376,0.49206349206349204,1.0,1.0,1/5,4.49%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),-0.6812752384091068,-1.0291167868140376,0.49206349206349204,1.0,1.0,1/5,4.49%,SLF1
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.5149151731831698,1.0287806795166607,0.4782608695652174,1.0,1.0,8/27,14.22%,UBC;UBB;MAPK8;CHUK;CCDC88C;NFKB1;MAP3K7;MAP2K7
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),0.6533158558725748,1.0285068826887482,0.5151515151515151,1.0,1.0,1/7,0.37%,DAO
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.5849671483457186,-1.0282161496060813,0.5081967213114754,1.0,1.0,5/11,29.17%,CLU;B4GALT6;MYRF;CNTNAP1;TENM4
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.5278669454159083,1.0281705809514343,0.4186046511627907,1.0,1.0,1/20,0.44%,SPIRE2
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.628579574761239,-1.0280286724479186,0.43333333333333335,1.0,1.0,4/13,13.14%,NEDD4L;LRRK2;SCN1B;CAV3
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.5021001327946033,-1.028005229721729,0.4492753623188406,1.0,1.0,5/45,13.87%,TRPM1;UVSSA;SLC24A1;TYR;TRIM32
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.6221752446906182,1.0278696551986684,0.4146341463414634,1.0,1.0,1/5,1.94%,LHFPL2
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),-0.6281281702387732,-1.027819112108535,0.47761194029850745,1.0,1.0,2/8,10.64%,FCHSD2;CYFIP1
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),-0.6318644744237822,-1.027667937274277,0.43333333333333335,1.0,1.0,2/6,13.03%,CARMIL1;DOCK2
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),0.6519143032104742,1.027347039067264,0.4444444444444444,1.0,1.0,2/7,13.50%,NCSTN;GALNT11
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.5538101182813663,-1.0273361755172639,0.4461538461538462,1.0,1.0,3/17,9.27%,TLR2;NCKAP1L;GATA1
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.5558371463978082,1.0271836844605797,0.46875,1.0,1.0,2/12,17.42%,DNMT1;RESF1
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.47366044661220097,-1.0269346935228925,0.4507042253521127,1.0,1.0,12/62,13.36%,EDN1;SLC8A3;ATP2B3;ATP2B2;HTR2C;SLC24A5;TPCN2;SLC8A1;HTR2B;SLC24A1;CAV1;HTR2A
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),0.6229115195493751,1.026867759912489,0.4772727272727273,1.0,1.0,3/8,5.51%,FOLH1B;AGBL1;AGBL2
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),-0.4776508469706438,-1.0268267622030909,0.44,1.0,1.0,14/59,19.07%,TGFB2;TTN;EDN1;CADPS2;FRMD4A;RAB3A;BMP6;TGFB3;RAB27B;KCNB1;MYH10;DNM1L;TGFB1;TMED10
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.6407076102742328,-1.0268053773060597,0.5357142857142857,1.0,1.0,2/8,11.60%,RFC3;RFC4
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.6407076102742328,-1.0268053773060597,0.5357142857142857,1.0,1.0,2/8,11.60%,RFC3;RFC4
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),-0.4075820884539579,-1.02664687446121,0.41333333333333333,1.0,1.0,50/206,26.02%,DACT1;SFRP4;BICC1;ANKRD6;SHISA6;PLEKHA4;IGFBP4;PSMB8;APC2;SOX9;PRICKLE1;DKK3;LRRK2;WWTR1;HECW1;KREMEN1;CAV1;GLI3;GPC5;AMER1;DAPK3;CDH3;DRAXIN;IGFBP2;ATP6AP2;PTK7;EGFR;GPC3;WNT5A;PSMC3;TGFB1;TMEM9;PRDM15;SCEL;RBX1;WLS;PPP1CA;TLE1;LYPD6;ZBED3;TMEM64;PSME1;PSMA3;CTNND2;PSMB2;MAD2L2;TMEM170B;FZD9;PSMD5;UBE2B
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.4866435912901692,-1.0266465297978307,0.4,1.0,1.0,12/57,18.91%,OLFM1;TGFB2;EPHA3;TGFBR2;EFNA1;TGFB3;WWTR1;CRB2;OVOL2;EZH2;HPN;TGFB1
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),-0.6542269763088921,-1.0264783320364828,0.4838709677419355,1.0,1.0,1/8,5.43%,SOX9
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.49117087302017487,-1.0261422861087761,0.4393939393939394,1.0,1.0,13/42,22.18%,LAMC1;ATRNL1;NTN4;TEK;NTNG1;LAMB1;EFNA1;ITGAV;NTNG2;FERMT3;LAMB4;LAMB2;ANTXR1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),-0.6227989991021643,-1.025953563257616,0.45614035087719296,1.0,1.0,2/8,5.43%,ACADL;SOX9
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.5172545960782936,1.0259060794013224,0.4,1.0,1.0,2/25,5.84%,SF3A3;PRPF4
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.610059003578876,-1.0257421400531288,0.53125,1.0,1.0,3/12,13.68%,ID2;LAPTM5;LYN
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),-0.6515551764213585,-1.0256875302564092,0.5192307692307693,1.0,1.0,1/5,12.26%,GLI3
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.586125567029224,-1.0254792364672005,0.47619047619047616,1.0,1.0,3/14,15.41%,P2RY12;RYR3;ABCC9
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.532260275599792,-1.0253168988333388,0.5,1.0,1.0,5/19,14.69%,KCNT2;ATP1B2;ATP1A1;KCNH2;KCNE1
prerank,GO_Biological_Process_2021__natural killer cell activation involved in immune response (GO:0002323),-0.6899912616326872,-1.0251007715247655,0.5555555555555556,1.0,1.0,3/5,16.13%,IFNA2;IFNK;IFNA6
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),-0.6327273241185997,-1.0244586046615298,0.5263157894736842,1.0,1.0,3/11,9.71%,VSTM2A;PIM1;FNDC5
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),-0.6097365213127007,-1.0244168918477994,0.423728813559322,1.0,1.0,3/13,9.71%,VSTM2A;PIM1;FNDC5
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.6065202558073449,-1.0243532868395846,0.5087719298245614,1.0,1.0,1/11,2.15%,DOCK8
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.49616312852463657,1.0241793937699653,0.45454545454545453,1.0,1.0,15/29,28.94%,FBP1;AKT2;BCKDK;SLC45A3;ADIPOR1;DGKQ;FOXK1;SIRT1;SIRT7;AKT1;KHK;SDHAF3;SELENOS;PRKN;USP7
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),0.5648220108573252,1.0240838660148401,0.45,1.0,1.0,2/10,11.70%,NPL;BCKDK
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.3960509727748709,1.0233317995481572,0.35135135135135137,1.0,1.0,8/97,4.77%,CXCR4;F2;TBXA2R;HMGB1;CCR3;WBP2NL;SLC35G1;KNG1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.47102566398810114,-1.0231828135559837,0.3939393939393939,1.0,1.0,11/51,18.15%,ITGB4;PROM1;CEBPD;TMC4;SLC44A3;AR;CLDN4;OVOL2;PPL;BTG1;WNT5A
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.6286917420364597,-1.0230033085889154,0.47540983606557374,1.0,1.0,1/6,14.36%,APAF1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.4054360415299805,1.0228398222922195,0.3611111111111111,1.0,1.0,13/119,10.72%,TEAD2;VDR;HDAC10;NR2C2AP;TAF13;MAML2;HDAC1;HDAC9;TAF5;TAF12;POLR2K;TEAD3;HNF4A
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.47128591508515544,-1.0225997369669206,0.4153846153846154,1.0,1.0,18/71,16.32%,BAIAP2;CCK;GAP43;NRCAM;L1CAM;SLITRK5;SLITRK4;NTNG1;GRM7;RAB3A;CDK5R1;PAK3;NREP;SLITRK3;RTN4RL2;NEFH;CNTN4;NTNG2
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.6689233609477903,-1.0225481028875258,0.5161290322580645,1.0,1.0,1/6,5.47%,DENND3
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.4220795964866119,-1.0224450609788835,0.4342105263157895,1.0,1.0,43/127,22.57%,PPARG;RHBDF2;TNFRSF1A;CYSLTR2;AOAH;TSHR;PRKAR1B;ADCY7;NLRP12;SIGLEC10;HLA-DRB1;TEK;FNDC4;NLRP3;RXFP1;FURIN;CD200;LRFN5;GPR176;LYN;ADCY8;GNG2;FCGR3A;CXCL17;ADCYAP1R1;GGT5;SYK;RAMP1;TNFRSF1B;PTH2R;NR1D1;TNFAIP6;GIT1;PLK2;PLCG1;NPSR1;HRH2;SLAMF8;VPS35;CD163;GPHB5;ADCY2;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.6754228840608467,-1.022274117767802,0.4727272727272727,1.0,1.0,4/5,29.01%,CHGA;RGS2;ADRA1A;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.5548837993375619,-1.0222440811340394,0.45901639344262296,1.0,1.0,4/14,18.94%,NCKAP1L;CAMK1D;DNM1L;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.5548837993375619,-1.0222440811340394,0.45901639344262296,1.0,1.0,4/14,18.94%,NCKAP1L;CAMK1D;DNM1L;TIRAP
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.541166972340422,-1.0222308395790667,0.47540983606557374,1.0,1.0,5/24,16.12%,CLU;LRRK2;XBP1;AQP11;CREB3L1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.5914396446644989,-1.0221670834667005,0.5,1.0,1.0,1/11,7.76%,LRRK2
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.602052805868472,1.0221399839281913,0.5,1.0,1.0,3/9,10.64%,HSPA1A;SACS;HSPA1B
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.6595246777402202,1.0217683068312198,0.5116279069767442,1.0,1.0,4/5,34.00%,PRIMPOL;SIRT7;DDX21;DDX23
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.46910201211607916,1.0217475853078615,0.4,1.0,1.0,4/44,8.40%,GPC4;TRIM67;GPC2;GBF1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.5559550344307767,-1.0215411288650877,0.4032258064516129,1.0,1.0,4/24,6.45%,PTPRM;PPARG;MEF2C;ANGPT2
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.4425378482621631,-1.0214477771696224,0.41333333333333333,1.0,1.0,18/72,14.27%,DPEP2;PTPRC;ADAM28;DOCK8;NCKAP1L;CR1;BIRC3;CD53;GMFG;SELL;SIGLEC10;P2RY14;ABCB4;STAG3;IL16;ARHGAP25;IKZF1;LY86
prerank,GO_Biological_Process_2021__response to heparin (GO:0071503),-0.6938650278207533,-1.0212319166384134,0.45,1.0,1.0,2/5,5.43%,GPIHBP1;SOX9
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.6554946619547986,-1.0209440803416174,0.543859649122807,1.0,1.0,3/6,18.67%,ADGRG1;HTR2B;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.5632511086217478,1.020863220192336,0.5151515151515151,1.0,1.0,2/11,17.42%,DNMT1;RESF1
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.5634287422568981,1.0197868280725721,0.4358974358974359,1.0,1.0,2/15,6.83%,CEP55;CHMP5
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.5230235296001657,-1.0192260735659324,0.4696969696969697,1.0,1.0,6/29,7.57%,LPL;TLR2;C5;IL6R;CSF1R;IL7
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),-0.5344045136561715,-1.0192174696416425,0.5079365079365079,1.0,1.0,12/28,26.53%,SYT1;RAB3A;SNCB;AMPH;PACSIN1;OPHN1;CDK5;SNCG;TBC1D24;SYT7;CANX;SYT2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.49901534163385464,-1.0190151046646292,0.42424242424242425,1.0,1.0,8/30,18.92%,IL12A;IL6R;ANO6;CSF1R;VEGFA;ZNF580;CXCL17;GAS6
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.5854975006795732,-1.0187845234666284,0.42105263157894735,1.0,1.0,1/13,2.10%,TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.6239000981217827,-1.0186188198309742,0.48484848484848486,1.0,1.0,3/9,21.75%,F3;PTPRJ;NDRG4
prerank,GO_Biological_Process_2021__caveolin-mediated endocytosis (GO:0072584),-0.7028159532437219,-1.0182132080464603,0.5344827586206896,1.0,1.0,2/5,20.27%,CAV1;MLC1
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.6506631295573653,-1.0181982423841625,0.5076923076923077,1.0,1.0,1/7,2.86%,TTN
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.5878460870207125,-1.018173423228984,0.5147058823529411,1.0,1.0,3/13,19.45%,RNFT1;CAV1;BCAP31
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.6840490575923336,-1.0180452027592173,0.5660377358490566,1.0,1.0,1/6,3.90%,CITED2
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.3795911542226905,-1.0180084584854212,0.43661971830985913,1.0,1.0,73/325,19.71%,ANGPT1;ROR1;PDGFD;NR4A3;BAIAP2;SLA;EPHA3;MUSK;NCKAP1L;BLNK;KALRN;MET;HGF;EPHA4;VAV3;FES;FGF22;ANGPT2;ANOS1;KIF16B;CSF1R;TEK;GFRA2;PTPRG;DDIT4;FLRT1;EFNA1;STYK1;SULF1;ATP6V1C2;CYFIP1;PLCB1;CDK5R1;PAK3;SIPA1L1;EFNA3;GRIN2B;EPHB6;UBASH3B;EPHA6;CAV2;RASA1;MPZL1;CHN1;EPHB1;ITGAV;LYN;TIE1;FLRT2;TNK2;AXL;PRKD2;DNM1;FGF7;PTPRT;GFRAL;VEGFA;EFNA5;EFNB2;EGFR;NGEF;NRG1;SYK;NCBP1;GIT1;NTRK3;STAT3;HPN;PIK3CB;ATP6V1D;PTPRJ;NEDD9;DDR2
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.39263061681782824,-1.0174984608135695,0.4533333333333333,1.0,1.0,29/176,22.38%,ROR1;TNFRSF1A;BIRC3;TRIM5;RHOC;APOL3;NLRP12;HLA-DRB1;TERF2IP;TRIM22;GJA1;HTR2B;TRIM25;NOD1;TRIM32;ALPK1;STAT1;NR1D1;WNT5A;RHOH;PLK2;TIRAP;CX3CL1;WLS;ZDHHC13;PER1;TLE1;TNFRSF10B;TRIM13
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.5025053941717321,-1.01738965708009,0.47761194029850745,1.0,1.0,11/31,15.61%,UTRN;FGF12;GLRX;NEDD4L;HECW1;SCN1B;CAV3;FGF14;YWHAH;SCN4B;NETO1
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.5226942916568305,-1.017178830431076,0.532258064516129,1.0,1.0,8/25,19.67%,RIMS1;SLC8A3;TMEM25;LRRK2;RIMS2;DLG4;NRXN1;PRKCZ
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),0.6291901258275971,1.0170369683137437,0.48,1.0,1.0,3/6,26.43%,RMI2;AXIN2;MSH3
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),-0.5717698006256358,-1.0170237742627306,0.515625,1.0,1.0,4/14,13.79%,SLC9C2;SLC5A2;SLC8A1;SLC9C1
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.47759041023525484,1.016991294389396,0.40625,1.0,1.0,5/26,14.04%,VCPKMT;ZNF335;ATPSCKMT;BEND3;KMT5B
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.4793049354561112,-1.0167511009678363,0.391304347826087,1.0,1.0,9/47,16.77%,ARHGAP18;FES;ACTN1;NRG4;LYN;DAPK3;VEGFA;EGFR;NRG1
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),-0.5591259358494653,-1.0165386161762804,0.45161290322580644,1.0,1.0,1/18,1.62%,PLSCR1
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.4297022323688693,1.0164191000771194,0.46153846153846156,1.0,1.0,11/65,7.35%,GUCA1C;PDE6A;MGLL;KCTD8;CNGB1;KLK6;DYNLT1;RGS11;PLCE1;PDE6B;GUCA1B
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.514916165789748,-1.0164050933003712,0.417910447761194,1.0,1.0,3/30,10.64%,GLRA3;GLRA2;XBP1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.5295530262813247,1.0162035341416522,0.5185185185185185,1.0,1.0,4/13,13.69%,DUSP1;NDC80;ANAPC15;TPR
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.5024605155906375,-1.016163763186479,0.40625,1.0,1.0,6/25,17.78%,ITGAM;PDZK1;CEMIP;KCNB1;KCNE1;DMTN
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.6169910918376825,-1.0161204626968319,0.4262295081967213,1.0,1.0,3/7,24.00%,ADH4;ACSS2;ADH5
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.6226009720317376,-1.016016747567481,0.5,1.0,1.0,3/9,11.75%,VIL1;CARMIL2;CARMIL1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.3790506418464875,-1.0157928376452188,0.3764705882352941,1.0,1.0,75/421,19.34%,CLDN5;TLR2;PDGFD;IL13RA1;TIMP1;TGFB2;IL12A;IL6R;KITLG;CR1;SFTPD;SPDYA;CITED2;EDN1;CIDEB;TSHR;TGFBR2;CAPN1;SOX9;ADGRG1;EPHA4;FGF22;CCND1;CSF1R;IL7;COX17;CAMK1D;CTF1;LGI1;STX3;BMP6;TGFB3;WWTR1;BST1;XBP1;CRLF1;HTR2B;IL12RB2;AQP11;CAV1;PRAME;AR;COPS9;DOCK2;ROMO1;ITGAV;LYN;LRP1;TRIM32;BMPR1B;TGFA;CDH3;PRKD2;FGF7;HPR;VEGFA;EFNB2;EGFR;OSMR;NRG1;FKBP1B;EZH2;NCBP1;TNFRSF1B;ZFP36;SERTAD1;PPP3CA;WNT5A;NTRK3;HPN;FLOT1;TGFB1;GAS6;KIF20B;PTPRJ
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.6177289576549584,1.0157203532139738,0.4722222222222222,1.0,1.0,2/7,4.18%,MALT1;NFKBIZ
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.534690842527356,-1.0154660169486003,0.47058823529411764,1.0,1.0,3/15,17.07%,MX1;DNM1;DNM1L
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),0.5944266636649223,1.0151493569194072,0.55,1.0,1.0,3/8,11.83%,SLC25A33;LYRM7;UQCRFS1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),0.5944266636649223,1.0151493569194072,0.55,1.0,1.0,3/8,11.83%,SLC25A33;LYRM7;UQCRFS1
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),-0.61815438514046,-1.0150512249319563,0.515625,1.0,1.0,3/7,21.64%,ADGRV1;LRTOMT;PDZD7
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.6306481321021082,1.014597422290146,0.4418604651162791,1.0,1.0,3/5,35.68%,ZRANB1;OTUD7A;OTUD7B
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.47540598585451443,-1.0145859115392515,0.42028985507246375,1.0,1.0,7/55,13.14%,PTPRC;CEACAM1;WWTR1;CAMK2N2;THY1;UBASH3B;CAV3
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),-0.6372234714224363,-1.0142982547065418,0.5070422535211268,1.0,1.0,2/8,14.03%,SOX9;BMPR1B
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),-0.5162575182648435,-1.014021295064344,0.5,1.0,1.0,9/38,21.12%,VIL1;DGKD;SOX9;KIF16B;TGFA;EGFR;TGFB1;PLCG1;PTPN11
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),-0.5797881390309916,-1.0138636754635257,0.4909090909090909,1.0,1.0,2/11,12.42%,KDM3A;AR
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5708950619026745,1.0137361869738264,0.4444444444444444,1.0,1.0,2/11,6.20%,CA6;TAS2R40
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.48041585783528323,1.0134670970909807,0.3548387096774194,1.0,1.0,1/38,0.14%,ABCA13
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.46076172266763715,-1.0132931685459936,0.4246575342465753,1.0,1.0,15/77,12.26%,FSTL1;FBLN1;PCOLCE;KANK2;PPARG;LRIG3;LAMC1;COL4A1;CCN5;BOC;LAMB1;WWTR1;NRG4;CAV1;GLI3
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.5698505296489805,-1.0130231717929585,0.4745762711864407,1.0,1.0,3/13,30.55%,ZFP36;ZFP36L1;DHX36
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.5698505296489805,-1.0130231717929585,0.4745762711864407,1.0,1.0,3/13,30.55%,ZFP36;ZFP36L1;DHX36
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.4257819901307942,-1.0126602934552043,0.40540540540540543,1.0,1.0,13/114,10.10%,TIMP4;ISG15;PLSCR1;SHMT2;TIMP1;IFITM3;ALDH1A2;MX1;IL6R;NLRP12;CSF1R;CHI3L1;XAF1
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.43878274129834693,-1.0122657151840804,0.4507042253521127,1.0,1.0,26/102,21.37%,MT1M;SYT1;SYT4;MEF2C;FOS;AQP1;GLRA2;ADCY7;HPCA;ADGRV1;LRRK2;RYR3;B2M;BMP6;DLG4;ADCY8;EGFR;SYT13;DMTN;WNT5A;SYT12;TRPM2;CPNE8;MT1E;ADD1;CDH1
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),0.5223011851735477,1.0122304108427518,0.4473684210526316,1.0,1.0,3/13,3.90%,PIWIL4;PIWIL2;SPOCD1
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),-0.6902764348693478,-1.0116550654582688,0.6363636363636364,1.0,1.0,2/5,4.88%,PDZK1;SLC22A4
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),-0.5257459849841553,-1.0112808090763563,0.5178571428571429,1.0,1.0,5/21,22.57%,EPHA3;DAPK3;EFNA5;CAMSAP3;VCL
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.6143378855222263,-1.0108726732722173,0.453125,1.0,1.0,1/9,1.33%,ISG15
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.5386874147640345,1.0108723322632966,0.43333333333333335,1.0,1.0,5/16,18.57%,ZNF639;CCNT1;RRP1B;SMARCA4;CTDP1
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),0.5742223450655555,1.0105763266096575,0.47368421052631576,1.0,1.0,1/8,8.90%,TAF12
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.5386641622227513,-1.0105112033724084,0.47619047619047616,1.0,1.0,1/17,0.78%,DPYS
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.43825955800173927,-1.0104643353410179,0.36619718309859156,1.0,1.0,1/70,0.05%,SLC28A2
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),-0.6277306169446475,-1.0103991039459426,0.5161290322580645,1.0,1.0,3/8,22.68%,SULF1;TBC1D8B;TMEM63C
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),-0.6581660242871226,-1.0103588715704455,0.4918032786885246,1.0,1.0,1/6,10.86%,NDP
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.6427855405424663,1.0103514012290582,0.5,1.0,1.0,2/5,13.72%,TNIP1;ITCH
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.4798746318199405,1.0103506739860297,0.37142857142857144,1.0,1.0,6/30,16.26%,ZDHHC16;ZDHHC12;ZDHHC3;ZDHHC14;HHAT;ZDHHC7
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.5236853479525594,-1.0103276827719088,0.42424242424242425,1.0,1.0,6/21,14.79%,PTPRC;RYR3;HTR2C;HTR2B;HTR2A;ITPR3
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.4887683369170074,1.0101357849328279,0.45714285714285713,1.0,1.0,8/33,17.30%,TCOF1;CAVIN1;POLR2K;ERCC2;POLR2L;UBTF;TAF1C;GTF2H5
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),-0.5849067908567824,-1.0100402391228702,0.49230769230769234,1.0,1.0,2/15,2.31%,PYGL;PPP1R3C
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.6193550841669407,-1.0099638742883827,0.5074626865671642,1.0,1.0,3/8,18.91%,MEF2C;EFNB2;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.45812679686832375,-1.0096613223091906,0.40625,1.0,1.0,8/54,17.47%,YBX3;CLU;BCL2L2;LRRK2;XBP1;TRIM32;CREB3L1;NOL3
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),0.5636613072002353,1.0096076123256954,0.4444444444444444,1.0,1.0,1/9,2.36%,LCK
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.46402624366486495,1.0095004627012047,0.4411764705882353,1.0,1.0,3/37,5.85%,BACE2;MUC4;SLC26A3
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.6656106525363408,-1.009428512786113,0.5538461538461539,1.0,1.0,2/7,17.21%,PRPS1;CTPS2
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.4845496734989792,-1.009252916000208,0.47368421052631576,1.0,1.0,5/43,5.63%,ITGB4;DUOX1;SFTPD;SMIM22;MUC16
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.687344887851493,1.0091795573262183,0.5853658536585366,1.0,1.0,1/5,3.26%,KIF3B
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.5970077404897836,1.0087996896722249,0.4634146341463415,1.0,1.0,2/6,7.49%,DSEL;DSE
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),-0.6919170201376138,-1.0085751680089208,0.532258064516129,1.0,1.0,2/5,25.90%,ZFP36;ZFP36L1
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,-0.49644441277282225,-1.0085073110202019,0.4838709677419355,1.0,1.0,1/34,0.73%,HEY1
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.5107435664665799,-1.0084173648819175,0.4852941176470588,1.0,1.0,3/23,7.18%,TTN;SMC4;NCAPH
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.4452874422455564,-1.008411718281512,0.45588235294117646,1.0,1.0,22/61,25.63%,DACT1;LRRK2;B2M;CAMK1;LRPAP1;CAV1;ZFPM1;MAP2;IFIT1;CARD18;DISC1;EFHB;CDKN1A;IFIT2;PPP1CA;DDX11;PRKCD;ITGB1BP1;RALB;AURKA;ADRB2;CTSZ
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.587065432329309,-1.0082043344906342,0.5087719298245614,1.0,1.0,2/11,13.20%,STX3;TMEM35A
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.5299539428160005,-1.0080845953605275,0.4461538461538462,1.0,1.0,7/17,32.09%,SMPD3;VPS4B;SDC4;ATP9A;SDCBP;TSG101;VPS4A
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.5788350092910914,1.0079719954995474,0.5,1.0,1.0,1/10,1.30%,CHRNA4
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.5847760063514288,-1.007879582619387,0.5081967213114754,1.0,1.0,3/10,24.45%,SAR1A;BCAP31;EDEM1
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.4639374665249973,-1.0074125471991446,0.43103448275862066,1.0,1.0,13/58,13.46%,DPEP2;PTPRC;EPSTI1;ARHGAP15;SLA;CD53;GMFG;SELL;CXCR6;IL16;ARHGAP25;IKZF1;ITK
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.518583133938866,-1.0073189929062034,0.4657534246575342,1.0,1.0,5/24,12.42%,TGFB2;TGFB3;ATP1A1;CAV1;AR
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.4748914764186374,1.0072205053210552,0.41935483870967744,1.0,1.0,1/28,0.68%,NUPR1
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.4446315774197821,1.0067387048882128,0.5,1.0,1.0,16/40,27.50%,NASP;HDAC1;ACTR5;GATAD2B;SMARCA4;RBBP4;CHD4;RNF8;DMAP1;SPTY2D1;HNRNPC;ARID1B;SMARCA5;PBRM1;ACTL6A;ERCC6
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.5881598387664818,-1.0067155659796576,0.47540983606557374,1.0,1.0,3/8,31.59%,OXSM;PCCB;MCEE
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.39197673477080713,1.0066984210330616,0.5357142857142857,1.0,1.0,18/104,11.99%,ETV5;CYBA;PYCR1;HSPA1A;PLA2R1;SOD3;ATF4;PRDX6;CAT;TMEM161A;KEAP1;ABL1;VKORC1L1;HSPA1B;PRR5L;RAD52;MAPK8;CHUK
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5590119220111816,-1.0063096924325061,0.4716981132075472,1.0,1.0,5/12,15.53%,SCN1B;CAV3;KCNH2;KCNE1;SCN4B
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.5677185480179887,1.0060204143640767,0.5,1.0,1.0,4/16,14.00%,EPHB4;SLIT2;GREM1;MIA3
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.4468696933287518,-1.0059842237302017,0.4626865671641791,1.0,1.0,19/62,26.17%,YBX3;GBP2;GBP3;CHI3L1;ADAMTS7;TRIM32;BRCA1;GGT5;ZFP36;NR1D1;CX3CL1;PID1;BAG4;CXCL16;ADAM9;ZFAND6;ZFP36L1;SELE;NPNT
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.5486127332308193,1.0056479925956803,0.3888888888888889,1.0,1.0,2/10,1.45%,AGER;CD274
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.4840139095201822,-1.0055889494984023,0.4166666666666667,1.0,1.0,9/29,17.66%,PLSCR1;DDX60;BMP6;NMI;IFNK;IFI35;LY86;SCIMP;SLC15A4
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.5792627214577323,1.0053977892329309,0.4838709677419355,1.0,1.0,5/11,24.50%,DKC1;CCT8;CCT2;CCT6A;CCT3
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.4420160111750405,1.0053362266105401,0.45454545454545453,1.0,1.0,8/46,4.69%,CXCR4;CD38;ZAP70;ITGAL;IL2RA;EVI2B;GPR174;CD247
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.6055836112375643,-1.0050734307641123,0.5076923076923077,1.0,1.0,3/7,23.62%,STAT3;TGFB1;ESR1
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.5095693429309569,-1.0049469844352146,0.4915254237288136,1.0,1.0,4/24,23.40%,TERF2IP;H1-0;CDKN1A;ZNF93
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.6713000565637074,-1.0049348237675362,0.5333333333333333,1.0,1.0,4/7,25.68%,CD200;LRFN5;IL31RA;HAVCR2
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.40100155730096665,-1.00483560946166,0.44776119402985076,1.0,1.0,50/177,19.01%,LRTM1;GFRA3;PTPRM;SEMA3E;ROBO4;EPHA3;GAP43;DOK6;EMB;L1CAM;ROBO2;NTN4;EPHA4;ANOS1;SEMA3D;GFRA2;LGI1;EFNA1;PALLD;CYFIP1;CDK5R1;EFNA3;SPTB;EPHB6;DOK1;EPHA6;VSTM2L;SEMA4G;SCN1B;CHN1;EPHB1;PRKCQ;NOTCH2;DRAXIN;VEGFA;EFNA5;CNTN4;DAB1;EFNB2;OPHN1;SIAH1;UNC5D;WNT5A;NRXN1;RHOH;PLXNC1;SEMA4B;PIK3CB;TNR;PLCG1
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.4695726060801606,1.004675215125534,0.35135135135135137,1.0,1.0,6/21,15.17%,SLC38A1;SLC38A2;LLGL2;SLC38A3;SLC7A5;SLC3A2
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),-0.5517338635753912,-1.0046181288974134,0.453125,1.0,1.0,4/19,18.18%,MUSK;LRRC4;DLG4;NRXN1
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),-0.6529699624490549,-1.0045506433439688,0.5555555555555556,1.0,1.0,2/5,24.94%,GRM7;SLC43A1
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.40932858684468687,1.0045320787002845,0.3333333333333333,1.0,1.0,13/70,19.98%,HSPA1A;SLC38A2;JMJD6;PTBP1;RBM23;RRP1B;AHNAK2;AFF2;RBM12B;HNRNPH1;TMBIM6;CELF1;RBM22
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),-0.6387583037658291,-1.0040453847038389,0.45901639344262296,1.0,1.0,3/7,18.61%,MEF2C;BMPR1B;TRPV4
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.36766535636890074,1.0036639997974073,0.41379310344827586,1.0,1.0,24/182,12.92%,CXCR4;NUPR1;DHFR;SQLE;MTHFD2L;SC5D;DHCR24;SLC7A11;HMGCS1;HPRT1;CYB5B;SERPINH1;GGA2;HMGCR;PSMD13;GLA;TUBG1;CCNG1;MTHFD2;IDI1;TMEM97;NIBAN1;LTA4H;SLC7A5
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),-0.619401261070401,-1.0036026242817695,0.5,1.0,1.0,3/7,14.69%,KCNT2;KCNH2;KCNE1
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),-0.48799739269539166,-1.0035388013034814,0.4603174603174603,1.0,1.0,11/57,19.01%,VIL1;DGKD;SOX9;KIF16B;NRG4;TGFA;PTPRR;EGFR;NRG1;TGFB1;PLCG1
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.6455157867486435,-1.0033732483450697,0.543859649122807,1.0,1.0,2/9,16.88%,NOS1;GPR37L1
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.5210091460025436,1.0027894498746668,0.4411764705882353,1.0,1.0,7/16,17.98%,GPC4;PTPRD;IL1RAPL1;SLITRK2;SNCA;LRFN4;MDGA1
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.5210091460025436,1.0027894498746668,0.4411764705882353,1.0,1.0,7/16,17.98%,GPC4;PTPRD;IL1RAPL1;SLITRK2;SNCA;LRFN4;MDGA1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.4361239077149233,-1.0027371455131384,0.40789473684210525,1.0,1.0,14/82,7.42%,FSTL1;MMRN2;TLR2;ADAMTS5;ROBO4;SERPING1;OLFML2B;ACTA2;FAP;AQP1;COL4A1;CALB2;DKK3;TEK
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.5832967381560127,-1.0027361809306727,0.5362318840579711,1.0,1.0,6/11,34.98%,NCBP1;LEO1;ZFP36L1;NCBP2;DHX36;PAF1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.6190964656016748,1.0023572909697178,0.525,1.0,1.0,3/6,15.39%,ZDHHC12;ZDHHC3;NLGN2
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.555707909746002,-1.0022606241284946,0.4406779661016949,1.0,1.0,3/16,3.87%,VSIR;CR1;IRF1
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.46524970029402624,-1.0021160746607605,0.5538461538461539,1.0,1.0,13/58,20.44%,HEY1;HOPX;SOX9;RPS6KA6;CST3;THY1;PRAME;GRIN3A;TGFB1;GAS6;KIAA0319;ALPK2;SPI1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),-0.4144287707910774,-1.0021135573592213,0.5,1.0,1.0,20/71,20.50%,CACNA1E;TRPC4;SLC8A3;NMUR2;ATP2B2;TUSC3;RYR3;CACNA1B;SLC8A1;CACNG8;SLC24A1;CAV1;CACNG3;CDH23;NIPAL2;RAMP1;GRIN3A;TRPV4;TRPM2;CACNA1C
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5734321650902684,-1.0020639575337658,0.4788732394366197,1.0,1.0,6/13,12.10%,PKP2;GJC3;GJA1;SLC8A1;ATP1B2;ATP1A1
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.6644719050709019,1.0020631770391712,0.6,1.0,1.0,2/7,23.87%,MIA3;AKT1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),-0.6531658264416187,-1.0018892052930275,0.4642857142857143,1.0,1.0,2/5,34.12%,TMEM33;ATL3
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.6431109309341834,1.0018334907159057,0.5,1.0,1.0,3/7,11.87%,CYBA;MFHAS1;TLR1
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.6350100358369457,-1.0018327737579764,0.4827586206896552,1.0,1.0,2/6,13.14%,TTN;CAV3
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.6051588312058729,1.0017729103789907,0.4634146341463415,1.0,1.0,1/8,4.16%,GRAMD2A
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.6041792739913767,1.0017717505199328,0.43243243243243246,1.0,1.0,4/9,20.06%,RIPPLY2;CXXC4;COBL;STIL
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.5445823812126049,-1.0017493993870268,0.5263157894736842,1.0,1.0,7/19,13.68%,GSAP;CLU;EPHA4;EFNA1;LRRTM3;EFNA3;LYN
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),0.5825781075514586,1.0017355690898462,0.5,1.0,1.0,3/7,18.53%,USH1C;ERCC2;USH2A
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.4501420131108344,1.0016069404752173,0.375,1.0,1.0,5/44,9.02%,F2;DCXR;SPHK2;PLIN5;SLC25A33
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),-0.5791171145140561,-1.0012833205265708,0.5094339622641509,1.0,1.0,4/12,15.59%,MYO7A;THY1;CRB2;VEGFA
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.5954783190538422,1.0009862469275532,0.4807692307692308,1.0,1.0,3/9,17.06%,EHD2;ACTN2;INPP5F
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.6493827515943275,-1.0005963342019268,0.5245901639344263,1.0,1.0,2/6,21.68%,TOMM7;ATP5IF1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.5450952233808619,-1.0004949685045195,0.54,1.0,1.0,2/14,7.14%,LAPTM5;FGL1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.4062885530558168,-1.0000507154121876,0.47692307692307695,1.0,1.0,37/247,18.98%,ANGPT1;GFRA3;NEFL;KITLG;RIT2;MEF2C;PSMB8;SOX9;MET;HGF;FGF22;MAP3K5;TEK;LRRK2;GFRA2;SCG2;IL3RA;HTR2B;GRIN2B;SPTB;NRG4;RASA1;RASA3;WDR83;ITGAV;PRKCQ;DLG4;TGFA;FGF7;LRRC7;EGFR;NRG1;ZFP36;PSMC3;TGFB1;CAMK2B;PIK3CB
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.42644510196851226,0.999743627897339,0.4444444444444444,1.0,1.0,11/72,7.04%,F2;C6;RNF128;F11;EYA4;MTTP;GRAMD2A;ENPEP;CLDN2;ABCA8;GJB1
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.3995418039009885,-0.9995768265674363,0.4794520547945205,1.0,1.0,12/180,10.39%,ANGPT1;LPL;SPARCL1;PPARG;STAT5A;ACADL;COL4A1;NMT1;MTARC2;PTGER3;DGAT1;TST
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5482756831722367,0.9995511067160401,0.4,1.0,1.0,4/10,20.17%,ERRFI1;VPS25;SOCS4;CBLB
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.6422407765617129,0.9993289996815249,0.5384615384615384,1.0,1.0,4/8,4.03%,CD274;TARM1;HMGB1;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.5218878488108546,-0.9993045462551831,0.5147058823529411,1.0,1.0,4/18,13.06%,NLRP12;NLRP3;NMI;IFI35
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.4664415694919075,-0.9989757255787397,0.5483870967741935,1.0,1.0,4/25,8.28%,TGFB2;MEF2C;SOX9;SGMS2
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.47583740614618153,-0.9989127398117239,0.5074626865671642,1.0,1.0,2/37,8.77%,NR4A3;ME3
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.6628167822912223,-0.9987607922576177,0.5,1.0,1.0,3/8,11.47%,ANK1;LIN7A;CRB2
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.6628167822912223,-0.9987607922576177,0.5,1.0,1.0,3/8,11.47%,ANK1;LIN7A;CRB2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),-0.65331167402762,-0.9987332837763525,0.5076923076923077,1.0,1.0,3/5,13.36%,HTR2C;HTR2B;HTR2A
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.6204800093295171,-0.9980827767213019,0.5625,1.0,1.0,1/10,1.52%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.5184101462145205,-0.9980582893186989,0.4520547945205479,1.0,1.0,5/26,13.56%,TGFB2;INHBC;BMP6;TGFB3;RBPMS
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),-0.6513960215259917,-0.9974491554656078,0.5161290322580645,1.0,1.0,1/7,15.79%,TRERF1
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.5274558777181781,0.9973831139688832,0.5135135135135135,1.0,1.0,3/22,8.56%,BPIFB1;MFHAS1;RAB7B
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.4297307544879493,-0.9973653080325788,0.4383561643835616,1.0,1.0,12/54,24.51%,FOS;AQP1;MAP3K5;ROMO1;ZNF580;EGFR;TRPM2;TPM1;PRKCD;PPIF;IMPACT;PDK2
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.5251749397414376,-0.9972688536231564,0.5172413793103449,1.0,1.0,7/24,21.58%,ITGAM;ARHGAP25;XKR4;RHOH;MSR1;GULP1;ARHGAP12
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.5157551222246428,0.9972070295045373,0.4864864864864865,1.0,1.0,4/20,17.30%,UBC;UBB;ERCC2;GTF2H5
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.47828322408106655,-0.9970341054239475,0.5079365079365079,1.0,1.0,13/40,23.66%,KLF9;GLRA2;ADCY7;ADCY8;GNG2;BRCA1;MLC1;GRAMD1C;CDH1;ADCY2;GLRA1;MAP4K1;ADCY1
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.4270357524836656,-0.9968424502346303,0.4666666666666667,1.0,1.0,24/79,17.24%,FGL2;ADAM28;RASSF4;GSAP;FMO5;C1QB;CHL1;CSF1R;ANKUB1;LRRK2;HLA-DPB1;ALDH1L1;SLC8A1;DDO;APOBEC4;C1QC;L3MBTL4;CP;HNMT;KCNE1;SMIM14;OMG;ERICH3;SLCO2B1
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.47106901783153127,0.9968250226653826,0.375,1.0,1.0,6/20,13.33%,SPRY2;USF3;SPRED1;SPRED2;BMP5;ADIPOR1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.44251759006847535,-0.9967666327307764,0.546875,1.0,1.0,22/121,12.15%,FSTL1;NOSTRIN;ADAMTS5;HOPX;ROBO4;AKAP12;ACTA2;PLSCR4;FAP;MEF2C;COL4A1;ANGPT2;DKK3;FILIP1L;ACTN1;TEK;GJA1;PALLD;SULF1;THY1;SH3BGRL;C1R
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.40515421408874713,0.9965686628025119,0.42857142857142855,1.0,1.0,8/84,4.88%,GJC1;TNNC2;CRYAB;MYH4;MYOF;MYH3;CASQ2;TPM2
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.4942115579902553,0.9960192700134607,0.4375,1.0,1.0,2/25,5.12%,ICAM1;RAPGEF1
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.6457654159396088,-0.9959071261216297,0.5079365079365079,1.0,1.0,2/7,10.88%,TTN;HTR2B
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),-0.6807995650830659,-0.9956854605832637,0.6181818181818182,1.0,1.0,2/5,18.18%,LRRC4;NRXN1
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.5123940348647243,0.9954604908893094,0.3939393939393939,1.0,1.0,1/22,0.27%,AMPD1
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.3640016683543926,-0.9953007725338763,0.475,1.0,1.0,87/535,18.39%,CLDN5;KANK2;IGFBP3;PDGFD;TP53I11;SFRP4;NR4A3;IL13RA1;TRNP1;TIMP1;TGFB2;ALDH1A2;CLU;STAT5A;SSTR1;WDR6;IL6R;KITLG;CR1;NOX4;SPDYA;SMIM22;IRF1;EDN1;FABP3;ID2;TSHR;TGFBR2;CAPN1;SOX9;P3H2;ADGRG1;FES;FGF22;DDAH1;CSF1R;MYO16;IL7;COX17;TMIGD3;CTF1;LDOC1;STX3;BMP6;TGFB3;WWTR1;BST1;INCA1;XBP1;CRLF1;HTR2B;IL12RB2;CDH13;AQP11;CD200;RERG;NMI;PRAME;AR;IFNK;COPS9;IFI35;CHRM1;ROMO1;ITGAV;LYN;UHRF1;TGFA;JAG2;CDKN3;FGF7;TP53INP1;VEGFA;STAT1;EFNB2;EGFR;OSMR;NRG1;OSGIN1;CDKN1A;EZH2;ELN;BTG1;SERTAD1;NEURL1;NTRK3;STAT3
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.592720224525719,-0.9951565696899667,0.4918032786885246,1.0,1.0,2/9,21.97%,DNM1L;VPS35
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.5527240119035803,0.9951356040902987,0.4634146341463415,1.0,1.0,4/13,5.87%,ICAM1;CFH;CYBA;NOX1
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.5774627728985152,0.9950820660081117,0.5142857142857142,1.0,1.0,2/8,5.04%,CD247;TGM1
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.6183713189442682,0.9948066775410614,0.48936170212765956,1.0,1.0,2/6,13.68%,NOC2L;BCL10
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.621256604341842,0.9946598249783917,0.46153846153846156,1.0,1.0,2/6,8.01%,NT5E;HPRT1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.5828581218533093,-0.9944585364988973,0.5166666666666667,1.0,1.0,4/13,17.24%,NR4A3;ANO6;AZIN1;ACSL5
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.5581661854194669,0.9944575210151941,0.5588235294117647,1.0,1.0,5/14,17.08%,DHFR;SPHK2;QDPR;ACER3;GCH1
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.43614704154123374,-0.9944409573113019,0.421875,1.0,1.0,18/88,21.20%,DACT1;APC2;NEDD4L;FURIN;HECW1;EEF1A2;TRIM32;AZIN1;C4BPA;EGFR;GPC3;WNT5A;OAZ3;PLK2;MAD2L1;TMEM9;DTL;PRKCG
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),0.6058322400569098,0.9943971620679495,0.5526315789473685,1.0,1.0,3/8,16.30%,GTF3C5;GTF3C6;POLR2L
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.5290389504585334,0.9937344737287346,0.5,1.0,1.0,8/24,20.80%,EXOSC8;NUDT16L1;TRIR;TENT4B;EXOSC7;DIS3;LIN28B;EXOSC5
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.5229200948782433,-0.993693947274896,0.43548387096774194,1.0,1.0,5/20,18.91%,TGFBR2;CAV1;RASA1;VEGFA;TGFB1
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.4478012909912596,0.9934944209713825,0.41379310344827586,1.0,1.0,15/41,22.22%,EYA4;H2AX;RNF168;TMEM161A;BRCC3;RAD52;UBE2N;POLH;UIMC1;DHX9;RNF8;RPS3;AXIN2;SIRT1;SIRT7
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.5711246702659644,-0.9932805282945346,0.5,1.0,1.0,3/14,11.75%,CSF1R;CYFIP1;CARMIL1
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.42793795739561147,-0.9931917325094732,0.4583333333333333,1.0,1.0,20/119,18.47%,ARHGAP18;ARHGAP15;ARHGAP4;A2M;RHOC;KALRN;VAV3;ARHGAP28;ARHGDIG;ARHGAP31;ARHGAP25;CHN1;ITGAV;RAC3;OPHN1;NGEF;ARHGAP10;DEPDC1B;SRGAP1;RHOH
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.5400591837588247,-0.9931898889186473,0.515625,1.0,1.0,4/14,10.76%,IGFBP3;MEF2C;BOC;PLCB1
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.6609956597856844,-0.9931364630337419,0.5517241379310345,1.0,1.0,4/5,33.90%,ABCA1;ABCA12;APOE;ABCA7
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.6078223631956223,-0.9930531623374407,0.5862068965517241,1.0,1.0,1/7,8.77%,ME3
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.5796552259205296,-0.9930274532002397,0.4666666666666667,1.0,1.0,3/9,24.00%,ADH4;ACSS2;ADH5
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.6319044618312515,-0.99302372147897,0.5483870967741935,1.0,1.0,3/7,33.08%,DNM1L;CHMP4B;CORO1C
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.477094627945147,-0.9929712230138769,0.4461538461538462,1.0,1.0,9/47,22.05%,PPARG;FABP3;PNPLA1;XBP1;ABCB4;RBP1;PNPLA2;ABCA1;USF2
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.4450944917249886,-0.9927288820408358,0.4927536231884058,1.0,1.0,17/75,24.38%,FBLN1;IGFBP3;LRRK2;TERF2IP;WWTR1;SH3GL2;LYN;PPP1R15A;PTPN13;NTRK3;TGFB1;PID1;ZBED3;IMPACT;INSM1;WARS1;CADM4
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.6821457124249058,0.9926906346259304,0.5,1.0,1.0,2/6,13.79%,KDM1B;DNMT3A
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),0.6198238210483683,0.9923547785423261,0.5,1.0,1.0,1/7,4.42%,ASAP1
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.5260194397218301,-0.9923449332924921,0.5161290322580645,1.0,1.0,3/18,12.46%,MEF2C;CAV1;CAV2
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.4032101802993754,-0.9923391665730761,0.5068493150684932,1.0,1.0,24/148,14.32%,TLR2;IRGM;ISG15;PPARG;SHMT2;H2BC11;HLA-E;IFITM3;SLA;MX1;CR1;SFTPD;TRIM5;FES;TRIM22;B2M;CHGA;STYK1;CX3CR1;TRIM25;LYN;TRIM32;ALPK1;TNK2
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3623349746558918,0.9923011101729625,0.3181818181818182,1.0,1.0,56/233,23.34%,U2AF1;SF3A3;LSM7;RNF113A;PRPF4;SF3B2;CRNKL1;RALY;PTBP1;PCF11;SNRPC;RBM8A;CPSF4;POLR2K;CSTF2;SNRNP25;SYMPK;GEMIN6;PPIL1;CCAR1;HNRNPU;PDCD7;RBM17;DNAJC8;POLR2L;HNRNPH1;CWC27;YBX1;SNIP1;RBM15B;DHX9;SRSF8;GEMIN5;SF3A2;HNRNPA2B1;CDC5L;DDX5;SNRNP35;RBM22;RBM5;SF3A1;CSTF1;MAGOH;ALYREF;POLR2E;ZMAT2;HNRNPR;SNRPB;SRSF9;HNRNPC;BCAS2;HNRNPM;GPATCH1;POLR2D;PUF60;TRA2A
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.6349039035870787,-0.9920742195323646,0.5370370370370371,1.0,1.0,3/5,30.78%,SLC7A8;SLC6A9;SLC6A17
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.4647337060551786,0.9920402093177018,0.3548387096774194,1.0,1.0,2/21,6.51%,TUBA1A;TUBA1C
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.533976744464042,-0.991872630457329,0.484375,1.0,1.0,3/23,10.68%,VIL1;TWF2;TMSB10
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.4964237589801895,-0.991710951047336,0.46875,1.0,1.0,9/34,19.76%,PLEKHA2;UTRN;TEK;THY1;CDH13;VEGFA;SKAP1;PTPRJ;CX3CL1
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.6216103875807768,0.9916651889666035,0.5517241379310345,1.0,1.0,3/6,30.23%,USP7;USP15;BAP1
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.4587087494303451,-0.991663938270029,0.4166666666666667,1.0,1.0,2/57,1.49%,F8;CD59
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.4587087494303451,-0.991663938270029,0.4166666666666667,1.0,1.0,2/57,1.49%,F8;CD59
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.4587087494303451,-0.991663938270029,0.4166666666666667,1.0,1.0,2/57,1.49%,F8;CD59
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.6142436643324682,0.9916258858428841,0.5,1.0,1.0,1/7,6.31%,NCSTN
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.5024155864697644,-0.9915125873628988,0.45588235294117646,1.0,1.0,11/29,19.10%,NEFL;MEF2C;CAPN1;GRIN2B;GRIA3;GRIA1;DLG4;DAPK1;LRRC7;CAMK2B;OPRM1
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),0.634654414360703,0.9910143422415919,0.5882352941176471,1.0,1.0,1/7,0.98%,PM20D1
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.38604826147132243,-0.9909184600995653,0.5128205128205128,1.0,1.0,58/377,18.47%,GPAT3;ARHGAP18;AKAP12;ARHGAP15;PAK5;RIT2;BIRC3;RMI1;TP73;ARHGAP4;PRKAR1B;A2M;RPA3;RHOC;NLRP12;KALRN;RFC3;VAV3;CEACAM1;RAD9A;TEK;LRRK2;DDIT4;TAF10;ARHGAP28;ARHGDIG;BST1;CDK5R1;PAK3;RFC4;ARHGAP31;ARHGAP25;CHN1;ITGAV;LYN;PIP5K1B;PRKD2;WRN;TP53INP1;RAC3;VEGFA;BRCA1;PRDM1;ATP6AP2;OPHN1;RAD50;EGFR;NGEF;ARHGAP10;SLC15A4;CDK5;PRKAB2;PTPN13;WNT5A;DEPDC1B;NTRK3;SRGAP1;RHOH
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),-0.5592359781717395,-0.9909175262568666,0.5538461538461539,1.0,1.0,5/14,19.76%,NLRP3;CX3CR1;CARD18;GIT1;CX3CL1
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.4243872153231574,-0.9908106199520087,0.46153846153846156,1.0,1.0,24/137,15.99%,CLDN5;PTPRM;SEMA3E;PPARG;TGFB2;F3;AQP1;CEACAM1;TEK;NINJ1;CHI3L1;SULF1;XBP1;CD160;EFNA3;PDE3B;TIE1;CNMD;PRKD2;BMPER;VEGFA;PGK1;BRCA1;STAT1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),0.5892921687922713,0.9907423815769428,0.5882352941176471,1.0,1.0,2/7,5.22%,CNGB1;EYS
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),0.5892921687922713,0.9907423815769428,0.5882352941176471,1.0,1.0,2/7,5.22%,CNGB1;EYS
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.603345318714422,-0.9903077162703091,0.4727272727272727,1.0,1.0,2/8,11.27%,VIL1;PLEKHH2
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.5301164072877922,-0.9902528288534121,0.4426229508196721,1.0,1.0,3/30,10.79%,PEX11A;VAV3;RIN3
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.5129623593828956,-0.9901291773586621,0.5,1.0,1.0,11/33,24.41%,CENPK;MIS18BP1;CENPA;CENPL;CENPQ;HIRA;ITGB3BP;OIP5;CENPI;CENPP;HAT1
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),-0.5555061488060812,-0.9900362525242247,0.5666666666666667,1.0,1.0,7/19,22.80%,SLC8A3;SOX9;EIF2B4;PTPRZ1;CDK5;EIF2B2;MYRF
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),-0.6375717069737696,-0.9899639965632001,0.5172413793103449,1.0,1.0,3/5,25.81%,DDAH1;NOL3;HYOU1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.41535781413224904,-0.9895329810987142,0.44285714285714284,1.0,1.0,19/111,20.20%,ITGAM;MX1;SFTPD;AMN;FCHSD2;TPCN2;CAV1;CAV2;SCARB1;LRP1;DNM1;HPR;SYK;RAMP1;LILRB1;MSR1;MRC1;COLEC12;FNBP1L
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),0.6215778982009147,0.9894833166257982,0.5111111111111111,1.0,1.0,3/5,34.79%,SALL1;ERBB3;CHD7
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),-0.6397428256243678,-0.9893465672738428,0.5606060606060606,1.0,1.0,5/6,28.39%,LAPTM5;DAPK1;SPI1;DLEC1;RBMS3
prerank,GO_Biological_Process_2021__positive regulation of calcium-mediated signaling (GO:0050850),-0.6360348471368691,-0.9893288742552094,0.58,1.0,1.0,1/5,11.53%,CDH13
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.6528591443439064,-0.9892683919805261,0.5555555555555556,1.0,1.0,2/5,28.80%,VEGFA;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),-0.6223717537926012,-0.9890734276046076,0.5,1.0,1.0,3/5,18.91%,MEF2C;EFNB2;TGFB1
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.3614178371992876,0.9887974657291502,0.36,1.0,1.0,25/195,10.09%,CFAP61;FBF1;TMEM138;KIF3B;CNGB1;TTC29;ASAP1;CFAP43;EHD2;FHDC1;PTPDC1;RILP;PCM1;FLNA;CILK1;CFAP70;FAM161B;GBF1;WDR90;EXOC7;TCTN3;MKS1;CFAP54;CEP290;TMEM216
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),-0.5249429979994401,-0.9887760015262143,0.42857142857142855,1.0,1.0,4/15,18.18%,ASTN1;CDK5R1;CNTN4;NRXN1
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.5256848483835389,-0.9886941506503993,0.49230769230769234,1.0,1.0,2/19,3.42%,FMO5;ACADL
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.4328724088585424,-0.9883182915089946,0.4925373134328358,1.0,1.0,27/114,15.62%,SEMA3E;CBLN2;C1QB;MUSK;NRCAM;SLC8A3;L1CAM;LRRC4;GPM6A;UNC13C;LRRK2;GRM5;NTNG1;PCDHB4;CACNB1;SNCB;CYFIP1;CX3CR1;PAK3;PCDHB11;LRFN5;C1QC;SLITRK3;GPC6;PCDHB9;CACNB2;MYOT
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.5245164330948613,-0.9882547635365772,0.5873015873015873,1.0,1.0,9/25,24.06%,CENPK;MIS18BP1;CENPA;CENPL;CENPQ;ITGB3BP;OIP5;CENPI;CENPP
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.5245164330948613,-0.9882547635365772,0.5873015873015873,1.0,1.0,9/25,24.06%,CENPK;MIS18BP1;CENPA;CENPL;CENPQ;ITGB3BP;OIP5;CENPI;CENPP
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.5216335863335496,-0.9880693982829585,0.4838709677419355,1.0,1.0,6/20,14.79%,PTPRC;RYR3;HTR2C;HTR2B;HTR2A;ITPR3
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.5219633194274687,-0.9880118920755496,0.4375,1.0,1.0,5/20,16.36%,PDGFD;CALM3;VEGFA;TOM1L1;RAD50
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.5411917366293663,0.9878619542056909,0.5,1.0,1.0,4/9,27.05%,DERL3;UBE2G2;ERLEC1;YOD1
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),-0.5167670400965206,-0.9874935680303847,0.5396825396825397,1.0,1.0,7/18,23.59%,SEMA3E;SEMA3D;SEMA4G;SEMA4B;SEMA6A;SEMA7A;SEMA6B
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),-0.6551249630773488,-0.9869559338056753,0.6,1.0,1.0,4/5,32.58%,KYNU;CDKN2D;ALPL;HLCS
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.6211883711407613,0.9867551488699592,0.5833333333333334,1.0,1.0,2/5,14.06%,NCK1;DDX3X
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.5273694661884181,0.9867123623623073,0.4722222222222222,1.0,1.0,4/10,27.05%,DERL3;UBE2G2;ERLEC1;YOD1
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.6309100850695245,-0.986702292473034,0.5223880597014925,1.0,1.0,1/6,12.64%,ATP23
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),-0.6478239293776255,-0.9865043884702304,0.47368421052631576,1.0,1.0,3/5,25.79%,MESP1;HES1;HEY2
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.5869164591427468,0.9863911820262579,0.5405405405405406,1.0,1.0,1/9,0.53%,GJC1
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.5540554014982346,0.9862285105543195,0.375,1.0,1.0,2/9,4.10%,ABCC2;ABCC1
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.3998847986704936,0.9861659682555364,0.45161290322580644,1.0,1.0,27/94,23.63%,U2AF1;RAE1;NUP42;NUP210;RBM8A;CPSF4;SYMPK;TPR;NXF1;EIF4E;NUP37;RBM15B;SARNP;HNRNPA2B1;ENY2;THOC2;NDC1;IWS1;MAGOH;SMG5;ALYREF;SEH1L;SRSF9;POLR2D;NUP85;NUP214;FYTTD1
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),-0.5237243486670404,-0.9861305091865297,0.5,1.0,1.0,9/25,24.85%,TSHR;ADCY7;TMIGD3;RXFP1;ADCY8;ADCY2;P2RY11;ADCY1;ADRB2
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.44803898799720354,0.9859412714445177,0.40625,1.0,1.0,5/30,9.96%,SLC22A6;SLC26A3;LRRC8A;SLC26A7;SLC22A24
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.6421660357105994,0.9856234195820528,0.5757575757575758,1.0,1.0,2/7,9.27%,WNK4;ATP1B1
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.5130518275460937,0.9852239359207979,0.5,1.0,1.0,2/10,14.49%,KLRF2;CLEC2A
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.4965344194624164,-0.9848729415749059,0.47761194029850745,1.0,1.0,7/33,18.91%,IRGM;CEMIP;CHI3L1;DDIT4;CALM3;DMTN;TGFB1
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),0.35733337786632474,0.9846890806539761,0.46875,1.0,1.0,46/190,22.12%,ADAT1;POP5;DICER1;RCL1;BYSL;MDN1;DCAF13;PIH1D1;RRP12;EXOSC8;NOL8;PRKRA;INTS8;DKC1;ESF1;PELP1;NOLC1;RPL18A;RRP1B;RRP36;MPHOSPH10;KRR1;RPL23A;WDR74;UTP3;EXOSC7;NOL11;HNRNPA2B1;RPL3;DDX10;RPL13;DIS3;UTP6;WDR36;RPL11;PUS10;LIN28B;PWP2;EXOSC5;RPL8;NOP56;RPL32;RPL21;RPS16;POP4;KARS1
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),-0.6513995415707443,-0.9846566867627324,0.5094339622641509,1.0,1.0,1/5,2.59%,ITGAM
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.49732899257037394,-0.9844807169038582,0.5074626865671642,1.0,1.0,4/28,9.20%,GUCY1A1;SERPING1;C3AR1;PLN
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.6200306862214284,-0.9843167320997561,0.4918032786885246,1.0,1.0,2/8,14.82%,MAP2;NEFH
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.40257407573459913,-0.9841801152007584,0.47761194029850745,1.0,1.0,36/161,21.69%,LPL;NUDT11;PTPRC;IMPA2;HDHD2;PLPPR5;PLCB3;NUDT4;INPP4B;LRRK2;PLPPR3;PFKFB2;PLCB1;HTR2B;PLAAT4;ITPKA;PLCB4;TNK2;INPP5D;PTPRB;PGK1;CDK5;PPP3CA;STAT3;GPX4;PFKM;TGFB1;PIK3CB;PLCG1;ITPK1;PLPPR1;GPI;PRKCG;TPTE2;PPP1CA;PLB1
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),0.545324922608403,0.9839492471037908,0.45454545454545453,1.0,1.0,5/15,16.79%,M1AP;NOC2L;BANF1;CHAF1B;RBBP4
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.4692687370265742,-0.9836274353870922,0.45901639344262296,1.0,1.0,14/50,15.96%,PTPRM;ROBO4;EMB;L1CAM;ROBO2;CADM3;CEACAM1;PALLD;TENM3;CDH13;VSTM2L;PTPRT;MYOT;CNTN4
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),-0.6766789962409088,-0.9834463421882743,0.5573770491803278,1.0,1.0,2/6,8.30%,EPHA4;OPALIN
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.49469784998296595,0.9834225168090509,0.36363636363636365,1.0,1.0,3/16,17.69%,SPHK2;EPC1;DMAP1
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.5038990060990789,-0.9829358473440146,0.5211267605633803,1.0,1.0,5/25,8.07%,PTPRC;NCKAP1L;SFTPD;ANO6;CAMK1D
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.6529768801652833,0.9828065989424254,0.5121951219512195,1.0,1.0,2/6,8.41%,EYS;AKIRIN1
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.39602761404382764,-0.9826926685130131,0.453125,1.0,1.0,39/166,17.97%,FOSL2;IGFBP3;AKAP12;PPP1R3C;ISG20;F3;CITED2;FOS;GLRX;PLAC8;CCN5;PIM1;KDM3A;HS3ST1;PAM;NEDD4L;CHST2;LXN;BHLHE40;DDIT4;EFNA1;TGFB3;PHKG1;EFNA3;CAV1;LDHA;CP;SCARB1;VEGFA;PGK1;EGFR;GPC3;PPP1R15A;CDKN1A;ZFP36;MAFF;GAPDHS;BTG1;KDELR3
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),-0.685269943416676,-0.9825734811232272,0.5689655172413793,1.0,1.0,1/6,3.04%,STAT5A
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.5642389730691123,-0.9824485789441786,0.5396825396825397,1.0,1.0,3/14,24.80%,RAD9A;MRE11;FANCD2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.5541989677794943,0.9823723877423259,0.45161290322580644,1.0,1.0,1/16,0.43%,F2
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.5423606532637368,0.9822877614008929,0.4878048780487805,1.0,1.0,2/10,10.64%,HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.6374370596606863,-0.9819382290419846,0.5692307692307692,1.0,1.0,1/5,12.64%,ATP23
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.6136712852134247,-0.981817223658468,0.6181818181818182,1.0,1.0,3/9,19.45%,CAV1;USP14;BCAP31
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.41665551088108693,-0.9816647174803276,0.5,1.0,1.0,16/108,9.70%,CD44;TLR2;TNFRSF1A;NOX4;FOS;BLNK;LOXL3;APOL3;CSF1R;TMIGD3;CHI3L1;SCG2;C3AR1;NLRP3;PTGER3;NAIP
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.4856734478003299,0.9815688344599741,0.43243243243243246,1.0,1.0,15/42,25.68%,RIDA;HSPA1A;HSPA1B;NUDT16L1;ZC3H12D;PNPT1;DHX34;DDX5;PDE12;ERN1;DXO;NBDY;RNH1;TUT4;RC3H1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5605548720410396,-0.9813141846265766,0.47692307692307695,1.0,1.0,1/10,7.34%,MAP3K5
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),0.5591557740416082,0.9811494471983728,0.5,1.0,1.0,1/8,0.37%,DAO
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.5216173529296024,-0.9811176088468293,0.5166666666666667,1.0,1.0,5/18,25.52%,RPA3;RPA2;RBX1;XPA;RPA1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.5216173529296024,-0.9811176088468293,0.5166666666666667,1.0,1.0,5/18,25.52%,RPA3;RPA2;RBX1;XPA;RPA1
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.41747486946932766,-0.9809053143315191,0.52,1.0,1.0,19/114,21.27%,CENPK;ERCC6L;CENPE;CENPF;SPC25;DYNC1LI1;ZWILCH;NUP43;CENPA;NUF2;DSN1;CENPL;CENPQ;ITGB3BP;PLK2;MAD2L1;CEP126;KIF2C;RPS27
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.41231128122361393,0.9805410144871842,0.42857142857142855,1.0,1.0,6/65,8.72%,NUPR1;RAE1;FBP1;NUP42;NUP210;CBFA2T3
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),-0.5667648497473825,-0.9805345894970764,0.5614035087719298,1.0,1.0,7/13,23.07%,FAP;ANGPTL7;TIE1;LRP1;RIC1;DDR2;AGT
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.4266530651252084,-0.9805140020531042,0.5466666666666666,1.0,1.0,19/93,18.73%,CLGN;PCSK4;HTR5A;NOS1;DBF4;NCAPH;ZC2HC1C;SCG3;IL12RB2;RFC4;NEFH;CDKN3;CCT6B;EZH2;GAD1;GAPDHS;MEP1B;CNIH2;OAZ3
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5571582886899062,-0.9805067069065014,0.5694444444444444,1.0,1.0,3/12,16.82%,PTPRC;CALM3;PPP1R15A
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.6077495188079893,-0.9803688067306917,0.5614035087719298,1.0,1.0,4/10,18.92%,IL7;AXL;WNT5A;GAS6
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.5260759905383129,0.9800877212275277,0.4838709677419355,1.0,1.0,3/13,13.08%,HMGB1;ABL1;TOP3B
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.6231981705007009,-0.9800738633018495,0.47368421052631576,1.0,1.0,2/7,14.97%,MX1;DNM1
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.5589685162818512,-0.9800683547720358,0.5645161290322581,1.0,1.0,6/15,24.94%,NEDD4L;CAV1;CAV3;KCNH2;PPIF;SLC43A1
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.5601490376809123,0.9799031473486162,0.5135135135135135,1.0,1.0,4/7,38.87%,CLN3;PKDCC;RACK1;ATP2C1
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.5572603816088582,-0.9795923947681098,0.5423728813559322,1.0,1.0,5/13,22.67%,PGAM5;DNM1L;ITPK1;LY96;PPIF
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),-0.6125121597181198,-0.979546798220223,0.5606060606060606,1.0,1.0,3/8,17.77%,ID2;PAX6;MYT1L
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.5634343249081457,0.9795129469008136,0.5476190476190477,1.0,1.0,2/7,17.27%,DDX3X;DHX9
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),-0.6644858587229063,-0.9793155297698529,0.578125,1.0,1.0,2/5,18.43%,NOTCH2;LILRB1
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.3730257235893682,-0.9792463895487593,0.5128205128205128,1.0,1.0,19/248,7.91%,FIGNL1;PTPRC;CENPF;TRNP1;TGFB2;IL12A;WDR6;SMIM22;BIRC3;TSPYL2;IRF1;CITED2;FAP;TP73;ID2;SOX9;CCND1;CRLF3;CKS2
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),-0.6283268127536501,-0.9792291875995481,0.5254237288135594,1.0,1.0,3/7,22.68%,SULF1;TBC1D8B;TMEM63C
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.5975096637811446,-0.9790933795500378,0.5789473684210527,1.0,1.0,3/8,12.26%,NCKAP1L;TGFBR2;GLI3
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.5485176015964129,-0.9790804239521523,0.48484848484848486,1.0,1.0,1/11,3.37%,IMPA2
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.5485176015964129,-0.9790804239521523,0.48484848484848486,1.0,1.0,1/11,3.37%,IMPA2
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.5530039562169176,-0.979059267504502,0.47761194029850745,1.0,1.0,4/17,15.68%,SLC2A12;SLC5A2;SLC5A9;SLC2A2
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.5269460059684588,-0.979048748330963,0.4626865671641791,1.0,1.0,1/12,3.37%,IMPA2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.5948742216235114,-0.9790021612448815,0.5576923076923077,1.0,1.0,4/11,13.77%,IGFBP3;MEF2C;PRKG1;LRP1
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.44047008474071264,-0.9789185320981406,0.4305555555555556,1.0,1.0,9/69,4.74%,ANGPT1;FSTL1;PCOLCE;ADAMTS5;SERPING1;ACTA2;FAP;AQP1;COL4A1
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.51652054087425,-0.9788103907738009,0.5076923076923077,1.0,1.0,3/14,20.12%,HLA-DRB1;STAT3;BTN3A3
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.6440947106725143,-0.9786077864797212,0.5862068965517241,1.0,1.0,2/5,15.57%,GRM5;ABCB1
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.5080289008319896,-0.9784641635981796,0.47368421052631576,1.0,1.0,5/25,10.76%,IGFBP3;MEF2C;SOX9;BOC;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.47996377956045927,-0.978323899169767,0.5,1.0,1.0,10/32,14.19%,ISG15;TGFB2;MEF2C;ANO6;ADGRV1;BMP6;TGFB3;SLC8A1;BMPR1B;NELL1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.5411244199969558,-0.9779486583950903,0.5230769230769231,1.0,1.0,5/12,14.63%,NOS1;NEDD4L;CAV1;CAV3;KCNH2
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.6443836823809767,-0.9779357330164752,0.6153846153846154,1.0,1.0,2/7,21.34%,ALOX12;SCD
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.4703933589716234,-0.9778586182103298,0.5,1.0,1.0,7/30,24.21%,NDUFC1;NDUFB9;NDUFB6;NDUFAF1;NDUFA8;NDUFS5;NDUFS3
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),0.629712119530773,0.9775645025813812,0.5526315789473685,1.0,1.0,7/8,33.02%,KIF25;NSFL1C;KIF11;UBXN2B;CHEK1;RANBP1;CEP85
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5738602356269857,-0.9773186223247861,0.5454545454545454,1.0,1.0,3/10,6.37%,CLDN5;CLDN16;CLDN20
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.6253701158523883,-0.9771735849858207,0.6296296296296297,1.0,1.0,2/11,11.11%,TERF2IP;CAMK1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.47137571375654064,0.9770507989100851,0.5,1.0,1.0,7/23,19.10%,UBC;UBB;UBE2N;ITCH;MAP3K7;IRAK2;TAB3
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),-0.6604351035776759,-0.9767003337713485,0.6140350877192983,1.0,1.0,2/5,18.67%,MEF2C;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.5929740580569256,-0.976660124053015,0.5849056603773585,1.0,1.0,1/8,4.57%,GLRX
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.35370711794030846,0.9766474790551234,0.5,1.0,1.0,38/280,14.70%,TEAD2;VDR;EAF2;SNAPC3;HDAC10;ATF4;NR2C2AP;TAF13;INTS14;CCNT1;MAML2;HDAC1;HDAC9;TAF5;PCF11;TAF12;ELL;CPSF4;NABP1;POLR2K;CSTF2;TEAD3;MNT;HNF4A;INTS8;ZBTB1;GMEB2;SYMPK;C5AR1;ELOC;NR6A1;MLLT3;ESRRG;NFKB1;MED18;TRIP11;TAF3;ZC3H8
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.44578639968534,-0.9766211404338815,0.5,1.0,1.0,20/70,16.75%,EPHA3;KALRN;EPHA4;VAV3;EFNA1;CDK5R1;PAK3;SIPA1L1;EFNA3;GRIN2B;EPHB6;EPHA6;RASA1;CHN1;EPHB1;LYN;DNM1;EFNA5;EFNB2;NGEF
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.5013488996163875,-0.9764070205881763,0.4852941176470588,1.0,1.0,7/26,7.57%,PARP14;IRGM;PARP9;EDN1;C1QTNF4;LAPTM5;IL7
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.4912765583986446,0.9763301939249984,0.5625,1.0,1.0,3/16,18.20%,SLC39A8;SLC30A10;SLC39A6
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.4690155753494187,-0.9762037019432106,0.5245901639344263,1.0,1.0,7/36,23.92%,IRGM;TIE1;SNCAIP;PTPN11;AGT;PARP10;INSM1
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),-0.5771257862336071,-0.9760683338009014,0.5555555555555556,1.0,1.0,2/14,14.03%,SOX9;BMPR1B
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.44455551676757277,-0.9755516126582947,0.5857142857142857,1.0,1.0,9/67,13.14%,ARIH2;CLU;LAPTM5;PRICKLE1;RNF217;LRRK2;RNF144B;MAGEF1;CAV3
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),-0.589341123645689,-0.9754227131280594,0.5373134328358209,1.0,1.0,4/11,10.39%,CPS1;NOX4;CBS;TST
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.48765145476944977,0.9751540602946652,0.5384615384615384,1.0,1.0,9/27,20.44%,B4GALNT2;DAD1;UGGT1;LMAN1;OST4;DERL3;DPM3;RPN2;ALG5
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.35082424361211617,0.9746969197283372,0.4482758620689655,1.0,1.0,46/196,21.67%,TBPL2;EAF2;MLF1;SNAPC3;ATF4;TAF13;CCNT1;PAX8;TAF5;TAF12;ELL;SLC25A33;EPC1;POLR2K;THAP1;MNT;GMEB2;ELOC;TFB2M;GTF3C5;MLLT3;GTF3C6;NFKB1;GTF3A;TRIP11;TAF3;POLR3GL;ERCC2;TFDP1;POLR2L;UBTF;TAF1C;GTF2H5;BTF3;CTDP1;TAF4;DDX5;NR4A2;IWS1;HOXD3;CCNK;HSF1;COPS2;POLR2E;POLR3K;TAF9B
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.58291367210157,0.9742816159605338,0.5526315789473685,1.0,1.0,1/8,5.75%,ST3GAL1
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.5296095952319487,-0.9742287986776322,0.55,1.0,1.0,4/22,13.62%,TP73;NMT1;E2F1;YWHAH
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.5296095952319487,-0.9742287986776322,0.55,1.0,1.0,4/22,13.62%,TP73;NMT1;E2F1;YWHAH
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.4049838957339364,0.9742024620483221,0.47058823529411764,1.0,1.0,21/61,20.47%,B4GALNT2;SLC39A8;MOGS;ST3GAL1;DAD1;GFPT2;UGGT1;LMAN1;OST4;DERL3;DPM3;GFPT1;ALG12;RPN2;DPAGT1;ALG3;TMEM165;ALG1;PMM1;ALG5;B4GALT1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.43485632525367346,-0.9739482154189061,0.47058823529411764,1.0,1.0,5/60,8.31%,HLA-F;HLA-E;PSMB8;HLA-A;B2M
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.522013814581235,-0.9737190533259525,0.4696969696969697,1.0,1.0,2/14,11.88%,ZWILCH;CENPA
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.5496166748211448,-0.9734428804983102,0.5,1.0,1.0,3/10,14.61%,MFNG;GPR183;NOTCH2
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.540956724396237,-0.9732394181342788,0.4838709677419355,1.0,1.0,4/20,22.27%,DKK3;NREP;TGFB1;BCL9
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),-0.5752705667061424,-0.9730179718318392,0.59375,1.0,1.0,5/12,18.18%,MPP4;ZDHHC15;DLG4;PCLO;NRXN1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.5524646408748749,-0.9729588290975921,0.453125,1.0,1.0,2/9,15.40%,SLC18A2;ABCD2
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.5254609439074901,0.9726887991597992,0.5384615384615384,1.0,1.0,1/16,0.43%,F2
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.4222472462339252,0.9724513074893967,0.5,1.0,1.0,10/64,10.88%,MAPRE2;KIF3B;ZNF207;FLNA;TPX2;NUMA1;KIFC2;HAUS5;KIFC1;BCCIP
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.41003351663609056,0.9723006324716453,0.5,1.0,1.0,7/69,10.61%,CELA2A;TRARG1;ENPP1;EPM2AIP1;HDAC9;SLC25A33;AKT2
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.3741843611975747,-0.9722402952146197,0.5694444444444444,1.0,1.0,42/280,14.19%,FBLN1;KANK2;IGFBP3;TP53I11;SFRP4;PPARG;IL26;TGFB2;ALDH1A2;IL12A;SSTR1;WDR6;NOX4;IRF1;FAP;FABP3;TP73;SOX9;P3H2;OGN;ADGRG1;DDAH1;MYO16;B2M;TMIGD3;LDOC1;E2F1;TGFB3;INCA1;CDH13;AQP11;CD200;RERG;NMI;AR;IFNK;E2F3;IFI35;LYN;TRIM32;BMPR1B;NELL1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.45285784377133026,-0.9719377401765278,0.4927536231884058,1.0,1.0,12/58,19.34%,TGFB2;CITED2;INHBC;BMP6;TGFB3;SULF1;CRB2;RBPMS;BMPR1B;RNF111;TGFB1;KIAA0319
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.5256852808725404,0.97170280593799,0.53125,1.0,1.0,4/16,10.64%,HSPA1A;EYA4;UNC5B;HSPA1B
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5256852808725404,0.97170280593799,0.53125,1.0,1.0,4/16,10.64%,HSPA1A;EYA4;UNC5B;HSPA1B
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.41904074853506296,-0.9716097659427622,0.4925373134328358,1.0,1.0,9/75,18.98%,IRGM;TRIM5;LRRK2;TRIM22;DAPK1;FBXO7;TP53INP1;PLK2;PIK3CB
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.46194879846813197,-0.9713083988714534,0.5652173913043478,1.0,1.0,13/59,21.34%,LPL;OLAH;PAM;LSS;XBP1;ACSM3;OXSM;LIPI;SREBF1;ACSL5;ACSS2;PDSS1;SCD
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.5121677396338832,0.9711644781203278,0.47368421052631576,1.0,1.0,1/18,0.43%,F2
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.4513142675777313,-0.9710900384890138,0.5625,1.0,1.0,9/50,13.77%,LPL;GPIHBP1;FABP3;XBP1;ACSM3;CAV1;CAV3;ABCG5;SCARB1
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.3923829090741386,0.9710497377944304,0.4411764705882353,1.0,1.0,24/89,23.63%,U2AF1;RAE1;NUP42;NUP210;RBM8A;CPSF4;SYMPK;TPR;NXF1;EIF4E;NUP37;RBM15B;SARNP;HNRNPA2B1;THOC2;NDC1;MAGOH;SMG5;ALYREF;SEH1L;SRSF9;NUP85;NUP214;FYTTD1
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.5360088627999992,0.9706095188322508,0.47368421052631576,1.0,1.0,4/12,19.89%,PCM1;BCCIP;BICD2;SAXO1
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.5838662075335803,0.9705254848435277,0.59375,1.0,1.0,4/14,17.38%,IFNLR1;ITCH;DHX9;TRAF3
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.5214784927065809,-0.9704427818797641,0.5616438356164384,1.0,1.0,2/19,2.69%,RHBDF2;IL12A
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.4091456153842424,-0.9704426879093727,0.53125,1.0,1.0,17/130,13.68%,FBLN1;IGFBP3;PTPRC;NLRP12;CEACAM1;LRRK2;TERF2IP;DDIT4;WWTR1;CAMK2N2;SH3GL2;THY1;CAV1;UBASH3B;CAV3;CALM3;LYN
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.5985215253524677,-0.970306934416931,0.5573770491803278,1.0,1.0,2/8,15.89%,WRN;RECQL4
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.41341051910591725,0.9702400014616147,0.4594594594594595,1.0,1.0,17/64,24.64%,EAF2;CCNT1;ELL;POLR2K;ELOC;MLLT3;ERCC2;POLR2L;GTF2H5;CTDP1;IWS1;CCNK;POLR2E;ELP4;POLR2D;CCNH;TCEA1
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.4915457907042954,0.9702060648655665,0.45,1.0,1.0,5/26,12.38%,HSPA1A;BAK1;OPTN;HSPA1B;DAXX
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.47753130617167683,-0.9702053335771333,0.5238095238095238,1.0,1.0,11/25,16.78%,PKP2;FGF12;NEDD4L;GJA1;ATP1A1;SCN1B;CAV3;KCNH2;KCNE1;SCN4B;CACNA1G
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.5298963283655421,-0.9700721224210087,0.546875,1.0,1.0,3/17,18.47%,CYFIP1;CDH13;RHOH
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.45123018034035167,-0.9700590771127844,0.546875,1.0,1.0,9/51,13.77%,LPL;GPIHBP1;FABP3;XBP1;ACSM3;CAV1;CAV3;ABCG5;SCARB1
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.45101800204583453,-0.970025486361194,0.47058823529411764,1.0,1.0,30/68,20.50%,IRGM;PTPRC;P2RY12;CHRM3;MCTP1;EDN1;MCTP2;NMUR2;CCR9;NUDT4;LRRK2;GRM5;CXCR6;TPCN2;SLC8A1;HTR2B;CX3CR1;EDNRB;KSR2;EGFR;FKBP1B;DMTN;PPP3CA;LAT2;PLCG1;ACKR4;PTPRJ;BCAP31;TRPM2;CACNA1C
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.5164881597461316,0.969899477301228,0.4117647058823529,1.0,1.0,2/16,4.98%,DAO;GLYAT
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.4507845676006646,-0.9698395153654521,0.5,1.0,1.0,16/62,18.94%,TLR2;IRGM;MEF2C;VIM;NLRP3;LDOC1;XBP1;CX3CR1;AXL;TNFRSF1B;ZFP36;NR1D1;WNT5A;GIT1;LILRB1;TIRAP
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.5824063436916519,-0.968973860987976,0.5333333333333333,1.0,1.0,3/13,23.42%,PRPF19;USP4;DDX20
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),-0.5180381645258407,-0.9688838385746813,0.5245901639344263,1.0,1.0,6/23,17.75%,SYT1;SNCB;AMPH;PACSIN1;OPHN1;CDK5
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),-0.5766069079874627,-0.9684613778069194,0.6065573770491803,1.0,1.0,1/8,0.81%,SRGN
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.46875060455848194,-0.9683233450603176,0.5,1.0,1.0,4/37,8.45%,FBLN1;PTPRC;RPS6KA6;LMO3
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.5282479792514261,0.9683160066832807,0.5217391304347826,1.0,1.0,2/11,10.29%,ZNF335;BEND3
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.5023035427041427,0.9682657649473873,0.4722222222222222,1.0,1.0,5/21,7.51%,M1AP;PIWIL2;MEIOSIN;FSHR;DMC1
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.4253327016193159,-0.9682152140379335,0.4264705882352941,1.0,1.0,13/66,21.84%,LAMP5;RAB11A;PRICKLE1;ZDHHC15;NUP62CL;E2F3;SYK;STAT3;SPRN;NUP88;HEATR3;NUP50;GCKR
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.6307216306981303,-0.9681824307474831,0.6461538461538462,1.0,1.0,3/6,28.98%,PLAT;PDGFRB;CCN3
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.421210059341859,0.9681362801746596,0.5,1.0,1.0,2/59,0.48%,NGF;BCL2A1
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.49831319356926634,-0.9678568093794208,0.5072463768115942,1.0,1.0,6/29,18.98%,CLU;B2M;LRPAP1;TNK2;FLOT1;PIK3CB
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.5506840649983813,0.9676131327387146,0.5,1.0,1.0,1/7,4.59%,RIPPLY2
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.35719545913261824,0.9672824802068674,0.38095238095238093,1.0,1.0,69/256,24.78%,U2AF1;SF3A3;LSM7;RNF113A;PRPF4;SRPK3;SF3B2;CRNKL1;RALY;PTBP1;PCF11;SNRPC;RBM8A;CPSF4;POLR2K;CSTF2;SNRNP25;SYMPK;GEMIN6;PPIL1;CCAR1;HNRNPU;PDCD7;RBM17;SNUPN;STRAP;DNAJC8;COIL;POLR2L;HNRNPH1;CWC27;YBX1;SNIP1;RBM15B;DHX9;SRSF8;GEMIN5;DCPS;SF3A2;HNRNPA2B1;CDC5L;DDX5;SNRNP35;RBM22;RBM5;SF3A1;CSTF1;MAGOH;ALYREF;TGS1;POLR2E;ZMAT2;HNRNPR;SNRPB;SRSF9;HNRNPC;BCAS2;HNRNPM;SMN1;GPATCH1;POLR2D;PUF60;TRA2A;RBM19;PRMT5;WBP4;DDX41;DDX46;SF3B4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.6127023802232648,-0.9672013134634269,0.5384615384615384,1.0,1.0,3/7,21.67%,CAV1;CAV3;FGF13
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.4980589405640572,-0.9670860178367097,0.5373134328358209,1.0,1.0,15/21,38.93%,PGK1;GAPDHS;PFKM;GPI;PFKL;TPI1;ALDOB;HK2;ADPGK;PFKP;PGAM2;PKM;FOXK2;ENO2;ENO1
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.42115350245129374,-0.9670196444411712,0.5147058823529411,1.0,1.0,22/75,24.07%,DACT1;LRRK2;E2F1;PLN;ARHGAP28;CAMK1;LRPAP1;CAV1;ZFPM1;IFIT1;CARD18;DISC1;EFHB;CDKN1A;NFKBIA;IFIT2;PPP1CA;DDX11;PRKCD;ITGB1BP1;RALB;AURKA
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.6385032273798275,-0.9669817188911646,0.6176470588235294,1.0,1.0,3/6,32.28%,FYN;NTRK2;BDNF
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5712059088125829,0.9665920332772221,0.5333333333333333,1.0,1.0,1/10,3.27%,HMGB1
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),-0.3948440000089195,-0.9664254615537146,0.4861111111111111,1.0,1.0,27/144,20.68%,HEY1;SRGN;ADAMTS5;TIMP1;MEF2C;SOX9;NLRP12;RPS6KA6;PTPRG;PROCR;EFNA1;GJA1;PGAM5;LRPAP1;PTPRR;OVOL2;EGFR;NR1D1;SLC6A4;HPN;TGFB1;GAS6;TRPV3;ACOT11;ALPK2;SPI1;SLAMF8
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.5792785042024288,0.9661772517295631,0.5172413793103449,1.0,1.0,5/10,24.50%,DKC1;CCT8;CCT2;CCT6A;CCT3
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.5463649874565379,0.9657055580802509,0.4523809523809524,1.0,1.0,4/8,24.86%,ABHD17A;ABHD10;LYPLAL1;LYPLA1
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.5463649874565379,0.9657055580802509,0.4523809523809524,1.0,1.0,4/8,24.86%,ABHD17A;ABHD10;LYPLAL1;LYPLA1
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.41239090377411136,0.9656457940920948,0.45161290322580644,1.0,1.0,11/68,6.91%,BACE2;MYOF;SH3RF2;ANXA2;LAMB3;PPP1R13L;ALDH1A3;CDC42EP5;ACADVL;TAX1BP3;MYO1C
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.4853965326661504,0.9653751743974518,0.4418604651162791,1.0,1.0,3/22,3.22%,ICAM1;NUPR1;SEMA5A
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",0.6655428710769146,0.9653639463182347,0.625,1.0,1.0,4/5,30.89%,TRIR;PDE12;TOE1;XRN1
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.5186416161981011,0.9646431957958314,0.5405405405405406,1.0,1.0,3/22,5.12%,ICAM1;COL18A1;RAPGEF1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.4651005870674794,-0.9646206276708155,0.578125,1.0,1.0,7/42,12.92%,FIGNL1;PPP4C;TERF2IP;POLQ;RADX;KLHL15;MAGEF1
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.3767063372823518,0.9646201235420532,0.4411764705882353,1.0,1.0,9/76,10.64%,CRYAB;HSPA1A;RAE1;NUP42;FKBP4;NUP210;MLST8;BAG2;HSPA1B
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),-0.6125034484742236,-0.964496209176013,0.6538461538461539,1.0,1.0,3/5,24.50%,WNT5A;PTPN11;DNAJC19
prerank,GO_Biological_Process_2021__secretion (GO:0046903),0.5727133243092539,0.9644348045579976,0.5277777777777778,1.0,1.0,2/10,0.96%,SLC22A2;SLC22A6
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.5258241579490867,0.9641549365618355,0.5454545454545454,1.0,1.0,3/8,17.56%,FBP1;GFPT2;GFPT1
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.6019211840869367,-0.9640421152259296,0.6166666666666667,1.0,1.0,4/9,17.57%,RSPH6A;BBOF1;RSPH9;CCDC39
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.6321178483232338,0.9634508573010234,0.625,1.0,1.0,3/8,12.38%,WNK4;ATP1B1;DLG1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5936460888124495,-0.9634430048875399,0.5423728813559322,1.0,1.0,3/10,18.39%,STAT5A;LYN;STAT3
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),0.5756478709891444,0.9634292443006731,0.5,1.0,1.0,3/7,21.79%,BAG2;ADAM8;NLRC4
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.4112450821951899,-0.9632648831232307,0.5606060606060606,1.0,1.0,21/123,16.55%,ROR1;EPHA3;MUSK;DTX3L;MET;RFC3;EPHA4;CSF1R;HLA-DRB1;TEK;RFC4;PLAAT4;CD200;EPHB6;EPHA6;EPHB1;PRKCQ;TIE1;AXL;RAD50;EGFR
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.5748900098629353,-0.9631795461909677,0.5573770491803278,1.0,1.0,3/12,7.76%,NOS1;ARG2;MTARC2
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.6379449345536137,-0.9631236491818541,0.6142857142857143,1.0,1.0,2/7,12.35%,CEBPB;UBASH3B
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.506553733332776,-0.9628954917485201,0.5555555555555556,1.0,1.0,2/24,5.71%,KDM4D;KDM3A
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.6031928844311398,-0.9626164752252148,0.532258064516129,1.0,1.0,3/6,18.94%,CAV1;FLOT1;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),-0.6512477337063511,-0.9625989400837759,0.5964912280701754,1.0,1.0,2/5,19.86%,WNT5A;NLRC5
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.6174985029195182,-0.9625339006498213,0.576271186440678,1.0,1.0,1/8,11.67%,H1-0
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.6174985029195182,-0.9625339006498213,0.576271186440678,1.0,1.0,1/8,11.67%,H1-0
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.6174985029195182,-0.9625339006498213,0.576271186440678,1.0,1.0,1/8,11.67%,H1-0
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.554104305625964,-0.962435178366028,0.49206349206349204,1.0,1.0,5/15,18.91%,TGFB2;TGFB3;CAV1;TRERF1;TGFB1
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),-0.6156219113824064,-0.9621589486470877,0.582089552238806,1.0,1.0,1/7,4.21%,NOS1
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.4481486029770126,0.9620671896471766,0.475,1.0,1.0,9/30,22.67%,HSPA1A;BAK1;OPTN;HSPA1B;DAXX;TMBIM6;HSF1;ERN1;DNAJC18
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),-0.5996957938987563,-0.9618994022425187,0.6037735849056604,1.0,1.0,2/8,15.43%,NCKAP1L;PPP2R3C
prerank,GO_Biological_Process_2021__negative regulation of pinocytosis (GO:0048550),-0.6499412994582633,-0.961632119998282,0.6166666666666667,1.0,1.0,1/5,12.21%,CAV1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.4864211081127161,0.9612508028542509,0.4594594594594595,1.0,1.0,1/23,0.43%,F2
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.48439993492150907,-0.9612011917860309,0.5573770491803278,1.0,1.0,8/35,11.57%,TGFB2;ITGAM;CLU;FOS;MAP3K5;DDIT4;CDK5R1;GRIN2B
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),-0.5722557210373946,-0.9611455736242385,0.576271186440678,1.0,1.0,6/8,20.40%,NTN4;NTNG1;LAMB1;NTNG2;LAMB4;LAMB2
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.614731107341195,0.9611216246247261,0.575,1.0,1.0,1/6,2.89%,MYOF
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-0.5857808690128398,-0.961038815180691,0.5614035087719298,1.0,1.0,3/7,10.74%,RAB11A;GRIP2;GRIP1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.4944156312988456,-0.9610264369117061,0.5757575757575758,1.0,1.0,5/23,14.98%,LGALS3;TRPC6;CAV1;GRM6;CACNB2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.4024709131068063,-0.9609372260856102,0.4936708860759494,1.0,1.0,21/126,12.21%,ITGB4;FSTL1;MMRN2;COX7A1;ROBO4;PLSCR4;AQP1;COL4A1;NTN4;BMX;TEK;ITGBL1;PROCR;PALLD;BMP6;WWTR1;FGD5;SULF1;GASK1B;C1R;CAV1
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.5759080247604883,-0.9609006477626542,0.546875,1.0,1.0,4/10,22.11%,RFTN1;SCIMP;COLEC12;SCARA3
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),-0.58757539394058,-0.9607842428157954,0.5714285714285714,1.0,1.0,3/6,21.64%,JAG2;LRTOMT;PDZD7
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.49124954568786167,0.9606903813544281,0.5526315789473685,1.0,1.0,5/18,17.09%,SMYD1;HDAC1;HDAC9;HDAC4;HDAC3
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.36165870026990754,0.9605876548542591,0.5862068965517241,1.0,1.0,34/162,22.24%,U2AF1;M1AP;DICER1;PIWIL2;SF3A3;YJU2;PRPF4;SF3B2;PTBP1;RBM8A;TENT4A;KIN;SNRNP25;RP9;DKC1;TENT4B;HNRNPU;PDCD7;MPHOSPH10;HNRNPH1;SF3A2;HNRNPA2B1;TSEN34;SNRNP35;CELF1;LIN28B;RBM5;SF3A1;MAGOH;HNRNPR;SNRPB;SRSF9;HNRNPC;BCAS2
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.4820608744853302,0.9605493534605756,0.42105263157894735,1.0,1.0,3/22,7.19%,SLC22A6;ABCC2;SLC26A7
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-0.6303299935286382,-0.9602014141718676,0.64,1.0,1.0,3/6,10.74%,RAB11A;GRIP2;GRIP1
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.4723461248690456,0.9601155170306941,0.5277777777777778,1.0,1.0,6/20,16.57%,MFHAS1;PPP1R1B;PTPA;ENSA;STYXL1;PPP1R8
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.556018133918041,-0.9599818760063934,0.5,1.0,1.0,1/12,0.78%,DPYS
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.5501204814641736,-0.9598717571954541,0.5409836065573771,1.0,1.0,2/17,6.08%,EDN1;PTGR1
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.5943492186516993,0.9594949622283657,0.5510204081632653,1.0,1.0,2/5,8.51%,PLIN5;HDAC9
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.4074806369271179,-0.9589981667136938,0.5428571428571428,1.0,1.0,17/92,17.99%,IRGM;SLC8A3;CCND1;CSF1R;CDK5R2;SLC8A1;CDK5R1;CAMK1;THY1;CCNJL;MTCP1;CALM3;CDKN3;CCNF;CDKN1A;EZH2;SERTAD1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.3887968675806223,-0.9587218600625327,0.5769230769230769,1.0,1.0,20/139,21.27%,CENPK;ERCC6L;CENPE;CENPF;SPC25;RAB11A;DYNC1LI1;ZWILCH;NUP43;CENPA;NUF2;DSN1;CENPL;CENPQ;ITGB3BP;PLK2;MAD2L1;CEP126;KIF2C;RPS27
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),-0.5839572004021687,-0.9586643435563406,0.5625,1.0,1.0,1/7,3.37%,IMPA2
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),0.4679577782461396,0.9586159707417089,0.4864864864864865,1.0,1.0,21/35,30.32%,TARS1;FARSB;DARS1;MARS1;HARS1;IARS1;HARS2;VARS1;CARS1;RARS2;FARSA;KARS1;RARS1;EPRS1;AARS1;FARS2;SARS1;GATC;IARS2;WARS2;LARS2
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),-0.5421396827979511,-0.9586062918900322,0.5614035087719298,1.0,1.0,2/13,10.20%,P3H2;OGFOD1
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.5645450564209467,-0.9586062869990104,0.5945945945945946,1.0,1.0,1/10,4.21%,NOS1
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.5961116698370337,0.9584513166952929,0.5535714285714286,1.0,1.0,4/5,38.35%,WDR70;CTR9;CDK9;RNF20
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.4253932107918138,-0.9582131393812319,0.5692307692307692,1.0,1.0,10/41,21.76%,UTRN;MEF2C;SGCE;CTF1;VAMP5;CAV3;POU6F1;SGCA;ITGA11;NEB
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.5233740813505178,0.9581978401867766,0.5,1.0,1.0,1/19,0.43%,F2
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.4750548845182559,0.958196844805901,0.5384615384615384,1.0,1.0,2/19,4.24%,DPEP1;ENPEP
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.44552102839031554,-0.9581333769919761,0.547945205479452,1.0,1.0,5/63,11.65%,ISG15;CTSO;FAP;ADAMTS7;PRPF19
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.5124042304046017,-0.9576838578121826,0.6231884057971014,1.0,1.0,8/18,25.61%,ID2;LRRK2;TOX;PTPRZ1;TAFA1;INSM1;SHCBP1;FZD9
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.48651255753808303,-0.9576520385278839,0.49230769230769234,1.0,1.0,5/21,13.59%,IL12A;NCKAP1L;HLA-DPB1;THY1;PRKCQ
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.5051903513332123,0.9576400291584812,0.5,1.0,1.0,2/13,2.22%,TCOF1;KBTBD8
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),-0.6283922065090153,-0.9575945254433094,0.55,1.0,1.0,4/6,17.10%,FES;ADGRE2;LYN;SYK
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.538767682648823,-0.9574685631113438,0.5645161290322581,1.0,1.0,3/15,18.59%,PIGH;PIGC;PIGB
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.5628156589526105,0.9570580256463849,0.5581395348837209,1.0,1.0,4/8,26.43%,PAX8;SALL1;GDNF;FGF2
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.4882088947085096,-0.9567946415117756,0.5,1.0,1.0,9/28,22.39%,ABCC4;CEACAM1;SLC16A8;SLC51A;ABCG5;ATP8B1;SLCO2B1;RXRA;SLC10A6
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.6045211976515179,0.9567939464007646,0.5277777777777778,1.0,1.0,1/9,5.08%,HMGA2
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.5576489199670833,-0.9565928518801307,0.5166666666666667,1.0,1.0,3/11,13.77%,CLU;LRPAP1;LRP1
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.5641435876679247,0.9563975008470147,0.475,1.0,1.0,1/5,22.59%,NAA20
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.44268196670421245,-0.9560462223425419,0.5,1.0,1.0,11/41,14.19%,SRGN;ISG15;MEF2C;ANO6;ADGRV1;SGMS2;BMP6;TGFB3;SLC8A1;BMPR1B;NELL1
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.5388405125011937,0.9559621555641288,0.4838709677419355,1.0,1.0,5/11,14.00%,DUSP1;SLIT2;GREM1;BMP5;MIA3
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.37662049425296834,-0.9558322971018938,0.5,1.0,1.0,58/217,23.95%,PPP1R17;ZIC4;ITGAM;GLIS2;NRCAM;SLC8A3;COL4A1;TGFBR2;SLC23A1;NMUR2;SOX9;LOXL3;ADGRG1;ROBO2;RPS6KA6;NPTX1;ZFHX2;DCLK1;DCX;DDIT4;BTD;SH3GL2;GRIK1;CDK5R1;CX3CR1;EMX1;GRIN2B;ADGRL2;TAGLN3;ASIC2;GRIN2D;TPP1;PAX6;PTPRZ1;CNTN4;NHEJ1;ATP6AP2;POU6F1;CHST8;CDK5;STAT3;TUBGCP2;EIF2B2;SETD1A;SPINK6;PTPN11;MAL;SERPINI1;NDRG4;SHROOM2;ALDH5A1;ZIC1;MYRF;MACROH2A2;SEMA6B;CA10;CIC;ALDH3A2
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.40645969778939933,-0.9556834438802335,0.5396825396825397,1.0,1.0,10/78,12.33%,PPARG;TNFRSF1A;AOAH;NLRP12;EPHA4;TEK;FNDC4;NLRP3;LRFN5;NMI
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.40247415847408285,-0.9556233174943883,0.5,1.0,1.0,18/119,12.42%,SRGN;ISG15;PTPRC;VSIR;IL12A;NCKAP1L;CR1;SFTPD;ADCY7;NLRP12;LAPTM5;CEACAM1;HLA-DRB1;NAV3;TRIM25;IFNA2;CD200;ZFPM1
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.45538375018272415,-0.9551590719025057,0.5483870967741935,1.0,1.0,7/28,14.56%,LGALS3;LAPTM5;CEACAM1;TESPA1;CD160;THY1;PRKD2
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.3657911151290174,-0.9549088138160321,0.5584415584415584,1.0,1.0,23/283,9.70%,CD44;ANGPT1;FSTL1;KANK2;AVEN;FIGNL1;NCKAP1L;BCL2L2;BIRC3;CITED2;AQP1;APIP;SOX9;PIM1;MET;HGF;LAPTM5;TEK;IL7;GATA1;TCIM;RNF144B;NAIP
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.4798958032286704,0.954843094427705,0.45,1.0,1.0,1/15,1.41%,B4GALNT2
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.49116599360144453,0.9545059932665355,0.5405405405405406,1.0,1.0,3/14,4.03%,F2;SERPINF2;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.6506249433937245,-0.9544121588441312,0.5517241379310345,1.0,1.0,3/5,31.01%,DMTN;ANK3;JAK1
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.4676327494230491,0.9543332977054103,0.4411764705882353,1.0,1.0,3/21,7.33%,DSCAM;SEMA5A;MEGF8
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.467544560393311,-0.954160447073177,0.53125,1.0,1.0,2/31,6.70%,NEFL;SYBU
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),-0.6487561252433455,-0.9540123391576284,0.5737704918032787,1.0,1.0,2/6,28.50%,MLLT11;ANK3
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.4683461064697742,-0.9539293938292225,0.5753424657534246,1.0,1.0,11/54,14.56%,RHBDF2;PRICKLE3;NBEAL2;CAPN1;SLC14A1;ANXA11;TMC4;TMCO4;TRIM25;TMEM79;PRKD2
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.5209053376125654,0.9537783083714388,0.4523809523809524,1.0,1.0,3/13,7.31%,HMGB1;DICER1;EXOG
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.4470743101630761,0.9537318160089635,0.5,1.0,1.0,2/27,6.43%,AGER;IGF1R
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),-0.5211445007525802,-0.9536839638875582,0.5238095238095238,1.0,1.0,1/15,0.78%,DPYS
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),0.588745237032029,0.9536761537537592,0.5833333333333334,1.0,1.0,2/5,8.44%,SPHK2;PIH1D1
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),-0.603958720125175,-0.9535415064514453,0.5862068965517241,1.0,1.0,1/8,24.94%,ADAM9
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.4733581925876278,-0.9535233664610306,0.52,1.0,1.0,4/31,12.89%,STMN2;APC2;NAV3;MAP2
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.5313889837009171,-0.9534041527835785,0.5692307692307692,1.0,1.0,2/18,6.37%,RAB11A;CCND1
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.3945335405728218,-0.9533521904106732,0.5294117647058824,1.0,1.0,11/139,7.76%,KANK2;IGFBP3;TP53I3;CLU;BCL2L14;BIRC3;CIDEB;TP73;SOX9;ACTN1;LRRK2
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.4472774897854451,0.9533060588272727,0.5,1.0,1.0,3/20,7.31%,HMGB1;DICER1;EXOG
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.4089923894473276,0.9532890529158065,0.43333333333333335,1.0,1.0,10/34,20.60%,MFHAS1;PPP1R16A;PTBP1;PTPA;SYMPK;ENSA;CAMTA1;PPP1R8;CALM1;CNEP1R1
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.45346478744805363,-0.9530269968531742,0.581081081081081,1.0,1.0,11/51,19.52%,PDGFD;EDN1;MAP3K5;LRRK2;DIRAS1;HTR2B;VEGFA;EGFR;EZH2;TGFB1;RASGRP1
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.5752488661712243,0.9529841673745907,0.5869565217391305,1.0,1.0,2/7,8.35%,AGER;ABL1
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.5729554281701347,0.9527442577610155,0.5348837209302325,1.0,1.0,4/7,26.43%,PAX8;SALL1;GDNF;FGF2
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.38189713294113214,-0.9527188520708545,0.5151515151515151,1.0,1.0,24/136,20.19%,RGS7;DOCK8;ARHGAP15;EPHA3;EPHA4;VAV3;LRRK2;RGS1;FGD5;LRCH1;THY1;SIPA1L1;CAV2;PRKG1;CHN1;EFNA5;NGEF;EZH2;RIC1;PLXNC1;RASGRP1;PLXNA2;CX3CL1;PLXNA4
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.5626385204303916,-0.9526925489782948,0.6031746031746031,1.0,1.0,4/10,23.44%,TYRP1;CDH3;OPN3;GIPC1
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.5096503098793744,0.9523219065418628,0.47368421052631576,1.0,1.0,3/8,19.30%,VAMP4;SNCA;STXBP6
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.47288211479901404,-0.9518720749884689,0.5342465753424658,1.0,1.0,3/28,12.26%,CC2D2A;PTCHD1;GLI3
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),-0.5693890095728609,-0.9518444227106451,0.5555555555555556,1.0,1.0,5/11,17.56%,SOX9;CEACAM1;CEBPB;CAV1;MAFF
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.37023634145635076,0.951705159445606,0.46875,1.0,1.0,11/99,6.84%,CXCR4;TXLNB;CRYAB;ADPRHL1;CASQ2;SMYD1;MTTP;PTH1R;ASB5;MYOM1;SRL
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),-0.5995527722011994,-0.9516099767989222,0.625,1.0,1.0,2/5,22.57%,SYK;PRKCD
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.39333429946379617,0.9514673151975317,0.46153846153846156,1.0,1.0,14/44,20.62%,MTERF3;MDN1;MRPS7;MRPS2;NLE1;DDX3X;RPSA;RPL23A;BRIX1;NPM1;RPL3;RPL11;MRPL22;PWP2
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.4813095704779319,0.9513935463012042,0.55,1.0,1.0,9/28,20.44%,B4GALNT2;DAD1;UGGT1;LMAN1;OST4;DERL3;DPM3;RPN2;ALG5
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.5003463834461191,-0.9513625191066553,0.5441176470588235,1.0,1.0,3/20,15.39%,PLSCR1;ABHD12B;PLA2G12A
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),-0.5278925114403348,-0.9513297274276519,0.5797101449275363,1.0,1.0,6/20,18.39%,MMP24;SLC8A3;SOX9;PTPRZ1;CDK5;STAT3
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.38195839264310916,-0.9513270343318945,0.5428571428571428,1.0,1.0,25/147,19.76%,ANGPT1;P2RY12;IL26;KITLG;F3;MET;HGF;FGF22;PIK3AP1;TEK;CHI3L1;CX3CR1;NRG4;TGFA;AXL;FGF7;GFRAL;EGFR;NRG1;NTRK3;TGFB1;GAS6;PIK3CB;PTPRJ;CX3CL1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5804566828568796,-0.9512942613414866,0.576271186440678,1.0,1.0,3/8,14.98%,NOS1;CACNB1;CACNB2
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),-0.6339717933473423,-0.9511564698303737,0.5517241379310345,1.0,1.0,1/5,13.14%,CAV3
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.4230834526995606,-0.9511484727313918,0.5671641791044776,1.0,1.0,33/115,27.61%,DACT1;SFRP4;PLEKHA4;PSMB8;LRRK2;CAV1;GPC5;AMER1;DAPK3;CDH3;ATP6AP2;PTK7;EGFR;GPC3;PSMC3;TGFB1;TMEM9;PRDM15;SCEL;WLS;LYPD6;ZBED3;PSME1;PSMA3;PSMB2;FZD9;PSMD5;UBE2B;PIN1;PSMC5;CSNK1D;LRRK1;CSNK1E
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),-0.5136564868137049,-0.9510534209075424,0.5614035087719298,1.0,1.0,2/15,5.08%,EDN1;NMUR2
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.5452475254288798,-0.9508941801746414,0.5161290322580645,1.0,1.0,6/15,29.38%,CAV2;DAPK3;BORA;KIF20B;PIN1;FBXO43
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.4413686765922579,-0.9508703451128868,0.5507246376811594,1.0,1.0,15/57,15.09%,NKAIN1;SYT1;SYT4;PDZK1;NOS1;NEDD4L;KCNJ4;KCNJ3;B2M;KCNJ6;NKAIN3;ATP1A1;CHRM1;YWHAH;KCNJ13
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.573066528490807,-0.9507285630541122,0.5873015873015873,1.0,1.0,5/9,17.39%,EPHA4;EFNA1;FURIN;NELL1;RIC1
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.4376263873664884,-0.9506894768483541,0.5373134328358209,1.0,1.0,20/48,24.26%,P2RY12;NMUR2;LPAR6;GRM5;HTR2C;C3AR1;PTGER3;HTR2B;CX3CR1;CHRM1;HTR2A;LTB4R;TACR1;GPR17;OPRM1;AGT;P2RY11;ESR1;FPR3;GRM1
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.5230579190707532,0.9504543738231853,0.5,1.0,1.0,4/10,21.36%,SMDT1;MCUR1;MAIP1;MCUB
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),-0.6710705871314571,-0.9502111163184158,0.6111111111111112,1.0,1.0,2/5,9.45%,B2M;BMP6
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.5134417321247494,-0.949990769274495,0.5789473684210527,1.0,1.0,1/16,5.73%,MET
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.42982332904753984,-0.9498470874579761,0.5454545454545454,1.0,1.0,5/62,8.31%,HLA-F;HLA-E;PSMB8;HLA-A;B2M
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.40758862116359057,-0.9497860300002124,0.6268656716417911,1.0,1.0,17/93,14.50%,ROR1;PTPRC;CENPE;EPHA3;MUSK;SPDYA;MET;EPHA4;CSF1R;HLA-DRB1;TEK;EPHB6;EPHA6;EPHB1;TIE1;EEF1A2;AXL
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.4062714236229711,-0.9495053167386445,0.47619047619047616,1.0,1.0,9/75,8.31%,CLDN5;KDM4D;DACT1;PPARG;PARP9;DTX3L;MET;LRRK2;B2M
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.4086614071968808,0.9493983349365012,0.4857142857142857,1.0,1.0,9/68,11.39%,SNAPC3;TAF13;INTS14;CCNT1;TAF5;ELL;NABP1;POLR2K;INTS8
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),-0.6363042749095216,-0.9489776293690972,0.5490196078431373,1.0,1.0,4/5,35.11%,CD27;CD70;CD74;SLA2
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.5700820414293385,0.9489735794911842,0.6097560975609756,1.0,1.0,3/9,15.22%,SLC12A9;SLC12A4;SLC12A2
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.5700820414293385,0.9489735794911842,0.6097560975609756,1.0,1.0,3/9,15.22%,SLC12A9;SLC12A4;SLC12A2
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),0.5955568092454602,0.9486850040636124,0.5945945945945946,1.0,1.0,2/7,17.00%,GBF1;PLK5
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.4149975123556603,0.9484354135841294,0.5652173913043478,1.0,1.0,2/46,3.40%,NGF;DICER1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.4547299525100382,-0.9482734274104099,0.5344827586206896,1.0,1.0,3/36,5.43%,H2BC11;NAP1L2;SOX9
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.5841769578413203,-0.9482426032067146,0.6363636363636364,1.0,1.0,2/12,11.11%,TERF2IP;CAMK1
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),0.5363610766893799,0.9482115406969547,0.5238095238095238,1.0,1.0,5/7,23.87%,HMGB1;NPM1;RPS3;SIRT1;AKT1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),-0.5561637181238206,-0.9481118922463928,0.5714285714285714,1.0,1.0,1/11,0.78%,DPYS
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.5631838002474684,0.9480726473089672,0.6111111111111112,1.0,1.0,4/10,10.62%,SERPINF2;SERPINE1;NLRP7;GAS1
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.5840517171566456,0.9479961200066277,0.5142857142857142,1.0,1.0,3/6,9.80%,CHRNA4;NLGN3;DRD4
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),-0.5964467287218208,-0.9474694005822667,0.6153846153846154,1.0,1.0,1/6,3.73%,RIT2
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),0.6397694470144242,0.9474277392952887,0.6666666666666666,1.0,1.0,3/5,24.08%,VKORC1L1;CYP4F11;CBR1
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),-0.5285498647570567,-0.9473969888837864,0.6119402985074627,1.0,1.0,4/14,15.77%,RMI1;FANCM;TOP2A;MEIOB
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.39611851123268316,-0.946989948327107,0.4927536231884058,1.0,1.0,21/105,13.68%,FRY;NPY;PTPRM;CFAP126;STMN2;L1CAM;GPRIN3;GPM6A;RAB11A;CSF1R;LAMB1;LGI1;STX3;CYFIP1;SH3GL2;CDK5R1;ATP1B2;CARMIL1;MANF;MAP2;LYN
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),-0.6503385354700801,-0.9469590163147611,0.6507936507936508,1.0,1.0,3/5,32.28%,FYN;NTRK2;BDNF
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-0.6210044877730844,-0.9468034309019738,0.5740740740740741,1.0,1.0,2/5,31.75%,TPRKB;OSGEP
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.378050622695629,0.9466354755245445,0.47368421052631576,1.0,1.0,14/64,17.85%,ACADS;ABHD2;ACAA2;CROT;ACADVL;ECHS1;PEX2;ECI1;LPIN3;ACAT2;ACOX1;HSD17B10;ACAD10;PECR
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.5914806564964468,-0.946520988414154,0.6865671641791045,1.0,1.0,3/9,14.64%,SMOX;HNMT;LRTOMT
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.43571461429637015,0.9460406434091274,0.5416666666666666,1.0,1.0,3/26,4.29%,NUPR1;PYHIN1;OSBPL7
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.5803560504785742,-0.9457055519986642,0.639344262295082,1.0,1.0,3/7,13.00%,SLC22A4;SLC25A48;SLC22A3
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.6313351585044271,-0.9456507989438498,0.5892857142857143,1.0,1.0,1/6,9.90%,TTLL4
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),-0.46558635533164644,-0.9455924593615334,0.5454545454545454,1.0,1.0,6/30,13.36%,NYAP1;EDN1;MYO16;HTR2B;CD160;HTR2A
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.3697147041753823,0.9455206725637078,0.5769230769230769,1.0,1.0,40/233,14.06%,NGF;TNFRSF8;USP27X;UBC;HMGB1;AIFM2;KLF11;VAV1;SCRIB;TNFAIP8;SAP18;FANK1;KNG1;HMGA2;MCF2L;SLIT2;ATF4;NCSTN;SPHK2;IP6K2;ITGA6;C3ORF38;BAK1;ABL1;CRADD;TCTN3;PRR7;RYBP;CASP9;PTPA;UBB;MAPK8;PIDD1;RRP1B;LATS2;CCAR1;MELK;BCL10;NOS2;DDX3X
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.4957580414118545,0.9451027867049913,0.46875,1.0,1.0,4/13,12.09%,CRHBP;CASQ2;TRPV1;RYR1
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.36928741780551705,-0.9448807839118892,0.589041095890411,1.0,1.0,30/162,19.52%,ANGPT1;IRGM;MUSK;ALG10B;SOX9;HGF;FGF22;CCND1;CSF1R;HLA-DRB1;TEK;LRRK2;TERF2IP;KNDC1;EFNA1;CAMK1;CALM3;LYN;ATG10;FGF7;VEGFA;EFNA5;EGFR;RAMP1;NTRK3;FLOT1;TGFB1;GAS6;NNMT;RASGRP1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.6140892497559676,-0.9447551564965684,0.5789473684210527,1.0,1.0,3/6,18.94%,NINJ1;IFI35;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.543545876620432,0.9442534563299264,0.5909090909090909,1.0,1.0,1/6,8.58%,TNIP1
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.3453002432713401,0.9439589753740882,0.3870967741935484,1.0,1.0,20/164,12.39%,PASK;DHFR;TCOF1;RIDA;ZNF598;PIWIL2;PLD1;EIF4E2;PUS7;EIF5;NAT10;EIF3B;EIF3E;EIF1;EIF3D;SAMD4A;RPS6KA1;NOLC1;NCL;NIBAN1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.49604989060335525,0.9438947304396557,0.5,1.0,1.0,10/16,33.21%,DDX3X;POLR2D;YTHDF1;MTOR;LARP1;RPS6KB1;KHDRBS1;UHMK1;CDC123;BOLL
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),-0.5676775256828946,-0.9438347045837145,0.640625,1.0,1.0,2/8,6.37%,NR4A3;CCND1
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.5623757566509601,0.9437637934576654,0.4722222222222222,1.0,1.0,2/7,4.10%,ABCC2;ABCC1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.5060707557054382,-0.943696691351024,0.5333333333333333,1.0,1.0,4/19,10.72%,HEY1;SOX9;SGMS2;CEBPB
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.655928056959542,-0.943654177165266,0.5573770491803278,1.0,1.0,2/5,18.43%,LYN;LILRB1
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.5569842656583216,-0.9436324795827148,0.5555555555555556,1.0,1.0,7/11,29.40%,TTN;FHOD3;MYLK3;NEB;NEBL;PDGFRB;PROX1
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.5678535060600095,-0.9433488676032808,0.6440677966101694,1.0,1.0,1/9,8.01%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.5678535060600095,-0.9433488676032808,0.6440677966101694,1.0,1.0,1/9,8.01%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),-0.6321721833089379,-0.9432224106408469,0.6333333333333333,1.0,1.0,2/5,8.45%,CITED2;LMO3
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),-0.6400745813510167,-0.9431653805003342,0.625,1.0,1.0,3/5,31.55%,SDC4;SDCBP;TSG101
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),-0.635631368109858,-0.9429748953173372,0.5714285714285714,1.0,1.0,3/6,25.10%,LRRK2;RBX1;MTA1
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.5007751270989532,-0.942691470641387,0.5517241379310345,1.0,1.0,7/29,23.33%,AQP1;MAP3K5;ZNF580;TRPM2;PRKCD;PPIF;IMPACT
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.5641228257739288,-0.9418858261706015,0.6,1.0,1.0,1/10,11.67%,H1-0
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.42572026423822806,-0.9418098359365952,0.5862068965517241,1.0,1.0,13/48,13.46%,HLA-F;PTPRC;HLA-E;SLA;AOAH;CD53;GBP2;SELL;HLA-DPB1;GPR183;IKZF2;IL16;ITK
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.549294286393795,-0.9413328221172884,0.6181818181818182,1.0,1.0,3/13,18.39%,STAT5A;LYN;STAT3
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.496097036434752,0.9412183209009196,0.4186046511627907,1.0,1.0,7/32,13.69%,SLC22A2;SLC38A1;SLC47A1;LRRC8A;SLC6A13;SLC7A5;SLC12A4
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),-0.4731707262148991,-0.9410147719687263,0.5396825396825397,1.0,1.0,10/28,23.59%,SEMA3E;SEMA3D;TRIM46;SEMA4G;MAP2;SEMA4B;KIAA0319;SEMA6A;SEMA7A;SEMA6B
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),-0.6034251305251901,-0.9404843409962796,0.6307692307692307,1.0,1.0,5/6,30.57%,FERMT3;CX3CL1;ITGB1BP1;FN1;COL16A1
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.5867834164270835,-0.9404370308000861,0.6,1.0,1.0,3/8,23.60%,ENTPD1;ENTPD3;ENTPD2
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),-0.4385067552902101,-0.9402421986146079,0.5882352941176471,1.0,1.0,10/55,19.30%,TGFB2;TTN;FRMD4A;BMP6;TGFB3;MYH10;DNM1L;TGFB1;TMED10;KIF20B
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.37735390314951883,0.9401551225326382,0.64,1.0,1.0,33/251,11.00%,NGF;TNFRSF8;NUPR1;USP27X;UBC;HMGB1;AIFM2;KLF11;VAV1;SCRIB;TNFAIP8;SAP18;FANK1;KNG1;HMGA2;PTGIS;MCF2L;SLIT2;ATF4;NCSTN;SPHK2;IP6K2;ITGA6;C3ORF38;BAK1;ABL1;CRADD;TCTN3;PRR7;RYBP;CASP9;PTPA;UBB
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.4139278680434412,-0.9399925746301558,0.5405405405405406,1.0,1.0,19/77,12.78%,FSTL1;ADAMTS5;SFRP4;ASPN;ACTA2;FAP;AQP1;COL4A1;ECM2;SYNPO2;TEK;SEMA3D;GJA1;RUNX1T1;SULF1;MYH11;THY1;C1R;PRKG1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.49530320239953074,-0.9399562452534224,0.5625,1.0,1.0,14/20,38.93%,PGK1;GAPDHS;PFKM;GPI;PFKL;TPI1;ALDOB;HK2;PFKP;PGAM2;PKM;FOXK2;ENO2;ENO1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.49530320239953074,-0.9399562452534224,0.5625,1.0,1.0,14/20,38.93%,PGK1;GAPDHS;PFKM;GPI;PFKL;TPI1;ALDOB;HK2;PFKP;PGAM2;PKM;FOXK2;ENO2;ENO1
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.5311889296964548,-0.9397642635343522,0.5285714285714286,1.0,1.0,6/17,24.80%,IHO1;RNF212B;MEIOB;KASH5;SYCP1;FANCD2
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.4483354049907192,-0.9397602253772239,0.5846153846153846,1.0,1.0,9/42,20.52%,HEY1;BHLHE40;B2M;CX3CR1;TRIM32;PAX6;OPRM1;CX3CL1;PRUNE1
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.49183817573187755,0.9395636668096577,0.425,1.0,1.0,2/15,6.64%,TNNC2;PLCE1
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),-0.46543539607017637,-0.9395523121898551,0.5492957746478874,1.0,1.0,6/28,14.39%,TTC8;MYO7A;ADGRV1;SCN9A;CDH23;GNAL
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.3818272709140269,0.9392022464249242,0.4230769230769231,1.0,1.0,2/75,0.98%,NGF;PM20D1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.4174669623877568,-0.9390223655789055,0.5245901639344263,1.0,1.0,6/47,12.92%,TERF2IP;POLQ;RADX;H1-0;KLHL15;MAGEF1
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.49624765508577323,-0.9388815656984811,0.5081967213114754,1.0,1.0,4/18,12.21%,TGFB2;TGFB3;ABCB4;CAV1
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),0.5679526753527104,0.9386287283385496,0.5952380952380952,1.0,1.0,1/7,3.98%,SOAT2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.5717958208617493,-0.938522037053869,0.582089552238806,1.0,1.0,1/9,6.64%,RPS6KA6
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.5334778613030715,-0.9384697842428263,0.5915492957746479,1.0,1.0,5/14,17.37%,PPARG;MEF2C;TGFB3;PRKG1;CDKN1A
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.4672491023025006,-0.938000868135605,0.589041095890411,1.0,1.0,9/36,18.61%,RND2;NCKAP1L;RHOC;FHOD3;RAC3;PPP2R3C;FHOD1;RHOH;TRPV4
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.6033893272613824,0.937709028488368,0.5952380952380952,1.0,1.0,3/5,15.67%,CRHBP;SLC12A2;DLG2
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.6033893272613824,0.937709028488368,0.5952380952380952,1.0,1.0,3/5,15.67%,CRHBP;SLC12A2;DLG2
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),-0.580988634517875,-0.9376989861796503,0.6379310344827587,1.0,1.0,2/9,17.44%,CDK5R1;GRIN3A
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),-0.4903927130647313,-0.937315567547879,0.6,1.0,1.0,2/22,8.08%,SFRP4;SPEF2
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.47208920490100004,-0.9372595637099789,0.5151515151515151,1.0,1.0,6/27,18.91%,E2F1;RUNX1T1;WWTR1;ZFPM1;WNT5A;TGFB1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),-0.5372211642617764,-0.9371764226958325,0.5396825396825397,1.0,1.0,2/13,11.81%,CHKB;ETNPPL
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.41484581568424256,-0.9371495891978504,0.5245901639344263,1.0,1.0,13/67,17.82%,GCNT1;ALG10B;B3GALNT1;ST3GAL5;CHST9;CSGALNACT1;ALG1L2;ST8SIA3;B3GALT1;BMPR1B;PMM2;CHST8;B3GALT2
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),-0.6083375672150244,-0.9370898126469657,0.6166666666666667,1.0,1.0,2/8,18.18%,LRRC4;NRXN1
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.4398067449648478,0.9370116587284734,0.42424242424242425,1.0,1.0,9/39,12.79%,ZDHHC16;ADAMTS18;FREM2;MEIS1;ABCB5;CEP290;PBX4;HES5;PBX3
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),-0.6292930814433315,-0.9369531588749105,0.5735294117647058,1.0,1.0,1/7,3.81%,CARMIL2
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.37994058998118324,-0.9368989237149938,0.5909090909090909,1.0,1.0,29/142,18.91%,ITGB4;IGFBP3;COX7A1;PPP1R3C;CLU;MEF2C;NOS1;FABP3;AGL;BHLHE40;CTF1;WWTR1;MYH11;CKMT2;CDH13;SLC6A8;PKIA;CAV3;KCNH2;DENND2B;ABLIM1;FKBP1B;IFRD1;GADD45B;CDKN1A;SGCA;PFKM;TGFB1;CAMK2B
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.5461198108361444,-0.936828566639894,0.546875,1.0,1.0,3/11,17.37%,PRAME;DHRS3;EZH2
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.4635003245467345,0.9367765866612733,0.5227272727272727,1.0,1.0,6/18,17.59%,TTLL9;TTLL1;VKORC1L1;TTLL11;AGTPBP1;TTLL3
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),-0.640510496953629,-0.9366153489794575,0.65,1.0,1.0,3/5,23.74%,TACR1;RNASE10;TAC4
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),-0.640510496953629,-0.9366153489794575,0.65,1.0,1.0,3/5,23.74%,TACR1;RNASE10;TAC4
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),-0.640510496953629,-0.9366153489794575,0.65,1.0,1.0,3/5,23.74%,TACR1;RNASE10;TAC4
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),-0.640510496953629,-0.9366153489794575,0.65,1.0,1.0,3/5,23.74%,TACR1;RNASE10;TAC4
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.5645752281227667,0.9364904976748583,0.5405405405405406,1.0,1.0,1/7,6.01%,EIF4E2
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.5645752281227667,0.9364904976748583,0.5405405405405406,1.0,1.0,1/7,6.01%,EIF4E2
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),-0.634368530794951,-0.9363238524182813,0.6666666666666666,1.0,1.0,2/5,19.76%,CX3CR1;CX3CL1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),-0.5358910761969535,-0.936064041023271,0.5384615384615384,1.0,1.0,2/13,14.77%,ENOX2;CYB561
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.5801189024174257,-0.9359770069172996,0.6290322580645161,1.0,1.0,2/7,28.41%,RAD50;NBN
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),-0.4055492152798967,-0.935495010558495,0.5714285714285714,1.0,1.0,18/80,16.95%,ANGPT1;CHST1;PRELP;CEMIP;OGN;HS3ST1;XYLT2;CHST2;CHST9;CSGALNACT1;GPC5;GPC6;CHST15;UST;B4GALT6;GPC3;OMD;CSPG5
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.42646557068250296,-0.9352606310745396,0.53125,1.0,1.0,4/51,11.42%,CTSO;FAP;DENND3;ADAMTS7
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.5449972118178352,-0.9351336954319973,0.5873015873015873,1.0,1.0,4/11,6.83%,ANGPT1;CLDN5;DDAH1;CEACAM1
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),0.5150057433557973,0.935003588699688,0.5,1.0,1.0,2/10,6.22%,HDC;TPH2
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.5979766853592301,-0.9349681680197288,0.6440677966101694,1.0,1.0,4/6,31.34%,GRIN2B;VPS35;APOE;FYN
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),0.531114546021486,0.934689180703032,0.5555555555555556,1.0,1.0,1/9,1.02%,CRYAB
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.5056068069997128,0.9346686426076982,0.5428571428571428,1.0,1.0,5/14,17.06%,ANXA2;SCRIB;OPTN;SNCA;INPP5F
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.6554498075486216,-0.9342979905265433,0.6666666666666666,1.0,1.0,1/5,13.33%,CALM3
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.5593519661839838,0.9342286700591839,0.5454545454545454,1.0,1.0,4/7,36.65%,ZFAND1;KIF5B;VCP;DHX8
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.540728712273909,-0.9337911917637784,0.5797101449275363,1.0,1.0,3/13,18.98%,DGKD;TNK2;PIK3CB
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.46573374858285105,0.9334895990993602,0.5,1.0,1.0,6/23,17.46%,PRELID2;MTTP;PRELID1;PITPNM1;ABCA3;NPC2
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.4628806148896806,-0.9326719078240852,0.6153846153846154,1.0,1.0,9/34,23.50%,TTN;SMC4;NCAPH;H1-0;TOP2A;NCAPG2;CHMP1A;NCAPD3;NCAPG
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),-0.5709354570481409,-0.932659848034632,0.65625,1.0,1.0,1/7,1.52%,NR4A3
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),-0.635610353044057,-0.9326527411949641,0.6923076923076923,1.0,1.0,3/5,18.91%,FRMPD4;CAMK1;CAMK2B
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.5478274062560256,0.9324924611582492,0.52,1.0,1.0,2/8,3.27%,AGER;HMGB1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.40894375671546684,-0.9324597557101496,0.5606060606060606,1.0,1.0,22/86,14.68%,HLA-F;PLSCR1;HLA-E;TGFB2;SFTPD;BIRC3;IRF1;IRF4;ADCY7;HLA-A;SELL;PIANP;FGL1;HLA-DRB1;ERAP1;B2M;SAMHD1;CD160;CD200;LYN;NCR3LG1;RSAD2
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.4677078128103484,-0.9321860055219648,0.5945945945945946,1.0,1.0,6/33,15.12%,TGFB2;INHBC;BMP6;TGFB3;RBPMS;BMPER
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),-0.4018031280785268,-0.9321408474146298,0.5753424657534246,1.0,1.0,27/106,24.77%,MEF2C;EPHA4;NEDD4L;CEACAM1;WTIP;LRRK2;KNDC1;ZDHHC15;HECW1;CDK5R1;PAK3;SIPA1L1;CRB2;CHN1;CLDN4;BMPER;EFNA5;ZMYM6;CDK5;TGFB1;PID1;BCL6;PLXND1;KIF1A;PAK1;WARS1;EPHB3
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3872183144103601,-0.9321371862111723,0.6567164179104478,1.0,1.0,23/114,19.76%,ROR1;TLR2;CLU;TRIM5;TERF2IP;TRIM22;NLRP3;CX3CR1;TRIM25;CAV1;AR;NOD1;PRKCQ;TRIM32;PRKD2;WNT5A;STAT3;CLOCK;FLOT1;TIRAP;NFKBIA;PRKCZ;CX3CL1
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.5564818135878624,-0.9319040367597001,0.5806451612903226,1.0,1.0,2/9,3.94%,IL12A;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.5168591304865497,0.9318366043780623,0.5609756097560976,1.0,1.0,7/14,21.62%,PAX8;CHRNA7;MAPK8;NFKB1;TMEM106A;EGF;APP
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.34296069311767285,0.931774840409862,0.5555555555555556,1.0,1.0,70/276,24.78%,U2AF1;SF3A3;LSM7;RNF113A;PRPF4;SF3B2;CRNKL1;RALY;PTBP1;PCF11;SNRPC;RBM8A;CPSF4;POLR2K;CSTF2;KIN;SNRNP25;SYMPK;GEMIN6;PPIL1;CCAR1;HNRNPU;PDCD7;RBM17;DNAJC8;ERCC2;POLR2L;HNRNPH1;CWC27;YBX1;SNIP1;RBM15B;DHX9;GTF2H5;SRSF8;GEMIN5;SF3A2;SARNP;HNRNPA2B1;CDC5L;DDX5;THOC2;SNRNP35;CELF1;RBM22;RBM5;SF3A1;CMTR2;CSTF1;MAGOH;ALYREF;POLR2E;ERN1;ZMAT2;HNRNPR;SNRPB;SRSF9;HNRNPC;BCAS2;HNRNPM;GPATCH1;POLR2D;PUF60;TRA2A;RBM19;CCNH;WBP4;DDX41;DDX46;SF3B4
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.5090380105360165,-0.9316514419109603,0.5909090909090909,1.0,1.0,4/21,13.14%,EDN1;VAV3;PRR16;CAV3
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.5743057074056318,-0.9316328474310812,0.6176470588235294,1.0,1.0,2/9,14.50%,CAV1;AXL
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.5944679756226631,-0.9316050056542813,0.6981132075471698,1.0,1.0,1/7,10.79%,RIN3
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),-0.5612748697989203,-0.9312966467110472,0.6,1.0,1.0,2/7,14.61%,MFNG;NOTCH2
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.4335571269627062,-0.9312248885405768,0.582089552238806,1.0,1.0,7/67,12.21%,ARIH2;CLU;PRICKLE1;RNF217;LRRK2;RNF144B;CAV1
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),-0.6011864642294473,-0.9310747330699812,0.6206896551724138,1.0,1.0,4/6,39.65%,NRL;BBS4;RORB;RPGRIP1L
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.4969693736897778,0.9309149667727331,0.5833333333333334,1.0,1.0,7/17,16.04%,KNG1;AJAP1;CRK;SERPINE1;CASK;SLC12A2;TFPI
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.44677586205737696,0.9306098332820907,0.5,1.0,1.0,10/30,26.07%,PIH1D1;RNF152;DGKQ;SESN1;CASTOR2;SEH1L;GPR137B;KPTN;C9ORF72;TELO2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.5009207330530203,-0.9305412655053746,0.59375,1.0,1.0,6/19,23.45%,PPARG;CAV1;LRP1;NFKBIA;RXRA;ABCA12
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),-0.6260286461840587,-0.9305009754410245,0.6290322580645161,1.0,1.0,2/5,21.37%,BRCA1;CDH1
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),-0.6260286461840587,-0.9305009754410245,0.6290322580645161,1.0,1.0,2/5,21.37%,BRCA1;CDH1
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.5969419950649554,-0.929927352197081,0.6133333333333333,1.0,1.0,2/7,8.31%,TLR2;B2M
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.5969419950649554,-0.929927352197081,0.6133333333333333,1.0,1.0,2/7,8.31%,TLR2;B2M
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.5080641222759367,-0.9297554935170365,0.6,1.0,1.0,2/15,9.31%,SNAP25;STX3
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.542764016991593,-0.9296892294498353,0.5901639344262295,1.0,1.0,2/10,16.73%,TMOD1;LMOD1
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),0.5348050027672273,0.9295875571846756,0.5714285714285714,1.0,1.0,2/9,9.33%,DPEP1;ALDH4A1
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.405712016599316,-0.9294785810293906,0.5901639344262295,1.0,1.0,18/95,22.79%,PEX11A;HSD11B2;CACNA1B;SLC25A19;ABCB4;YWHAH;DLG4;TOP2A;DHRS3;ABCD2;ABCB1;SIAH1;ACSL5;ACOT8;VPS4B;GSTK1;LONP2;RETSAT
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.48199714084796064,-0.9293426622354224,0.582089552238806,1.0,1.0,10/19,20.50%,TRPM1;JPH4;SLC8A1;GRIN2B;GRIN2D;ITPR3;TRPV4;JPH3;TRPM2;CACNA1C
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.5341666302554348,0.9293420429644471,0.625,1.0,1.0,5/13,20.20%,PUS7;DKC1;PUS1;RPUSD2;PUS10
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),0.4597723099549611,0.9291428109095901,0.5161290322580645,1.0,1.0,9/24,18.42%,VASH1;HMGA2;RSL1D1;CDK6;CGAS;PNPT1;YBX1;SLC30A10;ZKSCAN3
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.4194113939687193,-0.9290921066641417,0.5833333333333334,1.0,1.0,10/44,19.34%,CLDN5;TEK;THY1;CAV1;EPHB1;CLSTN3;VEGFA;NRXN1;FLOT1;PTPRJ
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.5216069326655101,0.9290538392783694,0.5333333333333333,1.0,1.0,2/9,4.18%,MALT1;NFKBIZ
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.4479227973004691,0.9287311953704512,0.5,1.0,1.0,9/24,28.76%,MTMR11;MTMR2;INPP5F;MTMR12;SYNJ2;INPP5J;MTMR10;MTMR9;MTMR3
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.5017414528610551,-0.9286282395349302,0.6,1.0,1.0,1/31,0.75%,MDFIC
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.4796115399781652,-0.9283002007955987,0.559322033898305,1.0,1.0,5/25,7.76%,CPS1;NOS1;ASAH2B;ARG2;MTARC2
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.46725047401238884,-0.9281052563322993,0.6338028169014085,1.0,1.0,5/26,22.96%,GLRA2;XBP1;VEGFA;NEURL1;GLRA1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.5102676045531631,-0.9279908293687557,0.5538461538461539,1.0,1.0,1/17,2.84%,CLU
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.32716364119583907,-0.9279621951363606,0.7727272727272727,1.0,1.0,109/852,18.92%,PARP14;FSTL1;PTPRM;IGFBP3;ISG15;SPARCL1;PTPRC;ASB4;CHRM3;FBXL16;TIMP1;PAK5;TGFB2;PARP9;IGFBP4;ALG10B;MACROD1;ASB18;PRSS23;GLRX;LAMC1;FBXW9;TGFBR2;PSMB8;PRKAR1B;GMFG;PIM1;MAP3K21;PIGH;FUCA2;RAB11A;B3GALNT1;PEAK3;BMX;CST3;TSSK3;MAP3K5;ST3GAL5;LRRK2;DCLK1;AFP;PTPRG;SCG2;FBXL18;LAMB1;USP6;FBXO41;FBXL13;RAB3A;HUNK;CPE;CHGB;OGFOD1;MEPE;LTBP1;SCG3;CAMK1;COQ8B;PAK3;PP2D1;ALG1L2;ASB14;ST8SIA3;PRKG1;STK17B;CP;LYN;B3GALT1;BMPR1B;CHRDL1;DAPK1;GLYCTK;FBXL5;ATG10;GRK6;DAPK3;PRKD2;FBXO10;CCNF;PTPRR;UST;FBXO7;PTPRT;RAB1B;STK17A;PTPRZ1;PTPRB;RCN1;FBXO17;FCGR3A;PMM2;GPC3;MYLK3;HIF3A;SYK;MAP3K12;GAD1;CDK5;B3GALT2;PNPLA2;PTPN13;PPP3CA;FBXO31;ANKRD9;PLK2;PSMC3;TGFB1;CAMK2B;GAS6
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.48230481960109783,0.9276654741694693,0.5609756097560976,1.0,1.0,1/14,1.41%,B4GALNT2
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),0.5899273443646751,0.9275278782861115,0.6666666666666666,1.0,1.0,2/8,24.20%,MBD4;SMUG1
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.4939695418208786,-0.9273619431574655,0.5797101449275363,1.0,1.0,2/19,7.06%,PTPRC;CSF1R
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.5495415469277064,-0.9273513734671401,0.6166666666666667,1.0,1.0,6/13,32.09%,SMPD3;VPS4B;SDC4;SDCBP;TSG101;VPS4A
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.5304445583108682,-0.9268118442207407,0.6142857142857143,1.0,1.0,8/15,23.24%,LRRK2;CX3CR1;VEGFA;DISC1;CX3CL1;PTN;TAFA1;FZD3
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),-0.6269510846470927,-0.9266618198987363,0.6774193548387096,1.0,1.0,3/5,29.40%,VEGFA;CCBE1;PROX1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.4162878717789885,-0.9265880248629214,0.5866666666666667,1.0,1.0,12/53,19.76%,PLEKHA2;UTRN;ECM2;CDH13;CARMIL1;RAC3;CSPG5;SKAP1;DMTN;FBLN2;NEDD9;CX3CL1
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.48723207924491657,0.9264276363071446,0.631578947368421,1.0,1.0,3/14,11.39%,ERI1;INTS14;INTS8
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.40968002761419486,0.9264132371172459,0.5428571428571428,1.0,1.0,14/32,28.18%,OTUD3;MAGI2;PHLPP1;THEM4;SIRT1;CIB1;PKHD1;MSTN;AKT1;BANK1;PPP2R5B;PHLDA3;PLEKHA1;DDIT3
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.4570825346701266,0.9264013863541931,0.5142857142857142,1.0,1.0,3/18,3.90%,PIWIL4;PIWIL2;SPOCD1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.4387354704223293,-0.92632324808985,0.6111111111111112,1.0,1.0,6/45,13.59%,NR4A3;MEF2C;GATA1;MOV10;ZFPM1;PRKCQ
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.40789767209403205,-0.926247724659016,0.6086956521739131,1.0,1.0,12/84,15.45%,NR4A3;PPARG;CYSLTR2;TSHR;PRKAR1B;ADCY7;CEACAM1;XBP1;CAV1;PDE3B;ADCY8;RAB15
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.5179413798945568,-0.9259275513318314,0.6290322580645161,1.0,1.0,4/16,19.76%,ACTL6B;SRRM4;B4GALT6;CX3CL1
prerank,GO_Biological_Process_2021__dehydroascorbic acid transport (GO:0070837),-0.6040430155401588,-0.9258325766455427,0.671875,1.0,1.0,2/5,15.68%,SLC23A1;SLC2A2
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.5070110686397735,0.9257583156743064,0.6585365853658537,1.0,1.0,4/26,13.69%,NUTF2;NUP42;RANBP17;TPR
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),-0.603404175719689,-0.9253774922316486,0.6060606060606061,1.0,1.0,1/8,2.59%,ITGAM
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),-0.45208066596312024,-0.9253344111128584,0.5833333333333334,1.0,1.0,11/42,19.12%,KIAA1614;FES;LRRK2;TRIM46;MAP2;ADGRE2;LYN;EFNA5;NR1D1;TTL;PARD6A
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.4675658973578779,-0.9250541297815413,0.5857142857142857,1.0,1.0,10/31,14.19%,ISG15;MEF2C;ANO6;ADGRV1;BMP6;TGFB3;SLC8A1;CEBPB;BMPR1B;NELL1
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),-0.6003519901869084,-0.9249026351759352,0.6885245901639344,1.0,1.0,4/7,17.10%,FES;ADGRE2;LYN;SYK
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,-0.4080157486099743,-0.9248541550747892,0.5797101449275363,1.0,1.0,12/66,17.89%,RND2;NKAIN1;FBN3;RIMS4;TMEM200C;CACNA1B;INA;MEX3A;GPC3;ZNF663P;UNC5D;GABRB3
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.43742111310694903,0.9245739996693141,0.5121951219512195,1.0,1.0,11/31,24.50%,PKIB;TNKS2;MAP2K7;ATR;HNRNPA2B1;ACD;NAF1;CCT8;CCT2;CCT6A;CCT3
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.5441542149198004,0.9243191326365225,0.5454545454545454,1.0,1.0,2/8,17.38%,ENPP1;PEA15
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.4694609950554878,-0.9242738114218236,0.59375,1.0,1.0,10/33,25.54%,CENPK;MIS18BP1;CENPA;CENPL;CENPQ;ITGB3BP;OIP5;CENPI;CENPP;ANP32E
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.34818133110436295,-0.9240470161496905,0.6103896103896104,1.0,1.0,32/347,12.75%,CD44;ANGPT1;FSTL1;AVEN;FIGNL1;NCKAP1L;BCL2L2;BIRC3;CITED2;MEF2C;AQP1;APIP;SOX9;PIM1;HGF;ALOX12;TEK;IL7;GATA1;TCIM;TGFB3;RNF144B;NAIP;XBP1;CRLF1;HTR2B;CX3CR1;CAV1;PRAME;VSTM2L;RASA1;NAA38
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.4572056029706277,0.9240375782798368,0.5757575757575758,1.0,1.0,3/41,5.26%,NUPR1;LCK;NOC2L
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.6030604570772651,-0.9239608589838839,0.6226415094339622,1.0,1.0,3/5,29.38%,UBASH3B;DDR2;COL4A6
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.42104627277644086,0.9238777849517594,0.5588235294117647,1.0,1.0,6/33,4.75%,AGER;MALT1;HMGB1;PYHIN1;NLRP2;STMP1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.44453711527528167,-0.9237696963178106,0.5737704918032787,1.0,1.0,5/33,12.35%,P2RY12;MEGF11;ACTN1;GATA1;UBASH3B
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.4162307888913368,-0.9236975860961434,0.5714285714285714,1.0,1.0,6/54,10.42%,BIRC3;IRF1;PIK3AP1;ERAP1;SAMHD1;BST1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.400705221184958,0.923637816350579,0.5263157894736842,1.0,1.0,12/49,16.95%,ACADS;ACAA2;CROT;ACADVL;ECHS1;PEX2;ECI1;ACAT2;ACOX1;IVD;HSD17B10;ACAD10
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.5336525238260241,0.9234022742269598,0.525,1.0,1.0,3/8,11.46%,HMGB1;RAB7B;PTPN22
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),0.5640293990734684,0.9233347259679733,0.5609756097560976,1.0,1.0,2/5,17.80%,EXOSC8;EXOSC7
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),0.5640293990734684,0.9233347259679733,0.5609756097560976,1.0,1.0,2/5,17.80%,EXOSC8;EXOSC7
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),0.5640293990734684,0.9233347259679733,0.5609756097560976,1.0,1.0,2/5,17.80%,EXOSC8;EXOSC7
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),0.5640293990734684,0.9233347259679733,0.5609756097560976,1.0,1.0,2/5,17.80%,EXOSC8;EXOSC7
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.5832034668081508,0.9230258709926611,0.6444444444444445,1.0,1.0,1/6,0.91%,VDR
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.4946363028355318,-0.9228578345265185,0.6133333333333333,1.0,1.0,3/19,17.73%,PRXL2C;PFKFB2;GAPDHS
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.4946363028355318,-0.9228578345265185,0.6133333333333333,1.0,1.0,3/19,17.73%,PRXL2C;PFKFB2;GAPDHS
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.5008831271026442,-0.9225487415723337,0.5882352941176471,1.0,1.0,3/19,15.59%,TGFB3;PTPRR;VEGFA
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.4475402491065177,-0.9225170405449891,0.6025641025641025,1.0,1.0,2/37,3.87%,ARIH2;TRIM5
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),-0.5808780115723211,-0.9224971905450878,0.5967741935483871,1.0,1.0,1/7,7.20%,ALOX12
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.5114985500760761,0.922461979701764,0.5333333333333333,1.0,1.0,4/14,8.68%,F2;KNG1;EPHB2;SERPINE1
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.4352214962124626,-0.9224178360087409,0.5454545454545454,1.0,1.0,3/35,9.67%,GSAP;NEDD4L;FURIN
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.35614800032711846,-0.9223645007816764,0.65,1.0,1.0,41/275,18.67%,ITGB4;RND2;NEFL;LOXL4;FIGNL1;STMN2;TGFB2;VIM;COL4A1;RHOC;P3H2;LOXL3;FIGN;COL11A1;MYO7A;CST3;ACTN1;B2M;TLL1;FURIN;FAT1;MYO5C;MYH11;CARMIL1;TMOD1;COL10A1;ARHGAP25;HOOK1;SNCAIP;MYO1H;COL21A1;RAC3;LMOD1;SIAH1;ADAMTS14;KASH5;MYO1B;P4HA3;RHOH;TRPV4;CAMSAP3
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.6144396643557903,-0.9222637657977628,0.5423728813559322,1.0,1.0,3/6,26.70%,GMPPB;PMM2;GMDS
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.6074493799009127,-0.922160809921156,0.6481481481481481,1.0,1.0,2/7,13.77%,ITGAV;LRP1
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.41229039969658754,0.9221546412359278,0.59375,1.0,1.0,14/42,22.22%,HDAC10;PRDM5;FLNA;HDAC1;HDAC9;ZNF541;HDAC4;MIER3;SIRT6;HDAC3;SUDS3;TBL1X;SIRT1;SIRT7
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.5040159929670127,0.9220668232681085,0.5348837209302325,1.0,1.0,1/11,0.44%,SPIRE2
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.34789546438961777,-0.9219393952177491,0.6455696202531646,1.0,1.0,51/220,19.67%,LPL;TLR2;ISG15;PTPRC;IL26;HLA-E;IL12A;C5;IL6R;F3;IRF1;IRF4;C1QTNF4;HLA-A;LAPTM5;RFTN1;CSF1R;IL7;POLR3H;HLA-DPB1;CHI3L1;NLRP3;SULF1;XBP1;CEBPB;PLCB1;HTR2B;IL12RB2;CD200;ZFPM1;NOD1;IL16;ITK;PRKCQ;PRKD2;BRCA1;ZNF580;CXCL17;SCAMP5;POU2F2;SYK;SCIMP;WNT5A;STAT3;LILRB1;FLOT1;TGFB1;TIRAP;TMED10;RASGRP1;PRKCZ
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.4773283876774539,-0.9218187448149412,0.6140350877192983,1.0,1.0,8/26,22.06%,BAIAP2;BAIAP2L2;ADD2;DMTN;MYO1B;NEDD9;ADD1;SHROOM2
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.4720813610090556,-0.9217690192964773,0.5757575757575758,1.0,1.0,2/33,2.75%,STMN2;EPHA3
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.4186738846511082,-0.921722616726846,0.5333333333333333,1.0,1.0,4/39,13.14%,CLU;LAPTM5;MAGEF1;CAV3
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.6209376458584881,-0.9215194979634732,0.6865671641791045,1.0,1.0,3/6,14.66%,PDZK1;SLC22A4;SLC25A20
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.4884111667356191,-0.921460795296866,0.640625,1.0,1.0,5/22,12.59%,ARHGAP18;FCHSD2;ARHGAP28;PAK3;RASA1
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.46868653080738276,0.9214413035398489,0.6451612903225806,1.0,1.0,7/29,18.30%,SMYD1;PRDM5;DPY30;ASH2L;WDR5B;KMT2B;MEN1
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.5444669393369769,0.9213709647220797,0.5454545454545454,1.0,1.0,2/6,17.38%,ENPP1;PEA15
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.3967918390364349,-0.9206518123866774,0.6666666666666666,1.0,1.0,9/97,14.03%,CLDN5;TGFB2;FOS;TGFBR2;BMP6;TGFB3;FURIN;HJV;BMPR1B
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.39653110587921103,0.9204330337981,0.5714285714285714,1.0,1.0,9/69,11.39%,SNAPC3;TAF13;INTS14;CCNT1;TAF5;ELL;NABP1;POLR2K;INTS8
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.4848134039937705,-0.920407335150648,0.5223880597014925,1.0,1.0,4/22,10.39%,CPS1;NOX4;CBS;TST
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.576931040483173,-0.9202820709462767,0.559322033898305,1.0,1.0,5/7,35.97%,SREBF1;ATP5IF1;HAX1;MAPT;PINK1
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.5815868353677782,0.9200790167217093,0.6190476190476191,1.0,1.0,1/8,6.18%,ATF4
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),-0.5746721754440856,-0.9198898685641644,0.625,1.0,1.0,2/8,6.80%,NOS1;DDAH1
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.4280401513261675,-0.9198240534230214,0.5797101449275363,1.0,1.0,5/56,6.61%,FSTL1;PCOLCE;ACTA2;COL4A1;DKK3
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.5837220789298239,-0.919770681635855,0.6333333333333333,1.0,1.0,4/6,34.98%,POU5F1;LEO1;RTF1;PAF1
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.5555444913951961,-0.919147898524234,0.5166666666666667,1.0,1.0,1/8,10.20%,OGFOD1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.4670881374004981,0.9190613372552279,0.4838709677419355,1.0,1.0,4/18,12.92%,SLC22A2;SLC47A1;SLC6A13;SLC7A5
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.4742789764892314,-0.9184831691507533,0.5571428571428572,1.0,1.0,4/35,19.86%,ISG15;TRIM25;LILRB1;NLRC5
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),0.565263913966216,0.9184578086387487,0.6285714285714286,1.0,1.0,1/9,0.77%,SLC22A2
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.6225316380445217,0.9183915214590046,0.6744186046511628,1.0,1.0,3/5,34.33%,PIGT;GPAA1;PGAP1
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.4916398793998452,-0.918368704207641,0.6129032258064516,1.0,1.0,9/27,24.06%,CENPK;MIS18BP1;CENPA;CENPL;CENPQ;ITGB3BP;OIP5;CENPI;CENPP
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.49613982487464353,0.918328175427723,0.5121951219512195,1.0,1.0,4/9,22.48%,EXOSC8;EXOSC7;EXOSC5;DXO
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.6109330760192679,-0.9182467061935239,0.6481481481481481,1.0,1.0,3/5,28.00%,SREBF1;ATP5IF1;HAX1
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.4831449561532418,0.9182112915789491,0.5833333333333334,1.0,1.0,4/14,17.12%,SEC23B;MIA3;SEC31A;SEC24B
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.39067885806156366,-0.9181261098042952,0.64,1.0,1.0,21/94,24.32%,ISG15;CLU;LGALS3;SLF1;RPA3;RHOC;VEGFA;NRG1;SKAP1;SYK;HRK;PSMC3;TGFB1;TIRAP;RPA2;ABCA1;RBX1;XPA;ESR1;FERMT1;WARS1
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.4873625784785537,-0.9180574757272678,0.65625,1.0,1.0,2/24,3.42%,FMO5;ACADL
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.3918381688104819,-0.9178168432653101,0.6301369863013698,1.0,1.0,26/99,17.42%,FGL2;NR4A3;PTPRC;SLA;ITGAM;LGALS3;AOAH;CD53;PLAC8;HLA-A;LAPTM5;HLA-DRB1;HLA-DPB1;HLA-DMA;IGSF6;PTAFR;CX3CR1;SEPTIN6;LY86;AXL;ETV6;WDFY4;FCGR3A;PPL;SCIMP;TNFRSF1B
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.5022321841900916,0.9176714761206635,0.5227272727272727,1.0,1.0,2/13,12.10%,RASGRF1;KAT2A
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.4911716472038569,-0.9176632503989237,0.546875,1.0,1.0,8/20,22.70%,EDN1;MEF2C;EFNB2;NRG1;MYLK3;TGFB1;MESP1;RBM24
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",0.5540574190078598,0.9175784373981296,0.5952380952380952,1.0,1.0,1/5,4.29%,FBP1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.5155573517859111,0.9172518598928245,0.65,1.0,1.0,2/13,9.31%,SPHK2;ATPSCKMT
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.3877306727090629,0.9169588909790325,0.5161290322580645,1.0,1.0,3/38,3.48%,CRYAB;HMGB1;OPRD1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.49862381537772915,-0.9167540499607313,0.5645161290322581,1.0,1.0,2/14,9.44%,ISG15;SAMHD1
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.359719062957162,-0.9167233870321272,0.6666666666666666,1.0,1.0,33/194,16.55%,ANGPT1;ROR1;IRGM;EPHA3;MUSK;NCKAP1L;SOX9;MET;HGF;EPHA4;FGF22;CCND1;PRXL2C;CSF1R;HLA-DRB1;TEK;LRRK2;KNDC1;EFNA1;PFKFB2;IFNA2;EPHB6;EPHA6;AR;EPHB1;LYN;TIE1;AXL;FGF7;VEGFA;EFNA5;RAD50;EGFR
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.4506490569250829,0.9165995829230565,0.5526315789473685,1.0,1.0,7/22,21.62%,PPP1R10;EIF4EBP1;EIF4E;CDC25B;PRKCA;HSF1;APP
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),-0.5146186726875732,-0.9163492284614714,0.5714285714285714,1.0,1.0,1/11,4.21%,NOS1
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.5385443670574811,0.9158099995547752,0.6818181818181818,1.0,1.0,3/8,20.86%,PCM1;CEP120;DOCK7
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.4899515587314828,-0.9158097283931409,0.5972222222222222,1.0,1.0,3/15,18.91%,PLN;IL16;CAMK2B
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.44525889043721756,0.9157143799434698,0.5277777777777778,1.0,1.0,2/13,10.76%,NCK1;ATF6B
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.5920236300630328,-0.9151108976485116,0.6470588235294118,1.0,1.0,3/5,40.78%,HSPA5;BFAR;DNAJB9
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.5201915201274622,-0.914977543442734,0.6607142857142857,1.0,1.0,5/11,30.06%,FURIN;TNFRSF1B;ADAM9;APOE;SNX33
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.38904336894991637,-0.9148963632514943,0.618421052631579,1.0,1.0,29/87,25.60%,TTN;SYT1;SYT4;MEF2C;HPCA;ADGRV1;RYR3;ANXA11;KCNMA1;CAV1;CALM3;ADCY8;ITPR3;SYT13;DMTN;PPP3CA;WNT5A;SYT12;TRPM2;CPNE8;ADD1;PPIF;ADCY1;SLC25A12;KCNH1;KCNMB3;ADAM9;SYT7;TRPC3
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.6170673919816092,-0.9148881867616832,0.6964285714285714,1.0,1.0,3/6,21.77%,PRPS1;PRPSAP1;PRPS2
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.4934836031312857,-0.914506305688746,0.6285714285714286,1.0,1.0,4/27,17.78%,SEMA3E;RASA1;PLET1;DMTN
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),0.382655262593427,0.9144989538286797,0.5882352941176471,1.0,1.0,14/51,20.76%,NOC2L;RSL1D1;MDN1;SDAD1;NLE1;GTF3A;LTO1;RPL23A;WDR74;BRIX1;NPM1;RPL3;RPL11;NSA2
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.44354875164547863,-0.9144161752105133,0.5671641791044776,1.0,1.0,7/31,23.62%,NLRP12;STAT1;NR1D1;RHOH;PER1;TLE1;ESR1
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),0.5832595462983721,0.9143469206338408,0.627906976744186,1.0,1.0,1/6,3.98%,SOAT2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),-0.6144068084238941,-0.9142145828437073,0.6842105263157895,1.0,1.0,2/5,24.85%,KCNMA1;ADRB2
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.5002913671626044,-0.9140901872603376,0.581081081081081,1.0,1.0,2/21,9.57%,MET;ARHGAP28
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),-0.6038338373923996,-0.9140882230888681,0.6153846153846154,1.0,1.0,1/5,10.89%,SH3GL2
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.5146093780066332,-0.9140414165600256,0.6481481481481481,1.0,1.0,2/14,1.81%,COX7A1;SHMT2
prerank,PanglaoDB_Augmented_2021__Ductal Cells,0.40084594918668365,0.9140372577946541,0.6,1.0,1.0,12/48,12.08%,ONECUT1;RNF128;GPRC5C;LAMB3;ALDH1A3;CLDN2;GJB1;LGALS4;S100A16;EPS8L2;MYH14;KRT8
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.47281151676332495,-0.9140206814561157,0.609375,1.0,1.0,7/19,34.02%,HLA-DRB1;AXL;TYRO3;FMR1;TSG101;VPS4A;CD74
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.38149882392292517,-0.9138758612417057,0.6268656716417911,1.0,1.0,14/79,13.06%,LPL;TLR2;PLSCR1;P2RY12;TNFRSF1A;DDX60;NLRP12;NINJ1;STX3;BMP6;NMI;IFNK;IL16;IFI35
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.4799789062606117,-0.9136885136115875,0.5714285714285714,1.0,1.0,4/15,13.93%,P2RY12;GAP43;NREP;RTN4RL2
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.45392267291218724,-0.9136841682511175,0.5735294117647058,1.0,1.0,6/22,15.57%,PDZK1;GLRX;TRPC6;COX17;ATP1B2;ABCB1
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),0.5609241273939208,0.9135818576119223,0.6363636363636364,1.0,1.0,1/7,4.83%,CMPK1
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.34131412867469374,-0.9134065891889589,0.7464788732394366,1.0,1.0,26/332,11.09%,FSTL1;IGFBP3;SPARCL1;CHRM3;TIMP1;RPL31;IGFBP4;SFTPD;PRSS23;LAMC1;DENND3;PAPPA;PIGH;FUCA2;CST3;AFP;SCG2;LAMB1;USP6;FURIN;CPE;CHGB;MEPE;RPL38;LTBP1;SCG3
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.5219568083992793,-0.9132325668389903,0.6461538461538462,1.0,1.0,3/11,23.62%,EGFR;TGFB1;ESR1
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),-0.62629833730503,-0.9131206891508494,0.6885245901639344,1.0,1.0,2/5,16.31%,TOX;OPHN1
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),0.5592399972303939,0.913119759053778,0.5483870967741935,1.0,1.0,1/6,1.90%,SPX
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),-0.5312202236215291,-0.9131149137651429,0.5714285714285714,1.0,1.0,1/10,2.14%,RDH13
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.3891830777829355,-0.9130543339584783,0.6571428571428571,1.0,1.0,21/90,19.07%,RHBDF2;TGFB2;IL12A;TTN;CACNA1E;SNAP25;STXBP5L;FRMD4A;BMP6;TGFB3;KCNC2;KCNB1;RSAD2;ITPR3;SLC2A2;MYH10;DNM1L;CLOCK;RAPGEF4;TGFB1;TMED10
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.5180975553010712,-0.9129853269748528,0.5692307692307692,1.0,1.0,5/13,20.47%,TGFB2;CELF4;BRCA1;CAMSAP3;SCEL
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.47202116623482876,-0.9128892358186509,0.6333333333333333,1.0,1.0,8/26,22.06%,BAIAP2;BAIAP2L2;ADD2;DMTN;MYO1B;NEDD9;ADD1;SHROOM2
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.5839311735455893,0.9127611767675742,0.6086956521739131,1.0,1.0,1/5,3.27%,HMGB1
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.4367525744784164,-0.9123860847245625,0.5238095238095238,1.0,1.0,8/44,18.61%,STMN2;EPHA4;GRIN2B;ITM2C;YWHAH;RTN4RL2;EFNB2;TRPV4
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.3624579831533774,0.9122535886404556,0.5588235294117647,1.0,1.0,24/93,23.63%,U2AF1;RAE1;NUP42;NUP210;RBM8A;CPSF4;SYMPK;TPR;NXF1;EIF4E;NUP37;RBM15B;SARNP;HNRNPA2B1;THOC2;NDC1;MAGOH;SMG5;ALYREF;SEH1L;SRSF9;NUP85;NUP214;FYTTD1
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.5917498017338156,0.9120297055601961,0.6216216216216216,1.0,1.0,2/6,9.47%,EIF3E;EIF3D
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.4240061312006911,0.9120183227503597,0.6052631578947368,1.0,1.0,4/41,5.34%,GPC4;B3GNT6;SDC2;GPC2
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.4608348786055637,-0.9117336044960835,0.6268656716417911,1.0,1.0,9/30,20.52%,ARHGAP18;FCHSD2;ARHGAP28;PAK3;RASA1;MAP2;CAMSAP3;ABITRAM;PRUNE1
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.39298622744928535,-0.9115475721245624,0.696969696969697,1.0,1.0,25/127,18.61%,RND2;VIL1;BAIAP2;GAS2L3;TTN;CARMIL2;RHOC;BAIAP2L2;MYO7A;ACTN1;FAT1;MYO5C;CARMIL1;TMOD1;ARHGAP25;MYO1H;FHOD3;RAC3;LMOD1;FHOD1;KASH5;DMTN;MYO1B;RHOH;TRPV4
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.45744466736454004,-0.9115054555339747,0.6029411764705882,1.0,1.0,13/37,25.79%,COL4A1;TGFBR2;SLC1A1;CAV1;RASA1;VEGFA;EFNB2;SYK;TGFB1;LOX;HES1;FLT1;HEY2
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.46779788196546646,-0.9112206515469122,0.6521739130434783,1.0,1.0,3/25,11.91%,CHKB;ETNPPL;PLAAT4
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.4768348251428037,-0.9112131358628707,0.5517241379310345,1.0,1.0,6/24,12.42%,TGFB2;KITLG;SOX9;ADAM21;GATA1;AR
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.5522595455068472,-0.911180993793923,0.5945945945945946,1.0,1.0,4/10,19.07%,TLR2;B2M;PGK1;MRC1
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.5372072747140806,-0.9109586901298634,0.647887323943662,1.0,1.0,5/11,41.43%,ZFP36;RBM4;AGO4;NOTCH4;TNRC6A
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.5372072747140806,-0.9109586901298634,0.647887323943662,1.0,1.0,5/11,41.43%,ZFP36;RBM4;AGO4;NOTCH4;TNRC6A
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.4452767243348882,0.9107755309357934,0.5833333333333334,1.0,1.0,11/29,26.62%,PKIB;TNKS2;MAP2K7;ATR;ACD;NAF1;CCT8;CCT2;CCT6A;CCT3;MAP3K4
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.5478189625992074,-0.9106990644028766,0.65625,1.0,1.0,1/10,11.47%,CRB2
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.3990107607900028,0.9105049268939369,0.5945945945945946,1.0,1.0,14/43,22.22%,HDAC10;PRDM5;HDAC1;HDAC9;ELK4;ZNF541;HDAC4;MIER3;SIRT6;HDAC3;SUDS3;TBL1X;SIRT1;SIRT7
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.4065159646814136,-0.9103105256406011,0.59375,1.0,1.0,9/56,15.59%,BAIAP2;NCKAP1L;VAV3;SULF1;CYFIP1;ITGAV;AXL;PRKD2;VEGFA
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.3982043741357798,0.9100934530091106,0.48148148148148145,1.0,1.0,6/43,7.05%,TEAD2;NES;ALDH1A3;ATF4;GLI2;PDGFA
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.41900173986490824,0.9099698595127075,0.6111111111111112,1.0,1.0,6/31,11.46%,ZAP70;LCK;LEPR;LFNG;SOX13;PTPN22
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.5102157617433597,-0.9099161413413578,0.6612903225806451,1.0,1.0,9/18,20.40%,NTN4;NTNG1;LAMB1;MYH11;NTNG2;TGFB1;GAS6;LAMB4;LAMB2
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),-0.4382008134946526,-0.9099120747669441,0.6623376623376623,1.0,1.0,5/44,14.03%,TGFB2;BMP6;TGFB3;HJV;BMPR1B
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.4113378921961488,0.9098667707390875,0.6060606060606061,1.0,1.0,11/19,31.80%,CROCC;ARHGAP35;CEP120;ZMYND10;SAXO1;MARK4;HAP1;SEPTIN9;CCDC88A;HTT;ENTR1
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.3949071864975802,-0.9097039003411165,0.6285714285714286,1.0,1.0,5/66,3.94%,LPL;PLSCR1;PPARG;CLU;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.4052393450474292,-0.9094597615629038,0.676923076923077,1.0,1.0,10/66,12.70%,EPHA3;CLU;MCTP1;CARMIL2;LGALS3;FAP;BMP6;CARMIL1;AR;DNAJB1
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),-0.4857661609221202,-0.9094012695722078,0.5866666666666667,1.0,1.0,2/25,6.31%,RHBDF2;STXBP5L
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.4843427810298589,0.9092695911858677,0.5,1.0,1.0,3/18,20.17%,RGPD4;IPO5;CBLB
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.4442585222709219,-0.9092011977086905,0.5967741935483871,1.0,1.0,13/32,15.60%,CD59;CLU;C1QB;C5;SERPING1;CR1;IRF4;HLA-DRB1;C3AR1;C1R;C1QC;CPB2;C4BPA
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.5286252521412252,-0.9088893544798069,0.6461538461538462,1.0,1.0,2/11,15.59%,PRKD2;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.458457857925414,-0.9085965723642556,0.65625,1.0,1.0,4/29,13.62%,TP73;NMT1;E2F1;YWHAH
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),0.516694330019786,0.9084447843462322,0.6136363636363636,1.0,1.0,4/6,27.32%,RFT1;NPC2;CLN3;PLTP
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.5907156312048337,-0.9081961476915794,0.6031746031746031,1.0,1.0,1/5,8.14%,LZTFL1
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.36650278515391793,-0.9081870279331348,0.6885245901639344,1.0,1.0,22/136,15.57%,GGH;HLA-F;OLFM1;CCK;TUBA4A;IRF1;FOS;KLHDC3;SLC6A12;DGAT1;FURIN;NPTX2;TST;RFC4;SLC6A8;DNAJB1;GRINA;LYN;DLG4;KCNH2;IGFBP2;ABCB1
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.39296311763466835,0.9081519006330927,0.6578947368421053,1.0,1.0,6/55,5.24%,AGER;SERPINF2;HMGB1;SH3RF2;MFHAS1;DUSP15
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.4811575678727038,-0.9081458994170691,0.609375,1.0,1.0,6/22,15.61%,KCNS1;NEDD4L;ATP1B2;CAV3;KCNE1;NETO1
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),-0.5195925245315111,-0.9079995675960503,0.6111111111111112,1.0,1.0,4/14,12.10%,NEDD4L;SLC8A1;ATP1B2;ATP1A1
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.4375782785313652,0.9079942866831457,0.5757575757575758,1.0,1.0,3/35,2.67%,RFWD3;TONSL;OOEP
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.4085994170255961,0.9079043895659968,0.5405405405405406,1.0,1.0,2/23,11.00%,UBC;UBB
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.4758629860652754,0.9077610535307719,0.5882352941176471,1.0,1.0,3/12,25.05%,PJVK;PIK3R4;TRAPPC8
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.48403299510324976,-0.9077490087213644,0.6486486486486487,1.0,1.0,6/23,9.87%,IRGM;H2BC11;IL6R;AQP1;CHGA;PRB3
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),-0.4645701446668914,-0.9076820592061018,0.7368421052631579,1.0,1.0,11/32,23.59%,SEMA3E;MET;SEMA3D;SEMA4G;SEMA4B;PLXNA2;PLXNA4;SEMA6A;PLXND1;SEMA7A;SEMA6B
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),-0.6142666815036593,-0.9076358901976816,0.6833333333333333,1.0,1.0,3/5,36.56%,SETMAR;SETD3;SETD5
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.40166240162424094,-0.9076270881937651,0.6410256410256411,1.0,1.0,6/87,9.68%,ARIH2;CLU;PRICKLE1;RNF217;LRRK2;RNF144B
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),0.5235597786777343,0.9075648727995609,0.6842105263157895,1.0,1.0,1/9,1.80%,CYB5A
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),0.5120774222885183,0.907458116430244,0.6086956521739131,1.0,1.0,1/12,0.68%,NUPR1
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.4079877883903259,-0.9072181667403275,0.6779661016949152,1.0,1.0,5/63,11.67%,H2BC11;NAP1L2;SOX9;LIN54;H1-0
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.3641183665517686,-0.9070159888321313,0.6857142857142857,1.0,1.0,15/97,20.60%,LPL;PPARG;AOAH;ALOX12;XBP1;ACSM3;ABCD2;OXSM;LIPI;GGT5;ACSL5;GPX4;ACOT8;ACOT11;ACOT2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.3852699454218219,0.9069861873818853,0.5142857142857142,1.0,1.0,4/37,7.34%,SPIRE2;OOEP;MGMT;PPP4R2
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.5484855061067563,0.9067678327481933,0.5869565217391305,1.0,1.0,5/8,22.18%,EPHB2;RYK;NFIB;SMO;GDNF
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.4650628755859396,-0.9064542404593502,0.6417910447761194,1.0,1.0,6/26,25.15%,EDN1;MAP3K5;MAPK8IP1;ZNF675;PAK1;HIPK3
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),-0.5923331619207568,-0.9064060341150317,0.6842105263157895,1.0,1.0,4/5,30.78%,SLC6A7;SLC1A4;SLC6A15;SLC6A17
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.47021946822024235,-0.9063011255907669,0.55,1.0,1.0,7/20,22.39%,ABCC4;CEACAM1;SLC51A;ATP8B1;SLCO2B1;RXRA;SLC10A6
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.5897219799670831,-0.9062233880681806,0.6129032258064516,1.0,1.0,2/6,17.26%,SMOX;SAT1
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.4489947240918644,0.9061380172088215,0.5526315789473685,1.0,1.0,3/17,5.35%,SLC22A2;SLC25A29;SLC47A1
prerank,PanglaoDB_Augmented_2021__B Cells,0.40255843481037806,0.9061179818350302,0.5769230769230769,1.0,1.0,7/91,4.05%,CXCR4;CD38;CD72;EAF2;ITGAL;EVI2B;GPR174
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.49691015734989136,-0.9059917535943062,0.6363636363636364,1.0,1.0,5/22,22.80%,TLR2;EIF2B4;CSPG5;EIF2B2;MYRF
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.43733579716632437,-0.9052740597170827,0.6142857142857143,1.0,1.0,11/36,21.37%,SPINT2;CITED2;CEACAM1;PTPRG;TENM3;PTPRR;EFNA5;FERMT3;TGFB1;RNASE10;CDH1
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.5503917979068099,-0.9052435491556218,0.6229508196721312,1.0,1.0,2/8,12.42%,EFNA1;ZFPM1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",-0.5716937471911234,-0.9051056136034008,0.6176470588235294,1.0,1.0,1/5,15.06%,NOP9
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",-0.5716937471911234,-0.9051056136034008,0.6176470588235294,1.0,1.0,1/5,15.06%,NOP9
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),-0.5716937471911234,-0.9051056136034008,0.6176470588235294,1.0,1.0,1/5,15.06%,NOP9
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.5045660525405146,-0.905003260051914,0.6428571428571429,1.0,1.0,2/19,2.84%,HOPX;CLU
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.40990079235766774,-0.9049787332817582,0.6666666666666666,1.0,1.0,4/64,7.72%,TLR2;ISG15;IRF1;POLR3H
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),-0.594771781851299,-0.9048215216191284,0.6730769230769231,1.0,1.0,1/5,4.30%,ABCC4
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.5134563610121667,0.9048191194398266,0.5555555555555556,1.0,1.0,3/13,8.48%,EPHB2;RELN;CHRNA7
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.3683700922957006,0.904763071372475,0.48484848484848486,1.0,1.0,11/84,12.57%,PASK;TRMT10C;PIWIL2;PLD1;NAT10;EIF3E;EIF3D;SAMD4A;FASTKD3;NIBAN1;CNBP
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),-0.5933283166265843,-0.9046445187583243,0.6964285714285714,1.0,1.0,3/7,18.04%,KNDC1;OPHN1;CEND1
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.42374112266590264,-0.9044300061630863,0.6031746031746031,1.0,1.0,12/42,23.59%,SEMA3E;PDXDC1;SEMA3D;HTR2B;SEMA4G;GPC3;SEMA4B;AMOT;SEMA6A;SEMA7A;FAT2;SEMA6B
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.5709120319710739,0.9043881063027874,0.6153846153846154,1.0,1.0,5/5,42.92%,CTR9;CDK9;RNF20;KDM1A;RNF40
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.515659615056535,0.9042656471953784,0.5714285714285714,1.0,1.0,1/9,1.90%,SPX
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.42086320275542,0.9041453280040639,0.475,1.0,1.0,8/39,19.70%,PINX1;PKIB;GREM1;DKC1;MAP2K7;MEN1;ACD;NAF1
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),-0.4936456669536824,-0.903870782229938,0.6349206349206349,1.0,1.0,1/21,3.30%,DPY19L2
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),0.5470944042930389,0.903358753289386,0.6666666666666666,1.0,1.0,4/7,18.75%,NASP;CHAF1B;RBBP4;ASF1B
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),0.5470944042930389,0.903358753289386,0.6666666666666666,1.0,1.0,4/7,18.75%,NASP;CHAF1B;RBBP4;ASF1B
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.424418385689777,-0.9032865537897768,0.5735294117647058,1.0,1.0,3/45,7.25%,KDM4D;FIGNL1;RAD9A
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),-0.4763965281544676,-0.903068713520045,0.6338028169014085,1.0,1.0,4/18,7.38%,VSIR;CR1;LAPTM5;HLA-DRB1
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.4493986542428595,-0.9030440043684054,0.5666666666666667,1.0,1.0,4/24,19.68%,PIGH;PIGC;PIGB;MPPE1
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),0.569266074391951,0.9026540591419735,0.5869565217391305,1.0,1.0,3/6,12.54%,CDK6;HES5;DLL1
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.4178845253645005,-0.9025609683801448,0.7142857142857143,1.0,1.0,21/64,18.63%,TLR2;FGL2;ITGAM;C1QB;AOAH;GPIHBP1;CD53;LAPTM5;P2RY13;CSF1R;C3AR1;IGSF6;PTAFR;C1QC;LY86;WDFY4;FCGR3A;TNFRSF1B;CLEC5A;LILRB1;MSR1
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),-0.5774645765502099,-0.9025480206950347,0.6615384615384615,1.0,1.0,3/6,24.13%,FAP;PTPRJ;PAK1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.3955618661074131,-0.9024918797599762,0.6521739130434783,1.0,1.0,32/104,23.66%,RHBDF2;CYSLTR2;CR1;LGALS3;TSHR;PRKAR1B;ADCY7;HLA-DRB1;RXFP1;FURIN;GPR176;NMI;LYN;ADCY8;GNG2;FCGR3A;ADCYAP1R1;GGT5;SYK;RAMP1;PTH2R;LILRB1;PLK2;PLCG1;NPSR1;SPI1;HRH2;CD163;GPHB5;ADCY2;P2RY11;ADCY1
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.4961683203818575,-0.9024809532617559,0.6507936507936508,1.0,1.0,1/19,2.84%,CLU
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5304472312083429,-0.9022768525625213,0.6,1.0,1.0,3/10,7.38%,NCKAP1L;IRF4;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.3954525489301218,-0.9021217346620681,0.6212121212121212,1.0,1.0,18/63,19.76%,LPL;TLR2;IL6R;NCKAP1L;C1QTNF4;EOLA1;NLRP12;XBP1;CD200;IL16;POU2F2;SYK;SCIMP;WNT5A;STAT3;GAS6;TIRAP;CX3CL1
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.42347594306829184,-0.9021016906617549,0.6379310344827587,1.0,1.0,9/57,12.42%,NR4A3;KLF9;MEF2C;ROBO2;GATA1;XBP1;ATP1A1;CAV1;AR
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.4518650348043656,-0.9019810918702278,0.5806451612903226,1.0,1.0,4/33,17.34%,KDM3A;AR;TRERF1;NR3C2
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.40063748935497684,0.9018480482797917,0.5428571428571428,1.0,1.0,16/70,22.90%,U2AF1;PCF11;RBM8A;CPSF4;CSTF2;SYMPK;TENT4B;SARNP;PAPOLG;THOC2;CSTF1;MAGOH;ALYREF;APP;SRSF9;POLR2D
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.529137435588096,-0.9017453293551444,0.6,1.0,1.0,6/16,21.59%,E2F1;GATA1;SRP54;CDKN1A;SPI1;RXRA
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.4265890049940208,-0.9017189086305305,0.647887323943662,1.0,1.0,17/55,18.91%,PTPRM;IL26;TGFB2;KLF9;SOX9;CEACAM1;B2M;SCG2;SULF1;AQP11;CAV1;CAV2;CNMD;STAT1;NR2F2;HPN;TGFB1
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.42658339594245087,0.9016397089496186,0.6285714285714286,1.0,1.0,8/24,23.90%,UBE2A;CDC26;ANAPC1;UBE2D4;UBE2E2;CDC23;ANAPC2;UBE2L3
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),-0.48069140335899946,-0.9016060110088705,0.5352112676056338,1.0,1.0,3/14,11.06%,TRPC4;TRPC6;TRPC7
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.41097887798013943,-0.9015153038708338,0.6716417910447762,1.0,1.0,11/61,19.01%,NR4A3;BAIAP2;NCKAP1L;VAV3;WIPF3;CYFIP1;LYN;FCGR3A;SYK;PIK3CB;PLCG1
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.44070361602710445,-0.9014432369569236,0.6666666666666666,1.0,1.0,14/45,22.07%,GGH;SMIM22;MUC16;CEACAM1;TMC4;GALNT6;CLDN4;CXCL17;OVOL2;TJP3;CBLC;GPX2;CDH1;TMEM184A
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.5587265689644214,-0.9014211102003983,0.640625,1.0,1.0,3/8,12.78%,CEACAM1;ALOX12;PRKG1
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),-0.5525201186169766,-0.9013237928319371,0.6307692307692307,1.0,1.0,2/7,16.23%,CBS;MTHFD1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),-0.5749056733747161,-0.9012573500865809,0.631578947368421,1.0,1.0,4/8,39.35%,DYRK2;CHP1;FHL2;PRNP
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.5749056733747161,-0.9012573500865809,0.631578947368421,1.0,1.0,4/8,39.35%,DYRK2;CHP1;FHL2;PRNP
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.4951323942210228,0.9012166945403688,0.5641025641025641,1.0,1.0,7/10,30.89%,EXOSC8;EXOSC7;EXOSC5;DXO;EXOSC9;PCID2;XRN1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.39419660133159523,0.9011986246131659,0.4827586206896552,1.0,1.0,6/62,8.57%,SPIRE2;ESPL1;CEP55;TRIM36;RAB35;SEPTIN10
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.3834839016338674,-0.9007436931169661,0.56,1.0,1.0,16/75,26.93%,CENPE;HLA-DRB1;HLA-DPB1;HLA-DMA;DYNC1LI1;SH3GL2;ACTR10;KIF3C;AP1S2;KIF5A;KIF2C;ARF1;KIF3A;CANX;HLA-DPA1;DYNLL2
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.4017805709618496,-0.9007239140941172,0.6266666666666667,1.0,1.0,7/64,15.33%,F8;CD59;SAR1A;GRIA1;TGFA;MCFD2;RAB1B
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.6062946248662844,-0.9006250480711127,0.7142857142857143,1.0,1.0,2/6,18.46%,P4HTM;P4HA3
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),-0.5813431442147001,-0.9006149772383172,0.6333333333333333,1.0,1.0,4/7,23.44%,TYRP1;CDH3;OPN3;GIPC1
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),-0.5813431442147001,-0.9006149772383172,0.6333333333333333,1.0,1.0,4/7,23.44%,TYRP1;CDH3;OPN3;GIPC1
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.47084690022429854,0.9006011420454179,0.625,1.0,1.0,5/29,8.61%,RAB32;ATP6V0A4;RAB39A;ATP6V1G2;ATP6V1G1
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.5217422571931576,-0.9005258812670661,0.625,1.0,1.0,4/8,39.80%,MACROH2A1;FMR1;RPS6KA4;AKAP8L
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.4741118003759487,-0.9004625164160595,0.5857142857142857,1.0,1.0,3/17,10.64%,GMFG;FCHSD2;CYFIP1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.4711463039989483,-0.9002139302532536,0.6461538461538462,1.0,1.0,5/18,18.94%,NCKAP1L;CAMK1D;BST1;DNM1L;TIRAP
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),-0.5915303164597349,-0.9001654393622246,0.631578947368421,1.0,1.0,3/5,27.94%,AOX1;NNMT;HAAO
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.3583164180014917,-0.9000933863629367,0.6575342465753424,1.0,1.0,30/183,19.76%,ROR1;TLR2;PPARG;CLU;TRIM5;EDN1;TERF2IP;TRIM22;CAMK1D;NLRP3;CX3CR1;TRIM25;CD200;CAV1;AR;NOD1;PRKCQ;TRIM32;ADCY8;PRKD2;VEGFA;WNT5A;STAT3;CLOCK;FLOT1;TIRAP;NFKBIA;PRKCZ;DDR2;CX3CL1
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.3992750418989125,0.9000096646436154,0.5454545454545454,1.0,1.0,12/45,21.59%,HSPA1A;BAK1;SERPINH1;DNAJB4;OPTN;HSPA1B;DAXX;DNAJC4;ERP44;TMBIM6;HSF1;ERN1
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),-0.5507253570720411,-0.8997877761933037,0.6363636363636364,1.0,1.0,2/10,10.05%,DGKD;DGKB
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.4572179064047397,-0.899328979960776,0.6129032258064516,1.0,1.0,10/27,25.81%,TTN;MYH11;SLC8A1;CAV3;VEGFA;ALPK2;NEB;HES1;HEY2;NEBL
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.42203479727545345,-0.8992014702573429,0.5901639344262295,1.0,1.0,4/27,19.68%,PIGH;PIGC;PIGB;MPPE1
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),-0.36014835683709173,-0.8991496016913664,0.676923076923077,1.0,1.0,6/129,10.72%,CARTPT;MAP3K5;LRRK2;ATP6V1C2;XBP1;CEBPB
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.477436286647877,-0.8990134449695796,0.6615384615384615,1.0,1.0,2/26,2.96%,STMN2;TWF2
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),-0.4895353870674356,-0.8989272111395614,0.6438356164383562,1.0,1.0,2/16,14.03%,SOX9;BMPR1B
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),0.566001890393537,0.8985530279521405,0.6511627906976745,1.0,1.0,3/5,38.87%,CLN3;RACK1;ATP2C1
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.40969628928749835,0.8983262521503005,0.5833333333333334,1.0,1.0,5/34,10.23%,B4GALNT2;NEU4;ST8SIA5;B3GALT4;GLA
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.42801264400241384,-0.8977343736021246,0.6351351351351351,1.0,1.0,7/36,14.15%,TIMP4;TIMP1;SERPING1;CST3;CRB2;LRP1;SERPINI2
prerank,GO_Biological_Process_2021__skin morphogenesis (GO:0043589),-0.6003241934613119,-0.8976435828542002,0.6612903225806451,1.0,1.0,1/5,0.30%,ITGB4
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.5025209320356107,-0.897563390657422,0.609375,1.0,1.0,3/14,16.13%,BTBD18;SLC25A31;SYCP3
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.6234826457080878,-0.8968258134899547,0.6571428571428571,1.0,1.0,2/5,17.07%,LRRK2;DNM1L
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.3810465008729942,-0.8967885431448576,0.6285714285714286,1.0,1.0,22/115,17.89%,NR4A3;P2RY12;SSTR1;MEF2C;AQP1;GABRG2;FES;LRRK2;RYR3;SLC1A1;GABRB2;ABCB4;HCN1;ATP1A1;AR;ADCY8;GNG2;KCNE1;BRCA1;EGFR;DMTN;GABRB3
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.42804745729288374,-0.8964490592508559,0.6724137931034483,1.0,1.0,2/31,9.18%,DND1;E2F1
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.4859422540220057,0.8961612579262118,0.5666666666666667,1.0,1.0,2/10,2.22%,TCOF1;KBTBD8
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.39509347527260974,-0.8960899728597624,0.6338028169014085,1.0,1.0,8/75,8.80%,ITGB4;LOXL4;TGFB2;COL4A1;P3H2;LOXL3;COL11A1;TLL1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.41833157411947347,0.8960196681189968,0.6756756756756757,1.0,1.0,5/29,4.75%,AGER;MALT1;PYHIN1;NLRP2;STMP1
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.5749713074595619,0.8959874128485941,0.6444444444444445,1.0,1.0,3/5,35.93%,ZFAND1;KIF5B;VCP
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.48005349562548627,0.8959334442291569,0.6486486486486487,1.0,1.0,5/26,17.88%,LRRC8A;UCN;ACSL4;NLGN2;CAPN10
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.46862372475794845,-0.8957292294812064,0.6615384615384615,1.0,1.0,8/24,15.09%,CHRM3;ANO6;NEDD4L;KCNJ4;KCNJ3;KCNJ6;KCNH2;KCNJ13
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",-0.544332108739944,-0.8956905741515238,0.6724137931034483,1.0,1.0,2/7,4.85%,VSIR;TGFBR2
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.49631548832563155,-0.8955538830831024,0.6,1.0,1.0,4/17,15.90%,AOAH;SAMHD1;ADAMTS9;FBXO17
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.4500072263203172,-0.8951269845174933,0.6756756756756757,1.0,1.0,3/28,10.64%,TWF2;CARMIL2;CYFIP1
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.49194787023878317,0.8951173167538201,0.696969696969697,1.0,1.0,4/12,18.86%,ALG12;DPAGT1;ALG3;ALG1
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),-0.5746769666030676,-0.8949920006049435,0.6,1.0,1.0,3/7,17.74%,CEACAM1;ZEB1;BTG1
prerank,GO_Biological_Process_2021__hydrogen peroxide biosynthetic process (GO:0050665),-0.5886068105435088,-0.8949840354796492,0.6271186440677966,1.0,1.0,2/5,3.45%,DUOX1;MAOB
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.5133185924613429,0.8946045571810866,0.625,1.0,1.0,2/9,13.08%,HMGB1;TOP3B
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),-0.46659994239665803,-0.8945623785552456,0.6129032258064516,1.0,1.0,5/21,8.53%,PIM1;NEDD4L;KCNJ4;KCNJ3;KCNJ6
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.3688864523877037,-0.894541251266913,0.5652173913043478,1.0,1.0,18/116,9.38%,CARTPT;SRGN;TLR2;PTPRC;GCNT1;TIMP1;HLA-E;TGFB2;IL12A;IFNGR2;IRF4;GBP2;HLA-A;IL7;B2M;HLA-DMA;NLRP3;IGSF6
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.4208788614450003,0.8944996188881223,0.6666666666666666,1.0,1.0,3/25,3.77%,LOC400499;CRHBP;NRIP1
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),-0.6302089239473787,-0.8943099203978523,0.7454545454545455,1.0,1.0,2/5,24.13%,LMO3;PAK1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.5461606429672098,-0.8938007629003154,0.65625,1.0,1.0,2/9,12.01%,LRCH1;CD200
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.6010953706454845,-0.8937972621690746,0.6612903225806451,1.0,1.0,2/7,34.75%,MTIF3;MCTS1
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.44250330369612806,-0.8937455311867285,0.6129032258064516,1.0,1.0,6/27,12.42%,ZNF366;CITED4;CITED2;TRIM25;CAV1;AR
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.45120409836260333,-0.8935026188836379,0.59375,1.0,1.0,7/26,24.48%,MEF2C;TGFBR2;CCDC39;MICAL2;MESP1;NDRG4;HES1
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.458130595433636,-0.8932331283337965,0.6833333333333333,1.0,1.0,5/20,15.36%,SHMT2;MPV17L2;TSFM;MTG1;RCC1L
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),-0.3760973431844448,-0.8931972781507915,0.6818181818181818,1.0,1.0,16/118,18.67%,IRGM;PAK5;RIT2;ANGPTL7;CEACAM1;NRG3;SLITRK4;CDH13;WFDC1;PRKCQ;PACSIN1;SNCAIP;OPHN1;WNT5A;OGFR;CAMSAP3
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.41332478679339457,0.8931934326419941,0.4634146341463415,1.0,1.0,7/24,18.30%,ZNF335;DPY30;BEND3;ASH2L;WDR5B;KMT2B;MEN1
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),-0.455360033627319,-0.8930913754020916,0.6153846153846154,1.0,1.0,3/22,8.00%,MEF2C;EPHA4;SLITRK4
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.3989128279510463,-0.8929031762108,0.6617647058823529,1.0,1.0,15/64,14.23%,RIMS1;SYT1;SLC8A3;CACNG2;GRIK2;LGI1;CACNG8;RIMS2;SLC24A1;GRIN2B;GRIN2D;CACNG3;CLSTN3;DLG4;ADCY8
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),-0.5754305964999011,-0.8927526782024178,0.6461538461538462,1.0,1.0,2/8,12.79%,PRKAR1B;PKIA
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.4028932167609643,-0.8925342800344044,0.6825396825396826,1.0,1.0,6/56,6.79%,TIMP4;TIMP1;WDR6;MET;HGF;CST3
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.4861070043741649,0.8923780749790636,0.5581395348837209,1.0,1.0,2/9,12.77%,DICER1;ITGAX
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.3662496933958792,-0.892200189513629,0.7183098591549296,1.0,1.0,13/127,14.28%,ARIH2;ITGAM;PDZK1;TP73;CEMIP;NMT1;E2F1;TOMM7;CAMK1;SAR1A;YWHAH;GTSE1;KCNB1
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.5159394547830403,0.8920862747123351,0.6904761904761905,1.0,1.0,1/11,6.94%,IFI27
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),-0.6091616388452508,-0.8917424855568191,0.6981132075471698,1.0,1.0,5/6,37.21%,STAT3;PXN;PIK3R1;PTK2;GHR
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.36501269925611807,0.8915385509576579,0.625,1.0,1.0,7/63,5.44%,ADAM33;ADAMTS2;CRYAB;REN;SEMA5A;SOD3;CDC42EP5
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.43146786988337105,0.8913486228594831,0.6538461538461539,1.0,1.0,11/28,26.27%,PCM1;IFI27;CEP290;PRR5L;TPR;ZFAND1;SIRT7;GCC2;PDCD10;NDEL1;PLK3
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.5790846014634113,-0.8912685669746133,0.6666666666666666,1.0,1.0,5/7,36.30%,KAT2B;WARS1;HPF1;XRCC1;PNKP
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),-0.6181717295522516,-0.8912301333763956,0.7049180327868853,1.0,1.0,2/5,9.20%,CHGA;PLN
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.41460868073982604,-0.8911623911453879,0.6323529411764706,1.0,1.0,11/49,29.30%,IRGM;CALCOCO2;TRIM13;RALB;BAG3;ADRB2;SPTLC2;SESN3;UVRAG;FYCO1;TBK1
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.528043472537154,-0.8910801574623117,0.6428571428571429,1.0,1.0,1/7,8.01%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.5113789273033391,-0.8910425548559991,0.6166666666666667,1.0,1.0,1/13,1.17%,IGFBP3
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.5945887362242912,-0.890871360724785,0.6481481481481481,1.0,1.0,1/5,19.20%,MAP2K5
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.39821226145128846,0.8907663365393017,0.6060606060606061,1.0,1.0,4/32,10.62%,CRYAB;NUMA1;ATPSCKMT;GAS1
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.5343730600382885,-0.890650186539198,0.6811594202898551,1.0,1.0,6/12,24.25%,CAV1;IFIT1;FLOT1;COLEC12;RALB;PQBP1
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.5107000927484922,-0.8905681919287716,0.6885245901639344,1.0,1.0,4/10,23.79%,COX17;STEAP4;SLC11A2;STEAP2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.39136876697133205,-0.8905299194000479,0.5964912280701754,1.0,1.0,6/48,4.86%,LPL;TLR2;PTPRC;HLA-E;CLU;C1QTNF4
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.42274674337039253,0.890448264132411,0.5142857142857142,1.0,1.0,7/33,15.06%,TRARG1;GGA2;RAB26;OPTN;VAMP4;MACF1;GGA3
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),-0.4990759854640177,-0.8902753257825478,0.6379310344827587,1.0,1.0,2/15,4.08%,PPARG;MEF2C
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.5270115221584615,-0.8902589694638897,0.5714285714285714,1.0,1.0,1/8,14.50%,ATG10
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.38190540502424786,-0.8902067835683338,0.6811594202898551,1.0,1.0,39/129,15.96%,CLDN5;PTPRM;ROBO4;CDH12;TGFB2;ITGAM;CLDN16;CDH9;MMP24;TGFBR2;EMB;L1CAM;LRRC4;ROBO2;SELL;CLDN20;CADM3;CEACAM1;CDH22;NTNG1;PCDHB4;PALLD;TENM3;CDH10;CDH18;CRB2;CDH13;PCDHB11;LRFN5;VSTM2L;SLITRK3;GPC6;CDH23;CDH3;PCDHB9;CLDN4;PTPRT;MYOT;CNTN4
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.5221473375047099,-0.8900408558554174,0.6666666666666666,1.0,1.0,5/13,18.43%,TGFB2;LTBP1;CD200;ITGAV;LILRB1
prerank,PanglaoDB_Augmented_2021__Nuocytes,0.4308340152489248,0.8897853068712293,0.7027027027027027,1.0,1.0,5/25,4.69%,ZAP70;IL2RA;GPR174;PYHIN1;CD247
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.6015569914234091,-0.8895216696756566,0.6428571428571429,1.0,1.0,2/6,22.57%,DAPK1;PRKCD
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.6242354906700868,-0.8893108012669386,0.6607142857142857,1.0,1.0,1/5,4.46%,FABP3
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.43978614375985864,0.8892460878661661,0.625,1.0,1.0,5/25,8.48%,AGER;EPHB2;RELN;ABL1;CHRNA7
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.382414667222921,-0.8889430879371435,0.7230769230769231,1.0,1.0,9/61,12.59%,ANGPT1;FBLN1;PTPRC;SPINT2;DACT2;ARHGDIG;CDH13;PDE3B;RASA1
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.4654526268428191,-0.888929869552515,0.6521739130434783,1.0,1.0,5/29,18.15%,TGFB2;ARG2;B2M;RSAD2;WNT5A
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.44277044117011666,0.8886455023089935,0.625,1.0,1.0,3/16,9.94%,VDR;CUBN;VKORC1L1
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.36819144713498386,-0.888331472508601,0.6666666666666666,1.0,1.0,20/142,19.86%,RGS7;DOCK8;ARHGAP42;APC2;GRTP1;USP6;RGS1;THY1;SIPA1L1;CAV2;ARHGAP25;TBC1D10A;NGEF;EZH2;RIC1;NTRK3;TBC1D8B;RASGRP1;CX3CL1;TBC1D9
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.48648253852499435,-0.8883194678952461,0.6964285714285714,1.0,1.0,3/12,38.37%,UBA5;RB1CC1;ULK1
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.5838267943866982,0.8883013750786982,0.64,1.0,1.0,2/5,10.45%,RYK;WNT3
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.5619839123412447,-0.8879157782470223,0.7115384615384616,1.0,1.0,3/7,21.50%,UBASH3B;DDR2;ITGA11
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.3206245962820899,-0.8877470230108392,0.8313253012048193,1.0,1.0,115/686,22.73%,FOSL2;HEY1;GRHL1;TLR2;NR4A3;PLSCR1;PPARG;IL26;TNFRSF1A;TGFB2;ELK3;GLIS2;CITED4;IRF1;CITED2;EDN1;MEF2C;IRF4;NOS1;FOS;PLAG1;TP73;PLAC8;SOX9;MET;HGF;MLIP;BCL11B;CRLF3;MACC1;RFX5;NLRP3;E2F1;GATA1;BMP6;TGFB3;WWTR1;CASZ1;ETV1;XBP1;CEBPB;RARB;BTBD18;CAMK1;MRTFB;CDH13;NR2F1;GLI3;HJV;AR;ZFPM1;E2F3;GLIS3;TOX2;MOSPD1;BMPR1B;UHRF1;PAX6;PRKD2;VEGFA;BRCA1;TRERF1;STAT1;SREBF1;EGFR;POU2F2;SKAP1;ESRRA;NR2F2;FHOD1;MAFF;NFYB;MICAL2;NR1D1;PPP3CA;WNT5A;RNF111;LDB2;STAT3;CLOCK;LILRB1;PFKM;PSMC3;TGFB1;NFKBIA;MAP2K5;RFXANK;NR1I3;PTPRN;CX3CL1;NLRC5;PID1;PRDM15;PLAGL1;ZNF593;SPI1;KAT2B;CIITA;MESP1;RREB1;BCL2L12;HLF;RXRA;PER1;CCNC;USF2;KAT6B;BCL9;BRD8;JUNB;CKAP2;HNF4G;EPAS1;PLXND1;TAF6L
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.5330409304192437,0.8875885557404706,0.5681818181818182,1.0,1.0,1/5,8.30%,PHF1
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.40731433753519775,0.8875333301001278,0.6410256410256411,1.0,1.0,13/41,22.48%,HSPA1A;SLC38A2;RIOK1;RIOK2;NFKB1;PNPT1;RELA;DDX5;RBM22;LIN28B;ERN1;SIRT7;DXO
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.46137967292873644,-0.8873958879816644,0.6666666666666666,1.0,1.0,3/18,7.20%,DUOX1;NOX4;ALOX12
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),0.4938161099966074,0.8873758988376487,0.6388888888888888,1.0,1.0,1/9,14.31%,BECN1
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),0.4938161099966074,0.8873758988376487,0.6388888888888888,1.0,1.0,1/9,14.31%,BECN1
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.4939106577064395,-0.8872847476053775,0.6417910447761194,1.0,1.0,2/12,18.49%,GNB3;MCM7
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3831349412454138,0.8871203721953204,0.5714285714285714,1.0,1.0,7/83,4.77%,CXCR4;TBXA2R;JPH1;HMGB1;CCR3;GPR174;KNG1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.3900663541065179,0.886899387872244,0.5789473684210527,1.0,1.0,15/51,22.90%,LSM7;EXOSC8;SAMD4A;DCP1A;DCP1B;CNOT9;PAN2;PATL1;DCPS;EXOSC7;DIS3;PDE12;EXOSC5;CNOT2;POLR2D
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.40905542144209084,-0.8868957016373816,0.5921052631578947,1.0,1.0,7/73,10.64%,P2RY12;TWF2;PLPPR5;CARMIL2;GPM6A;TGFB3;CYFIP1
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.4713424031766811,-0.8868178109144911,0.6,1.0,1.0,2/24,9.57%,MET;ARHGAP28
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.40983528038939543,-0.8868007511490266,0.6935483870967742,1.0,1.0,10/44,26.48%,GLIS2;GLI3;TULP3;TXNDC15;GPC3;ZIC1;MGRN1;WDR11;TUBD1;IFT122
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),-0.5707952260437151,-0.8867046046078894,0.6885245901639344,1.0,1.0,3/6,32.59%,AGT;APOE;LAMTOR1
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.42660917782689234,-0.8866094783877091,0.6721311475409836,1.0,1.0,4/30,12.61%,SEMA3E;SEMA3D;HTR2B;SEMA4G
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.3620322008893044,-0.8865800410292175,0.6521739130434783,1.0,1.0,8/146,4.79%,PARP14;CLDN5;OLFM1;TGFB2;PARP9;CITED2;MEF2C;ID2
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.46625379678906215,-0.8860210421190184,0.6551724137931034,1.0,1.0,7/24,22.67%,P3H2;FKBP5;OGFOD1;FKBP1B;NKTR;PPIH;PPIF
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.5135016288728522,-0.8859612858253333,0.6307692307692307,1.0,1.0,4/12,16.21%,IL6R;CAMK1D;LYN;ZNF580
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.32793508699595036,-0.8859258472189586,0.8533333333333334,1.0,1.0,51/426,13.06%,ANGPT1;FBLN1;KANK2;TLR2;IGFBP3;TP53I11;SFRP4;HOPX;PLSCR1;TGFB2;ALDH1A2;TEX15;CLU;SSTR1;WDR6;CR1;NOX4;TSPYL2;IRF1;NOS1;FABP3;P3H2;CCN5;ADGRG1;DDAH1;ACTN1;MYO16;CRLF3;TMIGD3;DACT2;LDOC1;GJA1;TGFB3;ARHGDIG;INCA1;BTBD18;HTR2B;CDH13;AQP11;CD200;TCHP;LRPAP1;RERG;NMI;PDE3B;PRAME;AR;IFNK;RASA1;WFDC1;IFI35
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.47136246615124355,0.8857708353261622,0.5588235294117647,1.0,1.0,3/11,12.96%,PEX5L;PEX6;PEX2
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.5272571492889557,-0.8857138781600361,0.6607142857142857,1.0,1.0,5/11,18.43%,LAPTM5;SCIMP;TNFRSF1B;WNT5A;LILRB1
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.5561503768052971,-0.8853538702081892,0.6857142857142857,1.0,1.0,3/8,22.36%,ARG2;AZIN1;ASL
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.45839469303560787,0.885049800235976,0.5757575757575758,1.0,1.0,10/26,15.81%,IL4R;GPA33;FBP1;KCNN4;SLC26A3;LGALS4;WNT3;DLL1;LGR4;ATG16L1
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.45465742882225946,-0.8848712765289228,0.6666666666666666,1.0,1.0,9/28,14.19%,ISG15;MEF2C;ANO6;ADGRV1;BMP6;TGFB3;SLC8A1;BMPR1B;NELL1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.3976154804272965,-0.8847259566417501,0.6481481481481481,1.0,1.0,6/46,4.86%,LPL;TLR2;PTPRC;HLA-E;CLU;C1QTNF4
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.4863276931569068,-0.8841424459488496,0.6333333333333333,1.0,1.0,2/18,4.49%,TEX15;FOS
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.4863276931569068,-0.8841424459488496,0.6333333333333333,1.0,1.0,2/18,4.49%,TEX15;FOS
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.3625444544565375,0.8837568493413449,0.6129032258064516,1.0,1.0,8/57,16.63%,OAS3;USP36;PTBP1;RRP1B;AHNAK2;AFF2;RBM12B;HNRNPH1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.47326524004053944,-0.883724902117703,0.6268656716417911,1.0,1.0,2/24,4.07%,PARP9;DTX3L
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),0.32360459389832785,0.8830078622188918,0.7666666666666667,1.0,1.0,46/164,21.97%,POP5;RCL1;BYSL;ERI1;RSL1D1;MDN1;DCAF13;TFB1M;NAT10;SRFBP1;PIH1D1;RRP12;EXOSC8;NOL8;RIOK1;DKC1;ESF1;PELP1;NOLC1;RPL18A;RIOK2;RRP1B;RRP36;MPHOSPH10;KRR1;RPL23A;WDR74;UTP3;EXOSC7;NOL11;RPL3;DDX10;RPL13;DIS3;UTP6;WDR36;RPL11;PWP2;NSA2;EXOSC5;RPL8;NOP56;RPL32;RPL21;RPS16;POP4
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),-0.5831794304067895,-0.8828262945615606,0.7241379310344828,1.0,1.0,3/6,23.68%,SLC25A22;SLC1A6;SLC25A12
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),-0.5745544809154745,-0.8828113430802249,0.6865671641791045,1.0,1.0,2/7,9.45%,DKK3;BMP6
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),-0.4245920577544283,-0.8826974482865384,0.6461538461538462,1.0,1.0,4/30,13.62%,NEDD4L;KNDC1;HECW1;YWHAH
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.48023133534526696,-0.8826220221632285,0.6811594202898551,1.0,1.0,9/15,18.92%,NCKAP1L;IL7;XBP1;AXL;CD27;PPP2R3C;SYK;RHOH;GAS6
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.488995433270746,-0.8824281232578548,0.7083333333333334,1.0,1.0,4/21,19.97%,FAR2;DGAT1;ACSL5;ELOVL2
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.48696228186131396,-0.8823672708981459,0.6567164179104478,1.0,1.0,2/19,3.94%,NCKAP1L;LGALS3
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),0.49472622815057565,0.8819722041475241,0.6,1.0,1.0,4/11,16.14%,SPHK2;KDSR;PLPP2;NAAA
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.40131019363639214,-0.8818423015259151,0.6666666666666666,1.0,1.0,34/94,29.98%,MCM2;DBF4;RMI1;RPA3;RFC3;RAD9A;RFC4;ORC2;WRN;BRCA1;RECQL4;RAD50;DONSON;MCM7;RPA2;MRE11;PTMS;ORC6;RBMS1;MCM5;CLSPN;RPA1;TOP3A;RPAIN;FAM111A;CDC7;ORC3;NBN;TIMELESS;POLD1;WDHD1;RBBP8;ORC5;PCLAF
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.33154806272479653,-0.8816605829026016,0.8,1.0,1.0,74/538,18.39%,HEY1;KANK2;ZNF366;ZIM2;DACT1;NR4A3;PPARG;PARP9;ZNF550;CRYM;GLIS2;CITED2;EDN1;MEF2C;ZNF343;ID2;ZNF239;SOX9;MLIP;NEDD4L;CCND1;ZEB1;BHLHE40;ZNF608;ZBTB32;EFNA1;E2F1;GATA1;GTF2IRD1;BMP6;ZNF764;CEBPB;RARB;ZNF217;H1-0;ORC2;NR2F1;ZNF20;CAV1;PCGF2;GLI3;HJV;AR;ZFPM1;DNAJB1;GLIS3;MOSPD1;ETS2;ZNF248;ZNF391;UHRF1;PAX6;EDNRB;CBX7;ZNF705G;ETV6;VEGFA;STAT1;ID3;PRDM1;TGIF1;POU6F1;EZH2;ZFP36;NR2F2;ZNF10;ZFP69;ZNF136;MYT1L;NR1D1;CBX8;LDB2;TENM2;STAT3
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.360814149293825,0.8814929139798887,0.5517241379310345,1.0,1.0,6/82,6.26%,F2;DHFR;RIDA;KNG1;EIF4E2;PUS7
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.43623211209562346,-0.8814348319015044,0.6060606060606061,1.0,1.0,10/31,14.69%,PDZK1;NOS1;KCNJ4;KCNJ3;KCNJ6;KCNMA1;GABBR2;GNG2;KCNH2;KCNE1
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.3387156316531295,0.8812686119596193,0.7096774193548387,1.0,1.0,20/65,22.94%,NT5E;ENPP1;PTBP1;POLR2K;POLG;HNRNPU;POLR2L;HNRNPH1;WDR74;HNRNPA2B1;EXD2;RAN;PDE12;POLR2E;HNRNPR;HNRNPC;HNRNPM;DXO;POLR2D;WTAP
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.4975806161530472,0.8809235150591632,0.625,1.0,1.0,3/13,9.80%,WNK4;ATP1B1;DRD4
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.5459440855016463,-0.8807976335558374,0.6851851851851852,1.0,1.0,2/8,18.91%,TGFBR2;TGFB1
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.4950625838659212,0.8807200725306388,0.6666666666666666,1.0,1.0,3/10,10.64%,HSPA1A;SACS;HSPA1B
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.558036632160653,-0.8804356859740728,0.6984126984126984,1.0,1.0,5/6,31.01%,STAT1;STAT3;STAT4;IL21R;JAK1
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.558036632160653,-0.8804356859740728,0.6984126984126984,1.0,1.0,5/6,31.01%,STAT1;STAT3;STAT4;IL21R;JAK1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.524630565842326,-0.8803778922365931,0.6417910447761194,1.0,1.0,1/10,11.72%,SAR1A
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.3481115220325112,-0.8803606066151538,0.7142857142857143,1.0,1.0,22/260,6.35%,ANGPT1;CLDN5;HEY1;TLR2;SFRP4;PLSCR1;VSIR;OLFM1;RIMS1;CLU;TTN;MUSK;F3;ACTA2;CITED2;DTX3L;MEF2C;ID2;VSTM2A;SOX9;LAPTM5;FGF22
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.4743346894038318,-0.8802281406519192,0.6438356164383562,1.0,1.0,5/19,17.57%,LOXL3;CHI3L1;FGF7;VEGFA;CCDC39
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.47978569473953925,0.8801740477519989,0.4857142857142857,1.0,1.0,2/9,12.70%,GGTA1;LTA4H
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.42004305213757215,-0.8798206386376911,0.6417910447761194,1.0,1.0,9/41,13.59%,PTPRC;DOCK8;NCKAP1L;HLA-A;IL7;HLA-DPB1;XBP1;THY1;PRKCQ
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.48636546130928393,0.8798140949623936,0.6,1.0,1.0,1/8,2.10%,PYCR1
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.368107561511226,-0.8798041094999928,0.7297297297297297,1.0,1.0,19/137,12.25%,ROR1;FSTL1;FBLN1;PROM1;CD59;ARHGAP42;LRIG3;KITLG;LAMC1;COL4A1;ANO6;PTPRG;LAMB1;GJA1;TENM3;FAT1;THY1;ADGRL2;PCGF2
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.48310867262015245,-0.8798006844834277,0.6785714285714286,1.0,1.0,2/12,18.50%,EDC3;PATL2
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.4595679236461696,0.8795427772099358,0.5945945945945946,1.0,1.0,3/20,8.86%,CMPK1;AK8;DCTD
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.4386117917606448,-0.8792887758578828,0.6896551724137931,1.0,1.0,9/32,25.17%,ENO4;PFKFB2;LDHA;PGK1;GAPDHS;PFKM;GPI;ENOSF1;PFKL
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.5641968528428849,0.8792460946622039,0.6585365853658537,1.0,1.0,1/5,4.35%,ABHD2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.4550421110783207,-0.8787827467032258,0.6716417910447762,1.0,1.0,6/31,25.42%,TP73;DDIT4;ZNF385B;PDK2;DYRK2;HINT1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.3174044798942026,0.8785812557329861,0.8,1.0,1.0,26/228,13.45%,CXCR4;CRTAM;TBXA2R;VDR;LEPR;IL4R;PLA2R1;IGF1R;NUMA1;MST1;PAX8;SERPINE1;PRLR;ACVR1;SNAI1;NFAM1;TRIM16;S100A13;UCN;KAT2A;ACVR1B;ITGAX;ESRRG;KLRF2;ADIPOR1;UCP2
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.4967725785965671,-0.8785028135111362,0.6825396825396826,1.0,1.0,5/14,12.10%,NEDD4L;KCNMA1;SLC8A1;ATP1B2;ATP1A1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.34812613578422474,0.8784431174888445,0.6764705882352942,1.0,1.0,19/140,8.51%,NGF;CXCR4;ETV5;MMP11;CFH;PTCD2;CA2;KCNN4;CROT;SPRY2;ALDH1A3;EPHB2;HSD11B1;ANKH;ZNF639;RELN;YRDC;DNMBP;HDAC9
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),-0.5797232667927014,-0.8783066659387244,0.7272727272727273,1.0,1.0,1/6,7.20%,ALOX12
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.4837283089480888,0.8779833420659544,0.5333333333333333,1.0,1.0,3/7,28.73%,CCDC88C;GSN;PIK3CA
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),-0.4798823293166279,-0.8778692691690765,0.6,1.0,1.0,4/13,19.01%,ST3GAL5;ST8SIA3;B4GALT6;ST6GALNAC5
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),-0.5841609024710236,-0.8774010941671813,0.7142857142857143,1.0,1.0,2/5,25.90%,ZFP36;ZFP36L1
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),0.39641710963692733,0.8771893194076221,0.5789473684210527,1.0,1.0,5/43,6.83%,ICAM1;AGER;ABCC1;IGF1R;CHMP5
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.39324752549276076,0.8771341554995935,0.6666666666666666,1.0,1.0,3/47,6.18%,DCXR;FBP1;ATF4
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.4061808454752472,0.8767421041488249,0.631578947368421,1.0,1.0,3/22,7.46%,NDC80;DYNLT1;NUMA1
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.5526264019168232,-0.8762014587986735,0.7096774193548387,1.0,1.0,3/10,12.78%,CEACAM1;ALOX12;PRKG1
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),-0.5958908844513761,-0.8761901392467859,0.7142857142857143,1.0,1.0,3/6,15.69%,OLAH;ABHD3;OXSM
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),0.4140879430902624,0.8761813888031921,0.6111111111111112,1.0,1.0,2/33,0.95%,LOC400499;DHFR
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),-0.5870512302995811,-0.8759105126093184,0.6875,1.0,1.0,3/6,11.74%,AQP1;SLC14A1;AQP11
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,-0.35913432376482357,-0.875808389202616,0.7101449275362319,1.0,1.0,36/169,16.83%,ITGB4;GJC3;TCEAL6;SPARCL1;SHISA6;C1QL2;HTR5A;ASTN1;TCEAL5;BRINP2;SYNPR;HPCA;ATP2B2;CADM3;CDH22;GRM5;OPALIN;SNCB;SLC25A19;LRRTM3;MPPED1;PHF24;ATP1B2;RGS7BP;ST8SIA3;AQP4;EPHB1;OPCML;ADCY8;PHYHIP;PTPRT;NFE2L3;MAPK4;OMG;LY6H;ADCYAP1R1
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),-0.5349998575175429,-0.8757924444937771,0.6363636363636364,1.0,1.0,2/8,12.25%,PCGF3;PCGF2
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.4488668266684388,-0.8756973568496423,0.6666666666666666,1.0,1.0,5/22,5.14%,F8;SERPING1;F3;EDN1;A2M
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.47562948042030223,-0.875520659478395,0.7049180327868853,1.0,1.0,5/19,22.06%,MFAP5;TENM3;VEGFA;STAT3;SHROOM2
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),-0.5910485447008595,-0.8754634070176139,0.7301587301587301,1.0,1.0,2/6,19.76%,CX3CR1;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.4215490565324661,0.875311002946626,0.5714285714285714,1.0,1.0,4/28,12.05%,HSPA1A;SLC38A2;PRDX6;NCL
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.3762998228847432,-0.8752840042273585,0.6666666666666666,1.0,1.0,4/78,4.85%,ANGPT1;SFRP4;PPARG;TGFBR2
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.3606038321256316,0.8751549303484438,0.71875,1.0,1.0,25/92,23.63%,U2AF1;RAE1;NUP42;NUP210;RBM8A;CPSF4;SYMPK;TPR;NXF1;EIF4E;NUP37;RBM15B;SARNP;HNRNPA2B1;RAN;THOC2;NDC1;MAGOH;SMG5;ALYREF;SEH1L;SRSF9;NUP85;NUP214;FYTTD1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.5226021842899812,0.8751400871540057,0.6458333333333334,1.0,1.0,2/8,10.61%,PLIN5;AKT2
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.5744982935577825,-0.875054925674144,0.7014925373134329,1.0,1.0,3/6,18.91%,PPARG;STAT1;TGFB1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.5744982935577825,-0.875054925674144,0.7014925373134329,1.0,1.0,3/6,18.91%,PPARG;STAT1;TGFB1
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),0.5236203286317852,0.8748653041165139,0.5833333333333334,1.0,1.0,4/10,18.72%,PLA2R1;SERPINE1;ATR;MME
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),-0.5365737555203396,-0.8748159514166178,0.6271186440677966,1.0,1.0,2/6,16.47%,TEKT3;RSPH9
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.5120035177989408,-0.8747057308679833,0.6857142857142857,1.0,1.0,3/14,33.08%,DMTN;ITGB1BP1;CORO1C
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.5120035177989408,-0.8747057308679833,0.6857142857142857,1.0,1.0,3/14,33.08%,DMTN;ITGB1BP1;CORO1C
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),0.5836777110189734,0.8744337582070693,0.6585365853658537,1.0,1.0,1/5,11.71%,SLC6A13
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.447311203910613,-0.8743842273915873,0.7272727272727273,1.0,1.0,5/23,18.91%,WTIP;EGFR;ZFP36;STAT3;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.5651584763243741,0.874348225798157,0.6578947368421053,1.0,1.0,4/6,16.58%,NOSIP;GLA;NFKB1;SNCA
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.39374595193022294,0.874321407394791,0.6206896551724138,1.0,1.0,8/35,12.79%,ZDHHC16;ADAMTS18;FREM2;MEIS1;PAX8;ABCB5;PBX4;PBX3
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.3861715873257507,-0.8742640357189664,0.7096774193548387,1.0,1.0,9/62,6.16%,DPEP2;HOPX;PTPRC;SLA;ITGAM;AOAH;CD53;GMFG;SELL
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.5330230596986354,0.8742134643235305,0.6153846153846154,1.0,1.0,3/6,30.72%,PLA2G6;GPAM;SLC27A1
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),-0.5427205738362096,-0.8737856261603442,0.671875,1.0,1.0,3/5,15.57%,PDZK1;ATP8B1;ABCB1
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),-0.5964253156444728,-0.873530955412413,0.7818181818181819,1.0,1.0,2/5,25.86%,PRKCQ;IL12RB1
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.43803033001831726,0.8733342978338077,0.5135135135135135,1.0,1.0,2/24,6.23%,SMYD1;CARM1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.37316309566266703,-0.8730656148433379,0.6301369863013698,1.0,1.0,16/77,26.93%,CENPE;HLA-DRB1;HLA-DPB1;HLA-DMA;DYNC1LI1;SH3GL2;ACTR10;KIF3C;AP1S2;KIF5A;KIF2C;ARF1;KIF3A;CANX;HLA-DPA1;DYNLL2
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.49641026881725525,0.8730284345327723,0.5714285714285714,1.0,1.0,1/6,20.52%,CALM1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.5346990649899132,0.8730133312037351,0.6176470588235294,1.0,1.0,1/6,2.60%,SERPINF2
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.3805611711711289,-0.8728767491406616,0.7205882352941176,1.0,1.0,12/72,17.99%,SPDYA;CCND1;CDK5R2;INCA1;CDK5R1;CCNJL;CDKN3;CCNF;EGFR;CDKN1A;NR2F2;SERTAD1
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.4863407288507993,0.8727725581239393,0.5588235294117647,1.0,1.0,1/9,2.10%,PYCR1
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.5217771699404015,-0.8726762519818311,0.7361111111111112,1.0,1.0,5/11,23.32%,MSMP;GPR183;GAS6;CX3CL1;CXCL16
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.5567898491979947,0.8722905806764024,0.6842105263157895,1.0,1.0,1/7,5.18%,PTGIS
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.46701209156675993,-0.8722121893915893,0.6379310344827587,1.0,1.0,2/21,4.49%,TEX15;FOS
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.4991887823307828,-0.8720227938990058,0.6891891891891891,1.0,1.0,4/20,15.10%,PTPRC;THY1;CAV1;SH3BP5
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.3699557638303025,0.8719743013495139,0.5483870967741935,1.0,1.0,13/70,11.95%,RS1;PDE6A;KCNJ14;OPRD1;CNGB1;MSANTD1;PDE6B;CRX;DRD4;CATSPER2;RGR;ZNF385C;SLC2A11
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.5050412704344229,0.871812983760934,0.6216216216216216,1.0,1.0,1/11,0.37%,PDE3A
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.38631205244106576,-0.8716310898035996,0.703125,1.0,1.0,1/58,0.75%,MDFIC
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.38398140939802744,-0.8714004521484152,0.717948717948718,1.0,1.0,13/62,25.47%,PPARG;DND1;WTIP;NUP43;ZFP36;STAT3;TGFB1;NUP88;NUP50;POU5F1;POM121;NUP160;POLR2J
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.5266492577298039,-0.8708661618650803,0.6417910447761194,1.0,1.0,2/8,8.31%,ARG2;B2M
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.4618692693934547,-0.8707921686777687,0.6901408450704225,1.0,1.0,6/29,14.68%,RHBDF2;IL12A;CHGA;CD200;KCNB1;RSAD2
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.37233246422781713,-0.8706281138156959,0.6933333333333334,1.0,1.0,31/114,28.12%,LAMP5;ISG15;GBP2;RAB11A;LRRK2;SCG3;TULP3;TRAM2;MTCH2;TRAM1L1;SNX10;PPP1R15A;SEC61G;FSIP2;ATP6V1D;RPA2;WDR35;VPS35;CEP68;XPA;FAM149B1;ALDH3A2;ARL1;RPA1;EHD1;IFT122;CSNK1D;OBSCN;CNTLN;BBS4;PAQR3
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.5079062651837372,0.870164230422994,0.6052631578947368,1.0,1.0,3/6,15.17%,LLGL2;SLC7A5;SLC3A2
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.41746339644988867,0.87014820053738,0.5151515151515151,1.0,1.0,7/33,12.92%,SLC38A1;ABCC1;SLC7A11;SLC38A2;SLC38A7;SLC38A3;SLC7A5
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.49845887072316336,0.8699188611196726,0.6857142857142857,1.0,1.0,4/8,26.88%,MLST8;MTOR;LARP1;SMG1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5002098830706974,0.869496766514509,0.6176470588235294,1.0,1.0,1/14,2.67%,OOEP
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.432101036502372,-0.869395783360664,0.6984126984126984,1.0,1.0,4/30,8.83%,RAB11A;FES;LRRK2;USP6
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.4825806231476253,0.8692578128395841,0.6,1.0,1.0,2/12,8.48%,CRYAB;CHRNA7
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.4224212921360748,-0.8690923731034734,0.75,1.0,1.0,4/41,6.35%,MGST1;TXNRD2;GLRX;FES
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.4109900547118198,-0.8690116964875184,0.7,1.0,1.0,2/32,6.42%,DMKN;RFTN1
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.5352220607656238,0.8688521949473497,0.6829268292682927,1.0,1.0,2/8,6.91%,GAB1;MYO1C
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),-0.5571813909831045,-0.86882943909686,0.704225352112676,1.0,1.0,1/7,4.08%,FAP
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.4847779530232969,0.8688197258753979,0.6470588235294118,1.0,1.0,2/11,7.49%,DSEL;DSE
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),-0.5738572415379215,-0.8685985823483185,0.7288135593220338,1.0,1.0,2/7,26.48%,TOM1L1;NME6
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.395528494473932,-0.8684722855729176,0.6338028169014085,1.0,1.0,19/71,23.91%,FBLN1;PTPRC;RPS6KA6;LMO3;CAV1;CAV3;LYN;PTPRR;PIK3CB;TIMP3;PTPRJ;CBLC;PRDM15;SEMA6A;DUSP26;PRKCD;RGS2;AGT;ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),0.49995624360771684,0.8684373001417784,0.5348837209302325,1.0,1.0,4/8,29.66%,UBB;PTTG1IP;PRKN;RPS7
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.40110541868109806,-0.8683283898076386,0.6610169491525424,1.0,1.0,16/64,18.91%,IRGM;MEF2C;VIM;NLRP3;LDOC1;XBP1;CX3CR1;LYN;AXL;TNFRSF1B;ZFP36;NR1D1;WNT5A;GIT1;LILRB1;TGFB1
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.37324658067509286,0.8683131170274687,0.7307692307692307,1.0,1.0,13/51,23.59%,RAE1;NUP42;NUP210;POLR2K;TPR;POLR2L;NUP37;NDC1;SEH1L;POLR2E;POLR2D;NUP85;NUP214
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.37324658067509286,0.8683131170274687,0.7307692307692307,1.0,1.0,13/51,23.59%,RAE1;NUP42;NUP210;POLR2K;TPR;POLR2L;NUP37;NDC1;SEH1L;POLR2E;POLR2D;NUP85;NUP214
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.42040212439422986,0.8683073681520894,0.5333333333333333,1.0,1.0,3/16,14.06%,ZNF335;PIH1D1;DNMT1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.46775625722651293,-0.8682146053516286,0.6842105263157895,1.0,1.0,5/23,17.51%,PTPRM;PTPRG;ADAMTS9;PTPRR;NR2F2
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-0.5468055433813752,-0.8682125584955914,0.6727272727272727,1.0,1.0,3/7,29.82%,CCDC39;ODAD4;OFD1
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.37337864932738773,-0.8681389756014041,0.6666666666666666,1.0,1.0,8/87,9.67%,CLDN5;TGFB2;MEF2C;FOS;TGFBR2;SOX9;TGFB3;FURIN
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.3763624900015522,-0.8678779763198465,0.6575342465753424,1.0,1.0,10/85,8.98%,RIMS1;TGFB2;TWF2;SYT1;SYT4;EDN1;L1CAM;NEDD4L;GOLGA4;LGI1
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.5711810610457054,-0.8675350850321372,0.7142857142857143,1.0,1.0,3/7,7.20%,DUOX1;NOX4;ALOX12
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.5689657575013277,-0.867320488988825,0.7307692307692307,1.0,1.0,2/7,19.45%,CAV1;BCAP31
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),-0.4431341945311085,-0.8672677132664084,0.671875,1.0,1.0,4/22,17.85%,ACADL;CEACAM1;BRCA1;PRKAB2
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),0.5079601872979892,0.8671369164951445,0.6410256410256411,1.0,1.0,2/8,14.30%,THAP4;QDPR
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.5174595922083186,-0.8670254592822212,0.7142857142857143,1.0,1.0,5/13,19.92%,EIF2B4;CEBPB;VEGFA;NR2F2;EIF2B2
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.49840612285972835,0.8669882592990166,0.6571428571428571,1.0,1.0,3/10,15.19%,RAB35;WASHC2A;MICALL1
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),-0.5819023641402555,-0.866671153460724,0.6610169491525424,1.0,1.0,1/5,14.26%,GLYCTK
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-0.5819023641402555,-0.866671153460724,0.6610169491525424,1.0,1.0,1/5,14.26%,GLYCTK
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.4897536937167672,-0.8666649404786052,0.75,1.0,1.0,4/15,20.68%,C5;CSF1R;CXCL17;SLAMF8
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.4899291877677492,0.8666538656280842,0.5897435897435898,1.0,1.0,2/7,10.23%,PTGIS;GLA
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.4899291877677492,0.8666538656280842,0.5897435897435898,1.0,1.0,2/7,10.23%,PTGIS;GLA
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.50858799957688,-0.8666303336550937,0.6666666666666666,1.0,1.0,2/9,8.31%,ARG2;B2M
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.5725204930510728,-0.8665232558624969,0.6875,1.0,1.0,1/5,29.25%,PISD
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.47012126809385646,0.8661137966410908,0.6744186046511628,1.0,1.0,2/10,6.08%,SSC5D;PGLYRP2
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.41410044447243244,0.8659946610075011,0.6666666666666666,1.0,1.0,8/36,10.31%,PIWIL4;DICER1;PIWIL2;TDRD12;HENMT1;PLD6;MOV10L1;PRKRA
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.5043626745980698,0.8659221819338193,0.6304347826086957,1.0,1.0,2/9,4.03%,EVI2B;RUNX1
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.3930827324031084,-0.8658909877893977,0.734375,1.0,1.0,7/61,16.31%,ASB4;DTX3L;SH3RF3;RNFT1;UHRF1;BRCA1;RNF213
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.456993185938862,0.865835143542735,0.6111111111111112,1.0,1.0,5/17,21.56%,TESK1;CDKN1C;DYNLL1;CDKN2C;SIRT1
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.5003281197904997,-0.8656630623242032,0.6842105263157895,1.0,1.0,3/11,31.61%,CAV2;APOE;NUCKS1
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),-0.5393515810414418,-0.8655984520907869,0.711864406779661,1.0,1.0,1/10,6.61%,PIK3AP1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.5371357985086802,0.8652392117697885,0.6595744680851063,1.0,1.0,3/6,24.91%,AKT2;AKT1;BAD
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.35415922151376134,0.8651509828667845,0.6585365853658537,1.0,1.0,8/96,5.52%,CXCR4;DSCAM;EPB41L4B;PLXNA1;DUSP1;SEMA5A;KNG1;EPHB2
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),-0.44946038430355345,-0.8650666121074861,0.6071428571428571,1.0,1.0,4/17,25.46%,SLC25A20;ABCD2;PRKAB2;SLC27A5
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.342576822740723,0.8648629055525168,0.6666666666666666,1.0,1.0,17/153,8.68%,CYP1A2;CYB5A;PYCR1;ABCC2;DCXR;F11;CA2;ENPEP;FBP1;CROT;HSD11B1;NQO1;CSAD;CAT;HPRT1;ATOH8;SERPINE1
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.5592365246030866,-0.8648476543020831,0.7692307692307693,1.0,1.0,3/8,19.73%,LRRK2;ATP6AP2;TMEM9
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.387999953790262,-0.8642660601616414,0.6875,1.0,1.0,12/42,18.94%,LPL;TLR2;IL6R;C1QTNF4;XBP1;IL16;POU2F2;SYK;SCIMP;WNT5A;STAT3;TIRAP
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.4022294681647363,-0.8641272548421872,0.6571428571428571,1.0,1.0,8/45,19.76%,SOX9;GBP2;GBP3;CHI3L1;ADAMTS7;MYLK3;NR1D1;CX3CL1
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.5247177623373565,0.8638446987261912,0.6216216216216216,1.0,1.0,3/10,9.27%,KCND3;KCNJ2;ATP1B1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.4452982157591857,-0.8634496064420792,0.6714285714285714,1.0,1.0,9/24,30.61%,ID2;BHLHE40;CLOCK;PPP1CA;PER1;MTA1;CRY2;RBM4;RBM4B
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.41906699498543853,0.8634133310918736,0.59375,1.0,1.0,9/45,14.72%,SPIRE2;MSRB1;CORO7;MSRB2;WASF3;MICAL1;WASHC5;PSTPIP1;CFL2
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.4073294168038404,-0.8633026193854935,0.7432432432432432,1.0,1.0,9/44,11.26%,RIMS1;TWF2;SYT1;SYT4;L1CAM;NEDD4L;GOLGA4;PLCB1;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.4844662674715805,-0.8630711075430993,0.6825396825396826,1.0,1.0,3/13,8.91%,LPAR6;HTR2C;C3AR1
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.31965652250251764,-0.8628703764160768,0.8875,1.0,1.0,101/744,18.40%,HEY1;MDFIC;KANK2;ZNF366;ZIM2;DACT1;NR4A3;PPARG;CENPF;MAEL;BASP1;ELK3;PARP9;ZNF550;CRYM;MIDEAS;GLIS2;IRF1;CITED2;EDN1;MEF2C;ZNF343;ID2;ZNF239;SOX9;LOXL3;MLIP;NEDD4L;PRICKLE1;CCND1;DKK3;ZEB1;BHLHE40;ZNF608;ZNF540;ZBTB32;EFNA1;E2F1;GATA1;GTF2IRD1;BMP6;RUNX1T1;ZNF764;CEBPB;RARB;PLCB1;CDK5R1;ZNF217;H1-0;IFNA2;ORC2;NR2F1;ZNF20;CAV1;PCGF2;GLI3;PRAME;HJV;AR;ZFPM1;DNAJB1;L3MBTL4;GLIS3;IKZF1;MOSPD1;ETS2;PBXIP1;ZNF248;ZNF391;UHRF1;PAX6;EDNRB;CBX7;ZNF705G;ETV6;ATP8B1;VEGFA;BRCA1;TRERF1;STAT1;ID3;CREB3L1;PRDM1;TGIF1;NRG1;POU6F1;EZH2;ZFP36;NR2F2;ZNF10;ZFP69;CDK5;ZNF136;MYT1L;NR1D1;CBX8;WNT5A;LDB2;TENM2;STAT3;CLOCK
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.424428359904928,-0.8628677530669464,0.6363636363636364,1.0,1.0,3/33,6.37%,CLDN5;CLDN16;CLDN20
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.4599440826220126,0.8628633401306741,0.6388888888888888,1.0,1.0,4/22,8.61%,ATP6V0A4;RAB39A;ATP6V1G2;ATP6V1G1
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.47702351646485996,0.8627427754356491,0.5789473684210527,1.0,1.0,1/6,8.40%,GBF1
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.47702351646485996,0.8627427754356491,0.5789473684210527,1.0,1.0,1/6,8.40%,GBF1
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.47702351646485996,0.8627427754356491,0.5789473684210527,1.0,1.0,1/6,8.40%,GBF1
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),0.4982844447793455,0.8627042616374729,0.5945945945945946,1.0,1.0,2/11,2.23%,DHFR;MTHFD2L
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.41713551173012947,-0.8626266788271167,0.6571428571428571,1.0,1.0,5/41,17.38%,ISG20;DENND3;ADAMTS9;FBXO17;NCBP1
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.45368171088656456,0.8624089927179764,0.6774193548387096,1.0,1.0,2/15,4.15%,CELA2A;ADAMTS18
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.37482128184911273,-0.8623016800533697,0.6935483870967742,1.0,1.0,31/108,21.75%,ROR1;STMN2;EPHA3;TWF2;RIT2;PLPPR5;CARMIL2;ROBO2;FES;CAMK1D;TENM3;TOX;GRIP1;CAMK1;ATP1B2;CARMIL1;SCN1B;LYN;DLG4;LRRC7;PTK7;WNT5A;NTRK3;PLXNC1;CAMK2B;PLXNA2;CX3CL1;PLXNA4;SERPINI1;PTN;NDRG4
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),0.3946419616708261,0.8622267869709918,0.6774193548387096,1.0,1.0,3/35,6.80%,CRTAM;SCRIB;PDE4B
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.3371312824987713,-0.8622004139621177,0.8507462686567164,1.0,1.0,18/203,17.07%,EPN1;RIMS1;MX1;CR1;SYT1;BAIAP2L2;AMPH;NEMP1;STEEP1;SH3GL2;SAR1A;CAV3;TGFA;DNM1;COX18;EGFR;NAPG;DNM1L
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),-0.546394435557552,-0.8621119452958629,0.7258064516129032,1.0,1.0,1/5,13.33%,CALM3
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.5032110225935471,0.8620672238257071,0.6666666666666666,1.0,1.0,1/8,0.95%,DHFR
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.515749349650322,-0.862031715622918,0.6923076923076923,1.0,1.0,3/10,14.47%,ALDH1A2;CYP3A5;ALDH8A1
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),-0.5264496467878875,-0.8617792323139323,0.6349206349206349,1.0,1.0,4/8,40.05%,WASHC1;DAB2IP;RUBCN;PPP2R5A
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.33397667365906636,0.8611898005833087,0.6551724137931034,1.0,1.0,22/107,12.92%,SLC22A2;SLC38A1;TXNIP;SLC52A1;ABCC2;ABCC1;SLC7A11;SLC25A29;SLC38A2;RILP;SLC52A2;ARRDC4;ARRDC3;ARRDC5;CUBN;CEP290;SCAMP2;CMTM6;SLC6A13;SLC38A3;CD320;SLC7A5
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.4809692765188373,-0.8611104719796971,0.75,1.0,1.0,5/19,13.68%,CR1;SFTPD;HLA-DRB1;CEBPB;LYN
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),0.5747423684058311,0.8610718923236443,0.6756756756756757,1.0,1.0,1/6,11.71%,SLC6A13
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.41022420941480564,-0.8609721599158743,0.6829268292682927,1.0,1.0,11/48,22.44%,IFNGR2;ID2;FURIN;WWTR1;ID3;TGIF1;PPP1R15A;TGFB1;CDH1;PPP1CA;JUNB
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.38396103849044566,-0.8609576304339982,0.6986301369863014,1.0,1.0,11/86,11.57%,PKP2;CLDN5;CDH12;NRCAM;CDH9;GPM6A;CDH22;PCDHB4;CDH10;CDH18;PCDHB11
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.4497264864351138,-0.8608515210569582,0.7068965517241379,1.0,1.0,3/20,13.14%,NUDT11;NUDT4;NT5C1A
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.5105416314609549,-0.8608130882364919,0.631578947368421,1.0,1.0,1/9,8.01%,TERF2IP
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),-0.5844570093132314,-0.8605863914701668,0.6607142857142857,1.0,1.0,2/5,24.66%,TMLHE;SHMT1
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),-0.5844570093132314,-0.8605863914701668,0.6607142857142857,1.0,1.0,2/5,24.66%,TMLHE;SHMT1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.466697771303452,-0.8600810652079363,0.6417910447761194,1.0,1.0,4/16,20.69%,LZTFL1;TGFB1;PID1;MRAP
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.490529875426749,0.8598981522177775,0.6363636363636364,1.0,1.0,4/10,23.25%,RNF152;SESN1;CASTOR2;KPTN
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.38737960753143413,-0.8597459206109526,0.6571428571428571,1.0,1.0,2/53,1.81%,COX7A1;SHMT2
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),-0.571097043630985,-0.8597408432076465,0.7090909090909091,1.0,1.0,2/8,20.47%,RAB27B;KIF5A
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),-0.571097043630985,-0.8597408432076465,0.7090909090909091,1.0,1.0,2/8,20.47%,RAB27B;KIF5A
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),-0.571097043630985,-0.8597408432076465,0.7090909090909091,1.0,1.0,2/8,20.47%,RAB27B;KIF5A
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.3964239350852947,-0.8596361003485202,0.5873015873015873,1.0,1.0,8/30,18.94%,TLR2;LAPTM5;PLCB1;IL16;SYK;SCIMP;LILRB1;TIRAP
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.35889299862303303,0.8596073961938484,0.6764705882352942,1.0,1.0,13/63,13.38%,KIF3B;NDC80;ESPL1;ZNF207;FLNA;TPX2;KIFC2;KIFC1;KIF25;TUBG1;BCCIP;NSL1;SGO2
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),0.554867240117457,0.8595407405527407,0.6578947368421053,1.0,1.0,1/5,5.02%,PLD1
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.5499691361938416,-0.859534952957349,0.7377049180327869,1.0,1.0,2/5,42.01%,RABL3;SVIP
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.4661457872529683,-0.8593098574902395,0.6842105263157895,1.0,1.0,5/19,28.64%,SOX9;ARHGAP12;VCL;ACTG1;TIMELESS
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),-0.3474627414888238,-0.8591134313091416,0.75,1.0,1.0,39/146,31.67%,TGFBR2;HIPK4;RPS6KA6;LRRK2;CAMK1D;CDK5R1;CAMK1;PRKCQ;PRKD2;MAP3K12;CDK5;PLK2;GAS6;PRKCZ;VRK3;PRKCG;PRKCD;MAP4K1;AURKA;DYRK2;STK38L;HIPK3;CLSPN;MASTL;STK38;CSNK1D;BRSK1;CDC7;CSNK1E;TLK1;RPS6KA3;TBK1;AKT3;CSNK1G1;SGK2;CAMKV;MKNK1;CAMK2D;STK32B
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.5119212411284157,-0.8586123390744761,0.7,1.0,1.0,2/11,27.44%,RASA1;NOVA1
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),0.5278525265219018,0.8584392723129608,0.6363636363636364,1.0,1.0,2/6,12.20%,TMEM98;TNFRSF21
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),-0.5622335356632366,-0.857969301910981,0.6470588235294118,1.0,1.0,2/7,14.17%,LGALS3;GRM6
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-0.549958755685759,-0.8575113261209957,0.660377358490566,1.0,1.0,2/5,27.85%,CPSF3;LSM11
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.3477819864067654,-0.8572843270037479,0.7857142857142857,1.0,1.0,40/184,22.92%,TLR2;MCM2;PLSCR1;PAK5;MX1;BCL2L14;IRF1;FAP;CIDEB;TGFBR2;RFK;SCN2A;DDIT4;NLRP3;PDE1B;KREMEN1;IFNA2;TCHP;DAPK1;APAF1;DAPK3;NOTCH2;EFNA5;PPP1R15A;SIAH1;CDK5;ATCAY;NFKBIA;PLAGL1;BBC3;TNFRSF25;CIT;IFIT2;MAL;NUDT2;TNFRSF10B;SEMA6A;PRKCD;IFI27L1;NLRP1
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),-0.4415081939630727,-0.8572612155183952,0.7272727272727273,1.0,1.0,1/28,1.25%,IRGM
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.3776566769797537,-0.8571861549130405,0.6857142857142857,1.0,1.0,24/104,16.93%,TRPC4;EDN1;SLC8A3;ATP2B3;CALB2;TRPC6;ATP2B2;HTR2C;SLC24A5;PLN;TPCN2;SLC8A1;HTR2B;TRPC7;SLC24A1;CAV1;CAV2;CAV3;HTR2A;CDH23;ADCY8;HCRTR2;SLC24A4;FKBP1B
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),0.518330466770691,0.8571115253659345,0.6341463414634146,1.0,1.0,2/6,9.18%,HMGB1;TMEM98
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.4845810126344663,0.8569602583830387,0.5833333333333334,1.0,1.0,2/12,7.49%,DSEL;DSE
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.5242234612292888,-0.8568856238212512,0.7540983606557377,1.0,1.0,1/10,6.11%,EPHA4
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.47494431048210145,0.8568442798769583,0.5882352941176471,1.0,1.0,4/14,10.35%,F2;H2BC21;GNLY;FAM3A
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.4861250580992743,-0.8568265908358592,0.6935483870967742,1.0,1.0,4/16,16.29%,LGALS3;CSF1R;LYN;CXCL17
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.5285924477530272,-0.8566271998511958,0.6818181818181818,1.0,1.0,2/10,12.27%,CENPE;NUF2
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.3143782403702401,0.8564365858609975,0.8095238095238095,1.0,1.0,52/393,14.26%,POU3F1;TEAD2;CD38;AFAP1L2;HIVEP3;MYRFL;KDM8;WBP2NL;RNF6;RUNX1;PYHIN1;FANK1;PAX3;MSANTD1;HMGA2;JMJD6;ATF4;CAND2;GLI2;BRPF1;HDAC1;PAX8;ATOH8;SMARCD3;EPC1;ACVR1;SNAI1;WNT4;CDKN1C;RBM23;CEP290;RYBP;RPS6KA1;HNF4A;PBX4;TRIM16;SP100;HES5;CHUK;KAT2A;CNBP;MLLT3;ESRRG;SMARCA4;NFKB1;KDM5A;BCL10;ZMIZ1;NFIB;MAP2K7;ANKRD49;PSRC1
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),-0.5217447382318676,-0.8563466408148156,0.6470588235294118,1.0,1.0,4/10,18.15%,DGKD;ADGRV1;VEGFA;WNT5A
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.4510450367513477,-0.8562164815461223,0.6716417910447762,1.0,1.0,4/21,15.02%,METTL21A;EEF2KMT;EEF1AKMT2;PRMT8
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.5093932317239402,-0.8561752823919967,0.6428571428571429,1.0,1.0,5/10,39.38%,ATG10;APOE;PORCN;UGCG;PIK3C3
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.5010357394837964,-0.8557318288649625,0.6037735849056604,1.0,1.0,1/7,17.97%,KDELR3
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),-0.5102331761573998,-0.8552034289629952,0.7636363636363637,1.0,1.0,1/7,8.01%,PIH1D2
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.40689147394606456,-0.8549532767979535,0.7205882352941176,1.0,1.0,2/37,9.59%,ADAMTS5;PGAM5
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.3638915763787766,0.8549464430706883,0.6571428571428571,1.0,1.0,14/46,23.59%,RAE1;NUP42;NUP210;TPR;NOS2;PNPT1;ZBTB7A;NUP37;NDC1;SEH1L;NOA1;PGAM1;NUP85;NUP214
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.35817871340335,0.8545923091452307,0.7352941176470589,1.0,1.0,11/49,13.02%,SH3RF2;HSPA1A;GNL3L;SPRY2;PINX1;ABL1;PRR7;BAG2;HSPA1B;NXN;LIMK1
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.41356767434228314,-0.8545782412935592,0.6515151515151515,1.0,1.0,3/36,6.37%,CLDN5;CLDN16;CLDN20
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5338367326183799,-0.8545005572337677,0.7241379310344828,1.0,1.0,3/9,25.22%,BMP6;VEGFA;MAD2L2
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.3683171151264913,-0.8544907539725312,0.7121212121212122,1.0,1.0,7/74,4.86%,LPL;TLR2;PTPRC;VSIR;HLA-E;CLU;C1QTNF4
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.35327450362758717,0.854440406463867,0.6944444444444444,1.0,1.0,12/71,7.85%,SLC22A6;CA6;SLC52A1;SLC39A8;CA2;CA5A;CYB5R1;CA3;SLC52A2;LRRC8A;SLC26A7;SLC2A14
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.4176804070542432,0.8541161939784778,0.6410256410256411,1.0,1.0,3/19,7.31%,HMGB1;DICER1;EXOG
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.4376015790166417,-0.8539589465729426,0.7333333333333333,1.0,1.0,3/30,1.74%,ITGB4;DMKN;IL13RA1
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.5041052768022497,0.8537367832518694,0.6060606060606061,1.0,1.0,3/6,20.09%,MTCL1;CFAP100;CFAP73
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.5404915231996872,-0.8536982848017467,0.6666666666666666,1.0,1.0,2/6,17.78%,LOXL3;DMTN
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.4495001495503894,0.8535647885379472,0.6,1.0,1.0,1/16,1.81%,FOLH1B
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.44851523625848844,-0.8534518068728815,0.6491228070175439,1.0,1.0,5/22,18.91%,KIF16B;MVB12A;TPP1;SIAH1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),-0.45822029443422774,-0.8533849191798981,0.68,1.0,1.0,7/25,22.03%,PLPPR5;GPM6A;TGFB3;NEURL1;TENM2;FNBP1L;TENM1
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),-0.5778785304035539,-0.8531646132135862,0.7966101694915254,1.0,1.0,1/5,10.64%,XBP1
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.5386223931935266,-0.852861731589637,0.6964285714285714,1.0,1.0,2/7,16.23%,LOXL3;MTHFD1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.4363952253994178,-0.8527163285751029,0.7142857142857143,1.0,1.0,5/29,12.92%,CYREN;POLQ;RADX;KLHL15;MAGEF1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.44683790157845316,-0.8526166292446739,0.6268656716417911,1.0,1.0,4/23,6.45%,MMRN2;PPARG;MEF2C;ANGPT2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.3678466304207486,0.8526073291910973,0.5555555555555556,1.0,1.0,15/56,16.79%,ESPL1;PPP1R10;DMRT1;EPC1;UXT;RYBP;KIF25;RNF2;CBX5;MGA;ZFYVE19;TFDP1;E2F6;PHC1;RBBP4
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.45165938150983187,-0.85239351819557,0.6666666666666666,1.0,1.0,3/23,7.38%,ID2;FES;HLA-DRB1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.47283029905511387,-0.8523870672129777,0.6557377049180327,1.0,1.0,8/14,36.52%,ATP5F1E;ATP5MC1;DMAC2L;ATP5ME;STOML2;ATP5PD;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.5159912590541111,0.8522909350040712,0.7297297297297297,1.0,1.0,1/9,1.90%,SPX
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),-0.5852156141516905,-0.8522205201682764,0.7692307692307693,1.0,1.0,3/5,15.39%,AMN;TCN2;CBLIF
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.4914024442762881,0.8521917604070159,0.5952380952380952,1.0,1.0,2/14,12.63%,ERI1;TENT4B
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),-0.45118120104696935,-0.8521861063545351,0.75,1.0,1.0,2/18,11.17%,ACTN1;THY1
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.4116277668626411,-0.852163527940915,0.6923076923076923,1.0,1.0,6/32,3.42%,CD59;CLU;C1QB;C5;SERPING1;CR1
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.3764215093940242,-0.8518117392672422,0.6901408450704225,1.0,1.0,12/88,19.30%,IHO1;DBF4;SOX9;RAB11A;CAV2;CALM3;DAPK3;BORA;GIT1;TTL;PLK2;KIF20B
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.39644738025361115,0.8516476977591557,0.5925925925925926,1.0,1.0,22/61,25.07%,ATF4;EIF4EBP1;EIF5;NCK1;EIF3B;EIF3E;EIF1;ATF3;EIF4G2;TPR;DDX3X;EIF4G3;NPM1;PAIP2B;KLHL25;EIF3H;POLR2D;YTHDF1;EIF4EBP2;EIF4B;PAIP2;LARP1
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.4341334901187126,0.8515354893627769,0.631578947368421,1.0,1.0,2/17,4.66%,RAB27A;TESK1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.36338673075099526,-0.8514601926802514,0.72,1.0,1.0,14/97,10.86%,ITGB4;FBLN1;SEMA3E;IGFBP3;HOPX;LRIG3;F3;MET;NTN4;KIAA1217;PALLD;WWTR1;SLC44A3;CRLF1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.4468020571264835,0.8514112279464221,0.6486486486486487,1.0,1.0,3/16,14.64%,MORC3;HNRNPU;TAF3
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.46215740337191197,0.8509116180576153,0.6206896551724138,1.0,1.0,5/14,10.76%,DUSP1;HMGB1;SLIT2;SERPINE1;GREM1
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),0.4673442340498726,0.8508973223732155,0.6875,1.0,1.0,2/10,5.48%,MGLL;AWAT2
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.4005984595432662,-0.850696901810983,0.7866666666666666,1.0,1.0,9/51,21.69%,LPL;PLPPR5;PLPPR3;PLAAT4;PLBD2;SMPD3;GPX4;PLPPR1;PLB1
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.5532364625009858,-0.8505668307251628,0.7538461538461538,1.0,1.0,3/6,34.21%,CACNA1C;AKAP5;CACNA1D
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.3091341369388644,-0.8499355242420904,0.8974358974358975,1.0,1.0,39/562,9.70%,CD44;ANGPT1;FSTL1;IGFBP3;SFRP4;AVEN;FIGNL1;TP53I3;OLFM1;CLU;NCKAP1L;BCL2L2;BCL2L14;BIRC3;CITED2;MEF2C;CIDEB;AQP1;APIP;TP73;SOX9;PIM1;KALRN;HGF;ANO6;VAV3;ACTN1;MAP3K5;TEK;IL7;E2F1;KCNMA1;TFPT;GATA1;PNMA2;TCIM;TGFB3;RNF144B;NAIP
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.43835131902846197,-0.8498978839156147,0.7230769230769231,1.0,1.0,8/29,11.26%,PDE7A;AQP1;SOX9;IRAG1;NUDT4;HTR2C;HTR2B;RIMS2
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.37045878963472406,-0.8498284884166621,0.78125,1.0,1.0,8/65,13.51%,CLU;BCL2L2;LGALS3;HGF;SCG2;CX3CR1;AR;ITGAV
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.39486740146462473,0.8496750565868414,0.6774193548387096,1.0,1.0,5/25,8.86%,CMPK1;AK6;AK8;DUT;DCTD
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),-0.49175016944801886,-0.8495629274219844,0.7246376811594203,1.0,1.0,2/11,10.64%,FCHSD2;CYFIP1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.4764619815576622,-0.8495064333113638,0.7049180327868853,1.0,1.0,4/16,13.14%,NOS1;CACNB1;UBASH3B;CAV3
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.44315092792986727,0.849471318149892,0.5789473684210527,1.0,1.0,5/16,11.21%,SQLE;AUP1;PLIN5;PLA2G4C;PNPLA3
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.3677301015367657,-0.848919490410881,0.7611940298507462,1.0,1.0,6/86,7.18%,CENPK;CENPE;TTN;SMC4;RAB11A;NCAPH
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.4235853911864218,-0.8487748522157434,0.6666666666666666,1.0,1.0,8/35,15.10%,PLPPR5;DGKD;ALOX12;PLPPR3;DGKB;SGPP2;CYP3A5;PLPP6
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.5111273602419253,-0.8486294470185618,0.7164179104477612,1.0,1.0,1/10,6.64%,RPS6KA6
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.3814911157787827,0.8483795380734886,0.7741935483870968,1.0,1.0,2/24,6.18%,PYCR1;ATF4
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),-0.49483225543051973,-0.84831632412055,0.671875,1.0,1.0,4/12,10.93%,EPHA3;NRCAM;EPHA4;CDK5R1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.49799890172755745,0.8481382630318971,0.6,1.0,1.0,3/7,30.54%,LIG4;MSH3;PRKDC
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.5314125900065555,-0.8480105047490784,0.6818181818181818,1.0,1.0,2/8,18.91%,EGFR;TGFB1
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.46627445697894404,0.8479320176650459,0.6206896551724138,1.0,1.0,4/11,12.54%,GLI2;SOX12;RELN;DLL1
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.454362883591349,-0.8479194665729798,0.6515151515151515,1.0,1.0,1/20,0.82%,PPP1R17
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.33842493432408044,-0.847854541785371,0.7702702702702703,1.0,1.0,41/155,31.67%,TGFBR2;HIPK4;RPS6KA6;LRRK2;CAMK1D;CDK5R1;CAMK1;PRKCQ;PRKD2;MAP3K12;CDK5;PLK2;GAS6;PRKCZ;VRK3;PRKCG;PRKCD;MAP4K1;AURKA;DYRK2;STK38L;HIPK3;CLSPN;MASTL;STK38;CSNK1D;POGLUT2;BRSK1;CDC7;CSNK1E;TLK1;RPS6KA3;TBK1;AKT3;CSNK1G1;SGK2;CAMKV;HPF1;MKNK1;CAMK2D;STK32B
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.5448641563982166,-0.8474186587352258,0.6923076923076923,1.0,1.0,1/8,1.72%,PTPRC
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),-0.541916078882813,-0.8469914323101554,0.6984126984126984,1.0,1.0,2/5,21.84%,XBP1;GCKR
prerank,MSigDB_Hallmark_2020__Coagulation,-0.35847144496446137,-0.8467632051952699,0.765625,1.0,1.0,8/86,5.14%,F8;TIMP1;CTSO;CLU;SERPING1;F3;PRSS23;A2M
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.5231211808731195,0.8466419324245474,0.625,1.0,1.0,1/8,1.56%,WNK4
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.49133247929093277,-0.846413171281272,0.7017543859649122,1.0,1.0,3/9,22.06%,ATP8B1;MAL;SHROOM2
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.4527091005555629,-0.8462765879258214,0.7166666666666667,1.0,1.0,4/17,15.84%,CRYM;DDO;SDS;SLC25A21
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.5567990445322667,-0.8458639363833814,0.7192982456140351,1.0,1.0,2/7,18.75%,BCAT2;MCCC1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.368108795078571,-0.8458199483836932,0.782608695652174,1.0,1.0,9/55,18.80%,SPDYA;DBF4;CCND1;CRLF3;E2F1;E2F3;CDKN3;CDKN1A;PLK2
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.46000103875371967,-0.8456310637641399,0.676923076923077,1.0,1.0,5/15,15.88%,CHRM3;NMUR2;CAV1;DAPK3;KCNB2
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.44834304394504093,-0.8456203772592932,0.6379310344827587,1.0,1.0,1/13,3.23%,NFKBIE
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.48443280991016946,-0.8455952497946672,0.6615384615384615,1.0,1.0,5/17,18.91%,C5;SULF1;BRCA1;CXCL17;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.38909392062229065,-0.8454331888401189,0.6571428571428571,1.0,1.0,10/42,11.04%,PTPRC;HLA-E;IL12A;NCKAP1L;MEF2C;VAV3;IL7;HLA-DPB1;BST1;GPR183
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.5200191740006842,0.8453732296136254,0.6666666666666666,1.0,1.0,2/5,25.56%,MAPK8;CAP1
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.386072553334401,-0.8453683775790938,0.765625,1.0,1.0,8/65,13.14%,STMN2;CLU;TWF2;APC2;NAV3;PLEKHH2;MAP2;CAV3
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.4776020479236925,0.8451618678873511,0.5862068965517241,1.0,1.0,1/13,0.37%,DAO
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.4832275360010753,-0.8448480845725089,0.7236842105263158,1.0,1.0,2/17,10.26%,LRRK2;LRCH1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.5368744809880991,0.8446200316764244,0.7021276595744681,1.0,1.0,2/6,18.45%,CAND2;FBXL7
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.4921899395908878,0.8444709666286797,0.5957446808510638,1.0,1.0,2/8,3.27%,AGER;HMGB1
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.4156536573096649,-0.8442217161791121,0.6865671641791045,1.0,1.0,8/34,20.44%,NCKAP1L;GATA1;ZFPM1;LYN;STAT1;ZFP36;STAT3;SPI1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5050785792690055,0.8436695070353335,0.65,1.0,1.0,4/11,11.28%,CREB3L3;ATF4;ATF6B;ATF3
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),-0.5551422392545684,-0.843340763888973,0.7213114754098361,1.0,1.0,2/5,20.52%,ATCAY;PRUNE1
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.521876420169013,-0.8433082345694463,0.7627118644067796,1.0,1.0,4/12,29.76%,WTIP;CIT;WWC3;SHANK2
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.3746825821834383,-0.8433072304093838,0.6716417910447762,1.0,1.0,10/82,9.23%,FOSL2;IL13RA1;RHBDF2;TNFRSF1A;CEBPD;LGALS3;DTX3L;GBP3;BHLHE40;ANXA11
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.4134476446495362,0.8432892383859358,0.65625,1.0,1.0,2/23,12.01%,AUP1;UGGT1
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.4404609058318957,-0.8432854644674749,0.6290322580645161,1.0,1.0,8/18,29.00%,PARP9;NNMT;PARP10;KYNU;NAPRT;HAAO;NMNAT2;NMNAT3
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.4785255935654146,-0.8431558158242394,0.7014925373134329,1.0,1.0,5/18,18.91%,C5;SULF1;BRCA1;CXCL17;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.38126402650665603,-0.8431513160488584,0.7419354838709677,1.0,1.0,10/49,24.07%,CIDEB;FBXO7;MLLT11;DNM1L;HRK;ZDHHC6;BBC3;VPS35;PPIF;AURKA
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.4766256509328898,-0.8429510160643783,0.6724137931034483,1.0,1.0,1/14,1.81%,SHMT2
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.33370634722036646,0.8428392373660705,0.8148148148148148,1.0,1.0,16/140,10.61%,PASK;PTH;PIWIL2;PTH1R;PLD1;NOS1AP;GLI2;CTC1;PLIN5;NAT10;EPM2AIP1;EIF3E;EIF3D;SAMD4A;ZEB2;AKT2
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.4325184856137959,-0.8425504682939502,0.734375,1.0,1.0,6/22,25.67%,HLA-DRB1;ADCY8;EFNA5;NR1D1;ABCA12;STX4
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),-0.37206946817616193,-0.8425347074446783,0.6666666666666666,1.0,1.0,15/61,14.11%,HEY1;NRCAM;MEF2C;ID2;BRINP2;DTX1;ZEB1;ZFHX2;LRRK2;CASZ1;CDK5R1;NREP;YWHAH;TRIM32;BRINP1
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.486811213990902,0.8424828802677033,0.6,1.0,1.0,3/5,13.68%,DCP1A;PNRC2;DCP1B
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),0.5555682306623766,0.8423176570866293,0.6764705882352942,1.0,1.0,2/5,23.60%,DKC1;CCT2
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),0.5555682306623766,0.8423176570866293,0.6764705882352942,1.0,1.0,2/5,23.60%,DKC1;CCT2
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),-0.5739642040962234,-0.8420504669823443,0.7450980392156863,1.0,1.0,1/5,17.66%,CEP135
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.3739530386697987,0.8419824430995104,0.6756756756756757,1.0,1.0,3/34,3.27%,AGER;CD274;HMGB1
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.4158113421244236,-0.8419631703284037,0.765625,1.0,1.0,3/32,13.75%,NEFL;RAB27B;AP3B2
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.45435013054169515,0.8415256126598696,0.7142857142857143,1.0,1.0,1/24,0.43%,F2
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),0.32754322474680725,0.8414634512422566,0.8484848484848485,1.0,1.0,53/182,21.97%,POP5;RCL1;BYSL;NOC2L;MDN1;DCAF13;LTV1;PIH1D1;DDX31;NOM1;RRP12;EXOSC8;NOL8;SDAD1;RIOK1;DKC1;ESF1;PELP1;NOLC1;RPL18A;RIOK2;RRP1B;GTF3A;RRP36;LTO1;MPHOSPH10;KRR1;URB2;RPL23A;METTL17;WDR74;UTP3;EXOSC7;NOL11;NPM1;RPL3;DDX10;RPL13;DIS3;UTP6;RAN;WDR36;NAF1;RPL11;MRPL22;PWP2;EXOSC5;RPL8;NOP56;RPL32;RPL21;RPS16;POP4
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.4401328989790269,-0.8414428605572218,0.7058823529411765,1.0,1.0,4/19,5.27%,MAEL;TEX15;TDRD1;EXD1
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.4745189504663876,0.8413909213220914,0.7297297297297297,1.0,1.0,2/11,8.45%,RFWD3;SDE2
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.4823110038982412,0.8413292044300531,0.725,1.0,1.0,1/9,9.06%,PLA2G4C
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.5363186504895772,-0.8413031766036609,0.6551724137931034,1.0,1.0,2/6,23.00%,SENP7;USPL1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.4988405920822452,-0.841242032660827,0.7068965517241379,1.0,1.0,2/10,3.85%,YBX3;BIRC3
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.40675537491423913,0.8412173233813093,0.6764705882352942,1.0,1.0,4/29,8.61%,ATP6V0A4;RAB39A;ATP6V1G2;ATP6V1G1
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.3940588387426026,-0.8410432090332691,0.6933333333333334,1.0,1.0,14/47,17.94%,FMO5;PDZK1;TSHR;SLC23A1;SMLR1;SLC22A9;TPO;SLC5A9;SLC3A1;ABCG5;CYP3A5;SLC2A2;ADH4;SLC6A4
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.38132998338913726,0.8408232522178081,0.6666666666666666,1.0,1.0,5/20,16.49%,CASQ2;CLIC2;DRD4;GPR35;THADA
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),-0.5703226694200698,-0.8406854997999822,0.7454545454545455,1.0,1.0,2/6,25.70%,NFATC2;NFATC1
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.34488765373979874,0.8406047093154881,0.7714285714285715,1.0,1.0,15/72,16.00%,ORC1;DHFR;KLF11;NASP;EIF4EBP1;ACVR1;USP37;CDK6;ACVR1B;CDK15;LATS2;CDK18;EIF4E;TFDP1;BCAT1
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.43975461962946877,0.8405592882211131,0.6216216216216216,1.0,1.0,1/12,2.89%,MYOF
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.4648757056467617,-0.8403722431278569,0.7183098591549296,1.0,1.0,3/14,16.82%,MEF2C;CALM3;PPP1R15A
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,-0.3609984759591455,-0.8403619287382124,0.8181818181818182,1.0,1.0,20/89,15.94%,SOX9;FIGN;BOC;DDAH1;TUSC3;CTXN1;PTPRG;GPR161;GTF2IRD1;TENM3;FAT1;ADGRL2;NR2F1;PCGF2;GLI3;GPC6;FHOD3;DZIP1;MEX3A;TRAM1L1
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.3670908540893969,-0.8403385165068937,0.7301587301587301,1.0,1.0,17/94,16.31%,SHMT2;ALDH1A2;GLRA3;APIP;NINJ1;RYR3;B2M;SAMHD1;POLQ;KCNC2;AQP11;HCN1;STEAP4;AQP4;ADCY8;PRMT8;RNF213
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.48701461310341276,0.8401376274922618,0.6904761904761905,1.0,1.0,3/7,10.57%,FGFR1;PLIN5;FGFR3
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.47322644029695704,0.84010203358946,0.6774193548387096,1.0,1.0,5/13,20.19%,NXF1;SARNP;ENY2;THOC2;IWS1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.4362254736642691,-0.8399739323460748,0.7321428571428571,1.0,1.0,6/26,7.38%,HLA-F;HLA-E;ITGAM;IL12A;HLA-A;HLA-DRB1
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.41532397556154244,-0.8399358665714662,0.75,1.0,1.0,7/27,15.70%,EDN1;RIN3;LRPAP1;ITGAV;DLG4;EDNRB;BRCA1
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.4903912161624161,-0.8398495735761249,0.6885245901639344,1.0,1.0,4/15,19.95%,DUOX1;ABCC9;STAT1;TRPM2
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.43555497881108574,0.8395212276926914,0.696969696969697,1.0,1.0,3/25,7.49%,CHST7;DSEL;DSE
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.5202407155813481,0.8394814366447212,0.7073170731707317,1.0,1.0,1/7,6.11%,SPRED1
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.46580704603011525,-0.8394663917036821,0.6779661016949152,1.0,1.0,8/15,36.52%,ATP5F1E;ATP5MC1;DMAC2L;ATP5ME;STOML2;ATP5PD;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.4335012610011659,-0.8392665439081697,0.671875,1.0,1.0,1/22,1.13%,TLR2
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.46724991131336463,-0.8388250497909205,0.7241379310344828,1.0,1.0,4/18,22.66%,EEF1AKMT2;SETMAR;SETD1A;SETD7
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.5234128749838708,-0.838574057854084,0.6842105263157895,1.0,1.0,1/8,15.40%,ABCD2
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.4314073481008084,-0.8382324541907089,0.676056338028169,1.0,1.0,2/23,7.89%,ID2;BHLHE40
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.4909518460948975,-0.8381913589114798,0.6779661016949152,1.0,1.0,1/16,1.90%,CENPF
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.4909518460948975,-0.8381913589114798,0.6779661016949152,1.0,1.0,1/16,1.90%,CENPF
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.4909518460948975,-0.8381913589114798,0.6779661016949152,1.0,1.0,1/16,1.90%,CENPF
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.39766815259228855,-0.8380446398833844,0.7692307692307693,1.0,1.0,8/53,18.60%,TGFB2;RFTN1;LGI1;PLCB1;TRIM32;EGFR;NCBP1;HPN
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.5458088230739956,-0.8380230235729995,0.7017543859649122,1.0,1.0,2/6,20.52%,ATCAY;PRUNE1
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),0.44711410228191883,0.8377704788758746,0.625,1.0,1.0,2/12,6.88%,NOC2L;SPHK2
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.40063530990733015,-0.8376921367151158,0.7121212121212122,1.0,1.0,1/29,1.30%,DACT1
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.431980809695347,0.8373734399361119,0.65625,1.0,1.0,2/26,5.34%,GPC4;GPC2
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.38760693159913795,-0.8368248665576863,0.7605633802816901,1.0,1.0,2/41,9.59%,ADAMTS5;PGAM5
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.3730360670200658,-0.8367189645992148,0.7090909090909091,1.0,1.0,5/46,11.67%,H2BC11;NAP1L2;SOX9;LIN54;H1-0
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.42340646766226425,0.8365834879565399,0.6578947368421053,1.0,1.0,4/17,22.14%,HMGA2;KAT2A;ZNF706;CNOT2
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.42149602637537115,0.8364733206484513,0.7647058823529411,1.0,1.0,8/15,23.07%,RUNX1;NLRP7;BAG2;GAS1;ADAM8;TMEM59;NLRC4;CLN3
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.48955625290311566,-0.8362129021139058,0.6610169491525424,1.0,1.0,1/17,1.90%,CENPF
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),-0.5536349307991308,-0.8359252605210539,0.7818181818181819,1.0,1.0,4/5,44.53%,IL12RB1;IL1R1;IL18;SLC11A1
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.44383490648098584,-0.8358217788457508,0.7258064516129032,1.0,1.0,6/15,29.00%,PRPS1;PRPSAP1;MTHFD1;PRPS2;NMNAT2;NMNAT3
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.49950253419339147,-0.8357283611078906,0.7246376811594203,1.0,1.0,3/9,28.80%,COPS9;EPAS1;HIF1A
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.545315743753364,-0.8356509203530809,0.7096774193548387,1.0,1.0,1/5,4.02%,EDN1
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.4831526064664175,-0.8354779944030696,0.7121212121212122,1.0,1.0,4/12,12.10%,CHGA;PLN;SLC8A1;ATP1A1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.40903359711012055,-0.8353284367489279,0.7017543859649122,1.0,1.0,7/23,13.68%,VSIR;CR1;EPHA4;EFNA1;EFNA3;GRIN2B;LYN
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.38532380393782256,-0.8352817983025342,0.7719298245614035,1.0,1.0,16/64,25.19%,CERS6;ST3GAL5;SGMS2;PNPLA1;ST8SIA3;SGPP2;PRKD2;B4GALT6;CERS5;ST6GALNAC5;ELOVL2;CERS3;AGK;ALDH3A2;SPTLC3;SPTLC2
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.42167529353745486,-0.8352644312656968,0.734375,1.0,1.0,7/29,9.12%,TIMP4;TIMP1;EPHA4;CST3;TM4SF20;LRRK2;EFNA1
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.4486171333292228,-0.8351267027623156,0.7230769230769231,1.0,1.0,2/18,12.21%,MEF2C;CAV1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),0.5109619173949744,0.8347355227797434,0.7333333333333333,1.0,1.0,1/5,10.76%,GREM1
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.3567417048480752,-0.834734887171721,0.782608695652174,1.0,1.0,8/89,7.38%,SRGN;ISG15;PTPRC;IL26;SFTPD;EOLA1;NLRP12;HLA-DRB1
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.4532597088109701,-0.8345606153877408,0.6986301369863014,1.0,1.0,2/15,8.84%,KIF16B;DOP1B
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.45774614865384206,-0.8345548083510405,0.7027027027027027,1.0,1.0,6/18,19.65%,NCKAP1L;CYFIP1;NEFH;RAC3;RHOH;RHOJ
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.5334242277947338,-0.8345476397546969,0.7333333333333333,1.0,1.0,1/6,3.48%,ALG10B
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.3571830424041977,0.8344443638889817,0.7692307692307693,1.0,1.0,16/65,24.37%,CDKL1;TBC1D12;USP6NL;TBC1D19;UBQLN2;TRAPPC12;STX18;ALMS1;NPM1;C10ORF90;STIL;TBC1D22A;TBC1D16;C9ORF72;TBC1D22B;ODAD3
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.3487755773481469,0.8344263602717537,0.7647058823529411,1.0,1.0,6/48,11.00%,RFWD3;FAAP100;UBC;RNF168;DCLRE1B;UBB
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.44144171429403595,-0.8344238582689363,0.7183098591549296,1.0,1.0,7/31,13.54%,LPL;DGKD;DGAT1;DGKB;CAV1;CAV3;DGAT2L6
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.4299321905847309,0.8343126638321848,0.6857142857142857,1.0,1.0,4/18,11.16%,SMIM20;COX19;COX10;FASTKD3
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),0.5261032201921637,0.8338605176594673,0.7073170731707317,1.0,1.0,1/5,23.87%,AKT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),0.5261032201921637,0.8338605176594673,0.7073170731707317,1.0,1.0,1/5,23.87%,AKT1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.5136042564475003,-0.8337197245728167,0.7741935483870968,1.0,1.0,1/7,2.69%,IL12A
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),0.33735108172478295,0.833337273637196,0.8181818181818182,1.0,1.0,4/88,5.50%,TNFRSF8;PSME2;TNFSF13B;EDARADD
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.49853247847442916,-0.8333306327944607,0.7213114754098361,1.0,1.0,1/11,2.54%,PARP9
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),-0.38609658751686615,-0.8330106983573904,0.6944444444444444,1.0,1.0,9/42,13.67%,TLR2;MUSK;MEF2C;ROBO2;LRFN5;SLITRK3;EPHB1;CLSTN3;GPC6
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),-0.40048327478860757,-0.8329620761292668,0.7037037037037037,1.0,1.0,3/26,13.81%,CHKB;SLC44A3;ABHD3
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.4796950719316264,-0.8326713777085651,0.717391304347826,1.0,1.0,3/17,20.15%,CLU;DNM1L;BBC3
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.37417946690932025,-0.8324987936111692,0.8,1.0,1.0,20/88,20.39%,KDM4D;MCM2;RMI1;RPA3;SAMHD1;POLQ;FANCM;RAD54L;XRCC2;WRN;AP5S1;BRCA1;MEIOB;RECQL4;RAD50;MCM7;LIG3;RPA2;RAD54B;MRE11
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.5057300727758504,0.8324212229671577,0.6363636363636364,1.0,1.0,3/6,17.31%,NFKB1;RELA;SLC30A10
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.38059172741163205,0.832413983439805,0.6571428571428571,1.0,1.0,2/31,3.69%,PTH;FGFR1
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.3686216195618535,0.8321848748454562,0.6756756756756757,1.0,1.0,3/28,11.97%,RAB27A;CHMP5;VPS25
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.5035378404475487,-0.8319018660840902,0.6901408450704225,1.0,1.0,4/8,19.07%,NLRP12;CEACAM1;GAS6;TMED10
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.4702167411725528,-0.8318596130069841,0.7313432835820896,1.0,1.0,5/16,20.20%,MYO7A;MYO5C;MYO1H;MYO1B;FNBP1L
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.3895551687830827,-0.8318294538876234,0.676923076923077,1.0,1.0,15/59,16.29%,TRPM1;RPGR;RDH12;COL11A1;MYO7A;ADGRV1;SLC4A10;BEST1;SLC24A1;GPR179;TYR;CDH23;PAX6;DHRS3;ABLIM1
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),0.43200613880048794,0.8314414413794159,0.6071428571428571,1.0,1.0,7/20,18.52%,TFB1M;NAT10;MTERF4;DKC1;TFB2M;METTL5;FTSJ3
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.441246429846072,-0.8312348920092167,0.7704918032786885,1.0,1.0,1/19,1.22%,MT1M
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.46816249985145897,0.8312304012741001,0.6774193548387096,1.0,1.0,5/11,29.26%,GBF1;PLK5;PDCD10;PLK3;VCPIP1
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.41288040458337566,-0.8311821416452893,0.746031746031746,1.0,1.0,6/29,3.42%,CD59;CLU;C1QB;C5;SERPING1;CR1
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.5140914549377564,-0.8310096305924012,0.7384615384615385,1.0,1.0,1/8,6.02%,MFAP5
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.3783886790661065,-0.8307547816509172,0.7631578947368421,1.0,1.0,13/74,12.15%,FSTL1;PCOLCE;ADAMTS5;TIMP1;OLFML2B;ACTA2;FAP;COL4A1;DKK3;GJA1;SULF1;THY1;C1R
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.452265510038822,0.8303513931256441,0.6585365853658537,1.0,1.0,3/13,14.22%,PKIB;TNKS2;MAP2K7
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),-0.5049055261126802,-0.8300850167169702,0.7049180327868853,1.0,1.0,2/8,8.60%,EDN1;PROCR
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.4033735112433159,-0.8300634164647777,0.726027397260274,1.0,1.0,11/36,23.84%,NEDD4L;CAMK1D;KNDC1;ZDHHC15;HECW1;PACSIN1;KIAA0319;CSMD3;PTN;RTN4IP1;BCL11A
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.46273389221471006,-0.8298107043004772,0.746268656716418,1.0,1.0,2/18,6.83%,ACADL;CEACAM1
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.43070821226955325,-0.8295581113344841,0.7096774193548387,1.0,1.0,1/21,1.22%,MT1M
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.4289892356243173,-0.8291733612663187,0.7538461538461538,1.0,1.0,4/18,19.04%,ADGRG1;LPAR6;SYNPO2L;GPR17
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.43657666726307875,-0.8287037253897116,0.6724137931034483,1.0,1.0,5/23,16.67%,GLIS2;GPR161;GLI3;TULP3;GPC3
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.39070961362277484,0.8284439902899786,0.8181818181818182,1.0,1.0,11/35,23.59%,RAE1;NUP42;NUP210;TPR;NUP37;YBX1;RAN;NDC1;SEH1L;NUP85;NUP214
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.35090079807617236,-0.8282235504228078,0.8405797101449275,1.0,1.0,18/98,25.19%,CERS6;PDXDC1;ESYT3;B3GALNT1;SGMS2;SGPP2;PRKD2;CERS5;SMPD3;ELOVL2;SUMF1;CERS3;ABCA12;AGK;ALDH3A2;PPP2R1A;SPTLC3;SPTLC2
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.3940887441753361,-0.8282126163889683,0.7213114754098361,1.0,1.0,11/29,18.91%,P2RY12;IL6R;F3;MET;STX3;CDH13;PRKD2;VEGFA;ZNF580;NTRK3;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.364559476735741,0.828064085705084,0.84,1.0,1.0,12/34,29.66%,QRICH2;RYBP;RPL11;EIF3H;PDCL3;RPL5;HIPK2;UBXN1;TLK2;FHIT;USP7;RPS7
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.3272779165698663,0.8279392674183339,0.8108108108108109,1.0,1.0,19/82,20.48%,PSME2;UBC;PSMD13;UBB;PELI2;CHUK;ST18;UBE2N;NFKB1;PSME4;MAP3K7;RELA;PSMF1;IRAK2;EGR1;BTRC;TAB3;PSMD11;PSMD4
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.5434103944113546,-0.8276116805668978,0.7543859649122807,1.0,1.0,3/5,34.98%,LEO1;RTF1;PAF1
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.459715312116244,-0.8274741652858665,0.6825396825396826,1.0,1.0,5/22,11.08%,ANGPT1;ANO6;TEK;SCG2;CD160
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.4159100071671903,0.8272996145660304,0.7380952380952381,1.0,1.0,4/25,8.87%,B3GNT6;GK5;TNIP1;GAL3ST2
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.47286639660928415,-0.8271752477598113,0.7538461538461538,1.0,1.0,4/14,13.14%,NEDD4L;PLN;HECW1;CAV3
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),0.34921558770406375,0.8271747822048977,0.8,1.0,1.0,3/56,3.21%,ORC1;PSME2;UBC
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.46327422766163223,0.8270097650777938,0.7027027027027027,1.0,1.0,1/9,3.52%,OR9Q1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.42309162682683515,0.8268165127327191,0.8125,1.0,1.0,7/17,25.46%,USP6NL;STX18;PDE4DIP;AKAP9;ARMH3;PDCD10;MAP2K2
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.38135946168187723,-0.8266836375768625,0.7058823529411765,1.0,1.0,4/51,7.19%,KCND2;SLC8A3;AQP1;SCN2A
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.34956049198019723,-0.8265528351516676,0.71875,1.0,1.0,14/81,24.25%,CLVS2;KIF16B;DOP1B;GOLGB1;SH3GL2;SORCS1;RP2;MYO1B;AP1S2;CCDC93;VPS13A;ARF1;STEAP2;OSBPL5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.4361926376576901,-0.8264791687137257,0.6666666666666666,1.0,1.0,2/16,4.19%,ISG15;IRF4
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),-0.5341439650677692,-0.8261508584732699,0.7321428571428571,1.0,1.0,1/5,3.90%,CITED2
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.3186021108604307,-0.8259139042482602,0.875,1.0,1.0,77/363,18.39%,PPP1R17;GFRA3;NAGLU;DACT1;CHRM3;WNT8B;ZIC4;ALDH1A2;GLIS2;NRCAM;PCDHB12;MEF2C;CNTFR;FGF12;NMUR2;L1CAM;APC2;KALRN;MET;GPM6A;ROBO2;RPS6KA6;SCN2A;NPTX1;ADGRV1;NINJ1;DCLK1;GFRA2;NRGN;PRPS1;DCX;PCDHB4;BTD;LGI1;NAIP;WWTR1;NAV3;NDP;SH3GL2;ACTL6B;GRIK1;NRSN2;EMX1;PCDHB11;TAGLN3;ASIC2;CHRM1;EPHB1;TPP1;DLG4;PAX6;NELL1;EDNRB;APAF1;AXL;NOTCH2;PCDHB9;SRRM4;PTPRZ1;GFRAL;VEGFA;EFNA5;CNTN4;NHEJ1;OPHN1;NRSN1;LY6H;NRG1;SIAH1;CSPG5;CHST8;CDK5;MYT1L;NRXN1;LDB2;NEURL1;STAT3
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.4994813878747275,-0.8256943932558429,0.703125,1.0,1.0,3/11,17.69%,B2M;BMP6;SLC11A2
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.3289482912369882,-0.825688901746978,0.9135802469135802,1.0,1.0,30/283,16.94%,ARIH2;FBXL16;TRIM5;DTX3L;FBXW9;UBOX5;PSMB8;THOP1;NEDD4L;RNF217;UBE2QL1;TRIM22;FBXL18;FBXO41;FBXL13;RNF144B;HECW1;PRPF19;PRAME;UNKL;TRIM32;FBXL5;FBXO10;CCNF;FBXO7;BRCA1;FBXO17;ANAPC13;RNF213;SIAH1
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.4710650088506486,0.8256449754592433,0.7096774193548387,1.0,1.0,2/11,4.69%,CRHBP;SLC38A2
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.46017186819642225,-0.8255459700691385,0.6935483870967742,1.0,1.0,3/15,14.03%,TGFB2;GLI3;BMPR1B
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.3935536373005015,-0.8255174733746757,0.7878787878787878,1.0,1.0,2/40,3.86%,ATAD5;TSPYL2
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.32998313439990745,0.8253403599824576,0.8205128205128205,1.0,1.0,14/83,16.69%,DHFR;RIDA;EIF4E2;PUS7;EIF4EBP1;EIF3E;SAMD4A;NCL;TPR;DDX3X;CNOT9;CPEB2;MRPL13;YBX1
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.3701041379981857,0.8249140398722988,0.7142857142857143,1.0,1.0,6/46,6.55%,MSRB1;PRSS57;TOR2A;GFI1B;NOSIP;RILP
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.3052406287063083,0.8248696994319714,0.8148148148148148,1.0,1.0,26/233,14.31%,USP27X;RNF128;PSME2;UBC;USP31;OTUD3;USP36;DESI2;INO80D;YY1;KEAP1;ACTR5;TNIP1;BRCC3;PSMD13;KDM1B;USP37;UBB;USP18;KAT2A;USP40;PSME4;CCNA2;MAP3K7;UIMC1;BECN1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.371518295395516,-0.824441841840665,0.8028169014084507,1.0,1.0,27/75,23.66%,RHBDF2;CYSLTR2;TSHR;PRKAR1B;ADCY7;HLA-DRB1;RXFP1;FURIN;GPR176;LYN;ADCY8;GNG2;FCGR3A;ADCYAP1R1;GGT5;SYK;RAMP1;PTH2R;PLK2;PLCG1;NPSR1;HRH2;CD163;GPHB5;ADCY2;P2RY11;ADCY1
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),0.33842371863687354,0.8243567273453999,0.7692307692307693,1.0,1.0,10/91,9.38%,DHFR;PM20D1;MTHFD2L;GLYAT;ST3GAL1;PDZD11;ATF4;ACOT6;PLPP2;MTRR
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.3071076994369589,-0.8243551928532401,0.9529411764705882,1.0,1.0,43/447,16.94%,ISG15;ARIH2;ASB4;H2BC11;FBXL16;ENC1;KLHL7;TRIM5;DTX3L;FBXW9;UBOX5;PSMB8;DTX1;HLA-A;THOP1;NEDD4L;RNF217;SH3RF3;RNFT1;UBE2QL1;TRIM22;FBXL18;FBXO41;FBXL13;RNF144B;HECW1;UVSSA;TRIM25;PRPF19;PRAME;UNKL;MAGEF1;TRIM32;UHRF1;FBXL5;FBXO10;CCNF;FBXO7;BRCA1;FBXO17;RNF213;HIF3A;SIAH1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.42430127972018744,0.8243262462813654,0.7352941176470589,1.0,1.0,3/17,5.08%,DUSP1;LAMB3;HMGA2
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.4770000350398798,-0.8243177710271709,0.765625,1.0,1.0,4/16,12.21%,PSMB8;CST3;FURIN;CAV1
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.5305202134339766,-0.8243053511525098,0.8,1.0,1.0,2/8,19.02%,GNPTAB;ITPK1
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),-0.5201810157908396,-0.8241247373671032,0.78125,1.0,1.0,2/8,8.45%,CITED2;LMO3
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.5208145516311167,0.823545289106919,0.6153846153846154,1.0,1.0,1/5,0.46%,DSCAM
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.4439285648512451,0.8235342150888764,0.7241379310344828,1.0,1.0,1/14,0.55%,GPC4
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.3458174092680435,-0.8234806278975095,0.8026315789473685,1.0,1.0,22/94,17.46%,AKAP12;P2RY12;TSHR;ADCY7;HTR1E;ADGRG1;ADGRG2;GPR161;RGS1;RXFP1;PTGER3;ADGRL2;ADGRE2;ADGRE3;ADCY8;GNAL;ADCYAP1R1;GPR37L1;CNR2;NPY1R;RAMP1;PTH2R
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.5043335777631902,-0.8233205290254726,0.7333333333333333,1.0,1.0,2/6,28.81%,FAM111A;SPRTN
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),-0.4445738717868408,-0.8232347398564478,0.765625,1.0,1.0,4/24,7.06%,MEF2C;COL4A1;MET;CSF1R
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.36386466317438626,0.8231300908767143,0.7647058823529411,1.0,1.0,9/62,13.39%,NUPR1;DUSP1;SCRIB;HECA;CDKN1C;GAS1;CDK6;LATS2;IPO5
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.3355284223021735,0.8229349491930089,0.75,1.0,1.0,13/102,10.61%,PASK;PTH;PIWIL2;PLD1;NOX1;GLI2;CTC1;NAT10;EPM2AIP1;EIF3E;EIF3D;SAMD4A;AKT2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.3696768723162627,0.8228399905165356,0.6666666666666666,1.0,1.0,5/61,4.66%,F2;NDC80;PYHIN1;GNL3L;TESK1
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.37038661424603125,-0.8225689750246284,0.7368421052631579,1.0,1.0,27/71,28.51%,PDGFD;EDN1;LRRK2;DIRAS1;HTR2B;CAV3;LYN;VEGFA;EGFR;EZH2;TGFB1;PIK3CB;PTPRJ;RASGRP1;CBLC;TENM1;PRKCD;RGS2;AGT;IL34;FLT1;STK38;PDGFC;PAQR3;APOE;UCHL1;PDGFRB
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.4725350551755151,-0.8224056490759186,0.746268656716418,1.0,1.0,1/13,2.15%,IHO1
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.43910428119343153,-0.8222494819501375,0.696969696969697,1.0,1.0,5/15,23.07%,SOX9;GJA1;VEGFA;WNT5B;AGT
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.33290509617727027,0.8220169299457519,0.8461538461538461,1.0,1.0,13/103,10.70%,BCAM;EPB41L4B;PTPRU;RNF128;SDC2;SOD3;CLDN2;ARHGEF10L;PRLR;TMEM98;ATP1B1;FGFR3;MYH14
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.4357415295838163,0.8218858415648559,0.7111111111111111,1.0,1.0,2/13,4.85%,LCK;KCNN4
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.3887160270916291,0.8217754833762195,0.6206896551724138,1.0,1.0,6/23,13.73%,PPP1R36;SH3RF2;PPP1R1B;PPP1R26;PTPA;STYXL1
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.3644349954740905,-0.8217661140764799,0.8059701492537313,1.0,1.0,8/52,13.06%,LPL;TLR2;TNFRSF1A;NLRP12;NINJ1;NMI;IL16;IFI35
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.39588181200334593,-0.8217480309600598,0.7727272727272727,1.0,1.0,4/40,6.37%,CLDN5;CLDN16;RHOC;CLDN20
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.44480804197421697,0.8214945346938946,0.7058823529411765,1.0,1.0,1/10,5.08%,HMGA2
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.3265620486423316,0.8213456284280487,0.75,1.0,1.0,10/69,8.68%,ECM1;SEMA5A;CCR3;RUNX1;GAB1;HMGA2;PTGIS;PIK3R6;CHRNA7;SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3684897881408239,0.8212767097544544,0.7058823529411765,1.0,1.0,9/49,12.18%,SH3RF2;HSPA1A;GNL3L;SPRY2;PINX1;PRR7;BAG2;HSPA1B;NXN
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.4205785296773238,0.8212530178918966,0.6,1.0,1.0,5/18,20.80%,INTS14;EXOSC8;INTS8;EXOSC7;EXOSC5
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.3443443678798761,0.8210207304935532,0.6774193548387096,1.0,1.0,5/44,4.75%,AGER;MALT1;PYHIN1;NLRP2;STMP1
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.48218417028599014,0.8208507439765677,0.775,1.0,1.0,1/10,3.04%,CASQ2
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.3719559293070075,0.8206354683224607,0.7941176470588235,1.0,1.0,4/41,8.28%,F2;KNG1;DNAJC1;BAK1
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),-0.45184935843535756,-0.8205440873646853,0.75,1.0,1.0,2/13,19.56%,RIMS2;PTPRN
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.2625418374033093,0.820437134634128,1.0,1.0,1.0,123/905,15.23%,POU3F1;TEAD2;CD38;PTH;ETV5;VDR;SSBP3;ONECUT1;EAF2;AFAP1L2;HIVEP3;MYRFL;SERPINF2;UBC;HMGB1;KDM8;WBP2NL;RASL11A;NRIP1;RNF6;RUNX1;PYHIN1;FANK1;PAX3;CREB3L3;MSANTD1;HMGA2;JMJD6;ATF4;CAND2;GLI2;ZNF639;TFEC;ZNF335;SOX12;MEIS1;CCNT1;ITGA6;BRPF1;MAML2;YY1;HDAC1;MEOX2;NCK1;ZNF24;PAX8;ABL1;ATOH8;AKIRIN1;CRX;TNIP1;SERPINE1;SPAG8;SMARCD3;MED21;DMRT1;ELL;TCF20;EPC1;ACVR1;SNAI1;E4F1;WNT4;ZEB2;CDKN1C;RBM23;CEP290;KDM1B;GABPB2;RYBP;ELK4;E2F4;RPS6KA1;HNF4A;GREM1;ATF6B;DHX33;UBB;PBX4;ATF3;TRIM16;BMP5;SP100;HES5;CHUK;PELP1;KAT2A;HELZ2;MLX;ST18;ZNF451;DLL1;CNBP;RRP1B;DPF3;MLXIP;MLLT3;ESRRG;SMARCA4;NFKB1;VEZF1;CCDC62;KDM5A;BCL10;HNRNPU;ZMIZ1;NFIB;DDX3X;PRDM4;MAP2K7;ANKRD49;PSRC1;POU2AF1;LPIN3;ZC3H8;LBHD1;CRTC1;HDAC4;RELA;DPF2;NHLH2;SOX30;ZNF281
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),-0.5074804357933983,-0.8201788198047179,0.7352941176470589,1.0,1.0,2/8,9.06%,IGSF1;DACT2
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.5155452106091702,0.8199853678585096,0.717391304347826,1.0,1.0,2/5,18.17%,OTUB1;RPS3
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.375786271207261,0.8196855735434468,0.7297297297297297,1.0,1.0,11/37,23.59%,RAE1;NUP42;NUP210;TPR;NUP37;NPM1;RAN;NDC1;SEH1L;NUP85;NUP214
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.46882923393412834,0.8196796532813521,0.6857142857142857,1.0,1.0,8/16,24.50%,PTP4A3;DKC1;CEP120;CORO2B;CCT8;CCT2;CCT6A;CCT3
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.48166195274725443,-0.8196639826172041,0.7647058823529411,1.0,1.0,3/11,18.92%,IFITM3;AXL;GAS6
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),-0.5334649018223176,-0.8195370141700473,0.7580645161290323,1.0,1.0,2/5,20.32%,SLC6A12;SLC6A11
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.5235123891315477,-0.8192518568748873,0.7166666666666667,1.0,1.0,2/6,15.59%,PRKD2;VEGFA
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.3656768238080204,0.819222969901668,0.71875,1.0,1.0,10/62,9.43%,DHFR;CYB5A;MTHFD2L;SLC52A1;ABCC1;ENPP1;PDZD11;SLC52A2;MTRR;CUBN
prerank,GO_Biological_Process_2021__aspartate metabolic process (GO:0006531),-0.5332025232909413,-0.8187443920190084,0.7592592592592593,1.0,1.0,1/5,10.64%,DDO
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.5142144257219219,-0.818688208911661,0.7017543859649122,1.0,1.0,4/12,29.87%,FGD5;FGD1;SPEF1;FGD6
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.4587155336834602,-0.818468942210879,0.7049180327868853,1.0,1.0,4/13,25.37%,ABCC4;SLC25A41;SLC25A42;ABCC5
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.39537308653495445,-0.8183281279426183,0.7205882352941176,1.0,1.0,4/41,14.50%,KDM4D;GRM5;LYN;ATG10
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.3754862840140509,-0.8182337372982662,0.828125,1.0,1.0,19/73,15.96%,PCSK1;SSTR1;TPH1;CNTN3;A2M;KALRN;SMLR1;TREH;AFP;SORBS2;DENND2A;GABRA2;THY1;GRIA3;FGF14;EDNRB;SLC38A11;SLC2A2;CNTN4
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),0.4854160321116805,0.8181600113945338,0.75,1.0,1.0,3/7,11.21%,MGLL;AWAT2;PNPLA3
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),0.4993429225120786,0.8174456017043179,0.7368421052631579,1.0,1.0,1/7,4.02%,RNF6
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),-0.5208886908700232,-0.8172607605951149,0.7735849056603774,1.0,1.0,1/5,15.00%,GDPD1
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),-0.5208886908700232,-0.8172607605951149,0.7735849056603774,1.0,1.0,1/5,15.00%,GDPD1
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),0.33154972035757446,0.8172147828098075,0.8648648648648649,1.0,1.0,7/106,6.08%,CYP1A2;MSMO1;GPAT2;CROT;GLYAT;ALDH1A3;PDZD11
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),0.5384268994916039,0.8170154905164337,0.7333333333333333,1.0,1.0,1/5,18.57%,CTDP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),-0.416165965674004,-0.8167629054244271,0.7301587301587301,1.0,1.0,7/20,18.94%,TLR2;LAPTM5;PLCB1;IL16;SYK;SCIMP;TIRAP
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.46818694793157245,0.816723377048206,0.66,1.0,1.0,1/6,8.48%,CHRNA7
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.42545777125635037,0.8167096514032984,0.5675675675675675,1.0,1.0,4/18,11.79%,NES;ALDH1A3;CEP290;HES5
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.5082040626827448,-0.8163884187164061,0.75,1.0,1.0,2/8,27.71%,KIF20B;FAM83D
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.3656017669396847,-0.816272187210898,0.7230769230769231,1.0,1.0,19/56,21.89%,SLC8A3;KCNJ4;KCNJ3;KCNJ6;SLC9C2;SLC5A2;SLC8A1;SLC24A1;ATP1B2;ATP1A1;SLC9C1;KCNH2;KCNJ13;ABCC9;TRPV4;TRPV3;TRPM2;SLC12A5;SLC9A7
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),-0.46603806441845425,-0.8161672513927613,0.746268656716418,1.0,1.0,2/13,14.33%,CIDEB;TBC1D10A
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.4304363767386522,-0.8161631700053441,0.7083333333333334,1.0,1.0,5/20,17.57%,LOXL3;CHI3L1;FGF7;VEGFA;CCDC39
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),0.36036457759024026,0.8160972012912262,0.8333333333333334,1.0,1.0,12/60,17.60%,TXNIP;OOEP;EVI2B;FSD1;DLL1;MLLT3;AHCTF1;PLK4;BECN1;TP63;PLK5;PIK3R4
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.5656697885748996,-0.815871649645928,0.7692307692307693,1.0,1.0,1/6,16.31%,RNF213
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.34504888706519127,-0.8157656439924449,0.8783783783783784,1.0,1.0,22/118,17.09%,PPP1R3C;LURAP1L;CLU;SERPING1;KITLG;MAOB;PLSCR4;AQP1;SOX9;NTN4;CST3;GATA1;MEIG1;C1R;AR;MATN2;LRP1;NOTCH2;ANKRD7;EGFR;LMOD1;SYNPO
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.5471497948027383,-0.815497723301723,0.765625,1.0,1.0,1/5,17.21%,CTPS2
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),-0.38155057572161527,-0.8153571320057345,0.8157894736842105,1.0,1.0,8/44,15.45%,SYT1;CADPS2;STXBP5L;RAB3A;RAB3C;RIMS2;RAB27B;RAB15
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.528594405418182,0.815292283679756,0.6829268292682927,1.0,1.0,1/6,6.17%,PLEKHA3
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),0.4311493391768337,0.814987815087523,0.696969696969697,1.0,1.0,9/17,33.63%,MRPS7;RPSA;PWP2;ABT1;RPS5;RPS28;PRKDC;MRPS11;RPS19
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,-0.36094494056552534,-0.8143327423649743,0.8243243243243243,1.0,1.0,18/64,18.40%,PPP1R1A;CNTFR;WIPF3;CMYA5;PTCHD1;CKMT2;ATP1B2;SPTB;ANO5;NT5C1A;SYNPO2L;PDE11A;CACNB2;MYLK3;ADCYAP1R1;HIF3A;SLC35F1;LRRC2
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.36269655271682805,0.8142113718092463,0.6451612903225806,1.0,1.0,5/52,4.29%,ETV5;AGER;EGFL6;LAMB3;FBP1
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.42845448441102807,0.8141776023429909,0.825,1.0,1.0,10/27,23.06%,HDAC1;TLE2;ASH2L;SMARCA4;TCF7L1;MEN1;BCL9L;AXIN2;KMT2D;TLE4
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.47781610494296933,-0.81396406879324,0.7272727272727273,1.0,1.0,3/10,14.21%,ADGRV1;GABBR2;EDNRB
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.47781610494296933,-0.81396406879324,0.7272727272727273,1.0,1.0,3/10,14.21%,ADGRV1;GABBR2;EDNRB
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.503766823888432,-0.8138181463492257,0.7407407407407407,1.0,1.0,4/9,34.48%,ACSS3;SLC27A5;BDH2;HMGCLL1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.5272099053625404,-0.8138067247965735,0.7575757575757576,1.0,1.0,1/7,16.31%,RNF213
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),-0.4762979585267878,-0.8137570054454586,0.6964285714285714,1.0,1.0,5/10,34.98%,NCBP1;LEO1;NCBP2;DHX36;PAF1
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.3703904596898451,-0.8133064268158054,0.8,1.0,1.0,27/76,23.66%,RHBDF2;CYSLTR2;TSHR;PRKAR1B;ADCY7;HLA-DRB1;RXFP1;FURIN;GPR176;LYN;ADCY8;GNG2;FCGR3A;ADCYAP1R1;GGT5;SYK;RAMP1;PTH2R;PLK2;PLCG1;NPSR1;HRH2;CD163;GPHB5;ADCY2;P2RY11;ADCY1
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.4609729966509719,-0.81324530015347,0.7192982456140351,1.0,1.0,3/17,17.66%,SLC25A19;SCARB1;SLC15A4
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.3342408873961513,-0.8132166213401034,0.8225806451612904,1.0,1.0,13/98,19.76%,RGS7;DOCK8;RHOC;RGS1;THY1;CD200;CAV2;CALM3;WRN;EZH2;RIC1;RASGRP1;CX3CL1
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.3477900931130481,-0.8131732734956328,0.8253968253968254,1.0,1.0,19/121,14.03%,HEY1;HOPX;EPHA3;CEBPD;LGALS3;ID2;APC2;FES;ST7;ZFHX2;CASZ1;CEBPB;CDK5R1;CAMK1;NREP;PRAME;AR;YWHAH;BMPR1B
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.43319697714383465,-0.8130935491369048,0.7564102564102564,1.0,1.0,4/21,18.06%,MPP4;DLG4;TJP3;PCLO
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.3629660254613877,-0.8128622598397224,0.7647058823529411,1.0,1.0,11/50,24.21%,DMAC1;NDUFC1;NDUFAF5;NDUFB9;NDUFB6;NDUFAF1;NDUFA8;NDUFS5;TIMM21;ECSIT;NDUFS3
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.3629660254613877,-0.8128622598397224,0.7647058823529411,1.0,1.0,11/50,24.21%,DMAC1;NDUFC1;NDUFAF5;NDUFB9;NDUFB6;NDUFAF1;NDUFA8;NDUFS5;TIMM21;ECSIT;NDUFS3
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),-0.5532133924711446,-0.81224542091305,0.7818181818181819,1.0,1.0,2/6,8.19%,MACROD1;PRPS1
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.3153210521080079,-0.8120861391053784,0.8805970149253731,1.0,1.0,11/261,5.69%,PARP14;CLDN5;SRGN;ENC1;OLFM1;TGFB2;PARP9;CITED2;MEF2C;ID2;NLRP12
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.5073953827604049,0.8120609591273693,0.7045454545454546,1.0,1.0,2/7,19.20%,NPM1;RAN
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.5363922158731808,-0.812055615347764,0.75,1.0,1.0,3/8,23.10%,CAV1;PTPRT;SOCS3
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.33243061164030635,0.8118067573364298,0.8292682926829268,1.0,1.0,6/74,4.69%,SLC22A6;SLC38A1;ABCC2;SLC7A11;SLC25A29;SLC38A2
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),0.43963507033498295,0.8117997957604403,0.6739130434782609,1.0,1.0,3/10,11.70%,MST1;WNT4;BCKDK
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),-0.36810509817965087,-0.8115025500945464,0.7246376811594203,1.0,1.0,3/61,1.78%,CARTPT;PYGL;PPARG
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.41983009399315835,0.8115014234200046,0.7209302325581395,1.0,1.0,1/17,0.23%,CRTAM
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.509680421332894,0.8112817530699459,0.6111111111111112,1.0,1.0,3/5,34.08%,NAPB;STX1B;UNC13B
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.5248683119790717,-0.8111910557894424,0.7301587301587301,1.0,1.0,3/7,28.40%,APOBEC2;METTL3;NUDT16
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.33382569354188224,0.8109967665071908,0.7096774193548387,1.0,1.0,19/111,10.62%,NGF;PTPRU;ZAP70;LCK;EPHB4;ALK;SHC4;FGFR1;RAPGEF1;CNKSR1;EPHB2;FRK;IGF1R;GUCA1B;EPHA10;RYK;PTPRD;FGFR3;SHC3
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),0.48352413175198117,0.8103975316576213,0.625,1.0,1.0,1/5,3.61%,ANXA2
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.3747545981790098,0.8103971325049537,0.7142857142857143,1.0,1.0,14/91,10.78%,TEAD2;PTPRU;MTCL1;NES;EHD2;RAI14;GLI2;FSHR;ADAMTS1;FJX1;SERPINH1;RND3;TEAD3;CD276
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.3689045451167891,-0.8101730126965833,0.8311688311688312,1.0,1.0,10/53,23.07%,BCL2L14;LGALS3;SCG2;CAV1;AR;ITGAV;NOL3;BCL2L12;TNFRSF10B;AGT
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.4716979610996756,0.8100581527024292,0.7346938775510204,1.0,1.0,1/10,2.64%,NT5E
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.4536189062098955,0.8099098972106348,0.6041666666666666,1.0,1.0,2/12,3.69%,SEMA5A;FGFR1
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.4676935711803928,-0.8098954506135682,0.7288135593220338,1.0,1.0,5/12,28.99%,PCGF3;BRCA1;METTL3;LRIF1;RLIM
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),-0.5305413658081505,-0.8096209663540622,0.7903225806451613,1.0,1.0,2/5,28.50%,KCNE1;ANK3
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.3942200667871497,0.809393631792974,0.7714285714285715,1.0,1.0,4/27,9.13%,MGLL;CASQ2;CRK;GRK5
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),-0.4775037773980164,-0.8087625844951798,0.7017543859649122,1.0,1.0,2/9,14.20%,SLC22A3;HNMT
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.3845414219184809,-0.8085411132096427,0.8235294117647058,1.0,1.0,8/50,14.76%,PPARG;NEDD4L;SLC4A10;PNPLA1;ABCB4;AQP11;AQP4;RBP1
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.33413172905576866,0.8084038815517842,0.7741935483870968,1.0,1.0,3/84,3.37%,CXCR4;LEPR;IL4R
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.38146275763455945,-0.8082974364506096,0.7571428571428571,1.0,1.0,18/54,24.80%,ITGB4;KDM3A;SGMS2;SLC44A3;CLDN4;OVOL2;PPL;STAT3;WNT5B;NNMT;NEDD9;CBLC;SCEL;CDH1;TMEM184A;SDC4;KLF5;BAIAP2L1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.4642784687410002,0.8082629393104804,0.725,1.0,1.0,6/14,23.24%,COX19;SLC31A2;COMMD1;ATP7B;APP;CCDC22
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.40247551235256007,-0.8080704319881096,0.7391304347826086,1.0,1.0,2/28,6.34%,TGFB2;PRICKLE1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.40247551235256007,-0.8080704319881096,0.7391304347826086,1.0,1.0,2/28,6.34%,TGFB2;PRICKLE1
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.4670585508108426,-0.8077139996646124,0.7619047619047619,1.0,1.0,1/12,2.95%,MCTP1
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.40760317662332823,-0.8075519933830666,0.711864406779661,1.0,1.0,5/20,17.82%,NDST3;B3GALNT1;CSGALNACT1;B3GALT1;B3GALT2
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.41378215138097285,0.8074051951408112,0.7105263157894737,1.0,1.0,2/15,12.67%,KANSL2;JADE3
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.41378215138097285,0.8074051951408112,0.7105263157894737,1.0,1.0,2/15,12.67%,KANSL2;JADE3
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.41359029005837367,-0.8073695466724263,0.7183098591549296,1.0,1.0,5/26,19.76%,VSIR;ARG2;LILRB1;GAS6;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.44389297185658794,-0.8073139413609692,0.7666666666666667,1.0,1.0,5/17,19.67%,RIMS1;RIMS2;DLG4;NRXN1;PRKCZ
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.39393301475099096,0.807121628730382,0.6666666666666666,1.0,1.0,2/22,3.22%,DSCAM;SEMA5A
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.47584547331633315,-0.8071178359430555,0.7377049180327869,1.0,1.0,1/9,1.69%,ARIH2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.4502404886201454,-0.8066537376282006,0.7454545454545455,1.0,1.0,5/14,15.53%,SCN1B;CAV3;KCNH2;KCNE1;SCN4B
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.40131540297929985,-0.8065139172800045,0.746031746031746,1.0,1.0,5/38,4.86%,DPEP2;PTPRC;ITGAM;AOAH;CD53
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.42161173850033423,-0.8063388739442839,0.7076923076923077,1.0,1.0,7/21,23.07%,AQP1;E2F1;CDKN1A;WNT5A;GAS6;DDR2;AGT
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.5085145730660298,0.8060434434299484,0.6842105263157895,1.0,1.0,1/5,10.76%,GREM1
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),0.4500054954659487,0.8049744067906855,0.6829268292682927,1.0,1.0,2/13,7.24%,CMPK1;AK8
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.44061643065888934,-0.8049641279992297,0.7777777777777778,1.0,1.0,1/21,2.14%,STMN2
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.3291960365831687,0.8048370318035435,0.7857142857142857,1.0,1.0,14/74,17.11%,SPHK2;MYO1C;ZNF335;PHF1;EPC1;POLR2K;KDM1B;KAT2A;DNMT3A;DNMT1;HDAC4;POLR2L;RBBP4;TAF1C
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.43491066252007915,0.8047108232564404,0.6888888888888889,1.0,1.0,2/9,5.59%,ACADS;ACADVL
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.42045177069415357,-0.8045929632693624,0.782608695652174,1.0,1.0,7/27,23.45%,PPARG;CAV1;LRP1;NFKBIA;RXRA;TTC39B;ABCA12
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.3630381781553762,0.8045599669489564,0.7741935483870968,1.0,1.0,6/41,7.04%,F2;EPB41L4B;RNF128;GPRC5C;CLDN2;GJB1
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.46998832180561584,-0.8044705405711285,0.7205882352941176,1.0,1.0,2/10,16.29%,CSF1R;CXCL17
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4191723012919235,0.8040146689750175,0.6551724137931034,1.0,1.0,7/17,21.77%,ERRFI1;VPS25;SOCS4;CBLB;EGF;APP;FBXW7
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.4589712442892724,-0.8039729408956893,0.7627118644067796,1.0,1.0,4/12,25.37%,ABCC4;SLC25A41;SLC25A42;ABCC5
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),0.49613256967957076,0.8033809124414775,0.7073170731707317,1.0,1.0,1/6,3.27%,HMGB1
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.3805389189139691,-0.8031111771989634,0.7910447761194029,1.0,1.0,18/59,19.00%,TRPM1;RPGR;RDH12;COL11A1;MYO7A;ADGRV1;SLC4A10;BEST1;SLC24A1;GPR179;TYR;PAX6;GRM6;DHRS3;ABLIM1;RP2;CACNA2D4;CRYBG3
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),0.3600135991573455,0.8030932167309615,0.7291666666666666,1.0,1.0,10/35,22.28%,MRPS7;SLC25A33;MRPS2;TFB2M;PTCD3;HARS1;MRPL47;MRPS16;RARS2;NOA1
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.4539467505503024,-0.8030435824690554,0.7377049180327869,1.0,1.0,2/12,13.83%,MOV10;GTPBP1
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.48034779450589726,0.8030007658615176,0.6956521739130435,1.0,1.0,2/8,24.09%,GTF2H5;CCNH
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.34365862544087367,-0.8029515419780701,0.8309859154929577,1.0,1.0,23/124,16.32%,BAIAP2;CCK;NCKAP1L;NYAP1;NRCAM;GPM6A;SLITRK5;MYO16;LRRK2;DCLK1;SLITRK4;NTNG1;FLRT1;RAB3A;PAK3;SLITRK3;MAP2;EPHB1;PACSIN1;DLG4;NEFH;CNTN4;NTNG2
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.4048331541615987,0.8027447886606315,0.6756756756756757,1.0,1.0,4/32,8.61%,ATP6V0A4;ATP6V1G2;TF;ATP6V1G1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",-0.46647194835939954,-0.8026763785311232,0.71875,1.0,1.0,1/12,4.77%,SYN3
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.4913682759538719,0.8026087023789231,0.6956521739130435,1.0,1.0,1/9,4.29%,OSBPL7
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.4450527971293387,-0.8025774239957062,0.8032786885245902,1.0,1.0,4/16,19.34%,TEK;THY1;VEGFA;PTPRJ
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.4965763678175965,-0.8020681953429548,0.7391304347826086,1.0,1.0,1/6,5.89%,FUCA2
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.4965763678175965,-0.8020681953429548,0.7391304347826086,1.0,1.0,1/6,5.89%,FUCA2
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.5101620481295628,-0.8020006882921273,0.7719298245614035,1.0,1.0,1/7,9.41%,TOMM7
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.43500865019421486,-0.8019038251578701,0.7230769230769231,1.0,1.0,1/25,1.25%,IRGM
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.5056533125182501,0.8018988978905653,0.7,1.0,1.0,1/6,8.28%,BAK1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.39497557484968104,-0.8018791901379395,0.8153846153846154,1.0,1.0,2/31,6.34%,TGFB2;PRICKLE1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.4668050877356936,-0.80175769664962,0.7384615384615385,1.0,1.0,1/17,1.30%,DACT1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),0.327497208579813,0.8016818280707245,0.8235294117647058,1.0,1.0,40/123,26.47%,DICER1;MDN1;SRPK3;EIF5;CRNKL1;MRPS7;SNRPC;GEMIN6;NLE1;SNUPN;STRAP;COIL;RPSA;LUC7L;RPL23A;DHX9;GEMIN5;BRIX1;SF3A2;RPL3;CELF1;NAF1;RPL11;RBM5;PWP2;TGS1;EIF2S2;SNRPB;SRSF9;SMN1;POLR2D;PUF60;PRMT5;EIF4B;WDR77;PRPF18;RPL5;ABT1;SF1;RSL24D1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),-0.41612294179838016,-0.8015922479664218,0.7592592592592593,1.0,1.0,4/22,17.37%,HGF;PRKD2;TOM1L1;CDKN1A
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),-0.5167723554529204,-0.8015569096494503,0.8064516129032258,1.0,1.0,2/9,18.67%,OPHN1;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.38770144883460544,-0.8014463530204616,0.7424242424242424,1.0,1.0,8/42,21.03%,FBLN1;CARMIL1;RAC3;EFNA5;CSPG5;DMTN;NEDD9;RREB1
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),0.334933286313555,0.8012437926008812,0.8064516129032258,1.0,1.0,13/71,20.48%,PSME2;UBC;CDC26;PSMD13;ANAPC15;UBB;PSME4;PSMF1;ANAPC1;CDC23;PSMD11;RB1;PSMD4
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),-0.46571817555019357,-0.8007795602397725,0.6666666666666666,1.0,1.0,1/7,7.30%,ADGRV1
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.48652258066383886,-0.8006917828372841,0.7727272727272727,1.0,1.0,2/9,14.69%,KCNS1;KCNE1
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),0.40065263270755525,0.8006838398996391,0.7142857142857143,1.0,1.0,3/16,12.46%,USP36;RIOK1;RIOK2
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),-0.5313688982539446,-0.8006206218952694,0.75,1.0,1.0,1/5,13.77%,LRP1
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.3866919902466261,-0.8004076580053978,0.7878787878787878,1.0,1.0,10/40,21.14%,VIL1;RHOC;SYNPO2;TGFB3;CARMIL1;SYNPO2L;SYNPO;FHOD1;CX3CL1;TPM1
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.392178317595017,-0.8003552914510126,0.7586206896551724,1.0,1.0,5/42,10.61%,GCNT1;GALNT12;MUC16;GALNT8;GALNT6
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.4910256874568326,-0.8001416153954201,0.734375,1.0,1.0,1/9,2.34%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3506747029530154,0.7999438353761773,0.7419354838709677,1.0,1.0,16/42,24.31%,TESK1;CRK;FLNA;ABL1;PTPRD;IL1RAPL1;MYADM;CASS4;CUL7;CDC42;ARHGEF7;RAC1;FERMT2;CIB1;OBSL1;CUX1
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.4143626465856799,0.7997553032466587,0.7209302325581395,1.0,1.0,5/18,8.81%,FBP1;SPRY2;EPHB2;SLIT2;SPRY3
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.4377501350901716,0.7995853726357518,0.7714285714285715,1.0,1.0,7/14,24.41%,PIH1D1;NCL;MARS1;SMARCA4;NOL11;SIRT7;MTOR
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.44913280530591626,-0.7995429380335923,0.7727272727272727,1.0,1.0,2/18,1.81%,GGH;SHMT2
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.5131581584926597,-0.7994868620187239,0.8333333333333334,1.0,1.0,4/8,34.48%,ACSS3;SLC27A5;BDH2;HMGCLL1
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),-0.5155330962412051,-0.7994473349086516,0.7910447761194029,1.0,1.0,1/5,9.12%,EFNA1
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),-0.5355912440694885,-0.7993014339815446,0.8,1.0,1.0,1/5,10.89%,SH3GL2
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.44073541856465726,0.7990995661302618,0.7111111111111111,1.0,1.0,4/9,24.86%,ABHD17A;ABHD10;LYPLAL1;LYPLA1
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),-0.48926069112376136,-0.7987945223130185,0.7866666666666666,1.0,1.0,2/7,29.55%,SKAP1;SASH3
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),0.49077752455799484,0.7986109389313278,0.7045454545454546,1.0,1.0,2/5,9.75%,PINX1;NOL8
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),-0.5386095552777268,-0.7986068576406767,0.8301886792452831,1.0,1.0,2/5,20.85%,XBP1;CIITA
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.4123168932113357,0.7984451776903787,0.675,1.0,1.0,5/20,9.71%,LEPR;ACADVL;COX10;LYRM7;GFPT2
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.4486631249473645,0.7982883571777581,0.7631578947368421,1.0,1.0,4/14,25.09%,FHDC1;FAM171A1;RHOA;PDCD10
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.4486631249473645,0.7982883571777581,0.7631578947368421,1.0,1.0,4/14,25.09%,FHDC1;FAM171A1;RHOA;PDCD10
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.40204631108372485,-0.7978288298851351,0.7580645161290323,1.0,1.0,7/28,21.67%,OSTN;TRIM46;MAP2;CDKN1A;SLC6A4;KIAA0319;FGF13
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.39065955351071946,0.7976907897831617,0.717948717948718,1.0,1.0,3/18,8.80%,SYNE2;MYO1C;MYO1D
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),-0.49727547531833366,-0.7972105791058656,0.7692307692307693,1.0,1.0,1/10,4.08%,FAP
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.4207296913600434,-0.7971216372198022,0.7586206896551724,1.0,1.0,8/24,23.10%,IL6R;PTPRT;STAT1;STAT3;PID1;SPI1;PTPN11;SOCS3
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),0.47269181122539977,0.7970949131962798,0.7352941176470589,1.0,1.0,1/8,4.96%,THAP4
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.4361104466179062,0.7970553487057795,0.6756756756756757,1.0,1.0,2/16,2.64%,TXNIP;NT5E
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.4565616031226662,0.7968704144100854,0.6756756756756757,1.0,1.0,3/7,31.50%,PRKAA2;TPPP;FNTA
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),-0.4132860135246109,-0.7962109160327709,0.6923076923076923,1.0,1.0,3/18,12.72%,GNPTAB;MAN1A1;ST8SIA3
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.3890037956570108,-0.7961527782871037,0.7571428571428571,1.0,1.0,6/35,10.74%,VIL1;ID2;HSD11B2;CHGA;FLI1;SLC44A3
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.40075622861019683,-0.796126336949015,0.7419354838709677,1.0,1.0,8/27,32.09%,RAB11A;MVB12A;VPS4B;CHMP1A;VPS37A;CHMP4B;TSG101;VPS4A
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.44728237930803805,0.7960249763747904,0.6774193548387096,1.0,1.0,5/17,11.59%,DHFR;MTHFD2L;MTRR;MTHFD2;PM20D2
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.35474348027983704,-0.795717989001335,0.7183098591549296,1.0,1.0,17/66,15.65%,DPEP2;PTPRC;ADAM28;NCKAP1L;CD53;GMFG;CLCA3P;SELL;LAPTM5;IL7;ZBTB32;IL16;ARHGAP25;IKZF1;LY86;CD27;WDFY4
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),-0.4563305982462559,-0.7956617731793924,0.8076923076923077,1.0,1.0,4/9,27.34%,PPP3CA;NFATC2;NFATC1;PPP3CC
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),-0.4563305982462559,-0.7956617731793924,0.8076923076923077,1.0,1.0,4/9,27.34%,PPP3CA;NFATC2;NFATC1;PPP3CC
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),0.45383550363706665,0.7951170029022391,0.7352941176470589,1.0,1.0,1/6,25.94%,NSUN5
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.4369722658509654,0.7950715550013071,0.8,1.0,1.0,2/11,22.22%,CTDP1;SIRT7
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.411826407393003,0.7949671352628539,0.8,1.0,1.0,2/14,9.06%,MBOAT1;PLA2G4C
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.4731723143476321,-0.7949575225426501,0.8484848484848485,1.0,1.0,2/11,17.94%,SPEF2;SLC6A4
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.35579092029342,-0.7949141431206742,0.8070175438596491,1.0,1.0,12/46,25.50%,CCND1;CDK5R2;CDK5R1;CCNJL;CDKN3;CCNF;CDKN1A;SERTAD1;MNAT1;CCNI2;CCNJ;CDKN2D
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.35661027493904973,0.7948313702977977,0.8214285714285714,1.0,1.0,3/73,3.37%,CXCR4;LEPR;IL4R
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),-0.3823294085513591,-0.7948200143847458,0.7761194029850746,1.0,1.0,4/27,10.45%,TRPM1;ATP2B3;JPH4;SLC8A1
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.39999100524298403,0.7946875458569982,0.7954545454545454,1.0,1.0,2/20,12.96%,GDAP1;PEX2
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.3911910603276588,-0.7943697518362294,0.7746478873239436,1.0,1.0,5/32,18.39%,NCKAP1L;FES;GATA1;STAT1;STAT3
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),0.50238410887756,0.794037237013467,0.7045454545454546,1.0,1.0,2/5,5.51%,AGBL1;AGBL2
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.5153183654038277,0.7938288483335056,0.7692307692307693,1.0,1.0,2/5,10.61%,ANXA2;AKT2
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.4491304152982942,-0.7932812783797625,0.7540983606557377,1.0,1.0,1/15,2.54%,PARP9
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.46418990859983533,0.7932021738858933,0.775,1.0,1.0,2/11,7.79%,COX19;SLC31A2
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.38107101374879243,-0.793170403112333,0.8253968253968254,1.0,1.0,5/28,17.85%,PPARG;FABP3;SLC25A20;ABCD2;PRKAB2
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.4505850132458708,0.7931526215032498,0.7111111111111111,1.0,1.0,4/10,22.27%,KLRD1;JAG1;CD55;BTN3A2
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),-0.4733846886673826,-0.7929359972709208,0.7543859649122807,1.0,1.0,4/9,17.10%,FES;ADGRE2;LYN;SYK
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.3707005834100179,0.7928645259857792,0.7222222222222222,1.0,1.0,1/29,0.84%,USP27X
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.3732896462656184,0.7927392779790735,0.6666666666666666,1.0,1.0,6/23,23.24%,NAT9;NAT10;NAA50;SIRT1;NAA11;NAA40
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.540147210224714,-0.7926485344127213,0.7794117647058824,1.0,1.0,1/6,4.10%,MMP24
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),0.46286444779362923,0.7926078881848209,0.725,1.0,1.0,1/7,18.30%,STAMBP
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.3353752305353204,0.7924686171815812,0.8181818181818182,1.0,1.0,6/59,10.70%,EPB41L4B;MYH3;FHDC1;ACTN2;TCAP;MYH14
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.3512116131205073,-0.7923708913370096,0.7808219178082192,1.0,1.0,16/68,17.42%,DPEP2;PPARG;ITGAM;AOAH;GMFG;ALOX12;FLI1;GATA1;MRTFB;ADGRE3;LRP1;VEGFA;FCGR3A;MPL;FERMT3;TNFRSF1B
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.3794073747829279,0.7922830975714752,0.8125,1.0,1.0,10/33,23.59%,RAE1;NUP42;NUP210;TPR;NUP37;RAN;NDC1;SEH1L;NUP85;NUP214
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.3794073747829279,0.7922830975714752,0.8125,1.0,1.0,10/33,23.59%,RAE1;NUP42;NUP210;TPR;NUP37;RAN;NDC1;SEH1L;NUP85;NUP214
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.49168994158811485,-0.7920661023700802,0.6909090909090909,1.0,1.0,1/9,4.02%,EDN1
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.45398099410696835,-0.7919302098343868,0.7313432835820896,1.0,1.0,1/14,2.64%,ATAD5
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.41982132219036405,0.7919211392213532,0.7647058823529411,1.0,1.0,4/20,9.53%,WNK4;CASQ2;PXK;ACTN2
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.39634275417242687,0.7917178830801028,0.7714285714285715,1.0,1.0,2/16,3.77%,CRHBP;NRIP1
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.3930853946085272,0.791691750661272,0.6774193548387096,1.0,1.0,8/30,22.06%,DPEP1;OPLAH;HAGH;GSTT2B;ETHE1;GGCT;GSTA4;SOD1
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.44060081322548506,-0.7916757452936022,0.7313432835820896,1.0,1.0,6/15,24.25%,CAV1;IFIT1;FLOT1;COLEC12;RALB;PQBP1
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),-0.49361783582902474,-0.7916275972822334,0.7796610169491526,1.0,1.0,3/7,25.68%,PEX1;LONP2;ZFAND6
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.36868799159716237,0.7914651971238089,0.75,1.0,1.0,5/59,7.63%,F2;PYHIN1;TESK1;FLNA;PINX1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.48134046523491936,0.7914231005295962,0.6756756756756757,1.0,1.0,3/11,8.81%,SPRY2;SHISA2;SPRY3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),0.3960893168958082,0.7913384015043751,0.7941176470588235,1.0,1.0,1/17,0.42%,ICAM1
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.4471724350907806,-0.7913184357429794,0.6825396825396826,1.0,1.0,3/12,13.68%,CR1;C3AR1;LYN
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),-0.4192523113853948,-0.7912725803106978,0.7936507936507936,1.0,1.0,6/24,18.32%,SYT1;SYT4;CHGA;KCNB1;SYT13;SYT12
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.4049411835126717,-0.7912624404193189,0.7777777777777778,1.0,1.0,6/29,19.88%,RAD9A;E2F1;PRPF19;DONSON;CLOCK;STK33
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.2771417815355647,-0.7912596968772517,1.0,1.0,1.0,246/1642,21.03%,ZNF215;FOSL2;HEY1;GRHL1;KANK2;ZNF366;TLR2;ZIM2;DACT1;NR4A3;HOPX;PLSCR1;PPARG;ZSCAN1;IL26;TNFRSF1A;ZIC4;ELK3;PARP9;ZNF550;CRYM;MIDEAS;CEBPD;KLF9;ZNF549;STAT5A;ZIK1;GLIS2;CITED4;IRF1;CITED2;EDN1;MEF2C;IRF4;NOS1;FOS;PLAG1;ZNF343;ZNF154;TP73;ID2;ZNF239;PLAC8;ZNF789;ZNF814;SOX9;CCNQ;KDM3A;MET;HGF;MLIP;DUXB;NEDD4L;CCND1;ZNF235;ZSCAN31;CSF1R;PURG;ALX3;BCL11B;ZEB1;ZFHX2;ZNF394;CRLF3;MACC1;BHLHE40;CPHXL;ZNF608;SP110;ZBTB22;ZNF540;RFX5;ZBTB32;ZNF584;NLRP3;FLI1;EFNA1;E2F1;ZSCAN22;GATA1;GTF2IRD1;BMP6;TGFB3;WWTR1;ZNF433;ZKSCAN7;CASZ1;ETV1;ZNF442;ZNF764;TOX;SOX21;MYT1;XBP1;CEBPB;RARB;ACTL6B;KLF3;ZNF217;CAMK1;ZFP30;PCGF3;EMX1;MRTFB;MED29;CDH13;ZNF233;H1-0;ORC2;NR2F1;ZNF20;IKZF2;CAV1;PCGF2;GLI3;MED12L;ZNF654;HJV;MOV10;AR;ZFPM1;ZNF850;E2F3;PROX2;DNAJB1;GLIS3;ZNF571;IKZF1;ZNF530;TOX2;MOSPD1;ETS2;ZNF367;ZNF671;EBF1;ZNF740;ZNF248;BMPR1B;ZNF391;UHRF1;PAX6;EDNRB;TGFA;PRKD2;CBX7;ZNF705G;ZNF572;ETV6;ZNF600;NFE2L3;VEGFA;BRCA1;TRERF1;ZNF790;STAT1;ID3;CREB3L1;ZSCAN29;ZNF580;PRDM1;SREBF1;OVOL2;EGFR;ZFY;ZNF652;TGIF1;POU2F2;HIF3A;POU6F1;IFRD1;SKAP1;ESRRA;ZNF597;HIRA;NR3C2;CDKN1A;EZH2;ZFP36;NR2F2;ZNF490;FHOD1;MAFF;NFYB;ZKSCAN8;ZNF10;ZFP69;ZNF136;MYT1L;NR1D1;ARID3A;ZNF776;MAF;ZNF763;CBX8;PPP3CA;WNT5A;RNF111;LDB2;ATXN7L3;ZNF546;TENM2;STAT3;CLOCK;LILRB1;ZNF157;ZNF420;ZNF565;ZNF765;PFKM;PSMC3;TGFB1;NFKBIA;NEUROD6;ZSCAN5A;ZSCAN32;MAP2K5;RFXANK;ZNF543;NR1I3;PTPRN;ZNF726;ZNF675;CX3CL1;NLRC5;ZNF566;ZNF768;PID1;PRDM15;ZNF213;PLAGL1;ZNF227;ZNF593;ZNF749;LHX6;SPI1;EBF2;ZNF140;ZNF33B;KAT2B;NFATC2;CIITA;KLF8;ZNF7;MESP1;ZBTB12;RREB1
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.42111911022846527,-0.7910713151248872,0.7746478873239436,1.0,1.0,3/22,17.73%,PRXL2C;PFKFB2;GAPDHS
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.4078747338245445,-0.7910611002039885,0.7068965517241379,1.0,1.0,4/17,22.46%,SLC18A2;ABCD2;BRCA1;SIRT5
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.4868896633679832,0.7909432619231045,0.75,1.0,1.0,1/6,8.48%,CHRNA7
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.3984785024133384,0.7907547370436224,0.7073170731707317,1.0,1.0,6/23,15.43%,DICER1;TMEM98;HES5;TNFRSF21;ITGAX;NKX6-2
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.4806642064871465,0.7906583992094727,0.723404255319149,1.0,1.0,2/9,15.39%,NLGN3;NLGN2
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.5133467298149195,-0.790459855558971,0.6923076923076923,1.0,1.0,3/5,45.67%,PEX7;DHRS7B;FAR1
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.5133467298149195,-0.790459855558971,0.6923076923076923,1.0,1.0,3/5,45.67%,PEX7;DHRS7B;FAR1
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),-0.45162212302303734,-0.7904094731626679,0.7058823529411765,1.0,1.0,2/12,7.11%,CHST1;CHST2
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.3127972173167202,0.7901562403589394,0.8918918918918919,1.0,1.0,1/92,0.21%,CXCR4
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.3205412632378468,0.7900265771617566,0.8181818181818182,1.0,1.0,35/150,20.78%,AFAP1L2;PSME2;CDK10;SCRIB;CDK11A;HECA;EIF4EBP1;PIM3;CDC26;GBF1;PSMD13;CDKN1C;THAP1;TMEM8B;ANAPC15;GAS1;MAEA;PSME4;HNRNPU;EIF4E;ERCC2;TRIM35;CKS1B;PSMF1;ANAPC1;CDC25B;BTRC;CDC23;PSMD11;CUL7;RB1;PSMD4;BTG2;PRKCA;HSF1
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),-0.49232872705930714,-0.7899860640588869,0.7586206896551724,1.0,1.0,3/8,25.68%,PEX1;LONP2;ZFAND6
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.4092723545759407,0.7895915816638198,0.7647058823529411,1.0,1.0,5/11,23.30%,NOC2L;ZNF451;SNCA;SIRT1;TAF7
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.44546531756880914,0.788729940269736,0.7142857142857143,1.0,1.0,3/12,9.27%,KCND3;KCNJ2;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.43069720483104723,-0.7883084020272928,0.828125,1.0,1.0,2/19,4.19%,PTPRC;IRF4
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.30059300124093513,0.7882607286398875,0.9375,1.0,1.0,24/142,13.88%,CD38;ZAP70;PSME2;LCK;SH2B2;MALT1;NFKBIZ;CD247;PDE4B;NCK1;PSMD13;MOG;NFAM1;CD276;PTPN22;CHUK;BTN2A1;TNFRSF21;ICOSLG;UBE2N;NFKB1;PSME4;BCL10;MAP3K7
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.3889957473623179,0.7881547423776105,0.78125,1.0,1.0,4/24,9.31%,VCPKMT;SMYD1;KMT5A;ATPSCKMT
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.3808958993288931,0.7880784525220563,0.75,1.0,1.0,3/35,3.47%,SCN11A;CHRNA4;KCNJ2
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.46408866402644194,0.7879663119706346,0.7666666666666667,1.0,1.0,2/12,15.21%,IDH2;IREB2
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.5036583300681582,0.7877240310771979,0.7352941176470589,1.0,1.0,1/6,3.05%,ALK
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.49785385078644506,-0.7876059003949916,0.7761194029850746,1.0,1.0,2/7,12.21%,LIN7A;CAV1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.44914971273439835,-0.787595821101419,0.7258064516129032,1.0,1.0,3/14,8.68%,ANGPT1;TEK;SCG2
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),0.450208073485386,0.7874548092978708,0.6666666666666666,1.0,1.0,1/5,5.75%,ST3GAL1
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.46035952072060415,0.787270971073228,0.813953488372093,1.0,1.0,1/11,6.18%,ATF4
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.3634608941099654,0.7872328242195568,0.7428571428571429,1.0,1.0,6/29,19.70%,PKIB;GREM1;DKC1;MAP2K7;ACD;NAF1
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.47299483242600016,0.7870389437540645,0.6818181818181818,1.0,1.0,1/12,4.29%,OSBPL7
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),-0.49069415651911674,-0.786984189574529,0.7719298245614035,1.0,1.0,3/7,13.68%,FES;ADGRE2;LYN
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.3562548819712846,0.7869776285024217,0.717948717948718,1.0,1.0,5/37,15.20%,RAB27A;RILP;WASHC4;WASHC5;SNX3
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.4196908098617655,-0.7868894187742723,0.6949152542372882,1.0,1.0,5/20,34.40%,PSMC3;ESR1;PSMC5;DHX36;MED14
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.35730597995594177,-0.7863412830046045,0.7605633802816901,1.0,1.0,17/59,24.20%,SYT1;SYT4;MEF2C;HPCA;ADGRV1;RYR3;ADCY8;SYT13;DMTN;WNT5A;SYT12;TRPM2;CPNE8;ADD1;PPIF;ADCY1;KCNH1
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.3933846703902172,0.7861491553610375,0.7586206896551724,1.0,1.0,6/17,17.57%,UBE2A;RNF168;RYBP;RNF2;PCGF1;RNF8
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.36206501802448854,0.7855949080349242,0.7741935483870968,1.0,1.0,6/40,12.31%,PSME2;LMNB1;ANXA2;RALA;AIP;CNN2
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.4535816723646889,0.7851963586747958,0.6176470588235294,1.0,1.0,1/9,0.95%,DHFR
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.48643507761676846,-0.7851851705347326,0.7407407407407407,1.0,1.0,2/7,25.70%,NFATC2;NFATC1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.43896823622147,0.784882457078209,0.6410256410256411,1.0,1.0,1/6,25.83%,IGBP1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.4903622901977326,0.7848406285002125,0.7142857142857143,1.0,1.0,3/5,21.48%,HS6ST1;HS2ST1;HS6ST2
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.523510285972403,0.7845965237935681,0.8260869565217391,1.0,1.0,1/5,9.44%,SNAI1
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),-0.4559920115949283,-0.7843934693926163,0.7758620689655172,1.0,1.0,1/11,3.42%,ACADL
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.44782063247799514,0.7842551473270077,0.7037037037037037,1.0,1.0,7/17,29.44%,GFI1B;KAT2A;EHMT1;NIPBL;DUSP6;INSR;CCSAP
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.4314550716263351,-0.7840736228499755,0.746268656716418,1.0,1.0,4/23,21.20%,EPHA4;EFNA1;OPHN1;PRKCG
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),0.5068987124661807,0.7840598265140676,0.7428571428571429,1.0,1.0,1/5,14.68%,PRKAA2
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.4417832350585065,-0.7838592454758468,0.828125,1.0,1.0,4/13,19.01%,ST3GAL5;ST8SIA3;B4GALT6;ST6GALNAC5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.39744804478481666,0.7837714099065841,0.8235294117647058,1.0,1.0,3/17,9.27%,CASQ2;CLIC2;ATP1B1
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),0.4228770333286586,0.7835586744693915,0.8108108108108109,1.0,1.0,2/18,11.55%,VASH1;SP100
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.3884179763270229,-0.7835558514548057,0.782608695652174,1.0,1.0,4/38,4.49%,KDM4D;PARP9;DTX3L;SLF1
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.4339392430857919,-0.7835482255617112,0.7719298245614035,1.0,1.0,2/13,2.84%,ITGAM;CLU
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.45955512854479236,-0.7835322542884918,0.7894736842105263,1.0,1.0,2/10,23.60%,ROMO1;AGK
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.4107768037563232,0.7834079356587713,0.725,1.0,1.0,3/23,2.66%,CD38;LCK;SH2B2
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.38258934699057723,-0.7831901109936117,0.8032786885245902,1.0,1.0,6/32,23.60%,ISG20;ENTPD1;NCBP1;ENTPD3;NUDT18;ENTPD2
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.4829587716497567,-0.7821866347977986,0.7833333333333333,1.0,1.0,3/8,21.75%,LRP1;PTPRJ;NDRG4
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),-0.4805638685833949,-0.7821838402599357,0.7413793103448276,1.0,1.0,3/6,15.04%,CDH3;NOTCH2;FGF7
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.3781971106216905,-0.782082103866914,0.7580645161290323,1.0,1.0,4/35,5.43%,TNFRSF1A;IRF1;AQP1;SOX9
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.32209624779514556,0.7818865644833237,0.9565217391304348,1.0,1.0,15/155,11.04%,USP27X;CRYAB;HSPA1A;PYHIN1;OTUD3;MORC3;USP36;ZNF207;FLNA;ZSWIM7;ATP1B1;BAG2;PRKRA;HSPA1B;PFN1
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.4686624441659291,0.7818163466536268,0.7073170731707317,1.0,1.0,1/8,8.61%,ATP6V1G1
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.3501884514235734,0.7816236633931568,0.7741935483870968,1.0,1.0,8/44,14.61%,EPB41L4B;MYOF;PDGFA;CORO1B;DST;AHNAK2;MIA3;MACF1
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.3311883402137856,-0.7813829960782221,0.8529411764705882,1.0,1.0,16/88,18.27%,P2RY12;MEF2C;AQP1;TSHR;GLRA2;GABRG2;SOX9;RYR3;GABRB2;XBP1;HCN1;KCNE1;BRCA1;DMTN;GABRB3;NEURL1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.45009823250539766,0.7813732472949158,0.7333333333333333,1.0,1.0,4/8,19.73%,ATP1B1;ACTN2;LRRC38;AKAP9
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),-0.36973907515885723,-0.7812676846574244,0.7777777777777778,1.0,1.0,10/52,25.19%,CERS6;SGMS2;SGPP2;PRKD2;CERS5;ELOVL2;CERS3;ALDH3A2;SPTLC3;SPTLC2
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.39860419942864783,-0.7811101142627713,0.8055555555555556,1.0,1.0,6/32,18.40%,RAD9A;E2F1;PRPF19;SETMAR;DONSON;CLOCK
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.48194241452558007,-0.7809225613694606,0.8307692307692308,1.0,1.0,1/8,20.18%,ZNF593
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.43002079021683787,-0.7808977810934461,0.803030303030303,1.0,1.0,10/16,40.05%,TGFB1;PID1;MRAP;RHOQ;CLTC;MRAP2;AP2M1;NUMB;BCL2L1;PPP2R5A
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),-0.34974197319643885,-0.7808904725713162,0.7941176470588235,1.0,1.0,2/49,4.59%,TRPM1;AQP1
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.4416921185738213,-0.7808751652113679,0.803030303030303,1.0,1.0,7/15,19.95%,PTPRC;GRM5;FKBP1B;DMTN;PTPRJ;BCAP31;TRPM2
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.4546041365994683,-0.7808398101575947,0.7878787878787878,1.0,1.0,2/10,10.26%,DOCK8;LRCH1
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.5262661333914325,-0.7807465259666891,0.7962962962962963,1.0,1.0,3/5,22.23%,PRPS1;CTPS2;DCK
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.31479267105789965,0.7807349101634499,0.9230769230769231,1.0,1.0,8/89,9.74%,PASK;PIWIL2;PLD1;NAT10;BAK1;EIF3E;EIF3D;SAMD4A
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.50963078531434,-0.7807156629330781,0.7777777777777778,1.0,1.0,1/6,17.66%,CEP135
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.3658766521545285,0.7804409128265344,0.8064516129032258,1.0,1.0,6/38,12.31%,PSME2;LMNB1;ANXA2;RALA;AIP;CNN2
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),-0.4421864804643172,-0.7802586166289804,0.7142857142857143,1.0,1.0,2/14,7.11%,CHST1;CHST2
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.37669648777283177,-0.7801251369724267,0.75,1.0,1.0,3/33,4.81%,GLRA3;GPIHBP1;GLRA2
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.37780803409226565,-0.7800197721227821,0.7846153846153846,1.0,1.0,5/29,16.63%,B2M;THY1;YWHAH;PAX6;OMG
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.4166340265295623,-0.7799842544833,0.8307692307692308,1.0,1.0,8/26,17.60%,PCSK2;PCSK1;DCX;CHGA;PAK3;PAX6;SLC2A2;SYT13
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),0.512298965761151,0.779841598708804,0.7105263157894737,1.0,1.0,1/5,6.18%,ATF4
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.3272357584168969,-0.7797637085784755,0.8833333333333333,1.0,1.0,6/111,5.43%,MCM2;H2BC11;NAP1L2;PSMB8;RPA3;SOX9
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.5409682817332409,-0.7796417055725429,0.828125,1.0,1.0,3/5,31.61%,TRPV4;SLC12A5;MYLK
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.3321302659032069,-0.7794656534532104,0.8356164383561644,1.0,1.0,5/76,13.87%,ISG15;IRF1;POLR3H;TRIM25;TRIM32
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.423430047701997,-0.7791043043925445,0.7833333333333333,1.0,1.0,1/14,2.16%,WNT8B
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.3407036310122008,-0.7788014366954866,0.8309859154929577,1.0,1.0,12/94,14.03%,GUCY1A1;AKAP12;ABCC4;CCND1;INPP4B;ACTN1;FKBP5;B2M;H1-0;STEAP4;ITGAV;BMPR1B
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.5096060434523154,0.7787536408391565,0.7714285714285715,1.0,1.0,2/5,15.17%,SLC25A29;SLC3A2
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.3535565930559793,-0.7787013679028387,0.8194444444444444,1.0,1.0,3/53,6.30%,ARIH2;DTX3L;NEDD4L
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.4580101522623484,0.7786047910470849,0.7714285714285715,1.0,1.0,3/11,18.55%,ARPC5;WHAMM;JMY
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.4511324006377432,-0.7785435275789778,0.7547169811320755,1.0,1.0,3/10,18.47%,EPHA4;CHN1;RHOH
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.3904793984836189,-0.7784029485491252,0.7794117647058824,1.0,1.0,5/33,13.38%,TRPC4;TRPC6;COX17;TRPC7;CP
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.3855067027989694,-0.7783426900676255,0.7746478873239436,1.0,1.0,4/25,18.39%,NCKAP1L;GATA1;STAT1;STAT3
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),0.3960288197174309,0.7781101931833463,0.7333333333333333,1.0,1.0,2/15,5.75%,SOAT2;ABCA8
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.4185486433668226,0.7777772893490308,0.8108108108108109,1.0,1.0,2/14,7.34%,AIFM2;COQ2
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.3714088094190575,0.7776496712311651,0.8064516129032258,1.0,1.0,2/13,11.95%,SLC2A14;SLC2A11
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),0.49408859868783284,0.7773502077245846,0.7547169811320755,1.0,1.0,2/5,32.59%,ACAA1;EPHX2
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.4004449435424167,0.7772565586397224,0.7272727272727273,1.0,1.0,8/25,17.50%,EPHB2;NLGN3;PTPRD;IL1RAPL1;SEMA4A;SLITRK2;NLGN2;GRID2
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.3325303057995101,-0.7772460934203627,0.8831168831168831,1.0,1.0,14/110,9.90%,FSTL1;LRIG3;KITLG;LAMC1;COL4A1;SOX9;MET;NTN4;BOC;DDAH1;LAMB1;KIAA1217;PALLD;WWTR1
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.41075269639992695,-0.7771754407866809,0.7666666666666667,1.0,1.0,9/19,31.25%,SCN2A;SIAH1;CDK5;CIT;NLRP1;NGFR;ATN1;BCL2;FAS
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.33447193148964394,0.7771619565157242,0.8235294117647058,1.0,1.0,9/74,13.40%,PSME2;UBC;HSPA1A;ATF4;PSMD13;UBB;ATF3;ELOC;PSME4
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.4594506575846712,-0.77712187556166,0.7735849056603774,1.0,1.0,5/10,25.87%,CD53;CAMK1;FLOT1;ADAM9;EHD1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.39857629895404245,0.7771120170119946,0.7619047619047619,1.0,1.0,4/22,11.28%,CREB3L3;ATF4;ATF6B;ATF3
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.4084256505027695,-0.7769862033581227,0.8032786885245902,1.0,1.0,5/25,21.12%,ISG15;SAMHD1;WNT5A;NLRC5;PTPN11
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.27677205106107844,0.7768052807261063,1.0,1.0,1.0,43/383,13.45%,TEAD2;TCOF1;ONECUT1;ZNF676;MLF1;HDAC10;SLC39A8;RNF6;CDK11A;APBB3;HMGA2;ZNF460;ATF4;CARM1;SOX12;PDGFA;ZNF117;SPIN2B;SBNO1;ACTR5;PHF1;ABL1;CRX;TAF5;PTP4A3;ZNF212;RBBP6;RYBP;THAP1;USP37;SOX13;PRRX2;ASCC2;NOLC1;ACVR1B;MLX;DAXX;CNBP;SLC2A4RG;ESRRG;CCAR1;CCNA2;ZNF488
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.28190691966257075,0.7766207652316041,1.0,1.0,1.0,40/346,13.90%,TEAD2;ONECUT1;ZNF676;MLF1;HDAC10;SLC39A8;RNF6;CDK11A;APBB3;HMGA2;ZNF460;ATF4;CARM1;SOX12;ZNF117;SPIN2B;SBNO1;ACTR5;PHF1;ABL1;RALY;CRX;TAF5;PTP4A3;ZNF212;RYBP;THAP1;SOX13;PRRX2;ASCC2;ACVR1B;MLX;DAXX;CNBP;SLC2A4RG;ESRRG;CCAR1;ZNF488;ZNF74;ZMIZ1
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.43150104217568097,0.7766088339511179,0.75,1.0,1.0,4/14,19.14%,RPL7L1;URB1;FTSJ3;NIFK
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.34410749068428975,-0.7759182968564733,0.88,1.0,1.0,12/58,19.53%,STAT5A;F3;TEK;SCG2;HTR2B;CDH13;PRKD2;VEGFA;ZNF580;WNT5A;PLCG1;EMC10
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.4826462365177022,0.7758038459840314,0.75,1.0,1.0,1/7,9.06%,PLA2G4C
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),0.5034172378352063,0.7756595357430547,0.625,1.0,1.0,1/5,0.67%,CELA2A
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.36589289709848194,-0.7754291485701231,0.8360655737704918,1.0,1.0,2/38,3.61%,TLR2;SFTPD
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.4600792555861537,-0.7752442667495396,0.8064516129032258,1.0,1.0,1/9,8.01%,PIH1D2
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.5097895732366295,-0.7750731539346482,0.8367346938775511,1.0,1.0,1/6,5.16%,GMFG
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.5097895732366295,-0.7750731539346482,0.8367346938775511,1.0,1.0,1/6,5.16%,GMFG
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.34434753356219105,-0.7746866203553215,0.7837837837837838,1.0,1.0,8/60,19.95%,TWF2;GAP43;CAV1;TBC1D10A;ATP8B1;DMTN;ABITRAM;TRPM2
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),-0.3633132331100223,-0.7745554148926703,0.8360655737704918,1.0,1.0,8/41,21.68%,ESYT3;B3GALNT1;ST3GAL5;ST8SIA3;B4GALT6;SMPD3;ST6GALNAC5;SUMF1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),-0.4363192583163662,-0.7743583151308147,0.7741935483870968,1.0,1.0,1/12,3.23%,NFKBIE
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.46047703327903755,0.7741166341445647,0.75,1.0,1.0,1/10,0.46%,DSCAM
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.4458522347335594,0.774011169567451,0.6808510638297872,1.0,1.0,3/6,28.73%,ARHGAP35;C9ORF72;PIK3CA
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.5108332098815095,-0.7739290790055369,0.7647058823529411,1.0,1.0,1/5,10.39%,TST
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.3461909434265331,0.7736578402161095,0.7575757575757576,1.0,1.0,10/22,30.64%,FAM47E;PHF1;DNMT1;SIRT1;SMAD4;JARID2;DNMT3B;KMT2A;AUTS2;PAXIP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.3779603298464045,0.7734753365059839,0.7352941176470589,1.0,1.0,2/14,6.40%,CASQ2;CLIC2
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.37816502728050255,0.7734690825635953,0.725,1.0,1.0,4/31,12.09%,TMEM11;BAK1;SAMM50;CHCHD6
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.4231983699016768,-0.7734598166888992,0.7611940298507462,1.0,1.0,2/14,13.83%,LRRK2;GTPBP1
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.3905431623202903,-0.7733172107950698,0.7777777777777778,1.0,1.0,6/25,16.05%,HOPX;CENPF;ADGRG1;CENPA;TOP2A;TYMS
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.35393764854713194,-0.7732087416241875,0.873015873015873,1.0,1.0,5/52,14.56%,RFC3;HGF;RFC4;PRKCQ;PRKD2
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.4187703359120393,0.7730860058914643,0.7222222222222222,1.0,1.0,8/15,34.37%,PIH1D1;SEH1L;GPR137B;TELO2;SIK3;CLEC16A;PIP4P1;RRAGB
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.42694300743122887,0.7729621478969221,0.7567567567567568,1.0,1.0,4/12,23.87%,AKT2;SLC45A3;SIRT1;AKT1
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.4920344058971108,-0.772909127505714,0.7213114754098361,1.0,1.0,2/7,17.56%,TMEM79;MAFF
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.34611701960632396,-0.7723947537302099,0.8333333333333334,1.0,1.0,16/50,32.35%,TXNRD2;FOS;ROMO1;EGFR;PTPRN;TPM1;PDK2;ADAM9;GPX1;APOE;HIF1A;MPV17;FYN;PDGFRA;CAMKK2;PXN
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.40650725363760176,0.7723167458119502,0.7272727272727273,1.0,1.0,2/15,6.97%,ISYNA1;IP6K2
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.31808403355663906,0.7720199249081188,0.96875,1.0,1.0,17/102,16.12%,HDAC10;EYA4;PRDM5;UBE2A;CARM1;USP36;HDAC1;HDAC9;ZNF541;KAT2A;UBE2N;CCNA2;HDAC4;MIER3;NAA50;PHC1;PRMT2
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.3422828653764308,0.7717318223897066,0.8421052631578947,1.0,1.0,3/43,4.78%,EVI2B;RUNX1;MFHAS1
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),0.4276658058865921,0.7716979507499457,0.7777777777777778,1.0,1.0,1/8,8.56%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.4125254390134377,-0.7716703204327425,0.7878787878787878,1.0,1.0,5/27,13.14%,MET;FES;NAV3;CDK5R1;CAV3
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.422267738326906,-0.7711819288370328,0.7735849056603774,1.0,1.0,4/16,11.53%,RIT2;LRRK2;BST1;CDH13
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),0.5159939872613768,0.7709849076751241,0.7297297297297297,1.0,1.0,2/5,13.51%,CYP7B1;HSD3B7
prerank,PanglaoDB_Augmented_2021__Trichocytes,0.39570923935151436,0.7705278905148165,0.84,1.0,1.0,10/31,12.08%,KRT86;CDSN;TNS4;LAMB3;PPP1R13L;S100A16;PSORS1C1;EPS8L2;TRIM16;KRT8
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.37585196650847097,0.7701494325881187,0.7368421052631579,1.0,1.0,2/19,12.67%,KANSL2;JADE3
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),-0.47792391174730015,-0.7697333628622256,0.8,1.0,1.0,2/5,13.57%,FANCM;RAD54L
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.44342114107945046,-0.7694221407889104,0.7285714285714285,1.0,1.0,1/10,6.61%,DKK3
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),-0.4474467491114167,-0.7693174665766405,0.8571428571428571,1.0,1.0,3/9,30.51%,PRKCZ;PTPN11;SORBS1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),-0.4474467491114167,-0.7693174665766405,0.8571428571428571,1.0,1.0,3/9,30.51%,PRKCZ;PTPN11;SORBS1
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),-0.4968887207222056,-0.7691036853911127,0.7966101694915254,1.0,1.0,1/6,6.61%,DKK3
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.3687005776023948,-0.7689554621117709,0.7808219178082192,1.0,1.0,13/43,25.52%,ISG15;RPA3;RFC3;TRIM25;RFC4;WRN;RPA2;DTL;FAAP20;SYCP1;PARP10;CDKN2D;RPA1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),-0.4700543174329187,-0.7689095913247159,0.7619047619047619,1.0,1.0,1/6,1.77%,VSIR
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.44792711375985594,-0.7687623426821502,0.7678571428571429,1.0,1.0,3/11,13.68%,PLSCR1;CD200;LYN
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.4290539346454247,0.7687113229595501,0.7567567567567568,1.0,1.0,4/8,27.36%,GMNN;METTL4;WDR18;BLM
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.4796588166074386,0.7686702780955394,0.7659574468085106,1.0,1.0,1/5,25.06%,ROCK2
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.2931946217204214,-0.7685232217234892,0.9871794871794872,1.0,1.0,46/356,20.64%,TTC8;CC2D2A;IRGM;ATG16L2;CENPE;CENPF;SMIM22;CDS1;ABCC4;RPGR;RAB11A;LZTFL1;TEKT3;DYNC2H1;CYS1;MVB12A;OGFOD1;GOLGA8B;GOLGA8O;CENPA;TMOD1;TTC39C;SEPTIN6;TXNDC15;DZIP1;DYNC2I2;RAB1B;TP53INP1;SPAG16;ABLIM1;SNX10;LMOD1;SYNPO;DISC1;KASH5;RP2;EDC3;PATL2;CFAP44;SSX2IP;ATP6V1D;TUBGCP2;FNBP1L;TMEM41B;MAK;CEP126
prerank,MSigDB_Hallmark_2020__Apical Surface,0.3729411995511589,0.7685071909886035,0.78125,1.0,1.0,6/33,10.62%,AFAP1L2;EPHB4;ATP6V0A4;CROCC;TMEM8B;GAS1
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.3648776110180607,0.7684289147663889,0.8,1.0,1.0,5/18,9.80%,STAC3;CACNB4;NOS1AP;PDE4B;DRD4
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.39919611859216053,-0.7683629763148603,0.8412698412698413,1.0,1.0,4/26,7.38%,ISG15;VSIR;IRF4;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.326895560961275,-0.7678535783217149,0.8260869565217391,1.0,1.0,22/148,19.24%,VIL1;BASP1;SOX9;GJA1;ZDHHC15;XBP1;CEBPB;GRIP1;PLCB1;CAMK1;TMEM79;AR;PACSIN1;DLG4;BMPR1B;VEGFA;DNM1L;WNT5A;NRXN1;NEURL1;CAMK2B;ZDHHC6
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.44150723833396316,-0.7676536599856304,0.7454545454545455,1.0,1.0,2/13,13.87%,CLU;TRIM32
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.3003777022467125,-0.7675016884086306,0.9629629629629629,1.0,1.0,36/239,21.48%,TTC8;CC2D2A;P2RY12;ABCC4;RPGR;RAB11A;ANO6;LZTFL1;TEKT3;DYNC2H1;CYS1;FGD5;CYFIP1;CDH13;CARMIL1;TTC39C;SEPTIN6;TXNDC15;DZIP1;ABLIM2;DYNC2I2;SPAG16;ABLIM1;OPHN1;SNX10;DISC1;DMTN;RP2;CFAP44;SSX2IP;ATP6V1D;FNBP1L;MAK;CEP126;WDR35;FGD1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),-0.45040547533663927,-0.7672820468972276,0.78125,1.0,1.0,4/9,14.63%,NEDD4L;CAV1;CAV3;KCNH2
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.35003924201668235,0.7668335611004062,0.8285714285714286,1.0,1.0,3/52,4.95%,CXCR4;MYOF;EHD2
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),-0.44910285656451937,-0.7665718714728513,0.8064516129032258,1.0,1.0,2/11,7.06%,ID2;CSF1R
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.4350632945152072,-0.7665276510941678,0.7796610169491526,1.0,1.0,4/13,36.57%,KIF20B;SEMA6A;DAB2IP;ZNF609
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.451938424658874,0.7664137689432553,0.7894736842105263,1.0,1.0,1/8,5.44%,CDC42EP5
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.451938424658874,0.7664137689432553,0.7894736842105263,1.0,1.0,1/8,5.44%,CDC42EP5
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3688281039644853,0.7661944955885673,0.6774193548387096,1.0,1.0,2/18,6.40%,CASQ2;CLIC2
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),0.49328477294218986,0.7660073164585534,0.7428571428571429,1.0,1.0,2/6,4.00%,NGB;CA2
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.3605630648716193,0.7658477131118854,0.7878787878787878,1.0,1.0,7/61,10.61%,SH2B2;GAB1;ATP6V0A4;IGF1R;ATP6V1G2;ATP6V1G1;AKT2
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),0.34892232211451774,0.7649695370605126,0.8888888888888888,1.0,1.0,5/37,10.26%,MLF1;PAX8;EPC1;POLR2K;THAP1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.4664087304449195,-0.7649289927697634,0.7142857142857143,1.0,1.0,1/8,1.04%,LPL
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.3466690186828148,0.7646993780603177,0.7931034482758621,1.0,1.0,7/29,12.79%,ZDHHC16;ADAMTS18;FREM2;MEIS1;ABCB5;PBX4;PBX3
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.2811908324352573,0.7645263731597628,0.9545454545454546,1.0,1.0,33/244,14.23%,ORC1;CHRNA4;POLD3;NT5E;PRIM1;UBC;HMGB1;UBE2A;ENDOV;MGMT;DMC1;CTC1;POLE4;PARP3;PURA;NABP1;DCLRE1B;UBB;ZBTB1;SP100;RAD52;POLG;ADPRS;CNBP;HELLS;UBE2N;TOP3B;POLH;PSME4;POLI;KMT5B;DNMT1;LTO1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.4334118153774537,-0.7643535290517679,0.71875,1.0,1.0,3/14,19.45%,LRRK2;PPP1R15A;BCAP31
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.46074037013173663,0.7642357301329018,0.6976744186046512,1.0,1.0,1/7,1.60%,DPEP1
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.46074037013173663,0.7642357301329018,0.6976744186046512,1.0,1.0,1/7,1.60%,DPEP1
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.34304576958631117,0.764109270404399,0.696969696969697,1.0,1.0,6/27,13.22%,HMGA2;ZNF639;CCNT1;HDAC1;RRP1B;SMARCA4
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),0.4450788718945266,0.7641068725695052,0.7083333333333334,1.0,1.0,1/10,2.64%,NT5E
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.3447605907839254,0.7640428538095798,0.7666666666666667,1.0,1.0,4/53,4.33%,CRTAM;CD274;HMGB1;SCRIB
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),-0.448702181850818,-0.764026100917011,0.7333333333333333,1.0,1.0,3/8,17.05%,TERF2IP;TOP2A;SETMAR
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.40232691680025384,-0.7639182275936255,0.7727272727272727,1.0,1.0,5/32,15.99%,CENPF;TGFB2;SULF1;VEGFA;STAT1
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.3462131699680111,-0.7636924300863438,0.7910447761194029,1.0,1.0,11/42,23.07%,EDN1;GRM5;EIF2B4;CYFIP1;UHRF1;EDNRB;RBM3;TGFB1;NFKBIA;VPS35;AGT
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.26120459431074394,0.7636137676643926,1.0,1.0,1.0,67/320,21.92%,U2AF1;MLF1;M1AP;RAE1;MRPL32;NUP42;PRPF4;RPS15A;FARSB;EEF1A1;NUP210;PAX8;DARS1;TNIP1;MRPS7;RPS3A;EPC1;MRPL3;RBM8A;CPSF4;POLR2K;THAP1;DKC1;SYMPK;RPL18A;MRPS5;TPR;HNRNPU;HARS1;TSPAN17;NXF1;MPHOSPH10;RPS23;EIF4E;MRPL52;MRPL24;RPSA;HARS2;POLR2L;MRPL13;HNRNPH1;NUP37;RPL23A;RBM15B;SARNP;HNRNPA2B1;RPS3;RPL3;RPL13;NR4A2;THOC2;NDC1;RPL11;MRPS16;HOXD3;RBM5;MAGOH;RPL8;MRPL43;SMG5;ALYREF;RPS8;SEH1L;POLR2E;RPL32;RPL21;RPS16
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.3468340394789597,0.7635799621075499,0.9117647058823529,1.0,1.0,6/48,12.99%,PRELID2;MTTP;ABCC1;PRELID1;PITPNM1;ATP11C
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.45183903208173765,0.7634746227109593,0.7619047619047619,1.0,1.0,2/9,21.31%,HDAC4;UBA2
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.3785267672157634,0.7633094498394315,0.7142857142857143,1.0,1.0,1/19,1.66%,CHST7
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.3133680702662178,-0.7632433813385789,0.9459459459459459,1.0,1.0,41/215,19.75%,PKP2;VIL1;BAIAP2;RIMS1;NCKAP1L;LAMC1;SOX9;BAIAP2L2;DCX;LIN7A;LRRTM3;CYFIP1;ADD2;STAG3;RSPH6A;SYCP2;DLG4;NEFH;SPAG17;SYCE2;RAC3;SPAG16;OPHN1;RSPH9;NAPG;DNM1L;NDUFAF1;DMTN;PCLO;WNT5A;MYO1B;RHOH;SKAP2;TGFB1;GAS6;TAPBP;PPIH;TUBGCP2;NEDD9;RHOJ;CFAP46
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.44271060470859536,0.763206439803895,0.8260869565217391,1.0,1.0,1/13,0.23%,CRTAM
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.44271060470859536,0.763206439803895,0.8260869565217391,1.0,1.0,1/13,0.23%,CRTAM
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),0.3491287182867887,0.7631108363258825,0.75,1.0,1.0,13/35,21.92%,TSR1;DCAF13;NAT10;SRFBP1;RIOK1;RIOK2;RRP36;UTP3;NOL11;UTP6;PWP2;RPS8;RPS16
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.42348850784996533,0.7628586149763751,0.78125,1.0,1.0,5/13,21.79%,MELTF;BAG2;ADAM8;PLGRKT;NLRC4
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.4031401853525599,0.7626162952882518,0.7714285714285715,1.0,1.0,1/21,0.48%,PTH
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.370188055584611,-0.7626026035698291,0.85,1.0,1.0,8/40,24.51%,KIF16B;STK17A;GNB3;FLOT1;PID1;VPS35;ARF1;PDK2
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.3225701771481146,0.7625154304060711,0.8,1.0,1.0,10/92,5.60%,ICAM1;AGER;ITGAL;RNF128;TNS4;GPA33;CDKL1;LAMB3;SEC23B;RAI14
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.348269708321402,-0.7618716402028797,0.8571428571428571,1.0,1.0,16/59,18.18%,NRCAM;GABRA1;GABRG2;LRRC4;GPM6A;PCDHB4;GABRB2;LRRTM3;GABRA2;PCDHB11;CBLN4;PCDHB9;CDK5;GABRB3;WNT5A;NRXN1
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.3518715085243246,0.7617075473907875,0.717948717948718,1.0,1.0,6/20,22.77%,CHMP5;NAT10;NPM1;SIRT1;MARK4;PKHD1
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.31675173464977396,-0.7616610500471231,0.9242424242424242,1.0,1.0,19/162,14.94%,ITGB4;CLDN5;ADAMTS5;PTPRC;BAIAP2;CALB2;CADM3;ACTN1;CNTN1;SGCE;DHX16;THY1;RASA1;MPZL1;YWHAH;FYB1;CDH3;KCNH2;CLDN4
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.31840275375505783,0.7615540754923059,0.7857142857142857,1.0,1.0,9/53,12.39%,UBC;HSPA1A;SPRY2;SPRED1;FAM89B;SPRED2;ADAMTSL2;UBB;ZNF451
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.34651207876613016,-0.7615192744252167,0.8208955223880597,1.0,1.0,10/60,19.01%,BAIAP2;NCKAP1L;VAV3;WIPF3;CYFIP1;LYN;FCGR3A;SYK;PIK3CB;PLCG1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.34651207876613016,-0.7615192744252167,0.8208955223880597,1.0,1.0,10/60,19.01%,BAIAP2;NCKAP1L;VAV3;WIPF3;CYFIP1;LYN;FCGR3A;SYK;PIK3CB;PLCG1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.39301707068290614,0.7615038344224286,0.6571428571428571,1.0,1.0,3/20,5.52%,CD38;TNFSF13B;EPHB2
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.3304931053568262,-0.7612543891305955,0.9,1.0,1.0,18/96,21.16%,MT1M;TGFB2;TSPYL2;CRLF3;GJA1;TCHP;RERG;WFDC1;NOTCH2;OSGIN1;CDKN1A;BTG1;TGFB1;GNG4;PTPRJ;MT1E;OSGIN2;BCL6
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.3900207237191612,0.7612498619921189,0.7142857142857143,1.0,1.0,2/18,8.44%,FAM47E;PIH1D1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.3523963396061717,-0.7610358030232842,0.8333333333333334,1.0,1.0,2/50,4.88%,AVEN;PSMB8
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.43289324395554774,0.7608516224836029,0.6585365853658537,1.0,1.0,3/11,18.45%,UQCRFS1;UQCRHL;CYC1
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.35225587833983063,0.7607655781415111,0.6923076923076923,1.0,1.0,3/26,9.28%,PRPF39;SF3A3;SNRPC
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.37602767206455034,-0.76065584850514,0.8518518518518519,1.0,1.0,6/24,19.76%,ITGAM;CLU;NMI;IFI35;SYK;CX3CL1
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),-0.4616196196539561,-0.7606232986636458,0.847457627118644,1.0,1.0,1/11,10.64%,XBP1
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.4440198174724209,-0.7604212186251865,0.8275862068965517,1.0,1.0,5/12,29.04%,DYNC2H1;DYNC2I2;WDR35;IFT122;IFT43
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3539977385609013,0.760388055372578,0.8260869565217391,1.0,1.0,5/33,17.69%,PIK3C2G;IP6K2;EFR3B;SOCS4;SOCS7
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.3041928144544347,0.7603735788755792,0.9090909090909091,1.0,1.0,18/124,14.06%,ERAS;PLD1;RAPGEF1;CNKSR1;CDC42EP5;RASGRP2;TAX1BP3;PLCE1;RALA;RRAS2;G3BP2;EPS8L2;SHC3;LIMK1;CCNA2;RRAS;RAP2B;DNMT1
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),-0.5315024325488658,-0.7601572623237616,0.8571428571428571,1.0,1.0,1/5,4.49%,SLF1
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.2951571712257634,-0.7600159754176842,0.961038961038961,1.0,1.0,44/363,18.92%,HEY1;MDFIC;PPARG;CENPF;MAEL;BASP1;ELK3;MIDEAS;GLIS2;IRF1;CITED2;ID2;SOX9;LOXL3;PRICKLE1;DKK3;ZEB1;BHLHE40;ZNF540;E2F1;RUNX1T1;PLCB1;CDK5R1;ZNF217;IFNA2;GLI3;PRAME;L3MBTL4;IKZF1;PBXIP1;ATP8B1;BRCA1;TRERF1;ID3;CREB3L1;NRG1;EZH2;NR2F2;CDK5;NR1D1;WNT5A;CLOCK;TGFB1;GAS6
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.335712252099681,0.759784094970089,0.8888888888888888,1.0,1.0,1/39,0.67%,CELA2A
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.362794481506761,0.7597343907413688,0.7777777777777778,1.0,1.0,2/21,6.83%,RILP;CHMP5
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.37444578055000766,0.7597233638219367,0.7142857142857143,1.0,1.0,4/27,6.27%,CD38;TNFSF13B;EPHB2;IKZF3
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.3545026586482647,0.7596979348842575,0.8571428571428571,1.0,1.0,6/45,11.37%,DHFR;MTHFD2L;AADAT;IDH2;MTRR;MTHFD2
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.5091861422027758,0.7594955530489274,0.725,1.0,1.0,2/6,31.99%,BTRC;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.40171041049866096,-0.7594843112244023,0.796875,1.0,1.0,3/14,16.12%,LRRK2;XBP1;CREB3L1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.36884978324949247,0.7591580659710404,0.825,1.0,1.0,6/24,21.62%,PCF11;SYMPK;TENT4B;PNPT1;PAPOLG;APP
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.36884978324949247,0.7591580659710404,0.825,1.0,1.0,6/24,21.62%,PCF11;SYMPK;TENT4B;PNPT1;PAPOLG;APP
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.3527768032222086,0.7591380549239323,0.875,1.0,1.0,13/32,27.40%,HSPA1A;HSPA1B;TRPV1;DAXX;TPR;ZFAND1;SUMO1;HSF1;POLR2D;IER5;CLPB;HMOX1;HIKESHI
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),-0.450494608063007,-0.758867780537337,0.7192982456140351,1.0,1.0,1/8,20.90%,RBX1
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),-0.5046624349405728,-0.7586856113904312,0.8055555555555556,1.0,1.0,3/6,29.81%,RHOJ;RHOU;WAS
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.4813907586917727,0.7584733931133965,0.717948717948718,1.0,1.0,3/7,10.64%,HSPA1A;CPNE1;HSPA1B
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),-0.4257815708494924,-0.7579673203730369,0.7538461538461538,1.0,1.0,3/12,15.66%,EPHB6;EPHB1;B4GALT6
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.45907907569543377,-0.7578363247209368,0.8103448275862069,1.0,1.0,3/10,21.40%,TPP1;NRXN1;UBA5
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.43834424551879214,0.7578164014293756,0.7368421052631579,1.0,1.0,3/8,16.58%,FGFR1;FGFR3;SNCA
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.3566334021111296,0.7577915930399344,0.8378378378378378,1.0,1.0,7/27,19.70%,PPP1R10;PKIB;TNKS2;MAP2K7;SIRT6;HNRNPA2B1;NAF1
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.3333328996992869,0.7576928479040462,0.8571428571428571,1.0,1.0,11/41,23.59%,RAE1;NUP42;NUP210;TPR;ZBTB7A;NUP37;NDC1;SEH1L;PGAM1;NUP85;NUP214
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.39522327316464456,0.7572752286800936,0.6829268292682927,1.0,1.0,3/13,14.32%,STAC3;TSPOAP1;CHRNB4
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),-0.43534700690230627,-0.7572738176873022,0.7419354838709677,1.0,1.0,2/10,17.13%,TGFBR2;EIF4A3
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.484844932948601,-0.7571185675384178,0.8307692307692308,1.0,1.0,3/8,17.66%,SLC7A7;SLC3A1;SLC15A4
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.3650186185011393,-0.7571022779787824,0.8088235294117647,1.0,1.0,5/44,7.89%,FOSL2;HOPX;LGALS3;SMAGP;BHLHE40
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.45371309250685776,-0.7568460242916605,0.7868852459016393,1.0,1.0,7/10,37.01%,ATP23;PMPCB;IMMP1L;PMPCA;STOML2;AFG3L2;MIPEP
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.4038766908611693,0.756829389860016,0.7419354838709677,1.0,1.0,1/14,0.46%,DSCAM
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.28482254788221933,0.7568133992235313,1.0,1.0,1.0,26/225,14.31%,USP27X;RNF128;PSME2;UBC;USP31;OTUD3;USP36;DESI2;INO80D;YY1;KEAP1;ACTR5;TNIP1;BRCC3;PSMD13;KDM1B;USP37;UBB;USP18;KAT2A;USP40;PSME4;CCNA2;MAP3K7;UIMC1;BECN1
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.3652923240641948,-0.7567559453455355,0.9078947368421053,1.0,1.0,5/42,11.60%,ISG15;RPA3;RFC3;TRIM25;RFC4
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.4325158036273448,0.7567287826516319,0.7391304347826086,1.0,1.0,1/9,6.83%,CHMP5
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.4325158036273448,0.7567287826516319,0.7391304347826086,1.0,1.0,1/9,6.83%,CHMP5
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.4911335924343531,-0.756225201078989,0.7678571428571429,1.0,1.0,5/8,33.90%,ABCA1;APOE;BMP1;APOM;ABCA7
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.3993802857744,0.7560222656313436,0.7021276595744681,1.0,1.0,3/12,16.20%,PLIN5;AKT2;TYSND1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.4087513113166974,0.7557329790161191,0.8,1.0,1.0,4/16,11.46%,BPIFB1;MFHAS1;RAB7B;PTPN22
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.48927112793981903,0.755480273335456,0.8048780487804879,1.0,1.0,2/5,11.46%,HMGB1;PTPN22
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.34780262258375866,0.7553108990470422,0.7428571428571429,1.0,1.0,4/28,12.25%,ZNF207;TPX2;TUBG1;MAP7D3
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.37372850921408163,-0.7552831295980942,0.7741935483870968,1.0,1.0,6/29,26.19%,NOS1;CAMK1;BRCA1;SPI1;TADA2A;MYOCD
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.44317051231075544,0.7552221635088007,0.7631578947368421,1.0,1.0,4/8,12.54%,SPRY2;SPRED1;SPRED2;DLL1
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.4066668255471647,-0.7552101989489566,0.803921568627451,1.0,1.0,2/11,14.56%,MET;PRKD2
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.3964203721431653,0.7550847486251666,0.7428571428571429,1.0,1.0,3/25,5.34%,GPC4;SDC2;GPC2
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.3810303342316643,-0.7548216471168137,0.8787878787878788,1.0,1.0,5/28,17.37%,ID2;E2F1;TCIM;CDKN1A;EZH2
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.37615798970648173,-0.7544493314468849,0.847457627118644,1.0,1.0,2/31,5.73%,TGFB2;MET
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.4301280489400974,-0.7541900281910056,0.84375,1.0,1.0,5/16,19.67%,HLA-A;B2M;NLRP3;RSAD2;PRKCZ
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.33054845580192765,0.7539137108961034,0.8484848484848485,1.0,1.0,2/61,0.55%,PTH;TBXA2R
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.3171186663568741,-0.7538516322440191,0.9014084507042254,1.0,1.0,4/68,9.85%,CHRM3;PIGH;USP6;CPE
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.3869519519753906,0.7537670802803619,0.7567567567567568,1.0,1.0,1/19,1.08%,AGER
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.33348280708959177,-0.7534775088701701,0.927536231884058,1.0,1.0,9/106,8.96%,SFRP4;NFKBIE;GLIS2;ID2;PIM1;NLRP12;BHLHE40;TMIGD3;NLRP3
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.423994805724715,-0.7534082987757662,0.8307692307692308,1.0,1.0,2/12,13.83%,LRRK2;GTPBP1
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.4411781844536725,0.753063097263189,0.8095238095238095,1.0,1.0,3/8,23.30%,PIH1D1;IWS1;TAF7
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),-0.30383551956302685,-0.7528456146927294,0.9692307692307692,1.0,1.0,26/203,19.14%,IRGM;DEPP1;WDR6;TRIM5;CAPN1;MET;HGF;LRRK2;TRIM22;TPCN2;ATP6V1C2;HTR2B;CDK5R1;DRAM1;EEF1A2;DAPK1;DAPK3;TP53INP1;SREBF1;DNM1L;CDK5;PRKAB2;STAT3;PLK2;PIK3CB;ATP6V1D
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),-0.5277940767469012,-0.7526931441914138,0.8444444444444444,1.0,1.0,3/5,18.15%,ADGRV1;VEGFA;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.46507580309667695,-0.7519211758809677,0.796875,1.0,1.0,2/7,18.43%,LYN;LILRB1
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.3763687738820021,0.7515213200964396,0.8604651162790697,1.0,1.0,4/27,15.02%,GAB1;SPRY2;GAS1;RELA
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),-0.42841769205699787,-0.7514438342205968,0.78125,1.0,1.0,3/12,15.69%,OLAH;ABHD3;OXSM
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.44604127657628856,-0.7513235026127861,0.8507462686567164,1.0,1.0,1/8,5.89%,FUCA2
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.4051407114234895,0.7512893685428571,0.8157894736842105,1.0,1.0,1/8,7.94%,YY1
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),-0.38102257221379954,-0.7508394989488315,0.7857142857142857,1.0,1.0,2/25,5.18%,TP73;RPA3
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.34968232698784874,0.7506661573115502,0.8333333333333334,1.0,1.0,8/39,17.80%,RIDA;HSPA1A;HSPA1B;NUDT16L1;ZC3H12D;PNPT1;PPP1R8;EXOSC7
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),-0.5009184969498877,-0.7504711321359377,0.8135593220338984,1.0,1.0,1/8,1.52%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),-0.46405249162808815,-0.7502462206273071,0.8064516129032258,1.0,1.0,1/6,19.12%,PARD6A
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.2998284964591916,0.7502243480975529,0.9117647058823529,1.0,1.0,10/79,8.68%,ECM1;SEMA5A;CCR3;RUNX1;GAB1;HMGA2;PTGIS;PIK3R6;CHRNA7;SERPINE1
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.37697675293423466,-0.7502067406688006,0.8472222222222222,1.0,1.0,15/27,23.23%,CACNA1E;CACNG2;SCN2A;SCN9A;CACNA1B;CAV1;SCN1B;YWHAH;KCNH2;CACNA1G;SCN1A;SCN3A;ATP5IF1;CACNA1A;SCN3B
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.46786950164560437,-0.750134523056703,0.8082191780821918,1.0,1.0,2/8,10.59%,TESPA1;TOX
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),-0.3804362478803118,-0.7499392663636404,0.8615384615384616,1.0,1.0,5/30,15.49%,CLDN16;SLC8A1;CAV1;KCNH2;SLC7A8
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.4075909384802947,0.7498066913359535,0.7272727272727273,1.0,1.0,4/11,16.16%,GLI2;PAX8;WNT4;SALL1
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),-0.4260531080308202,-0.7497761319210385,0.8305084745762712,1.0,1.0,6/14,16.78%,SYT4;RAB3A;KCNB1;RAB15;SCAMP5;CACNA1G
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.34566584400495426,-0.7497479804357502,0.8823529411764706,1.0,1.0,9/46,23.25%,MCM2;WRN;RECQL4;RAD50;MCM7;MRE11;RBX1;DDX11;XPA
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.4218360298288355,0.7492249654916494,0.7906976744186046,1.0,1.0,2/9,6.80%,NOS1AP;PDE4B
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.4402218294583531,-0.7491410503145286,0.7727272727272727,1.0,1.0,2/8,14.64%,SNCAIP;LRTOMT
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.33272741548937784,0.7490388869219796,0.8823529411764706,1.0,1.0,11/41,23.59%,RAE1;NUP42;NUP210;TPR;ZBTB7A;NUP37;NDC1;SEH1L;PGAM1;NUP85;NUP214
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.4051104643392397,0.7490265751732181,0.7692307692307693,1.0,1.0,2/8,11.50%,HMGCR;IDI1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.425064192685918,-0.7486535395937153,0.8405797101449275,1.0,1.0,3/11,11.58%,NOS1;GLRX;ATP1B2
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.3382493800961669,0.7485245719727743,0.7948717948717948,1.0,1.0,8/25,20.09%,ODAD2;DNAI4;CFAP100;DNAI1;DNAH8;DNAI3;ZMYND10;CFAP73
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.4765218748398916,-0.7482839390193581,0.7761194029850746,1.0,1.0,1/7,14.50%,AXL
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.48062635478721183,-0.7481534899491485,0.7931034482758621,1.0,1.0,2/7,20.85%,XBP1;CIITA
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.34703521080033806,-0.7480191417862292,0.8253968253968254,1.0,1.0,3/30,5.18%,MCM2;DBF4;RPA3
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.3843802108337835,0.7477391419761938,0.775,1.0,1.0,8/16,21.96%,PDZD11;PLEKHA7;AHCTF1;TPR;NDC1;RTN4;AFDN;P2RX7
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.32095970630591913,0.7476649112668955,0.9069767441860465,1.0,1.0,19/66,24.09%,CAVIN1;PCF11;CPSF4;POLR2K;CSTF2;SYMPK;MED18;ERCC2;POLR2L;UBTF;TAF1C;GTF2H5;CSTF1;POLR2E;POLR3K;SNRPB;SMN1;PRMT5;CCNH
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),-0.44511069981341067,-0.7474721098877297,0.8412698412698413,1.0,1.0,4/10,15.96%,NRCAM;EPHA4;CDK5R1;CNTN4
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.43709435638657773,0.7473729738048847,0.8205128205128205,1.0,1.0,3/12,16.57%,PLXNA1;NRP2;PLXNB1
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),0.4453280412886226,0.7471467991171077,0.7631578947368421,1.0,1.0,2/7,8.46%,CD274;PRELID1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),-0.5178079608388433,-0.7468905893273031,0.819672131147541,1.0,1.0,1/5,13.43%,ABCG5
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.42533539670906734,0.7468208864550538,0.9024390243902439,1.0,1.0,3/22,13.45%,ATP6V0A4;ATP12A;UCP2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.4849658514857889,-0.746796049364022,0.8305084745762712,1.0,1.0,3/5,35.97%,NONO;HIF1A;PINK1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.3984571080691435,-0.7467509473980888,0.7910447761194029,1.0,1.0,2/19,6.02%,ID2;MFAP5
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),-0.3850345732103731,-0.7467127165864472,0.7741935483870968,1.0,1.0,3/19,14.03%,SULF1;CRB2;BMPR1B
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),-0.44899920281868605,-0.7466355288781769,0.8181818181818182,1.0,1.0,1/7,19.93%,PID1
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.4396499470094628,0.746476873127735,0.7,1.0,1.0,4/7,24.56%,MTRR;SMS;MSRA;ADI1
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),-0.49058087726859967,-0.7463828951545491,0.8076923076923077,1.0,1.0,1/7,5.04%,ATP2B3
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.29200810772773933,0.7463006625346843,1.0,1.0,1.0,29/137,20.81%,PSME2;RIDA;UBC;HSPA1A;CSDC2;PSMD13;EXOSC8;SAMD4A;UBB;FASTKD3;DCP1A;PSME4;HNRNPU;ANP32A;FASTKD1;TENT5D;YBX1;PSMF1;EXOSC7;NPM1;DIS3;CELF1;PSMD11;MAPKAPK2;PDE12;PSMD4;PRKCA;EXOSC5;AXIN2
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.2913496924496703,-0.7461333247771178,0.971830985915493,1.0,1.0,43/271,23.51%,ANGPT1;SEPTIN12;GPIHBP1;RPGR;LAPTM5;MYO7A;GRTP1;LRRK2;USP6;STX3;GJA1;CPE;ZDHHC15;HPS6;PRPF19;SAR1A;ARF5;SEPTIN6;YWHAH;PACSIN1;TBC1D10A;FGF7;RAB1B;COX18;EGFR;NAPG;RIC1;WNT5A;SEPTIN3;TMED10;TBC1D8B;TBC1D9;STX19;AMOT;WLS;USP4;VPS35;RAB6B;VCL;CEP68;STX17;ABCA12;ARF1
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),0.45006687908651755,0.7459653840532307,0.6585365853658537,1.0,1.0,2/6,17.57%,SPHK2;GAB2
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),0.48198102557320016,0.7456940097301893,0.8536585365853658,1.0,1.0,1/6,0.68%,NUPR1
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.4431782726052783,-0.7453075968671441,0.8181818181818182,1.0,1.0,1/13,8.01%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.4105323870726506,0.7451981751235186,0.7027027027027027,1.0,1.0,5/27,8.68%,F2;EPHB2;AJAP1;CRK;SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.46963915759920505,0.7449550708812092,0.8055555555555556,1.0,1.0,3/9,5.61%,ERRFI1;TESK1;ENPP1
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.3354761464162052,0.7448366239167358,0.9,1.0,1.0,10/56,12.01%,TRMT10C;METTL2A;HENMT1;TFB1M;NSUN2;TRMT13;MTERF4;METTL8;VIRMA;TFB2M
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.43991491791451337,0.744817136140271,0.775,1.0,1.0,3/9,25.10%,RELA;RHOA;NFAT5
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.4247601188333246,-0.7445581517168065,0.7741935483870968,1.0,1.0,1/13,4.02%,EDN1
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),0.4160053830153255,0.744383917756879,0.8378378378378378,1.0,1.0,1/8,4.36%,ATP2A3
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.3313204259865982,-0.7442933444665543,0.9428571428571428,1.0,1.0,8/66,18.40%,KDM4D;FIGNL1;RAD9A;BRCA1;IKBIP;NHEJ1;CDKN1A;CLOCK
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.3456948930787927,0.7440320086292441,0.8235294117647058,1.0,1.0,8/37,9.53%,WNK4;KCNN3;KCNJ2;KCNN4;NOS1AP;FLNA;ATP1B1;ACTN2
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.31980911499643544,0.7438638472300488,0.8620689655172413,1.0,1.0,3/36,6.87%,KIF3B;DYNLRB1;PCM1
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.277028438566543,-0.7437980109741669,1.0,1.0,1.0,40/420,14.56%,TLR2;IGFBP3;PAK5;TGFB2;EPHA3;MUSK;TGFBR2;PRKAR1B;GMFG;HIPK4;PIM1;MAP3K21;EPHA4;PEAK3;FES;BMX;RPS6KA6;TSSK3;CSF1R;MAP3K5;TEK;LRRK2;DCLK1;CAMK1D;HUNK;CDK5R1;CAMK1;COQ8B;PAK3;PRKG1;STK17B;EPHB1;PRKCQ;LYN;BMPR1B;DAPK1;GLYCTK;GRK6;DAPK3;PRKD2
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.334741836037863,0.7434607424937392,0.7666666666666667,1.0,1.0,3/51,8.12%,CELA2A;NEU4;USE1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.2894969048855973,0.74332398698101,0.9354838709677419,1.0,1.0,11/139,9.13%,PASK;EPHB4;MYO3A;ALK;FGFR1;STK16;IGF1R;PIM3;OXSR1;ABL1;GRK5
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.36230918868154405,-0.743253960138099,0.8153846153846154,1.0,1.0,2/29,15.70%,NOS1;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.33851252055831754,-0.7431315329512462,0.8970588235294118,1.0,1.0,7/72,9.68%,ARIH2;CLU;PRICKLE1;RNF217;LRRK2;RNFT1;RNF144B
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),-0.45397041199958393,-0.7430784894206082,0.7647058823529411,1.0,1.0,2/9,17.85%,SLC25A20;PRKAB2
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.32812607836303603,-0.7430269747456395,0.9166666666666666,1.0,1.0,8/71,10.24%,TNFRSF1A;GSAP;CLU;VIM;EPHA4;EFNA1;PRR16;LRRTM3
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.3995136532941186,0.7424319961988928,0.8048780487804879,1.0,1.0,1/16,1.60%,DPEP1
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.3584673001747242,-0.7422172645065671,0.8275862068965517,1.0,1.0,3/27,16.35%,FABP3;SCARB1;SREBF1
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.32402483555868233,0.7420381052058701,0.8285714285714286,1.0,1.0,11/43,13.78%,SSC5D;AFAP1L2;HMGB1;HSPA1A;SERPINE1;HSPA1B;PTPN22;TLR1;IL17D;BCL10;NOS2
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.40995525253108667,-0.741849606623173,0.8208955223880597,1.0,1.0,2/18,5.49%,CITED2;MMP21
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.35385244783354186,-0.7414843252608994,0.881578947368421,1.0,1.0,2/43,2.34%,IL26;TGFB2
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.42667463896499414,0.7413705778227968,0.8292682926829268,1.0,1.0,2/7,8.35%,ATF4;ABL1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.42667463896499414,0.7413705778227968,0.8292682926829268,1.0,1.0,2/7,8.35%,ATF4;ABL1
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.45319241244244635,-0.7412824952236681,0.7833333333333333,1.0,1.0,3/9,20.75%,CCNF;BRCA1;KAT2B
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.43484184246732505,-0.741247212796772,0.7391304347826086,1.0,1.0,3/13,14.38%,MET;DACT2;CNMD
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.31257743044492264,0.7412289209577038,0.9,1.0,1.0,10/107,9.02%,TRARG1;SH2B2;GAB1;ATP6V0A4;ENPP1;IGF1R;ATP6V1G2;HDAC9;ATP6V1G1;SLC25A33
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.38564180037376317,-0.7407709907221228,0.9090909090909091,1.0,1.0,6/26,21.67%,TRIM46;THY1;MAP2;OMG;KIAA0319;FGF13
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.32154407914249483,-0.740746754333985,0.8701298701298701,1.0,1.0,13/82,12.78%,FSTL1;PPP1R3C;TTN;MUSK;COL4A1;CAPN1;ANGPT2;LAMB1;PALLD;WWTR1;SYNC;CAV1;PRKG1
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.46387382014365974,-0.7406593184606941,0.8125,1.0,1.0,4/7,37.12%,WNT5A;TNIP2;LBP;IL33
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.4378953046993005,0.7404231995483495,0.8409090909090909,1.0,1.0,2/11,3.47%,CASQ2;KCNJ2
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.3089473375563732,0.7404108349555742,0.84,1.0,1.0,14/76,19.63%,GDAP1;MYO1C;ZDHHC12;PEX2;RTP5;SRPRA;ICMT;ZDHHC3;ZDHHC14;MICALL1;SSR2;ZDHHC7;RABGEF1;SEC61A1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),0.2722237381585117,0.7401881724130097,0.9629629629629629,1.0,1.0,33/265,14.17%,CHRNA4;RFWD3;POLD3;FAAP100;UBC;HMGA2;UBE2A;ENDOV;MGMT;H2AX;RNF168;ACTR5;ABL1;BRCC3;PARP3;TENT4A;NABP1;GTF2H2C;DCLRE1B;UBB;ZBTB1;RAD52;MAPK8;ASCC2;ADPRS;COMMD1;UBE2N;POLH;HERC2;PSME4;POLI;KMT5B;UIMC1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.35471474337970554,0.7401356170382405,0.9166666666666666,1.0,1.0,4/24,9.72%,MAPRE2;FKBP4;ABL1;SKA3
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.39795048663611254,-0.7400712664615882,0.8714285714285714,1.0,1.0,6/21,15.68%,SLC23A1;AMN;TCN2;SLC35F3;CBLIF;SLC2A2
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),-0.504639084746196,-0.739963142496101,0.8888888888888888,1.0,1.0,2/5,23.07%,NTRK3;AGT
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),0.4562945937578559,0.7395764019919293,0.75,1.0,1.0,4/6,25.04%,PDCD7;SOX30;CALCR;AKR1C3
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.3815965098735586,-0.7394510967803207,0.8805970149253731,1.0,1.0,6/28,16.82%,TTN;TMOD1;SYNPO2L;FHOD3;LMOD1;MYLK3
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.4173852345664264,-0.7389355084604292,0.8596491228070176,1.0,1.0,2/15,3.45%,DUOX1;MAOB
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),-0.3659477879761769,-0.7389267721992514,0.8970588235294118,1.0,1.0,6/34,16.36%,PDGFD;NLRP12;CALM3;VEGFA;TOM1L1;RAD50
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),-0.39964385796167173,-0.7388316463476899,0.819672131147541,1.0,1.0,2/20,3.91%,SYT1;SYT4
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),-0.33180852755179974,-0.7386977277756894,0.8769230769230769,1.0,1.0,12/75,19.86%,ARHGAP42;APC2;GRTP1;USP6;SIPA1L1;ARHGAP25;TBC1D10A;NGEF;NTRK3;TBC1D8B;RASGRP1;TBC1D9
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.37195835106766834,0.7385389740493541,0.9032258064516129,1.0,1.0,5/21,19.76%,OSBPL7;CYP7B1;HSD3B7;HSD17B10;AKR1D1
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.4348839635854366,0.7385314486623177,0.8,1.0,1.0,3/5,21.33%,PLEKHA7;TJP1;FERMT2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.46401949482021865,-0.7385226622520482,0.8620689655172413,1.0,1.0,1/9,2.69%,IL12A
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.44959055263346404,-0.7382802268320457,0.9365079365079365,1.0,1.0,6/14,24.27%,CACNG2;CACNG8;CACNG3;NRXN1;CACNG5;TSHZ3
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),0.4151956157122091,0.7382624181074352,0.8181818181818182,1.0,1.0,4/11,23.59%,IFI27;TPR;SIRT7;NUP214
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),-0.45459004242463663,-0.7380860197536658,0.8909090909090909,1.0,1.0,2/8,22.03%,SRP54;CLMP
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),0.4072109629506953,0.7379504319407237,0.8333333333333334,1.0,1.0,4/12,10.76%,WNT9A;GDF5;ADAMTS12;GREM1
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.396746235183161,-0.7378162571890134,0.8518518518518519,1.0,1.0,1/19,10.60%,NEMP1
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),0.3187201386056471,0.7377024870707315,0.875,1.0,1.0,5/37,11.46%,DUSP1;SPRY2;SPRY3;DUSP7;PTPN22
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.46985197697292747,0.7376028180846416,0.8048780487804879,1.0,1.0,1/9,2.65%,PLXNA1
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.36824899364419666,-0.7374609185303629,0.8421052631578947,1.0,1.0,8/26,25.97%,DTX1;CCND1;NOTCH2;WNT5A;RBX1;HES1;APH1A;ST3GAL6
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),-0.4857220935202794,-0.7370899696776659,0.7777777777777778,1.0,1.0,2/6,13.14%,SLC8A3;CAV3
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.38623677558741826,0.7365796791502381,0.8387096774193549,1.0,1.0,4/13,19.01%,ODAD2;DNAI1;DNAH8;ZMYND10
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.36265052427865757,-0.7365724486966001,0.8028169014084507,1.0,1.0,11/44,18.80%,GRHL1;CDS1;CCND1;IGSF3;CDH3;CLDN4;TOM1L1;OVOL2;MYO1B;KLRG2;GNG12
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.41497480873725406,-0.736292392088074,0.8,1.0,1.0,1/12,2.15%,IHO1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.3869688217376749,0.7362819008759599,0.8409090909090909,1.0,1.0,2/16,12.96%,MORC3;PEX2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.36223246009837984,-0.7362194113005954,0.8709677419354839,1.0,1.0,9/33,18.94%,TLR2;F3;CHI3L1;NOD1;PRKD2;ZNF580;SYK;STAT3;TIRAP
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),-0.4225188447421103,-0.736206905015926,0.8153846153846154,1.0,1.0,5/13,24.77%,PAK3;EPHB1;DLG4;CTNND2;EPHB3
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),0.277209304482264,0.7361620109394736,1.0,1.0,1.0,40/151,21.97%,POP5;RCL1;BYSL;MDN1;DCAF13;PIH1D1;RRP12;EXOSC8;NOL8;DKC1;ESF1;PELP1;NOLC1;TRIR;RPL18A;RRP1B;RRP36;MPHOSPH10;KRR1;RPL23A;WDR74;UTP3;EXOSC7;NOL11;RPL3;DDX10;RPL13;DIS3;UTP6;NIFK;WDR36;RPL11;PWP2;EXOSC5;RPL8;NOP56;RPL32;RPL21;RPS16;POP4
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.4440426341834791,0.7359135417744158,0.7368421052631579,1.0,1.0,8/8,55.61%,VDAC2;BNIP3L;RHOT2;STPG1;ATF2;BNIP3;BLOC1S2;RHOT1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.3307770253841684,-0.7358938180698417,0.9420289855072463,1.0,1.0,4/56,6.37%,TGFB2;SPDYA;CITED2;CCND1
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.41924546749430097,-0.7358804721976151,0.8,1.0,1.0,2/13,12.79%,PRKAR1B;PKIA
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.3199222399363697,-0.7354676463242886,0.9166666666666666,1.0,1.0,15/74,26.69%,DACT1;PSMB8;PRICKLE1;DAAM1;WNT5A;PSMC3;PARD6A;FZD3;SPEF1;PSME1;PSMA3;PRICKLE2;PSMB2;PSMD5;PSMC5
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.4783668285253064,-0.7354191080096619,0.8064516129032258,1.0,1.0,1/5,30.50%,MCM3AP
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.3671434712673489,-0.7351720038141817,0.8787878787878788,1.0,1.0,3/28,7.44%,PTPRC;IL26;CRLF3
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),0.40804785514843683,0.7349037012118785,0.9090909090909091,1.0,1.0,4/11,10.76%,WNT9A;GDF5;ADAMTS12;GREM1
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),0.39859319790206627,0.7348925573544252,0.825,1.0,1.0,2/10,10.32%,THBS4;PLEKHA7
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.3664023074770091,-0.7348860807842532,0.8939393939393939,1.0,1.0,7/34,20.20%,SYT4;MYO7A;MYO5C;CCDC186;MYO1H;MYO1B;FNBP1L
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.315215355336252,-0.7344932991110892,0.9264705882352942,1.0,1.0,12/75,17.47%,SHMT2;GLRA3;HLA-DRB1;NINJ1;POLQ;KCNC2;AQP11;ADCY8;PRMT8;RNF213;DNM1L;NOL3
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.42270651987307717,-0.7343917491049701,0.8309859154929577,1.0,1.0,7/12,18.91%,ANGPT1;BMP6;FGFBP3;VEGFA;TJP3;TRPV4;TGFB1
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.3533374927034539,-0.734057024526009,0.8135593220338984,1.0,1.0,9/38,23.10%,AQP1;E2F1;TRIM32;CDKN1A;WNT5A;GAS6;DDR2;AGT;PARP10
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),0.2808907981830429,0.7333254270152836,0.967741935483871,1.0,1.0,5/116,3.21%,ORC1;POLD3;PSME2;PRIM1;UBC
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.3122474081443659,0.7328365141550491,0.8214285714285714,1.0,1.0,13/50,23.59%,RAE1;NUP42;NUP210;KIAA1586;ZNF451;TPR;NUP37;NDC1;SUMO1;UBA2;SEH1L;NUP85;NUP214
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.3971705378034959,-0.732771024759256,0.7966101694915254,1.0,1.0,4/16,22.80%,EIF2B4;B4GALT6;EIF2B2;MYRF
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.387229243347782,0.7326762355020605,0.7352941176470589,1.0,1.0,3/14,11.47%,WNT9A;MEGF8;DSCAML1
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),-0.4676655617752229,-0.7326402702056388,0.796875,1.0,1.0,1/6,19.42%,NNMT
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.35202973903422624,-0.7324502051293034,0.8533333333333334,1.0,1.0,9/53,21.87%,FIGNL1;FIGN;RAB11A;HOOK1;TRPV4;CAMSAP3;TUBGCP2;CEP126;VPS4B
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.379797725652674,-0.7323165371186259,0.8428571428571429,1.0,1.0,1/17,1.77%,VSIR
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.43567688281354633,0.7322798977902275,0.7777777777777778,1.0,1.0,4/7,17.63%,DCP1A;DCP1B;PATL1;DCPS
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.4117020066169879,0.7322491656581728,0.8611111111111112,1.0,1.0,4/9,23.30%,NOC2L;SNCA;SIRT1;TAF7
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),0.45779279486203417,0.7320290312923771,0.7,1.0,1.0,5/11,28.25%,DKC1;TENT4B;EXOSC5;LARP7;FBL
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.35698664235931377,0.7319812515168436,0.7906976744186046,1.0,1.0,5/31,13.78%,PCF11;CPSF4;CSTF2;SYMPK;MED18
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.38913295676459625,-0.7318607238655027,0.8656716417910447,1.0,1.0,2/18,17.05%,TERF2IP;SETMAR
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.4007976220482429,-0.7318036565627656,0.8714285714285714,1.0,1.0,6/15,26.45%,EMC3;EMC10;EMC1;CAMLG;EMC9;GET3
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.43585184378585595,-0.7316942126019446,0.8305084745762712,1.0,1.0,3/12,13.28%,EPHA4;EPHB6;EPHB1
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.3904822097401495,0.7315092965500545,0.8,1.0,1.0,4/13,11.82%,LEPR;RUNX1;THBS4;SUCO
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),-0.436465086645898,-0.7314505343805392,0.8,1.0,1.0,2/8,22.57%,MAP3K12;PRKCD
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.4028409053999432,-0.731402268835236,0.8709677419354839,1.0,1.0,4/17,18.43%,B2M;CAV3;PAX6;LILRB1
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),-0.4513020093259311,-0.7313597592946165,0.7586206896551724,1.0,1.0,1/6,18.97%,NFKBIA
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.2656471671919721,-0.7311255627240022,1.0,1.0,1.0,54/791,11.26%,PARP14;ANGPT1;ZNF100;CLDN5;HEY1;TLR2;YBX3;ZIM2;SFRP4;PLSCR1;PTPRC;VSIR;OLFM1;RIMS1;TGFB2;PARP9;CLU;TTN;MUSK;SFTPD;F3;ACTA2;TRIM5;CITED2;MEF2C;PLAG1;TP73;ID2;VSTM2A;EOLA1;SOX9;FGF22;ZNF486;WTIP;BHLHE40;TERF2IP;TRIM22;IGSF1;E2F1;GJA1;GTF2IRD1;BMP6;ELAVL2;WWTR1;CASZ1;SLC8A1;LIN54;SPIN2A;SOX21;MYT1;CEBPB;SH3GL2;ZNF217;RIMS2
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),0.3782221058143996,0.7306168557422509,0.9428571428571428,1.0,1.0,4/24,17.30%,UBC;UBB;ERCC2;GTF2H5
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.4292794063598704,-0.7303555996835581,0.8571428571428571,1.0,1.0,3/12,16.55%,BMX;ITK;EGFR
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.3288250333427112,0.7300434465568931,0.8846153846153846,1.0,1.0,8/38,15.56%,BRPF1;TAF5;TAF12;TRIM16;KAT2A;JADE3;MAP3K7;TADA3
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.371210867377661,-0.7297745289697766,0.8392857142857143,1.0,1.0,2/19,7.20%,PTPRC;TESPA1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.29925633788934625,-0.729517940683258,1.0,1.0,1.0,20/154,19.68%,F8;CD59;ANK1;GOLGB1;DYNC1LI1;STEEP1;SAR1A;SPTB;GRIA1;TGFA;MCFD2;RAB1B;ACTR10;PROS1;KDELR3;CNIH2;GAS6;TMED10;BCAP31;MPPE1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.4383298722444865,-0.7291632426748137,0.7627118644067796,1.0,1.0,5/10,28.85%,BRCA1;MACROH2A1;MACROH2A2;METTL3;LRIF1
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.39131534871164725,0.7289851009211624,0.7352941176470589,1.0,1.0,1/12,4.33%,SCRIB
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.413872904909231,0.7283717234682985,0.75,1.0,1.0,4/7,14.41%,H6PD;WNT4;BMP5;DGKQ
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.354554410512161,0.7283268183513077,0.7906976744186046,1.0,1.0,2/22,7.97%,ENPP1;NCK1
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),0.44332986465361734,0.7281625431147094,0.8,1.0,1.0,3/7,9.57%,BPIFB1;IFNLR1;H2BC21
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),-0.4410423915643888,-0.7277961282458875,0.7719298245614035,1.0,1.0,4/8,31.85%,STEAP4;SLC1A2;DISP1;MLKL
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),-0.4410423915643888,-0.7277961282458875,0.7719298245614035,1.0,1.0,4/8,31.85%,STEAP4;SLC1A2;DISP1;MLKL
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.4499370376127599,-0.7277370990515071,0.8235294117647058,1.0,1.0,1/8,6.03%,RAB11A
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),-0.3846796031760466,-0.7276565358079606,0.74,1.0,1.0,2/19,15.70%,NOS1;BRCA1
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.3547406104429489,-0.7276064104199909,0.9206349206349206,1.0,1.0,4/41,10.64%,PARP9;GRM5;EIF2B4;CYFIP1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.38884401371316535,-0.7275705260632307,0.8095238095238095,1.0,1.0,7/29,16.55%,NOSTRIN;DDAH1;HTR2B;CAV1;CAV3;SCARB1;EGFR
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.407349742989604,-0.7269949606562833,0.8524590163934426,1.0,1.0,2/15,10.64%,RNFT1;XBP1
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),-0.45198582142569066,-0.7269852816846952,0.8387096774193549,1.0,1.0,1/8,2.96%,TWF2
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.44616306549575774,0.7267713905154553,0.7567567567567568,1.0,1.0,3/8,27.76%,ERN1;MAP2K2;DYRK1A
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.4715181956591489,-0.7267081861269242,0.847457627118644,1.0,1.0,3/7,23.07%,SOX9;VEGFA;AGT
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.4715181956591489,-0.7267081861269242,0.847457627118644,1.0,1.0,3/7,23.07%,SOX9;VEGFA;AGT
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3836496047936689,0.726401127117747,0.8421052631578947,1.0,1.0,3/16,11.16%,SMIM20;COX19;FASTKD3
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),0.4500411204326756,0.7262991730137602,0.7941176470588235,1.0,1.0,2/6,14.06%,PIH1D1;DNMT1
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.3472846493941007,-0.7261841898112728,0.9230769230769231,1.0,1.0,1/39,1.56%,NOB1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.35284149795991293,0.7260414059135328,0.7906976744186046,1.0,1.0,2/23,7.97%,ENPP1;NCK1
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.4665482013558795,0.7259098748791991,0.875,1.0,1.0,2/7,14.06%,PTPN22;DDX3X
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.35808776262540454,0.7257488501417173,0.8823529411764706,1.0,1.0,2/21,4.49%,ANXA2;TBC1D12
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.3232920891056965,-0.7255028456629942,0.8985507246376812,1.0,1.0,3/54,10.19%,LGALS8;VIM;DYNC1LI1
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",-0.2536912536304909,-0.7254466233833536,1.0,1.0,1.0,211/1673,18.47%,ZNF215;FOSL2;ZNF100;HEY1;MDFIC;GRHL1;ZNF366;ZIM2;NR4A3;HOPX;PPARG;ZSCAN1;CENPF;ZIC4;MAEL;BASP1;ELK3;PARP9;ZNF550;MIDEAS;CEBPD;KLF9;ZNF549;STAT5A;ZIK1;GLIS2;ACTA2;IRF1;CITED2;DTX3L;MEF2C;IRF4;NOS1;FOS;PLAG1;ZNF343;ZNF154;TP73;ID2;ZNF239;ZNF789;ZNF814;SOX9;LOXL3;CCNQ;KDM3A;DUXB;PRICKLE1;ZNF486;DKK3;ZNF235;ZSCAN31;PURG;ALX3;BCL11B;ZEB1;MAP3K5;ZFHX2;HLA-DRB1;ZNF394;WTIP;DNAJC2;CRLF3;BHLHE40;TERF2IP;TRIM22;IGSF1;CPHXL;TSFM;ZNF608;SP110;ZBTB22;ZNF540;RFX5;ZBTB32;ZNF584;FLI1;E2F1;ZSCAN22;GATA1;TCIM;GTF2IRD1;ELAVL2;TGFB3;RUNX1T1;WWTR1;ZNF433;ZKSCAN7;CASZ1;ETV1;ZNF442;LIN54;ZNF764;SPIN2A;TOX;SOX21;MYT1;CEBPB;PLCB1;NDP;ACTL6B;NAT14;CDK5R1;KLF3;ZNF217;ZFP30;PCGF3;EMX1;MED29;ZNF233;IFNA2;NR2F1;ZNF20;IKZF2;GLI3;MED12L;PRAME;ZNF654;AR;TASP1;TULP3;ZNF850;IFNK;E2F3;PROX2;L3MBTL4;GLIS3;ZNF571;IKZF1;ZNF530;TOX2;ETS2;PRKCQ;YWHAH;ZNF367;ZNF671;EBF1;PBXIP1;ZNF740;ZNF248;ZNF391;PAX6;TGFA;ZNF736;DAPK3;KCNH2;FGF7;SNAI3;ZNF705G;ZNF572;ETV6;TP53INP1;ATP8B1;ZNF600;NFE2L3;VEGFA;MLLT11;BRCA1;TRERF1;ZNF790;STAT1;ID3;TYMS;CREB3L1;ZSCAN29;ZNF580;PRDM1;SREBF1;OVOL2;ZNF714;EGFR;ZNF730;ZFY;ZNF652;TGIF1;POU2F2;NRG1;HIF3A;POU6F1;IFRD1;SKAP1;ESRRA;ZNF597;HIRA;NR3C2;CDKN1A;EZH2;MAP3K12;NR2F2;ZNF490;MAFF;NFYB;ZKSCAN8;ZNF10;ZFP69;BTG1;CDK5;ZNF136;MYT1L;NR1D1;ARID3A;ZNF776;MAF;ZNF763;WNT5A;RNF111;ATXN7L3;ZNF546;STAT3;CLOCK;RHOH
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.2930696154581481,0.7252042828734704,0.967741935483871,1.0,1.0,21/112,20.80%,PSME2;UBC;HSPA1A;CSDC2;PSMD13;EXOSC8;SAMD4A;UBB;PRR5L;DCP1A;PSME4;ANP32A;PNPT1;PSMF1;EXOSC7;DIS3;PSMD11;MAPKAPK2;PSMD4;PRKCA;EXOSC5
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.3823525171573216,0.7247060973591138,0.84,1.0,1.0,3/19,5.52%,CRHBP;ERRFI1;EPHB2
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.3746722196743876,0.7244444514025127,0.8529411764705882,1.0,1.0,2/15,11.39%,INTS14;INTS8
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),0.34277451363360284,0.7244378799466952,0.896551724137931,1.0,1.0,3/25,9.31%,RSL1D1;RPL7L1;URB1
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),-0.4721345110234768,-0.7243243620902983,0.8360655737704918,1.0,1.0,3/7,27.40%,TST;MPST;TXN2
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.3833964472982884,-0.7239806093481227,0.8769230769230769,1.0,1.0,2/18,2.59%,TGFB2;ITGAM
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),-0.4411898074524222,-0.7236835014891161,0.85,1.0,1.0,3/6,38.61%,CNTNAP1;PARD3;LGI4
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),-0.4411898074524222,-0.7236835014891161,0.85,1.0,1.0,3/6,38.61%,CNTNAP1;PARD3;LGI4
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.40459930261706917,0.7233655410780414,0.7058823529411765,1.0,1.0,3/15,20.52%,TENT4A;TENT4B;BTG2
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.4593920616048043,0.7232431590904495,0.8571428571428571,1.0,1.0,2/7,18.30%,GLI2;MEN1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.3963906043337561,0.7229768872139422,0.8461538461538461,1.0,1.0,3/11,18.75%,NASP;RBBP4;ASF1B
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),-0.4145241662902698,-0.722735304439034,0.8703703703703703,1.0,1.0,3/9,31.68%,REP15;EHD3;NSG1
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.4577035466320619,0.7222904174892116,0.8611111111111112,1.0,1.0,3/5,23.30%,PIH1D1;SIRT1;TAF7
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.4313205883906356,-0.7222362112818871,0.8709677419354839,1.0,1.0,3/10,25.15%,MAPK8IP1;ZNF675;HIPK3
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3269226074956417,0.721822917551859,0.8666666666666667,1.0,1.0,11/29,22.56%,TESK1;CRK;FLNA;ABL1;MYADM;CASS4;CDC42;ARHGEF7;RAC1;FERMT2;CIB1
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.32542791552452616,0.7216482773161986,0.8620689655172413,1.0,1.0,13/51,17.85%,ACADS;ACAA2;CROT;ACADVL;ECHS1;PEX2;ADIPOR1;ECI1;ACAT2;ACOX1;HSD17B10;ACAD10;PECR
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.42685083203453333,-0.7215478655362427,0.88,1.0,1.0,4/15,26.14%,TGFB1;GAS6;ZFP36L1;TYRO3
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.4118112487273,-0.7214928481516706,0.8405797101449275,1.0,1.0,3/10,13.33%,SLC8A1;CAV1;CALM3
prerank,GO_Biological_Process_2021__monoacylglycerol biosynthetic process (GO:0006640),-0.49337308897658627,-0.7210408042519361,0.8548387096774194,1.0,1.0,2/5,13.54%,DGAT1;DGAT2L6
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.4542151009442542,0.7209532338236673,0.7647058823529411,1.0,1.0,1/9,1.60%,DPEP1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.37081150257895423,-0.7209060576251355,0.8939393939393939,1.0,1.0,4/27,17.37%,CCND1;PLCB1;EGFR;EZH2
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.40510141398724,-0.7208688222456215,0.8225806451612904,1.0,1.0,1/13,17.47%,ZFP36
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),-0.4248063040485199,-0.7207710374790355,0.75,1.0,1.0,3/9,28.95%,XBP1;APOE;POLD1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),0.4696458904962155,0.7203629058120485,0.8108108108108109,1.0,1.0,1/5,7.10%,FLNA
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.31118496886911495,-0.7203120959892219,0.9104477611940298,1.0,1.0,15/80,23.95%,CLU;GPIHBP1;PRICKLE1;NUP62CL;E2F3;ABCD2;SYK;STAT3;SPRN;NUP88;HEATR3;NUP50;GCKR;POM121;ALDH3A2
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.33287892707267736,-0.7203035239640169,0.9027777777777778,1.0,1.0,9/44,20.26%,ISG15;RPA3;RFC3;TRIM25;RFC4;BRCA1;RPA2;DTL;FAAP20
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.38775817729598505,0.7202204366303817,0.7647058823529411,1.0,1.0,3/18,11.54%,RELN;PTPRD;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.31101146692469595,-0.7198384210299655,0.9701492537313433,1.0,1.0,5/96,5.45%,IRGM;CLU;LGALS3;SLF1;RHOC
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.3304146602132092,-0.7195898402161803,0.9583333333333334,1.0,1.0,13/64,16.61%,LRIG3;F3;ACTA2;COL4A1;NTN4;PALLD;WWTR1;MYH11;CAV1;CAV2;CDH3;EGFR;OSMR
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),-0.4493969190238628,-0.7195845272982372,0.7936507936507936,1.0,1.0,2/8,19.67%,IFNA2;PRKCZ
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.31030031002953934,0.7195249450968655,0.9285714285714286,1.0,1.0,8/98,9.81%,TEAD2;CD247;MDN1;KNTC1;DARS1;LLGL1;MATN1;TCAP
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.3437695071651072,-0.719378708520481,0.8405797101449275,1.0,1.0,8/39,24.94%,AQP1;MAP3K5;ZNF580;TRPM2;PRKCD;PPIF;IMPACT;ADAM9
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.33218790428479394,-0.7187010902027446,0.9508196721311475,1.0,1.0,14/53,19.59%,PTPRC;BLNK;TOX;IFNA2;IFNK;IKZF1;JAG2;AXL;NHEJ1;IFNA6;RHOH;TPD52;PTPRJ;CR2
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.285719206314433,-0.7186186854126135,0.9864864864864865,1.0,1.0,25/180,20.99%,MCM2;CENPE;CDCA3;RPA3;SMC4;RFC3;SPC25;CKS2;PRPS1;ORC2;NAA38;TOP2A;CDKN3;BRCA1;RAD50;CDKN1A;EZH2;DIAPH3;DONSON;MCM7;MAD2L1;RPA2;MRE11;CIT;KIF2C
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.3918330969864773,0.7184955678214979,0.8823529411764706,1.0,1.0,2/18,11.26%,CCNT1;VIRMA
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),-0.4242768043786806,-0.7184491766244484,0.7777777777777778,1.0,1.0,1/7,18.40%,CLOCK
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.38899949286040536,-0.7182954694335171,0.8,1.0,1.0,3/16,6.15%,IL12A;LGALS3;ANO6
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.3914842577260995,-0.7182074903811425,0.8615384615384616,1.0,1.0,6/26,18.91%,MEF2C;SOX9;SULF1;BMPR1B;WNT5B;TGFB1
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),-0.44756926436222966,-0.7181631821518232,0.8873239436619719,1.0,1.0,1/8,3.04%,STAT5A
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),-0.44756926436222966,-0.7181631821518232,0.8873239436619719,1.0,1.0,1/8,3.04%,STAT5A
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.3047256913348138,0.7180396248078874,0.90625,1.0,1.0,20/84,21.69%,PSME2;MALT1;MUC4;KLRD1;PSMD13;CHUK;NFKB1;PSME4;BCL10;MAP3K7;RELA;CLEC4C;PSMF1;BTRC;TAB3;PSMD11;RAF1;PSMD4;PLCG2;PRKACB
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3047256913348138,0.7180396248078874,0.90625,1.0,1.0,20/84,21.69%,PSME2;MALT1;MUC4;KLRD1;PSMD13;CHUK;NFKB1;PSME4;BCL10;MAP3K7;RELA;CLEC4C;PSMF1;BTRC;TAB3;PSMD11;RAF1;PSMD4;PLCG2;PRKACB
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3047256913348138,0.7180396248078874,0.90625,1.0,1.0,20/84,21.69%,PSME2;MALT1;MUC4;KLRD1;PSMD13;CHUK;NFKB1;PSME4;BCL10;MAP3K7;RELA;CLEC4C;PSMF1;BTRC;TAB3;PSMD11;RAF1;PSMD4;PLCG2;PRKACB
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.45352698683851134,-0.7177738103991982,0.864406779661017,1.0,1.0,2/8,18.80%,ZWILCH;PLK2
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.4062190621050832,-0.7176829013089976,0.8450704225352113,1.0,1.0,3/12,14.21%,ADGRV1;GABBR2;EDNRB
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.4232466806247369,-0.7175800460601808,0.8333333333333334,1.0,1.0,1/12,2.74%,CRYM
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.4232466806247369,-0.7175800460601808,0.8333333333333334,1.0,1.0,1/12,2.74%,CRYM
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.3236785349178169,0.7174603108680369,0.8918918918918919,1.0,1.0,8/36,13.01%,TCOF1;KBTBD8;SEMA5A;NRTN;RADIL;NOLC1;CDH2;SEMA4A
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),0.46840773567581234,0.7172791097399267,0.7631578947368421,1.0,1.0,1/5,6.18%,ATF4
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.291275729338098,-0.717014560535528,1.0,1.0,1.0,34/230,20.21%,F8;VIL1;CD59;TNFRSF1A;RIMS1;NCKAP1L;LAMC1;SOX9;ANO6;LRRK2;LIN7A;ADD2;GRIA1;AMER1;DLG4;ADCY8;TGFA;MCFD2;RAB1B;RSPH9;FERMT3;NAPG;DNM1L;NOL3;NDUFAF1;DMTN;CNIH2;SKAP2;TMED10;TAPBP;PPIH;TUBGCP2;CX3CL1;RBBP5
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.3866742993376502,-0.7164693794479714,0.8103448275862069,1.0,1.0,1/18,1.43%,SFRP4
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),-0.311343626698306,-0.7163880232519595,0.9393939393939394,1.0,1.0,6/82,10.61%,GCNT1;GALNT12;MUC16;GALNT8;SLC35C1;GALNT6
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.3905723123948149,-0.7163772303679646,0.8135593220338984,1.0,1.0,8/18,18.94%,TLR2;NINJ1;CAV1;IFI35;RSAD2;SLC15A4;FLOT1;TIRAP
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),0.4611491562155082,0.7163567917452245,0.7931034482758621,1.0,1.0,2/6,9.18%,HMGB1;TMEM98
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.3756576579902828,0.7163133219605227,0.8666666666666667,1.0,1.0,1/16,1.24%,SCN11A
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.3332326811230656,-0.7162827979880909,0.9516129032258065,1.0,1.0,5/43,9.18%,BCL2L2;CIDEB;TP73;DDIT4;E2F1
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.4248771277833724,-0.7160382707081394,0.8082191780821918,1.0,1.0,2/10,12.34%,CEACAM1;PDE3B
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),0.41897122828125255,0.7157871005294565,0.8297872340425532,1.0,1.0,2/11,9.74%,CPSF4;CSTF2
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.42404903149087825,-0.715780337471843,0.8208955223880597,1.0,1.0,2/10,13.33%,SYT1;CALM3
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.31128072288192243,-0.7150677104440674,0.9393939393939394,1.0,1.0,15/74,20.44%,IL26;ANKRD6;TGFB2;SH3RF3;MAP3K5;PLCB1;CD27;VEGFA;MAPK8IP1;SCIMP;GADD45B;TIRAP;RASGRP1;EMC10;SPI1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.378830926162143,0.7149426682520043,0.8421052631578947,1.0,1.0,2/13,14.68%,ATF4;PRKAA2
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.3321069318955629,-0.714590091729239,0.9242424242424242,1.0,1.0,17/54,32.53%,NDUFC1;COX6C;NDUFB9;NDUFB6;NDUFAF1;NDUFA8;NDUFS5;COX4I1;NDUFS3;UQCR10;COA6;NDUFA3;NDUFB7;UQCRH;COX6A1;UQCRC1;NDUFA1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),0.3286872293697614,0.7145496012803574,0.9333333333333333,1.0,1.0,3/32,8.36%,CYB5A;EMC4;UBE2J2
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),-0.3281649556335882,-0.7143405626592721,0.8970588235294118,1.0,1.0,11/54,25.15%,TGFBR2;HIPK4;LRRK2;CDK5R1;PRKD2;MAP3K12;CDK5;CIT;PRKCD;DYRK2;HIPK3
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.35654137946592357,-0.7140099578182117,0.9,1.0,1.0,6/38,11.75%,BAIAP2;NCKAP1L;CARMIL2;BAIAP2L2;FCHSD2;CARMIL1
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.32201702800604987,-0.713847511964075,0.9104477611940298,1.0,1.0,7/63,19.24%,RAB11A;RFTN1;ZDHHC15;AQP11;COX18;EGFR;ZDHHC6
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.2551513175540903,0.7137798869554743,1.0,1.0,1.0,40/357,13.19%,CFAP61;TMEM11;AUP1;TTC29;PTCD2;RAB32;CEP55;STRIP1;PLCE1;CHMP5;VAPB;NUMA1;MSTO1;TFB1M;PLIN5;FMNL2;FAM161B;GBF1;USP6NL;SLC25A33;ATAD3B;ZNF135;OPTN;SPTBN5;KIF25;SYNE3;PNPLA3;WASF3;MICAL1;TMED5;TFB2M;PEX6;CNN2;LMAN1;DST;PEX2;CENPT;CLUH;TRAPPC12;PRDX3
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),0.4214603444614726,0.7136763702540505,0.7647058823529411,1.0,1.0,3/9,20.49%,MYLIP;AP2S1;AP2B1
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),0.4214603444614726,0.7136763702540505,0.7647058823529411,1.0,1.0,3/9,20.49%,MYLIP;AP2S1;AP2B1
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.37754843298022156,0.7132434344187876,0.8421052631578947,1.0,1.0,1/12,4.33%,SCRIB
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.41249047618165763,-0.7129289109951376,0.7962962962962963,1.0,1.0,2/11,27.47%,KDELR3;HSPA5
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.4046481260038166,0.7128835572135329,0.8484848484848485,1.0,1.0,7/18,17.92%,SLC22A2;SLC47A1;SLC6A13;SLC7A5;SLC3A2;SLC7A1;SLC7A2
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.36109458326059884,0.712731016469989,0.8378378378378378,1.0,1.0,3/14,11.75%,DMC1;SMC6;RAD52
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),0.43835388886674387,0.7126139418300312,0.8484848484848485,1.0,1.0,1/6,4.36%,ATP2A3
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.3446611379143215,0.7122141526763616,0.8611111111111112,1.0,1.0,7/25,17.57%,FAM9B;PLD6;TDRD5;GALNTL5;ACRBP;SOX30;RNF8
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.3398493501953943,-0.7119422538782757,0.8636363636363636,1.0,1.0,6/32,17.78%,DUOX1;AQP1;HCN1;KCNE1;STAT1;DMTN
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.3820901160621664,0.7115196225760185,0.7804878048780488,1.0,1.0,1/13,4.94%,RASGRF1
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.30719801734088653,0.7113892468228964,0.9534883720930233,1.0,1.0,7/52,10.16%,CHRNA4;ZAP70;MALT1;EPHB2;HDAC9;CD22;NFAM1
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.48276293139780907,-0.7113458611694862,0.8225806451612904,1.0,1.0,2/5,33.82%,BAG3;MAPT
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.3112364946800571,-0.7110658698645665,0.8955223880597015,1.0,1.0,13/77,19.93%,FBLN1;IGFBP3;LRRK2;TERF2IP;WWTR1;SH3GL2;LYN;CDKN1A;PTPN13;GIT1;NTRK3;TGFB1;PID1
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.4353890493620652,0.7108378977705341,0.7317073170731707,1.0,1.0,1/7,5.52%,EPHB2
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),-0.2820998971259784,-0.7104387923931647,0.9857142857142858,1.0,1.0,21/132,21.59%,PTPRM;PTPRC;HDHD2;PLPPR5;PTPRG;PLPPR3;PP2D1;SGPP2;PLPP6;PTPRR;PTPRT;PTPRZ1;PTPRB;PTPN13;PPP3CA;PTPRJ;PLPPR1;PTPN5;PPP2R3B;TPTE2;PPP1CA
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.3997201409359319,-0.7103988109087271,0.9285714285714286,1.0,1.0,4/21,18.92%,XBP1;ADCY8;KCNB1;GAS6
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),0.46873270662936944,0.7102766007481846,0.7297297297297297,1.0,1.0,1/5,14.06%,DDX3X
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.35179729954732036,0.7101500172806867,0.925,1.0,1.0,1/20,1.88%,AFAP1L2
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.4094230189782015,-0.7101182396765988,0.8787878787878788,1.0,1.0,1/11,7.73%,POLR1E
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.29808405655928577,-0.709894968159755,0.9523809523809523,1.0,1.0,24/98,26.99%,NR4A3;FOS;PSMB8;VAV3;ITK;PRKCQ;LYN;SYK;PPP3CA;LAT2;PSMC3;PIK3CB;PLCG1;NFATC2;PAK1;VAV2;PSME1;PSMA3;PSMB2;NFATC1;TEC;PSMD5;PSMC5;CARD11
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.3883495947280574,-0.7095845114225507,0.8548387096774194,1.0,1.0,1/17,3.90%,CITED2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.3883495947280574,-0.7095845114225507,0.8548387096774194,1.0,1.0,1/17,3.90%,CITED2
prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.26690955812917977,0.7095245924762859,0.9655172413793104,1.0,1.0,53/188,25.37%,U2AF1;RSL1D1;LSM7;HPRT1;EIF3B;DUT;EIF3D;CSTF2;HDGF;ERH;NOLC1;CNBP;YWHAQ;EIF4G2;PRDX3;CCNA2;HNRNPU;EIF4E;TFDP1;IARS1;EXOSC7;NPM1;HNRNPA2B1;RPS3;GLO1;CYC1;ACP1;RAN;AP3S1;SF3A1;G3BP1;EIF2S1;UBA2;FAM120A;EIF2S2;NOP56;HNRNPR;KARS1;HNRNPC;CDK4;CAD;RPS2;CCT2;UBE2L3;RPS6;DEK;STARD7;CCT3;ETF1;MCM6;GOT2;SRM;EPRS1
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.35323562407133763,-0.7093783387916779,0.9014084507042254,1.0,1.0,9/32,33.09%,GLRA2;XBP1;NEURL1;GLRA1;SESN3;FYN;LAMTOR1;RRAGD;RRAGC
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.3697382529485298,0.7087948010954523,0.8717948717948718,1.0,1.0,5/18,15.22%,ATP6V0A4;SLC12A9;SCNN1B;SLC12A4;SLC12A2
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.30405184409469116,-0.7083799903843275,0.9014084507042254,1.0,1.0,6/132,6.37%,AVEN;CENPF;TUBA4A;PSMB8;RAB11A;CCND1
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.3350578904856036,0.7082272397181925,0.8709677419354839,1.0,1.0,6/21,16.08%,WNT9A;GDF5;ADAMTS12;GREM1;TRPS1;CHADL
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.315198158326456,0.7081846433767605,0.8787878787878788,1.0,1.0,2/31,6.71%,PDE6A;PDE6B
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.3244358836202546,0.7078411152812654,0.8888888888888888,1.0,1.0,7/44,15.21%,ATP6V0A4;ATP6V1G2;TF;ATP6V1G1;MELTF;TTYH1;IREB2
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),-0.4609615792469214,-0.7077929409178264,0.9122807017543859,1.0,1.0,3/5,45.33%,FMR1;RPS6KA4;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.38495767373869794,0.7077641090314875,0.8571428571428571,1.0,1.0,2/11,29.60%,BTRC;SKP1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.3578444577165183,-0.7075554132954835,0.8333333333333334,1.0,1.0,2/27,6.03%,CLU;HGF
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.3306092202922252,-0.7072962885479595,0.9193548387096774,1.0,1.0,2/55,4.88%,AVEN;PSMB8
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.3579921656650809,-0.7071678184039649,0.9230769230769231,1.0,1.0,6/32,19.50%,SLF1;TERF2IP;CENPA;TPP1;IFFO1;RPA2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.38919153977319165,-0.7069328373050193,0.8461538461538461,1.0,1.0,1/14,2.69%,IL12A
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.39319406780828303,0.7068429727365292,0.8275862068965517,1.0,1.0,3/7,26.11%,CDC42;PDCD10;ARHGAP21
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),0.39278273287271237,0.7066959363223301,0.7777777777777778,1.0,1.0,1/6,5.75%,ST3GAL1
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.342078185567467,-0.7066796560877185,0.8955223880597015,1.0,1.0,5/34,15.70%,ACADL;CEACAM1;ACMSD;CAV1;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.393378497557067,0.7065009055343626,0.717391304347826,1.0,1.0,1/8,7.78%,OXSR1
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.33777861094306827,0.7064342002487778,0.8571428571428571,1.0,1.0,5/38,9.84%,PPP1R36;ECM1;SH3RF2;PLIN5;PPP1R26
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.3760559838490345,-0.7060391649981888,0.9016393442622951,1.0,1.0,2/19,13.44%,KIF16B;HOOK1
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),-0.49196107993009863,-0.7059063307044537,0.8615384615384616,1.0,1.0,1/5,9.33%,GJA1
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.2973954669135465,0.7057760534744794,0.9523809523809523,1.0,1.0,20/119,18.97%,TUBA1A;KDM8;NES;PCM1;HAUS5;CEP290;OPTN;TUBG1;ENSA;MELK;CCNA2;PLK4;CEP164;USH1C;TUBB4A;ALMS1;FBXL7;DYNLL1;CDC25B;BTRC
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.3770819643314185,-0.7054537756904284,0.855072463768116,1.0,1.0,6/17,37.90%,NOL3;NONO;HIF1A;NME5;PINK1;TRAP1
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.2977449990986738,0.7053607230953844,1.0,1.0,1.0,20/118,18.97%,TUBA1A;KDM8;NES;PCM1;HAUS5;CEP290;OPTN;TUBG1;ENSA;MELK;CCNA2;PLK4;CEP164;USH1C;TUBB4A;ALMS1;FBXL7;DYNLL1;CDC25B;BTRC
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.3124966648176109,0.705319702004126,0.875,1.0,1.0,3/29,4.42%,DCXR;FBP1;GALT
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.3542628059072898,-0.7052621571577482,0.9242424242424242,1.0,1.0,3/26,9.94%,AMN;GOLGA4;VAMP5
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.4092325634455091,-0.7049313276231676,0.819672131147541,1.0,1.0,4/9,28.33%,ABCB4;LRP1;ABCA12;APOE
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.4426745329453074,-0.7048715376897381,0.8813559322033898,1.0,1.0,3/9,31.24%,DDX11;TIMELESS;FMR1
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.36580523456156366,0.7048588392901697,0.8108108108108109,1.0,1.0,6/16,27.33%,ALG12;DPAGT1;ALG3;ALG1;DOLPP1;ALG13
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.31542664563992057,0.7046024505428975,0.9655172413793104,1.0,1.0,7/49,11.05%,B3GNT6;GANC;NEU4;TNIP1;GAL3ST2;ST8SIA5;MAN2A1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.30768089134167526,-0.7044364352839532,0.9393939393939394,1.0,1.0,15/83,17.42%,BCL2L2;CIDEB;TP73;SCN2A;MAP3K5;E2F1;CEBPB;TMEM117;APAF1;MLLT11;BRCA1;ZNF385B;PPP1R15A;CDKN1A;TNFRSF1B
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.34192037573819395,0.7044321234511027,0.8333333333333334,1.0,1.0,7/36,12.92%,SLC38A1;SLC7A11;SLC25A29;SLC38A2;SLC38A7;SLC38A3;SLC7A5
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.32503494008616185,0.7044101135835477,0.868421052631579,1.0,1.0,7/52,13.16%,NUPR1;LEPR;USP36;DAPL1;KIF25;PTPN22;EIF4G2
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.4408828253814828,-0.7043612914909663,0.85,1.0,1.0,5/8,26.48%,CITED2;MESP1;NDRG4;HES1;IFT122
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.3081242832813431,0.7042796911087794,0.9629629629629629,1.0,1.0,6/27,13.50%,PTBP1;PTPA;ITGA1;SYMPK;MAGI2;CAMTA1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.33437046315131685,-0.7041590976226927,0.9365079365079365,1.0,1.0,13/38,26.48%,BRINP2;ZWILCH;BRINP1;TOM1L1;BRINP3;BTG1;PLK2;TGFB1;MAD2L1;BCL6;FZD3;ZFP36L1;NME6
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.34638271499545015,0.7041559788841865,0.8571428571428571,1.0,1.0,1/26,2.67%,OOEP
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.4470753252052819,-0.7041390962045841,0.8805970149253731,1.0,1.0,2/8,24.00%,RREB1;FERMT1
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.34723419028354086,0.7039112862547896,0.8108108108108109,1.0,1.0,2/19,12.01%,AUP1;UGGT1
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.4116538433085122,-0.7035515408673287,0.875,1.0,1.0,3/11,24.13%,HGF;HPN;PAK1
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),-0.43581950060981256,-0.703535503797351,0.8524590163934426,1.0,1.0,4/10,28.21%,CSPG5;VCAN;CSPG4;HEXB
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),0.42418763975450785,0.703503882713031,0.6842105263157895,1.0,1.0,5/5,57.59%,LDLRAP1;FGF1;ABCG1;SCAP;PRKAA1
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),0.3978010012776033,0.7035035280427868,0.8604651162790697,1.0,1.0,2/10,6.73%,AADAT;AFMID
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.34492970070778106,-0.7034988714061543,0.9365079365079365,1.0,1.0,1/33,1.30%,DACT1
prerank,"GO_Biological_Process_2021__negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)",-0.46891509245470475,-0.7034332775901933,0.8028169014084507,1.0,1.0,1/5,1.77%,VSIR
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.40489422239755934,-0.7032186124177666,0.7843137254901961,1.0,1.0,7/14,32.02%,ENTPD1;ENTPD3;NUDT18;ENTPD2;NUDT16;NUDT1;NUDT15
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),-0.3839913532937077,-0.7030104673224769,0.828125,1.0,1.0,5/16,15.59%,CAMK1D;CD200;ADCY8;PRKD2;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),0.38354300173964795,0.7029771211773392,0.7959183673469388,1.0,1.0,1/13,1.24%,TRMT10C
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.4393469085828351,-0.7028928828866948,0.8307692307692308,1.0,1.0,2/7,17.09%,FERMT3;SKAP1
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),0.396283578055522,0.7025850731948455,0.76,1.0,1.0,1/10,1.76%,B3GNT6
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.396283578055522,0.7025850731948455,0.76,1.0,1.0,1/10,1.76%,B3GNT6
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.31045984730548204,-0.7025018335109972,0.927536231884058,1.0,1.0,17/90,16.55%,SPATA24;KIAA2012;MAEL;TEX15;BCL2L14;TSSK3;TSACC;CCDC91;DEPDC4;AQP11;MEIG1;TMEM53;HOOK1;XRCC2;SLC25A31;BRCA1;EGFR
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),-0.448192971517949,-0.7021674434981663,0.8305084745762712,1.0,1.0,2/6,13.03%,TGFBR2;DOCK2
prerank,GO_Biological_Process_2021__translation (GO:0006412),0.2553541297476781,0.7019455221656867,1.0,1.0,1.0,57/192,25.54%,MRPL32;EEF1D;TARS1;RPS15A;FARSB;EEF1A1;DARS1;TNIP1;MRPS7;RPS3A;MRPL3;MRPS2;RWDD1;PTCD3;RPL18A;MARS1;MRPS5;HARS1;RPS23;MRPL52;MRPL24;MRPL47;IARS1;RPSA;HARS2;MRPL13;RPL23A;RPS3;RPL3;VARS1;CARS1;RPL13;RPL11;MRPS16;RPL8;MRPL43;RARS2;RPS8;RPL32;RPL21;RPS16;FARSA;KARS1;NOA1;RPS2;RPS18;RPL7;RPS6;MRPL57;EIF4EBP2;ETF1;RARS1;RPL29;MRPS18C;MRPL28;EPRS1;RPL5
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),-0.45252568645738356,-0.7018935651704384,0.8307692307692308,1.0,1.0,2/8,10.39%,CBS;TST
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.3064134552011125,-0.7017497459281536,0.9178082191780822,1.0,1.0,11/62,20.90%,IHO1;ISG20;RPA3;RFC3;RFC4;RAD50;SETMAR;EDC3;RPA2;MRE11;RBX1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.43243189321223174,-0.7016796009750491,0.8305084745762712,1.0,1.0,1/9,21.48%,DLAT
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.2605863574821435,0.7013030271859108,1.0,1.0,1.0,51/161,25.68%,ERI1;RPS15A;EIF3E;RPS3A;RBM8A;EXOSC8;SAMD4A;DCP1A;HELZ2;RPL18A;TENT4B;PNRC2;DCP1B;CNOT9;RPS23;DHX34;PAN2;RPSA;SMG9;RPL23A;PATL1;DCPS;EXOSC7;RPS3;RPL3;RPL13;DDX5;RPL11;PDE12;EXOSC5;MAGOH;RPL8;SMG5;RPS8;RPL32;RPL21;PPP2R2A;RPS16;CNOT2;DXO;POLR2D;RPS2;RPS18;RPL7;RPS6;ETF1;RPL29;NBDY;RPL5;TUT4;RC3H1
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.37547862050402797,0.7008072752608124,0.8055555555555556,1.0,1.0,4/22,10.14%,TBXA2R;MEOX2;HDAC9;STARD13
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.3380197031851536,-0.700725517167204,0.9166666666666666,1.0,1.0,5/30,17.48%,CENPK;SMC4;DSN1;TOP2A;NCAPG2
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.3782377875931252,-0.7006686808099905,0.8548387096774194,1.0,1.0,10/19,40.04%,ME3;UQCR10;UQCRH;UQCRC1;MTFR1;OXA1L;MDH2;SLC25A14;NDUFS7;MTFR1L
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.3819992164059627,-0.7005211066672251,0.8857142857142857,1.0,1.0,1/23,1.78%,CENPE
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.4463243400318776,-0.7004776761749353,0.8852459016393442,1.0,1.0,3/8,31.24%,DDX11;TIMELESS;FMR1
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.3420984922570858,0.7003235745385175,0.84,1.0,1.0,1/28,2.21%,RNF128
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),-0.42843986689904123,-0.7000192051864889,0.8688524590163934,1.0,1.0,2/8,4.24%,SMIM22;CDS1
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.34049839459379533,0.6998532323271965,0.8529411764705882,1.0,1.0,6/28,15.86%,GRPEL2;TIMM23;GRPEL1;PEX6;PEX2;TOMM40L
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),0.3753719017219341,0.6996760378954261,0.8181818181818182,1.0,1.0,4/16,15.86%,GRPEL2;TIMM23;GRPEL1;TOMM40L
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.3945017832721318,-0.6996379253394422,0.8235294117647058,1.0,1.0,3/12,24.38%,ACOT8;ELOVL2;FADS2
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.3390302301918844,0.6995987551485551,0.9,1.0,1.0,2/18,13.49%,SPHK2;ARV1
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),-0.4305496263804001,-0.6994664269167664,0.7843137254901961,1.0,1.0,1/8,5.94%,ROBO2
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.30816601091201157,0.6992554566304748,0.9130434782608695,1.0,1.0,8/54,9.08%,HMGB1;EYA4;PPP1R10;H2AX;RNF168;TMEM161A;BRCC3;PARP3
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),-0.4621555328345084,-0.6991449127559647,0.8095238095238095,1.0,1.0,2/6,10.85%,TEX15;BTBD18
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.3625531034519611,-0.6991448906570903,0.8529411764705882,1.0,1.0,1/31,1.25%,IRGM
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),-0.3765790471982224,-0.698815050342998,0.9298245614035088,1.0,1.0,2/16,11.57%,KCNC2;GRIN2B
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.28558291652802126,-0.6982771563839755,0.9871794871794872,1.0,1.0,24/166,18.91%,ITGB4;RHBDF2;BAIAP2;TSPYL2;FOS;VWA5A;RAD9A;NINJ1;PROCR;DDIT4;CDK5R1;TCN2;CDH13;DRAM1;TGFA;APAF1;JAG2;PPP1R15A;OSGIN1;SAT1;CDKN1A;BTG1;PLK2;TGFB1
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.43802924563299434,-0.6982699082762739,0.8360655737704918,1.0,1.0,1/8,4.02%,EDN1
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.3408498120375487,0.697834389453215,0.8571428571428571,1.0,1.0,2/25,8.36%,CYB5A;UBE2J2
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.4732164342759554,-0.6976386173117708,0.90625,1.0,1.0,3/5,34.05%,TMEM9;ALDOB;VMA21
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.3944015936261354,0.6976020701397642,0.8205128205128205,1.0,1.0,3/15,14.45%,SLIT2;HNRNPU;PDCD7
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.3669971169490892,-0.6975111378211671,0.8805970149253731,1.0,1.0,3/22,11.60%,RPA3;RFC3;RFC4
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.3261473834503807,-0.6974985027176458,0.96875,1.0,1.0,16/53,32.53%,NDUFC1;COX6C;NDUFB9;NDUFB6;NDUFAF1;NDUFA8;NDUFS5;COX4I1;NDUFS3;UQCR10;NDUFA3;NDUFB7;UQCRH;COX6A1;UQCRC1;NDUFA1
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.3017700368841453,-0.6974804045639654,0.9487179487179487,1.0,1.0,3/76,3.85%,CENPF;ATAD5;TUBA4A
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),-0.42151447472538695,-0.6973369359145811,0.8421052631578947,1.0,1.0,2/9,16.67%,ROBO2;GPC3
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),-0.3978287925468398,-0.6972504842178361,0.8405797101449275,1.0,1.0,5/17,25.05%,ADGRV1;GABBR2;EDNRB;CACNA1C;AKAP5
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.3051443014067804,0.6970602331382143,0.9428571428571428,1.0,1.0,2/72,0.60%,DAO;HDC
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.3601333933753342,-0.6966930530003002,0.8923076923076924,1.0,1.0,5/21,15.53%,TTN;SLC8A1;SCN1B;KCNH2;SCN4B
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.3817509276137453,0.6965611807809445,0.7692307692307693,1.0,1.0,4/12,23.24%,NAA50;NAA11;NAA20;NAA40
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.3593294066528975,0.6965515573938716,0.8,1.0,1.0,4/23,8.48%,EPHB2;IGF1R;MTMR2;CHRNA7
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),-0.4574713929500489,-0.6964335805921318,0.8387096774193549,1.0,1.0,3/6,40.48%,FZD3;BCL2L1;PAK2
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.34403727505418485,0.6960020138351387,0.9090909090909091,1.0,1.0,5/13,23.50%,FAM47E;ZMIZ1;CDCA4;PADI2;ARID1B
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.31618969015731496,0.6957375522277425,0.8095238095238095,1.0,1.0,6/42,11.91%,GDAP1;GRPEL2;RALA;TIMM23;GRPEL1;AIP
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.3474901745226181,0.6951106038182551,0.9696969696969697,1.0,1.0,5/24,19.76%,OSBPL7;CYP7B1;HSD3B7;HSD17B10;AKR1D1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.40849236894561247,0.6949410654047417,0.782608695652174,1.0,1.0,1/7,5.26%,NOC2L
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.41375168828374054,-0.6945746766124042,0.8333333333333334,1.0,1.0,2/8,15.59%,MANF;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.4255535660500164,-0.6944366280852534,0.8356164383561644,1.0,1.0,1/9,15.24%,FBXO7
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.3759422958907928,0.6940949233384884,0.84375,1.0,1.0,6/19,26.00%,TPX2;TUBG1;SLAIN2;AKAP9;NDEL1;RANBP9
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.32046340762489356,-0.6937961182617342,0.9090909090909091,1.0,1.0,16/70,20.39%,KDM4D;RMI1;RPA3;SAMHD1;POLQ;XRCC2;WRN;AP5S1;BRCA1;MEIOB;RECQL4;RAD50;LIG3;RPA2;RAD54B;MRE11
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),-0.4891546374101441,-0.6935353831643731,0.9666666666666667,1.0,1.0,2/5,4.79%,CARTPT;ID2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.3940271232902605,-0.6935218950606605,0.8805970149253731,1.0,1.0,1/15,4.07%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.4363765075164465,0.6934569927924421,0.7857142857142857,1.0,1.0,1/7,1.08%,AGER
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.38563899248989514,0.6934193413000171,0.7741935483870968,1.0,1.0,3/11,26.08%,ATIC;LHPP;PFAS
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.4419239073538008,-0.693412877044701,0.8823529411764706,1.0,1.0,1/8,4.86%,CD53
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),-0.44091255089446446,-0.6933095816962139,0.8135593220338984,1.0,1.0,1/6,4.02%,EDN1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.45402893442253545,-0.6932201599213375,0.8787878787878788,1.0,1.0,1/7,16.31%,RNF213
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),-0.4544684415647702,-0.6930489674651635,0.8275862068965517,1.0,1.0,2/5,33.89%,METRNL;UCP1
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.392181564449945,-0.692983126636654,0.9230769230769231,1.0,1.0,3/15,17.38%,CELF4;RBM3;NCBP1
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.2974672168872532,-0.692978490369203,0.9863013698630136,1.0,1.0,20/100,21.67%,TGFB2;TSPYL2;CRLF3;OSTN;TRIM46;GJA1;TCHP;RERG;WFDC1;MAP2;OSGIN1;CDKN1A;BTG1;TGFB1;GNG4;KIAA0319;PTPRJ;OSGIN2;BCL6;FGF13
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),-0.423242254010909,-0.6927980362602543,0.9107142857142857,1.0,1.0,2/8,6.80%,PLCB3;DDAH1
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),-0.42933806349528547,-0.6927935388143643,0.9,1.0,1.0,1/9,7.76%,LRRK2
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.374179838757727,0.6925764007882679,0.8571428571428571,1.0,1.0,5/14,25.39%,NAA50;POGZ;RB1;NIPBL;BOD1
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.38541823052958435,-0.6925255838390107,0.8636363636363636,1.0,1.0,2/20,7.76%,NR4A3;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.3791799942856658,0.6924898682205624,0.8333333333333334,1.0,1.0,2/7,9.53%,CASQ2;ACTN2
prerank,GO_Biological_Process_2021__type B pancreatic cell development (GO:0003323),0.4857458226718218,0.6923375846223135,0.8,1.0,1.0,4/5,12.84%,CDK6;BMP5;DLL1;CDH2
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.4690674254022227,-0.6922365017933326,0.8793103448275862,1.0,1.0,1/6,9.20%,PLN
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),-0.46658183550440036,-0.6921382545298684,0.9166666666666666,1.0,1.0,1/5,16.62%,GNB3
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.4270219122005168,0.6921273648899062,0.8292682926829268,1.0,1.0,1/9,1.08%,AGER
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.33404985811578664,0.6920524266066481,0.8863636363636364,1.0,1.0,4/23,13.77%,UBC;UBB;UGGT1;AMFR
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.3806053464710111,-0.6920334187054132,0.9384615384615385,1.0,1.0,3/21,11.60%,RPA3;RFC3;RFC4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",0.3312535588700173,0.6918366666297597,0.918918918918919,1.0,1.0,2/24,3.21%,POLD3;UBC
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.3885069703746933,-0.6918355761907161,0.828125,1.0,1.0,2/9,18.75%,BTD;MCCC1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),0.41737464943344665,0.6917106536025968,0.8085106382978723,1.0,1.0,3/5,28.07%,ERLIN2;SOD1;ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),0.41737464943344665,0.6917106536025968,0.8085106382978723,1.0,1.0,3/5,28.07%,ERLIN2;SOD1;ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),0.41737464943344665,0.6917106536025968,0.8085106382978723,1.0,1.0,3/5,28.07%,ERLIN2;SOD1;ERLIN1
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.3383641656350441,-0.6914418034971713,0.9193548387096774,1.0,1.0,11/47,23.51%,SCG2;RAB3A;RAB3C;RIMS2;OLFM2;RAB15;PTPRN;ABCA1;NAGPA;WLS;TVP23A
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.3768650037698858,-0.691332766300797,0.8695652173913043,1.0,1.0,1/21,8.01%,TERF2IP
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.3436016213630322,-0.6910694082501079,0.9,1.0,1.0,1/37,1.14%,CPS1
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),-0.40936540927630327,-0.6910580561551194,0.8225806451612904,1.0,1.0,1/7,9.37%,TCIM
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.3382765711282443,0.6910345450941088,0.8717948717948718,1.0,1.0,5/10,15.61%,TAX1BP3;ACTN2;COMMD1;GOPC;GPM6B
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3754808628031202,-0.6908583558252326,0.8225806451612904,1.0,1.0,9/21,18.83%,NOS1;HPCA;PLN;JPH4;CACNB1;CAV3;CACNB2;FKBP1B;JPH3
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.40751395499894716,-0.6907524273476753,0.8870967741935484,1.0,1.0,1/9,15.72%,IFIT1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-0.46012822795898545,-0.690617579403708,0.8333333333333334,1.0,1.0,4/5,48.76%,DAG1;PHLDB2;CLASP2;PHLDB1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-0.46012822795898545,-0.690617579403708,0.8333333333333334,1.0,1.0,4/5,48.76%,DAG1;PHLDB2;CLASP2;PHLDB1
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.3359876883914311,0.6904297756266854,0.9459459459459459,1.0,1.0,4/29,5.43%,PYCR1;SLC39A8;AADAT;RIMKLA
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.40746081475514917,-0.6901048991324363,0.9137931034482759,1.0,1.0,7/12,38.15%,ZWILCH;MTBP;SPDL1;ZW10;MIS12;CDK1;IK
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.24546345654681503,0.6900674625694684,1.0,1.0,1.0,24/118,18.28%,HDAC10;HMGA2;HDAC1;FAM47E;PHF1;PIH1D1;SMARCD3;SNAI1;ZBTB1;KAT2A;DAXX;SMARCA4;KDM5A;KDM5B;HDAC4;ZBTB7A;KDM5D;RBBP4;BRWD1;HDAC3;HP1BP3;NPM1;TCF7L1;NUDT5
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),-0.4193651600486915,-0.6900372423774689,0.847457627118644,1.0,1.0,1/9,1.81%,SHMT2
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.42182592525532014,0.6900214610623302,0.7272727272727273,1.0,1.0,2/7,13.69%,PYHIN1;TPR
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.33151818700853725,-0.6898286227295631,0.90625,1.0,1.0,8/35,24.72%,CLU;CAV1;ABCG5;SCARB1;MSR1;ABCA1;OSBPL5;OSBPL2
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.3989560334286549,0.6898268585067762,0.9024390243902439,1.0,1.0,7/13,25.07%,EIF4EBP1;EIF3E;TPR;PAIP2B;EIF4EBP2;PAIP2;LARP1
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.4231671381206047,-0.6898092278315369,0.8615384615384616,1.0,1.0,5/11,23.24%,CX3CR1;VEGFA;DISC1;CX3CL1;FZD3
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),0.38529379851242795,0.6895698579991482,0.8125,1.0,1.0,2/12,9.74%,CPSF4;CSTF2
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.4336789012546254,0.6895644416265501,0.7894736842105263,1.0,1.0,1/8,1.08%,AGER
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),0.33753035569814793,0.6893787580015142,0.9473684210526315,1.0,1.0,5/31,9.35%,TRMT10C;TRMT1;METTL2A;NSUN2;TRMT13
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.39069963162985566,0.6891609537232928,0.7948717948717948,1.0,1.0,3/9,9.27%,KCNJ2;ATP12A;ATP1B1
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.4694723255302006,-0.6888907152979981,0.875,1.0,1.0,1/6,23.92%,MOCS3
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.291651165221323,-0.6887211384102206,0.975,1.0,1.0,24/149,20.39%,KDM4D;PARP9;DTX3L;RMI1;RPA3;CYREN;SAMHD1;POLQ;PRPF19;ATP23;XRCC2;WRN;AP5S1;BRCA1;MEIOB;RECQL4;NHEJ1;RAD50;SETMAR;IFFO1;LIG3;RPA2;RAD54B;MRE11
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.26009019788518345,0.6884310358430007,1.0,1.0,1.0,21/126,13.88%,ZAP70;PSME2;LCK;MALT1;NFKBIZ;CD247;PDE4B;NCK1;PSMD13;MOG;CD276;PTPN22;CHUK;BTN2A1;TNFRSF21;ICOSLG;UBE2N;NFKB1;PSME4;BCL10;MAP3K7
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.38049758970735387,-0.6879385920753076,0.8769230769230769,1.0,1.0,2/15,10.26%,DOCK8;LRCH1
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.43516680281245845,-0.6877185600796883,0.9259259259259259,1.0,1.0,5/7,32.42%,MTHFD1;KYNU;HAAO;GLUD1;GOT1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.3116687311159039,-0.687220784599937,0.9393939393939394,1.0,1.0,9/44,19.45%,CIDEB;MAP3K5;NLRP3;GRIN2B;NOD1;DAPK1;TBC1D10A;SYK;BCAP31
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),-0.4431678751869087,-0.6870109815202549,0.7971014492753623,1.0,1.0,2/6,19.12%,CSF1R;PARD6A
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.2965492072497933,-0.6869827120928976,0.987012987012987,1.0,1.0,21/105,17.54%,FSTL1;ADAMTS5;OLFML2B;FAP;COL4A1;COL11A1;BOC;DKK3;GJA1;SULF1;THY1;C1R;GLI3;COL10A1;LRP1;VEGFA;STAT1;CCDC80;LMOD1;GADD45B;ELN
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.41052337056256644,0.6866728629016007,0.9166666666666666,1.0,1.0,2/14,15.49%,CROT;ACOX1
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.38715591194456994,0.6865609204181179,0.8857142857142857,1.0,1.0,5/23,10.76%,EPHB2;NLGN3;RELN;HDAC1;GREM1
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),0.45648328931694543,0.6862492184099881,0.8372093023255814,1.0,1.0,4/6,28.22%,ABCA3;ROCK2;SELENOS;LDLR
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.36683697697470036,-0.6862068668296883,0.9104477611940298,1.0,1.0,3/17,16.91%,MAN1A1;SRP54;SEC61G
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.25872769153142655,-0.6861686158394391,1.0,1.0,1.0,52/431,18.92%,HEY1;MDFIC;PPARG;CENPF;ENC1;MAEL;BASP1;ELK3;MIDEAS;GLIS2;TSPYL2;IRF1;CITED2;ID2;SOX9;LOXL3;PRICKLE1;DKK3;ZEB1;BHLHE40;ZNF540;E2F1;RUNX1T1;PLCB1;CDK5R1;ZNF217;IFNA2;GLI3;PRAME;L3MBTL4;IKZF1;PBXIP1;DAPK1;DAPK3;ATP8B1;BRCA1;TRERF1;ID3;TYMS;CREB3L1;NRG1;EIF4A3;CDKN1A;EZH2;NR2F2;CDK5;NR1D1;WNT5A;CLOCK;PATL2;TGFB1;GAS6
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.3442188523909825,-0.6856230901361333,0.8904109589041096,1.0,1.0,6/32,25.74%,AQP11;OPHN1;PRKCG;CAMLG;GIPC1;SDCBP
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.3228459840083335,-0.6856045895698062,0.9558823529411765,1.0,1.0,4/42,9.06%,ITGB4;MET;ALOX12;DACT2
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),-0.44362999674860115,-0.6854840397901777,0.8888888888888888,1.0,1.0,1/7,4.86%,CD53
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.35755304306020175,-0.6851216666685874,0.9253731343283582,1.0,1.0,6/29,17.00%,PRELP;OGN;TST;OMD;CSPG5;GGT5
prerank,PanglaoDB_Augmented_2021__Sebocytes,0.3108494198598892,0.6849039570215798,0.9090909090909091,1.0,1.0,4/39,5.43%,VDR;LAMB3;FBP1;LLGL2
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.36654425811726365,0.6847040462067243,0.96875,1.0,1.0,2/14,7.49%,DSEL;DSE
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.33433714347400656,-0.6844844465477719,0.9078947368421053,1.0,1.0,9/38,21.37%,DUOX1;AQP1;TMC4;CLCA4;CP;CXCL17;PPL;CBLC;CDH1
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.30153571152904374,0.6843485831466111,0.9642857142857143,1.0,1.0,8/35,16.85%,UBC;UBB;MAPK8;UBE2N;MAP4K2;MAP3K7;MAP2K7;IRAK2
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.3411736452363217,-0.6840173858611561,0.9516129032258065,1.0,1.0,5/25,15.53%,TTN;SLC8A1;SCN1B;KCNH2;SCN4B
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),0.3816759347559186,0.683902062931586,0.9230769230769231,1.0,1.0,3/12,11.32%,VDR;NUMA1;TRIM16
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.3334062000617337,-0.6838354872764636,0.8783783783783784,1.0,1.0,10/37,16.98%,LPL;GPIHBP1;RDH12;GPC5;GPC6;LRP1;RBP1;DHRS3;GPC3;ADH4
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.4511156292583376,-0.6837567876049148,0.896551724137931,1.0,1.0,3/5,14.69%,KCNJ3;KCNH2;KCNE1
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.3103881625972208,-0.6834928552815883,0.9577464788732394,1.0,1.0,9/81,18.90%,FBXL16;PSMB8;FBXL18;FBXL13;FBXL5;CCNF;FBXO17;FBXO31;PSMC3
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.422083098607524,0.6833212811820926,0.8297872340425532,1.0,1.0,1/6,5.26%,NOC2L
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.31954712615385816,-0.6831754465554001,0.8857142857142857,1.0,1.0,2/38,7.38%,GRHL1;HLA-DRB1
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.36026034323145506,-0.6826624941361837,0.8805970149253731,1.0,1.0,5/21,13.40%,MEF2C;INSYN2A;LRRK2;GRIN2B;GRIN2D
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.3462309131228206,-0.6826077835581789,0.8507462686567164,1.0,1.0,6/25,20.26%,XYLT2;CHST9;CSGALNACT1;CHST15;CSPG5;B3GAT2
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.33606849565145075,-0.6823840484648698,0.9104477611940298,1.0,1.0,9/25,24.06%,STAT5A;CACNA1B;EIF2B4;STAT1;STAT3;EIF2B2;CACNA1A;NLRP1;STAT4
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.4347787838977062,0.6821633801010236,0.7419354838709677,1.0,1.0,1/5,7.97%,NCK1
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.3936572592409885,0.6819696351377242,0.8048780487804879,1.0,1.0,2/6,28.91%,SNCA;PRKN
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),-0.4588040035812651,-0.6818064337291817,0.86,1.0,1.0,2/5,20.75%,BRCA1;KAT2B
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.4121512405433148,-0.6813936322794847,0.875,1.0,1.0,3/9,23.66%,ADCY8;ADCY2;ADCY1
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.4121512405433148,-0.6813936322794847,0.875,1.0,1.0,3/9,23.66%,ADCY8;ADCY2;ADCY1
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),0.3638781440736861,0.6813374313005923,0.926829268292683,1.0,1.0,4/10,24.16%,RIOK1;RIOK2;SIRT7;UTP15
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),-0.4146675409751912,-0.681171002727752,0.8771929824561403,1.0,1.0,3/9,18.91%,NRXN1;NEURL1;CAMK2B
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.2799657403069792,0.6810877856160756,1.0,1.0,1.0,35/111,25.09%,BET1;FHDC1;GBF1;USP6NL;OPTN;SPTBN5;TMED5;VAMP4;LMAN1;TRAPPC12;STX6;TRIP11;ZFP69B;SEC22B;PLK5;BLZF1;NSFL1C;CUL7;GOLGA8A;CDC42;GOLGA8H;GOLGA8M;ARHGEF7;COG2;SEC23IP;FAM174B;ARFGEF1;PRMT5;OBSL1;VTI1A;TJAP1;UBXN2B;GCC2;TRAPPC8;PDCD10
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.41857054421266304,-0.681066913024714,0.9622641509433962,1.0,1.0,1/10,0.65%,MMRN2
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.4127032021293182,-0.6809929106025463,0.890625,1.0,1.0,1/9,4.13%,CHST1
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.3399561303412045,-0.6806337896355483,0.9375,1.0,1.0,8/36,11.04%,PTPRC;NCKAP1L;MEF2C;VAV3;IL7;BST1;XBP1;GPR183
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),-0.3930115933744588,-0.6804351169704033,0.847457627118644,1.0,1.0,3/7,28.75%,B4GALT6;MYRF;CNTNAP1
prerank,GO_Biological_Process_2021__innate immune response in mucosa (GO:0002227),-0.44905363828274025,-0.6803283435344749,0.8947368421052632,1.0,1.0,1/5,1.87%,H2BC11
prerank,PanglaoDB_Augmented_2021__Luteal Cells,-0.28520931480310335,-0.6802565346426869,0.9722222222222222,1.0,1.0,9/116,9.85%,SFRP4;PPP1R3C;LRIG3;CITED4;DDAH1;FKBP5;FNDC4;KIAA1217;CPE
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),0.32584459502012014,0.6799716173655554,0.8787878787878788,1.0,1.0,8/29,19.35%,HMGCS1;GLYAT;ACOT6;ACOT12;THEM4;ACBD6;ACSM6;OGDH
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.2437621453907284,0.6797379599473757,1.0,1.0,1.0,8/168,6.93%,BCAM;CA2;RCL1;SLC7A11;MFHAS1;CLIC2;UBAC1;CAT
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.337284533790581,-0.6796827976196201,0.8970588235294118,1.0,1.0,4/30,13.20%,NEDD4L;STX3;CAV3;TMEM35A
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.26852040768692287,-0.679377468507216,0.971830985915493,1.0,1.0,18/167,19.29%,SRGN;CR1;LRRK2;DYNC2H1;DOP1B;GOLGB1;GOLGA8B;GOLGA8O;CAV2;CAV3;HOOK1;DNM1;ATP8B1;SNX10;DNM1L;PI4K2A;TMED10;ATP8B4
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.2816511349924185,0.6792773495225635,0.975,1.0,1.0,12/76,16.70%,PSME2;RUNX1;PUS7;ABL1;NSUN2;PSMD13;HES5;PSME4;ITCH;HNRNPU;JAG1;PSMF1
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),-0.4307725051335116,-0.6791396595471691,0.8484848484848485,1.0,1.0,2/7,20.94%,CRB2;MESP1
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),0.24346036956630443,0.6790932069650796,1.0,1.0,1.0,22/278,10.26%,PTH;ORC1;B3GNT6;POLD3;MLF1;MRPL32;EEF1D;RPS15A;FARSB;EEF1A1;PAX8;DARS1;DUT;TNIP1;MRPS7;GAL3ST2;RPS3A;EPC1;MRPL3;POLR2K;KIN;THAP1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.42567579033353614,0.6780643614064972,0.8125,1.0,1.0,3/9,26.69%,GALNT1;POGLUT1;GALNT2
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.2798840414578041,-0.6779982651691073,0.9666666666666667,1.0,1.0,31/125,26.69%,YBX3;TNFRSF1A;BIRC3;PSMB8;GBP2;GBP3;CHI3L1;ADAMTS7;CD27;BRCA1;STAT1;TNFRSF1B;ZFP36;NR1D1;PSMC3;NFKBIA;CX3CL1;PID1;TNFRSF25;BAG4;PSME1;PSMA3;PSMB2;PLVAP;ZFAND6;ZFP36L1;PSMD5;NPNT;TRAF5;TNFSF4;PSMC5
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.34231402195322436,0.6778932488795524,0.90625,1.0,1.0,4/27,10.48%,CRHBP;RAPGEF1;SLC26A3;HCN2
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.31979766837604523,0.6778892761384074,0.88,1.0,1.0,4/17,16.53%,RNF168;RYBP;RNF2;PCGF1
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),0.3965670183946918,0.6778814618905797,0.8125,1.0,1.0,2/12,10.18%,PARP3;TNKS2
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.3539839759979486,0.6776788264152426,0.8717948717948718,1.0,1.0,2/15,10.71%,NEU4;ADAMTS12
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.4142371672296282,-0.6776639396284716,0.8939393939393939,1.0,1.0,4/9,43.04%,VCL;ACTB;PAK2;JAM3
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),-0.3378184272067315,-0.6775193295054313,0.9393939393939394,1.0,1.0,4/25,24.07%,LRRK2;DNM1L;VPS35;AURKA
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),-0.3068818732838865,-0.6773732770281239,0.9402985074626866,1.0,1.0,12/60,25.15%,TGFBR2;HIPK4;LRRK2;CDK5R1;PRKD2;MAP3K12;CDK5;CIT;PRKCD;GALNTL6;DYRK2;HIPK3
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.44366961317270237,0.6771292235121771,0.75,1.0,1.0,2/5,9.47%,EIF3E;EIF3D
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.2988564116862832,-0.6770381842719897,0.9861111111111112,1.0,1.0,8/83,15.82%,PPARG;ASPN;TGFBR2;IGSF1;CAV1;BMPR1B;BMPER;VWC2L
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.38029631063793634,0.6770227297513406,0.8,1.0,1.0,1/11,4.35%,ABHD2
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.27120149862773446,0.6767426806738809,1.0,1.0,1.0,12/79,16.69%,DHFR;RIDA;EIF4E2;PUS7;CHRNA7;SAMD4A;NCL;DDX3X;CNOT9;GGA3;MRPL13;YBX1
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.35498935134830917,0.6762680459221723,0.8484848484848485,1.0,1.0,4/11,19.97%,H6PD;RPIA;PGLS;TKT
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.35219040131032764,-0.6761490523710624,0.9090909090909091,1.0,1.0,4/21,16.13%,BTBD18;SLC25A31;MEIOB;SYCP3
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.39117769312695666,0.6756087957216452,0.875,1.0,1.0,3/11,15.19%,EHD2;WHAMM;MICALL1
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),-0.443740172138052,-0.6755975028045741,0.84375,1.0,1.0,1/5,6.03%,RAB11A
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.3413648425686845,-0.675438315637709,0.9491525423728814,1.0,1.0,3/20,18.26%,DTX3L;UHRF1;ATXN7L3
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.44814771623822663,0.6754000997406876,0.8717948717948718,1.0,1.0,5/7,25.04%,H6PD;DGKQ;EGR1;PPTC7;AKR1C3
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.4609131641520938,-0.6753897317489135,0.8823529411764706,1.0,1.0,1/5,18.90%,PSMC3
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.3239630535091963,0.6750443645194887,0.8947368421052632,1.0,1.0,2/20,14.29%,COX10;RSAD1
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.3981308123302182,-0.6748846341592634,0.9193548387096774,1.0,1.0,3/11,12.10%,PLN;SLC8A1;ATP1A1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.3419355388745966,-0.6745885848487551,0.8805970149253731,1.0,1.0,4/26,20.39%,TERF2IP;RAD50;NOP10;MRE11
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.4513718003262071,-0.6745580067574278,0.873015873015873,1.0,1.0,2/6,19.73%,ATP6AP2;TMEM9
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3327478059723707,0.6743020201817498,0.8620689655172413,1.0,1.0,5/27,13.26%,CD274;DICER1;CHRNA7;PTPN22;PTPN6
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.32415036441439615,-0.6736766295369404,0.8823529411764706,1.0,1.0,1/35,3.41%,NCKAP1L
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),0.3812281852045369,0.6735864308912813,0.9032258064516129,1.0,1.0,2/12,7.73%,VCPKMT;PXK
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.3262125669364707,0.6731900119959631,0.9761904761904762,1.0,1.0,3/25,12.96%,GDAP1;PEX6;PEX2
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.2871846197824039,0.6726284881766605,0.9393939393939394,1.0,1.0,7/49,12.70%,RIDA;ENPEP;NPL;USE1;ADO;BCKDK;LTA4H
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.38300277158739837,-0.6721764503402904,0.8533333333333334,1.0,1.0,3/12,18.66%,LRRK2;DNM1L;ATCAY
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.2386437141016631,0.6721397319398027,1.0,1.0,1.0,36/308,14.41%,BCL2A1;CHRNA4;ZDHHC16;RFWD3;MACROD2;UBE2A;ENDOV;MGMT;H2AX;RNF168;SMC6;YY1;BAK1;PHF1;ABL1;PARP3;RBBP6;NABP1;KIN;CASP9;ZBTB1;RAD52;CHCHD6;ADPRS;PIDD1;ASH2L;CBX5;POLH;HERC2;SLF2;PSME4;POLI;CGAS;KMT5B;CDKN2AIP;ALKBH7
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.4070643579638003,-0.6720598727317683,0.9152542372881356,1.0,1.0,4/16,29.76%,WTIP;CIT;WWC3;SHANK2
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),-0.29154254894197024,-0.6719636165735885,0.9850746268656716,1.0,1.0,26/92,23.88%,SLC8A3;TRPC6;TRPM3;ANO6;SLC1A1;CNGB3;SLC24A5;SLC8A1;SLC26A4;PKD1L3;SLC24A1;SLC5A12;AQP11;SLC25A22;SLC24A4;SLC15A4;SLC26A8;SLC17A6;SLC1A6;SLC1A2;SLC12A5;SLC9A7;TMEM63C;GLRA1;PLP2;SLC17A7
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.3614515537903055,0.6717425912430968,0.8529411764705882,1.0,1.0,1/11,3.03%,MALT1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.3862750278652526,0.6717113588092715,0.825,1.0,1.0,2/7,21.84%,BMP5;PHACTR4
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),-0.4239560588695634,-0.6707938010417783,0.8983050847457628,1.0,1.0,1/7,7.76%,LRRK2
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.3217470981714947,-0.6704996289339824,0.9090909090909091,1.0,1.0,7/44,19.50%,RPA3;RFC3;POLQ;RFC4;WRN;LIG3;RPA2
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.3419474274781815,-0.6704785291074072,0.8805970149253731,1.0,1.0,4/25,20.39%,TERF2IP;RAD50;NOP10;MRE11
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.43031629543725325,-0.6702781367895253,0.8666666666666667,1.0,1.0,1/6,21.87%,VPS4B
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),-0.27428260190856024,-0.6701331861345701,1.0,1.0,1.0,31/187,27.33%,ENC1;TRIM9;PSMB8;NEDD4L;SIAH3;HECW1;PRPF19;PRAME;SIAH1;NR1D1;CLOCK;ANKRD9;PSMC3;RBX1;RNF139;RNF5;KCTD2;TRIM13;PSME1;DNAJB12;PSMA3;MTA1;RNF4;PSMB2;PSMD5;UBE2B;WWP1;KCTD5;PSMC5;CDC34;ARMC8
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.2564863872407084,0.6700984048405034,1.0,1.0,1.0,13/76,15.13%,DMAC2;SMIM20;COX19;SLC25A33;LYRM7;NDUFV3;FASTKD3;SDHAF1;UQCRFS1;SAMM50;FOXRED1;NDUFAF7;IMMP2L
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.3259003449837808,0.6700020391094691,0.9142857142857143,1.0,1.0,4/28,15.49%,SLC27A6;HACD1;PEX2;ACOX1
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.28213356377200294,0.6697423094891813,0.9696969696969697,1.0,1.0,7/86,6.43%,AGER;SERPINF2;HMGB1;SH3RF2;MFHAS1;DUSP15;IGF1R
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.3807578653880596,0.6697046152121295,0.9210526315789473,1.0,1.0,2/10,12.21%,HDAC10;SMS
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.3401433560739049,-0.6696710697676572,0.9178082191780822,1.0,1.0,9/29,22.07%,SMIM22;PTGR1;SLC44A3;LGALS2;CLDN4;ATP8B1;CBLC;GPX2;TMEM184A
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.28222596941809197,-0.6693920682651251,0.9672131147540983,1.0,1.0,18/88,22.79%,PEX11A;SLC23A1;BMP6;AR;PEX1;ALDH8A1;RBP1;ABCD2;DIO2;ACSL5;NR3C2;PFKM;ABCA1;GCLM;RXRA;GSTK1;LONP2;RETSAT
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),-0.41132281963209094,-0.6692871603063589,0.9056603773584906,1.0,1.0,2/6,17.82%,B3GALT1;B3GALT2
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),-0.41132281963209094,-0.6692871603063589,0.9056603773584906,1.0,1.0,2/6,17.82%,B3GALT1;B3GALT2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.3141862314924575,0.6691765982377359,0.8421052631578947,1.0,1.0,7/31,17.30%,CAVIN1;POLR2K;ERCC2;POLR2L;UBTF;TAF1C;GTF2H5
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.40708737670573497,-0.6689267120547908,0.8852459016393442,1.0,1.0,3/9,16.23%,SHMT2;TYMS;MTHFD1
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),0.4210758276627621,0.6680209787234755,0.8285714285714286,1.0,1.0,1/5,6.07%,CIAO3
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.35651603610607563,-0.667630960698582,0.8983050847457628,1.0,1.0,11/21,20.50%,SCN2A;SCN9A;SLC8A1;SCN1B;YWHAH;KCNH2;SCN4B;CACNA1G;SCN1A;SCN3A;CACNA1C
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.430070972450069,-0.6669349004696628,0.8793103448275862,1.0,1.0,5/8,37.70%,SLC2A2;TJP2;KCNQ1;SLC2A5;UGCG
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),-0.3767652482961987,-0.6667002259912789,0.8947368421052632,1.0,1.0,3/11,16.32%,NTNG1;MOV10;NTNG2
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.4010564340106239,0.6663341624247809,0.8333333333333334,1.0,1.0,1/6,8.30%,PHF1
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.2899854526273019,0.6662834982768646,0.9545454545454546,1.0,1.0,12/53,14.87%,OOEP;TRIM67;TESK1;RSL1D1;MMD2;STX10;CEP290;MAPK8;DLG1;STX6;TPR;PPM1F
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.3044034426773145,0.666133436620942,0.9393939393939394,1.0,1.0,3/25,10.64%,HSPA1A;DNAJB4;HSPA1B
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.36867264699130714,0.6660484661736104,0.9473684210526315,1.0,1.0,6/17,15.22%,KCNJ2;ATP12A;SLC12A9;ATP1B1;SLC12A4;SLC12A2
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.30864957929487247,-0.665941985271729,1.0,1.0,1.0,2/61,3.19%,TRMO;WDR6
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),0.32040225672688427,0.6658930187648042,0.868421052631579,1.0,1.0,1/18,6.85%,COX10
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.31165845735120257,-0.6657208832017698,0.9714285714285714,1.0,1.0,5/39,21.97%,LRRK2;SREBF1;DNM1L;PID1;VPS35
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),-0.34355601167431166,-0.6656312746289452,0.9565217391304348,1.0,1.0,2/18,12.21%,SLC8A1;CAV1
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.36702217686987704,-0.6654824072848495,0.9393939393939394,1.0,1.0,3/19,12.21%,NOSTRIN;DDAH1;CAV1
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.3238917572667522,-0.665323673992843,0.9344262295081968,1.0,1.0,6/38,21.30%,PLPPR5;PLPPR3;SGPP2;PLPP6;PLPPR1;TPTE2
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.40575609423308556,0.6651853416204124,0.875,1.0,1.0,3/11,9.27%,KCND3;KCNJ2;ATP1B1
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),-0.4464681261686647,-0.6651448028433626,0.8833333333333333,1.0,1.0,1/6,2.58%,MPV17L2
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.28259366658984403,0.6650425555588567,1.0,1.0,1.0,12/74,15.20%,GPC4;WNT9A;UBC;RYK;WNT4;WNT3;UBB;NXN;CCDC88C;DDX3X;CELSR2;SNX3
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.4124769284192922,-0.6643003945769573,0.8275862068965517,1.0,1.0,1/6,10.23%,SLC25A19
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.28738692136698263,0.6640398629872238,1.0,1.0,1.0,12/56,19.10%,UBC;UBB;MAPK8;CHUK;UBE2N;MAP4K2;NFKB1;MAP3K7;MAP2K7;IRAK2;BTRC;TAB3
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.41723159500784046,-0.6638176988769923,0.864406779661017,1.0,1.0,1/5,29.25%,SLC6A9
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.28786835029841346,0.66359251753284,0.9411764705882353,1.0,1.0,15/115,13.40%,SQLE;SC5D;PSME2;HMGCS1;CARM1;NQO1;PMVK;SMARCD3;HMGCR;PSMD13;HNF4A;IDI1;HELZ2;ADIPOR1;PSME4
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.4041152493352511,0.663534317620871,0.8571428571428571,1.0,1.0,2/6,15.34%,CAT;ERCC2
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.33898759485739616,0.6635069827171987,0.96875,1.0,1.0,6/26,13.90%,PINX1;ABL1;CDKN1C;LIMK1;PRDX3;HNRNPU
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.26306063431646437,-0.6635053786626655,1.0,1.0,1.0,38/274,20.74%,TTC8;CC2D2A;ARL13A;TUBA4A;ABCC4;RPGR;RAB11A;LZTFL1;DCX;TEKT3;DYNC2H1;CYS1;TTC39C;RSPH6A;CEP70;SEPTIN6;BBOF1;TXNDC15;DZIP1;DYNC2I2;SPAG16;ABLIM1;RSPH9;SNX10;DISC1;CCDC39;CEP135;RP2;KIF3C;CFAP44;SSX2IP;ATP6V1D;CFAP46;FNBP1L;CEP76;MAK;CEP126;CEP152
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.4202968494179592,0.6631671279598078,0.8461538461538461,1.0,1.0,2/5,22.84%,TRIP11;TBC1D23
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),-0.43823886053897165,-0.6630242053638935,0.875,1.0,1.0,3/5,38.33%,CCBE1;PROX1;BMPR2
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.4064179109396733,-0.6625057928889064,0.9032258064516129,1.0,1.0,3/8,31.45%,DONSON;TIMELESS;ZRANB3
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.3102640010271411,0.662299393373439,0.9393939393939394,1.0,1.0,4/59,8.35%,NUPR1;OSBPL7;KEAP1;ABL1
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.3525961705657583,-0.6622948710655482,0.875,1.0,1.0,5/20,22.96%,TGFBR2;GRIN2B;GRIN3A;TGFB1;GLRA1
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),0.33134348172857625,0.6622714779462409,0.8387096774193549,1.0,1.0,7/24,17.93%,CROT;GLYAT;ACOT6;ACOT12;THEM4;ACBD6;ACSM6
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),0.33134348172857625,0.6622714779462409,0.8387096774193549,1.0,1.0,7/24,17.93%,CROT;GLYAT;ACOT6;ACOT12;THEM4;ACBD6;ACSM6
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.3528244018419782,0.6617107108376657,0.918918918918919,1.0,1.0,3/16,12.79%,STAC3;ATP1B1;P2RY6
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),-0.45630906622509865,-0.6616297263329844,0.8833333333333333,1.0,1.0,1/5,10.37%,MYH11
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.4120406428910869,0.6615277183483818,0.7837837837837838,1.0,1.0,3/6,27.50%,ZBTB7A;LIG4;ERCC6
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.31731987867718003,0.6613417589191692,0.9117647058823529,1.0,1.0,4/30,12.01%,HSPA1A;DNAJB4;HSPA1B;UGGT1
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.26635257453250905,0.6609900757988278,0.9565217391304348,1.0,1.0,26/115,22.94%,M1AP;DICER1;PRPF4;PTBP1;POLR2K;DKC1;HNRNPU;DDX3X;FASTKD1;MPHOSPH10;PNPT1;POLR2L;PPP1R8;HNRNPH1;DHX9;WDR74;EXOSC7;HNRNPA2B1;PAPOLG;RBM5;POLR2E;HNRNPR;HNRNPC;HNRNPM;POLR2D;WTAP
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.3695448068033207,0.6608300196483502,0.8857142857142857,1.0,1.0,2/14,8.35%,FGFR1;ABL1
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.3831913850622344,-0.6607561560208214,0.8253968253968254,1.0,1.0,3/11,25.22%,TGFB1;SHLD2;MAD2L2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.3083009380936275,0.6607123228434114,0.9428571428571428,1.0,1.0,9/54,10.57%,ZAP70;LCK;FGFR1;EPHB2;IGF1R;RELN;ABL1;PRLR;FGFR3
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.3250126487931433,-0.6606863100173934,0.8714285714285714,1.0,1.0,5/33,19.50%,RPA3;RFC3;RFC4;LIG3;RPA2
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),-0.38210387832657244,-0.6606680731943118,0.9054054054054054,1.0,1.0,3/14,15.79%,ATP1A1;AR;TRERF1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.2734470675817968,-0.6592372514600906,1.0,1.0,1.0,13/104,19.12%,SFRP4;PSMB8;PLCB3;PRICKLE1;PLCB1;MOV10;FZD8;GNG2;DAAM1;PPP3CA;WNT5A;PSMC3;PARD6A
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.40622148673764247,-0.6586548564592464,0.8769230769230769,1.0,1.0,1/8,11.91%,PLAAT4
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.315436938888985,0.6586438636336865,0.9629629629629629,1.0,1.0,6/22,20.60%,PTBP1;PTPA;SYMPK;CAMTA1;CALM1;CNEP1R1
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.3166355288669292,0.6584611314954348,0.7777777777777778,1.0,1.0,3/18,15.02%,NCSTN;NFKB1;RELA
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.33476548234977144,0.6584429932328996,0.8823529411764706,1.0,1.0,5/16,13.52%,GLI2;PRLR;WNT4;WNT3;ARHGAP35
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.262056302211999,-0.6584218253080664,0.9871794871794872,1.0,1.0,24/138,23.92%,YBX3;PTPRC;TRIM5;TP73;EOLA1;KIF16B;TRIM22;SLC8A1;RASA1;NELL1;PRDM1;GNB3;NFKBID;FLOT1;TAPBP;RFXANK;ALPK2;TRIM17;CDH1;MARF1;KDM6A;POU5F1;ARF1;INSM1
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),-0.44679151387397403,-0.6583840938700574,0.875,1.0,1.0,2/6,28.79%,APOE;LHFPL4
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.35833178998654436,-0.6582213411983125,0.8852459016393442,1.0,1.0,3/15,22.65%,STAT1;KAT2B;PLXND1
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.35847374315895675,-0.6580074341847619,0.9076923076923077,1.0,1.0,3/16,16.55%,CSF1R;GPR183;SNX10
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),-0.4446575729882763,-0.6575519689137228,0.9152542372881356,1.0,1.0,3/5,39.77%,RABGGTB;RABGGTA;CHM
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.37581840148401163,-0.6573473379546638,0.8852459016393442,1.0,1.0,2/16,6.48%,EPHA4;SIGLEC10
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.42639004904457245,0.6571333846675029,0.9130434782608695,1.0,1.0,2/5,26.56%,PRKCA;PKN1
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.36708889707257036,-0.6571330889532747,0.8448275862068966,1.0,1.0,3/12,18.89%,DDO;GAD1;ACOT8
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.3120020537082423,-0.6571283626489094,0.9411764705882353,1.0,1.0,1/36,2.03%,DND1
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),-0.43644201382414094,-0.6570380082310069,0.9387755102040817,1.0,1.0,2/6,17.42%,NMD3;TNFRSF1B
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.3366078856244015,0.6569863475832985,0.8666666666666667,1.0,1.0,1/16,2.15%,POLD3
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.30934298207005834,0.656783389552889,0.9310344827586207,1.0,1.0,2/22,8.92%,CCNT1;ELL
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.28365792280253305,0.6565070414243911,1.0,1.0,1.0,14/67,18.95%,BRPF1;TAF5;TAF12;EPC1;BEND3;TRIM16;KAT2A;JADE3;MAP3K7;TADA3;NAA50;MRGBP;DMAP1;CHD5
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.3722305105778061,0.6564527306315933,0.9230769230769231,1.0,1.0,1/8,7.49%,MST1
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.36917068383898155,-0.656093183342772,0.9473684210526315,1.0,1.0,7/15,23.23%,SLC8A1;SCN1B;CACNB2;SCN4B;CACNA1G;CACNA1C;SCN3B
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.31244199914001053,0.6560744919869946,0.9444444444444444,1.0,1.0,4/30,11.11%,SEMA5A;NLGN3;CPNE1;NRP2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.2993205154643658,0.6557767162546715,0.9230769230769231,1.0,1.0,6/47,8.35%,ZAP70;LCK;FGFR1;EPHB2;RELN;ABL1
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.3246798252702376,0.6554258848550012,0.9411764705882353,1.0,1.0,2/24,8.96%,PRR5;MLST8
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),-0.4532560677884603,-0.6553310638633051,0.921875,1.0,1.0,1/5,17.75%,CDK5
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.3946987653256164,0.6551728027245134,0.8372093023255814,1.0,1.0,1/7,7.78%,OXSR1
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.3946987653256164,0.6551728027245134,0.8372093023255814,1.0,1.0,1/7,7.78%,OXSR1
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.40251414232800575,0.6546373195850586,0.9459459459459459,1.0,1.0,1/8,8.06%,THBS4
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.40893301747950006,0.6544710555564862,0.84375,1.0,1.0,3/10,9.27%,KCND3;KCNJ2;ATP1B1
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),0.40723233682246185,0.6540822398143856,0.8301886792452831,1.0,1.0,1/5,18.96%,SLC35B3
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),0.40723233682246185,0.6540822398143856,0.8301886792452831,1.0,1.0,1/5,18.96%,SLC35B3
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.3057538584166605,0.6539940623382208,0.9655172413793104,1.0,1.0,2/35,2.98%,KBTBD8;ZNF598
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.3310182304330639,0.6536744438058237,0.8571428571428571,1.0,1.0,10/27,25.48%,VAPB;STAU1;DDX3X;FKBP6;NR5A2;RAD23A;PDE12;HACD3;LARP1;ADARB1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.36822195225092297,-0.6534661007294347,0.9473684210526315,1.0,1.0,2/14,13.88%,TERF2IP;TPP1
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.3297352835988713,-0.6533863992815604,0.90625,1.0,1.0,7/39,19.30%,EDN1;CAV2;TGFA;DAPK3;TOM1L1;BORA;KIF20B
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.2776889722376883,0.6533767137358472,1.0,1.0,1.0,4/52,8.97%,RFWD3;HMGA2;SDE2;BRCC3
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),-0.4417376548393084,-0.6533617901746318,0.9166666666666666,1.0,1.0,2/5,19.45%,LRRK2;BCAP31
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),-0.4585133436409107,-0.6533489249751276,0.9444444444444444,1.0,1.0,2/5,26.08%,SLC6A4;WWC3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.32704323831081195,-0.6532694228488696,0.9538461538461539,1.0,1.0,8/30,14.69%,KCNJ4;KCNJ3;KCNJ6;KCNMA1;GABBR2;GNG2;KCNH2;KCNE1
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.29712033713060054,-0.6531793271331546,0.9852941176470589,1.0,1.0,6/79,7.47%,ERCC6L;CENPF;ATAD5;FANCI;RFC3;ZGRF1
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.44106081949294307,-0.6529416711152332,0.9074074074074074,1.0,1.0,1/6,12.46%,CAV2
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.424172333586551,-0.6529189437681717,0.8305084745762712,1.0,1.0,2/5,22.57%,DDX11;PRKCD
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.3663357791363472,0.6523512692591292,0.8,1.0,1.0,8/13,22.36%,YAE1;ISCA2;CIAO2B;LTO1;NFU1;GLRX3;ISCA1;CIAO1
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.3505389558513876,0.6521912133196042,0.9166666666666666,1.0,1.0,5/17,16.58%,APLP1;KLK14;ADA;GRK2;SNCA
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.4310074403899887,0.6519741772155153,0.8809523809523809,1.0,1.0,2/6,15.39%,ZDHHC12;NLGN2
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.3391895709599322,0.6518991895832201,0.8333333333333334,1.0,1.0,2/10,7.49%,DSEL;DSE
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.3464608659387729,0.651586028783948,0.918918918918919,1.0,1.0,1/12,4.33%,SCRIB
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.2933188971958016,-0.6514319765231817,0.9850746268656716,1.0,1.0,22/66,28.38%,SLC8A3;PRKAR1B;SLC8A1;INCA1;PKIA;CAV3;LYN;NR2F2;PIK3CB;PTPRJ;CBLC;PRKCD;MACROH2A1;RGS2;AGT;PKIG;MYOCD;TFAP4;STK38;PAQR3;APOE;UCHL1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.35423901968797156,-0.6511522959234056,0.9701492537313433,1.0,1.0,2/14,16.36%,TERF2IP;RAD50
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.28976822487945886,0.6501648628488177,0.9722222222222222,1.0,1.0,9/43,12.92%,SLC38A1;SLC25A29;SLC38A2;LLGL2;SLC66A1;SLC16A13;SLC6A13;SLC38A3;SLC7A5
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.34573972979297224,-0.6491570212530365,0.9516129032258065,1.0,1.0,2/18,23.07%,CAV1;AGT
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.30758574055428245,-0.6489003904824993,1.0,1.0,1.0,4/44,11.53%,ARHGAP4;ADGRG1;ARHGDIG;CDH13
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.3366826416317538,-0.648552839119206,0.9104477611940298,1.0,1.0,3/24,18.26%,DTX3L;UHRF1;ATXN7L3
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.39806841429183115,0.648478465876207,0.8260869565217391,1.0,1.0,5/5,60.20%,ADCYAP1;DRD2;CHD7;GHRL;SELENOT
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),-0.39293311894445093,-0.6482520006553698,0.9375,1.0,1.0,2/12,14.41%,TUSC3;NIPAL2
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.3857040039382136,0.6478748599201513,0.9148936170212766,1.0,1.0,3/11,12.60%,RUNX1;GFI1B;IL17D
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.32762878565520853,0.6474651321816638,0.90625,1.0,1.0,3/14,15.49%,NEU4;GLA;ACER3
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.3701498863237752,-0.6472541192376943,0.8970588235294118,1.0,1.0,4/14,15.57%,SLC23A1;SLC1A1;BEST1;ABCB1
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.34335101984544036,-0.6470713646603826,0.9523809523809523,1.0,1.0,5/19,22.67%,FKBP5;FKBP1B;NKTR;PPIH;PPIF
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.33529648751316316,0.6470021350675836,0.9024390243902439,1.0,1.0,6/21,27.66%,SAMD4A;CNOT9;PAN2;CNOT2;TUT4;CNOT6
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.24476337017497624,-0.6469452682460978,1.0,1.0,1.0,44/348,18.98%,IGFBP3;PAK5;TGFB2;TGFBR2;PRKAR1B;GMFG;DGKD;PIM1;GNPTAB;MAP3K21;PEAK3;BMX;TSSK3;MAP3K5;LRRK2;DCLK1;HUNK;DGKB;HTR2B;CAMK1;COQ8B;PAK3;PRKG1;STK17B;LYN;BMPR1B;DAPK1;GLYCTK;TNK2;GRK6;DAPK3;PRKD2;STK17A;PGK1;MYLK3;SYK;MAP3K12;CDK5;STAT3;PLK2;TGFB1;CAMK2B;GAS6;PIK3CB
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",-0.44856820677854525,-0.6469378559572281,0.9,1.0,1.0,2/6,30.48%,ELOVL2;ELOVL4
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",-0.44856820677854525,-0.6469378559572281,0.9,1.0,1.0,2/6,30.48%,ELOVL2;ELOVL4
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",-0.44856820677854525,-0.6469378559572281,0.9,1.0,1.0,2/6,30.48%,ELOVL2;ELOVL4
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",-0.44856820677854525,-0.6469378559572281,0.9,1.0,1.0,2/6,30.48%,ELOVL2;ELOVL4
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.32579710022956265,0.6468657410300495,0.9090909090909091,1.0,1.0,5/23,17.75%,UBC;UBB;CHUK;TRAF3;TICAM1
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.32579710022956265,0.6468657410300495,0.9090909090909091,1.0,1.0,5/23,17.75%,UBC;UBB;CHUK;TRAF3;TICAM1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),0.36581379416855164,0.6467946924883895,0.9047619047619048,1.0,1.0,4/11,17.58%,SPHK2;PIH1D1;ZNF451;RAPGEF3
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.4371693105384365,-0.6462370132672903,0.890625,1.0,1.0,2/5,26.63%,GNG2;TNFSF4
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.403728335438433,-0.6461783488234799,0.9090909090909091,1.0,1.0,2/9,9.70%,APIP;NAIP
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.2851860944288567,-0.6457851839389442,0.9733333333333334,1.0,1.0,3/71,4.34%,PLSCR1;EDN1;DBF4
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.3548404838816116,-0.6456699455236855,0.8611111111111112,1.0,1.0,4/18,20.39%,BRCA1;RAD50;SETMAR;MRE11
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),-0.4255737787745394,-0.6453477877518832,0.8857142857142857,1.0,1.0,1/6,20.44%,SPI1
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.2660999479031818,-0.6452913021786819,1.0,1.0,1.0,23/171,19.34%,PAK5;TGFB2;TSPYL2;CEACAM1;NRG3;CRLF3;LGI1;GJA1;TCHP;RERG;WFDC1;PRKCQ;TRIM32;EGFR;OSGIN1;CDKN1A;NCBP1;BTG1;OGFR;HPN;TGFB1;GNG4;PTPRJ
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.2758596634335427,0.6450498934600535,1.0,1.0,1.0,8/71,10.26%,LCK;SLC39A8;COX19;HMOX2;SLC31A2;TF;ATP6V1G1;CYBRD1
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.3416443287832386,0.6449928908569237,0.8421052631578947,1.0,1.0,4/12,21.11%,PCM1;CEP19;BICD2;NIN
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.34974438999879676,-0.6448834201784944,0.875,1.0,1.0,5/17,27.91%,GOLGB1;SNX10;NEDD1;CSNK1D;BBS4
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.2324681022034252,0.6445518695639937,1.0,1.0,1.0,67/283,22.99%,TRARG1;NUTF2;TBC1D12;RAB32;NUP42;PPP1R10;LTBP2;SGSM1;ERP29;MYO1C;EVI5L;USP6NL;SNX1;GGA2;STX10;RANBP17;RAB19;AKT2;AP3D1;AP4B1;TMED5;VPS25;LMAN1;FAM53A;HERC2;IPO5;STX6;TPR;SRPRA;SGSM2;GGA3;UNC93B1;KIF13B;VPS26B;STXBP3;SNX27;RAB23;SEC31A;RAB24;TRAK1;NXT2;STX7;VPS29;NPM1;ARFIP2;RAN;STX12;AP4E1;ACD;NAPB;RPL11;RAB5B;GGA1;ARCN1;MAIP1;PKD1;SAR1B;ARL17A;KATNB1;TBC1D22A;TBC1D16;RAB7A;TRAK2;VPS26A;SEC23IP;ARFIP1;PTTG1IP
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3399768690222925,-0.6444057163504555,0.9206349206349206,1.0,1.0,6/29,18.67%,ANK1;LIN7A;CRB2;LRRC7;OPHN1;CAMSAP3
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),-0.4146079523584948,-0.644339344352053,0.8571428571428571,1.0,1.0,1/5,5.43%,SOX9
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.30524153706505114,0.6440982541360641,0.9714285714285714,1.0,1.0,2/34,3.21%,POLD3;UBC
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.3832171348856127,0.644044416208772,0.875,1.0,1.0,1/7,3.39%,NDC80
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.3832171348856127,0.644044416208772,0.875,1.0,1.0,1/7,3.39%,NDC80
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.28029111770686016,0.6437664988063764,1.0,1.0,1.0,25/79,26.52%,SAP18;JMJD6;PRDX6;PTBP1;RBM8A;RBM23;NCL;RBFOX1;HNRNPU;ZBTB7A;RBM15B;DDX5;CELF1;RBM5;MAGOH;SRSF9;WTAP;PUF60;TRA2A;NSRP1;SF3B4;LARP7;SF1;MBNL1;DAZAP1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.274753393126188,0.643649038810776,0.975609756097561,1.0,1.0,7/59,13.72%,PSME2;RUNX1;PUS7;ABL1;PSMD13;PSME4;ITCH
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.3251033861396211,0.64362458276763,0.9090909090909091,1.0,1.0,7/29,17.30%,CAVIN1;POLR2K;ERCC2;POLR2L;UBTF;TAF1C;GTF2H5
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.341796159175882,0.6432238325806512,0.9354838709677419,1.0,1.0,7/11,30.49%,ZMIZ1;CDCA4;PADI2;ARID1B;ARID1A;CHEK1;ELOF1
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.3617169259386153,-0.6430636690415324,0.971830985915493,1.0,1.0,4/16,16.82%,TTN;SYNPO2L;FHOD3;MYLK3
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.3271134216074626,-0.6429784867175221,0.9402985074626866,1.0,1.0,2/26,10.19%,VIM;DYNC1LI1
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.35087671471907544,-0.6427272615850258,0.9365079365079365,1.0,1.0,4/15,16.12%,FGFBP3;SULF1;PRKD2;CREB3L1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.3685848782858867,0.6426648521280891,0.8125,1.0,1.0,3/8,17.78%,DPH1;CPEB2;DPH3
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.28032028670263043,0.6426346623474927,0.9705882352941176,1.0,1.0,1/29,1.52%,TCOF1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.31728920186295334,-0.6424286759175978,0.9701492537313433,1.0,1.0,6/47,17.69%,B2M;BMP6;HJV;CP;FBXL5;SLC11A2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.35423915852318205,-0.6423959509360333,0.9375,1.0,1.0,1/19,4.11%,SLC8A3
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.3238467769409141,0.6423401126226167,0.9047619047619048,1.0,1.0,2/15,8.82%,OOEP;DMRT1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.32780880340027696,0.6421873883904237,0.8421052631578947,1.0,1.0,6/19,24.12%,PTBP1;CAMTA1;PLCG2;CIB1;CLEC7A;AKAP6
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),0.3819186239862307,0.6418046119870277,0.9230769230769231,1.0,1.0,2/5,20.64%,DLL1;PRKCA
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),-0.3132036750998369,-0.6417132989991614,0.9821428571428571,1.0,1.0,5/36,12.76%,ANO6;SLC4A10;BEST1;SLC26A4;ANO5
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),-0.39572870831114704,-0.6415472740761966,0.9411764705882353,1.0,1.0,2/7,17.82%,B3GALT1;B3GALT2
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.3240091304684538,0.6414916414314797,0.9714285714285714,1.0,1.0,8/24,21.45%,FLNA;IPO5;TPR;HDAC3;DMAP1;RAN;RBM22;JUP
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.2953307020120877,-0.641339277396084,0.9661016949152542,1.0,1.0,4/63,9.27%,KITLG;TP73;PSMB8;GATA1
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.2918489295488194,0.6412550208331815,0.9459459459459459,1.0,1.0,5/45,9.86%,GPC4;SDC2;GPC2;FUCA1;HS6ST1
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),-0.4211749478660459,-0.6406604072602887,0.9722222222222222,1.0,1.0,2/6,22.24%,SPI1;TNFRSF10B
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",0.30517874980568094,0.6405424316645217,0.9696969696969697,1.0,1.0,2/36,3.21%,POLD3;UBC
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.36537318996806667,0.6404530357692191,0.8478260869565217,1.0,1.0,2/9,11.05%,NOX1;TRPV1
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),0.4302081465501659,0.6403754788880349,0.8461538461538461,1.0,1.0,4/6,12.84%,CDK6;BMP5;DLL1;CDH2
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.39467036425513713,0.6401304891279451,0.9,1.0,1.0,1/6,8.44%,PIH1D1
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.33476701064618763,-0.6394959767610956,0.9324324324324325,1.0,1.0,4/30,21.19%,BCL2L14;CX3CR1;CX3CL1;BCL2L12
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.3319155970938219,0.639188907950351,0.8958333333333334,1.0,1.0,8/20,16.28%,CCR3;GNLY;C5AR1;VEZF1;BECN1;LGALS3BP;RELA;RAB23
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.3548279103737405,-0.639123351590412,0.9705882352941176,1.0,1.0,2/16,17.75%,AR;CDK5
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.40326705648437455,0.6388100809203181,0.8421052631578947,1.0,1.0,2/6,17.43%,PAX8;EGR1
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.25799698976292607,0.63791582616179,1.0,1.0,1.0,6/102,7.62%,DSCAM;RAE1;TESK1;NUP42;NUP210;ITGA6
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.41820084691084575,-0.637873661796037,0.8688524590163934,1.0,1.0,2/5,29.35%,KDM6A;KDM6B
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),-0.415683895195349,-0.6375981070271856,0.8867924528301887,1.0,1.0,1/7,12.46%,CAV2
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.39415155026275783,-0.6372126428335786,0.953125,1.0,1.0,4/9,34.38%,ADH4;CYP46A1;APOE;CYP27A1
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.2769049399868264,-0.6368550824012046,0.9538461538461539,1.0,1.0,12/75,24.53%,CENPE;ARF5;RAB1B;KDELR3;KIF3C;TMED10;TAPBP;KIF5A;KIF2C;RAB6B;KIF3A;ATP9A
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.2857438370039219,0.6365997527558289,1.0,1.0,1.0,24/80,25.03%,GBF1;RAB7B;SNX1;WASHC2A;STX10;LMAN1;STX6;SGSM2;SNX3;VPS26B;VPS54;VPS29;GGA1;TRAPPC10;RAB9A;RAB7A;VPS26A;TBC1D23;PHETA1;RNF126;TMEM87A;VTI1A;GCC2;SPAG9
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.2825148306939534,0.6365286286478616,1.0,1.0,1.0,8/46,18.95%,KANSL2;EPC1;BEND3;TRIM16;JADE3;TADA3;DMAP1;CHD5
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.39298617842838324,-0.6361982759507908,0.8297872340425532,1.0,1.0,1/6,7.27%,DPH6
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.39298617842838324,-0.6361982759507908,0.8297872340425532,1.0,1.0,1/6,7.27%,DPH6
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.3929227086777328,-0.6361978477655686,0.9137931034482759,1.0,1.0,2/8,12.10%,ATP1B2;ATP1A1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),-0.32291591976586576,-0.6361913271460526,0.9375,1.0,1.0,8/27,15.41%,KCNJ4;KCNJ3;KCNJ6;ATP1B2;ATP1A1;KCNH2;KCNJ13;ABCC9
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.37327968770465886,0.6361697035534919,0.875,1.0,1.0,3/5,30.35%,DHX9;KHDRBS1;CPSF6
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.37327968770465886,0.6361697035534919,0.875,1.0,1.0,3/5,30.35%,DHX9;KHDRBS1;CPSF6
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.3220315751014988,0.6361117852511514,1.0,1.0,1.0,8/25,21.45%,FLNA;IPO5;TPR;HDAC3;DMAP1;RAN;RBM22;JUP
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.38958852882004724,0.6358187219204847,0.8292682926829268,1.0,1.0,1/5,7.92%,RELN
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.3950022352777709,-0.6356124183752547,0.9322033898305084,1.0,1.0,4/10,21.77%,PRPS1;PRPSAP1;MTHFD1;PRPS2
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.32727519374261427,-0.6356029468167077,0.9655172413793104,1.0,1.0,12/25,33.98%,SLC4A10;SLC9C2;SLC9C1;SLC9A7;SLC9B1;SLC4A4;SLC4A8;SLC4A9;SLC9A9;SLC9A5;CHP1;SLC9A8
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.27994827387317034,0.6348383887783603,1.0,1.0,1.0,11/61,12.75%,BPIFB1;MUC4;NWD1;CFAP43;ATP12A;HYDIN;DNAH12;ATP1B1;MYH14;FER1L6;CGN
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),0.35554636828792363,0.634277842520794,0.8918918918918919,1.0,1.0,2/14,11.55%,CRHBP;BMP8A
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.36142296959648595,0.6336874691453123,0.9117647058823529,1.0,1.0,3/11,12.38%,SEMA5A;THAP1;DLG1
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.3596074648118128,-0.6335781185761986,0.890625,1.0,1.0,2/10,17.57%,DNAH7;CCDC39
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.3499738257269308,0.6335332562994355,0.8837209302325582,1.0,1.0,11/11,65.02%,SLC37A4;SLC25A10;XPR1;SLC20A2;SLC37A3;SLC20A1;SLC25A11;SLC25A3;SLC25A14;SLC25A30;SLC37A1
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.3499738257269308,0.6335332562994355,0.8837209302325582,1.0,1.0,11/11,65.02%,SLC37A4;SLC25A10;XPR1;SLC20A2;SLC37A3;SLC20A1;SLC25A11;SLC25A3;SLC25A14;SLC25A30;SLC37A1
prerank,PanglaoDB_Augmented_2021__Parietal Cells,-0.2743625338730623,-0.6335236647842929,1.0,1.0,1.0,22/100,21.75%,SPARCL1;PROM1;MAOB;KALRN;SYBU;SORBS2;MYO5C;AQP4;CP;HOOK1;ABLIM2;PTPRT;ABLIM1;MAPK4;SYT13;PATJ;CAMSAP3;PRKCZ;PLPPR1;HLF;PDE9A;ABAT
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.32812873469378767,-0.6335041773157192,0.9558823529411765,1.0,1.0,2/24,12.26%,TGFB2;GLI3
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.40566352213240886,0.6334347059301593,0.8571428571428571,1.0,1.0,3/7,27.50%,LIG4;SIRT1;ERCC6
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),-0.3322482147722283,-0.6319533150294906,0.9117647058823529,1.0,1.0,4/23,22.57%,ID2;CDKN1A;SPI1;PRKCD
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.370189531717808,0.6309663845400378,0.9,1.0,1.0,2/8,18.88%,ARHGEF10L;ERLIN2
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.370189531717808,0.6309663845400378,0.9,1.0,1.0,2/8,18.88%,ARHGEF10L;ERLIN2
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),0.3338412001924533,0.630737564082319,0.8666666666666667,1.0,1.0,2/10,11.47%,ALK;BMP5
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.25335543609956157,-0.6307051555297472,1.0,1.0,1.0,34/160,24.75%,PDE10A;BCL2L2;DGKD;NLRP12;WTIP;DDIT4;NLRP3;CAV1;NMI;PDE3B;ARHGAP25;IFI35;CAV3;LYN;PDE11A;STAT1;NR1D1;TNFAIP8L1;RHOH;PIK3CB;PTPRJ;PRDM15;SPI1;CIT;ARHGAP12;PER1;TLE1;PPIF;ITPR1;ESR1;MGRN1;NDUFS3;DGKG;PHLPP2
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.3897588785275495,-0.6294816075676962,0.8888888888888888,1.0,1.0,2/9,27.91%,SREBF1;LPCAT3
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.3384194460769425,0.6293988432884604,0.9473684210526315,1.0,1.0,5/11,28.56%,CNEP1R1;PRKCA;NEK9;CCNB1;LPIN1
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.3467201845094212,-0.6293097412779705,0.9491525423728814,1.0,1.0,4/16,16.18%,AMN;TCN2;CBLIF;MMACHC
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.3467201845094212,-0.6293097412779705,0.9491525423728814,1.0,1.0,4/16,16.18%,AMN;TCN2;CBLIF;MMACHC
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.37345138057660604,0.6288466663279387,0.925,1.0,1.0,2/7,8.68%,HMGB1;SERPINE1
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.3503436666846613,-0.6285329133760782,0.9344262295081968,1.0,1.0,3/15,18.80%,ZWILCH;SETMAR;PLK2
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.3219387146819529,0.6281170770177352,0.9444444444444444,1.0,1.0,1/17,4.64%,ATP6V0A4
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.27447400268144045,-0.62781758760244,1.0,1.0,1.0,14/121,11.70%,CENPF;COL4A1;TGFBR2;SLC23A1;ADGRG1;ROBO2;ZFHX2;SPEF2;DDIT4;CDK5R1;CX3CR1;EMX1;GRIN2B;ADGRL2
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.42234383373916085,-0.6274101963213832,0.9811320754716981,1.0,1.0,2/6,31.13%,TGFB1;EID2
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.28035817449434713,-0.6272983363166305,0.971830985915493,1.0,1.0,13/60,21.59%,SFTPD;CALY;NEDD4L;CAMK1D;DOCK2;CHRM1;LRP1;CDH3;GPC3;FLOT1;GAS6;MLC1;RXRA
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.2456985138678047,-0.6272979183787424,1.0,1.0,1.0,21/178,20.02%,ISG15;ARIH2;DTX3L;NEDD4L;RNF217;RNF150;RNF144B;UBL7;XBP1;TRIM25;KLHL15;TRIM32;UHRF1;FBXO10;FBXO7;RNF213;SIAH1;RNF111;MAD2L1;CBLC;DTL
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.3458338426019122,0.6271485445464726,0.8888888888888888,1.0,1.0,4/15,14.41%,SPRY2;SPRED1;SPRED2;DGKQ
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.26805243536687595,0.6271347212677306,1.0,1.0,1.0,1/31,1.41%,B4GALNT2
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),0.27478203639393195,0.6270891297002598,0.975,1.0,1.0,5/47,13.40%,PSME2;NQO1;PSMD13;BCKDK;PSME4
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),-0.3481476654458826,-0.6269868940652309,0.9090909090909091,1.0,1.0,3/13,17.98%,SCARB1;SREBF1;PNPLA2
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.3919456826447647,-0.6267703418919783,0.9154929577464789,1.0,1.0,3/7,32.64%,ZCCHC17;FMR1;SLIRP
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.3440164083511691,0.6267561263657795,0.9117647058823529,1.0,1.0,2/16,10.74%,MEIS1;CDK6
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.3570787738246961,-0.6266596894884593,0.9491525423728814,1.0,1.0,5/14,29.29%,SHLD2;MAD2L2;TNFSF4;CD226;C17ORF99
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.3383577408158335,0.6263809913394568,0.8918918918918919,1.0,1.0,4/19,14.17%,USP36;BRCC3;KAT2A;UIMC1
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.2973949459501006,0.62637329324173,0.9705882352941176,1.0,1.0,11/36,25.36%,SNRPC;GEMIN6;SNUPN;STRAP;COIL;GEMIN5;TGS1;SNRPB;SMN1;PRMT5;WDR77
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.3164120041360167,0.6263403203072325,0.9714285714285714,1.0,1.0,5/17,12.38%,LLGL2;STRIP1;FMNL2;LLGL1;DLG1
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.33979650096368286,0.6261422650995329,0.8913043478260869,1.0,1.0,3/12,8.25%,MYO3A;EPHB2;PAX8
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.2760335642176939,0.6259436747894319,1.0,1.0,1.0,3/64,3.40%,PSME2;MALT1;DICER1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),-0.3261565036610132,-0.6257764625017079,0.967741935483871,1.0,1.0,10/21,35.02%,CAMK1;NEURL1;CAMK2B;LRP8;APOE;DBNL;DHX36;FMR1;SHANK1;CUX2
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.2395627491458462,0.6257377002683776,1.0,1.0,1.0,12/123,11.46%,PTPRU;DUSP1;PPM1M;EYA4;PPP4R2;MTMR2;NCK1;DUSP7;PTPRD;PTPRH;PPP2R2C;PTPN22
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.39443031590123573,-0.62568478286264,0.8840579710144928,1.0,1.0,2/7,26.63%,GNG2;TNFSF4
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),-0.4324524578429181,-0.625445155224786,0.9047619047619048,1.0,1.0,1/5,23.35%,VPS13A
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.3065153107603907,0.6253252317868163,1.0,1.0,1.0,3/33,14.31%,ATG9A;CTSK;BECN1
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),0.40551911103830945,0.6251798625939614,0.8947368421052632,1.0,1.0,4/6,25.43%,DKC1;RPUSD2;RPUSD1;TSR3
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.23180090316515145,-0.6249947881563906,1.0,1.0,1.0,24/341,15.70%,ISG15;ARIH2;H2BC11;ENC1;KLHL7;TRIM5;DTX3L;DTX1;HLA-A;NEDD4L;TRIM22;HECW1;NUP43;UVSSA;RNF212B;MAGEF1;TRIM32;UHRF1;FBXL5;ATG10;FBXO10;CCNF;FBXO7;BRCA1
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.2942773510147552,0.624772743532097,0.9375,1.0,1.0,8/40,15.86%,GRPEL2;SEC61A2;TIMM23;AKT2;GRPEL1;PEX6;PEX2;TOMM40L
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.31313470678673033,-0.6235438954899446,0.9692307692307692,1.0,1.0,3/19,16.12%,LRRK2;XBP1;CREB3L1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.31638709923986363,-0.6233534125748158,0.9848484848484849,1.0,1.0,7/22,37.70%,NMI;TYRO3;C1QBP;RNF26;DHX58;ILRUN;SIGIRR
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.3172731878448689,-0.6233207994386564,0.9591836734693877,1.0,1.0,5/30,21.97%,CLU;DNM1L;BBC3;IFIT2;VPS35
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.25578963182635445,0.6231025791802097,1.0,1.0,1.0,30/115,20.47%,B3GNT6;SLC39A8;MOGS;ST3GAL1;EOGT;DAD1;POMK;GFPT2;ST8SIA5;B3GALT4;GALNTL5;GALNT1;B3GNT3;DPM3;GALNT18;TRAK1;GFPT1;B3GALT9;ALG12;RPN2;DPAGT1;ALG3;TMEM165;ALG1;POGLUT1;PMM1;ST8SIA1;PLOD3;ALG5;B4GALT1
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.3302944376468194,-0.6225767143344265,0.96,1.0,1.0,4/18,13.99%,RIN3;LRPAP1;ITGAV;DLG4
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.2854703917176698,0.6221935387841888,1.0,1.0,1.0,10/60,12.90%,ENPP6;PRDX6;PLA2G4C;PIGF;CPNE1;PNPLA3;HDHD5;CPNE7;LCAT;DGKH
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.33270486031263213,-0.6220822571673352,0.9180327868852459,1.0,1.0,3/16,20.39%,TERF2IP;RAD50;MRE11
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.3061227463539644,-0.6220009880405506,0.9130434782608695,1.0,1.0,8/29,34.59%,LIX1;STX17;UVRAG;ATG14;TSG101;LAMP2;TECPR1;MAP1LC3A
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.2751068766877091,-0.6219314604332954,0.9846153846153847,1.0,1.0,11/54,20.94%,SLC23A1;SLC1A1;SLC25A19;SLC6A8;SLC25A22;SLC7A8;SLC25A21;SLC25A41;SLC35A2;SLC1A6;SLC1A2
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.3841031318636793,-0.6213598754052362,0.9322033898305084,1.0,1.0,3/8,29.86%,SCARB1;APOE;APOM
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.3920357513956097,-0.6210005011100597,0.8769230769230769,1.0,1.0,1/6,14.21%,EDNRB
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.26256147604572716,0.6205499477725233,1.0,1.0,1.0,9/57,11.54%,NOC2L;ATF4;TMEM161A;YY1;ACTR5;BAK1;SDE2;CASP9;ZBTB1
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.2621465774399374,0.6204423762337117,1.0,1.0,1.0,9/88,10.75%,TUBA1A;FBF1;PCM1;HAUS5;TCTN3;MKS1;CEP290;TMEM216;TUBG1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.2743324488264749,-0.6204226097790952,1.0,1.0,1.0,6/78,12.21%,ASPN;CITED2;TGFBR2;DKK3;NREP;CAV1
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.3448087284042848,0.6203315303648594,0.9024390243902439,1.0,1.0,3/8,23.29%,NRP2;UNC5C;ASCL1
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.33666813299356146,-0.6198012310739534,0.9253731343283582,1.0,1.0,3/17,23.24%,LRRK2;ATCAY;ZBED3
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.3143505571086372,-0.6197278362196519,0.9850746268656716,1.0,1.0,5/36,17.37%,METTL21A;EEF2KMT;EEF1AKMT2;PRMT8;EZH2
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.25681482515409054,-0.619540703537774,1.0,1.0,1.0,25/175,19.50%,MCM2;CENPE;CENPF;DBF4;SMC4;CCND1;CKS2;E2F1;POLQ;CENPA;E2F3;RAD54L;TOP2A;NOTCH2;CDKN3;WRN;CCNF;EFNA5;HIRA;EZH2;TGFB1;KIF20B;LIG3;MAD2L1;RPA2
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.3105207937393801,0.6187342830589356,0.9230769230769231,1.0,1.0,1/22,1.88%,AFAP1L2
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.36773073356439284,0.6183387428018101,0.9545454545454546,1.0,1.0,4/8,32.53%,CDC42;CCNB1;SIRT2;RACGAP1
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),0.2633080305695925,0.618295393929895,1.0,1.0,1.0,6/46,11.55%,POLD3;CTC1;SMC6;PARP3;DCLRE1B;SP100
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.273826325715751,-0.6180770001805301,0.9861111111111112,1.0,1.0,8/67,20.13%,RPS6KA6;E2F1;GTSE1;RBL2;CDKN1A;ARID3A;PLK2;PLAGL1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.2658331832259433,0.6176279289052449,1.0,1.0,1.0,1/41,2.45%,RIDA
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.2770421314750195,0.6169689669101097,0.9782608695652174,1.0,1.0,8/48,15.86%,GDAP1;GRPEL2;TIMM23;GRPEL1;AIP;SAMM50;IMMP2L;TOMM40L
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),0.38273465658348715,0.6166684769989133,0.8181818181818182,1.0,1.0,1/5,19.20%,RAN
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),-0.3939261691830423,-0.6165428113040228,0.8793103448275862,1.0,1.0,1/5,12.89%,MAP2
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.3787330679897296,-0.6165324923724232,0.9491525423728814,1.0,1.0,1/9,10.64%,XBP1
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.273972559581943,0.6161904111875643,0.9696969696969697,1.0,1.0,3/34,7.51%,HDAC10;HMGB1;DMC1
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),-0.3785358945333506,-0.6161753976902459,0.9310344827586207,1.0,1.0,3/10,18.91%,NRXN1;NEURL1;CAMK2B
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.3366830273499791,-0.6158184457631984,0.9206349206349206,1.0,1.0,4/17,18.94%,NCKAP1L;CAMK1D;DNM1L;TIRAP
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.35131784351039685,0.6157956233806462,0.8627450980392157,1.0,1.0,1/13,2.64%,NT5E
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.30631160795751866,0.6154174625837839,0.9714285714285714,1.0,1.0,7/22,22.22%,IFI27;ANP32B;SP100;TPR;RAPGEF3;RBM22;SIRT7
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.3533273406910355,0.6153171343664555,0.8571428571428571,1.0,1.0,4/9,24.32%,ZSWIM4;ZSWIM8;YTHDF1;ZSWIM5
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),0.343991962352884,0.6147505662291496,0.9,1.0,1.0,3/8,21.11%,NOS1AP;TMEM106A;RAC1
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.27373024175841776,0.6144620028204205,1.0,1.0,1.0,7/56,10.57%,FGF6;FGFR1;SPRED1;PTBP1;SPRED2;POLR2K;FGFR3
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.32482049006715785,0.6144569049986333,0.9090909090909091,1.0,1.0,3/13,17.27%,CHUK;DDX3X;DHX9
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.3679167073999587,-0.6144487877883015,0.9076923076923077,1.0,1.0,4/10,22.23%,SLC25A19;CTPS2;TYMP;DCK
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.37261790760173247,0.6143840777380224,0.8958333333333334,1.0,1.0,2/6,18.35%,PLIN5;DAGLB
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.4042017845318826,-0.6138780180429814,0.9107142857142857,1.0,1.0,3/7,33.23%,GLYCTK;TPI1;ALDOB
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),-0.40283284405350583,-0.6138339580240618,0.9384615384615385,1.0,1.0,2/5,14.38%,MET;CNMD
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.3402869106927832,-0.6138332130451253,0.9672131147540983,1.0,1.0,6/19,18.92%,XKR4;ITGAV;SCARB1;LRP1;RHOH;GAS6
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.3430821512818715,-0.6138054041171099,0.9402985074626866,1.0,1.0,3/18,17.07%,FBXO7;SREBF1;DNM1L
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.38431894952186113,0.6137843098479876,0.9555555555555556,1.0,1.0,5/5,61.58%,ATP8A1;ATP8A2;SCARB2;ATP11B;TMEM30A
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.3506927397041083,0.6133729759642056,0.90625,1.0,1.0,1/9,4.64%,ATP6V0A4
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.27460161871808203,0.6132342110645466,1.0,1.0,1.0,13/96,14.06%,ERAS;PLD1;CNKSR1;RASGRP2;PLCE1;RALA;RRAS2;G3BP2;SHC3;CCDC88C;CCNA2;RRAS;DNMT1
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),0.40185054073643833,0.6130388243148007,0.9736842105263158,1.0,1.0,2/5,28.25%,SIRT7;FBL
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.40889751884494696,0.6127668809333539,0.926829268292683,1.0,1.0,1/6,7.90%,DPY30
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),-0.3577360668716343,-0.61272445526064,0.9516129032258065,1.0,1.0,6/13,40.69%,TMEM33;REEP2;REEP1;RAB18;ATL1;ATL2
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.3078782377322611,-0.612464519224314,0.9253731343283582,1.0,1.0,2/28,5.49%,CITED2;MMP21
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.2842955940636399,-0.6122135760571015,0.9859154929577465,1.0,1.0,11/58,20.39%,CYREN;POLQ;PRPF19;ATP23;BRCA1;NHEJ1;RAD50;SETMAR;IFFO1;LIG3;MRE11
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.40422424510854543,-0.6121836714261392,0.9523809523809523,1.0,1.0,1/5,10.64%,XBP1
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.32287362440711753,0.6119328448754767,0.9090909090909091,1.0,1.0,1/13,8.28%,BAK1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.33963528335599635,0.6117136948944879,0.9375,1.0,1.0,2/18,10.57%,FGFR1;FGFR3
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),0.38769357495432727,0.6116169464830762,0.8571428571428571,1.0,1.0,1/5,15.48%,NPHP4
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.311611442840512,0.611615374476099,0.9512195121951219,1.0,1.0,5/21,15.74%,CDK10;ADAMTS1;DDX3X;HYAL1;TFDP1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.30566001808920845,0.6112357888874412,0.9555555555555556,1.0,1.0,17/17,69.46%,MITF;MED4;PAXIP1;BCLAF1;SRF;MED13;SETX;JUN;HNF1A;MED1;MED12;MED24;MED30;SUB1;MED16;MED14;DHX36
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.36312249732082125,-0.6109993004476915,0.9508196721311475,1.0,1.0,4/12,31.45%,DONSON;LIG3;TIMELESS;ZRANB3
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.373014767548962,-0.6109987078102874,0.9672131147540983,1.0,1.0,2/10,12.70%,CITED2;DNAJB1
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.2997897972176278,0.6106915990017826,1.0,1.0,1.0,11/36,19.58%,EPHB2;NLGN3;ZNF335;PTPRD;IL1RAPL1;SLITRK2;NLGN2;FAIM;GRID2;MME;LIG4
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.3336489529157562,0.6104337722469704,0.8947368421052632,1.0,1.0,3/13,12.56%,ANXA2;YJEFN3;MYADM
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.235594604719173,-0.6104241763503081,1.0,1.0,1.0,34/303,20.01%,PPARG;CENPF;CLU;GPIHBP1;RPGR;LAPTM5;GRTP1;SCG2;AMN;USP6;GOLGA4;RAB3A;STX3;RAB3C;VAMP5;ATP6V1C2;SAR1A;ARF5;OLFM2;YWHAH;LRP1;TBC1D10A;RAB1B;RAB15;SCAMP5;NAPG;RAMP1;RIC1;TMED10;ATP6V1D;REP15;TBC1D8B;TBC1D9;ABCA1
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.34447798518606737,0.610156641103265,0.975609756097561,1.0,1.0,5/10,17.63%,DCP1A;PNRC2;DCP1B;PATL1;DCPS
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.37558088693276426,0.6098683958038004,0.825,1.0,1.0,2/5,21.51%,CNTNAP2;CNTN2
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.2966528680057563,0.6098005511227966,0.9761904761904762,1.0,1.0,5/23,13.15%,ITGAL;SCRIB;FLNA;DLG1;MAGI2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.3328367016766718,-0.6095724155713362,0.9420289855072463,1.0,1.0,1/19,4.11%,SLC8A3
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),-0.39561341450920084,-0.6091254156487597,0.8771929824561403,1.0,1.0,3/6,22.70%,NRG1;MESP1;RBM24
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),0.27363590861555565,0.6087060877502679,1.0,1.0,1.0,9/44,22.97%,TMEM11;SAMM50;CHCHD6;MTX2;ATP5F1C;MAIP1;TIMM9;MTX3;TIMM22
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.3609503068178943,-0.6084786997331862,0.9047619047619048,1.0,1.0,4/10,25.42%,EMC3;EMC10;EMC1;EMC9
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.31271916146657286,0.608266047425414,0.972972972972973,1.0,1.0,2/16,9.10%,LLGL2;LLGL1
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.2534385288307637,-0.6081230674692972,1.0,1.0,1.0,5/105,7.19%,KCND2;SLC8A3;AQP1;PSMB8;SCN2A
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.25702989928347497,-0.608076994692773,1.0,1.0,1.0,13/70,25.52%,RPA3;RFC3;UVSSA;RFC4;PRPF19;LIG3;RPA2;RBX1;XPA;MNAT1;COPS7A;POLR2J;RPA1
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.3215074178035269,0.6079599672353867,1.0,1.0,1.0,1/22,1.56%,WNK4
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.29242867977199677,-0.6079577331447382,1.0,1.0,1.0,10/40,24.49%,PTGR1;ALOX12;GPX4;ACOT8;AWAT1;FAAH2;ELOVL2;SCD;FADS2;EPHX1
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.2722221371526036,0.6077173685597225,1.0,1.0,1.0,9/27,22.77%,CHMP5;NAT10;CEP120;ALMS1;NPM1;C10ORF90;STIL;SIRT1;PKHD1
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.3207307704861869,-0.6075375733613901,0.9047619047619048,1.0,1.0,1/19,5.05%,BCAT2
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.3207307704861869,-0.6075375733613901,0.9047619047619048,1.0,1.0,1/19,5.05%,BCAT2
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),-0.37167613394249094,-0.6072598589688382,0.9193548387096774,1.0,1.0,3/8,25.79%,NFATC2;NFATC1;HEY2
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.2909553130253324,0.6071839619788983,0.9767441860465116,1.0,1.0,2/33,6.18%,FBP1;ATF4
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.35916696303168916,0.607069664338849,0.8947368421052632,1.0,1.0,2/7,11.77%,HMGA2;NUDT16L1
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.4000160360523949,-0.6069801762337586,0.9833333333333333,1.0,1.0,3/6,34.57%,FANCB;RAD21L1;XRCC1
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.350997756780549,-0.6069089982420507,0.9076923076923077,1.0,1.0,1/11,10.85%,BTBD18
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.3669777429538322,-0.6067451481862258,0.967741935483871,1.0,1.0,1/11,7.03%,ASAH2B
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.3669777429538322,-0.6067451481862258,0.967741935483871,1.0,1.0,1/11,7.03%,ASAH2B
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),-0.3635504461022886,-0.6064088263797363,0.9310344827586207,1.0,1.0,2/8,19.54%,DMTN;NEDD9
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),-0.32235488498008724,-0.6063619001145972,0.9538461538461539,1.0,1.0,1/14,15.39%,PLA2G12A
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.35721256660233636,-0.6062058597815927,0.9122807017543859,1.0,1.0,4/14,24.79%,CAMK1;GTSE1;GAS6;BAG3
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.36476025427932635,-0.6058676871937906,0.9354838709677419,1.0,1.0,2/10,13.14%,MACROD1;NT5C1A
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.2850900440365364,0.6054735975905364,0.9696969696969697,1.0,1.0,6/36,14.26%,MTCL1;ZNF207;NUMA1;NAV1;JHY;PSRC1
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.34065462591255047,0.6053796537262358,0.9512195121951219,1.0,1.0,5/16,20.52%,SPHK2;PLPP2;NAAA;GCH1;CALM1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.28524000669555055,0.6051789850102456,1.0,1.0,1.0,4/21,15.25%,MAPRE2;ABL1;PPM1F;MAP4K4
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.2660161920680799,-0.6044216468938567,1.0,1.0,1.0,21/78,25.63%,CLU;CIDEB;CCN5;LRRK2;SNCB;HTR2B;LRPAP1;EPHB1;LRP1;HPR;TNFRSF1B;PACRG;VPS4B;VPS35;TRIM13;IMPACT;SNCG;SPEF1;ACOX2;NPAS2;CTSZ
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.28720560250122074,0.6040562496921885,0.9393939393939394,1.0,1.0,5/30,13.73%,PPP1R1B;PTPA;ITGA1;MAGI2;STYXL1
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.3554368872172109,0.6040210906647996,0.868421052631579,1.0,1.0,2/9,21.56%,KAT2A;SIRT1
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.26678332842256935,0.6034996061935659,1.0,1.0,1.0,8/59,15.74%,RFWD3;CARM1;SDE2;CRADD;E2F4;PIDD1;CNOT9;TFDP1
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.3022874411646308,-0.6026263795859627,1.0,1.0,1.0,2/23,14.27%,EDN1;TGFA
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.35125618576322803,0.6025763573673197,0.925,1.0,1.0,8/8,64.89%,CLN3;PIP4K2B;ARL8B;ATP13A2;PIP4K2A;RUBCNL;VPS39;PLEKHM1
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.42003910692865937,0.6025200021146598,0.9,1.0,1.0,2/5,19.19%,RYK;NR4A2
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),-0.3419926535257444,-0.6020646834896873,0.96875,1.0,1.0,1/15,12.30%,INTS12
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),-0.3516712708022173,-0.6011885262884495,0.9285714285714286,1.0,1.0,4/15,20.63%,TGFBR2;TGFB1;MLC1;GRAMD1C
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.3212908325853256,0.6010960715144177,0.9666666666666667,1.0,1.0,3/12,17.09%,HDAC1;HDAC4;HDAC3
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),0.38144958947264246,0.6008903089633231,0.8461538461538461,1.0,1.0,2/7,13.21%,DYNLT1;STAU1
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.3324952401249826,-0.6003234217840059,0.9833333333333333,1.0,1.0,4/16,22.42%,CD200;LRFN5;WNT5A;IL31RA
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),-0.376123252120276,-0.599887321716185,0.96875,1.0,1.0,2/10,17.11%,RAB1B;TJP3
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),-0.37309624492587046,-0.5993835828531323,0.8793103448275862,1.0,1.0,2/6,14.98%,STAC2;CACNB2
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),-0.4113824708848458,-0.5992667858897182,0.95,1.0,1.0,2/5,10.45%,RYR3;SLC8A1
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),-0.4113824708848458,-0.5992667858897182,0.95,1.0,1.0,2/5,10.45%,RYR3;SLC8A1
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.39843267587253456,-0.5991655213725969,0.9354838709677419,1.0,1.0,2/5,31.61%,TRPV4;MYLK
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.26093019650766613,0.5989241462370527,0.9666666666666667,1.0,1.0,14/38,21.64%,EPC1;UXT;RYBP;RNF2;CBX5;MGA;TFDP1;E2F6;PHC1;RBBP4;BMI1;YAF2;EHMT1;RAD51
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),-0.3765585268208807,-0.5988609085464175,0.8857142857142857,1.0,1.0,2/6,28.40%,METTL3;NUDT16
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.3251879881378774,0.5980961614054668,0.9487179487179487,1.0,1.0,3/17,15.49%,LPIN3;CYP4F11;ACOX1
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),0.3644192796307751,0.5978738354377922,0.9302325581395349,1.0,1.0,7/7,63.57%,MSH3;SSBP1;MSH2;CHTOP;GTF2H2;MSH6;POT1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.2848753125656857,-0.5978044041474028,0.9859154929577465,1.0,1.0,2/43,6.03%,CENPE;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.31689304444339766,-0.5977602256639958,0.9538461538461539,1.0,1.0,8/20,25.61%,TOX;CX3CR1;VEGFA;DISC1;CX3CL1;FZD3;INSM1;FZD9
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.31817349502343306,-0.5975882850418276,0.9824561403508771,1.0,1.0,7/24,23.14%,MAP3K5;CEBPB;TMEM117;PPP1R15A;BBC3;TNFRSF10B;ITPR1
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.3662731886922513,0.5972164387093568,0.8888888888888888,1.0,1.0,2/6,15.39%,NLGN3;NLGN2
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.3003518118858659,0.5969185102505035,0.9555555555555556,1.0,1.0,8/13,29.60%,DPH3;URM1;ELP4;MTO1;ALKBH8;GTPBP3;CTU1;ELP3
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.3412418705712789,-0.5957177478484721,0.918918918918919,1.0,1.0,2/11,16.23%,CBS;MTHFD1
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.338088481170687,0.5952182555902606,0.9047619047619048,1.0,1.0,6/10,33.89%,HNRNPA2B1;PUS10;SMAD1;SMAD2;DGCR8;MRPL44
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.3527158970652523,-0.5948375504460258,0.9545454545454546,1.0,1.0,2/12,15.59%,BMPER;VEGFA
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.35385640196031776,0.5939053502574729,0.9487179487179487,1.0,1.0,7/7,64.63%,PLA2G6;PLA2G10;LIPC;ENPP2;PLA2G15;PLA2G4A;PNPLA8
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.337873495632084,0.5938567678857777,0.925,1.0,1.0,2/11,10.91%,XKR8;XKR7
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.3415350567356704,0.5938334252161614,0.8928571428571429,1.0,1.0,3/8,12.79%,CASQ2;RYR1;P2RY6
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),0.32712462827960986,0.5937714362717875,0.8809523809523809,1.0,1.0,1/8,6.94%,IFI27
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.40275858841284884,-0.5934035718926493,0.9215686274509803,1.0,1.0,1/5,31.61%,NUCKS1
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.308642215926578,-0.5923046685517088,0.9692307692307692,1.0,1.0,2/21,10.08%,KIF16B;MVB12A
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.31896755053501286,0.5920737613002948,0.9444444444444444,1.0,1.0,2/14,11.72%,OR9Q1;C5AR1
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.3610871247583274,0.5909113592814861,0.9142857142857143,1.0,1.0,2/9,12.13%,ACVR1;ACVR1B
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.30118296381986287,0.5904838951986097,0.9117647058823529,1.0,1.0,1/11,5.23%,KMT5A
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.3188382456655545,-0.5903946823082803,0.9836065573770492,1.0,1.0,4/28,14.35%,B2M;HJV;CP;FBXL5
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.3016176702485056,-0.5897981227574469,0.9841269841269841,1.0,1.0,5/34,15.45%,SCG2;RAB3A;RAB3C;OLFM2;RAB15
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.29517823829849427,0.5897263275411547,0.975609756097561,1.0,1.0,3/19,14.22%,PKIB;TNKS2;MAP2K7
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.32677750733201943,0.5896495022651419,0.90625,1.0,1.0,6/15,24.50%,DKC1;NAF1;CCT8;CCT2;CCT6A;CCT3
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.33646638284676467,0.5895187741909825,0.9444444444444444,1.0,1.0,2/10,11.69%,PCM1;CEP19
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.3512060516675389,0.589510746217515,0.8936170212765957,1.0,1.0,5/5,64.89%,C9ORF72;ARL8B;VPS39;VPS41;PLEKHM1
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.3669344075367188,-0.5894043691139065,0.95,1.0,1.0,2/6,25.86%,PRKCQ;IL12RB1
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.3095735671656328,0.5893239856498264,0.9722222222222222,1.0,1.0,1/11,6.43%,IGF1R
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.3259554934367315,-0.5886343793373725,0.8983050847457628,1.0,1.0,3/19,17.78%,DDIT4;CAV1;DMTN
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.34371810907540823,-0.5880099381995741,0.9384615384615385,1.0,1.0,1/10,13.68%,LYN
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.3403626664178962,-0.5878279751657113,0.9464285714285714,1.0,1.0,4/18,19.38%,RFC3;RFC4;MCM7;LIG3
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.24106185278633302,-0.5870359710504824,1.0,1.0,1.0,5/167,4.88%,CENPE;CENPF;TUBA4A;ID2;PSMB8
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.35895535557493746,0.5867375244066645,0.8979591836734694,1.0,1.0,1/5,8.44%,PIH1D1
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.3315777991062695,0.586619286430806,0.972972972972973,1.0,1.0,5/12,24.51%,ARV1;STAR;NPC2;RELCH;NPC1
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.3712037449222235,0.5866143866255442,0.95,1.0,1.0,4/8,22.15%,IL1RAPL1;SNCA;STXBP6;RAB7A
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.3342703365940423,0.5866020760704892,0.8604651162790697,1.0,1.0,3/6,25.48%,PPM1F;NPM1;ADARB1
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.34116833523487217,-0.5865134817276438,0.96875,1.0,1.0,2/14,14.28%,CHGA;KCNB1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.2674192364317498,0.5861136768869131,0.9512195121951219,1.0,1.0,2/32,7.97%,ENPP1;NCK1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.30984479416094957,-0.58557284397786,0.9824561403508771,1.0,1.0,3/20,23.60%,ROMO1;COX18;AGK
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.3484785568005838,-0.5854719811091366,0.9384615384615385,1.0,1.0,2/8,16.61%,NLRP3;OSMR
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.30906889395426274,0.5854122494421152,0.925,1.0,1.0,3/7,13.68%,DCP1A;PNRC2;DCP1B
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.3563224764203314,-0.5852420677343455,0.967741935483871,1.0,1.0,3/7,35.38%,LILRB1;C1QBP;CCR7
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),0.3240539168928736,0.5850579923494698,0.9523809523809523,1.0,1.0,3/9,17.09%,HDAC1;HDAC4;HDAC3
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),-0.38383226411436444,-0.5847874116939438,0.9193548387096774,1.0,1.0,1/5,11.38%,ABCB4
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.26956116187693263,0.5847119879171734,0.9512195121951219,1.0,1.0,7/30,15.61%,MFHAS1;TAX1BP3;ACTN2;COMMD1;LATS2;GOPC;GPM6B
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.27129518443171824,-0.5844842481533418,1.0,1.0,1.0,7/42,22.26%,CELF4;CELF2;PRPF19;NCBP1;NOL3;SRSF5;GCFC2
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),-0.3844212161769841,-0.5838746104326864,0.9230769230769231,1.0,1.0,2/6,26.63%,GNG2;TNFSF4
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.28722534442770775,-0.5835971961350994,0.9552238805970149,1.0,1.0,1/20,8.01%,TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.28722534442770775,-0.5835971961350994,0.9552238805970149,1.0,1.0,1/20,8.01%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.3673154262987922,-0.5831225909841404,0.9482758620689655,1.0,1.0,1/7,11.16%,PCGF3
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.2978449034297203,0.5830756321089645,0.9459459459459459,1.0,1.0,2/13,14.04%,PARP3;KMT5B
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.28958210613417396,-0.5829597482529832,0.9523809523809523,1.0,1.0,10/46,28.41%,RAD9A;E2F1;PRPF19;DONSON;CLOCK;STK33;MAD2L2;CLSPN;TIPRL;NBN
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),0.37245583379677183,0.5829467135363169,1.0,1.0,1.0,2/6,11.47%,SLIT2;BMP5
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),0.36933250868262024,0.5826055658504866,0.9069767441860465,1.0,1.0,5/5,63.08%,PRKN;STX1B;GPER1;DTNBP1;BAIAP3
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),0.3405083931945686,0.5823052341237273,0.9393939393939394,1.0,1.0,2/9,16.99%,ABL1;ABL2
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),0.36752462058137875,0.5819074378286749,0.9019607843137255,1.0,1.0,5/5,63.26%,SLC25A10;SLC25A11;SLC13A3;SLC25A14;SLC25A30
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),0.36752462058137875,0.5819074378286749,0.9019607843137255,1.0,1.0,5/5,63.26%,SLC25A10;SLC25A11;SLC13A3;SLC25A14;SLC25A30
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),-0.3882249476655356,-0.5818959517439751,0.9552238805970149,1.0,1.0,2/6,37.98%,MAD2L2;CREB1
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.30904758686725287,-0.5817721407806049,0.9552238805970149,1.0,1.0,2/16,25.95%,TXNDC15;TUBD1
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.32832952145029604,-0.5817441770520484,0.8947368421052632,1.0,1.0,1/10,8.43%,SULT4A1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.26342704361885055,-0.5815686545620415,0.9864864864864865,1.0,1.0,7/47,21.67%,TSPYL2;KLHDC3;XBP1;TPP1;KDELR3;ADD1;DDX11
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.26316991282720636,0.5812700730391057,0.9230769230769231,1.0,1.0,14/36,21.64%,EPC1;UXT;RYBP;RNF2;CBX5;MGA;TFDP1;E2F6;PHC1;RBBP4;BMI1;YAF2;EHMT1;RAD51
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.38290166504012,-0.5810971605407252,0.9016393442622951,1.0,1.0,1/5,5.43%,SOX9
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.2451752021511724,-0.5809994784948053,1.0,1.0,1.0,22/105,23.27%,NYAP1;SOX9;DDAH1;FNDC4;FAT1;CPE;NR2F1;SMIM10L2B;DZIP1;PHYHIP;EGFR;MAPK8IP1;NGEF;GPR37L1;LARP6;NDRG4;SHROOM2;SCARA3;ANTXR1;TMEM59L;KIAA1549L;FARP1
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.26586698320013985,0.5808044282680711,1.0,1.0,1.0,6/34,18.38%,ATF4;TBL2;BECN1;PRKAA2;PIK3R4;SESN1
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),0.2566952067655274,0.5806964659510249,0.975609756097561,1.0,1.0,3/44,9.50%,PSME2;NQO1;PSMD13
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),-0.37713312417568845,-0.5806218593742621,0.9516129032258065,1.0,1.0,1/6,16.98%,ADH4
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.30578192603706633,-0.5803923300807244,1.0,1.0,1.0,6/22,32.09%,MVB12A;TOM1L1;VPS4B;VPS37A;TSG101;VPS4A
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.31445122690700805,-0.5803724347099652,1.0,1.0,1.0,7/23,23.68%,SLC1A1;SLC25A22;SLC7A8;SLC1A6;SLC1A2;SLC1A4;SLC25A12
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.3144071663081072,-0.5801516011299204,0.9649122807017544,1.0,1.0,4/13,20.75%,BRCA1;PLK2;CEP76;KAT2B
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.38019628009505335,0.5800000169725584,0.9722222222222222,1.0,1.0,2/5,13.11%,YY1;POLH
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.33459612961056784,0.5790958740203948,0.9347826086956522,1.0,1.0,4/15,15.39%,NLGN3;PTPRD;IL1RAPL1;NLGN2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.2518987832977335,0.5783754287630407,1.0,1.0,1.0,17/44,25.02%,LLGL1;GGA2;RAB26;OPTN;COMMD1;VAMP4;MACF1;GOPC;GGA3;BLZF1;STXBP6;GGA1;GOLGA7;CCDC22;SPTBN1;RAB31;GCC2
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.3347692853157751,-0.5781078056846947,0.9242424242424242,1.0,1.0,4/9,35.46%,C1QBP;TSPAN6;RIOK3;DHX58
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.2658246447459572,0.5775659445375037,1.0,1.0,1.0,4/35,8.35%,SERPINF2;TESK1;ARHGEF10L;ABL1
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.2288915215967479,0.5774912795230155,1.0,1.0,1.0,25/155,17.40%,TMEM11;AIFM2;PTCD2;RAB32;GDAP1;MSTO1;TFB1M;PLD6;SLC25A33;ATAD3B;TIMM23;MYH14;AIP;SAMM50;TFB2M;CLUH;PRDX3;POLG2;PNPT1;IMMP2L;MTX2;WDR81;HSD17B10;TRAK1;AGTPBP1
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.32076251984126725,-0.5772578741710735,0.9272727272727272,1.0,1.0,5/17,20.39%,RFC3;RFC4;RAD50;MCM7;MRE11
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.3341104819907694,0.5771887731158515,0.9090909090909091,1.0,1.0,7/7,66.60%,TMEM39A;CLEC16A;PHF23;HDAC6;UBQLN4;IRAK3;RUBCN
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.237894668722273,0.5767141898014765,1.0,1.0,1.0,8/71,14.15%,AUP1;UBXN4;UBE2J2;TMEM129;UBQLN2;AMFR;DERL3;ECPAS
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),-0.349187772310699,-0.5762864130014539,0.9807692307692307,1.0,1.0,2/10,16.35%,SCARB1;SREBF1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.3816539793009235,-0.5760097131765334,0.9032258064516129,1.0,1.0,1/5,12.07%,LRPAP1
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.2817974696878767,-0.5759174825412242,0.984375,1.0,1.0,8/38,21.20%,CLU;EDN1;ITGAV;EDNRB;AZIN1;EGFR;MAD2L1;PRKCG
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.23190525576567064,0.5759109829500502,1.0,1.0,1.0,9/84,14.15%,AUP1;UBXN4;UBE2J2;TMEM129;UGGT1;UBQLN2;AMFR;DERL3;ECPAS
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.2873315244744546,0.5758214103723911,0.9666666666666667,1.0,1.0,1/22,4.11%,MAP10
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),0.36952281269327736,0.5756084549032177,0.9361702127659575,1.0,1.0,5/5,63.06%,FABP5;SLC27A1;MFSD2A;CD36;SLC27A4
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.2822379181797172,0.5748885689961583,1.0,1.0,1.0,8/13,29.60%,DPH3;URM1;ELP4;MTO1;ALKBH8;GTPBP3;CTU1;ELP3
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),-0.36643126319609975,-0.5748725179504387,0.9636363636363636,1.0,1.0,1/7,15.40%,ABCD2
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.33028036434903685,-0.5742774444195794,0.9180327868852459,1.0,1.0,4/11,30.97%,NNMT;MYOCD;PARG;HPF1
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),0.25107151847929066,0.574172248734037,1.0,1.0,1.0,7/40,16.06%,POLD3;CTC1;PARP3;DCLRE1B;SP100;LTO1;ATR
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.38344569046084687,0.5739473911918119,0.9523809523809523,1.0,1.0,1/6,4.29%,FBP1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.28343464283245146,0.5737942092990223,1.0,1.0,1.0,3/36,14.31%,ATG9A;CTSK;BECN1
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.3510930067266157,0.5735721036843908,1.0,1.0,1.0,3/9,20.00%,OPLAH;HAGH;GGCT
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.2212272433337646,-0.5732122498326232,1.0,1.0,1.0,36/316,22.38%,ARIH2;DTX3L;TRIM9;PSMB8;NEDD4L;RNF217;SIAH3;RNF150;RNF144B;MVB12A;UBL7;XBP1;HECW1;TRIM25;KLHL15;PRAME;TRIM32;UHRF1;FBXO10;FBXO7;TOM1L1;RNF213;SIAH1;RNF111;CLOCK;ANKRD9;PSMC3;MAD2L1;CBLC;DTL;RBX1;RNF5;KCTD2;VPS4B;RNF215;TRIM13
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),-0.3634089510462517,-0.5721159980318197,0.9354838709677419,1.0,1.0,2/6,16.61%,PTGER3;OSMR
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,-0.23464896554349715,-0.5719028377747827,1.0,1.0,1.0,19/189,19.54%,CENPE;CENPF;TUBA4A;ARHGAP4;SMC4;SORBS2;PALLD;RASA1;DOCK2;TOP2A;NOTCH2;OPHN1;MYH10;ARHGAP10;SYNPO;KIF3C;KIF20B;TUBGCP2;NEDD9
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.34527837559376634,-0.5718688888258758,0.9014084507042254,1.0,1.0,1/15,3.81%,CARMIL2
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.35143324530038433,0.5716940926552697,0.9166666666666666,1.0,1.0,1/5,21.56%,SIRT1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),0.3346783401358639,0.5706266952181852,0.8958333333333334,1.0,1.0,4/7,27.42%,G3BP2;CCDC22;FAF1;NFKBIB
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.2547573231223645,-0.5703316205511019,1.0,1.0,1.0,6/92,11.70%,LOXL4;METTL21A;LOXL3;EEF1AKMT2;NUP43;RNF212B
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.2789468553624873,0.5697401693053078,0.9736842105263158,1.0,1.0,3/27,12.96%,GDAP1;PEX6;PEX2
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.35864566276682774,0.5694941294750151,0.95,1.0,1.0,1/7,10.61%,AKT2
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,0.23000104868812668,0.5694819852393861,1.0,1.0,1.0,20/104,16.32%,SRPRB;ATF4;EIF4EBP1;TARS1;BANF1;H2AX;NABP1;SDAD1;ATF3;MTHFD2;DKC1;DCP1A;NOLC1;SLC7A5;SRPRA;EIF4E;CKS1B;IARS1;PSAT1;SEC31A
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.2584967165347184,0.5693457638093653,0.9761904761904762,1.0,1.0,8/29,22.56%,NCSTN;ABL1;MAPK8;ABL2;MID1IP1;PHACTR4;SOD1;CIB1
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.3072826688317092,0.5678947597130262,1.0,1.0,1.0,5/13,28.56%,CNEP1R1;PRKCA;NEK9;CCNB1;LPIN1
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.32787665365946517,0.5675829611994994,0.8913043478260869,1.0,1.0,10/10,67.23%,BAD;BAX;VDAC2;BNIP3L;BCL2L11;RHOT2;BNIP3;BLOC1S2;RHOT1;MOAP1
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.3382338947568751,0.5671144242833165,0.8913043478260869,1.0,1.0,6/6,66.19%,APP;HSPA8;DCTN1;SPG11;APBA1;MAPT
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.23626290893912416,0.5647595365727816,1.0,1.0,1.0,11/96,12.39%,ATP2A3;CREB3L3;RASGRF1;ATF4;NCK1;THBS4;BAK1;TMX1;ATF6B;ATF3;NIBAN1
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.3096595257205625,0.5645569870167788,0.925,1.0,1.0,2/11,16.73%,HPRT1;UPP1
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.3160044806857761,-0.5638227327953733,1.0,1.0,1.0,2/17,12.86%,ASAH2B;SGPP2
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.30856567010798963,-0.5635996593988896,0.984375,1.0,1.0,5/21,20.01%,ABCB4;ATP8B1;ABCB1;ATP8B4;ABCA1
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.2579727698853694,-0.5635088248987391,1.0,1.0,1.0,8/64,17.07%,LRRK2;DOP1B;STEEP1;CAV2;TRAM2;TRAM1L1;SEC61G;DNM1L
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.25353297088922655,-0.5623369488785356,1.0,1.0,1.0,18/76,25.53%,CACNA1E;SNAP25;CHGA;KCNC2;KCNB1;ITPR3;EFNA5;SLC2A2;NR1D1;CLOCK;RAPGEF4;CACNA1C;CACNA1A;ITPR1;ABCA12;CACNA2D2;TM7SF3;SYT7
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.3594842761311196,0.5622293488808083,0.8857142857142857,1.0,1.0,5/5,64.06%,HIPK2;SERBP1;ETS1;PML;HABP4
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.2362880138717224,-0.5620499304990927,1.0,1.0,1.0,23/98,26.99%,FOS;PSMB8;VAV3;ITK;PRKCQ;LYN;SYK;PPP3CA;LAT2;PSMC3;PIK3CB;PLCG1;NFATC2;PAK1;VAV2;PSME1;PSMA3;PSMB2;NFATC1;TEC;PSMD5;PSMC5;CARD11
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),0.36072125220039025,0.562010919947722,0.9,1.0,1.0,5/5,63.94%,ACAA1;CRYZ;GSTM3;GSTO1;GSTM4
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.349531737075282,-0.5618214835676181,0.9615384615384616,1.0,1.0,4/10,34.15%,NRG1;SCIN;KCNQ1;GPLD1
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),-0.3617001369368623,-0.5614196987746728,0.9285714285714286,1.0,1.0,1/5,19.38%,LIG3
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),-0.28582021812524344,-0.5613895002291576,0.9857142857142858,1.0,1.0,9/32,25.74%,CADPS2;RAB3A;RAB27B;RAB15;SMPD3;VPS4B;CADPS;SDC4;SDCBP
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.33951334998276206,-0.5613571191397184,1.0,1.0,1.0,1/9,12.21%,CAV1
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.30770525545573435,-0.5609858013805861,0.9850746268656716,1.0,1.0,3/20,10.05%,DGKD;DGAT1;DGKB
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),-0.37992140366858274,-0.5603678537868071,0.9622641509433962,1.0,1.0,1/6,20.44%,SPI1
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),-0.33696240756565304,-0.5600801345407004,0.9076923076923077,1.0,1.0,1/6,11.05%,CX3CR1
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.254463657804834,0.5600513840150898,1.0,1.0,1.0,8/56,16.31%,ZDHHC16;PIGF;ZDHHC12;ZDHHC3;ZDHHC14;HHAT;ZDHHC7;DPM3
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.2874367815840687,0.5593540114407818,0.9117647058823529,1.0,1.0,4/11,26.00%,CHRNA7;PICALM;ROCK2;RANBP9
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.3054756882030641,-0.558998532696932,0.9523809523809523,1.0,1.0,5/20,26.28%,INCA1;CDKN1A;NR2F2;MYOCD;TFAP4
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),-0.36609457246289157,-0.5584693206889073,0.971830985915493,1.0,1.0,2/6,14.14%,BMP6;PAX6
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.32829187049559166,0.5580802565138122,0.9148936170212766,1.0,1.0,2/8,13.73%,UGT8;GALC
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),0.2557510047919009,0.5580031014128027,1.0,1.0,1.0,4/30,11.48%,CTC1;PINX1;DCLRE1B;DKC1
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.36180409007689557,-0.5579631544288355,0.9041095890410958,1.0,1.0,1/5,13.25%,SRP54
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.2814116284632881,0.5576915179794258,1.0,1.0,1.0,5/27,16.79%,PHF1;EPC1;DNMT3A;DNMT1;RBBP4
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.31569824543862435,-0.5575597619697905,0.9523809523809523,1.0,1.0,3/14,30.29%,AR;ESR1;SAFB
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.28019925331927453,-0.5565839197340905,1.0,1.0,1.0,5/37,16.94%,CST3;B2M;FURIN;SNCAIP;SIAH1
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.333967740400628,0.5557932694160215,0.9130434782608695,1.0,1.0,7/7,66.61%,ATG2A;ATG13;ATG2B;ATG7;ULK2;ULK1;RB1CC1
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.333967740400628,0.5557932694160215,0.9130434782608695,1.0,1.0,7/7,66.61%,ATG2A;ATG13;ATG2B;ATG7;ULK2;ULK1;RB1CC1
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),-0.3516990065151337,-0.5554610358558014,0.9491525423728814,1.0,1.0,1/5,21.87%,VPS4B
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.3401171485810075,-0.5554544723902795,0.9841269841269841,1.0,1.0,1/7,12.34%,PDE3B
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.21493250377691495,0.5552511897040522,1.0,1.0,1.0,37/186,19.73%,TUBA1A;KDM8;NES;NASP;EIF4EBP1;PCM1;ACVR1;HAUS5;CEP290;OPTN;USP37;CCNB3;CDK6;TUBG1;CCNG1;ENSA;ACVR1B;LATS2;MELK;CCNA2;PLK4;CEP164;USH1C;EIF4E;BCAT1;TUBB4A;ANAPC1;ALMS1;CUL2;FBXL7;CTDP1;DYNLL1;CDC25B;BTRC;CDC23;CDKN2C;AKAP9
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.23895792769594645,0.5552181913321309,1.0,1.0,1.0,16/66,23.25%,ATF4;ATP6V1G2;ATP6V1G1;DAPL1;MLST8;MAPK8;RNF152;LAMTOR4;WDR59;SESN1;CASTOR2;EIF2S1;SEH1L;ATP6V0E1;MIOS;KPTN
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.31308886390196705,-0.5545178468793682,0.9833333333333333,1.0,1.0,3/20,17.38%,CELF4;RBM3;NCBP1
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.24325948333009553,0.5538815519412827,1.0,1.0,1.0,13/59,19.59%,NWD1;NLRP2;PTGIS;G3BP2;CHUK;COMMD1;ITCH;PRMT2;IRAK2;TRAF3;ANXA4;COMMD6;RBCK1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.29421390862465513,0.5538729033136802,0.9772727272727273,1.0,1.0,3/16,17.44%,BAK1;ALKBH7;THEM4
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.3483684351465729,0.5535411476704327,0.926829268292683,1.0,1.0,2/6,14.06%,HELLS;DNMT1
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.36726643868393627,-0.553476016541682,0.9538461538461539,1.0,1.0,2/7,25.80%,LIG3;TOP3A
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.2920819426497929,0.553145089315479,0.967741935483871,1.0,1.0,7/19,24.02%,DDX3X;RPS23;PRRC2C;G3BP1;EIF2S1;YTHDF1;C9ORF72
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.34971450823860417,0.5530662048341788,0.9459459459459459,1.0,1.0,3/5,30.37%,JAK3;RC3H1;SMAD7
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.25018290158077255,-0.5522134542731952,1.0,1.0,1.0,7/51,20.13%,E2F1;GTSE1;RBL2;CDKN1A;ARID3A;PLK2;PLAGL1
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.223340904905868,0.5521634591835455,1.0,1.0,1.0,20/91,20.49%,BET1;GBF1;TMX1;ERGIC3;GLA;VAMP4;LMAN1;DST;GALC;SEC22B;SEC31A;SGMS1;STX7;TSPAN8;AP2S1;STX12;AP3S1;COG2;ARCN1;AP2B1
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.32538044642854935,0.5514965033843633,0.9487179487179487,1.0,1.0,3/8,20.64%,DEF8;ADAM8;PRKCA
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.2737023949269868,0.550533709521386,1.0,1.0,1.0,6/20,29.66%,BAG2;BTRC;RPL11;RPL5;SKP1;RPS7
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),-0.35613546007757907,-0.5504017915148212,0.9090909090909091,1.0,1.0,1/5,22.04%,LY96
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.3091343630596608,0.550386617984293,0.9666666666666667,1.0,1.0,1/7,9.26%,HMGCR
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),-0.2760462726115654,-0.5501164438877924,0.9830508474576272,1.0,1.0,4/30,13.79%,LRRK2;SLC4A10;SLC9C2;SLC9C1
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.355322911991324,0.5500261307673925,0.9347826086956522,1.0,1.0,2/10,15.39%,NLGN3;NLGN2
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.25245357780770794,-0.5499084632910272,1.0,1.0,1.0,8/42,22.49%,RHOC;CENPA;RASA1;SEPTIN6;MYH10;TTC19;CIT;CKAP2
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2031612699894604,0.5496416092533818,1.0,1.0,1.0,23/294,14.15%,FEM1A;SPSB2;PSME2;UBC;DMAC2;AUP1;UBXN4;UBE2A;IFI27;CDC26;UBE2J2;PSMD13;TMEM129;ANAPC15;UBB;MAEA;FBXL14;UBQLN2;PSME4;ITCH;AMFR;DERL3;ECPAS
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.2273443699779775,-0.5495679358406117,1.0,1.0,1.0,15/142,17.85%,RMI1;TP73;RPA3;RFC3;RAD9A;TAF10;CDK5R1;RFC4;WRN;TP53INP1;BRCA1;PRDM1;RAD50;CDK5;PRKAB2
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.23329503381041478,0.5493155721926781,1.0,1.0,1.0,28/110,22.97%,GDAP1;SRPRB;LTBP2;MYO1C;TIMM23;ZDHHC12;AP4B1;AIP;PEX6;RTP5;SRPRA;ICMT;ZDHHC3;ZDHHC14;MICALL1;KIF13B;ZDHHC7;TRAK1;RABGEF1;AP4E1;SEC61A1;RPL11;TIMM17A;TIMM9;KATNB1;GOLGA7;TRAK2;TIMM22
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.313450453344727,0.5492308527235812,0.9772727272727273,1.0,1.0,4/12,22.10%,FARSB;KRT10;PKD1;FARSA
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),-0.33441904045383997,-0.5490477537106839,0.9836065573770492,1.0,1.0,1/10,10.05%,DGKB
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),-0.2819829309977437,-0.5486390519819188,0.984375,1.0,1.0,4/27,16.77%,NRG4;PTPRR;EGFR;NRG1
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.30437161040427785,0.5485083095598133,0.9761904761904762,1.0,1.0,4/12,23.70%,GREM1;PLXNB1;SOX8;RHOA
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.2690048168800093,-0.5483558539796457,0.987012987012987,1.0,1.0,7/29,21.12%,UBASH3B;PTPRT;PTPRZ1;PTPRB;PTPN13;PTPRJ;PTPN11
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.29993229461320714,-0.547996827238005,0.967741935483871,1.0,1.0,3/21,13.51%,COL11A1;LAMB1;ITGAV
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.34559894977769917,-0.547984730210937,0.9661016949152542,1.0,1.0,2/6,19.75%,NMD3;NUP88
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.2525633198437861,-0.5479019024388054,1.0,1.0,1.0,2/29,14.23%,HLA-DRB1;ADCY8
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.3298527295149425,0.5477154627458017,0.9,1.0,1.0,1/5,10.61%,AKT2
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.23648473479151416,0.5475722886477143,1.0,1.0,1.0,15/68,23.07%,USP6NL;ZEB2;LMAN1;PJVK;CAPN2;STX18;PLXNB1;PDE4DIP;TJP1;AKAP9;STOX1;SAR1B;ARMH3;SIRT7;CLN3
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.3089441348526031,-0.5471264619890832,0.9672131147540983,1.0,1.0,3/13,19.93%,CSPG5;DNM1L;PID1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.33429657508403765,-0.547001074003027,1.0,1.0,1.0,2/9,10.79%,C5;RIN3
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.27837443517824945,-0.5466433351955544,1.0,1.0,1.0,10/25,36.52%,ATP5F1E;MICOS13;ATP5MC1;DMAC2L;ATP5ME;ATP5PD;APOOL;AFG3L2;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),0.3535845025795726,0.5466338915769728,0.9487179487179487,1.0,1.0,3/6,20.42%,GRK5;GRK2;TACR3
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.3294531620948896,-0.5464401969894019,0.9365079365079365,1.0,1.0,2/10,22.23%,TYMP;DCK
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.3294531620948896,-0.5464401969894019,0.9365079365079365,1.0,1.0,2/10,22.23%,TYMP;DCK
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.23516597599790648,-0.5457577210819095,1.0,1.0,1.0,13/84,26.69%,DBF4;PSMB8;TCIM;GTSE1;CDKN1A;PSMC3;MAD2L1;PSME1;PSMA3;PSMB2;PSMD5;TFAP4;PSMC5
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.28260522730393733,-0.5456692383031237,1.0,1.0,1.0,1/35,2.75%,EPHA3
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),0.27106216398423555,0.5455819066301159,1.0,1.0,1.0,8/30,24.09%,POLR2K;ERCC2;POLR2L;GTF2H5;CMTR2;POLR2E;POLR2D;CCNH
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),0.27106216398423555,0.5455819066301159,1.0,1.0,1.0,8/30,24.09%,POLR2K;ERCC2;POLR2L;GTF2H5;CMTR2;POLR2E;POLR2D;CCNH
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.3505421815050639,0.5448650766325077,1.0,1.0,1.0,1/7,8.95%,PRLR
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.25492209982910646,-0.5447843751779855,1.0,1.0,1.0,6/49,21.87%,RAB11A;CCND1;PLCB1;EGFR;DTL;VPS4B
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.2735879108485916,-0.5445675825421954,1.0,1.0,1.0,3/30,17.47%,WTIP;MOV10;ZFP36
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.23524270329621952,0.5445010528630438,1.0,1.0,1.0,16/67,23.25%,ATF4;ATP6V1G2;ATP6V1G1;DAPL1;MLST8;MAPK8;RNF152;LAMTOR4;WDR59;SESN1;CASTOR2;EIF2S1;SEH1L;ATP6V0E1;MIOS;KPTN
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.27941150338466064,-0.544365570026272,0.9836065573770492,1.0,1.0,7/23,28.33%,EPHA4;EFNA1;USP14;ATP5IF1;PSME1;GPX1;APOE
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.3340786907084066,0.544340573839694,0.925,1.0,1.0,5/5,66.60%,TMEM39A;CLEC16A;PHF23;UBQLN4;RUBCN
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.3560660822300234,-0.5441407414716887,0.9636363636363636,1.0,1.0,1/5,14.36%,APAF1
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.3181077612854165,-0.5440190945105536,0.9538461538461539,1.0,1.0,3/14,24.25%,CELF4;RSRC1;PQBP1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.2863238161750296,0.5436033326798746,1.0,1.0,1.0,5/21,16.16%,ZNRF3;MEGF8;GREM1;KAT2A;SALL1
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),0.31899237125319635,0.5428141308279291,0.95,1.0,1.0,3/8,19.58%,RNF168;RNF8;LIG4
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.3440107130006157,0.5425839155061871,0.9791666666666666,1.0,1.0,3/5,25.57%,MYADM;WNK1;MBP
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.3440107130006157,0.5425839155061871,0.9791666666666666,1.0,1.0,3/5,25.57%,MYADM;WNK1;MBP
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.27661638548080925,0.5425541114631862,0.9642857142857143,1.0,1.0,11/76,13.33%,SQLE;SC5D;HMGCS1;CARM1;PMVK;SMARCD3;HMGCR;HNF4A;IDI1;HELZ2;ADIPOR1
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.25529884306803663,0.5418530224192091,1.0,1.0,1.0,3/32,17.63%,GBF1;PLK5;ZFAND1
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),0.3455920833531566,0.5403290549829673,0.9310344827586207,1.0,1.0,5/5,65.45%,VPS13D;VDAC1;SLC25A5;TSC2;SLC25A4
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),-0.319803948518816,-0.5395351674211003,0.9827586206896551,1.0,1.0,2/12,17.88%,SLC26A4;SLC26A8
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.31816215248809193,-0.5388375046132611,1.0,1.0,1.0,3/11,13.99%,RIN3;LRPAP1;DLG4
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),-0.24987935177894485,-0.5386139542109897,1.0,1.0,1.0,9/47,24.13%,SIPA1L1;THSD7A;FGF7;PTK7;DMTN;TRPV4;NEDD9;ANTXR1;PAK1
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.2973387970620295,0.5381597826371762,0.9166666666666666,1.0,1.0,1/11,6.97%,IP6K2
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.30448477488575,0.5380913019738847,0.972972972972973,1.0,1.0,3/15,18.18%,AADAT;OAT;MTHFS
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.2878758532651014,-0.5376648592032298,1.0,1.0,1.0,5/19,28.81%,DMTN;TGFB1;DDR2;ITGB1BP1;GNA12
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.30590019713218347,-0.5376286965605898,0.9375,1.0,1.0,4/12,25.20%,BRCA1;AASS;MACROH2A1;MTF2
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.30962085261607575,-0.5376139680067178,0.9558823529411765,1.0,1.0,1/8,11.38%,ABCB4
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.2528461402247631,-0.5373676067935772,1.0,1.0,1.0,2/46,6.12%,ESYT3;B3GALNT1
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),-0.30033338554417144,-0.5369881233773158,1.0,1.0,1.0,2/13,16.35%,SCARB1;SREBF1
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.28488839275184297,-0.5368045772287666,0.9836065573770492,1.0,1.0,6/19,21.77%,PRPS1;NT5C1A;PRPSAP1;MTHFD1;GDA;PRPS2
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.29843649205504563,0.5365162039843121,0.9714285714285714,1.0,1.0,3/10,23.29%,NRP2;GDNF;ASCL1
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),-0.3109650983239881,-0.5362401625917811,0.9259259259259259,1.0,1.0,3/10,29.08%,PKD1L3;IMPACT;CTSS
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.3173547386097158,-0.5351241290882368,0.9393939393939394,1.0,1.0,2/12,20.33%,COX6C;COX4I1
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.24740326871851798,-0.5347468962023854,1.0,1.0,1.0,6/62,13.83%,RHOC;MET;TGFB3;ARHGAP28;CARMIL1;SYNPO2L
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),-0.2963678440093317,-0.5346269487147093,0.9855072463768116,1.0,1.0,3/16,19.01%,ST3GAL5;ST8SIA3;ST6GALNAC5
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.22526132462191287,0.533956131360109,1.0,1.0,1.0,15/64,21.15%,U2AF1;RAE1;RBM8A;RBFOX1;TPR;NXF1;PNPT1;EIF4E;YBX1;SARNP;HNRNPA2B1;THOC2;RTRAF;MAGOH;ALYREF
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),-0.2317652143876086,-0.5339479851453173,1.0,1.0,1.0,2/91,5.43%,KDM4D;SOX9
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.3458683694260104,-0.5327942126360122,0.9622641509433962,1.0,1.0,3/5,32.40%,TAPBP;STX4;CALR
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.23014081781333892,0.5324047999600934,1.0,1.0,1.0,13/47,23.14%,SAP18;PTBP1;RBM8A;RBFOX1;HNRNPU;ZBTB7A;RBM15B;DDX5;CELF1;RBM5;MAGOH;WTAP;PUF60
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),-0.34014355469218566,-0.5322411595961114,1.0,1.0,1.0,1/7,14.56%,PRKD2
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.34930954463065855,-0.531917024763367,0.984375,1.0,1.0,1/7,16.81%,DIO2
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.34930954463065855,-0.531917024763367,0.984375,1.0,1.0,1/7,16.81%,DIO2
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.2682807093835761,0.5315795211747999,0.9487179487179487,1.0,1.0,1/13,5.20%,PPP1R10
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.23368473947250173,-0.5312434914134301,1.0,1.0,1.0,5/53,15.39%,CHKB;SLC44A3;PLAAT4;ABHD3;PLA2G12A
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.28602174979697703,-0.5308725263086285,0.9830508474576272,1.0,1.0,1/15,8.43%,SULT4A1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.31956124356721005,-0.53058482412273,0.9661016949152542,1.0,1.0,3/8,35.97%,FYN;LANCL1;PINK1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.33120129877147453,0.5305226100254505,0.9090909090909091,1.0,1.0,1/6,8.44%,PIH1D1
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.32922142519873,0.5300188189527667,0.9523809523809523,1.0,1.0,1/7,6.39%,MGMT
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.25343864159219,-0.5297112310892768,0.9833333333333333,1.0,1.0,3/37,15.69%,TERF2IP;RADX;TOM1L1
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.35255560011814097,-0.5295649302891539,0.9464285714285714,1.0,1.0,2/7,21.67%,WRN;DDX11
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.23100588477055517,-0.5294666830718686,1.0,1.0,1.0,15/106,25.43%,LAPTM5;KIF16B;CCDC91;DOP1B;DENND2A;HOOK1;TBC1D10A;RIC1;VPS35;RAB6B;HEATR5B;SNX32;VPS13A;WASHC1;ARL1
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.2818008458964457,-0.5287754122204118,1.0,1.0,1.0,3/28,13.14%,TWF2;PLEKHH2;CAV3
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.33149206494857003,-0.5285230418666109,0.9666666666666667,1.0,1.0,1/6,29.25%,SLC6A9
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.29152682513924966,0.5273374954263522,0.95,1.0,1.0,2/10,16.16%,HDAC1;SALL1
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.2915023419868508,-0.5272459844122075,0.9827586206896551,1.0,1.0,4/14,26.21%,PKD1L3;IMPACT;HVCN1;GPR68
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.2319592193540116,0.5270092931659286,1.0,1.0,1.0,19/81,18.30%,UBE2A;NOC2L;ATF4;CAT;TMEM161A;YY1;BAK1;SDE2;CASP9;ZBTB1;MAPK8;POLH;MAP2K7;RELA;ERCC2;ATR;PRIMPOL;NPM1;MEN1
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.3288786512072756,0.5263091052370981,0.9787234042553191,1.0,1.0,3/9,15.39%,NLGN3;C5AR1;NLGN2
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.2830250274941221,0.5253924392998341,0.9807692307692307,1.0,1.0,2/12,10.61%,PLIN5;AKT2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.2634502678934919,-0.5253167092082547,1.0,1.0,1.0,7/23,27.25%,NTNG1;FBXO7;NTNG2;DISC1;VPS35;ZNF804A;BRSK1
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.24854867794603844,0.5251399889287435,1.0,1.0,1.0,2/36,6.18%,FBP1;ATF4
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.22184856901551966,0.525006273217873,1.0,1.0,1.0,6/65,13.40%,PSME2;UBC;PSMD13;UBB;ELOC;PSME4
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.30342597470066907,0.5247235542595302,0.9714285714285714,1.0,1.0,1/9,7.92%,RELN
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.28599887656625755,0.5239891486632714,0.9714285714285714,1.0,1.0,1/8,9.06%,PLA2G4C
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.3031825657936766,-0.523867165644526,0.9454545454545454,1.0,1.0,1/9,10.64%,XBP1
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),0.3203811748604525,0.5238651274126298,0.95,1.0,1.0,3/5,26.97%,HADHB;HADHA;PLA2G6
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.21684492705269182,0.5233345188939128,1.0,1.0,1.0,15/72,21.11%,PSME2;RYK;PSMD13;PFN1;CELSR3;MAGI2;PSME4;CELSR2;PSMF1;AP2S1;PSMD11;CDC42;PSMD4;AP2B1;RAC1
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.25062111208227783,0.5232226625243978,1.0,1.0,1.0,4/33,10.83%,SDC2;EPHB2;CHRNA7;CTNNA2
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.272567213894837,0.523145352211722,0.9565217391304348,1.0,1.0,9/9,72.75%,CLN3;LGMN;DRD2;CHRNB2;MAP1A;SLC6A1;ADCY3;SHANK1;BRSK1
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.26053615567999827,-0.5227054377089062,1.0,1.0,1.0,5/44,17.69%,BMP6;HJV;CP;FBXL5;SLC11A2
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),0.3209459459459459,0.5227045530707575,0.925,1.0,1.0,8/8,67.92%,VPS8;VPS11;ANKFY1;TGFBRAP1;VPS39;VPS41;SAMD9;VPS4A
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.2774314958575522,0.522492862039388,0.9743589743589743,1.0,1.0,4/12,27.36%,BRCC3;LIG4;NIPBL;BLM
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.3119727273415687,0.5214519331762302,0.9393939393939394,1.0,1.0,2/8,16.58%,EEF1A1;SNCA
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.30759368184315566,0.5214120512866672,0.9761904761904762,1.0,1.0,2/9,14.70%,ELL;ZC3H8
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.24311828158274637,-0.5208146975860691,1.0,1.0,1.0,10/42,30.06%,FURIN;TRIM32;TBC1D10A;TNFRSF1B;ATP5IF1;WDR48;ADAM9;CCBE1;APOE;SNX33
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.2485919634016614,0.5204373739424187,1.0,1.0,1.0,4/22,16.26%,ZDHHC12;ZDHHC3;ZDHHC14;ZDHHC7
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.2485919634016614,0.5204373739424187,1.0,1.0,1.0,4/22,16.26%,ZDHHC12;ZDHHC3;ZDHHC14;ZDHHC7
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),-0.3497715874552485,-0.5199707000545927,0.9642857142857143,1.0,1.0,2/6,28.57%,PARP10;GPS2
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.2868054782530469,0.5197997171793827,0.975,1.0,1.0,3/12,19.20%,H6PD;DGKQ;RAN
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.316083872137155,0.5197763223377957,1.0,1.0,1.0,3/10,20.00%,OPLAH;HAGH;GGCT
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.3151642735669832,-0.5196493788419544,0.9444444444444444,1.0,1.0,2/7,22.84%,GARS1;DARS2
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.21535379481618858,0.518997434276279,1.0,1.0,1.0,14/52,24.71%,SPHK2;MYO1C;POLR2K;KAT2A;ZMIZ1;CDCA4;POLR2L;TAF1C;POLR2E;PHF2;PADI2;ARID1B;DEK;SMARCA5
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.2880799428979302,0.5185349070331899,0.9736842105263158,1.0,1.0,9/9,71.20%,AIPL1;FNTA;RCE1;PGGT1B;FNTB;PTAR1;CHM;RABGGTA;RABGGTB
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.3016951249513804,-0.5181132651923447,0.9818181818181818,1.0,1.0,2/12,18.91%,LYN;TGFB1
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),-0.30756561538702193,-0.5180197238713224,0.9649122807017544,1.0,1.0,5/9,28.87%,ACMSD;KYNU;KMO;HAAO;TDO2
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),-0.30756561538702193,-0.5180197238713224,0.9649122807017544,1.0,1.0,5/9,28.87%,ACMSD;KYNU;KMO;HAAO;TDO2
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),-0.3101053180745656,-0.5175336218610759,0.9629629629629629,1.0,1.0,1/6,20.20%,FNBP1L
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.3196405186512321,0.5174084356908891,0.9555555555555556,1.0,1.0,1/7,9.95%,MCUR1
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),0.30722152674180764,0.5173991662299516,1.0,1.0,1.0,2/13,13.31%,ENPP1;SMPDL3A
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),-0.34124777476457857,-0.5172135540358528,0.9615384615384616,1.0,1.0,4/6,42.83%,SLC4A8;BAIAP3;DTNBP1;GPER1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.23165051507618592,-0.5171940644774976,1.0,1.0,1.0,16/68,28.85%,PRICKLE1;NUP62CL;E2F3;SYK;STAT3;SPRN;NUP88;HEATR3;NUP50;GCKR;POM121;RPAIN;RGPD3;TNPO2;NUP188;NUP107
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),-0.2892206959783888,-0.5170644611122333,0.96875,1.0,1.0,3/10,32.62%,IMPACT;SESN3;RRAGD
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.2854339741480321,0.5164427880239446,1.0,1.0,1.0,2/18,16.49%,BAK1;THADA
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),-0.2789264643547461,-0.5162589192215911,0.9850746268656716,1.0,1.0,1/16,6.27%,LAPTM5
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.28819928214996315,-0.5154559988077556,0.9852941176470589,1.0,1.0,2/19,16.56%,GMPPB;PMM2
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),0.33921689899614627,0.51534063796426,0.9285714285714286,1.0,1.0,5/5,66.09%,EXOSC5;EXOSC6;APOBEC3H;EXOSC4;CDADC1
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),-0.31756666759432056,-0.5147609154685001,1.0,1.0,1.0,2/10,17.84%,SGMS2;SMPD3
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.29437323139356497,0.5146043801492982,0.975,1.0,1.0,4/9,24.73%,LATS2;WWC2;SOD1;DUSP6
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.1961831664027236,0.5142178999319915,1.0,1.0,1.0,31/142,21.92%,MRPL32;RPS15A;FARSB;EEF1A1;DARS1;TNIP1;MRPS7;RPS3A;MRPL3;GGTA1;RPL18A;MRPS5;HARS1;RPS23;MRPL52;MRPL24;RPSA;HARS2;MRPL13;RPL23A;RPS3;RPL3;RPL13;RPL11;MRPS16;RPL8;MRPL43;RPS8;RPL32;RPL21;RPS16
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),0.3132003336315901,0.5141970572229295,1.0,1.0,1.0,2/7,16.57%,GREM1;PLXNB1
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),-0.3019302205391131,-0.5134552255119783,0.9642857142857143,1.0,1.0,5/9,28.84%,CHI3L1;PTPRT;PID1;ST3GAL6;SELPLG
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.21978068239785914,-0.5130784577474068,1.0,1.0,1.0,7/87,21.27%,RPL31;RPL38;RPL37A;GSPT2;RPS29;RPL34;RPS27
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.22227697817610176,-0.5128172000094937,1.0,1.0,1.0,13/107,20.90%,PSMB8;SOX9;GBP2;GBP3;PLCB1;ADAMTS7;NOD1;MYLK3;NR1D1;PSMC3;NFKBIA;CX3CL1;RBX1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.3233686422728186,-0.5122860077763804,0.984375,1.0,1.0,3/10,29.45%,WRN;NBN;XRCC3
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.3233686422728186,-0.5122860077763804,0.984375,1.0,1.0,3/10,29.45%,WRN;NBN;XRCC3
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.3233686422728186,-0.5122860077763804,0.984375,1.0,1.0,3/10,29.45%,WRN;NBN;XRCC3
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.3151560001389665,-0.5112931517015143,0.9655172413793104,1.0,1.0,2/7,36.25%,FMR1;SYT11
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),-0.2896823258304347,-0.5111423824654021,0.9850746268656716,1.0,1.0,2/13,23.68%,SLC25A22;SLC25A12
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),-0.3299913558025528,-0.5109674635066275,0.967741935483871,1.0,1.0,1/6,19.56%,PTPRN
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.3163831816679909,-0.5108576870905591,0.9830508474576272,1.0,1.0,5/9,39.49%,ATP5MC1;ATP5PD;ATP5PB;ATP5F1A;ATP5MC3
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),-0.26880967067135864,-0.5108241294996272,1.0,1.0,1.0,5/27,30.51%,CEACAM1;PRKAB2;HSD17B13;APOE;SORBS1
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",0.27900641574588225,0.5105659223441082,0.9722222222222222,1.0,1.0,2/7,19.63%,SEC61A2;SEC61A1
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),0.28366759830542826,0.5102030313197954,0.9795918367346939,1.0,1.0,5/10,30.70%,COPS2;TOR1A;COPS6;GPS1;COPS3
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.27435234164098654,-0.5098451960339461,1.0,1.0,1.0,7/24,29.00%,ZDHHC15;TMED10;VPS13A;ARL1;CSNK1D;PAQR3;GAK
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.21171786252556737,-0.5095748332100988,1.0,1.0,1.0,16/98,26.57%,RPA3;RFC3;UVSSA;RFC4;PRPF19;RNF111;LIG3;RPA2;USP45;RBX1;XPA;MNAT1;COPS7A;POLR2J;RPA1;MMS19
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.31944492295204363,0.5092666335876368,0.9761904761904762,1.0,1.0,3/7,19.20%,LTV1;NPM1;RAN
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.2765159094393711,-0.5088224063568737,0.9830508474576272,1.0,1.0,2/20,15.59%,XBP1;VEGFA
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),0.3058924953613874,0.5081143333318306,0.925,1.0,1.0,1/8,14.31%,BECN1
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.32489146492572074,-0.5078920121210648,0.9666666666666667,1.0,1.0,1/6,17.47%,NOL3
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.3187267867718846,0.5078522343596688,0.975609756097561,1.0,1.0,2/10,16.35%,MTMR2;ABCA3
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.30653099752354696,-0.5077954930489248,0.9827586206896551,1.0,1.0,4/6,41.49%,BRSK1;NPHP1;VANGL2;FUZ
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.29624661784011175,-0.5062203753143967,0.9830508474576272,1.0,1.0,2/11,22.50%,XBP1;TMEM33
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),-0.2557717646786284,-0.5053465526174241,0.9846153846153847,1.0,1.0,4/23,22.46%,CX3CR1;TNFRSF1B;PRKAB2;SIRT5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.2536330005334148,-0.5051724668447392,1.0,1.0,1.0,6/26,25.52%,RPA3;RPA2;RBX1;XPA;MNAT1;RPA1
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),0.3013939768780628,0.5041401409098999,0.9743589743589743,1.0,1.0,5/5,69.87%,CLN3;SLC25A23;LETM1;EFHD1;MICU1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.2678224904269597,-0.5036734608342139,1.0,1.0,1.0,3/22,20.39%,TERF2IP;RAD50;MRE11
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),0.291693364132145,0.5035068942505363,0.9761904761904762,1.0,1.0,2/5,18.72%,HYAL1;MME
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.25463735939308346,-0.5032452194873769,1.0,1.0,1.0,4/27,25.74%,USP14;CAMLG;GIPC1;SDCBP
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),0.30819556352425703,0.5021669582708197,0.9545454545454546,1.0,1.0,2/6,22.75%,QDPR;KYAT1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.2865525970516198,0.5019511081059338,0.95,1.0,1.0,1/10,7.81%,PLD6
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.2611116398591417,0.5014205518376045,1.0,1.0,1.0,10/10,73.90%,SESN1;MTOR;UBR1;UBR2;KLHL22;SESN2;LARS1;RPTOR;RRAGD;SESN3
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.2611116398591417,0.5014205518376045,1.0,1.0,1.0,10/10,73.90%,SESN1;MTOR;UBR1;UBR2;KLHL22;SESN2;LARS1;RPTOR;RRAGD;SESN3
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.29678555647771215,-0.500872038061523,0.9848484848484849,1.0,1.0,3/13,29.17%,PLCB1;ZBED3;TENM4
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.22894637447481153,0.5006912867736522,1.0,1.0,1.0,11/41,21.45%,FLNA;ANP32B;IPO5;TPR;HDAC3;DHX9;RAPGEF3;DMAP1;RAN;RBM22;JUP
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.1969958243542393,0.5006905934710457,1.0,1.0,1.0,41/105,28.93%,RPS15A;EIF3E;RPS3A;RBM8A;DCP1A;HELZ2;RPL18A;PNRC2;RPS23;DHX34;RPSA;SMG9;RPL23A;RPS3;RPL3;RPL13;RPL11;MAGOH;RPL8;SMG5;RPS8;RPL32;RPL21;PPP2R2A;RPS16;RPS2;RPS18;RPL7;RPS6;ETF1;RPL29;RPL5;RPL15;SMG1;RPL41;RPS5;RPS13;RPL14;RPL10;RPLP1;RPS28
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.3266311771397212,0.49888592440939367,1.0,1.0,1.0,1/5,12.60%,IL17D
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.3266311771397212,0.49888592440939367,1.0,1.0,1.0,1/5,12.60%,IL17D
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.3160473856986535,0.4985608232701726,0.9767441860465116,1.0,1.0,5/5,68.40%,NIPBL;XRCC6;ATM;XRCC5;NUCKS1
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.27037525238553217,0.49749136877458333,0.9259259259259259,1.0,1.0,5/11,30.37%,CDC42;ARCN1;PDCD10;ARHGAP21;HOOK3
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.25404421069591226,0.49739373955509747,1.0,1.0,1.0,4/13,24.68%,DESI2;UBA1;UBA2;UBA7
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),0.27258331083021614,0.4970611622052716,0.9393939393939394,1.0,1.0,3/8,20.52%,DRD4;GPR35;CALM1
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.34327582520823535,-0.4960195180363662,0.9538461538461539,1.0,1.0,2/5,28.57%,PARP10;GPS2
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.23155462858716294,-0.49585676259537936,1.0,1.0,1.0,12/53,26.69%,PSMB8;CAV1;AZIN1;OAZ3;PSMC3;SIRT5;PSME1;PDK2;PSMA3;PSMB2;PSMD5;PSMC5
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.26733945827581296,0.4955600652144288,0.9696969696969697,1.0,1.0,17/17,73.29%,DPM3;CRPPA;DPM2;TMTC2;TMTC3;TMTC1;DPM1;POMT2;FKTN;LARGE1;TMTC4;RXYLT1;SDF2L1;POMGNT2;FKRP;POMT1;B4GAT1
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.30075157010087783,0.495462580257974,0.95,1.0,1.0,1/7,14.20%,GRK2
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.2455474550876236,0.49487381629301186,0.9736842105263158,1.0,1.0,1/15,6.87%,PCM1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.27089253713877093,-0.49464531591682015,1.0,1.0,1.0,1/12,15.70%,BRCA1
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.3069941943224863,-0.494299453762712,1.0,1.0,1.0,1/8,15.59%,VEGFA
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),0.32148671978553695,0.4938954576688526,0.9696969696969697,1.0,1.0,4/6,34.40%,DPAGT1;DOLPP1;NUS1;DOLK
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),0.32148671978553695,0.4938954576688526,0.9696969696969697,1.0,1.0,4/6,34.40%,DPAGT1;DOLPP1;NUS1;DOLK
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.3351856847096536,-0.4937820564262527,0.9838709677419355,1.0,1.0,2/5,28.91%,VEGFA;C1QBP
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.2512287650247267,0.4937126219536593,1.0,1.0,1.0,3/16,17.27%,CHUK;DDX3X;DHX9
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.2906669866793216,0.49371170501856365,1.0,1.0,1.0,2/6,22.06%,ZBTB1;SOD1
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.26707606152635344,0.4935770620160256,0.967741935483871,1.0,1.0,1/8,7.97%,NCK1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),0.3087852586272188,0.49279257294038037,0.9787234042553191,1.0,1.0,3/5,26.43%,RAC1;MACIR;FGF2
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),-0.31169205293873176,-0.4912554302261383,0.9791666666666666,1.0,1.0,1/5,23.92%,MOCS3
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.216389271327438,-0.4909360934637083,1.0,1.0,1.0,9/97,21.27%,RPL31;MAN1A1;RPL38;SRP54;RPL37A;SEC61G;RPS29;RPL34;RPS27
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.22596310262257857,-0.490278736192278,1.0,1.0,1.0,20/62,32.62%,RAB11A;CALM3;GIT1;PLK2;DCDC1;KIF20B;CIT;GIPC1;AURKA;KLHL9;UVRAG;PIN1;RAB11FIP4;SVIL;BBS4;CUL3;KIF14;VPS4A;ECT2;CENPV
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.1978553093775681,0.4899901697570205,1.0,1.0,1.0,12/89,15.80%,NUTF2;PPP1R10;MORC3;PINX1;NOL8;RANBP17;FAM53A;IPO5;TPR;HNRNPU;TAF3;ZBTB7A
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.2762354538617882,0.4898216884509169,0.975609756097561,1.0,1.0,4/11,23.66%,VAPB;STX18;RTN4;BNIP1
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.25606359485180924,0.4894739897615386,1.0,1.0,1.0,1/13,4.55%,AADAT
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.28719345067089963,-0.48905361891516397,1.0,1.0,1.0,2/9,21.14%,NHEJ1;GCLM
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.2765511990864102,0.4885845453873065,0.9743589743589743,1.0,1.0,8/8,72.36%,AKR1D1;SCARF1;MT3;CEL;SNX17;CYP27A1;APOE;CYP46A1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.2765511990864102,0.4885845453873065,0.9743589743589743,1.0,1.0,8/8,72.36%,AKR1D1;SCARF1;MT3;CEL;SNX17;CYP27A1;APOE;CYP46A1
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.28168163421193054,-0.4883734527670825,1.0,1.0,1.0,5/15,24.72%,CAV1;ABCG5;MSR1;OSBPL5;OSBPL2
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.2759719068162104,-0.4871498502313395,0.9814814814814815,1.0,1.0,4/14,28.40%,TGFB1;KAT2B;ESR1;NUDT16
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.2947827022952896,-0.48714217759628875,1.0,1.0,1.0,3/12,19.75%,NMD3;NOP9;NUP88
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.33945477900946747,0.4863692185249242,1.0,1.0,1.0,5/5,66.06%,FTO;ALKBH3;TDG;ALKBH1;ALKBH2
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),-0.3081894536684129,-0.48628783050300706,1.0,1.0,1.0,2/7,24.41%,KAT2B;HAT1
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),0.2664489194494386,0.48562823034862423,0.9302325581395349,1.0,1.0,2/8,22.75%,QDPR;KYAT1
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.20639051599053837,0.4849918642969724,1.0,1.0,1.0,2/107,3.20%,MTERF3;HDAC10
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.2626509918033739,-0.48456191197791765,0.9838709677419355,1.0,1.0,5/18,30.07%,PLA2G12A;PLB1;LPCAT2;LPCAT3;MBOAT2
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.3201051367264903,-0.48384041245557924,0.9803921568627451,1.0,1.0,2/6,22.57%,GAS6;PRKCD
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.3167759509173148,-0.48238968767207935,1.0,1.0,1.0,2/7,15.59%,PRKD2;VEGFA
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.21652919921130107,-0.4808868599366631,1.0,1.0,1.0,12/67,23.42%,PRICKLE1;NUP62CL;E2F3;SYK;STAT3;SPRN;NUP88;HEATR3;NUP50;GCKR;POM121;DDX20
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.19274344820463515,-0.4787572207312522,1.0,1.0,1.0,18/180,21.48%,PDHX;MAOB;COX17;NDUFC1;COX6C;LDHA;ATP5F1E;SLC25A20;NDUFB6;NDUFA8;GPX4;DECR1;MRPS12;ATP6V1D;COX4I1;GPI;ATP5MC1;DLAT
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),-0.2711648205916858,-0.4787014842725933,0.9682539682539683,1.0,1.0,6/13,32.79%,COQ8B;PDSS1;COQ5;COQ6;UBIAD1;COQ3
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),-0.2711648205916858,-0.4787014842725933,0.9682539682539683,1.0,1.0,6/13,32.79%,COQ8B;PDSS1;COQ5;COQ6;UBIAD1;COQ3
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),0.27753723176476175,0.47829373612619236,0.9565217391304348,1.0,1.0,7/7,72.26%,ADCK1;PRKN;MUL1;TFRC;HUWE1;BNIP3;VAT1
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.273078120805497,0.4771828757258354,0.9565217391304348,1.0,1.0,1/7,11.11%,NRP2
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.2716455122530206,-0.47707124836292086,1.0,1.0,1.0,5/17,29.41%,RRP15;WDR12;EXOSC10;RPF1;LAS1L
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),-0.3190021207136384,-0.4767179111624107,1.0,1.0,1.0,2/5,22.70%,ELAVL4;RBM24
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.28844413369913213,0.4759157719790819,1.0,1.0,1.0,4/14,21.56%,BCKDK;ADIPOR1;FOXK1;SIRT1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.2609571716516211,-0.4756443855775939,0.9824561403508771,1.0,1.0,1/15,10.20%,OGFOD1
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),-0.31891756984206565,-0.4755323290644202,1.0,1.0,1.0,2/6,22.70%,ELAVL4;RBM24
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.1951262669106325,-0.47489097336737873,1.0,1.0,1.0,26/103,33.40%,CAPN1;LRRK2;ATP6V1C2;CDK5R1;CDK5;PRKAB2;ATP6V1D;VPS35;TRIM13;SNX32;SESN3;UCHL1;TBK1;SNX6;ATP6V1C1;ATP6V1E1;ATP6V0D2;ATP6V0E2;TBC1D25;LAMTOR1;RRAGD;ATP6V1B2;RRAGC;LZTS1;ATP6V0A2;RB1CC1
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.2709017368546278,0.4748236002261121,0.9444444444444444,1.0,1.0,9/9,72.92%,HADHB;HADHA;PLA2G6;SLC27A1;PGS1;TAMM41;PLA2G4A;PNPLA8;LCLAT1
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),0.2571682204080298,0.4731665132845876,1.0,1.0,1.0,1/10,7.80%,SMC6
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),0.3012988248727341,0.4727400773108242,0.9743589743589743,1.0,1.0,5/5,69.88%,RAC1;PIP5K1A;AIF1L;INPP5K;ARF6
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.26406847258000876,0.4716165865156098,0.9777777777777777,1.0,1.0,1/7,8.48%,CHRNA7
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.2523891400820405,-0.4711617330993884,0.9836065573770492,1.0,1.0,12/22,34.75%,WRN;RECQL4;RAD50;MRE11;DDX11;RECQL;NBN;DHX36;ZRANB3;HMGB2;MCM9;SUPV3L1
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.25719541547449337,-0.47088085467679586,1.0,1.0,1.0,3/15,37.74%,SCD;PPT1;ACAT1
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.28788956379174735,-0.47028660703450215,0.9848484848484849,1.0,1.0,2/11,25.90%,ZFP36;ZFP36L1
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.3285649158214812,-0.4681701509637238,0.9682539682539683,1.0,1.0,1/5,19.38%,LIG3
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.25926400097706204,-0.46589965346724205,1.0,1.0,1.0,4/18,26.28%,INCA1;NR2F2;MYOCD;TFAP4
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.243534365422853,-0.4654461422112275,0.9857142857142858,1.0,1.0,3/17,28.33%,SREBF1;LPCAT3;APOE
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.28562186944174045,-0.4649731576569502,1.0,1.0,1.0,1/7,26.19%,MYOCD
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.2650398336158267,0.4648435608578244,1.0,1.0,1.0,3/6,25.68%,DKC1;METTL4;MEPCE
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.2895424423642397,0.4647455938586262,1.0,1.0,1.0,2/6,22.77%,DLG1;PKHD1
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.26453406394545276,0.46430359484889366,1.0,1.0,1.0,5/12,25.06%,ASAP3;ALMS1;CDC42;RAC1;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),0.28903796745646576,0.46378964882601753,0.972972972972973,1.0,1.0,6/6,71.10%,SEC14L1;UFD1;NPLOC4;GPATCH3;DHX58;C1QBP
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),-0.29880483288528914,-0.4629112700643089,0.9833333333333333,1.0,1.0,2/7,28.53%,PARP10;TLK1
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),-0.26559392430043727,-0.462536544759177,1.0,1.0,1.0,2/14,22.58%,NRG1;EPAS1
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),-0.24822758806962214,-0.46248016326901864,1.0,1.0,1.0,7/22,31.08%,MAP2;CAMSAP3;PRUNE1;GPX1;APOE;AKAP13;MAPRE3
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.30497706675385183,-0.46158564339309704,1.0,1.0,1.0,3/5,40.02%,ANK3;CLIP3;SERINC1
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),0.19170174223020997,0.46132686724178096,1.0,1.0,1.0,37/88,29.66%,SRP9;RPS15A;RPS3A;RPL18A;SRPRA;RPS23;SSR2;RPSA;RPL23A;RPS3;RPL3;RPL13;SEC61A1;RPL11;RPL8;RPS8;RPL32;RPL21;RPS16;RPS2;RPS18;RPL7;RPS6;RPL29;RPL5;RPL15;RPL41;RPS5;RPS13;RPL14;RPL10;RPLP1;RPS28;TRAM1;RPL10A;SIL1;RPS7
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),0.26612805974563813,0.46121489346098893,0.9761904761904762,1.0,1.0,2/6,20.84%,NFKB1;EGF
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),0.2803178076977972,0.46111373761979985,0.9555555555555556,1.0,1.0,5/5,71.97%,BECN1;SQSTM1;AMBRA1;GPS2;ATG14
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.26682471226353366,0.46093483506700145,0.9772727272727273,1.0,1.0,3/10,23.41%,PIH1D1;ACD;NIPBL
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),-0.3157313632677494,-0.46069104256755267,1.0,1.0,1.0,1/5,18.18%,NRXN1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),-0.3157313632677494,-0.46069104256755267,1.0,1.0,1.0,1/5,18.18%,NRXN1
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.2737853274238454,-0.45993718346967744,0.9836065573770492,1.0,1.0,1/12,14.21%,EDNRB
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.28907922912205564,0.4582045700818622,1.0,1.0,1.0,9/9,71.10%,ITCH;PCBP2;MUL1;TARBP2;TRAF3IP1;ILRUN;RNF26;TSPAN6;C1QBP
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.22528628812826462,-0.4577251172487155,1.0,1.0,1.0,6/28,37.80%,NAPG;RAB6B;RAB6C;COG8;COPG2;RAB33B
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.2715336438011011,-0.45756030264149133,0.9833333333333333,1.0,1.0,2/12,19.65%,VEGFA;RHOJ
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),0.2440993860144965,0.4564453273875143,1.0,1.0,1.0,1/12,9.02%,SLC25A33
prerank,GO_Biological_Process_2021__regulation of dendritic cell cytokine production (GO:0002730),-0.3067384903278521,-0.45632533181187934,0.9838709677419355,1.0,1.0,1/5,17.13%,SCIMP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.2616409859405855,-0.4552358745973107,0.9830508474576272,1.0,1.0,5/10,37.12%,WNT5A;CD226;TNIP2;LBP;IL33
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.23649956664696334,-0.45495645528437584,1.0,1.0,1.0,10/28,32.16%,BRCA1;CDKN1A;DONSON;DTL;MRE11;CLSPN;BRSK1;NBN;TAOK3;MRNIP
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.222195390926793,0.4546638919165204,1.0,1.0,1.0,1/27,4.11%,MAP10
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.2559909946142453,0.4542438513833325,1.0,1.0,1.0,2/12,13.90%,MLLT3;HNRNPU
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.2143128213259588,0.454153053930875,1.0,1.0,1.0,4/25,17.26%,KAT2A;ATAT1;NAA50;MRGBP
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.27485134844147285,-0.45353924594844724,1.0,1.0,1.0,1/9,15.70%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),0.26425155080570323,0.4527913105375738,0.9761904761904762,1.0,1.0,1/9,8.82%,DMRT1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.26040089966063495,-0.4518446930095071,1.0,1.0,1.0,2/13,22.23%,TYMP;DCK
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.25817077742805844,-0.45027876151820645,0.9857142857142858,1.0,1.0,1/15,17.47%,NOL3
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.2379925966058884,0.4501129894286288,1.0,1.0,1.0,2/26,12.63%,ERI1;TENT4B
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.20612608207175426,0.44929293632519635,1.0,1.0,1.0,13/51,25.26%,BANF1;AHCTF1;NUP37;RAN;NSFL1C;NDC1;SUMO1;SEH1L;PPP2R2A;NUP85;UBXN2B;CC2D1B;CCNB1
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.2676533074062025,0.4482578274961858,1.0,1.0,1.0,5/11,23.87%,QDPR;MTHFD1L;GCH1;CALM1;AKT1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.26997107323476066,0.44723171929074107,0.9722222222222222,1.0,1.0,3/11,20.05%,AP3D1;AP3S2;AP3S1
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.26997107323476066,0.44723171929074107,0.9722222222222222,1.0,1.0,3/11,20.05%,AP3D1;AP3S2;AP3S1
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),0.29421000047576,0.44685124801212606,1.0,1.0,1.0,5/5,70.59%,VAMP8;VAMP7;VAMP3;SNX4;SNX6
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),0.25260544059022855,0.44631846673648784,1.0,1.0,1.0,3/9,25.54%,BAG2;RPL11;RPL5
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.19712869790316956,-0.44552039010222705,1.0,1.0,1.0,7/85,21.27%,RPL31;RPL38;SRP54;RPL37A;RPS29;RPL34;RPS27
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),-0.2753097579291043,-0.4445608718369249,0.9821428571428571,1.0,1.0,1/6,20.37%,LHX6
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.253628360694742,0.4435555243561163,1.0,1.0,1.0,9/9,74.65%,PRKAA2;SIRT1;PARK7;DIP2B;DIP2A;PRKAA1;SETD5;MYOCD;KLF15
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),0.254918691864921,0.4434191706559097,0.972972972972973,1.0,1.0,5/10,25.43%,DKC1;RPUSD2;NAF1;RPUSD1;TSR3
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.2940000951610601,0.4432924535344265,1.0,1.0,1.0,7/7,70.61%,SMO;ENG;PTCH1;NF1;EFEMP2;MYLK;PROX1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),-0.23075039631427652,-0.4423996584695197,1.0,1.0,1.0,4/28,26.58%,DDIT4;TNFAIP8L1;SESN3;TBC1D7
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.24241761289567404,0.4411380419146157,1.0,1.0,1.0,1/19,7.24%,RALA
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.2647878757171089,0.44072610853812744,0.9655172413793104,1.0,1.0,5/11,29.23%,HACD1;HACD3;TECR;ELOVL1;ELOVL6
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.26370221872828936,0.4391904560792906,1.0,1.0,1.0,5/12,29.23%,HACD1;HACD3;TECR;ELOVL1;ELOVL6
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.23961602103023055,0.4365165635231206,1.0,1.0,1.0,5/14,27.73%,CHRNA7;PLS1;APP;LGMN;INSR
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),-0.281543134256748,-0.43475629982509667,1.0,1.0,1.0,2/6,28.80%,NONO;HIF1A
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.2515106818289956,0.43347513405703053,0.972972972972973,1.0,1.0,7/7,74.86%,CAPN10;GSN;RYR2;HIPK1;BMPR2;DAB2IP;COL4A3
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.27388762656345045,-0.43169920606328477,1.0,1.0,1.0,2/7,28.03%,STX17;ATG14
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),-0.27123217371361713,-0.4313642525198145,1.0,1.0,1.0,1/9,15.40%,ABCD2
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.28859864697285,-0.43103470811742167,1.0,1.0,1.0,2/6,25.02%,MTHFD1;PLOD2
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.2566051095458821,0.4308200602681234,1.0,1.0,1.0,3/7,24.11%,IL17D;TICAM1;CLEC7A
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),0.28673193203677366,0.43003542707166076,0.9767441860465116,1.0,1.0,4/5,28.91%,DUSP12;MIDN;BAD;PRKN
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),-0.29593479908625575,-0.4294031549216939,1.0,1.0,1.0,1/5,21.67%,FGF13
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.1962927966299534,-0.42912803760779245,1.0,1.0,1.0,8/51,24.50%,TOMM7;FBXO7;SLC25A31;COX18;BCAP31;TMEM14A;PPIF;DNAJC19
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),0.26957845656104273,0.42854347815792476,1.0,1.0,1.0,6/6,73.05%,EXOSC5;EXOSC2;EXOSC6;PARN;EXOSC4;EXOSC10
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.24970821243282337,-0.42716273882848826,1.0,1.0,1.0,4/11,31.35%,SEC61G;GET3;HSPA5;CHMP4B
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.25811271356083,-0.42696573158681506,1.0,1.0,1.0,3/9,34.96%,PARD6A;CEP72;CEP250
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.22837888783657098,0.42659297657176887,1.0,1.0,1.0,4/14,26.54%,CYRIB;ARFGEF1;ROCK2;GSN
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.2870084318769171,-0.4258554425587801,1.0,1.0,1.0,1/5,18.75%,MCCC1
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.2630466607558717,-0.4253787084983074,0.9841269841269841,1.0,1.0,1/8,19.30%,KIF20B
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),-0.28331002103103176,-0.4216170804494043,1.0,1.0,1.0,2/7,23.91%,GCLM;ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),-0.28331002103103176,-0.4216170804494043,1.0,1.0,1.0,2/7,23.91%,GCLM;ITGB1BP1
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.24352156447271786,0.42113530926278747,1.0,1.0,1.0,5/7,33.42%,KMT2B;KMT2D;KMT2A;KMT2C;SETD4
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),-0.27090828919150634,-0.41833491739473044,1.0,1.0,1.0,1/6,22.67%,PPIF
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.20683384794823453,-0.416200425956918,1.0,1.0,1.0,8/25,34.34%,FCHSD2;FNBP1L;CANX;GAK;CLTC;ITSN2;AP2A2;CLTA
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.24514655500571003,0.4125786320827807,0.9736842105263158,1.0,1.0,8/8,75.49%,PDPR;PDK1;GSTZ1;PDP2;PDP1;PDK4;PDK3;PDK2
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.24514655500571003,0.4125786320827807,0.9736842105263158,1.0,1.0,8/8,75.49%,PDPR;PDK1;GSTZ1;PDP2;PDP1;PDK4;PDK3;PDK2
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.2860745040201722,0.41101554298463483,0.9795918367346939,1.0,1.0,5/5,71.40%,IMMP2L;MIPEP;PMPCA;IMMP1L;PMPCB
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),0.26733697301274884,0.4109942742472038,1.0,1.0,1.0,2/6,19.65%,NDUFV3;NDUFV1
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),-0.2505785269880882,-0.40983207567950813,1.0,1.0,1.0,2/7,31.24%,RBM24;FMR1
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),0.23702025112978028,0.40787636688016954,1.0,1.0,1.0,3/6,27.83%,KMT2B;KMT2D;KMT2A
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.21600378883033292,-0.4073726174424288,1.0,1.0,1.0,4/26,26.24%,ACSL5;ELOVL2;SCD;ACSBG2
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.23418835958692238,-0.405999075516286,1.0,1.0,1.0,11/11,76.60%,NNMT;AKAP8L;CTBP1;SAP30BP;BRMS1;AKAP8;FNTA;DYRK1A;ZBTB7B;ING2;NIPBL
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.2685069226505309,-0.40408592582186914,1.0,1.0,1.0,2/6,31.34%,CX3CL1;FYN
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.18395605717109037,0.4028619619878641,1.0,1.0,1.0,11/48,25.26%,BANF1;AHCTF1;NUP37;RAN;NDC1;SUMO1;SEH1L;PPP2R2A;NUP85;CC2D1B;CCNB1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.18395605717109037,0.4028619619878641,1.0,1.0,1.0,11/48,25.26%,BANF1;AHCTF1;NUP37;RAN;NDC1;SUMO1;SEH1L;PPP2R2A;NUP85;CC2D1B;CCNB1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.21528719350943834,0.3991914882796705,1.0,1.0,1.0,5/16,25.60%,HACD1;ACSL4;ACSF3;TECR;ELOVL1
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),-0.25618044614928676,-0.3982045479294172,0.9838709677419355,1.0,1.0,2/7,28.41%,THOC3;THOC7
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),-0.25618044614928676,-0.3982045479294172,0.9838709677419355,1.0,1.0,2/7,28.41%,THOC3;THOC7
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated immunity (GO:0002705),0.27461665965594195,0.3979962174581138,1.0,1.0,1.0,3/5,24.11%,NOS2;PLCG2;CLEC7A
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.23001142204454605,0.39507931800422486,0.9743589743589743,1.0,1.0,12/12,77.01%,AFF2;HIPK2;SERBP1;ZPR1;ETS1;SRPK2;DYRK3;PML;HABP4;USP50;WRAP53;USPL1
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.2211366221170215,-0.3946887664264304,0.9841269841269841,1.0,1.0,5/17,30.96%,RBKS;GPI;PGM2L1;G6PC3;RPE
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),0.22900047033834192,0.39407534523562043,1.0,1.0,1.0,1/13,8.90%,SELP
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.2164607829542393,-0.388153806544789,1.0,1.0,1.0,2/11,19.93%,DNM1L;PID1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.19956392581197144,-0.3863577333906893,1.0,1.0,1.0,4/20,30.55%,AR;TENM1;POLR3C;DHX36
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.26263742616231844,0.38440744604793575,1.0,1.0,1.0,1/5,13.52%,ARHGAP35
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),-0.25993346739928314,-0.3839586554100363,1.0,1.0,1.0,2/5,29.40%,NR1D1;PROX1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),-0.25213793602942536,-0.38320660142905105,1.0,0.9999159934849715,1.0,1/7,17.13%,SCIMP
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.21451713621735732,0.381998770120704,1.0,1.0,1.0,6/14,30.22%,STAR;NPC2;RELCH;NPC1;LDLR;LDLRAP1
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.23314844887760372,0.37759081786104454,1.0,1.0,1.0,1/6,12.11%,SLC38A3
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.24195890926799096,0.3761386793881105,1.0,1.0,1.0,3/7,25.75%,PECR;PHYH;SLC25A17
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.19757316202712338,0.375932581525449,1.0,1.0,1.0,9/9,80.25%,ADGRB3;APP;SCARF1;FARP2;RND1;ANKS1A;C3;C1QA;CX3CL1
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.1943765960330373,0.37448625202456226,1.0,0.9999828791756371,1.0,14/26,33.13%,GREM1;JMY;DDX5;BOK;PPP1R13B;MDM4;FHIT;MYBBP1A;PAXIP1;USP10;IFI16;TP53BP2;NDRG1;TP53
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.20860906520849343,-0.37035127638098353,1.0,0.9999274461345332,1.0,2/13,24.79%,CAMSAP3;BAG3
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.20558308491515606,0.36466541822680115,1.0,0.9997366381864501,1.0,6/18,24.50%,DKC1;NAF1;CCT8;CCT2;CCT6A;CCT3
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.20084773148580176,-0.3435860132883273,1.0,0.9999359819352661,1.0,2/13,24.45%,BCAP31;EDEM1
